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Summary 
The work in this thesis describes a series of studies utilising diverse data 
sources which were analysed using a number of regression methods (logistic, 
linear, Cox, Poisson), to address the factors associated with normal and 
abnormal pregnancy outcome. A series of maternal characteristics were 
related to adverse pregnancy outcome. Teenage pregnancy was not 
associated with an increased risk of any adverse outcome among first births, 
but was strongly associated with adverse outcome among second births [8]. 
Parity also interacted with body mass index: maternal obesity was associated 
with an increased risk of preterm birth among nulliparous but not multiparous 
women. This was explained by higher rates of elective preterm deliveries 
among obese nullipara [31]. There was a linear relationship between maternal 
age and the duration of labour, and the risk of operative vaginal and caesarean 
delivery [37]. It was hypothesised that age-related deterioration in obstetric 
performance was due to prolonged hormonal stimulation prior to the first birth. 
This hypothesis was supported by the observation that later menarche was 
independently associated with a decreased risk of operative delivery [38]. A 
short inter-pregnancy interval was associated with an increased risk of 
spontaneous preterm birth, but not stillbirth or intra-uterine growth restriction 
[16]. The risk of unexplained stillbirth at term was increased among nulliparous 
women [5] and nulliparous women also had slightly longer pregnancies [7]. A 
U-shaped relationship between birth weight and caesarean risk was observed 
at term. There was an interaction between fetal sex and caesarean risk: small 
boys were at increased risk of emergency caesarean [3]. The same interaction 
was observed for antepartum stillbirth [4]. Previous pregnancy outcome was 
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predictive of the outcome of subsequent pregnancies. Women who were 
delivered by caesarean section in their first pregnancy had an increased risk of 
unexplained stillbirth in their second [17]. This finding was confirmed in a 
separate cohort and associations were also observed between previous 
complicated livebirths and the subsequent risk of unexplained stillbirth [32]. 
Some specific situations were also studied (vaginal birth after caesarean 
section (VBAC) and twins). Among women attempting VBAC, the absolute risk 
of delivery-related perinatal death was comparable to primiparous women but 
was significantly higher than women delivered by elective caesarean section 
[11]. The risk of perinatal death associated with uterine rupture was increased 
in low throughput obstetric units and among women induced with 
prostaglandins [19]. Using simple maternal characteristics, approximately 50% 
of women attempting VBAC could be classified into having a high (>40%) or 
low (<10%) risk of emergency caesarean [24]. This was better discrimination 
than could be achieved using similar characteristics among nulliparous women 
being induced at term [21]. The risk of delivery related perinatal death was 
increased among second twins, although this was only evident among births at 
term [13]. The association was observed among sex discordant twins, but was 
not observed among twins delivered by elective caesarean section [23]. The 
association between birth order and the risk of death due to anoxia was 
confirmed in data from England and Wales [33]. Ultrasonic measurements of 
the fetus were related to eventual birth weight. The range of error associated 
with such estimates was quantified and abdominal circumference on its own 
was as predictive as models using abdominal circumference and femur length 
[1]. Estimating fetal weight using ultrasound was not found to be a better 
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measure of human fetal blood volume than simply using gestational age [10]. A 
series of ultrasonic measurements in the first and second trimester were 
predictive of pregnancy outcome, including smaller than expected crown rump 
length and intra-uterine growth restriction, preterm birth and low birth weight 
[2]; a long cervix in mid gestation and caesarean section [36]; and, high 
resistance patterns of uterine artery Doppler flow velocimetry and stillbirth [30]. 
Biochemical measurements performed in early pregnancy were also predictive 
of later adverse outcome: low maternal levels of pregnancy-associated plasma 
protein A (PAPP-A) were associated with an increased of pre-eclampsia, 
preterm birth and growth restriction [9]; low PAPP-A prior to 13 weeks was 
associated with birth weight at term in healthy pregnancies [12] and with a 
dramatically increased risk of stillbirth due to placental dysfunction [22]. Low 
first trimester levels of placenta growth factor were associated with increased 
risks of pre-eclampsia and growth restriction, whereas there was no 
association between elevated levels of the soluble fms-like receptor and 
adverse outcome [35]. Measurements of biochemical variables in the second 
trimester were also predictive of outcome, with elevated maternal serum alpha-
fetoprotein (AFP) being associated with an increased risk of stillbirth [34] and 
spontaneous preterm birth [29]. Women with the combination of low first 
trimester PAPP-A and high second trimester AFP were at particularly high risk 
of complications, reflecting the synergistic predictive ability of the two 
measures [27]. Given proposed similarities between stillbirth and sudden infant 
death syndrome (SIDS), this outcome was also studied. Elevated second 
trimester levels of AFP were also associated with an increased subsequent risk 
of SIDS [20]. Women with a pregnancy resulting ultimately in SIDS were found 
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to be more likely to have had complications in past and future pregnancies [25]. 
The risk of SIDS declined with advancing gestational age at term following 
spontaneous, but not elective birth [15]. Obstetric characteristics were used to 
generate a predictive model for SIDS [26]. Pregnancy outcome was also 
predictive of other aspects of child health, specifically, respiratory morbidity 
following birth at term was associated with an increased risk of hospital 
admission for asthma [18]. Pregnancy complications were also related to long 
term maternal health. Elective caesarean delivery for breech presentation did 
not appear to have an independent effect on fertility [28]. However, pregnancy 
complications were associated with the mother’s subsequent experience of 
cardiovascular disease. Women experiencing growth restriction, preterm birth 
or pre-eclampsia were at increased risk of subsequent ischaemic heart disease 
(IHD) [6] and the risk of this was also related to the number of miscarriages 
experienced prior to the first birth [14]. The parents of women who had 
experienced pregnancy complications or recurrent miscarriage had an 
increased incidence of IHD [39 & 40, respectively]. 
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1. Introduction 
1.1 Studying adverse pregnancy outcome 
Adverse pregnancy outcome contributes to between 5 and 10% of global 
morbidity and mortality.1 The significance of complicated pregnancy in 
determining global burdens of disease is possibly not proportionately reflected 
in support by funding agencies for research into the factors determining 
complicated pregnancy. Better understanding of these factors can potentially 
lead to better stratification of pregnant women attending for care and therefore 
more efficient use of resources. Moreover, understanding the mechanisms 
behind these adverse outcomes could also help develop novel therapies to 
reduce the burden of morbidity and mortality. The work described in this thesis 
examines adverse pregnancy outcome from multiple different perspectives.  
 
1. 2 Inter-relationships and overall perspective of the body of published 
work 
The thesis is based on published work. Therefore, the thesis consists of a 
series of papers, each of which has an introduction which sets the work in 
context, a methods section which describes the approach, a results section 
which describes the data and a discussion which puts the findings in context. I 
have grouped the papers into 6 major thematic areas. At the start of each 
section, I provide text which shows the inter-relationships between the various 
studies in the section. I have also included a section where the work is put in 
the context of the rest of the literature. Each introduction and discussion clearly 
addresses this for the given paper at the time of its publication. The main 
approach to further discussion of the relationship between these papers and 
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the rest of the literature was to identify papers which subsequently cited each 
of the individual outputs. I did this using a search in the Institute of Scientific 
Information website at the beginning of August 2010. For some of the papers, 
particularly those published recently, the introduction and discussion needs 
very little further development as there has been relatively little change in the 
literature since the publication. However, many of the papers in the thesis have 
been extensively cited. Hence, the extent of the discussion around each paper, 
placing it in the context of the rest of the scientific literature, generally varies in 
relation to the number of times it was subsequently cited. 
 
1.3 Data sources employed 
With the exception of one paper, all work in this thesis is derived from 
secondary analysis of data collected for some other purpose. The exception is 
the second paper in Section 3 where I personally retrieved information from 
case notes to perform the analysis of estimating human fetal blood volume. In 
total, 16 different data sources were employed for secondary analysis and 
these are listed in Table 1. A key feature of the approach of many of the 
studies described in this thesis was to employ record linkage to create novel 
collections of information on the basis of routinely collected data. Of the 16 
data sources used, 12 were employed in some form of record linkage. In total, 
11 different combinations of these data sources (Table 2) were utilised in the 
papers presented in the thesis and the specifics of each linkage are described 
in the methodology section of each paper. All record linkages were approved 
by the Privacy Advisory Committee of the Information and Statistics Division 
(ISD) of NHS Scotland, and all linkages were performed within the ISD.  
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Table 1. Data sources 
Name of Data Source Abbreviation Nature of Data 
Scottish Morbidity 
Record 02 
SMR02* National registry of pregnancy data 
Scottish Stillbirth and 
Infant Death Survey 
SSBIDS* National registry of perinatal death 
Scottish Morbidity 
Record 11 
SMR11* Neonatal database 
Scottish Morbidity 
Record 01 - Infant 
SMR01* Hospital admission of infants 
Scottish Morbidity 
Record 01 - mother 
SMR01* Hospital admission of mothers 
Scottish Morbidity 
Record 01 – 
grandparent 
SMR01* Hospital admission of grandparents 
of child whose record is stored in 
SMR02 
General Registrar’s 
Office Birth Certificate 
Database 
GRO Birth  
Certificate* 
Details from birth certificate, 
includes parents’ names and dates 
of birth, child’s name and date of 
birth 
General Registrar’s 
Office Death Certificate 
– infant 
GRO Death  
Certificate – 
infant* 
Death certificate of infant whose 
record is stored in SMR02 
General Registrar’s 
Office Death Certificate 
– mother 
GRO Death  
Certificate – 
mother* 
Death certificate of woman whose 
pregnancy is recorded in SMR02 
General Registrar’s 
Office Death Certificate 
– grandparent 
GRO Death  
Certificate – 
grandparent* 
Death certificate of the parent of the 
woman whose record is recorded in 
SMR02 
West of Scotland 
Regional Genetics 
Service Glasgow 
No 
abbreviation* 
Database of routine Down’s 
Syndrome biochemical screening 
data 
Combined Ultrasound 
and Screening Study 
CUBS Study* Prospective cohort study of 
unselected women evaluating first 
trimester screening for Down’s 
Syndrome 
Queen Mother’s 
Hospital Ultrasound 
Database 
QMH  
Database 
Prospective cohort study of all 
women attending Queen Mother’s 
Hospital for antenatal care between 
1985 and 1995 
Avon Longitudinal 
Study of Parents and 
Children 
ALSPAC Prospective cohort study of women 
resident in Avon UK between April 
1991 and December 1992 
Confidential Enquiry 
into Maternal and Child 
Health 
CEMACH Registry of perinatal deaths in 
England and Wales 
Fetal Medicine 
Foundation Second 
Trimester Screening 
Group 
FMF Prospective cohort study of women 
attending for antenatal care in 
seven hospitals in London 
 
 *Used in 1 or more record linkages 
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Table 2. Record linkages 
Data Sources 
SMR02 + SSBIDS 
SMR02 + SSBIDS + SMR11 
SMR02 + SSBIDS + SMR11 + SMR01-infant 
SMR02 + SSBIDS + SMR11 + GRO Death Certificate - infant 
SMR02 + SSBIDS + SMR01 + GRO Death Certificate – mother 
SMR02 + SSBIDS + GRO Birth Certificate + GRO Death Certificate – infant 
SMR02 + SSBIDS + GRO Birth Certificate + GRO Death Certificate – infant 
+ West of Scotland Regional Genetics Service Glasgow 
SMR02 + SSBIDS + CUBS Study 
SMR02 + SSBIDS + CUBS Study + West of Scotland Regional Genetics 
Service Glasgow 
SMR02 + SSBIDS + SMR01-mother + GRO Death Certificate – mother 
SMR02 + SSBIDS + GRO Birth Certificate-mother – SMR01-grandparent + 
GRO Death Certificate - grandparent 
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1.4 Key themes in the body of work 
In the text below, I address some over-arching themes which highlight common 
areas in papers across the six sections, focusing on those themes which are 
most novel and those which encompass multiple papers in different sections of 
the thesis. 
 
1.4.1 Gestational age and prediction of outcome 
An important aspect of a number of the papers described in this thesis is the 
relationship between when a measurement was made in pregnancy and the 
risk of subsequent adverse outcome. There is a historical perspective on this, 
namely the previously proposed phenomenon of ‘maternal impression’. For a 
very substantial proportion of human history, it was believed that congenital 
abnormalities of the infant may be related to events that happen to a mother in 
late pregnancy.2 For example, cleft lip has the colloquial expression ‘hare lip’. It 
was thought that cleft lip in the child may be explained by the mother being 
frightened by a hare near the time of birth. The term ‘maternal impression’ 
referred to the belief that a particular environmental stimulus in the mother 
would have a related effect on the fetus. It is now appreciated that the vast 
majority of congenital abnormalities have their origins in the very early stages 
of pregnancy in the period of embryonic development. A theme which runs 
through this thesis is that many other complications of pregnancy, such as 
growth restriction, pre-term birth and pre-eclampsia, also have their origins in 
the very earliest weeks of gestation. A significant proportion of these 
complications are related in some way to the dysfunction of the placenta.3 It is 
plausible, therefore, that in the same way that the early development of the 
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fetus is important in determining the final structure of the baby, that the early 
development of the placenta is important in determining placentally-related 
complications in later pregnancy. The thesis describes both ultrasonic and 
biochemical measurements made in the first 10 weeks post-conception which 
demonstrate striking associations between markers of placentation and the 
subsequent risk of these outcomes, supporting this hypothesis. Some of these 
papers represented the first description of early pregnancy markers of such 
complications and this is an area that has been significantly developed as 
evidenced by the number of citations for this work.  
 
Another important aspect of the thesis that relates to gestational age is multiple 
analyses of whether given risk factors for adverse pregnancy outcome are 
more strongly associated with complications at a particular stage in pregnancy. 
This question is of immediate practical significance. If a woman has a risk 
factor for antepartum stillbirth, this can be seen as a rationale for offering early 
delivery, such as induction of labour at 37 or 38 weeks gestation. This is 
common practice in women who have pre-existing diabetes mellitus or who 
have had a previous stillbirth. By extension, therefore, it may be regarded as 
logical or indicated in women who have other risk factors for stillbirth. However, 
before considering such interventions, it is important to know whether the risk 
of stillbirth associated with a given factor varies in relation to the gestational 
age. The same rationale can be developed for the risk of pre-term birth. There 
may be an association between a given characteristic or measurement and 
overall rates of prematurity. However, it could be that this risk differs in relation 
to whether the pre-term birth was extreme, moderate or mild. Multiple papers in 
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this thesis perform systematic examination of the gestational age dependence 
of risk factors. This was conducted by the application of time to event analytic 
methods and this is discussed in more detail before. This whole area 
represents a situation where making very practical clinical statements is 
intertwined with quite sophisticated questions around the appropriate use of 
statistical methods. These issues underline the importance of a high quality 
methodological approach when analysing observational data.  
 
1.4.2 Application of novel statistical methods to studying clinical epidemiology 
of human pregnancy 
1.4.2.1 Time to event analysis 
The section above introduced the issue of studying gestational age 
dependence of markers. Specifically, what I did in these analyses was to 
perform time to event analysis where gestational age was used as the 
timescale. When studying antepartum stillbirth, the event was taken as 
antepartum stillbirth and censoring was taken as either intrapartum stillbirth or 
live birth. In the case of spontaneous pre-term birth, a spontaneous delivery 
(defined in the details of the papers) was taken as the event and all other births 
were taken as being censored. In these cases, I then analysed the data using a 
Cox proportional hazards model. It is an assumption of a Cox model that the 
hazard ratio associated with a given factor is constant across the range of time 
of follow-up. This assumption can be formally tested using a statistical test 
described by Grambsch and Therneau.4 I used a Cox proportional hazards 
model in the analysis of the risk of both stillbirth and spontaneous pre-term 
birth and in both cases employed the test of the proportional hazards 
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assumption to determine whether there was objective evidence that the 
strength of association of a given factor did or did not vary across the range of 
gestation. These analyses provided objective evidence that certain biochemical 
and ultrasonic markers of risk varied in their predictive ability across the range 
of gestational age. The general pattern that I found was that measurements 
made in the second trimester of pregnancy were particularly strongly 
associated with the risk of adverse outcome at extreme pre-term gestations. 
This was true for alpha-fetoprotein (AFP) and human chorionic gonadotrophin 
(hCG) for both pre-term birth and stillbirth. It was also true of high resistance 
patterns of uterine artery Doppler flow velocimetry and the risk of stillbirth. To 
my knowledge, I was the first person to employ the use of the proportional 
hazards model in assessing stillbirth risk in pregnancy. Others may have used 
time to event analysis to assess the risk of pre-term birth but, to the best of my 
knowledge, I was the first to use the Grambsch and Therneau test of the 
proportional hazards assumption to assess the gestational age dependence of 
risk factors for spontaneous pre-term birth. 
 
1.4.2.2 Using paired statistical methods in twins 
Another slightly surprising innovation in this thesis was the use of paired 
statistical methods to compare the risk of death between the first and second 
twin. When I reviewed the literature on the association between birth order and 
the risk of perinatal death in twins, I was extremely surprised to discover that all 
the major studies that were available had used non-paired statistical tests to 
compare the outcome of first and second twins. That’s not to say that no study 
had ever used paired statistical methods, but such studies were certainly in the 
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minority. However, in relation to previous analyses of birth order and the risk of 
perinatal death, none of the studies which were adequately powered had used 
paired tests to make this comparison. Therefore, when I examined the 
relationship between birth order and the risk of perinatal death, I used 
McNemar’s test, which is the appropriate method for the comparison of a 
dichotomous outcome in paired observations. This is self evidently the 
appropriate approach to comparing outcome within pairs of twins. The slightly 
more innovative approach was to use conditional logistic regression to model 
the effect of birth order and to determine whether the risk of birth order 
interacted with gestational age. To my knowledge, this was the first application 
of conditional logistic regression to study the gestational age dependence 
effects of birth order. As discussed in the specific section, these studies have 
led to a large-scale randomised trial and the insights of these papers may turn 
out to be highly clinical relevant. 
 
1.4.2.3 Adjusted likelihood ratios for predicting risk 
A number of the papers in the thesis described the conversion of complex 
multivariate logistic regression models into tables of adjusted likelihood ratios. 
The method to perform this was developed by Mr Ian White, a Senior Scientist 
at the MRC Biostatistics Unit in Cambridge, following my specific request. The 
background to this request was that clinicians are generally comfortable using 
likelihood ratios when discussing the risk of Down’s syndrome with women. I 
felt that if other predictive models could be converted into likelihood ratios, it 
may facilitate the clinical uptake of the models. The method is described in 
detail in its initial description in the American Journal of Obstetrics and 
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Gynecology (Section 3.4) and then Ian White refined the method further in the 
paper described in PLoS Medicine (Section 3.3). 
 
1.4.2.4 Using the proportional hazards model for assessing family history of 
disease 
Another relatively innovative approach was a further development of time to 
event analysis. This is employed in two papers looking at the risk of 
cardiovascular disease in the parents of women whose pregnancy was 
recorded in the SMR02. The issue in these analyses was that the age of the 
parents of the women was highly variable and their risk of experiencing 
cardiovascular disease would clearly vary in relation to their age. By treating 
the parents as a cohort and analysing the risk of ischaemic heart disease (IHD) 
using a Cox proportional hazards model, I was able to estimate the relative risk 
of IHD in the parents while avoiding confounding through variation in their age. 
As a given pair of parents are non-independent, this required a model that 
allowed for multiple levels of clustering within the cohort of parents and this 
was overseen by Ian White. This is not something that I have seen used 
elsewhere in the obstetric literature although I am not sufficiently familiar with 
the cardiology literature to know whether it may have been previously 
employed. 
 
1.4.2.5 Accounting for non-independence in biological replicates 
Finally, I also applied sophisticated statistical methods to address the question 
of non-independence in studies of uterine smooth muscle (myometrium) 
contractility. Many studies have described measurement of myometrial 
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contractility in vitro where strips of uterine muscle are obtained at the time of 
caesarean section and studied in an organ bath. A problem arises when more 
than one strip of muscle is obtained from the same woman as these cannot be 
treated as being independent in any subsequent statistical analysis. In practice, 
the non-independence of different strips from the same woman is generally 
ignored and statistical methods which do not account for this are employed. 
However, when I addressed the effect of maternal age on the spontaneous 
contractile activity of human myometrium, I was aware that I could not simply 
ignore the violated assumption of independence. Therefore, I applied 
regression methods employing the generalised estimating equations clustered 
on a maternal identifier to account for the non-independence of different strips 
of muscle from the same woman. It is an interesting reflection on the general 
awareness of the importance of using appropriate statistical methods that this 
approach was flagged as a problem by one of the reviewers, rather than as a 
sophisticated solution to an often ignored methodological flaw. However, I was 
able to convince the Journal’s editors, through their statistical reviewer, that the 
method was appropriate.  
 
Collectively, the above underline the importance, when analysing complex 
numerical information, of making every effort to use appropriate methods. In 
the case of twin pregnancy, the failure to use appropriate methods may have 
resulted in clinical conclusions which were incorrect, misleading and potentially 
dangerous to individual women and their babies. The scope for- severe 
consequences in using inappropriate methods to analyse myometrial smooth 
muscle contractility is less immediately apparent. However, given the 
Page 29
substantial investment of charities and research councils in this work, it would 
seem reasonable that, if it generates complex numerical information, the 
information is examined and analysed in a competent and appropriate manner. 
In conclusion, I feel I that any substantial body of work that makes a significant 
contribution in the analysis of complex data will generally involve generation of 
new statistical methods and/or novel application of existing sophisticated 
statistical methods. I think this is true for the work described in this thesis. 
 
1.4.3 Using epidemiological research methods to study human reproductive 
biology 
Some of the studies could be viewed as describing aspects of human biology 
using clinical information. Moreover, the biological questions addressed are 
clinically relevant as they are associated with variation in important clinical 
outcomes. An example is the analysis of the relationship between age and the 
risk of emergency caesarean section. This study combined a population 
analysis of women with a first singleton pregnancy presenting cephalically at 
term and demonstrated a linear association between the age of the mother and 
the risk of emergency caesarean section and assisted vaginal delivery. The 
nature of this association was such that the rise in risk started from age 16 
upwards and the proportional increase in risk of caesarean section associated 
with a given increase in age was the same across the whole of the range of 
maternal age. This observation led to basic laboratory studies of the 
contractility of smooth muscle from the uterus, which are also described in the 
same paper. These experiments demonstrated that the uterine muscle from 
older women demonstrated reduced spontaneous contractions and greater 
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numbers of coupled (multi-phasic) contractions. These observations led to a 
specific hypothesis that the age-related deterioration of the uterus was due to 
prolonged pre-pregnancy hormonal stimulation by sex steroids. The steroid 
exposure could either be endogenous, from the ovarian cycle among women 
who either abstained from intercourse or used barrier methods. Alternatively, it 
could be due to the effects of exogenous synthetic sex steroids given in the 
form of the combined pill. This biological explanation for the clinical observation 
made a specific prediction, namely, that earlier age at menarche would be 
associated with increased rates of operative delivery. This prediction was 
tested using data from the ALSPAC cohort and that analysis confirmed the 
prediction, supporting the biological hypothesis.  
 
Another essentially descriptive biological finding was the estimation of the 
normal duration of human pregnancy. This was performed using data from 
women with a very accurate menstrual history and where the gestational age of 
the baby was confirmed by measurement of the crown-rump length in the first 
trimester of pregnancy. This cohort was analysed using a statistical method 
developed for longitudinal epidemiological research studies, namely, time to 
event analysis. The paper developed the arguments why time to event analysis 
is well suited to assessing the normal duration of human pregnancy. This study 
demonstrated an average duration of first human pregnancy of 283 days and of 
subsequent pregnancies of 281 days. Hence, clinical observations and clinical 
research methods could be applied to clinical data to make a basic biological 
description of human reproductive characteristics.  
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Finally, two papers again used complex statistical methods to test the 
biological hypothesis that male babies may be more vulnerable to hostile 
intrauterine environments than female babies. The first paper addressed 
antepartum stillbirth of normally formed babies in relation to their sex and 
gestational age-specific birth weight percentiles comparing the risks for male 
and female babies. This demonstrated that growth restricted males were at 
increased risk of stillbirth whereas males of normal weight or males which were 
large for gestational age were not at increased risk of stillbirth compared with 
similarly sized females. Interestingly, a similar interaction was noted in relation 
to emergency caesarean section at term. The relative risk of emergency 
caesarean delivery was compared for male and female babies across a range 
of birth weights. Again, an interaction was found such that male fetal sex was 
associated with an increased risk where the baby was small, but not if the baby 
was of average, or above average, size. Both observations are discussed in 
the context of basic laboratory studies of the control of the stress responses in 
relation to the sex of an infant.  
 
1.5 Use of routinely collected data 
An interesting feature of the papers included in this thesis is that most of the 
data were collected for some other purpose. The opportunity for conducting 
research was based partly on understanding the value of individual data 
sources which had not been completely exploited. It was also based on 
understanding the opportunities for record linkage to take individual datasets 
with less interest and, by combining them with other sources, create extremely 
powerful datasets to interrogate a specific question. Perhaps the best example 
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of this in the thesis is the record linkage of the SMR02, the West of Scotland 
Regional Genetics Service Database of Down Syndrome Screening, the Birth 
Certificate Database and the General Registrar’s Office Death Certificate 
Database to identify infant deaths. This allowed us to test a specific hypothesis, 
namely, that raised levels of AFP in early pregnancy would be predictive of an 
increased risk of sudden infant death syndrome (SIDS). This paper was 
published in the New England Journal of Medicine and received worldwide 
press attention.  
 
However, it is equally important that the limitations of these analysis is also 
recognised, in particular the well recognised problems of poor quality of 
routinely collected data. Fortunately, in the case of the SMR02, the dataset is 
subjected to regular quality assurance exercises. It was a deliberate focus in 
much of this work to concentrate on the fields within the SMR02 which have 
high levels of quality. Hence, relatively few of the analyses involved the use of 
the International Classification of Disease (ICD) diagnostic codes included in 
the SMR02 as these are known to be less than wholly reliable. Most of the 
analysis was confined to variables which were >90% and indeed >98% free of 
major or minor errors. Another key aspect of interpreting observational data is 
to be aware of the possibilities for confounding and bias. As outlined in the 
hierarchy of evidence, the studies which are least likely to be affected by bias 
are randomised control trials. The issues with observational data are well 
recognised and discussed in detail elsewhere.5 However, the reality is that 
many important obstetric questions will never be able to be answered by a 
randomised control trial as women will not consent to being randomly allocated 
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to treatments which they feel very strongly about. For example, when a trial of 
mode of delivery was attempted among women with a previous caesarean, 
very few women were prepared to be randomly allocated to either attempting 
vaginal birth or having a repeat elective caesarean section. Therefore, the 
literature on vaginal birth after caesarean section (VBAC) is almost exclusively 
composed of studies of routinely collected data. In each of the papers, I 
attempt to identify and discuss the potential sources of bias and to explore how 
these biases might have led to spurious associations. I have also employed 
multivariate modelling methods to examine whether associations were 
dependent or independent of the other maternal characteristics which had 
been measured. I also systematically examined interactions in many of the 
papers to see if apparent associations were consistent across sub-groups of 
individuals. A feature of this work is that many of the papers are published in 
general journals and I feel that this is an objective testimony to the quality of 
the analytic approach, despite the limitations of secondary analysis of routinely 
collected data. 
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2. Maternal and fetal characteristics and the outcome of pregnancy 
 
The papers included in this section relate a number of outcomes of pregnancy 
to a mother’s characteristics or to fetal characteristics. The significance of each 
of the analyses varies according to the question addressed. In some, it may 
seek to inform the consequences of certain choices. Examples would include 
the analysis of stillbirth risk in the second pregnancy in relation to caesarean in 
the prior pregnancy. These findings may help inform decision making around 
performing caesarean section by providing information about the 
consequences of that decision for future pregnancies. Similarly, inter-
pregnancy interval is potentially within the control of parents and modifiable 
through advice from healthcare providers. Hence, analyses of the outcomes 
following a short inter-pregnancy interval are potentially informative in decision 
making. Another example of a potentially modifiable characteristic associated 
with adverse outcome is maternal obesity. Demonstrating a striking association 
between obesity and both the risk of neonatal death and an extremely low birth 
weight long-term survivor provides a rationale and motivation for counselling 
women about pre-pregnancy weight reduction, where appropriate.  
 
Some of the other publications in this section relate to the classification of 
women as being at high or low risk of particular events in relation to a number 
of characteristics. These include analyses of the risk of stillbirth in relation to 
complications in the previous pregnancy and in relation to gestational age at 
term. The information in both analyses can be used to inform the use of 
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investigations to assess fetal wellbeing, as well as potentially informing 
decisions around elective delivery in women who have a relevant history. 
 
2.1 BMJ 2001;323:476-479 
Teenage pregnancy and the risk of adverse perinatal outcomes 
associated with first and second births: population based retrospective 
cohort study.  
Cited 47 times 
Two citations made direct attempts at comparable analyses. A UK based study 
compared just under 2000 pregnant teenagers with 10,000 women aged 20 to 
39 and demonstrated no increased risk of pre-term birth or stillbirth but 
confirmed reduced rates of operative delivery.6 These results were consistent 
with my analysis. A study using US birth certificate data7, however, found 
increased rates of complications amongst teenagers having a first birth in the 
United States. It may be that there is a true difference between outcomes in the 
UK and the US. For example, there is free access to maternity care in the UK 
and it is plausible that the different structure of healthcare provision in the 
United States results in disadvantages to teenagers. It is also possible that 
ethnic or social differences may explain the different observations between the 
UK and US studies. However, an important caveat to these points is that the 
data source employed in the US study was the US birth certificate database, 
which is known to have profound weaknesses.8 The data verification, quality 
and completeness is less well developed than the Scottish Morbidity Record 
employed in the BMJ paper 2001. As discussed in the paper, there are a 
number of studies that suggest there is no true increased risk of perinatal 
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complications in teenagers. Taking the prior work, this paper, and subsequent 
work, it seems reasonable to say that first teenage pregnancy in the UK is not 
strongly associated with adverse outcome. However, as the paper makes 
clear, a second teenage pregnancy is strongly associated with preterm 
delivery. 
 
2.2 Am J Public Health 2007;97:157-162 
Maternal obesity in early pregnancy and risk of spontaneous and elective 
preterm deliveries: a retrospective cohort study.  
Cited 43 times 
Maternal obesity is a focus of increasing concern and this is reflected in the 
fact that this paper is cited 43 times over the interval from publication to August 
2010. As described in the paper, the analysis was intended to try and describe 
the relationship between obesity and preterm birth separately into elective and 
spontaneous preterm delivery. Of the subsequent papers, one almost perfectly 
replicated the methodological approach using data from Missouri maternally-
linked files.9 This is a regional dataset within the US which has reasonably high 
quality pregnancy data. The authors of this paper found essentially the same 
observation, namely that obesity was associated with a reduced risk of 
spontaneous preterm birth but an increased risk of elective preterm delivery. 
Furthermore, they extended the findings by also studying twin pregnancies and 
they demonstrated very similar findings in multiple pregnancy. The replication 
of this finding in a separate population strengthens the conclusion that this 
observation is going to be generally applicable for pregnant women in high 
income countries. The observation that obesity is associated with premature 
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birth through elective preterm delivery, often due to pre-eclampsia, indicates 
potential strategies for ameliorating this risk, such as the use of aspirin in very 
obese women.  
 
2.3 PLoS Medicine 2008;5:1123-1132 
The effect of delaying childbirth on primary caesarean section rates.  
Cited 3 times 
This paper is discussed together with the study below. 
 
2.4 BJOG 2009;116:1613-1621 
Age at menarche and the risk of operative first delivery.  
Cited 0 times 
This study was published relatively recently and has not yet been cited. The 
key inter-relationships in the literature are between this study and the study 
above. In the PLoS Medicine paper of 2008, I made a specific prediction that 
age at menarche would be associated with caesarean section and operative 
vaginal delivery. The nature of the relationship is such that earlier menarche 
was predicted to be associated with increased rates of operative delivery. This 
was a specific prediction arising from the hypothesis that prolonged hormonal 
stimulation of the uterus prior to a first pregnancy was harmful to uterine 
function. The analysis with age at menarche was consistent with this 
hypothesis in three important ways. First, the effect on the risk of operative 
delivery was very similar comparing a 5-year decrease in age at menarche and 
a 5-year increase in age at first birth. The hypothesis is that the interval 
between menarche and first birth has a major influence on how the uterus 
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functions during labour, such that longer intervals will result in less effective 
contraction. Therefore it would be anticipated that increasing this interval at 
either end of the range would have the same effect for the given number of 
years. Second, the association between age at menarche and operative 
delivery disappeared on adjusting for the interval between the age at menarche 
and birth. This indicates that the interval between menarche and birth is the 
true underlying association and age at menarche was associated with this 
outcome by its influence on the duration of this interval. Third, the specificity of 
this association was confirmed by demonstrating that the association between 
the age of menarche and other maternal characteristics, such as body mass 
index, were unaffected by adjusting for the menarche to birth interval. I am 
currently supervising studies in mice where the animal’s hormonal environment 
is being manipulated and the effect of this on age-related changes in 
myometrial contractility is being studied.  
 
2.5 BMJ 2003;327:313-318 
 Interpregnancy interval and the risk of preterm birth and neonatal death: 
retrospective cohort study.  
Cited 34 times 
The most relevant subsequent study was a meta-analysis of studies examining 
the relationship between the inter-pregnancy interval and perinatal outcome.10 
The BMJ paper fulfilled the quality criteria for inclusion in this meta-analysis 
and was one of the studies incorporated. The meta-analysis confirmed the 
association with preterm birth which I described in the BMJ paper. There was, 
however, a significant difference between the BMJ conclusion and the meta-
Page 39
analysis. The meta-analysis suggested a shortened inter-pregnancy interval (< 
6 months) was associated with odds ratio of 1.26 (95% confidence interval (CI) 
1.18-1.33) for delivery of a small for gestational age baby. In the BMJ analysis I 
did not observe this association. However, a critical feature in all meta-
analysis, and in particular meta-analysis of observational studies, is the quality 
of the data which is used for the primary research. In the case of the BMJ 
paper, I demonstrated that women who had a shorter inter-pregnancy interval 
were much more likely to have the first pregnancy result in perinatal death or 
delivery of a growth restricted baby. Therefore, when I performed the analysis 
of inter-pregnancy interval, I excluded women who had delivered a baby that 
was stillborn or was delivered pre-term. This exclusion was simply not possible 
in many of the studies included in the meta-analysis as they lacked the same 
level of detailed information on the outcome of the first pregnancy. Given the 
importance of confounding as a source of positive results in observational 
analyses, I feel that the advantage of including all of these studies in the meta-
analysis may be somewhat outweighed by the drawback of many of the 
individual studies lacking the level of detailed information required to isolate 
any true biological effect of a short inter-pregnancy interval. 
 
2.6 Am J Obstet Gynecol 2001;184:489-496 
Life-table analysis of the risk of perinatal death at term and post term in 
singleton pregnancies.  
Cited 42 times 
Many of the citations papers subsequently citing this work attempted to put the 
observed risk in a context and draw conclusions about clinical care. One of the 
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citations is from an American College of Obstetrics and Gynecology Practice 
Bulletin regarding the clinical management of women having a post-dates 
pregnancy11. Similarly, the data in this study are quoted in the National Institute 
of Clinical Excellence (NICE) guideline on antenatal care.12 One of the 
particularly noteworthy features of this paper is that it is the first application of 
time to event analysis for stillbirth risk. The paper used the simplest form of 
time to event analysis, namely, life-table analysis. This is comparable to 
Kaplan-Meier except that the timescale of follow-up is by fixed periods whereas 
Kaplan-Meier allows calculation of the cumulative probability at varying time 
intervals. The idea to use time to event analysis to assess stillbirth risk was my 
own and the rationale was developed in this paper. I subsequently developed 
this further by using both Kaplan-Meier analysis and Cox proportional hazards 
models to assess stillbirth risk. In these analyses, the gestational age (in days 
or weeks) is used as the timescale, the event is taken as stillbirth, and 
censoring is taken as birth of a live-born infant or birth of a baby that was an 
intrapartum stillbirth. I wrote a review article in the American Journal of 
Obstetrics and Gynecology in 2005 summarising the advantages of the time to 
event approach.13 In brief, the advantages are that gestational age is used as 
the time-scale. This means that the denominator for the risk of stillbirth at any 
given stage of the pregnancy is the number of on-going pregnancies at that 
given gestational age. It is now generally accepted that relating stillbirth risk at 
a given week of gestation to the numbers of births at the given week of 
gestation is methodologically flawed and leads to misleading patterns of risk. 
However, simply relating the number of births to the number of on-going 
pregnancies at the start of the week without using time to event methods over-
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estimates the denominator. Within any given time interval, a proportion of 
women will deliver. Therefore, if one uses the total number of women with an 
on-going pregnancy at the start of the 40th week as the denominator and the 
number of stillbirths is the numerator, the denominator will be over-estimated 
as a proportion of the women at this stage in gestation will deliver over the 
course of that week and therefore not be exposed to a full week’s worth of risk. 
Time to event analysis adjusts the denominator for the effect of women being 
censored due to delivery. The application of Kaplan-Meier analysis allows 
stillbirth risk to be demonstrated graphically in relation to the week of gestation. 
The application of the Cox proportional hazards model allows measures of 
relative risk to be adjusted for other maternal characteristics. Moreover, the 
hypothesis that a given characteristic varies in relation to gestational age can 
be formally tested by a statistical method which tests the hypothesis that the 
hazard ratio associated with a given factor systematically varies in relation to 
the time-scale (gestational age).4 Since pioneering this method, there are many 
subsequent applications of time to event analytical methods in the analysis of 
stillbirth risk. 
 
2.7 Human Reproduction 2001;16:1497-1500 
Use of time to event analysis to estimate the normal duration of human 
pregnancy.  
Cited 12 times 
The majority of the citations were reviews around the management of post-
dates pregnancy. A novel part of this paper was again the use of time to event 
analysis. On this occasion, it was used to estimate the duration of pregnancy 
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and the probability of labour on any given day of delivery. A major development 
of this was one of my later papers published in Nature where I used the same 
analytical approach to determine the association between biochemical 
measurements in early pregnancy and the duration of pregnancy (discussed in 
more detail below). 
 
2.8 Am J Epidemiol 2000;151:614-619 
Sex, birth weight, and the risk of stillbirth in Scotland, 1980-1996.  
Cited 19 times 
Many of the subsequent citations were reviews putting the finding in the 
context of other risk factors for stillbirth. However, as discussed in the 
introductory comments to this section, the observation in this paper suggest a 
greater vulnerability of poorly grown male babies. This paper demonstrates this 
quality for stillbirth and a comparable observation was made for caesarean 
section. Interestingly, one of the papers citing this made a very similar 
comparison in relation to cerebral palsy.14 These authors examined almost 
3,500 cases of cerebral palsy and found that male sex was a risk factor but it 
was much more strongly associated with cerebral palsy when the birth weight 
was less than the third percentile. Hence, this follow-up study was also 
consistent with the underlying hypothesis behind this analysis namely, that 
male babies are more vulnerable to intra-uterine stress than female babies. 
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2.9 BJOG 2000;107:740-744 
A population study of birthweight and the risk of caesarean section: 
Scotland 1980-1996.  
Cited 4 times 
As discussed above the most significant context is the differential probability 
between male and female babies to a hostile intra-uterine environment. The 
paper has also been cited in relation to understanding rising rates of caesarean 
section. 
 
2.10 Lancet 2003;362:1779-1784  
Caesarean section and the risk of unexplained stillbirth in subsequent 
pregnancy.  
Cited 103 times 
This paper attracted worldwide publicity when it was published, as an 
increased risk of stillbirth in association with caesarean section has major 
implications for public health given relatively high rates of caesarean delivery. 
Many of the articles citing this paper put the finding in the context of decision-
making around having caesarean section or other modes of delivery. A number 
of papers analysed the risk of stillbirth in other populations. Crucially, this 
included an examination of the following three years worth of data from 
Scotland, which is published in the next paper in this section (Am J 
Epidemiology 2007;165:194-202). This analysis was performed after 
publication of the Lancet paper. It demonstrated a virtually identical association 
between previous caesarean section and the risk of stillbirth in Scotland in the 
following three years of data. All the inclusion criteria, definitions and analytic 
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methods were identical to the original Lancet paper. The level of statistical 
significance in the replication study was P<0.001. This, therefore, essentially 
dismissed the possibility that the original finding published in the Lancet was 
observed through the play of chance. It did not, however, exclude the 
possibility that the association may be explained by some hidden bias. That 
question will never be adequately resolved, except by a randomised control 
trial. Realistically, no trial of appropriate size or duration of follow-up would ever 
be practical. 
 
The analysis of caesarean section risk is a situation where applying the 
appropriate analytical methods is essential. A significant proportion of women 
who have a previous caesarean section will have an elective repeat caesarean 
section around 38-39 weeks. Therefore, these women are not at risk of stillbirth 
at 40 weeks gestation and beyond. In contrast, women who have not had a 
previous caesarean section will have a normal distribution of timing of delivery. 
Therefore, this will include women whose pregnancies are on-going at 40, 41, 
and 42 weeks. Therefore, women who have not had a previous caesarean 
section will be exposed to a greater duration of risk of stillbirth due to longer 
duration of pregnancy. It is essential, therefore, that an analytic method is 
applied which takes into account the different duration of pregnancy with 
women with a previous caesarean section and those without. Other key 
features in the analytic approach are that I confined the original analysis to 
second pregnancies. The total number of pregnancies will vary systematically 
according to whether a woman has had a prior experience of caesarean 
section. In order to remove this source of bias, the original Lancet analysis and 
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the follow-up analysis were confined to second pregnancies. If other studies 
failed to confine the analysis to second pregnancies, biases could be 
introduced which could affect the associations observed. Third, in the analysis 
of the Scottish data sets, all stillbirths are classified according to a standardised 
system. Classification is performed by a single medically qualified individual 
who has a complete description of the case and has access to post-mortem 
data. It is possible, therefore, to identify stillbirths due to congenital abnormality 
and pre-existing maternal disease. Failure to exclude these cases could lead to 
biases both to increase and decrease associations with caesarean section. 
The results of subsequent studies which sought to test the finding in other 
populations were inconsistent. Some studies confirmed an association 
between previous caesarean section and stillbirth15-18. A study of a large 
dataset from the United States did not demonstrate an association between 
previous caesarean section and stillbirth. However, this study used the US birth 
certificate database and the weaknesses of this data source are well 
recognised.8 Moreover, these authors did not employ a method which took into 
account the different duration of pregnancy in women with a previous 
caesarean section. As the study did not replicate the methods of the Lancet 
paper, it is very hard to make direct comparisons. Another American study 
using the Missouri maternity linked cohort did demonstrate an association 
between previous caesarean section and stillbirth. However, this was observed 
in black, but not white, women.19 Finally, a study of over 150,000 second births 
in a Canadian perinatal database concluded that there was no association 
between previous caesarean section and stillbirth. However, their adjusted 
hazard ratio for previous caesarean section was 1.36 with 95% Confidence 
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Interval (CI) between 0.98 and 1.89.20 The Lancet analysis reported hazard 
ratios of 1.64 with 95% CI of 1.17 to 2.30. Clearly, these two results are 
consistent with each other. Moreover, given that the lower 95% CI in this 
analysis was very close to 1.0, the authors clearly cannot confidently exclude 
an association between previous caesarean section and stillbirth. In 
correspondence following their paper, the authors suggested that the relatively 
modest overall association between previous caesarean section and stillbirth, 
namely a 60-70% increase in risk, suggests that it was unlikely to be causal in 
nature. However, this betrays a misunderstanding of the entity of stillbirth. 
Stillbirth is simply death of a baby prior to birth. This can be the end process of 
many diverse pathophysiological pathways. If caesarean section has a causal 
role in stillbirth, such as through increasing rates of severe growth restriction, 
one would not expect there to be a global increase in all different types of 
stillbirth. The Lancet paper demonstrated a particular association between 
structurally normal babies which were growth restricted. These losses only 
constitute a minority of all stillbirths. Even if caesarean section is strongly 
associated with this outcome, the overall association with stillbirth will 
necessarily be relatively weak. I am aware of an Australian group who have 
performed a meta-analysis of risk factors for stillbirth and they have confirmed 
that previous caesarean section is statistically associated with this outcome. 
However, one would have to accept that the association does not equal 
causation and although the association appears to be true, further work is still 
required to determine whether this is a true biological effect of caesarean 
delivery.  
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Finally, one of the practical consequences of the increased risks of caesarean 
section is that women who have had a previous caesarean section and who 
are considering vaginal birth are going to be exposed to the risk of antepartum 
stillbirth in the interval from 39 weeks until they deliver. That is to say, if a 
woman chooses to have an elective caesarean section at 39 weeks she is not 
exposed to the risks of antepartum stillbirth at 40, 41 and 42 weeks. However, 
if a woman with a previous caesarean section chooses VBAC, she would 
normally be allowed to go up to 10 days after her due date before induction of 
labour would be recommended.21 One of the points raised in the Lancet paper 
was that the greatest risk of perinatal death among women with a previous 
caesarean section is not the risk of the baby dying due to uterine rupture but 
the risk of an antepartum stillbirth while awaiting the onset of labour. The 
absolute risk estimated in the Lancet paper was approximately one antepartum 
stillbirth per thousand births. A large scale prospective study in the United 
States, sponsored by the National Institutes of Health, demonstrated a virtually 
identical absolute risk of stillbirth from 39 weeks gestation onwards. Moreover, 
in that analysis of women with previous caesarean section, the greatest risk of 
perinatal mortality in those attempting vaginal birth was an increased risk of 
antepartum stillbirth.22 Hence, this study confirmed both my findings and my 
interpretation. 
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2.11 Am J Epidemiol 2007;165:194-202 
Previous pre-eclampsia, preterm delivery, and delivery of a small for 
gestational age infant and the risk of unexplained stillbirth in the second 
pregnancy: a retrospective cohort study, Scotland, 1992-2001.  
Cited 8 times 
Most of the citations were related to putting the paper in a clinical context. 
However, one paper published in 200923 reporting a similar analysis of the 
Medical Birth Registry of Norway, drew almost identical conclusions, such that 
pre-term birth, growth restriction and pre-eclampsia were all strongly 
associated with stillbirth in a subsequent pregnancy. The importance of this 
paper in the context of previous caesarean section is also discussed above. 
These finding underline the importance of increased surveillance of women 
who had these complications in previous pregnancies. 
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3. Delivery-related complications in special situations (multiple 
pregnancy and among women attempting vaginal birth after caesarean 
section) 
 
The focus of the papers in this section is to understand the associations 
between obstetric factors and the risk of adverse events in the context of twin 
pregnancy and VBAC. The data informing decisions around VBAC are wholly 
observational in nature21 due to the difficulty of performing any randomised 
controlled trial, particularly trials with statistical power to study perinatal death 
or uterine rupture. These studies all make use of the high quality national 
audits of perinatal death that take place in the UK. In the case of the studies 
linking the Scottish registries of pregnancies and perinatal deaths, this 
combination results in a database with unique strengths internationally. Even 
some of the Scandinavian databases (which are often regarded as a “gold 
standard” of routinely collected data) lack detailed information on the cause of 
stillbirth. Hence, many of these studies represent use of a data resource of 
international importance. 
 
3.1 JAMA 2002;28:2684-2690 
Risk of perinatal death associated with labor after previous caesarean 
delivery in uncomplicated term pregnancies.  
Cited 96 times 
Many of the articles citing this paper were reviews and the estimate of absolute 
risk are quoted both in UK guidelines (NICE and Royal College of Obstetricians 
and Gynaecologists (RCOG)) and in international guidelines. As discussed in 
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the paper, a key difference between this study and previous publications is that 
I confined the estimation of the risk of death to deliveries at term. This meant 
that the absolute risk of perinatal death for both women attempting vaginal birth 
and those having repeat caesarean section were much lower than previously 
reported.24 A number of follow-up studies took the same approach and drew 
very similar conclusions. For example Kwee et al25 quoted an absolute risk of 
perinatal death of 1.2 per thousand VBAC attempts which was virtually 
identical to the figure quoted in the JAMA paper. One aspect of the JAMA 
paper is that the data were from the whole of Scotland. Therefore, this 
summarised information from hospitals of very different types, from low 
throughput units to high throughput tertiary centres. One subsequent follow-up 
study demonstrated an even lower absolute risk of perinatal death associated 
with VBAC in the region of 1/5000 VBAC attempts.22 That study reported data 
from the National Institutes of Child Health and Development (NICHD) 
Maternal Fetal Medicine network units. These are all tertiary referral centres 
with well in excess of 3,000 births per annum and with highly sophisticated out 
of hours and weekend cover on delivery unit. In the following paper, I 
addressed the size of unit and the risk of death during an attempted vaginal 
birth amongst women with a previous caesarean section and confirmed that 
the absolute risk varied inversely with the throughput of the unit. Therefore, I 
see the data presented in the JAMA paper as representing a summary of the 
national experience and that international experience was consistent with this 
when accounting for the type of obstetric facilities. Consistent with this 
interpretation, a systematic review of VBAC26 produced an estimate of the risk 
of death due to uterine rupture associated with VBAC of 1.4/10,000 with CI of 
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0.00 to 9.8. The JAMA analysis demonstrated an absolute risk of perinatal 
death amongst women attempting VBAC with just over 10/10,000 with 
approximately one-third of these due to uterine rupture. Therefore, our results 
were consistent with the meta-analysis. 
 
3.2 BMJ 2004;329:375-379 
Factors predisposing to perinatal death related to uterine rupture during 
attempted vaginal birth after caesarean section: retrospective cohort 
study. 
Cited 28 times  
 As discussed above, one of the key issues was the relationship between the 
risk of perinatal death due to uterine rupture and hospital throughput. A key 
observation here is that the absolute risk of death due to uterine rupture in 
large centres was in the region of 1/5000. As discussed above this figure was 
consistent with that reported in the same year by the NICHD Fetal Medicine 
Unit network. The other key finding reported in this paper was that the risk of 
perinatal death due to uterine rupture was increased among women who had a 
prostaglandin induction of labour. This finding was confirmed by two 
subsequent studies,27;28 both of which demonstrated increased rates of uterine 
rupture amongst women induced with prostaglandin. These, and other studies 
which demonstrated associations between uterine rupture and prostaglandin, 
led the American College of Obstetrics and Gynecology to advocate strongly 
against the use of prostaglandin in women with previous caesarean section. I 
regard that recommendation as understandable but not necessarily appropriate 
for all women. One of the major issues for women to consider who have had 
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one previous caesarean section and are considering mode of delivery in their 
current pregnancy is how many further pregnancies they will be having in the 
future. One of the major long-term complications of caesarean section is the 
increased rate of placental complications in women who have had large 
numbers of previous caesarean sections. The NICHD Maternal Fetal Medicine 
Network study, referred to above, demonstrated rates of hysterectomy between 
5 and 10% amongst women who have had five or more previous caesarean 
sections. Therefore, a decision to perform a repeat caesarean section in a 
second pregnancy could have long-term adverse effects on the woman if she 
was planning a large family. This is an issue that I discussed in detail as the 
senior author in the RCOG guideline on VBAC.21 In the RCOG Guideline, 
despite the increased risk of perinatal death due to uterine rupture associated 
with the use of prostaglandins, I recommended that prostaglandin induction 
should still be considered amongst women who are considering the possibility 
(or have the potential) for many future pregnancies, where the alternative is to 
perform a repeat caesarean section. I felt there was a balance between the 
increased relative risk of uterine rupture in these women in the current 
pregnancy and the risk of severe placental-related complications in subsequent 
pregnancies. The relative risk of uterine rupture with prostaglandins is in the 
region of 3. The absolute risk of uterine rupture is therefore in the region of 1-
2%. Moreover, if the induction of labour is taking place in a large centre, many 
of the infants will have a good outcome even if uterine rupture occurs. 
Therefore, the decision around induction of labour in these women must reflect 
a balance between the short-term risks of uterine rupture and the longer-term 
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risks of placental-related complications in women who were planning to have a 
large family. 
 
3.3 PLoS Medicine 2005;2:871-878  
Predicting caesarean section and uterine rupture among women 
attempting vaginal birth after prior caesarean section. 
Cited 7 times 
 An editorial accompanied this paper and described the method for predicting 
caesarean risk as ‘a great leap forwards’.29 A number of other studies have 
produced predictive models for VBAC and these have variable levels of 
discrimination. In this analysis I made a conscious decision not to include the 
birth weight of the baby in the predictive model, as the birth weight cannot be 
known accurately prior to delivery. We do know, however, that birth weight is 
associated with a higher rate of emergency caesarean section. Some other 
predictive models which followed this publication did include birth weight and, 
unsurprisingly, their models had greater predictive power. However, these 
models lack clinical utility as they are predicated on a measurement which is 
not available prior to birth. The NICHD Maternal Fetal Medicine Network group 
developed a predictive model from their dataset. This had the advantage that 
the study was prospective and therefore they collected more information than 
there was available from the Scottish Morbidity Record. For example, they had 
information on body mass index, which is known to be an important predictor of 
caesarean section.  
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A key point in the discussion of the PLoS Medicine paper was that by 
identifying women at high risk of emergency caesarean section, one might be 
able to select women who would have a lower composite risk of morbidity if 
they chose to have an elective caesarean section. The rationale for this is that 
the highest rates of maternal morbidity are observed among women who 
attempt VBAC but end up with emergency caesarean section. This hypothesis 
was tested directly by the NICHD Maternal Fetal Medicine Network group who 
applied their model in a separate population.30 They demonstrated that the risk 
of maternal morbidity became lower as the predicted chance of successful 
VBAC increased amongst the women who attempted vaginal birth, but not 
amongst those delivered by elective caesarean section. Hence, the results of 
that analysis supported the rationale for trying to predict the success or 
otherwise of VBAC. 
 
3.4 Am J Obstet Gynecol 2004;191:2029-2034 
Combined logistic and Bayesian modelling of caesarean section risk. 
Cited 10 times 
This paper was the first describing our method for converting complex 
multivariate logistic regression models into adjusted likelihood ratios. Most of 
the subsequent citations were papers producing other predictive models of 
emergency caesarean section. One aspect of this analysis was the idea that 
likelihood ratios were conceptually more straightforward than logistic 
regression models. A complexity that arises when we consider caesarean 
section is that this outcome is relatively common. As likelihood ratios deal with 
odds, all calculations using likelihood ratios require that the prior probability 
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and the posterior probability are expressed as odds. The odds equate to the 
probability when the outcome is uncommon, (this is termed the ‘rare disease 
assumption’). However, any outcome which affects >10% of the population is 
regarded as common and there is a significant difference between the odds 
and the probability. This introduces the problem that, in order to apply a 
likelihood ratio-based model, one has to convert the prior probability into odds, 
multiply by the likelihood ratios and then convert the posterior odds back into 
probability. This hurdle may have limited the clinical applicability of using a 
likelihood ration based approach in the context of caesarean delivery. 
 
3.5 BMJ 2002;325:1004-1006 
Birth order, gestational age, and risk of delivery related perinatal death in 
twins: retrospective cohort study. 
Cited 30 times 
One of the key methodological innovations in this paper was to use McNemar’s 
test and conditional logistic regression for the comparison of outcomes 
between first and second twins. Both of these methods are appropriate for 
situations where one is comparing a dichotomous outcome in a matched pair. 
As discussed in the paper, virtually all previous studies had compared the 
outcome of first and second twins using statistical tests that involved the 
assumption that the first and second twins had been selected at random from a 
general population, i.e. that the twins were not paired. It is extraordinary that 
this was the case but this reflects a general lack of understanding of the 
importance of some very basic statistical principles when analysing clinical 
epidemiological data. A follow-up study replicated the methods with the use of 
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McNemar’s test as I had employed in the BMJ analysis.31 These authors then 
observed a very similar finding, namely an increased risk of death of the 
second twin compared with the first. Moreover, this was observed where the 
delivery was a planned vaginal birth but it was not observed when the delivery 
was by planned caesarean section. In the discussion of the BMJ paper, I 
speculated about the potential protective effect of elective caesarean section 
for the second twin although I did not have direct evidence that this was 
beneficial. A second follow-up study compared second twins delivered by 
caesarean section with second twins delivered following vaginal delivery of the 
first twin.32 Moreover, as I had demonstrated that the effect of birth order was  
particularly marked at term, these authors also confined their analysis to babies 
with a birth weight >2.5Kg. This would effectively exclude most pre-term 
deliveries. These authors demonstrated that vaginal birth was associated with 
an odds ratio for perinatal death (excluding losses due to congenital 
abnormality) of 4.64, with 95% CI of 1.9 to 13.9.  
 
The BMJ analysis was published at a time when a colleague in Toronto (Dr Jon 
Barrett) was applying for a grant to perform a randomised controlled trial of 
elective caesarean section for twins. On the basis of personal communication, I 
understand that the publication was pivotal in his securing funding and he 
describes the rationale for the trial and its conduct in a publication.33 I had the 
opportunity to look at the protocol for this trial and there is one potential cause 
for concern in the way that it has been put together. A key aspect of the BMJ 
analysis was that the difference in birth order was apparent for births at term 
but not pre-term. The explanation for this is that the absolute risk of death to 
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the second twin due to delivery complications is relatively low. Amongst pre-
term infants, there are high absolute rates of death due to prematurity and 
clearly this will be the same for the first and the second twin. Therefore, a small 
additional increased risk of death to the second twin is masked by the very high 
rates of perinatal death for both twins related to gestational age. Therefore, I 
found (using conditional logistic regression analysis) an interaction between 
birth order and gestational age, such that birth order was only associated with 
an increased risk of adverse outcome at term. A concern that I have regarding 
the design of the Twin Birth Study is that women are recruited at around 32-
weeks gestation and all deliveries thereafter are going to be analysed on the 
basis of randomisation to caesarean section or planned vaginal birth. The 
primary outcome for the trial is neonatal morbidity or mortality. The rates of pre-
term delivery of twins from 32 weeks onwards will be quite substantial as twins 
are well recognised as having an increased risk of pre-term birth. I suspect, 
therefore, that in both groups there will be substantial numbers of babies born 
in the interval 32 to 36 weeks, i.e. preterm. Hence, both intervention and 
control groups will have high rates of the primary outcome which are due to 
preterm birth and are independent of mode of delivery. My concern is, 
therefore, that a true protective effect of planned caesarean section at term will 
be obscured by high rates of morbidity in both the elective caesarean section 
and planned vaginal birth groups due to high rates of prematurity. I have 
communicated with Dr Barrett on a number of occasions that I think they 
should set out a pre-specified subgroup analysis, namely, to compare the risk 
of morbidity in relation to elective caesarean section or planned vaginal birth 
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confining the analysis to babies born at 37 weeks or beyond. The trial is on-
going and should report in the next few years. 
 
3.6 BJOG 2005;112:1139-1144 
Mode of delivery and the risk of delivery-related perinatal death among 
twins at term: a retrospective cohort study of 8073 births. 
Cited 26 times 
This paper extended the previous publication by increasing the total number of 
births available for analysis. Moreover, the analysis was confined to births at 
term. The key difference to the previous paper is that the dataset included 
almost 1500 deliveries by planned caesarean section and I was able to make a 
direct comparison of the risk of death of either twin in relation to whether the 
delivery was by planned caesarean section or by some other means. This 
demonstrated a 75% lower risk of death amongst twins delivered by planned 
caesarean section. One study attempted to replicate this analysis to some 
degree using the Swedish Medical Birth Registry.34 They compared twin pairs 
delivered by caesarean section for breech presentation and twin pairs who 
were delivered vaginally. They included babies of all gestational age, both pre-
term and term, although they stratified the analysis by gestational age. Their 
outcome was neonatal mortality, but it was not sub-divided by cause of death. 
The rates of neonatal mortality were low for both vaginally born second twins 
and second twins born by caesarean section from 34 weeks and beyond. 
There was no statistically significant difference, although the CI were 
consistent with a 90% reduction in the risk of death of the second twin 
delivered by caesarean section, compared with vaginal birth. Hence, this study 
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was under-powered to analyse the difference in risk of death of the second twin 
in relation to mode of delivery. An important point in the interpretation of that 
study is that the Swedish Medical Birth Registry has very limited information on 
causes of perinatal death. Therefore, stillbirth is merely indicated as a 
dichotomous outcome with no sub-division according to whether the baby died 
before or after the onset of labour. In contrast, the Scottish Morbidity Record is 
linked to a national registry of all perinatal deaths. It is possible, therefore, in 
the Scottish Morbidity Record to identify stillbirths which occurred following 
death of the baby during labour (intrapartum stillbirth). Moreover, I am able to 
identify and exclude deaths which are related to congenital abnormality. The 
Swedish Medical Birth Registry, lacks information on the 30% of neonatal 
deaths that are related to congenital abnormality. The Swedish Medical Birth 
Registry is seen as one of the most valuable international resources for 
population-based research. The comparison of these two analyses 
demonstrates some of the strengths of the Scottish national data. 
 
3.7 BMJ 2007;334:576-578 
Birth order of twins and risk of perinatal death related to delivery in 
England, Northern Ireland, and Wales, 1994-2003: retrospective cohort 
study. 
Cited 11 times 
This paper describes an analysis of the effect of birth order on the risk of 
perinatal death in England and Wales. This was a useful validation of the 
findings I made in the Scottish databases and allowed me to determine 
whether the association between birth order and the risk of death was apparent 
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in the rest of the UK. A major problem with perinatal data collection in England 
and Wales is the lack of a national registry. Whereas there is a national registry 
of all births which is centrally maintained by the Information Services Division 
of NHS Scotland, there is no equivalent Registry of all births in England and 
Wales. However, there is a national enquiry of perinatal deaths within England 
and Wales (called the Confidential Enquiry into Maternal and Child Health 
(CEMACH)) at the time of this analysis. However, the problem which limits 
analysis of these data is the lack of any denominator information. All that is 
available is relatively detailed information on the cause of death (stillbirth and 
neonatal deaths), but CEMACH lacked information on the babies that survived. 
This paper represents one of the analytical studies which has been possible 
using the English and Welsh data. The ability to analyse in this situation relates 
to the unusual situation of making a comparison in twins. As discussed above, 
comparison of a first and second twin should be performed using a paired 
statistical test, i.e. McNemar’s test or conditional logistic regression when 
comparing a dichotomous outcome. The approach of these methods is to 
ignore all pairs which are concordant for the outcome. Therefore, twin pairs are 
ignored where either both twins survive or both twins die. This property means 
that a complete analysis can be performed using a dataset which has 
information only on perinatal death. So long as all deaths are identified, one 
would be able to identify all cases where one twin died but the other twin did 
not. On the basis of this slightly circuitous approach, I was able to perform an 
analytical study using the CEMACH data. Using this approach, I was able to 
confirm the key associations observed using the Scottish data. There was no 
difference between the risk of death in first and second babies born pre-term. 
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There was a significant interaction with gestational age, and there was an 
increased risk of death of the second twin due to anoxia at term. Put together, 
these three papers provide strong evidence regarding a problem with twin 
mortality within the United Kingdom. This makes it particularly important that 
the Twin Birth Study is completed and is appropriately analysed so that correct 
inferences can be made about the potential benefit of elective caesarean 
section to prevent perinatal morbidity and mortality. 
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4. Ultrasonic predictors of pregnancy outcome 
 
The papers in this section all relate to ultrasonic measurements made during 
pregnancy to outcomes for the baby. The main focus of these studies are (1) 
the way in which measurements of the fetus in a 2 dimensional plane may be 
associated with the weight of the baby, or associated factors (such as blood 
volume), (2) the way in which assessment of blood flow using Doppler flow 
velocimetry can be used to predict adverse outcome. The studies span all 
three trimesters of pregnancy and use routinely collected and research data. 
There is a further study which employs measurement of a maternal structure 
(the cervix) in the prediction of mode of delivery. 
 
4.1  BJOG 1997;204:186-190 
The relation between fetal abdominal circumference and birthweight: 
findings in 3512 pregnancies. 
Cited 39 times 
The majority of the subsequent citations were review articles where the paper 
was discussed. One study followed up the suggestion that adding femur length 
to abdominal circumference for the prediction of birth weight was not of great 
value by addressing this question in women with a baby with an abnormal 
umbilical artery Doppler.35 Whereas the conclusion of the BJOG paper was that 
femur length added relatively little to the estimation of weight, these authors 
actually found that adding femur length to the equation reduced the accuracy of  
ultrasound to estimate birth weight. Hence although the populations were 
different, similar conclusions were drawn. An important aspect of this paper 
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was the extent to which ultrasound could rule in or rule out a baby that was 
macrosomic, namely had a birthweight of >4.5Kg (UK definition) or over 4 Kg 
(US definition). The paper was cited by the American College of Obstetrics and 
Gynecology Practice bulletin on shoulder dystocia.36 Another study followed up 
the suggestion that an abdominal circumference > 36cm was sensitive for the 
detection of a macrosomic infant. This study demonstrated that an abdominal 
circumference > 35cm had 93% sensitivity for babies weighing 4Kg or more. 37  
This is consistent with my finding that an abdominal circumference of >36cm 
had 100% sensitivity for macrosomia defined by the UK threshold of 4.5Kg.  
 
Stepping back from the specifics of these analyses, there is a very important 
question regarding how fetal biometry and estimated fetal weights are 
employed clinically. For example, as discussed above, there are associations 
between the baby’s birth weight and the risk of emergency caesarean section. 
However, birth weight is not known prior to delivery and it is difficult to 
incorporate this information. A key finding in the BJOG paper was that a given 
abdominal circumference is associated with quite a wide range in birth weight. 
Therefore, what is currently missing is high quality data that relates the 
ultrasonic measurement of the fetus, in particular the abdominal circumference, 
to the likelihood of important clinical outcomes, such as caesarean section. 
Many studies have addressed this question. However, there is a major issue in 
relation to bias. In the vast majority of such studies, the ultrasound estimation 
of fetal weight is known by the clinician who is managing the labour. It is clear, 
therefore, that the decision-making of an obstetrician looking after a woman in 
labour may be influenced by whether the baby is suspected to be small or large 
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for gestational age. Even if there was a poor relationship between predicted 
and actual birth weight, estimated fetal weight could be associated with 
increased rates of intervention due to the effect of this knowledge on clinical 
decision-making. What is currently lacking from the literature is very high 
quality data on whether ultrasound is independently predictive of mode of 
delivery. To answer this question, information would be required where the 
ultrasound scan had been performed but where the clinician was ‘blinded’ to 
the result. As one of the follow-ups to the work described in this thesis, I am 
currently conducting a large-scale prospective cohort study of women in their 
first pregnancy and one aspect of this is making ultrasonic measurements at 28 
and 36-weeks of gestation but concealing the fetal biometry from the attending 
clinician.38 Clearly, a proportion of women will end up having a clinically 
indicated scan but over half of the cohort have not had any further scans in the 
third trimester. I will, therefore, be able to relate these fetal biometric 
measurements to the risk of important outcomes in labour and delivery, such 
as emergency caesarean section.  
 
4.2 BJOG 2002;109:721-722 
Estimating human fetal blood volume on the basis of gestational age and 
fetal abdominal circumference. 
No citations 
This was a clinical paper which addressed a very specific, rather technical, 
point in relation to an uncommonly performed treatment. The key finding of this 
study was that abdominal circumference and gestational age were similarly 
predictive of the outcome (post-transfusion haematocrit) following intrauterine 
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blood transfusion. Therefore, the paper has a largely practical and clinical utility 
such that if a woman attends for intrauterine transfusion where the gestational 
age is not known, the abdominal circumference can be used in the equation 
described in this analysis and a similar result can be expected to equations 
based on gestational age. 
 
4.3 New Eng J Med 1998;339:1817-1822 
First trimester growth and the risk of low birth weight. 
Cited 113 times 
This paper was the first piece of work on a theme which is elaborated in a 
series of papers in the rest of this thesis, namely, that adverse pregnancy 
outcome is determined (at least in part) in very early pregnancy. The paper 
exploited a virtually unique database where highly detailed menstrual history 
had been collected as part of a prospective cohort study in a single centre. The 
detailed nature of the menstrual history allowed optimising the accuracy of 
estimation of the date of conception amongst women having spontaneous 
conception. Another feature of the hospital, which was unusual at the time, was 
that all women were dated by first trimester crown-rump length. This partly 
reflected the fact that the hospital (The Queen Mother’s Hospital, Glasgow) 
was the centre where ultrasound was pioneered by Professor Ian Donald. 
Moreover, a research technologist who assisted Professor Donald, Mr John 
Fleming, had made one of the first descriptions of crown-rump length to 
estimate  gestational age.39 Hence, the data source presented an extremely 
valuable opportunity to test the hypothesis that growth restriction would be 
evident in very early pregnancy. The key finding, that smaller than expected 
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crown-rump length was associated with an increased risk of being delivered 
small for gestational age, was then replicated in a series of other databases. 
Importantly, many of these studies did not have the same level of information 
on the menstrual history and, therefore, could not provide as accurate 
estimation of the expected size of the baby in the first trimester. The expected 
size is clearly critical in determining whether the baby was small or large in the 
first trimester of pregnancy. Nevertheless, the association was sufficiently 
robust that it was observed in a number of other populations.40-45 Two of these 
follow-up studies warrant particular consideration. First, Bukowski et al (2007)43 
were able to identify 1,000 pregnancies where conception was through an 
assisted reproductive technology method. One of the relative weaknesses of 
the original analysis was that, despite the fact that the menstrual history was as 
close to perfect as possible, the estimate of the expected size of the babies still 
involved certain assumptions. In particular, I assumed that ovulation had taken 
place on day 14 (where day 1 is the first day of the last menstrual period). It 
was possible that differences in the observed versus expected size of the 
embryo or fetus may have been due to differences in the assumed time of 
ovulation. It is conceivable, therefore, that the true association was between 
some maternal determinant of the timing of ovulation and intrauterine growth 
restriction. The major strength of the Bukowski paper is that they were able to 
remove the uncertainty around the time of conception by studying assisted 
reproductive technology pregnancies. This analysis confirmed the findings 
almost perfectly, with a smaller than expected crown-rump length being 
associated both with earlier delivery and an increased risk of delivering a small 
for gestational age infant. The second study, Mook-Kanamori et al (2010) also 
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extended the finding. Like the NEJM paper, these authors relied on the 
menstrual history. However, in addition to the birth weight, these authors also 
had data on the growth of the children following birth. They found that where 
the baby had been small in the first trimester of pregnancy and was 
subsequently delivered small for gestational age, there was post-natal catch-up 
growth, i.e. the fetal growth was reduced resulting in reduced birth weight but 
the baby subsequently established a normal weight in infancy and childhood. 
This strongly supports the interpretation that the association with first trimester 
growth genuinely reflects intrauterine growth restriction. Intrauterine growth 
restriction is essentially a theoretical concept that is defined as a baby that fails 
to reach its genetically determined growth potential. The lower birth weight 
percentile compared with the weight percentile achieved in infancy and 
childhood suggests that these children had a higher genetically determined 
growth than they achieved in utero, presumably because their growth was 
restricted by some process. The contrast with this outcome is the situation 
where a baby simply is constitutionally small. It could have been that a small 
crown-rump length represented a baby that was genetically determined to be 
small. Hence, a baby that was small in utero, was small at birth and remained 
small through infancy and childhood. Therefore, the follow up studies 
confirmed my observation of the early onset of variation in fetal growth and 
secondly, support the interpretation that this is due to pathological restriction of 
growth rather than physiological variation. I also went on to follow-up this study 
by looking at other pregnancy parameters and in particular biochemical tests 
(see below). I am currently the principal investigator of a prospective cohort 
study38 that is in process is taking measurements in the first trimester and I 
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have preliminary data that other ultrasonic parameters which can be measured 
in the first trimester of pregnancy are also associated with the risk of delivering 
a small for gestational age baby. I wrote an editorial to accompany the Mook-
Kanamori paper in JAMA46 which elaborates on the whole area of the early 
determination of late complications of pregnancy. It is likely that this field of 
research will continue to grow over the coming years. 
 
4.4 New Eng J Med 2008;358:1346-1353 
Cervical length at mid-pregnancy and the risk of primary caesarean 
delivery. 
Cited 8 times 
This paper is in some ways thematically related to papers in the preceding 
section relating maternal age and age at menarche to the risk of emergency 
caesarean section. The last 30 years has seen a very dramatic rises in rates of 
caesarean section and much of the focus of attention has been on variation in 
medical practice as a determinant of this. These three papers all report studies 
of primary caesarean section as being something that is, to some extent, 
biologically determined. The most common indication for emergency 
intrapartum caesarean section during a first labour is failure to progress. 
Failure to progress in labour could be regarded as an essentially biological 
complication: a women presents in labour but progressive dilation and 
effacement of the cervix fails to occur, often despite medical intervention. 
Despite the clear physiological basis for this, the concept that caesarean 
section represents a failure of some underlying biological process is not 
particularly widely discussed. A key aspect of this paper is that it had parallels 
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to findings which had been made in a series of animal species, such that 
preparation for labour and delivery, in terms of uterine biology, are occurring as 
a continuing process of modelling and remodelling during gestation. This 
paper, which demonstrated a striking association between the length of the 
cervix in mid-gestation and the ultimate risk of caesarean section in women in 
a first labour at term, suggests similar remodelling of the uterus is occurring 
during human pregnancy. Again, with our prospective cohort study,38 a key 
focus is to try and identify other early pregnancy ultrasonic and biochemical 
predictors of caesarean section risk. 
 
4.5 Obstet Gynecol 2007;109:144-151 
Maternal uterine artery Doppler flow velocimetry and the risk of stillbirth. 
Cited 10 times 
This paper addressed the clinical prediction of stillbirth risk. This is the focus of 
a number of papers in this thesis. An important contribution of these papers 
has been to raise the profile of stillbirth as a condition which is potentially 
predictable on the basis of ultrasonic and biochemical measurements. The 
clinical problem of stillbirth, its biological determinants, the clinical prediction 
and the scope for future research is summarised in a review that I was asked 
to write for Lancet.3 A key aspect of this work that ties in with other studies in 
the thesis is the use of time to event analysis to examine the relationship 
between abnormal uterine artery Doppler and the risk of stillbirth in relation to 
gestational age using the Cox proportional hazards model. I found highly 
significant, non-proportionality of the hazards ratio associated with abnormal 
artery Doppler. This rather technical point led to the clinically very important 
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observation that uterine artery Doppler was a very good predictor of stillbirth 
prior to 33 weeks gestation, but it was a poor predictor of stillbirth at term. This 
is a clinically pertinent point to make as a obstetrician may be falsely reassured 
about a woman’s stillbirth risk at term if she had normal uterine artery Doppler 
test performed at 23 weeks. This test is seen as a good indicator of impaired 
trophoblast invasion (thought to be a key determinant of abnormal 
placentation47). The finding that stillbirth was strikingly associated with the 
measurement made in the middle of pregnancy was consistent with a 
subsequent study48 which demonstrated that impaired fetal growth between the 
first and second trimester was also associated with a very significant risk of 
perinatal death.  
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5. Biochemical predictors of pregnancy outcome 
 
The studies in this section all relate biochemical measurements made in 
pregnancy to the outcome. Measurements are confined to the first and second 
trimesters. The biochemical measurements were generally made for the 
purpose of assessing Down’s syndrome risk, either from a research study or 
from routine screening. The exception is the fourth study where proteins were 
assayed which had been implicated in the pathophysiology of pre-eclampsia. 
All biochemical measurements are normalised for gestational age and, if 
appropriate, for maternal age and smoking and expressed as multiples of the 
median. This reduces the possibility of biases related to the gestational age 
when the woman attended. Many research studies ignore gestational age 
variation. This represents poor practice, as no clinical Down’s syndrome 
screening programme would employ non-gestational age corrected values. 
 
5.1 J Clin Endocrinol Metab 2002;87:1762-1767 
Early pregnancy levels of pregnancy-associated plasma protein A and 
the risk of intra-uterine growth restriction, premature birth, pre-
eclampsia, and stillbirth. 
Cited 114 times 
This work was stimulated by the study described in the previous section about 
early fetal growth and the risk of growth restriction in later pregnancy. The data 
for this study were collected as part of a Down’s syndrome screening study. 
One of the proteins measured as part of Down’s syndrome screening, 
pregnancy-associated plasma protein A (PAPP-A), is a placentally-derived 
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regulator of the insulin-like growth factor system. Studies of mice lacking 
PAPP-A have demonstrated that this is associated with early onset intra-
uterine growth restriction.49 When used in Down’s syndrome screening, PAPP-
A is measured between 10 and 14 weeks gestation. Therefore, this study 
allowed an ideal opportunity to test the hypothesis that conditions in very early 
pregnancy may determine complications in late pregnancy. As this paper 
elaborates, associations were demonstrated with delivery of a small for 
gestational age infant, pre-term birth and stillbirth. The analysis has been 
replicated in many subsequent studies and these findings confirmed. Perhaps 
the key studies are two other large scale prospective Down’s syndrome 
screening cohorts which were conducted in the United States. Dugoff et al 
reported data from over 30,000 women recruited as part of the FASTER 
study.50 Krantz et al reported the results of another Down’s syndrome study 
recruiting over 8,000 women.51 Both studies confirmed the association with 
growth restriction, pre-term delivery and stillbirth. Many centres now 
incorporate PAPP-A as part of their screening programme to identify women at 
increased risk of growth restriction and stillbirth.  
 
5.2 Nature 2002;417:916 
Early-pregnancy origins of low birth weight. 
Cited 47 times 
This paper investigated PAPP-A as a marker of variation in fetal growth in 
uncomplicated pregnancies and in those where the sampling was performed in 
first trimester of pregnancy. As such, its focus was more on using this clinical 
measurement as a way of understanding biological variation in fetal growth. A 
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number of studies have developed this concept. Bukowski et al used maternal 
serum levels of PAPP-A in uncomplicated pregnancies as a way of 
characterising its association with normal variation in fetal growth. They then 
examined customised birth weight percentiles, i.e. adjusting the birth weight 
percentile for maternal serum levels of PAPP-A and a series of other 
physiologic determinants of fetal growth and found that customised percentiles 
better classified women into abnormal and normal outcome of pregnancy.52 
Canini et al confirmed that PAPP-A was associated with physiologic variation in 
fetal growth in a smaller sample.53 Bukowski et al, in the same paper referred 
to above in relation to crown-rump length,43 confirmed that physiological 
variation in fetal growth was also determined to some extent in the first 
trimester of pregnancy. Hence collectively these observations are in support of 
the concept of both normal and abnormal variation in human fetal growth is 
determined, at least in part, in the first trimester of pregnancy. 
 
5.3 JAMA 2004;292:2249-2254 
First-trimester placentation and the risk of antepartum stillbirth. 
Cited 33 times 
While understanding the physiological determinants of variation in growth is of 
interest, perhaps the key practical significance is that poor fetal growth is a 
major determinant of the risk of antepartum stillbirth. The previous paper in 
JCEM had assessed overall risks of stillbirth, as had the large American cohort 
studies. However, stillbirth is simply death of the baby in utero and can be the 
end point of diverse processes. Some of these could be related to the function 
of the placenta and some of these could be unrelated to placental function. 
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Therefore, by relating PAPP-A to all causes of stillbirth, one might 
underestimate the strength of association with the types of stillbirth which are 
specifically related to placental function in early pregnancy. Moreover, as 
discussed above, a particular interest was in the extent to which these 
associations were true in the very early stages of pregnancy. This analysis 
developed previous work by (1) strictly confining analysis to measurements 
made prior to 13 weeks of gestation and, (2) through record linkage to the 
Scottish Stillbirth and Infant Death Survey (SSBIDS), relating concentrations of 
PAPP-A to specific causes of stillbirth. This analysis revealed striking 
associations between levels of PAPP-A and risk of stillbirth attributed to a 
placental cause. This division of stillbirths into placental and non-placental 
causes is used in other sections of the thesis. For example, this distinction was 
also made for the analysis of uterine artery Doppler and risk of stillbirth. As was 
the case with abnormal uterine artery Doppler, the strongest associations were 
for stillbirth due to growth restriction, pre-eclampsia and abruption (the three 
categories of loss which we regarded as placentally related). The term 
‘placentally related stillbirth’ is potentially open to criticism. There is evidence 
that normally formed babies with an unexplained stillbirth where the birth 
weight was normal are also related to function of placenta, discussed in my 
Lancet review of stillbirth published in 2007.3 However, the pathophysiology of 
abnormal placental function in this group is less well understood than it is for 
losses due to growth restriction, pre-eclampsia and abruption. 
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 5.4 Obstet Gynecol 2007;109:1316-1324 
Circulating angiogenic factors in early pregnancy and the risk of pre-
eclampsia, intrauterine growth restriction, spontaneous preterm birth, 
and stillbirth. 
Cited 23 times 
Subsequent to the publications on PAPP-A, maternal circulating levels of 
another system of proteins was described as being predictive of pre-eclampsia. 
In a series of papers by Levine it was demonstrated that women who went on 
to develop pre-eclampsia had elevated levels of soluble fms-like tyrosine-
kinase-1 (sFlt-1) and low levels of placental growth factor (PlGF).54 The model 
that was proposed was that the placenta releases sFlt-1 as a response to 
hypoxia. Soluble Flt-1 then binds and inactivates circulating PlGF and VEGF. 
The reduced levels of PlGF and VEGF then have an anti-endothelial effect 
which leads to the clinical manifestations of pre-eclampsia. However, the work 
of Levine et al focused on measurements of sFlt-1 and PlGF in the later stages 
of pregnancy, from about 16 weeks onwards. I found that low PAPP-A was 
strikingly associated with outcome even when measured in the first 10 weeks, 
suggesting that this may precede the observed changes in sFlt-1 and PlGF. 
Therefore, the stored samples from the Down’s syndrome screening study 
which I had used for the PAPP-A analysis were subsequently analysed for sFlt-
1 and PlGF. This paper reports these results. The key observation was that 
PlGF was low and predictive of pre-eclampsia at a gestational age when the 
sFlt-1 levels were normal amongst women who subsequently went on to 
experience pre-eclampsia. That is, among women who go on to develop pre-
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eclampsia, low PlGF precedes elevation of sFlt-1. This indicates that low PlGF 
is not occurring purely as a consequence of elevated levels of sFlt-1. Another 
key feature of this paper is that low levels of PlGF were also associated with 
other adverse outcomes, in particular delivery of a small for gestational age 
baby. Subsequent work has confirmed these findings. Cowans et al confirmed 
that low PlGF in the first trimester was associated with increased risks of 
delivery a small for gestational age baby55 and a similar observation was made 
by Poon et al.56 The key finding that low PlGF preceded elevated sFlt-1 was 
confirmed by Akolekar et al.57 These observations do not undermine the 
potential importance of the findings regarding sFlt-1 and PlGF. However, they 
do indicate that the model of sequestration of PlGF by elevated sFlt-1 is, 
perhaps, too simplistic. It also suggests that the elevation of sFlt-1 is an event 
which is downstream of other factors. Therefore, it cannot be regarded as the 
initiating event that ultimately leads to pre-eclampsia. Nevertheless, sFlt-1 may 
be an important therapeutic target for the treatment of pre-eclampsia if it is 
causally related to endothelial dysfunction. 
 
5.5 BJOG 2007;114:705-714 
Maternal and biochemical predictors of antepartum stillbirth among 
nulliparous women in relation to gestational age of fetal death. 
Cited 8 times 
Unlike the novel observations made about PAPP-A, this paper added to an 
already extensive existing literature on how maternal levels of AFP and hCG 
were associated with the subsequent risk of perinatal death.   The analysis 
extended previous studies in two major ways.  First, information was obtained 
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on a large number of women through record linkage of routinely collected 
prenatal screening data to the SSBIDS. Secondly, as in other analyses in this 
thesis, I applied time to event analytic methods to determine whether the 
relative risk of particular adverse outcomes was associated with the gestational 
age. This analysis very clearly demonstrated that elevated second trimester 
AFP and hCG were particularly strongly associated with stillbirth at extreme 
preterm gestations. There is a clear parallel between this finding and the 
finding made about uterine artery Doppler and the risk of stillbirth. Namely, 
these were all strikingly associated with the risk of death at extreme preterm 
gestations but not associated with the risk of death at term. Again, this 
statistically innovative approach has yielded clinically important information 
regarding when a woman should be regarded at an increased risk in relation to 
measurements made in early pregnancy. 
 
5.6 Int J Epidemiol 2006;35:1169-1177 
Maternal and biochemical predictors of spontaneous preterm birth 
among nulliparous women: a systematic analysis in relation to the 
degree of prematurity. 
Cited 15 times 
Again, this paper utilised time to event analytic methods. The same parallels 
can be drawn with the analyses on stillbirth. The analytic approach was that 
delivery following onset of spontaneous labour was taken as the event, delivery 
without the onset of spontaneous labour was taken as censoring and 
gestational age was used as the timescale. This was the same analytic 
approach that I employed for the estimation of duration of human pregnancy, 
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described above. However, the approach in this analysis was to try and 
determine whether these biochemical markers were differentially related to 
preterm delivery at extreme preterm gestations. The use of the Cox 
proportional hazards model and the test of the proportional hazards 
assumption allowed formal assessment of whether the variation in relative risk 
was significantly different in relation to extreme, moderate or mild prematurity. 
This paper clearly demonstrated that both AFP and hCG were particularly 
strongly associated with spontaneous preterm birth at extreme preterm 
gestational ages. Hence, this is a further example of the innovative use of time 
to event analysis to understand biological determinants of adverse pregnancy 
outcome and also to draw inferences about the clinical utility of measurements 
in relation to degree of prematurity. One aspect of many of these analyses 
relating maternal characteristics, biochemical measurements or ultrasonic 
measurements is the performance of the given measurements as a screening 
test. Again, this is a theme which has run through many analyses, such as 
predicting caesarean risk, stillbirth and, in this case, spontaneous preterm birth. 
In this paper, I make the point that, although the biochemical measurements 
were strongly associated with extreme preterm delivery, predictive models 
based on these measurements in combination with maternal characteristics 
performed relatively poorly as a screening test. This partly reflected the fact 
that preterm delivery at 24-28 weeks (the clinically most important preterm 
birth) is very uncommon. Therefore, although women in the top 5% of predicted 
risk had a very significantly elevated relative risk, because the prior risk was so 
small, the majority of women in the “high risk” did not experience this outcome. 
The distinctions between relative risk, absolute risk, and the screening 
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properties of a given factor are important when presenting analyses of this type 
of association. 
 
5.7 Obstet Gynecol 2006;107:161-166 
Pregnancy-associated plasma protein A and alpha-fetoprotein and 
prediction of adverse perinatal outcome. 
Cited 28 times 
This analysis combined two of the measurements I had made namely, first 
trimester PAPP-A and second trimester AFP. The findings of this study are 
particularly relevant in the context previously described. Women who have a 
combination of both a low PAPP-A and a high AFP had a very substantial 
absolute risk of having a complicated pregnancy with approximately one third 
of them delivering a baby weighing <2.5Kg. This outcome is a composite of 
both preterm birth and intrauterine growth restriction. This is one of the highest 
absolute risks described for the prediction of adverse outcome in a low risk 
population and this level of positive predictive value places this combination in 
the category of offering clinically useful prediction. Subsequent follow-up 
studies also examined the same question. Proctor et al evaluated a number of 
methods of assessing outcome in women who had a low PAPP-A and found 
that elevated AFP was one of only two measures which offered significant 
additional prediction.58  Fox et al also identified a subset of women who had 
low PAPP-A where the baby was poorly grown in the second trimester.59 
Again, the combination of low PAPP-A and poor growth in the second trimester 
was associated with a high absolute risk of complications. These studies 
suggest that multiple measurements may hold the key to generating clinically 
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useful prediction of risk. Again, this is a theme which I have taken up with our 
on-going prospective cohort study where I am attempting combined ultrasonic 
and biochemical assessment of placentation with the aim of generating 
meaningful separation of high and low risk women with the minority of 
misclassification.38 
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6. Obstetric predictors of long term infant outcome 
 
The papers in this section all report outcomes in the infant which include 
events occurring after the neonatal period. All of these analyses have involved 
record linkage of pregnancy and infant health records. In the first linkage a 
neonatal database was employed as the source of identifiers to link the two 
data sources. In the remainder, after the success of the first approach, the birth 
certificate was employed. Linkage of these data sources represents a highly 
cost-effective approach to studying long term outcome of the infant in relation 
to maternal characteristics or pregnancy complications. 
 
6.1 Pediatrics 2003;111:1367-1371 
Risk of sudden infant death syndrome and week of gestation of term birth 
Cited 3 times  
6.2 New Eng J Med 2004;351:978-986 
Second-trimester maternal serum levels of alpha-fetoprotein and the 
subsequent risk of sudden infant death syndrome. 
Cited 13 times 
6.3 Lancet 2005;366:2107-2111 
Sudden infant death syndrome and complications in other pregnancies. 
Cited 3 times  
6.4 Pediatrics 2006;117:60-66 
Predicting the risk for Sudden Infant Death syndrome from obstetric 
characteristics: a retrospective cohort study of 505,011 live births. 
Cited 5 times 
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 These four papers will be discussed together. Very few studies have attempted 
replication of these analyses, reflecting in part the fact that there are few other 
countries in the world where these analyses could be performed. Hence, the 
discussion will focus on the inter-relationships between the four studies and 
parallels with other work in this thesis. 
 
A major focus of the other work in this thesis is around the factors determining 
the risk of stillbirth. There are a number of important parallels between stillbirth 
and SIDS. 60-70% of stillbirths affect a baby which had no congenital 
abnormality and where there is no specific cause that clearly and wholly 
explains why the baby died. However, as with SIDS, there is an association 
with poor growth in utero. Given the body of work developed on stillbirth, it was 
a logical progression to use the same data sources to study obstetric 
associations with SIDS. The first of these papers (Pediatrics 2003), addressed 
the relationship between gestational age and SIDS. This analysis followed on 
from the paper in Section 1, published in the American Journal of Obstetrics 
and Gynecology in 2001, where I related the risk of stillbirth to gestational age 
at term. That paper demonstrated that with advancing week of gestation at 
term, there was an increased risk of stillbirth. Interestingly, exactly the opposite 
pattern was observed in relation to SIDS. The risk of SIDS was highest 
amongst babies delivered at 37 weeks gestation and steadily declined through 
to 42 weeks gestation. However, this was observed for spontaneous births but 
not babies delivered electively. This pattern suggests that the association 
between gestational age and SIDS was not directly related to the week of 
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gestation of delivery but rather to the factors which led to an earlier onset of 
labour. In the paper, I then developed a hypothesis to explain the 
commonalities and differences between SIDS and stillbirth. I postulated that 
stillbirth and SIDS shared a common characteristic of being related to an 
adverse intra-uterine environment. I hypothesised that when an adverse intra-
uterine environment led to spontaneous labour at an earlier week of gestation, 
the baby was live-born and at increased risk of SIDS. However, if the process 
did not lead to the onset of labour, the baby succumbed in utero, hence the 
association with stillbirth. This interpretation led to a prediction, namely, that 
any indicator of an adverse intra-uterine environment which was associated 
with the risk of stillbirth would also be associated with the risk of SIDS. As 
discussed in the preceding section, many previous studies had observed that 
second trimester levels of AFP were strongly associated with the risk of 
stillbirth. By record linking a population-based screening system for Down’s 
syndrome (where AFP was measured in the middle of pregnancy) to the 
Scottish national registries, I was able to determine whether this prediction held 
true in a large population. An important issue for the analysis is that SIDS is 
rare and very large numbers of children would need to be studied in order to 
draw reliable inferences. The study, published in New England Journal of 
Medicine in 2004, demonstrated that there was a striking association between 
mid-trimester maternal serum levels of AFP and the risk of SIDS. This was in 
part related to the fact that elevated maternal serum AFP was also associated 
with pre-term birth which is in turn a risk factor for SIDS. However, even after 
adjustment for birth weight and gestational age, a significant association 
persisted. Therefore, the hypothesis that SIDS may be the ultimate 
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manifestation of a hostile uterine environment was supported by this study. 
Subsequent analyses have analysed the brain stem of SIDS infants and have 
demonstrated abnormalities in the neurotransmitter, serotonin. Taken together, 
these data suggest that a hostile uterine environment may adversely affect the 
baby’s autonomic nervous system development which could in turn predispose 
to SIDS.  
 
The interrelationship between SIDS and obstetric complications are explored 
further in the Lancet paper of 2005. This analysis addressed an area which 
was highly topical at the time, namely, whether the risk of SIDS was increased 
in other children born to the same mother who had lost a baby due to SIDS. 
The context for interpreting the study is that there had been a number of highly 
publicised cases where women had had multiple babies affected by SIDS. An 
expert opinion had been volunteered that the probability of this was extremely 
small and, hence, the deaths may have been murder. However, this opinion 
rested on an assumption that the probability of SIDS was independent in 
different pregnancies. Given that I had shown that SIDS was related to hostile 
intrauterine environment and given that pregnancy complications tend to recur, 
it was plausible that the woman who had a sudden infant death event may 
have been more likely to have had obstetric complications in their prior or 
following pregnancies. These in turn could predispose the woman’s other 
children to SIDS and could lead to an increased chance of recurrence. Hence, 
in the Lancet paper, I tested the prediction that the woman who had 
experienced a baby die of SIDS would have increased rates of obstetric 
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complications in preceding and subsequent pregnancies, and I found this to be 
the case. 
 
The final paper in this series of contributions regarding SIDS related to our 
ability to predict the risk of SIDS on the basis of obstetric characteristics. There 
are clear parallels between this study and the work I have done creating 
predictive models for stillbirth and caesarean section. Again, I used the method 
whereby complex logistic regression models were converted into adjusted 
likelihood ratios. The issue referred to above in relation to caesarean section 
prediction, namely, that the odds and the probability significantly differ when 
the outcome is common was not a problem in this analysis, as SIDS is rare. 
Therefore, a likelihood ratio model could be developed which would allow 
parents to make a fairly simple estimation of the risk of their baby being 
affected by SIDS without needing to have a sophisticated understanding of 
statistics. An editorial accompanying this paper in Pediatrics described the 
method as “putting power back into the hands of parents”.60 
 
6.5 Arch Dis Child 2004;89:956-960 
Neonatal respiratory morbidity at term and the risk of childhood asthma. 
Cited 13 times 
This paper has parallels with the penultimate paper in Section 1 (Lancet 2003) 
in that it examined potential long-term effects of caesarean delivery. However, 
this paper was focused on the long-term outcome of the infant. A number of 
studies had suggested that there was an association between caesarean 
delivery and asthma. Other studies had indicated that babies who experienced 
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respiratory complications following premature birth were more likely to develop 
asthma in later life. It was already recognised that a planned caesarean section 
increased the chance of short-term respiratory problems in the early neonatal 
period. Therefore, it was plausible that respiratory complications secondary to 
caesarean delivery at term might also be associated with later asthma and that 
was the primary observation of this paper. Subsequent to that study, two meta-
analysis were published which demonstrated striking associations between 
caesarean section and later asthma.61;62 Furthermore, two studies specifically 
followed up our novel observation of the association between transient 
tachypnoea of the newborn and asthma and both confirmed an association.63;64 
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7. Obstetric outcome and the risk of subsequent maternal disease 
 
As with the previous section, these studies utilise record linkage to allow 
pregnancy characteristics to be related to other outcomes. These include 
events that may have occurred in the past, such as IHD in a mother’s parents, 
or events occurring many years after the index birth. Again, record linkage 
represents a highly cost effective way to address associations with remote 
outcomes. A theme arising in a number of the papers in this section is the 
description of associations which are of biological interest, but are not causal. 
For example, a woman who experiences recurrent miscarriages is more likely 
to have IHD in later life, and she is also more likely to have parents who have 
experienced IHD. However, it is not proposed that the miscarriage led directly 
to either her experience of disease or her parents’ experience of disease. 
Rather, associations are interpreted as indicating some common predisposing 
factor. Although the relationship is not causal, it may be clinically important as 
understanding such common underlying determinants may allow identification 
of women who would benefit from assessment for specific risk factors for IHD. 
 
7.1 Fertil Steril 2006;85:90-95 
First caesarean birth and subsequent fertility. 
Cited 7 times 
This paper presents a further analysis which addresses the potential long-term 
adverse effects of caesarean delivery. A number of lines of evidence had 
suggested that there was an association between caesarean delivery and 
subsequent infertility. However, the studies were small scale and the evidence 
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was not of particularly high quality. As this will clearly be a critical issue for 
women who are considering a first delivery by caesarean section, a larger 
scale adequately powered study was required. This study indicated that there 
was no strong evidence that caesarean section affected future fertility.  
 
A series of papers in the thesis have addressed the potential beneficial and 
harmful effects of caesarean section. Some of these papers demonstrated an 
improved outcome with caesarean section. For example, risks of perinatal 
death are lower with planned repeat caesarean section among women with a 
previous section and in women with a twin pregnancy. However, caesarean 
section was associated with an increased risk of stillbirth in the future and with 
an increased risk of asthma in the child. Finally, in this paper, caesarean 
section was neither beneficial or harmful. As an anecdotal aside, I have been 
asked whether I believe caesarean section is a “good” or “bad” thing, as the 
individual was confused by the fact that I had published research which 
suggested both risks and benefits of the procedure. The question betrays a 
view of medical research that individual researchers may be biased to produce 
results which support their prior beliefs. However, in my own work I have 
demonstrated both risks and benefits of caesarean delivery. I feel that this 
represents a realistic situation. Virtually every medical intervention will be 
associated with some advantages and some drawbacks and the decision 
around having a given procedure depends on the balance of all the risks and 
benefits for the individual making the decision. The goal of all of these studies 
around caesarean section has not been either to promote or to inhibit 
caesarean section but merely to provide information to women considering 
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caesarean section so they can make an informed choice. Moreover, by 
providing detailed analyses in relation to the mother’s characteristics, the work 
acknowledges that the balance of risks and benefits will vary according to a 
woman’s individual characteristics. For example, a woman of 20 years old and 
a woman of 40 years old will have a number of differing priorities and concerns 
in relation to the choice. The woman who is 20 may be exercised by thoughts 
of future fertility and the possibility that she may have large numbers of future 
deliveries each of which could be affected by the prior caesarean section. A 
further argument in favour of attempting normal birth is that, being young, she 
would have a very good chance of a normal delivery if she laboured. In 
contrast, an older woman faces an increased risk of emergency caesarean 
section should she attempt normal birth and may have fewer concerns about 
future fertility and the effects of large numbers of future pregnancies. 
Therefore, overall the work on caesarean section in this thesis acknowledges 
the complexity of both medical interventions and balancing the risks and 
benefits of interventions in relation to the characteristics of an individual 
woman. 
 
7.2 Lancet 2001;357:2002-2006 
Pregnancy complications and maternal risk of ischaemic heart disease: a 
retrospective cohort study of 129,920 births. 
Cited 224 times 
As indicated by the number of citations, this paper made an important and 
novel contribution and was followed by a series of studies which replicated the 
finding and attempted to explore the basis for the observations. As explained in 
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the paper, there were prior studies which suggested relationships between 
birth weight and pre-eclampsia and the mother’s subsequent risk of 
cardiovascular disease. However, this paper extended these findings to look at 
both the delivery of a small for gestational age infant and preterm delivery. 
Moreover, I was able to incorporate all of these major outcomes and relate 
them to the mother’s subsequent risk of ischaemic heart disease. The key 
findings of the paper were approximate doubling in the risk of subsequent IHD 
in association with having experienced delivery of a small baby, preterm birth 
or pre-eclampsia. The combination of all three was associated with a seven-
fold risk of IHD. The association was particularly striking when looked at by 
birth weight, with a greater than ten-fold risk of death due to IHD amongst 
women giving birth to low birth weight (<2.5kg) babies.  
 
Subsequent to the paper, multiple studies throughout the world have replicated 
the findings, confirming associations with pre-eclampsia, preterm birth, delivery 
of a small for gestational age infant and low birth weight. A number of meta-
analyses have been performed. McDonald et al performed a meta-analysis of 5 
case control with 10 cohort studies and found a two- to three-fold risk of 
cardiovascular disease among women who had a history of pre-eclampsia in 
both types of study design.65 Smith et al performed a meta-analysis in relation 
to birth weight and found increased risks of cardiovascular disease in both the 
mother and the father. Many studies have also performed more detailed 
investigation for cardiovascular risk factors and found multiple abnormalities in 
women who had pre-eclampsia including hypertension, dyslipidaemia and 
endothelial dysfunction.66-69 The interpretation of these observations is that 
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there are common risk factors for maternal cardiovascular disease and for 
pregnancy complications. My hypothesis is that an individual may have occult 
cardiovascular dysfunction which is manifested in pregnancy complications 
during her reproductive years and, in later life, is manifested as cardiovascular 
disease. Further exploration of these associations is described below. 
 
7.3 BMJ 2003;326:423-424 
Spontaneous loss of early pregnancy and risk of ischaemic heart disease 
in later life: retrospective cohort study. 
Cited 11 times 
In the preceding paper relating pregnancy complications to cardiovascular 
disease, one of our proposed mechanisms was a common dependence on a 
pro-thrombotic tendency (thrombophilia). The basis for this was that 
thrombophilias have been associated both with an increased risk of 
cardiovascular disease and increased risk of pregnancy complications. 
However, thrombophilia is particularly associated with the risk of recurrent 
miscarriage. The use of aspirin and heparin is widely employed to try and 
improve outcomes in women with recurrent miscarriage. If a pro-thrombotic 
tendency was part of the explanation for the link between pregnancy 
complications and cardiovascular disease, one would also anticipate 
associations between recurrent miscarriage and cardiovascular disease.70 
Therefore, the next study was undertaken to test this hypothesis. The number 
of miscarriages experienced prior to the first birth was related to the women’s 
subsequent risk of cardiovascular diseases using the same dataset as the 
Lancet paper of 2001. This study confirmed a positive association between the 
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number of miscarriages prior to the first birth and the risk of cardiovascular 
disease. Associations had previously been shown between miscarriage and 
later cardiovascular disease in a number of papers published in the 1950’s and 
the 1960’s. These studies suggested that low oestrogen levels were the 
potential linking mechanism. The weakness of these studies was that they had 
not taken into account the total number of pregnancies experienced by a 
woman. In the BMJ paper I used the number of miscarriages prior to the first 
birth as obtaining an indication of a woman’s propensity to miscarriage which 
was independent of her total number of pregnancies.  
 
7.4 Am J Epidemiol 2010;171:736-744 
Birth weight and the risk of cardiovascular disease in the maternal 
grandparents. 
No citations 
My interpretation of the Lancet paper of 2001 was that pregnancy 
complications and cardiovascular disease were both manifestations of some 
underlying common determinant. Other authors who subsequently made 
similar observations in other populations interpreted this slightly differently. It 
was suggested that pre-eclampsia, growth restriction etc. during a pregnancy 
may damage the mother’s cardiovascular system and that this long-standing 
damage to the cardiovascular system may provide the link with later 
cardiovascular disease. One context to the observation relating birth weight to 
the maternal risk of cardiovascular disease was the extensive literature on the 
relationship between an individual’s birth weight and their personal risk of 
cardiovascular disease in later life. As it was now apparent that there were 
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associations between the birth weight of a baby and the risk of the mother 
having IHD, it was tempting to speculate that there may be some inheritable 
predisposition involved. If this was the case, it would favour the model that the 
associations were explained by common predisposing factors rather than the 
damaging effect of a complicated pregnancy. This hypothesis made a specific 
prediction, namely, that complicated pregnancies would be associated with a 
family history of IHD. This paper tested the hypothesis using a complicated 
record linkage performed using the Scottish data. The pregnancy records were 
linked to the mother’s own birth certificate and the birth certificate was used to 
link the pregnancy record to the hospital admission and death data for the 
women’s parents (i.e. the grandparents of the baby). By assessing the risk of 
cardiovascular disease in the grandparents, I was able to quantify the 
association between pregnancy complications and family history in first degree 
relatives. The risk of both IHD and cerebro-vascular disease in the 
grandparents declined with increasing birth weight of the baby. This strongly 
supported the model that the relationship between pregnancy complications 
leading to low birth weight and cardiovascular disease was some inheritable 
predisposition as the association was evident both for the individual, for the 
parent and for the grandparents. Perhaps the most tempting interpretation 
would be that there may be some common genetic link. However, I was able to 
adjust these associations for the characteristics of the mother at the time of the 
birth. Specifically, I adjusted for her age, height, smoking status, marital status 
and the area of socio-economic deprivation that she lived in (another striking 
feature of this paper was that the socio-economic area where the woman lived 
at the time of her pregnancy was itself strongly associated with her parents’ 
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risk of heart disease). Adjusting for this series of characteristics attenuated the 
association between pregnancy complications and the grandparents risk of 
cardiovascular disease. Therefore, rather than placing a genetic interpretation 
on these data, I interpreted them as indicating familial aggregation of 
environmental factors. For example, a woman who smokes during her 
pregnancy is more likely to have a small baby. The woman who smokes during 
her pregnancy is more likely to have parents who smoke. Therefore, the same 
risk factor tends to stay within the family, a property known as familial 
aggregation. This paper has been published in 2010 and I understand following 
a discussion at a scientific meeting that a very similar observation has been 
made in one of the Scandinavian databases and that this should be published 
soon. 
 
7.5 BJOG 2010 In press 
Recurrent miscarriage is associated with a family history of ischaemic 
heart disease: a retrospective cohort study. 
This paper has clear parallels with the paper immediately preceding. I had 
demonstrated that women who experience miscarriage were more likely to 
experience IHD in later life and had hypothesised that this may be due to 
common genetic predisposing factors. This made the prediction that recurrent 
miscarriage would be associated with a family history of IHD. I addressed this 
by examining the relationship between the number of miscarriages prior to a 
woman’s first birth and her parents’ risk of IHD. I found that there was an 
association. Interestingly, and in contrast to the previous paper, this was not 
affected by adjusting for available maternal characteristics. This led me to 
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interpret the finding as being supportive of other common determinants of 
miscarriage and IHD. The hypothesis predicts that genetic predisposing factors 
for IHD will also be associated with an increased risk of recurrent miscarriage 
and this hypothesis is readily testable. 
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Teenage pregnancy and risk of adverse perinatal
outcomes associated with first and second births:
population based retrospective cohort study
Gordon C S Smith, Jill P Pell
Abstract
Objective To determine whether first and second
births among teenagers are associated with increased
risk of adverse perinatal outcomes after confounding
variables have been taken into account.
Design Population based retrospective cohort study
using routine discharge data for 1992›8.
Setting Scotland.
Main outcome measures Stillbirth, preterm delivery,
emergency caesarean section, and small for
gestational age baby among non›smoking mothers
aged 15›19 and 20›29.
Results The 110 233 eligible deliveries were stratified
into first and second births. Among first births, the
only significant difference in adverse outcomes by age
group was for emergency caesarean section, which
was less likely among younger mothers (odds ratio
0.5, 95% confidence interval 0.5 to 0.6). Second births
in women aged 15›19 were associated with an
increased risk of moderate (1.6, 1.2 to 2.1) and
extreme prematurity (2.5, 1.5 to 4.3) and stillbirth (2.6,
1.3 to 5.3) but a reduced risk of emergency caesarean
section (0.7, 0.5 to 1.0).
Conclusions First teenage births are not
independently associated with an increased risk of
adverse pregnancy outcome and are at decreased risk
of delivery by emergency caesarean section. However,
second teenage births are associated with an almost
threefold risk of preterm delivery and stillbirth.
Introduction
Teenage pregnancy is an important public health prob›
lem as it often occurs in the context of poor social
support and maternal wellbeing. Some studies have
suggested that first teenage pregnancies have a higher
frequency of adverse perinatal outcomes.1 2 However,
there is argument about whether this is an independent
association1 2 or explained by confounding factors.3–5 In
general, the risk of adverse outcomes is lower in second
pregnancies. However, longitudinal studies comparing
outcomes in first and second pregnancies in teenagers
have produced inconsistent results.6–9 Cross sectional
studies comparing the outcome of second births in
teenagers and older women have observed increased
rates of preterm birth, low birth weight, and perinatal
death10 11 but have failed to adjust for potential
confounding factors such as smoking and socio›
economic deprivation.
Scotland is well placed to study the outcomes of
teenage pregnancy. Teenage pregnancy rates in the
United Kingdom are the highest in western Europe.
Routine obstetric data have been collected on more
than 99% of births in Scotland for over 20 years.12
Scotland has a population that is relatively homogene›
ous in terms of race, and health care is free at the point
of access, including all medical, surgical, drug, and den›
tal treatment during pregnancy. The aims of this study
were to determine whether teenage pregnancy was
associated with increased rates of adverse perinatal
outcome, whether the association differed by parity,
and whether any associations were independent of
confounding factors.
Methods
Data collection and selection criteria
Throughout Scotland discharge data are routinely col›
lected on all patients admitted to NHS maternity hos›
pitals using the Scottish morbidity record 2 (SMR2).12
The SMR2 database has regular quality assurance
studies. An analysis of 1414 records in 1996›7 showed
that the database was free of major errors in more than
98% of records in all the fields used in the present
analysis, with the exception of postcode (94.0%), height
(96.2%), and estimated gestation (94.4%) (Jim Chalm›
ers, Information and Statistics Division, NHS, Scotland,
personal communication).
We used the SMR2 database to identify all singleton
births resulting in a live or stillborn baby during 1992›8.
Inclusion in the main study group was restricted to first
or second births, gestation at birth of between 24 and 43
weeks, birth weight > 500 g, maternal age between 15
and 29 years, and non›smoking mothers. We also
selected a second cohort who fulfilled all the above crite›
ria except that they were classified as smokers at the time
of first attendance for antenatal care.
Definitions and denominators
First births were defined as births to women who had
had no previous pregnancies or whose previous preg›
nancies had all ended in abortion. Second births were
defined as having been preceded by only one
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pregnancy that did not result in abortion. Gestational
age at birth was defined as the number of completed
weeks of gestation based on the estimated delivery date
in the clinical record. A small for gestational age baby
was defined as a live baby who was less than the 5th
percentile of birth weight for the given week of
gestation, using percentiles derived from all Scottish
singleton live births recorded in the SMR2 database
with values for both birth weight and gestational age in
1992›8 (n = 409 541). The denominator was all live
births.
Very preterm delivery was defined as birth of a live
baby at 24 to 32 weeks’ gestation, and the denominator
was all live births at or after 24 weeks’ gestation. Mod›
erately preterm delivery was defined as live births at 33
to 36 weeks’ gestation, and the denominator was all live
births at or after 33 weeks’ gestation. Stillbirth was
defined as delivery of a dead baby at or after 24 weeks’
gestation, and the denominator was all births at or after
24 weeks’ gestation. Neonatal death was defined as
death of a liveborn baby in the first 28 days of life, and
the denominator was all live births. Emergency caesar›
ean section was defined as any unplanned caesarean
delivery, and the denominator was all live births.
Maternal age was defined as the age of the mother
in completed years at the time of birth because many
of the outcomes were delivery related. Maternal height
was measured in centimetres. Postcode of residence
was used to derive Carstairs socioeconomic depriva›
tion scores.13 These are based on 1991 census data on
car ownership, unemployment, overcrowding, and
social class within postcode sectors. The deprivation
scores were then used to categorise women into quin›
tiles based on the study population. Non›smoking was
defined as never having smoked at the time of first
attendance for antenatal care, and smokers were
defined as women who were current smokers at the
time of first attendance for antenatal care.
Statistical analyses
We did separate analyses for six dichotomous
outcomes: delivery of a small for gestational age baby,
moderately and extremely preterm delivery, stillbirth,
neonatal death, and emergency caesarean section. For
each outcome, we compared the risk between different
groups using odds ratios and 95% confidence intervals.
We tested the null hypothesis that the risk of adverse
outcomes associated with maternal age 15 to 19 was
the same for first and second births using the Mantel›
Haenszel test of homogeneity.14
We calculated adjusted odds ratios by logistic
regression analysis.15 Height category, maternal age
category, socioeconomic deprivation quintile, and pre›
vious spontaneous and therapeutic abortion were
entered into the model as dummy variables. We
excluded cases with missing values for height from
multivariate analysis.
We estimated the significance of main effects using
the Wald test and the significance of interaction terms
using the likelihood ratio test. We assessed goodness of
fit of models using the Hosmer and Lemeshow test
based on deciles of probability.15 Continuous variables
were summarised by the mean and standard deviation,
and we compared groups using analysis of variance.
We used the Stata software package (Stata Corpora›
tion, Texas, USA), version 6.0, for all analyses.
Results
There were 411 553 singleton births in Scotland
during 1992 to 1998. Data were missing on gestational
age at birth for 691 (0.2%), on parity for 1012 (0.2%),
on birth weight for 304 (0.1%), on maternal age for 12
( < 0.1%) and on smoking status for 38 334 (9.3%).
Data on all these variables were complete in 371 531
(90.3%) cases, and the main study group comprised the
110 233 non›smoking women aged between 15 and 29
years having a first or second birth between 24 and 43
weeks gestation of a baby weighing over 500 g.
Table 1 shows the demographic characteristics and
the frequency of adverse outcomes in the study group.
Within the study group there were missing values for
mode of delivery in 24 ( < 0.1%) and for maternal
height in 8201 (7.4%). Several women who had live
births experienced multiple adverse outcomes (pre›
term birth, emergency caesarean section, being small
for gestational age, or neonatal death): 1942 had two
adverse outcomes, 159 had three, and four women had
all four outcomes.
We then compared the risk of adverse outcomes
associated with maternal age 15›19 between first and
second births using the Mantel›Haenszel test. This
indicated that the risk of delivering a small for
gestational age baby and of having an emergency cae›
sarean section did not differ significantly by parity.
However, when the risk of adverse obstetric outcomes
associated with maternal age 15›19 was compared for
first and second births, there were significant
differences in the odds ratios of moderately premature
birth (P = 0.01), extremely premature birth (P = 0.004),
and stillbirth (P = 0.03) (table 2). Therefore, the
multivariate analyses were stratified by parity.
Table 1 Study group characteristics and crude outcomes. Values are numbers
(percentages) of women unless stated otherwise
Women aged 15›19 Women aged 20›29
P
value*
First births
(n=9699)
Second births
(n=1225)
First births
(n=59 315)
Second births
(n=39 994)
Demographic characteristics
Mean (SD) height (cm) 161.8 (6.3) 160.9 (5.9) 162.9 (6.5) 162.3 (6.4) <0.001
Socioeconomic deprivation quintile:
1 698 (7.2) 65 (5.3) 11 411 (19.2) 6 856 (17.1)
<0.001
2 1299 (13.4) 150 (12.2) 11 890 (20.0) 8 014 (20.0)
3 1889 (19.5) 265 (21.6) 11 737 (19.8) 8 141 (20.4)
4 2340 (24.1) 309 (25.2) 11 719 (19.8) 8 113 (20.3)
5 3257 (33.6) 411 (33.6) 11 163 (18.8) 7 969 (19.9)
Unclassified 216 (2.2) 25 (2.0) 1 395 (2.4) 901 (2.3)
Previous spontaneous abortions:
0 9206 (94.9) 1099 (89.7) 52 647 (88.8) 32 781 (82.0)
<0.0011 452 (4.7) 119 (9.7) 5 726 (9.7) 5 954 (14.9)
>1 41 (0.4) 7 (0.6) 942 (1.6) 1 259 (3.1)
Previous therapeutic abortions:
0 9192 (94.8) 1158 (94.5) 54 581 (92.0) 36 598 (91.5)
<0.0011 488 (5.0) 66 (5.4) 4 345 (7.3) 3 053 (7.6)
>1 19 (0.2) 1 (0.1) 389 (0.7) 343 (0.9)
Outcomes
Birth weight <5th percentile 410 (4.2) 24 (2.0) 2 281 (3.8) 832 (2.1) <0.001
Delivery 24›32 weeks 121 (1.2) 17 (1.4) 602 (1.0) 220 (0.6) <0.001
Delivery 33›36 weeks 481 (5.0) 56 (4.7) 2 588 (4.4) 1 173 (2.9) <0.001
Stillbirth 46 (0.5) 9 (0.7) 247 (0.4) 121 (0.3) 0.002
Neonatal death 22 (0.2) 3 (0.2) 146 (0.2) 67 (0.2) 0.07
Emergency caesarean section 831 (8.6) 51 (4.2) 8 346 (14.1) 2 240 (5.6) <0.001
*÷2 and analysis of variance tests applied to categorical and continuous data respectively.
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Among first births, women aged 15›19 years were not
at increased risk of any of the six adverse outcomes
studied compared with women aged 20›29 (table 2).
However, among second births, mothers aged 15›19
were at significantly increased risk of moderately and
extremely premature birth and stillbirth (table 2). The
sizes of these associations were minimally attenuated
by adjustment for socioeconomic deprivation quintile,
height, year of delivery, previous abortions, and
previous pregnancy resulting in a perinatal death. On
multivariate analysis, emergency caesarean section was
less likely among younger mothers at both first and
second births. There were no significant interactions
between maternal age at the time of delivery and
socioeconomic deprivation quintile, height, year of
delivery, or previous abortions for any of the outcomes
for either first or second births.
When the risk of adverse outcome was compared
within the age range 15›19, there was no significant
variation in the risk of moderately or extremely
premature birth, stillbirth, neonatal death, or delivery
by emergency caesarean section. However, compared
with 19 year old women, the risk of delivering a baby
weighing less than the fifth percentile for gestational
age was significantly lower among women aged 16 to
18 (figure).
The proportion of women who were current smokers
but fulfilled the other inclusion criteria at the time of
first attendance for antenatal care varied by age and
parity. Among women aged 15›19, 12 862 (47.5%) of
first births and 2148 (54.8%) of second births were to
smokers, whereas among women aged 20›29, 28 875
(27.4%) of first births and 26 120 (34.1%) of second
births were to smokers (P < 0.001).
When outcomes among 70 005 smokers were ana›
lysed, the risks associated with maternal age 15›19
again varied by parity. Among first births to smokers,
there was a weak positive association between being
aged 15›19 and moderately premature birth (table 3).
Among second births to smokers, women aged 15›19
were at increased risk of moderately and extremely
premature delivery and neonatal death. For both first
and second births among smokers, being aged 15›19
was associated with a decreased risk of delivering a
small for gestational age baby and being delivered by
emergency caesarean section (table 3).
Discussion
Compared with older women, women who had a first
birth during their teenage years were not at increased
risk of any of the adverse outcomes studied and,
indeed, were at significantly decreased risk of requiring
emergency caesarean section. A previous study from
the United States found that first teenage birth was
independently associated with an increased risk of
intrauterine growth restriction and of premature deliv›
ery,1 and a Swedish study observed that first teenage
births were at increased risk of perinatal death.2 The
main weakness of both studies was the failure to adjust
for maternal smoking. Smoking is one of the strongest
risk factors for adverse perinatal outcomes,16 and pre›
vious studies have shown that pregnant teenagers are
more likely to smoke than pregnant older women.17 18
Our findings in non›smoking mothers suggest that the
positive associations previously reported among first
births might simply reflect inadequate adjustment for
Table 2 Univariate and multivariate logistic regression analysis of the risk of adverse perinatal outcomes among women aged 15 to
19 years of age compared with women aged 20›29 years (non›smokers)
Outcomes
First births (n=63 565) Second births (n=38 467)
Unadjusted odds ratio
(95% CI)
Adjusted odds ratio†
(95% CI)
Unadjusted odds ratio
(95% CI)
Adjusted odds ratio†
(95% CI)
Birth weight <5th percentile 1.1 (1.0 to 1.2) 1.0 (0.9 to 1.1) 1.0 (0.7 to 1.5) 0.9 (0.6 to 1.4)
Delivery 24›32 weeks 1.2 (0.9 to 1.4) 1.1 (0.9 to 1.4) 2.7 (1.6 to 4.6)** 2.5 (1.5 to 4.3)***
Delivery 33›36 weeks 1.1 (1.0 to 1.2)* 1.1 (1.0 to 1.2) 1.7 (1.2 to 2.2)*** 1.6 (1.2 to 2.1)**
Stillbirth 1.2 (0.8 to 1.7) 1.1 (0.8 to 1.6) 2.7 (1.4 to 5.4)** 2.6 (1.3 to 5.3)**
Neonatal death 0.8 (0.4 to 1.3) 0.8 (0.5 to 1.4) 1.2 (0.3 to 5.0) 1.0 (0.2 to 4.3)
Emergency caesarean section 0.6 (0.5 to 0.6)*** 0.5 (0.5 to 0.6)*** 0.8 (0.6 to 1.0) 0.7 (0.5 to 1.0)*
* P<0.05, **P<0.01, ***P<0.001.
†Adjusted for maternal height category, socioeconomic deprivation quintile, previous spontaneous and therapeutic abortions, and year (risks associated with second
births also adjusted for previous perinatal death).
Maternal age (years)
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0
0.4
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0.8
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1.2
1.4
0.2
Adjusted odds ratios and 95% confidence intervals for delivering a
small for gestational age baby (less than the 5th percentile for
gestational age) associated with maternal age among first teenage
births to non›smokers. Odds ratios were adjusted for maternal height
category, socioeconomic deprivation quintile, previous spontaneous
and therapeutic abortions, and year. The reference category was
women giving birth aged 19
Table 3 Adjusted odds ratios† (95% confidence intervals) for adverse outcomes in first
and second births to women aged 15 to 19 compared with women aged 20›29 (smokers)
Outcomes First births (n=38 087) Second births (n=25 992)
Birth weight <5th percentile 0.8 (0.7 to 0.9)*** 0.8 (0.6 to 1.0)*
Delivery 24›32 weeks 1.1 (0.9 to 1.4) 2.1 (1.5 to 2.9)***
Delivery 33›36 weeks 1.1 (1.0 to 1.3)** 1.5 (1.2 to 1.8)***
Stillbirth 0.9 (0.7 to 1.2) 0.5 (0.2 to 1.2)
Neonatal death 1.4 (0.9 to 2.1) 2.5 (1.3 to 4.8)**
Emergency caesarean section 0.5 (0.5 to 0.6)*** 0.7 (0.6 to 0.9)**
*P<0.05, **P<0.01, ***P<0.001. †Odds ratios adjusted for maternal height category, socioeconomic
deprivation quintile, previous spontaneous and therapeutic abortions, and year (risks associated with second
births also adjusted for previous perinatal death).
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confounding variables. Indeed, when outcomes were
compared within the age range 15›19, women aged
16›18 had a decreased risk of intrauterine growth
retardation, which is consistent with a previous
population based study from the United States.19
By contrast, we found that second births among
women aged between 15 and 19 years were associated
with an almost threefold risk of extremely premature
birth and stillbirth compared with women aged
between 20 and 29 years (table 2). A similar pattern was
observed among women who smoked. However, the
Scottish mortality record database does not include
information on the number of cigarettes smoked a day
or the duration of smoking. Both of these might be
expected to vary systematically with age. Since there is
a dose›effect relation between smoking and adverse
outcomes,20 the findings among smokers should be
interpreted with caution.
Study design and confounding factors
Previous longitudinal studies of first and second births
among teenagers have produced conflicting results.
Some have described consistently worse outcomes
in the second birth,6 others have reported better
outcomes,8 and others have described reduced risk of
intrauterine growth retardation but increased risk of
preterm birth.9 The weakness of longitudinal studies is
that, overall, first births are at a greater risk of
intrauterine growth retardation, preterm birth, and
stillbirth than subsequent births.21 22 The cross sectional
design of our study allows the normal protective effect
of second birth to be taken into account.
The strength of the association between second
teenage birth and adverse outcomes was virtually unal›
tered by adjusting for confounding variables. This
suggests that there may be a causal relation between
second teenage birth and these outcomes. Alterna›
tively, the persistence of the association in the
multivariate analysis might reflect incomplete adjust›
ment for social deprivation. Although not perfect, dep›
rivation scores based on postcode sector have been
shown to be strongly associated with deprivation
related diseases.13 Furthermore, other methods of
adjusting for deprivation used in previous studies have
greater weaknesses. Some studies have used marital
status as a measure of deprivation.1 19 However, the
relation between preterm delivery and marriage varies
with maternal age.10 Some studies used the woman’s
highest eventual educational attainment as an index of
social deprivation.17 23 It is difficult to distinguish
between cause and effect with this indicator because
childbearing in teenage years and complications of
pregnancy may both adversely affect a woman’s chance
of completing higher education.
Conclusions
Our findings suggest a causal relation between second
teenage birth and adverse pregnancy outcome. It is
unlikely that the association can be explained by differ›
ences in the interval between pregnancies among
teenage and older mothers since the associations
observed were much greater than those previously
reported for short intervals between pregnancies.24
Furthermore, teenage mothers were not at increased
risk of a small for gestational age baby, which is known
to be more common after a short interval between
pregnancies.24 A biological cause could be confirmed
or refuted only by access to more detailed socio›
economic information at the individual level. This
would require prospective collection of data.
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 RESEARCH AND PRACTICE 
Objectives. We sought to determine the association between maternal body
mass index and risk of preterm delivery.
Methods. We assessed 187290 women in Scotland and estimated adjusted
odds ratios for spontaneous and elective preterm deliveries among overweight,
obese, and morbidly obese women relative to normal-weight women.
Results. Among nulliparous women, the risk of requiring an elective preterm
delivery increased with increasing BMI, whereas the risk of spontaneous preterm
labor decreased. Morbidly obese nulliparous women were at increased risk of all-
cause preterm deliveries, neonatal death, and delivery of an infant weighing less
than 1000 g who survived to 1 year of age (a proxy for severe long-term disability).
By contrast, obesity and elective preterm delivery were only weakly associated
among multiparous women.
Conclusions. Obese nulliparous women are at increased risk of elective preterm
deliveries. This in turn leads to an increased risk of perinatal mortality and is
likely to lead to increased risks of long-term disability among surviving offspring.
(Am J Public Health. 2007;97:157–162. doi:10.2105/AJPH.2005.074294)
Maternal Obesity in Early Pregnancy and Risk of 
Spontaneous and Elective Preterm Deliveries: 
A Retrospective Cohort Study
| Gordon C.S. Smith, MD, PhD, Imran Shah, MSc, Jill P. Pell, MD, Jennifer A. Crossley, PhD, and Richard Dobbie, BSc
Because ELBW infants have a 40% to 45%
risk of severe neurodevelopmental delays in
childhood,9 we used ELBW as a proxy mea-
sure of severe long-term morbidity.
METHODS
Data Sources and Patient Selection
The Scottish Morbidity Record (SMR2) col-
lects information on clinical and demographic
characteristics and outcomes for all women dis-
charged from Scottish maternity hospitals. The
registry is subjected to regular quality assur-
ance checks, and its data have been more than
99% complete since the late 1970s.10 In addi-
tion, the Scottish Stillbirth and Infant Death
Enquiry (SSBIDE), a national register, routinely
classifies all perinatal deaths in Scotland.11
All women presenting for prenatal care in
the west of Scotland are offered biochemical
screening, using maternal serum α-fetoprotein
and human chorionic gonadotrophin, to assess
their risk of having a fetus affected by Down
syndrome or a structural fetal abnormality.12
Maternal weight is recorded at the time of
sampling for biochemical screening to allow
for weight correction of analytes. This process
corrects levels of these proteins for the effect
of maternal size and improves prediction of
Down syndrome risk. The laboratory informa-
tion management system of the West of Scot-
land Regional Genetics Service (Institute of
Medical Genetics) contains a database includ-
ing this maternal information along with bio-
chemical screening results. The General Regis-
trar’s Office maintains computerized birth and
death registration records.
We used a probability-based matching ap-
proach13 with maternal identifiers to link in-
formation from the SMR2, the SSBIDE, the
Institute of Medical Genetics prenatal screen-
ing database, and the General Registrar’s Of-
fice database of birth certificates. We used
offspring identifiers contained in the birth cer-
tificates used to link biochemical, pregnancy,
and perinatal mortality data to the death cer-
tificate registry, allowing us to identify deaths
among offspring. We excluded multiple births,
stillbirths, and births occurring outside 22 to
43 weeks of gestation.
Births in the cohort assessed here occurred
between November 1991 and December
The association between maternal obesity
and pregnancy outcomes is complex. Mater-
nal obesity is known to be associated with in-
creased rates of complications in late preg-
nancy such as stillbirth, cesarean delivery,
gestational diabetes, and shoulder dystocia.1–3
However, a low body mass index (BMI) is as-
sociated with an increased risk of preterm de-
livery, and some studies have shown that
BMIs above the “normal” range are protective
against spontaneous preterm births.4–6 A
large-scale retrospective cohort study demon-
strated an interaction between BMI and par-
ity: obese nulliparous women were at in-
creased risk of extreme preterm deliveries
and neonatal death, whereas obese multi-
parous women were not at increased risk of
these outcomes.7 The reasons for these com-
plex patterns of association are unclear.
Preterm deliveries can occur as a result of
preterm labor or can be elective procedures.
Preeclampsia is the reason for elective preterm
deliveries in more than 40% of cases.4 It is
well recognized that obese women are at in-
creased risk of preeclampsia8 and that nulli-
parous women are at higher risk of preeclamp-
sia than multiparous women. We hypothesized
that the higher background risk of preeclamp-
sia among nulliparous women might lead to a
stronger association between obesity and elec-
tive preterm deliveries and might therefore ex-
plain the association between obesity and ex-
treme preterm deliveries among these women.
Our aim was to determine the association
between maternal obesity in early pregnancy
and risk of preterm delivery, with attention
given to type of delivery (spontaneous vs
elective), parity (nulliparous vs multiparous),
and the most important negative conse-
quences of prematurity. In assessing conse-
quences of prematurity, we examined both
neonatal death and long-term survival of
extremely low-birthweight (ELBW) infants.
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2001. The cohort was defined as women
who (1) had a record in the prenatal screen-
ing database (in which maternal weight was
recorded), (2) could be linked to an SMR2
record, (3) had given birth to a singleton in-
fant weighing more than 400 g, and (4) had
given birth between 22 and 43 weeks of ges-
tation. In addition to excluding stillbirths and
perinatal deaths because of fetal abnormali-
ties, we excluded women with missing data.
Definitions
Several outcomes were examined: preterm
delivery, spontaneous preterm delivery, elec-
tive preterm delivery, neonatal death, delivery
of an ELBW infant, delivery of an ELBW in-
fant surviving to 1 year of age, and preeclamp-
sia. A preterm delivery was defined as a birth
occurring before 37 weeks of gestation, and a
term delivery was defined as a birth occurring
at or after 37 weeks of gestation. A sponta-
neous delivery was defined as a vaginal birth
or a birth in which the woman was docu-
mented as having been in labor at the time of
delivery but the labor was not documented as
having been induced and was therefore pre-
sumed to be spontaneous. An elective delivery
was defined as a birth in which the woman did
not experience spontaneous labor (i.e., an in-
duced vaginal birth or cesarean birth without a
documented duration of labor).
Infants weighing between 400 g and 1000 g
were classified as ELBW infants. Infants re-
corded as having been live born but not as
having died (according to either the SSBIDE
database or the General Registrar’s Office
death certificate database) in the first year
of life were defined as surviving to 1 year of
age. Preeclampsia was defined according to
International Classification of Diseases, Ninth
Revision, diagnostic codes in relation to post-
delivery hospital discharge.14
Maternal age, parity, postcode of residence,
and all outcome data were obtained solely
from the SMR2. Data on maternal weight
were obtained solely from the biochemical
database. When possible, maternal height and
smoking data were obtained from the SMR2;
in instances in which this information was
missing, the biochemical database was used.
Smoking status (defined as the smoking status
of the woman at the time of her first prenatal
care visit) was determined as recorded in the
patient’s case record. Maternal age was classi-
fied as the age of the mother at the time of
delivery. Maternal weight was defined as that
recorded at the time of Down syndrome
screening. BMI (defined as weight in kilo-
grams divided by height in meters squared)
was categorized as lean (less than 20 kg/m2),
normal (20–24.9 kg/m2), overweight (25–
29.9 kg/m2), obese (30–34.9 kg/m2), and
morbidly obese (35 kg/m2 or above).
Postcode of residence was used to calculate
Carstairs socioeconomic deprivation values
(higher values indicated greater deprivation).
Deprivation classifications were based on 1991
census data on car ownership, unemployment,
overcrowding, and social class within postcode
sectors containing, on average, approximately
1600 residents.15 Since the early 1990s, gesta-
tional age has been confirmed (in the first half
of pregnancy) using ultrasound in more than
95% of pregnancies in the United Kingdom.16
Gestational age at birth was defined as com-
pleted weeks of gestation on the basis of the
estimated date of delivery from each woman’s
clinical record, and standard national criteria
exist for using menstrual and ultrasound data
to estimate date of delivery. However, the spe-
cific means employed in a given record are not
specified. Birthweight was categorized into
gender-specific and gestational age–specific
percentiles derived from the study cohort.
Statistical Analysis
We summarized continuous variables (age,
height, and BMI) using medians and inter-
quartile ranges, and we compared groups
using the Kruskal–Wallis test. We made uni-
variate comparisons of dichotomous data cat-
egories using the χ2 test or the Fisher exact
test. All continuous variables were catego-
rized. The level of statistical significance was
set at P<.05 (2-sided). Logistic regression
analyses were used to calculate adjusted odds
ratios (ORs).17 Independent variables were
BMI, age, height, deprivation category, smok-
ing and marital status, and numbers of previ-
ous spontaneous early pregnancy losses and
therapeutic abortions.
In analyses of birth outcomes for which the
same women may have been included 2 or
more times as a result of successive pregnan-
cies, we estimated odds ratios using logistic
regressions involving robust standard errors
and clustering with maternal identifiers. We
assessed interaction terms using the Wald
test, as is appropriate for clustered data.17 We
used Stata Version 8.2 (Stata Corp, College
Station, Tex) to conduct all statistical analyses.
RESULTS
The linked database contained 227490
records of singleton births. Data for height
were missing in 6270 cases (2.8%) and data
for weight in 24835 cases (10.9%); in 26171
(11.5%) records, either or both of these values
were missing. Among the remaining 201319
records, we excluded 206 (0.1%) deaths be-
cause of fetal abnormalities and 893 (0.4%)
stillbirths because of other causes, leaving
200220 records. Of this total, birthweight
data were missing or birthweights were less
than 400 g in 57 cases (0.03%), and data on
gestational age were missing or gestational age
was outside 22 to 43 weeks in 62 cases
(0.03%). Among the remaining 200104 rec-
ords, maternal age was missing in 3 cases (less
than 0.01%), parity was missing in 23 cases
(0.01%), deprivation category was missing in
347 cases (0.2%), and smoking status was
missing in 12487 cases (6.2%). Overall, 1 or
more of these values were missing in 12814
records (6.4%), leaving a study sample of
187290 singleton births.
Table 1 presents maternal characteristics
and basic outcome data broken down by
term delivery, spontaneous preterm delivery,
and elective preterm delivery. All of the fac-
tors assessed varied among these 3 cate-
gories, although the highly statistically signifi-
cant differences in maternal height actually
reflected very small differences in mean
height and the 3 groups had identical median
values. Among women with preterm deliver-
ies, elective delivery was associated with a
reduced risk of neonatal death (relative risk
[RR]=0.72; 95% confidence interval
[CI]=0.55, 0.94; P=.02) and no overall in-
creased risk of delivering an ELBW infant
(RR=1.06; 95% CI=0.88, 1.28; P=.51).
However, it was associated with an increased
risk of delivering an ELBW infant who
survived to 1 year of age (RR=1.92; 95%
CI=1.49, 2.47; P<.001).
In the case of all adverse outcomes, nulli-
parous women were at greater risk than
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TABLE 1—Maternal Characteristics and Pregnancy Outcome Data, by Type of Delivery: 
Cohort of Scottish Women, 1991–2001
Term Delivery Preterm Spontaneous Preterm Elective 
(n = 177 098) Delivery (n = 5835) Delivery (n = 4357)
Median age, y (IQR) 28 (24–32) 28 (23–31) 29 (25–32)
Median height, cm (IQR) 162 (158–167) 162 (157–166) 162 (157–166)
Median body mass index, kg/m2 (IQR) 23.9 (21.7–27.0) 23.1 (20.8–26.2) 24.2 (21.7–27.7)
Deprivation category, no. (%)
1 (least deprivation) 26 055 (14.7) 673 (11.5) 558 (12.8)
2 30 841 (17.4) 924 (15.8) 691 (15.9)
3 33 577 (19.0) 1023 (17.5) 787 (18.1)
4 36 703 (20.7) 1219 (20.9) 939 (21.6)
5 (most deprivation) 49 922 (28.2) 1996 (34.2) 1382 (31.7)
Smoking status, no. (%)
Never 110 657 (62.4) 3044 (52.2) 2497 (57.3)
Former 13 428 (7.6) 374 (6.4) 302 (6.9)
Current 53 113 (30.0) 2417 (41.4) 1558 (35.8)
Marital status, no. (%)
Married 106 841 (60.3) 3002 (51.5) 2423 (55.6)
Not married 70 257 (39.7) 2833 (48.6) 1934 (44.4)
Previous spontaneous losses, no. (%)
0 142 618 (80.5) 4531 (77.7) 3293 (75.6)
≥1 34 480 (19.5) 1304 (22.4) 1064 (24.4)
Previous therapeutic abortions, no. (%)
0 159 033 (89.8) 5081 (87.1) 3882 (89.1)
≥1 18 065 (10.2) 754 (12.9) 475 (10.9)
Parity status, no. (%)
Nulliparous 79 421 (44.9) 3101 (53.1) 2179 (50.0)
Multiparous 97 677 (55.2) 2734 (46.9) 2178 (50.0)
Outcome of pregnancy, no. (%)
Neonatal death 91 (0.1) 160 (2.8) 87 (2.0)
ELBW infant 0 (0.0) 265 (4.5) 210 (4.8)
ELBW infant surviving to 1 year 0 (0.0) 105 (1.8) 148 (3.4)
Preeclampsia 3 910 (2.2) 73 (1.3) 934 (21.4)
Note. IQR = interquartile range; ELBW = extremely low birthweight. All between-group differences were significant at P ≤ .001
level (P values derived from the Kruskal–Wallis test, the χ2 test, or the Fisher exact test as appropriate).
TABLE 2—Associations Between Parity and Pregnancy Outcomes: Cohort of Scottish
Women, 1991–2001
Nulliparous Multiparous Odds Ratioa (95% 
Outcome (n = 84 701), No. (%) (n = 102 589), No. (%) Confidence Interval)
Overall preterm delivery 5280 (6.2) 4912 (4.8) 1.32 (1.27, 1.38)
Spontaneous preterm delivery 3101 (3.7) 2734 (2.7) 1.39 (1.32, 1.46)
Elective preterm delivery 2179 (2.6) 2178 (2.1) 1.22 (1.15, 1.29)
Neonatal death 203 (0.24) 135 (0.13) 1.82 (1.47, 2.27)
ELBW infant 298 (0.35) 177 (0.17) 2.04 (1.69, 2.46)
ELBW infant surviving to 1 year 162 (0.19) 91 (0.09) 2.16 (1.67, 2.80)
Preeclampsia 3272 (3.9) 1645 (1.6) 2.47 (2.32, 2.62)
Note. ELBW = extremely low birthweight. All outcomes were significant at P < .001.
aEstimated via logistic regressions clustered on maternal identifiers.
multiparous women (Table 2). There were sta-
tistically significant interactions between nulli-
parity and BMI for overall preterm deliveries,
spontaneous preterm deliveries, and elective
preterm deliveries (all Ps< .001). There was a
nonsignificant trend toward interactions be-
tween BMI and nulliparity for preeclampsia
(P=.12), delivery of an ELBW infant (P=.06),
and neonatal death (P=.23). All further analy-
ses of outcomes related to BMI involved strati-
fication according to parity.
Risk of spontaneous preterm deliveries de-
creased with increasing BMI, and this protec-
tive effect of increasing BMI was stronger
among multiparous women (Figure 1a;
Tables 3 and 4). By contrast, risk of elective
preterm deliveries increased with increasing
BMI, and the association was stronger among
nulliparous women (Figure 1b; Tables 3
and 4). Therefore, the net effect of BMI on
key outcomes associated with prematurity dif-
fered according to parity status. Among nulli-
parous women, a BMI of 35 or above was as-
sociated with increased risks of overall
preterm birth, neonatal death, and delivery of
an ELBW infant still alive at 1 year of
age (Table 3). By contrast, multiparous
women with a BMI of 35 or above were not
at increased risk of any of these outcomes
(Table 4).
Among nulliparous women with a BMI of
35 or above who had had an elective preterm
delivery, 40.2% (49 of 122) had been diag-
nosed with preeclampsia; the corresponding
percentage for multiparous women was 18.0%
(25 of 139; P<.001). Preeclampsia had been
diagnosed in 4917 (2.6%) women in the co-
hort overall. Among nulliparous women, nei-
ther neonatal death (adjusted OR=1.23; 95%
CI=0.57, 2.66; P=.59) nor delivery of an
ELBW infant who survived until 1 year of age
(adjusted OR=1.75; 95% CI=0.81, 3.77;
P=.15) was associated with obesity (BMI of 35
or above) after adjustment for gestational age
at delivery. In the same group, adjustment for
preeclampsia resulted in attenuation of the as-
sociations between obesity and elective pre-
term delivery (adjusted OR=1.43; 95%
CI=1.16, 1.75; P=.001), neonatal death
(adjusted OR=2.43; 95% CI=1.35, 4.41;
P=.003), and delivery of an ELBW infant
who survived until 1 year of age (adjusted
OR=2.52; 95% CI=1.40, 4.52; P=.002).
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Note. The χ2 test for trend was significant at P < .001 for all associations except elective preterm birth among multiparous
women (P = .12).
FIGURE 1—Relationship between maternal body mass index (BMI) in early pregnancy in
nulliparous and multiparous women and the proportion of spontaneous preterm births (a)
and elective preterm births (b).
Of the original 227490 records, 38795
(17.1%) were excluded as a result of missing
data for BMI, maternal age, parity, depriva-
tion category, or smoking status. The rates of
prematurity (5.84%) and low birthweight
(5.65%) in this group were slightly higher
than (but similar to) those of the study popu-
lation. Among the group with missing data,
12814 (33.0%) had a BMI recorded. We
compared the relation between BMI (ex-
pressed as a continuous variable) and risk of
prematurity in the group with missing data
and the study population. The odds ratio for
spontaneous preterm delivery associated
with a 1-unit increase in BMI was 0.96 in
both the group with missing data (95%
CI=0.94, 0.98; P < .001) and the study
population (95% CI=0.95, 0.96; P < .001).
Odds ratios for elective preterm delivery
were 1.03 (95% CI = 1.01, 1.05; P = .008)
in the group with missing data and 1.02
(95% CI=1.01, 1.04; P < .001) in the study
population.
DISCUSSION
The main finding of this study is that obe-
sity in early pregnancy is associated with an
increased risk of elective preterm delivery.
By contrast, obesity was associated with a
decreased risk of spontaneous preterm deliv-
ery. The net effect of obesity depends, there-
fore, on the balance between these 2 out-
comes. We found that morbidly obese
nulliparous women had a more than 2-times
greater risk of elective preterm delivery but
only a 20% lower risk of spontaneous pre-
term delivery. The net effect was that these
women were at increased risk of all-cause
prematurity, neonatal death, and delivery of
an ELBW infant who survived to 1 year of
age. These data indicate that morbidly obese
women who are planning to conceive should
be encouraged to lose weight before their
first birth and that rising rates of morbid obe-
sity in the prepregnant population are likely
to lead to increased rates of severe morbidity
and neonatal death related to prematurity.
This is the first study, to our knowledge, to
demonstrate an increased risk of elective pre-
term delivery among obese women. It has
previously been shown that obese women are
at lower risk of spontaneous preterm birth.4–6
Two recent studies analyzing the relation be-
tween BMI and elective preterm delivery did
not demonstrate an overall association.4,18
The probable explanation for this apparent
discrepancy is that data on nulliparous and
multiparous women were pooled. In addition,
both cohorts included fewer than 3000
women. The cohort used in our study was
more than 50-times larger than the cohorts
from these previous studies, and the highly
statistically significant results indicate that the
associations described are very unlikely to be
chance findings.
Moreover, it is biologically plausible that
such associations would be observed. Forty
percent of morbidly obese nulliparous women
who had had an elective preterm delivery had
been diagnosed with preeclampsia, compared
with only 2.6% of the remainder of the study
population. Many previous studies have shown
that preeclampsia risk increases with increas-
ing BMI, and this effect is thought to be medi-
ated by the cardiovascular influences of insulin
resistance and dyslipidemia.19 We found that
increasing BMI was associated with compara-
bly increased relative risks of preeclampsia in
nulliparous and multiparous women (Tables 3
and 4). However, overall rates of preeclampsia
were 3.9% and 1.6%, respectively, in these
2 groups (Table 2). The stronger association
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TABLE 3—Body Mass Index (BMI) in Early Pregnancy and Outcome of First Pregnancy: 
Cohort of Scottish Women (n=84701), 1991–2001 
BMI < 20 BMI 20–24.9b BMI 25–29.9 BMI 30–34.9 BMI ≥ 35
No. ORa ORa No. ORa No. ORa
(%) (95% CI) No. (%) No. (%) (95% CI) (%) (95% CI) (%) (95% CI)
Overall preterm delivery 750 (7.8) 1.36 (1.25, 1.48) 2697 (5.9) 1234 (5.9) 0.99 (0.93, 1.07) 404 (6.7) 1.12 (1.00, 1.25) 195 (8.0) 1.34 (1.15, 1.56)
Spontaneous preterm delivery 507 (5.3) 1.46 (1.32, 1.62) 1654 (3.6) 678 (3.3) 0.89 (0.82, 0.98) 189 (3.1) 0.85 (0.73, 0.99) 73 (3.0) 0.81 (0.64, 1.03)
Elective preterm delivery 243 (2.5) 1.16 (1.00, 1.34) 1043 (2.3) 556 (2.7) 1.15 (1.03, 1.27) 215 (3.6) 1.52 (1.31, 1.77) 122 (5.0) 2.13 (1.75, 2.58)
Neonatal death 31 (0.3) 1.67 (1.10, 2.54) 88 (0.2) 54 (0.3) 1.35 (0.96, 1.90) 17 (0.3) 1.46 (0.86, 2.46) 13 (0.5) 2.77 (1.54, 4.99)
ELBW infant 40 (0.4) 1.35 (0.94, 1.93) 135 (0.3) 73 (0.4) 1.20 (0.90, 1.60) 26 (0.4) 1.47 (0.96, 2.24) 24 (1.0) 3.31 (2.13, 5.14)
ELBW infant surviving to 1 year 18 (0.2) 1.02 (0.61, 1.72) 79 (0.2) 36 (0.2) 1.02 (0.69, 1.52) 15 (0.3) 1.47 (0.84, 2.56) 14 (0.6) 3.36 (1.89, 5.98)
Preeclampsia 208 (2.2) 0.79 (0.68, 0.91) 1350 (3.0) 1025 (4.9) 1.68 (1.54, 1.82) 446 (7.4) 2.57 (2.30, 2.88) 243 (10.0) 3.60 (3.12, 4.17)
Note. OR = odds ratio; CI = confidence interval; ELBW = extremely low birthweight. The total numbers of births across the 5 BMI categories were 9573 (11.3%), 45 812 (54.1%), 20 819 (24.6%),
6060 (7.2%), and 2437 (2.9%), respectively.
aAdjusted for maternal age, height, deprivation category, smoking and marital status, and number of previous spontaneous early pregnancy losses and therapeutic abortions and referent to women
with a BMI of 20–24.9.
bReference group.
TABLE 4—Body Mass Index (BMI) in Early Pregnancy and Outcomes of Multiparous Women: 
Cohort of Scottish Women (n=102589), 1991–2001 
BMI < 20 BMI 20–24.9b BMI 25–29.9 BMI 30–34.9 BMI ≥ 35
No. ORa No. ORa No. ORa No. ORa
(%) (95% CI) No. (%) (%) (95% CI) (%) (95% CI) (%) (95% CI)
Overall preterm delivery 675 (8.0) 1.70 (1.55, 1.86) 2280 (4.6) 1273 (4.3) 0.93 (0.87, 1.00) 438 (4.3) 0.91 (0.81, 1.01) 246 (5.1) 1.09 (0.95, 1.26)
Spontaneous preterm delivery 447 (5.3) 1.87 (1.67, 2.10) 1320 (2.7) 639 (2.2) 0.82 (0.74, 0.90) 221 (2.2) 0.80 (0.69, 0.92) 107 (2.2) 0.83 (0.67, 1.01)
Elective preterm delivery 228 (2.7) 1.37 (1.18, 1.60) 960 (1.9) 634 (2.2) 1.10 (0.99, 1.22) 217 (2.1) 1.06 (0.91, 1.24) 139 (2.9) 1.45 (1.21, 1.75)
Neonatal death 17 (0.2) 1.49 (0.86, 2.58) 58 (0.1) 39 (0.1) 1.18 (0.78, 1.77) 17 (0.2) 1.44 (0.84, 2.47) 4 (0.1) 0.73 (0.27, 2.01)
ELBW infant 22 (0.3) 1.61 (0.99, 2.62) 70 (0.1) 54 (0.2) 1.33 (0.93, 1.90) 24 (0.2) 1.65 (1.03, 2.64) 7 (0.1) 1.04 (0.48, 2.26)
ELBW infant surviving to 1 year 7 (0.1) 0.96 (0.43, 2.14) 41 (0.1) 24 (0.1) 0.96 (0.58, 1.59) 13 (0.1) 1.46 (0.78, 2.76) 6 (0.1) 1.45 (0.61, 3.44)
Preeclampsia 62 (0.7) 0.77 (0.59, 1.01) 515 (1.0) 531 (1.8) 1.72 (1.52, 1.94) 307 (3.0) 2.89 (2.50, 3.34) 230 (4.7) 4.57 (3.88, 5.38)
Note. OR = odds ratio; CI = confidence interval; ELBW = extremely low birthweight. The total numbers of births in the 5 BMI categories were 8395 (8.2%), 49 704 (48.5%), 29 395 (28.7%), 10 245
(10.0%), and 4850 (4.7%), respectively.
aAdjusted for maternal age, height, deprivation category, smoking and marital status, and number of previous spontaneous early pregnancy losses and therapeutic abortions and referent to women
with a BMI of 20–24.9; estimated via logistic regressions clustered on maternal identifiers.
bReference group.
between obesity and elective preterm delivery
among nulliparous women was probably
because of these women’s higher background
risk of preeclampsia.
Areas of Future Study
Among nulliparous women, obesity was
not associated with risk of either neonatal
death or delivery of an ELBW infant who
survived to 1 year of age after adjustment for
gestational age at delivery. This finding sug-
gests that the association between obesity
and these clinically important outcomes is
mediated by obesity’s association with pre-
maturity. Adjustment for preeclampsia re-
sulted in marked, but not complete, attenua-
tion of the associations observed between
morbid obesity and elective preterm delivery,
neonatal death, and delivery of an ELBW
infant who survived to 1 year of age. The
persistence of positive associations between
morbid obesity and these outcomes after ad-
justment for preeclampsia may reflect errors
in preeclampsia diagnoses, or, alternatively,
other complications of pregnancy may be
associated with obesity and may lead to an
increased risk of these outcomes. This issue
requires further study.
Many studies addressing factors associated
with preterm labor lack either the data or the
statistical power necessary to address the im-
portant consequences of prematurity. In addi-
tion to neonatal deaths, the record linkages
used in the present study allowed us to iden-
tify long-term survivors whose birthweights
were below 1000 g. Follow-up studies of
these survivors in childhood demonstrated
that 40% to 45% had severe neurodevelop-
mental impairments,9 as mentioned earlier,
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and this finding led to our designation of
ELBW as a proxy for severe long-term
morbidity. We demonstrated that morbidly
obese nulliparous women were at increased
risk of both perinatal mortality and perinatal
outcomes likely to lead to severe morbidity.
This underlines the clinical significance of the
association with preterm delivery described
here. Ideally, future studies will analyze risks
of long-term severe morbidity directly rather
than use a proxy measure.
The overall rate of prematurity in our study
was relatively low, at 5.4%. This result is con-
sistent with the findings of other European
studies.7 By contrast, previous US studies have
reported overall prematurity rates of 10% to
15%.4,18 However, these cohorts included 40%
to 60% African American women and in-
volved similarly high percentages of women
who were unmarried or living in households
with incomes below the poverty level. The
present data are applicable to a relatively low-
risk population. However, as observed in our
comparisons of nulliparous and multiparous
women, associations of birth outcomes with
BMI depend on the relative balance of back-
ground risks of spontaneous and elective pre-
term deliveries. Among nulliparous women at
high risk of spontaneous preterm delivery, an
increased BMI may be associated with a re-
duced overall risk of prematurity. Again, this is
an issue for further study.
Limitations
As is the case with any large-scale study in
which routinely collected data are used, our
study involved a number of weaknesses. The
SMR2 database does not routinely collect
data on maternal weight, and we were able to
obtain this information only by linking records
to a prenatal screening database. As a result,
the population studied was selected on the
basis of women having accepted screening for
congenital abnormalities. However, 81% of
women in the west of Scotland undergo serum
screening,12 and thus, the study included most
women seeking prenatal care.
Because maternal weight was used to adjust
prenatal screening results, the value recorded
was that from early pregnancy. As a result, we
lacked data on prepregnancy weight and
weight gain during pregnancy. However, our
primary aim was to determine the probable
effects of rising obesity rates in the general
population on negative consequences of
prematurity. BMI in early pregnancy is a good
proxy for prepregnancy BMI, given that rela-
tively little weight gain will have occurred be-
tween these intervals. Finally, approximately
17% of eligible women were excluded be-
cause of missing data, raising the possibility
that our study population was biased. How-
ever, associations between BMI and sponta-
neous and elective preterm deliveries were
similar when women with missing data on
other maternal variables were compared with
the study population.
Our results show that maternal obesity is
associated with an increased risk of elective
preterm delivery. The association is stronger
among nulliparous women, probably as a re-
sult of their increased risk of preeclampsia,
and here it led to an overall association be-
tween obesity and preterm birth in this group.
Obese nulliparous women are at increased
risk of the serious negative consequences
associated with preterm births.
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A B S T R A C T
Background
The relationship between population trends in delaying childbirth and rising rates of primary
cesarean delivery is unclear. The aims of the present study were (1) to characterize the
association between maternal age and the outcome of labor, (2) to determine the proportion
of the increase in primary cesarean rates that could be attributed to changes in maternal age
distribution, and (3) to determine whether the contractility of uterine smooth muscle
(myometrium) varied with maternal age.
Methods and Findings
We utilized nationally collected data from Scotland, from 1980 to 2005, and modeled the risk
of emergency cesarean section among women delivering a liveborn infant in a cephalic
presentation at term. We also studied isolated myometrial strips obtained from 62 women
attending for planned cesarean delivery in Cambridge, England, from 2005 to 2007. Among
583,843 eligible nulliparous women, there was a linear increase in the log odds of cesarean
delivery with advancing maternal age from 16 y upwards, and this increase was unaffected by
adjustment for a range of maternal characteristics (adjusted odds ratio for a 5-y increase 1.49,
95% confidence interval [CI] 1.48–1.51). Increasing maternal age was also associated with a
longer duration of labor (0.49 h longer for a 5-y increase in age, 95% CI 0.46–0.51) and an
increased risk of operative vaginal birth (adjusted odds ratio for a 5-y increase 1.49, 95% CI
1.48–1.50). Over the period from 1980 to 2005, the cesarean delivery rate among nulliparous
women more than doubled and the proportion of women aged 30–34 y increased 3-fold, the
proportion aged 35–39 y increased 7-fold, and the proportion aged 40 y increased 10-fold.
Modeling indicated that if the age distribution had stayed the same over the period of study,
38% of the additional cesarean deliveries would have been avoided. Similar associations were
observed in multiparous women. When studied in vitro, increasing maternal age was
associated with reduced spontaneous activity and increased likelihood of multiphasic
spontaneous myometrial contractions.
Conclusions
Delaying childbirth has significantly contributed to rising rates of intrapartum primary
cesarean delivery. The association between increasing maternal age and the risk of intrapartum
cesarean delivery is likely to have a biological basis.
The Editors’ Summary of this article follows the references.
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Introduction
Rising rates of cesarean delivery are a major public health
concern. In recent years, the proportion of women attempt-
ing vaginal birth after cesarean (VBAC) has declined [1].
Hence, rates of primary cesarean delivery will become an
increasingly important determinant of overall cesarean
rates. Many studies have demonstrated that rates of primary
cesarean delivery have risen throughout the developed world
in recent years [2–4], and the reasons for this are unclear.
Some of the increase can be explained by changes in
obstetric practice, such as the trend toward elective cesarean
delivery when the infant presents by the breech [5].
However, the rise in primary cesarean rates has coincided
with a trend of increasing average maternal age at the time
of ﬁrst birth. Previous studies have demonstrated that the
risk of cesarean delivery increases with advancing maternal
age. However, it is currently unclear whether the association
reﬂects a biological effect of advanced age [6,7] or is a
consequence of physician and maternal preference [8,9]. The
contribution of delaying childbirth to recent rises in
cesarean delivery rates is also unclear [3,10–12]. The aims
of the present study were (1) to characterize the association
between maternal age and the outcome of labor, (2) to
determine the proportion of the increase in primary
cesarean rates that could be attributed to changes in
maternal age distribution, and (3) to determine whether
the contractility of uterine smooth muscle (myometrium)
varied with maternal age.
Methods
Population
The Scottish Morbidity Record (SMR2) collects informa-
tion on clinical and demographic characteristics and out-
comes for all patients discharged from Scottish maternity
hospitals. The register has been greater than 99% complete
since the late 1970s [13]. A quality assurance analysis in 1996–
1997 compared 1,414 records with the clinical notes. This
analysis demonstrated that the register was free from
signiﬁcant errors in greater than 98% of records in all the
speciﬁc ﬁelds used in the present analysis, with the exception
of postcode (94.0%), height (96.2%), estimated gestation
(94.4%), and method of induction of labor (93.6%). The mode
of delivery ﬁeld was 99.2% accurate. The main focus of the
present study was nulliparous women having a singleton birth
in Scotland between 1980 and 2005, inclusive. The exclusion
criteria were preterm birth, stillbirth, delivery by prelabor
cesarean, noncephalic presentation of the infant, and records
with missing data on key variables. We repeated the analyses
in women who had one or two previous vaginal births.
Definitions
Emergency intrapartum cesarean delivery was deﬁned as
any nonplanned cesarean delivery with a documented
duration of labor. Operative vaginal delivery was deﬁned as
birth using the assistance of obstetric forceps or vacuum
(ventouse). Maternal age was deﬁned as the age of the mother
at the time of birth. Maternal height was measured in
centimeters, and the value used was that documented in each
Table 1. Demographic and Outcome Characteristics of Eligible Nulliparous in Relation to Mode of Delivery
Characteristic Category/Units Vaginal Birtha (n ¼ 518,787) Cesarean Sectiona (n ¼ 65,056) p-Valueb
Age (y) Median (IQR) 24 (21–28) 27 (23–31) ,0.001
Height (cm) Median (IQR) 162 (158–167) 160 (156–165) ,0.001
Missing 58,239 (11.2) 8,737 (13.4) ,0.001
Deprivation category 1 (least deprived) 26,311 (5.1) 3,696 (5.7) ,0.001
2 66,416 (12.8) 8,711 (13.4) —
3 102,152 (19.7) 12,988 (20.0) —
4 125,015 (24.1) 15,994 (24.6) —
5 80,840 (15.6) 10,142 (15.6) —
6 61,787 (11.9) 7,809 (12.0) —
7 (most deprived) 42,293 (8.2) 4,944 (7.6) —
Missing 13,973 (2.7) 772 (1.2) ,0.001
Gestational age (wk) 37 23,111 (4.5) 2,369 (3.6) ,0.001
38 54,602 (10.5) 5,164 (7.9) —
39 103,701 (20.0) 9.495 (14.6) —
40 189,502 (36.5) 19,952 (30.7) —
41 121,778 (23.5) 21,561 (33.1) —
42 25,324 (4.9) 6,278 (9.7) —
43 769 (0.2) 237 (0.4) —
Onset of labor Spontaneous 378,390 (72.9) 31,313 (48.1) ,0.001
Induced 140,397 (27.1) 33,743 (51.9) —
Sex Male 262,114 (50.5) 37,408 (57.5) ,0.001
Female 256,655 (49.5) 27,645 (42.5) —
Missing 18 (,0.1) 3 (,0.1) 0.5
Birth weight percentile Median (IQR) 43 (21–67) 56 (26–81) ,0.001
Missing 221 (,0.1) 29 (,0.1) 0.76
aData summarized as n (%) unless stated otherwise.
bMann-Whitney U test, the v2 test or v2 test for trend, as appropriate.
IQR, interquartile range.
doi:10.1371/journal.pmed.0050144.t001
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woman’s clinical record. Gestational age at birth was deﬁned
as completed weeks of gestation on the basis of the estimated
date of delivery in each woman’s clinical record. Gestational
age has been conﬁrmed by ultrasound in the ﬁrst half of
pregnancy in more than 95% of women in the United
Kingdom since the early 1990s. Preterm birth was deﬁned as
delivery before 37 completed wk of gestation. Birth weight
was converted into percentiles for week of gestation and
these were calculated separately for males and females.
Myometrial Contractility Studies
Biopsies of the uterus were obtained from nonlaboring
patients, undergoing routine elective cesarean delivery at the
Rosie Hospital, Cambridge, UK at 38–40 wk pregnancy. Most
of the cesarean deliveries were performed for breech
presentation or previous cesarean delivery. The procedure
was approved by the Cambridge Local Research Ethics
Committee 2, and all patients gave written informed consent
to participate. Following delivery of the infant, placenta, and
membranes, specimens were taken from the upper edge of
the lower segment uterine incision and placed into ice-cold
Krebs solution. Samples were stored in Krebs solution at 4 8C
(with EDTA-free protease inhibitors) overnight and then
cleared of serosa, ﬁbrous or damaged tissue, and any visible
blood vessels. The muscle tissue was dissected into longitu-
dinal strips (following the plane of the muscle ﬁbers) of
approximately 1–3 mm 3 8–12 mm. Tissue strips were
mounted in an organ bath (Radnoti) ﬁlled with Krebs solution
at 37 8C and gassed with 95% O2 and 5% CO2. The Krebs
solution was changed at 15-min intervals. Myometrial strips
were secured by thread to an isometric tension transducer
(MLT0201/RAD, ADInstruments), and the signal ampliﬁed
and stored in a commercial data acquisition system (Octal
ML228 Bridge Ampliﬁer; Chart, version 5.2.2, both ADInstru-
ments). Strips were stretched to 2 g tension, which was re-set
30 min later. After a total period of 90 min of equilibration
following initial set up, a standardized contraction in
response to 50 mM KCl was obtained.
Statistics
Continuous variables were summarized by the median and
interquartile range, and groups were compared using the
Mann-Whitney U test. Dichotomous data were compared
between groups using the v2 test or v2 test for trend, as
appropriate. All p-values were two sided, and statistical
signiﬁcance was assumed at p , 0.05. In the analysis of
cesarean section risk, the numerator was all intrapartum
cesarean deliveries and the denominator was all births. In the
analysis of the risk of operative vaginal delivery, the numerator
was all forceps or vacuum deliveries and the denominator was
all vaginal births. Adjusted odds ratios were obtained using
logistic regression using age as a continuous variable and with
all other variables categorized [14]. Women with missing data
on covariates were excluded from the multivariate analysis.
The association between maternal age and cesarean section
risk was compared between the whole population and those
with complete data on covariates. Linearity of age in logistic
models was tested using fractional polynomials, and inter-
actions were tested using the likelihood ratio test.
In order to estimate the effect of changes in the age
distribution on cesarean rates, we performed an analysis where
we estimated what the annual cesarean section rate would have
been had the age distribution of mothers remained unchanged
over the period from 1980 to 2005. We did this by calculating a
new age variable to represent the age of each mother had the
age distribution remained constant over the period from 1980
Figure 1. Maternal Age and the Risk of Cesarean Delivery
Proportion of women being delivered by emergency intrapartum
cesarean section in relation to age of mother (n ¼ 583,847). Bars are
binomial 95% CIs.
doi:10.1371/journal.pmed.0050144.g001
Figure 2. Stratified Analysis of Maternal Age and Risk of Cesarean
Section
Adjusted odds ratio for a 5-y increase in maternal age (bars are 95% CIs)
stratified by maternal age, year of delivery, week of gestation, and
deprivation category. Interactions were statistically significant for year of
delivery (p , 0.001), week of gestation (p ¼ 0.002), and deprivation
category (p ¼ 0.002) using the likelihood ratio test. Odds ratios are
adjusted for maternal age, height, deprivation category, onset of labor,
week of gestation, sex, birth weight percentile of infant, and year. The
vertical dashed line indicates unity.
doi:10.1371/journal.pmed.0050144.g002
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to 2005. For example, a woman having a ﬁrst birth in 2003 who
was on the 76th percentile of age for 2003 would have a new
age variable equivalent to the 76th percentile of age in 1980.
The logistic regression equations ﬁtted for the observed values
of age were then used to derive an estimated probability of
cesarean delivery using the new age variable. The mean
probability for all women in a given year was then taken as the
estimated rate of cesarean delivery had the maternal age
distribution stayed the same as in 1980.
All recording of spontaneous contractile activity was
performed blind to the mother’s age. Contractile activity
was quantiﬁed by integrating the area under the tension
curve. Spontaneous activity was quantiﬁed as the ratio of the
area under the curve for the 15 min prior to addition of
potassium to the area under the curve for the 7 min in the
presence of 50 mM potassium. The ratio was log transformed
to normalize its distribution and the log10 of the ratio was
called the ‘‘contraction unit.’’ A multiphasic contraction was
deﬁned as having two or more distinct peaks prior to the
return to baseline. In order to maximize the statistical power
of the analysis, we studied multiple strips from the same
women. However, most regression methods assume that
observations are independent and our approach necessitated
that we use regression methods that could account for the
nonindependence of different strips from the same woman.
Hence, analysis of the association between maternal age and
spontaneous contractile activity was performed using a linear
mixed model with a random effect at the maternal level, to
account for the nonindependence of different strips obtained
from the same woman. The probability of multiphasic
contractions was assessed using logistic regression, and the
frequency of spontaneous contractions prior to potassium
was assessed using Poisson regression. Both regression
methods employed generalized estimating equations and
were clustered on the maternal identiﬁer to account for
nonindependence. All analyses were performed using Stata,
version 10 (Stata Corporation).
Results
Study Cohort
There were 1,531,261 available records from the Scottish
Morbidity Record over the period from 1980 to 2005. Among
these, there were 8,111 stillbirths (0.5%), 72,119 noncephalic
births (4.7%), 851,486 multiparous women (55.6%), 89,964
preterm births (5.9%), 91,904 elective cesarean deliveries
(6.0%), 40,224 prelabor emergency cesarean deliveries (2.6%),
510 with missing data on mode of delivery (,0.1%), and 478
with missing data on method of induction of labor (,0.1%). A
total of 947,414 women had one or more of these exclusions
Table 2. Unadjusted and Adjusted Odds Ratios for Intrapartum Cesarean Section among Nulliparous Women, Scotland 1980–2005
Characteristic Category/Units Unadjusted Odds Ratio 95% CI p-Value Adjusted Odds Ratioa 95% CI p-Value
Age Per 5 y 1.49 1.48–1.51 ,0.001 1.49 1.48–1.51 ,0.001
Onset of laborb Induced 2.93 2.88–2.98 ,0.001 2.48 2.43–2.53 ,0.001
Week of gestation 37 0.96 0.92–1.01 0.14 0.82 0.78–0.86 ,0.001
38 0.90 0.87–0.93 ,0.001 0.81 0.78–0.84 ,0.001
39 0.87 0.84–0.89 ,0.001 0.85 0.82–0.87 ,0.001
40 (1.00)c — — (1.00)c — —
41 1.64 1.61–1.68 ,0.001 1.35 1.32–1.38 ,0.001
42 2.35 2.28–2.43 ,0.001 1.79 1.73–1.86 ,0.001
Deprivation category 1 (least deprived) 1.08 1.04–1.13 ,0.001 0.91 0.87–0.96 ,0.001
2 1.03 1.00–1.06 0.04 0.91 0.88–0.94 ,0.001
3 1.00 0.97–1.03 0.98 0.94 0.91–0.97 ,0.001
4 (1.00)c — — (1.00)c — —
5 0.99 0.96–1.01 0.33 1.04 1.01–1.07 0.01
6 1.02 0.99–1.05 0.18 1.06 1.02–1.09 0.001
7 (most deprived) 0.94 0.91–0.98 0.002 1.08 1.04–1.12 ,0.001
Height (cm) ,155 2.47 2.40–2.55 ,0.001 3.98 3.85–4.11 ,0.001
155–159 1.59 1.54–1.63 ,0.001 2.19 2.13–2.26 ,0.001
160–164 1.22 1.19–1.25 ,0.001 1.44 1.41–1.49 ,0.001
165–169 (1.00)c — — (1.00)c — —
170–174 0.86 0.83–0.90 ,0.001 0.73 0.70–0.76 ,0.001
175 0.75 0.71–0.80 ,0.001 0.53 0.49–0.57 ,0.001
Sexb Male 1.33 1.31–1.36 ,0.001 1.39 1.37–1.42 ,0.001
Birth weight percentile 1–5 1.27 1.22–1.31 ,0.001 1.03 0.99–1.07 0.17
6–10 0.86 0.82–0.90 ,0.001 0.74 0.70–0.77 ,0.001
11–20 0.78 0.76–0.81 ,0.001 0.71 0.69–0.74 ,0.001
21–80 (1.00)c — — (1.00)c — —
81–90 1.69 1.64–1.74 ,0.001 1.88 1.82–1.93 ,0.001
91–95 2.26 2.18–2.35 ,0.001 2.59 2.49–2.70 ,0.001
96–100 3.60 3.47–3.74 ,0.001 4.28 4.11–4.46 ,0.001
Analysis confined to women with complete data.
aAdjusted for maternal age, height, deprivation category, onset of labor, week of gestation, sex, birth weight percentile of infant, and year (unadjusted and adjusted odds ratios for year
are presented in Table 3).
bReferent category for onset of labor was spontaneous and for sex was female.
cReferent category.
OR, odds ratio.
doi:10.1371/journal.pmed.0050144.t002
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leaving a main study group of 583,847 nulliparous women
delivering a liveborn infant at term in a cephalic presenta-
tion, which was 86% of all nulliparous women in the
database. The characteristics of the study group are described
in relation to whether the women were delivered by
emergency cesarean section (Table 1). This latter group was
older, shorter, and likely to live in an area of low socio-
economic deprivation. They delivered at later weeks of
gestation, were more likely to have an induced labor, more
likely to deliver a male infant, and the birth weight percentile
of their infants was higher. A total of 81,407 (13.9%) records
had missing data for one or more of height, birth weight
percentile, or deprivation category.
Age and Cesarean Risk
The risk of cesarean delivery increased progressively from
16 y of age (Figure 1). The proportional increase in risk for a
5-y increase in age was similar comparing women ,20 y,
those aged 20–29 y, and those aged 30 y (Figure 2). The
linearity of the relationship between age and risk of cesarean
was further assessed using fractional polynomials. None of
eight polynomial expressions tested provided a better ﬁt than
a simple linear model. The odds ratio for a 5-y increase in age
was 1.51 (95% conﬁdence interval [CI], 1.50–1.53) and was
1.49 (95% CI, 1.48–1.51) when conﬁned to records with no
missing data. Adjusting for a series of maternal and obstetric
characteristics (Table 2) was without effect. When the
covariate data were expressed continuously and nonlinear
terms selected using multiple fractional polynomials, the
odds ratio for a 5-y increase in age was 1.52 (95% CI, 1.51–
1.54), which was very similar to the odds ratio obtained when
the continuous variables were categorized. There were
statistically signiﬁcant interactions between age and week of
gestation, socioeconomic deprivation, and year (all p , 0.01),
and these are illustrated in a stratiﬁed analysis (Figure 2). This
analysis demonstrates that the degree of variation between
strata of these variables was relatively minor, and the
statistical signiﬁcance of the interaction terms reﬂects the
large sample size.
Information on body mass index was available for a
previously described subset of the cohort [15]. Among the
72,137 of these women who fulﬁlled the inclusion criteria for
the main cohort and who had complete data, the odds ratio
for a 5-y increase in age was 1.52 (95% CI, 1.49–1.55) adjusted
for the same characteristics as the present analysis and was
1.48 (95% CI, 1.44–1.51) when also adjusted for body mass
index. The database employed lacked details on the indica-
tion for cesarean delivery. However, we performed a
subgroup analysis where we compared the strength of
association between maternal age and the risk of emergency
intrapartum cesarean section in relation to whether the baby
had a 5-min Apgar score of ,7. The adjusted odds ratio for a
5-y increase in maternal age was 1.52 (95% CI, 1.50–1.54) for
cesarean delivery with a normal Apgar score and 1.30 (95%
CI, 1.22–1.38) for cesarean delivery with a low Apgar score.
Population Trends, 1980–2005
Over the period from 1980 to 2005, the proportion of
women having their ﬁrst birth aged 30–34 y increased
approximately 3-fold, the proportion aged 35–39 y increased
approximately 7-fold, and the proportion aged 40 y
increased approximately 10-fold (Figure 3A). Over the same
period of time, the rate of cesarean delivery more than
doubled (Figure 3B). Adjustment for age signiﬁcantly reduced
the strength of the association between year of delivery and
the risk of cesarean delivery, both when analyzing year alone
and when included with all other covariates (Table 3). Over
the period 1981–2005, there were 16,548 more cesarean
deliveries than would have occurred had the rate stayed the
same as it was in 1980. Of these additional procedures, it was
estimated that 37.6% would not have been performed had the
maternal age distribution remained constant. The ﬁgure was
very similar when adjusted for all other maternal character-
istics (37.8%) and all other maternal characteristics plus
statistically signiﬁcant interactions (38.7%).
Duration of Labor and Operative Vaginal Birth
The average duration of spontaneous labor progressively
increased from aged 16 y upwards (Figure 4A). The
Figure 3. Time Trends in Maternal Age Distribution and Cesarean Section
Rates in Scotland between 1980 and 2005
(A) Proportion of women per year delivering within the age ranges 30–
34, 35–39, and 40 y.
(B) Proportion of women per year delivered by emergency cesarean
section.
doi:10.1371/journal.pmed.0050144.g003
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association appeared to plateau around 35 y of age and
above. Between the ages of 16 and 30 y, a 5-y increase in age
was associated with a 0.49 h longer duration of labor (95% CI,
0.46–0.51). The risk of operative vaginal birth also increased
linearly with age (Figure 4B). The odds ratio for a 5-y increase
in age, adjusted for the same factors as employed in the
multivariate analysis described in Table 2, was 1.49 (95% CI,
1.48–1.50).
Multiparous Women
We then examined the relationship between maternal age
and the risk of emergency cesarean section in multiparous
women, analyzing women who had either one or two previous
vaginal births but who otherwise fulﬁlled the inclusion
criteria for the main study group (Table 4). All women who
had a previous cesarean delivery were excluded. The odds
ratio for intrapartum cesarean delivery associated with a 5-y
increase in maternal age and adjusted for the same series of
maternal characteristics as above was 1.38 (95% CI, 1.34–1.41)
among women with one previous vaginal birth and 1.49 (95%
CI, 1.43–1.55) among women with two previous vaginal births.
The adjusted odds ratios for operative vaginal birth associ-
ated with a 5-y increase in maternal age were 1.48 (95% CI,
1.45–1.50) and 1.52 (95% CI, 1.47–1.58), respectively. Ap-
proximately 30% of the increase in cesarean section rate
among multiparous women was related to increasing mater-
nal age.
Age and Myometrial Contractility
Myometrial biopsies were obtained from 62 women of
varying parity, and a total of 181 strips were studied in vitro.
The average number of strips studied per woman was 2.9 and
the range 2–4. The characteristics of this group are
summarized in Table 5. Figure 5A illustrates estimation of
contraction units and shows an example of a multiphasic
contraction in a biopsy from a 40-y-old woman. The mean
peak response to potassium was 3.5 g tension, and there was
no association between the age of the mother and the peak
response to potassium (coefﬁcient for a 5-y increase in age¼
0.15 g tension, 95% CI, 0.12 to 0.43, p ¼ 0.27).
Of the 181 strips, 67 (37.0%) exhibited one or more
spontaneous contractions prior to potassium stimulation.
There was a nonsigniﬁcant trend towards a decreased
frequency of spontaneous contraction with advancing age
(change in contraction frequency for a 5-y increase in age ¼
26.4%, 95% CI,50.9% to 10.2%, p¼ 0.14). When expressed
as contraction units, the mean spontaneous activity was0.49
contraction units and the standard deviation 0.44. The mean
contraction unit value for each patient is plotted against
maternal age (Figure 5B). Regression modeling demonstrated
a signiﬁcant negative association between spontaneous
contractile activity and maternal age, with a coefﬁcient of
0.086 contraction units for a 5-y increase in age (95% CI,
0.161 to 0.012, p ¼ 0.02). Spontaneous activity increased
with advancing gestational age (coefﬁcient for one week
increase ¼ 0.10; 95% CI, 0.01–0.18, p ¼ 0.04) and number of
previous vaginal births (coefﬁcient for each additional
vaginal birth ¼ 0.17; 95% CI, 0.01 to 0.34, p ¼ 0.07).
However, adjustment for these factors and other maternal
characteristics (number of previous cesarean deliveries,
height, and body mass index) had virtually no effect on the
association between age and spontaneous activity (adjusted
coefﬁcient for 5-y increase in age¼0.084, 95% CI,0.155 to
0.012, p ¼ 0.02). When the analysis was conﬁned to the 67
strips that exhibited at least one spontaneous contraction,
there was still a statistically signiﬁcant decrease in contrac-
tility with advancing age (coefﬁcient of 0.080 contraction
units for a 5-y increase in age, 95% CI,0.149 to0.009, p ¼
0.03). The risk of these spontaneous contractions being
multiphasic also increased with advancing maternal age
(Figure 5C). A 5-y increase in age was associated with an
odds ratio for multiphasic contractions of 1.93 (95% CI, 1.41–
2.63, p, 0.001). This odds ratio was also virtually unaltered by
adjusting for maternal characteristics (adjusted odds ratio
1.95, 95% CI, 1.43–2.64, p , 0.001), and age was the only
maternal characteristic associated with multiphasic contrac-
tions.
Discussion
We show that the risk of intrapartum cesarean delivery
among women having their ﬁrst birth at term increased with
advancing maternal age from 16 y old upwards. The
Table 3. Effect of Adjusting for Age on the Association between Year of Delivery and the Risk of Emergency Intrapartum Cesarean
Section among Nulliparous Women, Scotland 1980–2005
Year Unadjusted Adjusted for Age Alone Adjusted for All Factors Except Agea Fully Adjustedb
OR 95% CI p-Value OR 95% CI p-Value OR 95% CI p-Value OR 95% CI p-Value
1980–1982 (1.00)c — — (1.00)c — — (1.00)c — — (1.00)c — —
1983–1985 1.09 1.05–1.14 ,0.001 1.07 1.03–1.12 0.001 1.19 1.14–1.24 ,0.001 1.16 1.11–1.21 ,0.001
1986–1988 1.12 1.07–1.16 ,0.001 1.07 1.03–1.11 0.001 1.27 1.22–1.32 ,0.001 1.21 1.16–1.26 ,0.001
1989–1991 1.16 1.12–1.20 ,0.001 1.06 1.02–1.10 0.004 1.35 1.30–1.41 ,0.001 1.23 1.18–1.28 ,0.001
1992–1994 1.35 1.30–1.40 ,0.001 1.17 1.12–1.21 ,0.001 1.60 1.54–1.66 ,0.001 1.37 1.32–1.43 ,0.001
1995–1997 1.47 1.42–1.53 ,0.001 1.23 1.18–1.27 ,0.001 1.76 1.69–1.83 ,0.001 1.46 1.40–1.52 ,0.001
1998–2001 2.00 1.93–2.07 ,0.001 1.63 1.57–1.69 ,0.001 2.37 2.28–2.46 ,0.001 1.93 1.86–2.01 ,0.001
2002–2005 2.33 2.24–2.41 ,0.001 1.87 1.80–1.94 ,0.001 2.93 2.82–3.05 ,0.001 2.34 2.25–2.44 ,0.001
aAdjusted for height, deprivation category, onset of labor, week of gestation, sex, and birth weight percentile of infant.
bAs above plus maternal age.
cReferent category.
OR, odds ratio.
doi:10.1371/journal.pmed.0050144.t003
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association was linear and was not explained by a range of
other maternal characteristics. Over the period 1980 to 2005,
the proportion of women in Scotland having their ﬁrst birth
aged 30–34 y increased approximately 3-fold, the proportion
aged 35–39 y increased approximately 7-fold, and the
proportion aged 40 y increased approximately 10-fold
(Figure 3B). The cesarean rate more than doubled over the
same period. This increase represented approximately 16,500
more procedures than would have occurred had the cesarean
rate stayed at the level observed in 1980. Using these
nationally collected data, we estimated that approximately
38% of these additional procedures would have been avoided
had the maternal age distribution stayed the same as in 1980.
Hence, we show that a substantial proportion of the increase
in rate of emergency primary cesarean delivery in recent
years may be attributed to the trend of delaying of ﬁrst
childbirth. The current observations cannot be explained by
the offer of planned cesarean delivery to older women.
Previous studies addressing the effects of population trends
in delaying childbirth on cesarean delivery rates had
produced inconsistent ﬁndings. An analysis of US birth
certiﬁcate data from 1991 to 2002 concluded that increasing
rates of cesarean delivery were unrelated to maternal risk
proﬁles [12]. A recent study of 432,327 singleton cephalic
births at term in Western Australia reached the same
conclusion [10]. However, an earlier study of 225,466 births
in Washington State estimated that 18% of the increase in
cesarean rates between 1970 and 1987–1990 might be
explained by the combined effects of changes in maternal
age, parity, and birth weight [11], and an analysis of 127,564
births between 1988 and 2000 in Nova Scotia suggested that
virtually all of the increase in cesarean rates over that period
could be attributed to changes in age, parity, and maternal
weight [3]. The strengths of the present analysis are that we
studied a large number of women, that we had quality assured
data collected in a standardized fashion, that data were
nationally collected covering a population with free access to
health care, and that we could exclude prelabor cesarean
deliveries. Moreover, the analytic method employed directly
addressed the question of what would have been predicted
had the age distribution remained constant. The analysis also
indicates that part of the increase in cesarean rates was
independent of changes in maternal age. Other possible
determinants of increased rates of cesarean delivery may
include changes in other maternal characteristics, such as
Figure 4. Maternal Age and the Duration of Labor and Risk of Operative
Vaginal Birth
(A) Mean duration of spontaneous labor in relation to maternal age (n¼
409,703). Bars are 95% CIs of the mean.
(B) Proportion of nulliparous women who required operative vaginal
delivery in relation to maternal age among the 518,787 women delivered
by a means other than emergency cesarean section. Bars are binomial
95% CIs.
doi:10.1371/journal.pmed.0050144.g004
Table 4. Outcome of Labor among Multiparous Women, Scotland 1980–2005
Numbers, Odds Ratios, and Population Trends Mode of Delivery One Previous Birth
(n ¼ 412,253)
Two Previous Births
(n ¼ 186,141)
Operative births, n (%) Cesarean section 8,254 (2.0) 2,960 (1.8)
Operative vaginal birth 18,282 (4.4) 4,014 (2.4)
Adjusteda odds ratio (95% CI) for 5-y increase in age Emergency cesarean section 1.38 (1.34–1.41) 1.49 (1.43–1.55)
Operative vaginal birth 1.48 (1.45–1.50) 1.52 (1.47–1.58)
Additional cesarean deliveries compared with static rate — 2,361b 776b
Proportion additional procedures attributed to age — 29.8%c 28.8%c
aAdjusted for maternal age, height, deprivation category, onset of labor, week of gestation, sex, birth weight percentile of infant, and year.
bNumber of cesarean deliveries that would have been avoided had the rate stayed the same as it was in 1980.
cEstimated proportion of the additional cesarean deliveries that would have been avoided had the maternal age distribution stayed the same as it was in 1980.
doi:10.1371/journal.pmed.0050144.t004
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body mass index, or changes in obstetric practice, such as
generally more liberal use of cesarean section.
Some authors had interpreted higher rates of cesarean
delivery among older women as reﬂecting physician and
maternal preference. We interpret the current data as
supporting a biological effect of aging on performance
during labor. First, we adjusted for a range of maternal
characteristics. The lack of effect of statistical adjustment for
both body mass index and birth weight percentile suggest the
ﬁndings are not explained by comorbidities, such as obesity
or gestational diabetes. Secondly, previous analysis by
indication for cesarean delivery demonstrated that 80% of
procedures performed during term labor in nulliparous
women include failure to progress in the indication [16].
This ﬁnding suggests that any factor that is strongly
associated with primary intrapartum cesarean delivery
among nulliparous women at term is likely to be associated
with poor progress during labor. Thirdly, we found that other
indicators of poor progress in labor were also associated with
increasing age. The duration of labor increased linearly with
advancing age, as did the risk of requiring operative vaginal
delivery. The latter observation also indicates that the
association between age and cesarean delivery is not merely
a reﬂection of a tendency toward performing a cesarean
delivery rather than an operative vaginal birth in older
women. Finally, the associations were all strikingly linear
across the maternal age range 20–29 y. This pattern cannot
plausibly be explained either by bias on the part of the
obstetrician or a tendency to vascular complications affecting
older women. We also found that the association was stronger
for procedures performed where the infant had a normal
Apgar score than procedures where the infant was delivered
with a depressed Apgar, indicating that the association is
unlikely to be explained by effects of aging on the risk of fetal
distress, other than as a consequence of prolonged labor.
Given these ﬁndings, we hypothesized that aging is
associated with impairment of myometrial contractility. We
Table 5. Characteristics of Women Who Provided Myometrial
Biopsies
Characteristic Unit/Category Values
Age (y) Median (IQR) 33 (29–36)
Height (cm) Median (IQR) 165 (159–170)
Body mass index Median (IQR) 23.4 (21.4–27.9)
Week of gestation 37 4 (6.4)
38 12 (19.4)
39 42 (67.7)
40 4 (6.5)
Previous vaginal births 1 12 (19.4)
2 1 (1.6)
3 0
Previous cesarean deliveries 1 29 (49.8)
2 8 (12.9)
3 0
Data expressed as n (%) unless stated otherwise. IQR, interquartile range.
doi:10.1371/journal.pmed.0050144.t005
Figure 5. Myometrial Contractility in Relation to Maternal Age
(A) Trace of isometric tension from myometrial strip obtained from a 40-y-old woman being delivered by planned cesarean section. The blue line
represents the 15 min before addition of potassium, and the red line 7 min in the presence of 50 mM of potassium. The area under the curve is the
space between the tension trace and the baseline, indicated by the blue and red lines. The log10 of the ratio of these two areas is the contraction unit.
The spontaneous contraction before the addition of potassium and the contraction following potassium being washed out are both multiphasic.
(B) Mean spontaneous contractile activity (quantified as contraction units) of isolated strips of myometrium obtained from women (n¼ 62) at the time
of planned cesarean section in relation to the age of the donor. Regression line: y¼ 0.1078þ (0.01743 age); 95% CI for slope,0.0326 to0.0022.
(C) Proportion of spontaneous contractions that were multiphasic in relation to maternal age (n¼62, 181 samples). See text for regression analysis of (B)
and (C).
doi:10.1371/journal.pmed.0050144.g005
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tested this hypothesis by obtaining uterine biopsies at the
time of planned cesarean section and assessing their
contractility in vitro. We quantiﬁed spontaneous contractile
activity blind to the age of the donor. We found that
advancing age was associated with a reduced degree of
spontaneous contraction compared with a standardized
response to potassium. Moreover, the spontaneous contrac-
tions observed were more likely to be multiphasic. Our
contractility studies included women of mixed parity.
However, we demonstrated that the association between
maternal age and the risk of both cesarean section and
operative vaginal birth was similar in multiparous women as
we observed in nulliparous women. Moreover, multivariate
statistical methods demonstrated that the association be-
tween age and the contractility of isolated myometrial strips
was independent of other maternal characteristics. The
association between age and both spontaneous activity and
the coordination of contractions may indicate adverse effects
of aging on control of electrical activity in the myometrium,
for example, membrane depolarization or conduction be-
tween cells, which could be mediated by effects of aging on
the composition of the uterine wall, such as increasing
connective tissue between muscle bundles. Alternatively, it
could be mediated at the cellular level, such as effects of aging
on gap junction or ion channel expression. Further studies
will be required to deﬁne further the extent of this functional
impairment and its molecular basis. Whatever the case, these
observations suggest that the increased risk of operative
delivery associated with advancing maternal age may be a
manifestation of impaired uterine function, which is con-
sistent with the overall importance of poor progress in labor
as an indication for cesarean delivery [17]. There are also
speciﬁc ﬁndings that are consistent with an association, for
example the observation that the presence of multiphasic
(also called ‘‘coupled’’) contractions during labor among
nulliparous women monitored with intra-uterine pressure
catheters was associated with prolonged labor and an
increased risk of emergency cesarean delivery [18].
We propose that an association between advancing age and
impaired uterine function is biologically plausible. Women
who delay childbirth using the combined oral contraceptive
pill, barrier methods, nonhormonal intra-uterine devices, or
sexual abstinence (which collectively constitute the majority
of women), will have repetitive cyclical stimulation by
estrogens and progestogens. Myometrium expresses both
estrogen and progesterone receptors and these hormones
have profound effects on myometrial growth, metabolism,
and contractility (see review [19]). We hypothesize that the
adverse effect of advancing maternal age on myometrial
contractility may be a consequence of this prolonged cyclical
stimulation of the myometrium by estrogen and progester-
one. This hypothesis is falsiﬁable, as it predicts that early
menarche would be independently predictive of the risk of
dysfunctional labor. If this hypothesis is true, it may be that
the effect of delaying childbirth on the outcome of labor
varies according to the method of contraception used, which
could be of clinical and public health relevance. Whatever the
case, understanding the determinants and management of
dysfunctional labor in older women is central to designing
strategies for reducing population cesarean delivery rates
without adversely affecting maternal and infant outcomes.
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Editors’ Summary
Background. The rising rates of cesarean sections have been a concern
for over two decades. An acceptable rate of cesarean sections is between
10% and 15% for countries in the developed world, according to the
World Health Organization (WHO). However, the estimated rate in the
United Kingdom was 20% in 2004. In Canada, it was estimated at 22.5%
in 2001–2002. And in the United States, the rate was 30.2% in 2005
(rising 46% since 1996).
This increase may have implications for the mother, baby, healthcare
providers, and policy makers. Though it is difficult to directly compare
risks between vaginal and cesarean deliveries, higher mortality and
morbidity rates are associated with the latter. Risks encountered during
the operation may include anesthetic complications and difficulty in
stopping bleeding. Later risks include infections, wound healing
problems, and increased risk of problems in subsequent pregnancies
including malpresentation, placenta previa, and uterine rupture.
Why Was This Study Done? The trend of increased rates of cesarean
sections with maternal age appears to be consistent in different
countries and has previously been reported by several epidemiological
studies. However, it remains unclear why the risk of having cesarean
section is associated with advancing maternal age. Could the association
reflect a biological effect of advanced age, or is it a consequence of
physician and maternal preference?
The researchers aimed to (1) characterize the association between
maternal age and the outcome of labor, (2) determine the proportion of
the increase in primary cesarean rates that could be attributed to
changes in maternal age distribution, and (3) determine whether the
contractility of uterine smooth muscle (myometrium) varied with
maternal age.
What Did the Researchers Do and Find? To address aims (1) and (2),
the researchers analyzed data collected over the period 1980 to 2005 by
the Scottish Morbidity Record (SMR2), which has been demonstrated to
be 99% complete since the late 1970s and free from substantial errors in
more than 98% of the records in most of the specific fields used for their
analysis.
Their analysis showed a linear association between the risk of having a
cesarean section and advancing maternal age in first pregnancies. The
cesarean rate also more than doubled over the study period. They
estimated that 38% of the additional procedures would have been
avoided if maternal age distribution had remained the same as in 1980.
Therefore they conclude that a substantial part of the increase may be
associated with the trend of delaying of first childbirth.
They then hypothesized that this trend is a result of a biological effect of
aging on the contractility of the uterus. This hypothesis was further
evaluated with aim (3) of the study, where they biopsied the uteri of 62
women (of mixed parity) undergoing routine elective cesarean delivery
to test their contractility. They found that advancing age was associated
with impaired uterine function as evidenced by a reduced degree of
spontaneous contraction and the type of spontaneous contraction.
What Do These Findings Mean? This study adds to the evidence that
advancing maternal age is associated with higher rates of cesarean
sections. It also suggests a possible mechanism for this association, i.e.,
impaired uterine function. Though it was not studied here, the
researchers hypothesize that impaired uterine contractility may be a
consequence of prolonged stimulation of the uterus by estrogen and
progesterone, resulting from a prolonged interval between menarche
and first birth. Further research is needed to understand the
determinants and management of dysfunctional labor in older women
to help design strategies for reducing population cesarean delivery rates
without adversely affecting maternal and infant outcomes.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0050144.
 NHS Choices is a patient information Web site developed to help
patients take control of their health care
 Wikipedia has a section on cesarean section (Note that Wikipedia is an
internet encyclopedia that anyone can edit)
 MedlinePlus also has information on cesarean section
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Objective The risk of operative delivery at term increases linearly
with age at first birth. It has been hypothesised that this is because
of a deleterious effect of a prolonged interval between menarche
and first birth on uterine function. The aim of this study was to
test a prediction from the hypothesis, namely, that the risk of
operative first delivery would decline with later age at menarche.
Design Retrospective analysis of a prospective cohort study.
Setting The ALSPAC prospective cohort study enrolled pregnant
women resident in Avon, UK with expected dates of delivery from
1 April 1991 to 31 December 1992.
Population A total of 3739 primipara recruited to the ALSPAC
cohort who experienced labour at term with a singleton infant in
a cephalic presentation.
Main outcome measure Operative delivery, defined as caesarean
section or operative vaginal birth.
Result The rate of operative delivery was highest among women
with age at menarche in the bottom quartile (32.4%, menarche
aged £12) and was lower in the second (30.3%, menarche aged
13), third (29.2%, menarche aged 14) and top (26.9%,
menarche aged ‡15) quartiles (test for trend, P = 0.01). When
adjusted for height, body mass index, marital status, smoking
status, induction of labour, week of gestation of delivery and
birthweight percentile; the odds ratio for operative delivery
associated with a 5-year increase in age at menarche (0.78, 95%
CI 0.61–0.99) was very similar to the odds ratio for a 5-year
decrease in age at delivery (0.73, 95% CI 0.67–0.79). There was
no association between age at menarche and the risk of
operative delivery following adjustment for the interval between
menarche and the first birth (adjusted odds ratio 0.98, 95% CI
0.77–1.25).
Conclusion Later menarche is associated with a decreased risk of
operative delivery by decreasing the interval between menarche
and first birth. The observation is consistent with the hypothesis
that prolonged hormonal stimulation of the uterus prior to the
first birth has a deleterious effect on uterine function.
Keywords Age, ALSPAC, menarche, operative delivery, pregnancy.
Please cite this paper as: Smith G. Age at menarche and the risk of operative first delivery. BJOG 2009;116:1613–1621.
Introduction
Many studies have demonstrated that the risk of caesarean
delivery was increased among older parturients. Some have
suggested that this observation may reflect physician or
maternal preference1,2 and others that it may reflect a true
biological effect of aging.3,4 The risk of emergency caesar-
ean delivery, the risk of operative vaginal delivery and the
duration of labour all increase linearly with age, from
16 years upwards.3–5 It has been suggested that the pres-
ence of a linear relationship across the whole range of age
at first birth cannot be explained by physician or maternal
preference and is most likely to represent a true biological
effect of aging.3 Consistent with this, it has been shown
that the spontaneous contractility of isolated human myo-
metrial strips in vitro declines with advancing maternal
age.5 Collectively, these observations are consistent with a
biological effect of aging on uterine function. However, it
is currently unclear why advancing age across the range of
the reproductive years might impair uterine function.
Women who delay childbirth will experience prolonged
exposure to the female sex hormones prior to their first
birth. Depending on the contraceptive method employed,
these could be endogenous (for example, women using bar-
rier methods, non-hormonal intrauterine devices and sex-
ual abstinence) or exogenous synthetic derivatives of
progesterone and estrogen (for example, women using the
combined pill). Uterine smooth muscle (myometrium) and
ª 2009 The Author Journal compilation ª RCOG 2009 BJOG An International Journal of Obstetrics and Gynaecology 1613
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the cervix express estrogen and progesterone receptors6,7
and many aspects of uterine function are controlled by the
levels of these hormones (see review8). It had previously
been hypothesised that the association between increasing
age at first birth and dysfunctional labour may be related
to an adverse effect of prolonged pre-pregnancy stimulation
of the uterus by estrogen and progesterone.5 The aim of
the present study was to test a prediction arising from the
hypothesis, namely, that later age at menarche would be
independently predictive of a lower risk of operative first
delivery.
Methods
The ALSPAC prospective cohort study enrolled pregnant
women resident in Avon, UK with expected dates of deliv-
ery from 1 April 1991 to 31 December 1992. The study
design is described in detail elsewhere.9 Ethical approval for
the study was obtained from the ALSPAC Law and Ethics
Committee and the Local Research Ethics Committees.
Women recruited to the study completed questionnaires in
the prenatal period. Pregnancy outcome data were obtained
for cohort members delivering at Southmead or
St Michael’s Hospitals by linking the ALSPAC data to the
hospitals’ computerised birth records (both hospitals
employed the same maternity database, ‘STORK’). These
data were not available for women who delivered in the
other local hospital (Weston General) or who delivered at
home.
Ethnicity, pre-pregnancy weight, height, marital status,
parity and smoking status were all obtained from prenatal
questionnaires. Gestational age was defined using the last
menstrual period with adjustment for ultrasound estima-
tion of gestation where this was available. The birthweight
was taken from the infant’s birth record and was converted
into a percentile for gestational age using previously
described data.10 Cephalic presentation was defined as any
case where the presentation was by the occiput, brow or
face and where both the mode of delivery and indication
for operative delivery were consistent with cephalic presen-
tation. Labour was defined by a non-missing value for
duration of labour and where the mode of delivery was not
elective caesarean delivery. Operative vaginal delivery was
defined as delivery using forceps or vacuum (ventouse) and
all operative delivery was defined as operative vaginal or
caesarean delivery. The computerised birth record was
compared with the clinical notes in a random sample of 50
women from each hospital in both 1991 and 1992. This
demonstrated overall rates of error in coding of method of
labour onset in 6%, presentation in 2% and mode of deliv-
ery in 3%. Checks of internal consistency of the hospital
database also indicated low rates of error. Among 11 089
records documenting cephalic vaginal delivery, only 23
(0.2%) had a missing value for duration of labour. Among
542 records documenting delivery by elective caesarean,
there was only a single record (0.2%) with a documented
duration of labour. Among 11 883 records documenting
cephalic presentation, only 27 (0.2%) documented a mode
of delivery that was indicative of non-cephalic presentation.
The inclusion criteria for the current study were nullipa-
rous women, delivering a singleton, liveborn infant in a
cephalic presentation, in labour at term, who had a docu-
mented age at menarche. Records with any of the above
internal inconsistencies were excluded.
Statistics
Continuous variables were summarised by the median and
inter-quartile range and groups were compared using the
Kruskal–Wallis test. Univariate comparisons of categorical
data were performed using the v2 test for trend. All P val-
ues were two-sided, and a P value <0.05 was considered
significant. Adjusted odds ratios were estimated using mul-
tivariate logistic regression.11 Analysis of the association
between age at menarche and the risk of operative birth
was performed by categorizing age at menarche into quar-
tiles. In further analyses, to compare the relationship
between age at menarche and age at delivery, both variables
were treated as continuous. When treated continuously,
age-related variables were divided by 5 to result in a more
precise estimate of the association when odds ratios were
expressed to 2 decimal places. Age at delivery was expressed
as the odds ratio for a 5-year decrease in age to allow
direct comparison with age at menarche. Approximately
0.5% of values for age at menarche were outside the range
9–17: values below and above this range were truncated as
9 or 17 respectively. Approximately 0.7% of values for age
at delivery were outside the range 16–40: values below and
above this range were truncated as 16 or 40 respectively.
Linearity in the log odds scale was assessed using fractional
polynomials.12 Interactions were tested using the likelihood
ratio test. The principal method for treatment of missing
data was multiple imputation using chained equations.13
To assess whether the method of treatment of missing vari-
ables influenced the analysis, the results of multivariate
analysis using this method was also compared with using
dummy variables to indicate missing data and replacing
missing values with the median (continuous) or most com-
mon (categorical) value for the population. The inter-
relationships between age at menarche, duration of labour,
the interval between menarche and first birth, body mass
index and height were analyzed using multiple linear
regression. All of the above statistical analyses were per-
formed using the Stata software package (Stata Corpora-
tion, College Station, TX, USA), version 10.1. The power
of the study to assess the relationship between age at men-
arche and mode of delivery was assessed using the SD of
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the age at menarche within the study cohort. Power was
calculated using the assumption that a given magnitude of
increase in age at menarche would have the same propor-
tional effect on the odds of operative delivery as the same
decrease in age at the time of the first birth. Power calcula-
tions were performed using nQuery Advisor version 7.0
(Statistical Solutions, Saugus, MA, USA).
Results
The ALSPAC study recruited 14 541 pregnant women who
either returned at least one questionnaire or attended a
‘Children in Focus’ clinic by 19/7/99. There were 9997
(68.2%) records of a liveborn, singleton pregnancy, with a
mode of delivery recorded on the STORK database and
with a documented age at menarche. Among this group,
4382 (43.8%) were documented as nulliparous. Among
these women, 284 (6.5%) delivered outside the range 37–
43 weeks, 369 (8.4%) did not document the infant as being
in a cephalic presentation and 216 (4.9%) had no docu-
mented duration of labour. A total of 643 (14.7%) records
had one or more of these exclusions leaving 3739 eligible
women who were the study group for the present analysis.
The distribution of age at menarche and age at first birth
are illustrated (Figure 1). The mean age at menarche was
12.9 and the SD was 1.55. Age at menarche was positively
associated with height and negatively associated with body
mass index (Table 1). There was a linear decline in the risk
of operative delivery with increasing quartile of age at men-
arche (Figure 2). The rate of operative delivery was highest
among women with age at menarche in the bottom quar-
tile (32.4%, menarche aged £12) and was lower in the sec-
ond (30.3%, menarche aged 13), third (29.2%, menarche
aged 14) and top (26.9%, menarche aged ‡15) quartiles
(odds ratio for 1 quartile increase 0.92, 95% CI 0.86 to
0.98, test for trend, P = 0.01). Adjustment for other mater-
nal characteristics, with missing data handled using multi-
ple imputation, had a minimal effect on the association
between age at menarche and the risk of operative delivery
(adjusted odds ratio for 1 quartile increase 0.93, 95% CI
0.87 to 1.00, test for trend, P = 0.04, Table 2). When the
composite outcome was divided into its two components, a
one quartile increase in age at menarche was associated
with an odds ratio for caesarean section of 0.94 (95% CI
0.82–1.08, P = 0.39) and an odds ratio for assisted vaginal
delivery of 0.92 (95% CI 0.86–0.99, P = 0.02).
A series of analyses was then conducted where age at
menarche and age at delivery were treated as continuous
variables. Logistic regression analysis using multiple frac-
tional polynomials demonstrated that the association
between operative delivery and both age at menarche and
age at delivery were linear in the log odds scale. The pro-
tective effect of a 5 year increase in age at menarche was
very similar to the protective effect of a 5 year decrease in
age at the time of the first delivery (Table 3). Adjustment
for other maternal characteristics has a minimal effect on
the nature and statistical significance of the associations.
Three methods for handing missing data yielded virtually
identical results. The association between operative delivery
and a 5-year increase in age at menarche was unchanged if
cases with extreme values of menarche were excluded
rather than truncated (unadjusted odds ratio 0.72, 95% CI
0.60–0.96, P = 0.02). There was no significant interaction
between age at menarche and whether the onset of labour
was spontaneous or induced (odds ratio for interaction
term 0.86, 95% CI 0.51–1.48, P = 0.59).
The median interval from menarche to first delivery was
14 years (inter-quartile range 11 to 17). This interval was
inversely correlated with age at menarche (r2 = 0.06,
P < 0.001). Adjustment for the duration of this interval
resulted in complete loss of the association between age at
menarche and the risk of operative delivery, but had no
effect on the associations between age at menarche and the
pre-pregnancy body mass index or height (Table 4).
The duration of labour did not differ across the quartiles
of age at menarche. The relationship between age at menar-
che, age at delivery and duration of labour was explored
using linear regression. A 5-year increase in age at menar-
che was associated with )0.09 hour difference in the dura-
tion of labour (95% CI )0.61 to 0.43, P = 0.7). A 5-year
decrease in age at delivery was associated with a )0.33 dif-
ference in duration of labour (95% CI )0.49 to )0.16,
P < 0.001).
Power calculations were performed with the assumption
that a 1 SD increase in age at menarche would be associ-
ated with an odds ratio of 0.879, based on a previous anal-
ysis.5 Setting alpha at 0.05 (two-sided), the size of the
study group yielded 38% power for an outcome with 5%
frequency, 89% power for an outcome with 25% frequency
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Figure 1. Distributions of age at menarche and age at the time of first
birth.
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and 92% power for an outcome with 30% frequency. The
frequency of caesarean delivery in the study group was
5.4%, the frequency of operative vaginal delivery was
25.2% and the frequency of the composite outcome of all
operative delivery was 30.5%.
Discussion
The main finding of the present study is that the risk of
operative delivery at term among nulliparous women
decreased with later age at menarche. The association was
linear and persisted after adjusting for potential confound-
ers, such as maternal height and body mass index. The
relationship between age at menarche and the risk of oper-
ative delivery was because of the fact that age at menarche
in part determined the duration of the interval from men-
arche to the first birth (also known as the gynaecologic
age14). Adjustment for this interval resulted in complete
loss of the association between age at menarche and the
risk of operative delivery. Hence, it is concluded that later
menarche is associated with a decreased risk of operative
delivery by decreasing the interval between menarche and
first birth.
It had previously been hypothesised that increasing age
at the time of first birth increased the risk of operative
delivery by increasing the interval between menarche and
first birth.5 This hypothesis predicts that a woman’s age at
menarche would be negatively associated with her risk of
Table 1. Characteristics of the cohort by quartile of age at menarche
Maternal characteristics and outcome Quartile of age at the time of menarche* **P
1 (n = 1503) 2 (n = 1102) 3 (n = 644) 4 (n = 490)
Age at menarche (range) 8–12 13 14 15–24
Age at delivery
Median (IQR) 27 (24–30) 27 (24–30) 28 (24–30) 27 (24–30) 0.053
Height
Median (IQR) 163 (160–168) 165 (160–170) 165 (160–170) 165 (160–170) <0.001
Body mass index
Median (IQR) 22.4 (20.6–24.5) 21.7 (20.3–23.6) 21.6 (20.3–23.5) 21.5 (19.9–23.5) <0.001
Smoking status
Current 261 (17.4) 168 (15.2) 112 (17.4) 83 (16.9) 0.89
Ethnicity
White 1409 (97.2) 1054 (98.2) 607 (98.1) 447 (97.4) 0.46
Marital status
Married 1033 (70.0) 785 (72.6) 442 (70.5) 314 (66.8) 0.33
Week of gestation
Median (IQR) 40 (39–41) 40 (39–41) 40 (39–41) 40 (39–41) 0.59
Onset of labour
Spontaneous 1171 (77.9) 890 (80.8) 514 (79.8) 398 (81.2) 0.10
Duration of labour
Median (IQR) 8.8 (5.8–12.3) 8.9 (6.0–12.4) 8.5 (5.7–11.9) 8.6 (5.6–12.1) 0.37
Mode of delivery
Operative vaginal 401 (26.7) 278 (25.2) 152 (23.6) 110 (22.4) 0.03
Caesarean 86 (5.7) 56 (5.1) 36 (5.6) 22 (4.5) 0.39
Birthweight percentile
1–5 75 (5.0) 66 (6.1) 34 (5.4) 25 (5.2) 0.85
6–10 76 (5.1) 48 (4.4) 22 (3.5) 21 (4.4) 0.19
11–25 206 (13.9) 134 (12.3) 83 (13.0) 65 (13.5) 0.70
26–75 819 (55.2) 620 (56.9) 353 (55.5) 269 (55.8) 0.80
76–90 218 (14.7) 153 (14.0) 103 (16.2) 73 (15.2) 0.54
91–95 56 (3.8) 45 (4.1) 27 (4.2) 18 (3.7) 0.84
96–100 35 (2.4) 23 (2.1) 14 (2.2) 11 (2.3) 0.87
IQR, inter-quartile range.
Data were missing from (n) records in relation to height (61), body mass index (254), marital status (86), ethnicity (138) and birthweight percentile
(47).
*Numbers in quartiles are unequal due to ties.
**Chi-square test for trend or Kruskal–Wallis test, as appropriate. Data expressed as n (percent) unless stated otherwise.
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operative delivery. Three features of the present analysis
support this hypothesis. First, the relationship between age
at menarche and the risk of operative delivery was indepen-
dent of other maternal characteristics. Second, the propor-
tional effect of a given increase in the age at menarche was
similar to a given decrease in age at first birth. Third, the
association between age at menarche and the risk of opera-
tive delivery was no longer apparent when adjusted for the
interval between menarche and first birth. The current
analysis provides strong evidence in support of the hypoth-
esis. Hence, this analysis is significant in that it is the first
description of the association between age at menarche and
the risk of operative birth. However, the key significance of
the current analysis is that it suggests a mechanism linking
delayed childbirth to the risk of operative delivery, that is
that the true mediator of the associations between the risk
of operative delivery and both age at menarche and age at
first birth is the duration of the interval between menarche
and first birth. The public health importance of this is that
delaying childbirth is a major determinant of recent rises in
the caesarean section rate.5
A prolonged interval between menarche and first birth
will result in prolonged pre-pregnancy stimulation of the
uterus by estrogen and progesterone, with the exact pattern
being determined by the contraceptive method employed.
The most common cause for operative delivery among
women having their first birth during labour at term is
poor progress during labour.15,16 The current analysis is
consistent with the hypothesis that prolonged pre-preg-
nancy stimulation of the uterus by estrogen and progester-
one adversely affects the uterus in a way that impairs its
function during labour. The hypothesis has parallels in
relation to other disorders of the female reproductive
organs, in particular the risk of breast cancer. The risk of
this condition is also decreased with later age at menarche.
This association is thought to be because of an adverse
effect of prolonged stimulation by mammotrophic hor-
mones, principally estrogens and progestogens.17 Given that
the uterus is also profoundly under the control of these
hormones,8 it is biologically plausible that prolonged pre-
pregnancy stimulation of the uterus by estrogen and pro-
gesterone could also adversely affect uterine function.
The prospective design of this study means that women
were asked about their age at menarche prior to delivery,
precluding the possibility of recall bias in relation to ulti-
mate mode of delivery. A further strength of this study was
the availability of detailed information on relevant potential
confounders. Early menarche was associated with short
stature and obesity and both are recognised to be risk fac-
tors for operative delivery.18 Although the association was
largely unchanged by multivariate analysis, the persisting
association may be explained by residual confounding. In
particular, body mass index is a proxy measure of adiposity
and it is possible that residual confounding by obesity may
explain the results observed. This question was addressed
by examining the effect of adjusting associations between
age at menarche for the interval between menarche and
first birth. It was observed that adjustment for this interval
abolished the association between age at menarche and the
risk of operative delivery (Table 4). By contrast, adjustment
for the interval between menarche and first birth had no
material effect on the association between age at menarche
and either maternal height or BMI. This analysis demon-
strates that age at menarche is associated with the risk of
operative delivery by its contribution to the interval
between menarche and first birth. Moreover, it indicates
that the association between age at menarche and maternal
anthropometric characteristics is mediated by a different
mechanism.
A relative weakness of this study is that these data were
collected in 1991–1992. Consequently, the rates of operative
delivery were relatively low, with a caesarean delivery rate
of 5.4%. Power calculations demonstrated that the study
had approximately 90% power to detect an effect of age at
menarche on the risk of all operative delivery, but only
approximately 40% power to detect an association with
caesarean delivery. Hence, the study was underpowered to
detect an effect of age at menarche on caesarean section
risk alone but was adequately powered to detect an effect
on the composite outcome of operative delivery. It may be
argued that the composite outcome is determined by many
factors, such as fetal distress and maternal exhaustion.
However, the primary aim of the present study was to shed
light on the relationship between maternal age and the risk
of operative delivery. In a previous study of nulliparous
women in labour at term with an infant in a cephalic pre-
sentation, we demonstrated that a 5-year increase in mater-
nal age was associated with an odds ratio for assisted
vaginal delivery of 1.49 (95% CI 1.48–1.50) and an odds
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Figure 2. Proportion of operative deliveries by age at menarche.
P value is estimated using chi-square test for trend.
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Table 2. Unadjusted and adjusted odds ratios for operative delivery in relation to maternal characteristics
Variable Unadjusted Adjusted
Odds ratio (95% CI) P Odds ratio (95% CI) P
Quartile of age at menarche
1 (referent) (1.0) (1.0)
2 0.91 (0.77–1.07) 0.26 0.94 (0.79–1.12) 0.47
3 0.86 (0.70–1.05) 0.14 0.87 (0.71–1.08) 0.21
4 0.77 (0.61–0.97) 0.02 0.80 (0.63–1.01) 0.06
Trend 0.92 (0.86–0.98) 0.01 0.93 (0.87–1.00) 0.04
Age at delivery
<20 0.33 (0.23–0.47) <0.001 0.34 (0.23–0.50) <0.001
20–24.9 0.54 (0.44–0.67) <0.001 0.53 (0.43–0.67) <0.001
25–29.9 0.76 (0.63–0.91) 0.002 0.74 (0.62–0.89) 0.001
30–34.9 (referent) (1.0) (1.0)
35–39.9 0.99 (0.72–1.36) 0.96 0.98 (0.70–1.36) 0.90
‡40 0.88 (0.37–2.10) 0.78 1.00 (0.41–2.43) >0.99
Height
<155 1.53 (1.18–1.99) 0.001 1.75 (1.33–2.31) <0.001
155–159 1.31 (1.03–1.68) 0.03 1.48 (1.14–1.92) 0.003
160–164 1.20 (0.99–1.46) 0.06 1.25 (1.02–1.53) 0.03
165–169 (referent) (1.0) (1.0)
170–174 0.88 (0.71–1.10) 0.26 0.84 (0.67–1.05) 0.12
>175 0.94 (0.68–1.31) 0.73 0.84 (0.60–1.18) 0.31
Body mass index
<20 0.91 (0.75–1.10) 0.33 1.08 (0.89–1.31) 0.44
20–24.9 (referent) (1.0) (1.0)
25–29.9 1.18 (0.96–1.46) 0.12 1.06 (0.85–1.31) 0.61
30–34.9 1.36 (0.88–2.09) 0.17 1.05 (0.67–1.64) 0.83
‡35 2.09 (1.06–4.13) 0.03 1.49 (0.73–3.04) 0.28
Smoking status
Nonsmoker (referent) (1.0) (1.0)
Smoker 0.80 (0.66–0.96) 0.02 0.98 (0.80–1.21) 0.87
Ethnicity
White (referent) (1.0) (1.0)
Non-White 0.86 (0.53–1.39) 0.53 0.95 (0.57–1.57) 0.84
Marital status
Married (referent) (1.0) (1.0)
Un-married 0.68 (0.58–0.80) <0.001 0.89 (0.74–1.08) 0.24
Onset of labour
Spontaneous (referent) (1.0) (1.0)
Induced 1.89 (1.61–2.23) <0.001 1.72 (1.44–2.05) <0.001
Week of gestation
37 0.67 (0.46–0.96) 0.03 0.53 (0.36–0.78) 0.001
38 0.74 (0.57–0.96) 0.02 0.64 (0.49–0.84) 0.001
39 0.79 (0.64–0.97) 0.02 0.74 (0.60–0.92) 0.006
40 (referent) (1.0) (1.0)
41 1.40 (1.16–1.69) <0.001 1.41 (1.17–1.71) <0.001
42 1.88 (1.46–2.42) <0.001 1.65 (1.26–2.16) <0.001
43 1.60 (0.56–4.52) 0.38 1.16 (0.39–3.43) 0.79
Birthweight percentile
1–5 1.00 (0.73–1.37) >0.99 0.82 (0.59–1.15) 0.25
6–10 0.94 (0.66–1.33) 0.74 0.85 (0.59–1.22) 0.38
11–25 0.87 (0.69–1.08) 0.20 0.78 (0.62–0.98) 0.04
26–75 (referent) (1.0) (1.0)
76–90 1.12 (0.91–1.37) 0.28 1.23 (0.99–1.53) 0.06
91–95 1.29 (0.91–1.84) 0.15 1.61 (1.11–2.32) 0.01
96–100 2.17 (1.40–3.38) 0.001 2.66 (1.67–4.25) <0.001
CI, confidence interval.
*Adjusted for quartile of age at menarche (categorical), maternal age, height, body mass index, smoking status, ethnicity, marital status, induced
labour, gestational age at birth and birthweight percentile. Missing data handled by multiple imputation using chained equations.
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ratio for emergency caesarean section of 1.49 (95% CI
1.48–1.51).5 Given the virtually identical relationships
between maternal age and the risk of both assisted vaginal
delivery and emergency caesarean section, we conclude that
the composite outcome is appropriate given our primary
interest in the effects of maternal age.
The STORK database lacked validated information on
the indication for delivery. However, a prospective analysis
of the indication for primary intrapartum caesarean section
in nulliparous women at term in 1991 demonstrated that
over half of these procedures with the infant in a cephalic
presentation were due to failure to progress.19 Although we
did not observe significant variation in the duration of
labour in association with age at menarche, linear regres-
sion analysis demonstrated wide confidence intervals and
these included the point estimate for the association with
maternal age. Duration of labour is difficult to define and
any retrospective analysis of data collected for other pur-
poses is likely to face problems with the reliability of indi-
cators of progress in labour. We are addressing this by
conducting a prospective cohort study of unselected nullip-
arous women, which addresses some of the weaknesses of
the present analysis, in that we are collecting detailed infor-
mation on contraceptive history, in addition to age at men-
arche, and outcome data is being collected in a systematic
fashion and includes information on duration and dose of
oxytocin use.20
The public health importance of this finding is that pop-
ulation trends in delaying childbirth appear to be an
important determinant of recent increases in caesarean
delivery rates.5 The present analysis suggests a likely mecha-
nism for this association. Moreover, age at menarche has
fallen over recent years.21 The current data suggest that a
consequence of this change may be to increase the inci-
dence of poor progress during labour and, hence, popula-
tion trends of earlier menarche may also have contributed
to recent rises in rates of caesarean delivery. Mechanistic
understanding of the basis for this effect could possibly
identify whether different methods of hormonal contracep-
tion might have different effects on the deterioration in
Table 3. Analysis of age at menarche and age at birth as continuous variables
OR for 5 year increase
in age at menarche (95% CI)
P OR for 5 year decrease
in age at delivery (95% CI)
P
Unadjusted 0.76 (0.60–0.95) 0.02 0.73 (0.71–0.75) <0.001
Adjusted* 1 0.78 (0.61–0.99) 0.04 0.73 (0.67–0.79) <0.001
Adjusted* 2 0.78 (0.61–1.00) 0.046 0.72 (0.67–0.79) <0.001
Adjusted* 3 0.77 (0.60–0.98) 0.04 0.72 (0.66–0.78) <0.001
CI, confidence interval; OR, odds ratio.
Adjusted odds ratios using three methods for treating missing data: 1 using multiple imputation using chained equations, 2 by assigning median
or most common value to missing value, 3 by creating dummy variables for missing value and including in the model.
*Adjusted for height, body mass index, smoking status, ethnicity, marital status, induced labour, gestational age at birth and birthweight percen-
tile.
Table 4. The effect of adjustment for the duration of the interval between menarche and first delivery on the associations with age at menarche
Associations with a 5-year increase in age at menarche
Unadjusted (95% CI) P Adjusted* (95% CI) P
Operative delivery
Odds ratio 0.76 (0.60–0.95) 0.02 0.98 (0.77–1.25) 0.87
Body mass index
Coefficient )1.69 ()2.07 to )1.31) <0.001 )1.58 ()1.97 to )1.19) <0.001
Height
Coefficient 2.16 (1.46–2.85) <0.001 2.40 (1.69 to 3.11) <0.001
Body mass index is expressed in kg/m2, height is expressed in cm. Odds ratios estimated using logistic regression and coefficients by linear regres-
sion.
*Adjusted for the interval between menarche and first birth only.
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uterine function among women who wish to delay child-
birth. For example, it is possible that any adverse effect on
the uterus of prolonged pre-pregnancy use of exogenous
synthetic estrogen and progesterone for contraception may
differ in relation to cyclical or noncyclical administration.
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Interpregnancy interval and risk of preterm birth and
neonatal death: retrospective cohort study
Gordon C S Smith, Jill P Pell, Richard Dobbie
Abstract
Objective To determine whether a short interval
between pregnancies is an independent risk factor for
adverse obstetric outcome.
Design Retrospective cohort study.
Setting Scotland.
Subjects 89 143 women having second births in
1992-8 who conceived within five years of their first
birth.
Main outcome measures Intrauterine growth
restriction (birth weight less than the 5th centile for
gestational age), extremely preterm birth (24-32
weeks), moderately preterm birth (33-36 weeks), and
perinatal death.
Results Women whose subsequent interpregnancy
interval was less than six months were more likely
than other women to have had a first birth
complicated by intrauterine growth restriction (odds
ratio 1.3, 95% confidence interval 1.1 to 1.5),
extremely preterm birth (4.1, 3.2 to 5.3), moderately
preterm birth (1.5, 1.3 to 1.7), or perinatal death (24.4,
18.9 to 31.5). They were also shorter, less likely to be
married, and more likely to be aged less than 20 years
at the time of the second birth, to smoke, and to live
in an area of high socioeconomic deprivation. When
the outcome of the second birth was analysed in
relation to the preceding interpregnancy interval and
the analysis confined to women whose first birth was
a term live birth (n = 69 055), no significant
association occurred (adjusted for age, marital status,
height, socioeconomic deprivation, smoking, previous
birth weight vigesimal, and previous caesarean
delivery) between interpregnancy interval and
intrauterine growth restriction or stillbirth. However, a
short interpregnancy interval ( < 6 months) was an
independent risk factor for extremely preterm birth
(adjusted odds ratio 2.2, 1.3 to 3.6), moderately
preterm birth (1.6, 1.3 to 2.0), and neonatal death
unrelated to congenital abnormality (3.6, 1.2 to 10.7).
The adjusted attributable fractions for these
associations were 6.1%, 3.9%, and 13.8%. The
associations were very similar when the analysis was
confined to married non-smokers aged 25 and above.
Conclusions A short interpregnancy interval is an
independent risk factor for preterm delivery and
neonatal death in the second birth.
Introduction
Several studies have shown that women with a very
short interval between pregnancies are at increased
risk of complications such as preterm birth, neonatal
death, and intrauterine growth restriction.1–10 However,
these studies do not clarify whether the associations
are due to confounding effects of adverse obstetric his-
tory or to demographic factors.Women with very short
interpregnancy intervals are more likely to have had
complications such as perinatal death, preterm birth,
and intrauterine growth restriction in their first
pregnancy.11 A short interpregnancy interval is also
associated with known demographic risk factors for
complications of pregnancy.12 13 Many previous studies
of the association between interpregnancy interval and
the risk of adverse outcome have lacked information
on maternal demographic factors and have had either
no information on the outcome of previous pregnan-
cies or minimal information. None of the studies that
were powered to detect differences in rare but
important outcomes, such as perinatal death and
extremely preterm birth, had data on key obstetric and
demographic confounders.6 7 9 10 We report the relation
between interpregnancy interval and the outcome of
first and second births in a cohort of 89 143 women.
Methods
Data sources
The Scottish Morbidity Record collects information on
clinical and demographic characteristics and outcomes
for all patients discharged from Scottish maternity
hospitals. The register is subjected to regular quality
assurance checks and has been greater than 99% com-
plete since the late 1970s.14 We linked records from the
register to records from the Scottish Stillbirth and
Infant Death Enquiry, a national register that routinely
classifies all perinatal deaths in Scotland. It is virtually
100% complete and has been described in detail
elsewhere.15 16 We also linked the records from different
pregnancies in the same women. All linkages were per-
formed as previously described.17
Study cohort
The population studied consisted of all second births
in Scotland in 1992-8. The study focused on births in
1992-8 as the Scottish Morbidity Record database
included smoking status only from 1992 onwards.
When studying the relation between interpregnancy
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interval and the outcome of the first pregnancy, we
used exclusion criteria (both pregnancies) of multiple
pregnancy, delivery outside the range 24-43 weeks’
gestation, and birth weight less than 500 g. We also
excluded cases in which the interpregnancy interval
was negative or implausibly short, a discrepancy
existed between the documented mode of delivery in
the first record and the previous caesarean delivery
field in the second record, or the number of previous
spontaneous or therapeutic abortions differed
between the first and second birth record. The last of
these processes excluded cases in which the records
were discrepant (fewer losses documented for the
second birth) and cases in which the woman had expe-
rienced losses between the two births (more losses
documented for the second birth). These inclusions
and exclusions identified the first study group.
We analysed the relation of interpregnancy interval
to the outcome of the second birth in a subgroup of
the main cohort. We defined this subgroup by exclud-
ing cases in which the first birth was outside the range
37-43 weeks, the first birth was a perinatal or infant
death, or the birth weight of the first child was less than
1500 g. We also excluded cases in which data were
missing on potential confounders in the second preg-
nancy record: maternal age, marital status, height, dep-
rivation category, or smoking status. We also excluded
cases in which the birth weight vigesimal of the first
pregnancy was missing. These inclusions and exclu-
sions identified the second study group.
Definitions
Maternal characteristics
In the comparison of risk of adverse obstetric outcome,
we considered the following demographic factors as
possible confounders: socioeconomic deprivation,
smoking, maternal age, and maternal height; their
classification has been defined elsewhere.18 We also
included marital status, defined as the status docu-
mented at the time of booking for antenatal care and
categorised into married and non-married.
Obstetric characteristics
We defined first births as either first pregnancies or
births preceded only by pregnancies that resulted in
abortion. We defined second births as having been
preceded by one pregnancy that did not result in abor-
tion. We defined gestational age at birth as the number
of completed weeks of gestation based on the
estimated delivery date contained in the clinical record.
Over the study period the vast majority of estimates of
gestational age in the United Kingdom incorporated
ultrasound measurements taken in the first half of
pregnancy.19 We defined interpregnancy interval as the
interval from the first birth until the estimated date of
the last menstrual period before the second pregnancy,
expressed in completed months. We calculated the
ultrasound corrected date of the last menstrual period
by subtracting the gestational age at birth from the date
of delivery. In order to avoid bias in categorisation of
interpregnancy interval, we used the categories used by
a previous large scale study.7
We categorised birth weight into sex specific and
gestational age specific vigesimals (20 equal groups)
derived from live births among the whole population.
We defined a small for gestational age baby as a liveborn
baby with a birth weight in the smallest vigesimal (that is,
0 to 5th centile), and the denominator was all live births.
We defined very preterm delivery as live births between
24 and 32 weeks’ gestation inclusive, and the denomina-
tor was all live births at or after 24 weeks’ gestation. We
defined moderately preterm delivery as live births
between 33 and 36 weeks’ gestation inclusive, with a
denominator of all live births at or after 33 weeks’ gesta-
tion. We defined spontaneous preterm birth as vaginal
birth at the given gestational age, excluding cases in
which labour was induced.We defined stillbirth as deliv-
ery of a dead baby at or after 24 weeks’ gestational age,
and the denominator was all births at or after 24 weeks’
gestational age.We defined neonatal death as death of a
liveborn infant in the first four weeks of life, and the
denominator was all live births.
Perinatal deaths
We defined deaths caused by congenital anomaly as
any structural or genetic defect incompatible with life
or potentially treatable but causing death. We classified
stillbirths as antepartum (deaths before the onset of
labour) or intrapartum (deaths during labour). We
classified the cause of antepartum stillbirth according
to a modified version of the Wigglesworth hierarchical
system,20 which is described in detail elsewhere.16 We
classified perinatal deaths into four mutually exclusive
categories: (a) all deaths related to fetal abnormality or
rhesus isoimmunisation; (b) unexplained stillbirths; (c)
all other stillbirths; and (d) all other neonatal deaths
(excluding category (a)).
Statistical analyses
We summarised continuous variables by the median
and interquartile range and used the Mann-Whitney U
test to make comparisons between groups. We made
univariate comparisons of dichotomous data by using
the 2 test ( > 5 observations in all cells) or Fisher’s
exact test ( ≤ 5 observations in one or more cells). The
P values for all hypothesis tests were two sided, and we
set statistical significance at P < 0.05. We used
multivariate logistic regression analysis to assess the
risk of adverse obstetric outcome. We did both univari-
ate and multivariate analyses on only those records
with no missing values for any of the maternal covari-
ates included in the multivariate model. We used the
Hosmer and Lemeshow test to assess the goodness of
fit of logistic regression models.21 We assessed the
statistical significance of interaction terms by using the
likelihood ratio test and assumed significance of inter-
actions at P < 0.01. We defined the attributable fraction
as Pr(exposed/disease)*(1 − 1/relative risk). This can
be conceptualised as the proportion of cases that
would have been prevented if the exposure did not
exist in a population. We calculated adjusted attribut-
able fractions after multivariate logistic regression by
using the method of Greenland and Drescher.22 We
used the Stata software package, version 7.0, for all
statistical analyses.
Results
The figure outlines the selection of the two study
groups. Approximately 5.4% of the cohort had an
interpregnancy interval of less than six months.
Papers
page 2 of 6 BMJ VOLUME 327 9 AUGUST 2003 bmj.com
Page 137
Women who subsequently had a short interpregnancy
interval were more likely to have experienced compli-
cations in their first pregnancy (table 1). Compared
with women who had an interpregnancy interval of
18-23 months, those with an interval of less than six
months had a 30-50% excess of intrauterine growth
restriction and moderately preterm birth in their first
pregnancy, a fourfold excess of extremely preterm
birth, and a greater than 20-fold excess of perinatal
deaths. An excess of extremely preterm first births
existed among women whose subsequent interpreg-
nancy interval was 2-5 years.
All analyses of the outcome of the second birth
were confined to the subgroup of women whose first
birth was a term live birth. Even among this group, at
the time of their second delivery, women with a short
interval between their first and second pregnancy were
more likely to be aged less than 20, to smoke, and to
live in an area of high deprivation and were less likely
to be married, to be aged greater than 35, and to live in
an area of low socioeconomic deprivation (table 2).
On univariate analysis of obstetric outcome in the
second birth, women with a short interpregnancy inter-
val were more likely to have an extremely preterm birth,
a moderately preterm birth, or a neonatal death (table
3). The strength of these associations was attenuated by
adjustment for maternal age, marital status, height,
socioeconomic deprivation category, smoking, previous
birth weight vigesimal, and previous caesarean section,
but significant associations persisted in multivariate
analysis. The adjusted attributable fractions for these
associations were 6.1% (95% confidence interval 1.9% to
10.2%) for extremely preterm birth, 3.9% (1.3% to 4.2%)
for moderately preterm birth, and 13.8% (0.2% to
25.6%) for neonatal death unrelated to fetal abnormality.
The excess of preterm second births persisted when the
analysis was confined to spontaneous preterm births.An
interpregnancy interval of less than six months was
associated with an increased risk (compared with an
interpregnancy interval of 18-23 months) of spontane-
ous preterm birth, both 24-32 weeks (adjusted odds ratio
2.2, 95% confidence interval 1.2 to 4.1) and 33-36 weeks
(1.6, 1.2 to 2.2). The associations between interpreg-
nancy interval and unexplained stillbirth were virtually
identical when estimated using time to event methods
(data not shown).
We explored the relations between interpregnancy
interval, maternal age, and other maternal factors and
the outcome of the second birth in more detail. The
attenuation of the association between interpregnancy
interval and adverse outcome in multivariate analysis
was principally due to the effect of adjustment for age
(table 4). The odds ratio for interpregnancy interval
adjusted for age alone was very similar to the odds
ratio adjusted for age plus the other maternal
covariates. Maternal age less than 20 years at the time
of the second birth was strongly associated with
preterm birth and neonatal death. The association
remained statistically significant in multivariate analy-
sis but was attenuated by adjustment for both
interpregnancy interval and other maternal factors. No
statistically significant interactions existed between
interpregnancy interval and maternal age, marital
Second births, 1992-8 (n=144 457)
Study group 1 (n=89 143)
Study group 2 (n=69 055)
Data on birth weight and gestation available
for second pregnancy (n=144 043)
Data missing or ineligible (n=414)
Number of therapeutic or spontaneous abortions
identical in first and second records
First pregnancy within range 37-43 weeks, birth weight
>1500 g, and did not end in perinatal death (n=83 290)
Record for first pregnancy in 1980-98, interpregnancy
range 29-1826 days (inclusive) (n=107 414)
Data on birth weight and gestation available for first
pregnancy and no discrepancy between mode of delivery in
first record and previous caesarean field in second (n=105 270)
No missing values in second pregnancy record
for maternal height, deprivation category,
age, smoking status, or marital status
No record or outside
range (n=36 629)
Data missing or records
discrepant (n=2144)
Number differs (n=16 127)
Missing values (n=14 235)
First pregnancy outside range,
birth weight <1500 g, or ended
in perinatal death (n=5853)
Flow diagram of cohort selection
Table 1 Outcome of first pregnancy in relation to interval between first and second pregnancies (n=89 143)
Outcome of first pregnancy
Interpregnancy interval*
1-5 months 6-11 months 12-17 months
18-23
months* 24-59 months
No (%)
Odds ratio
(95% CI) No (%)
Odds ratio
(95% CI) No (%)
Odds ratio
(95% CI) No (%) No (%)
Odds ratio
(95% CI)
No of births 4816 – 11 927 – 15 771 – 15 014 41 615 –
Birth weight <5th centile 298 (6.6) 1.3 (1.1 to 1.5) 613 (5.2) 1.0 (0.9 to 1.1) 804 (5.1) 1.0 (0.9 to 1.1) 768 (5.1) 2347 (5.6) 1.1 (1.0 to 1.2)
Preterm delivery:
24-32 weeks 146 (3.2) 4.1 (3.2 to 5.3) 181 (1.5) 1.9 (1.5 to 2.4) 155 (1.0) 1.2 (1.0 to 1.6) 120 (0.8) 458 (1.1) 1.4 (1.1 to 1.7)
33-36 weeks 257 (5.9) 1.5 (1.3 to 1.7) 570 (4.9) 1.2 (1.1 to 1.4) 662 (4.3) 1.1 (1.0 to 1.2) 592 (4.0) 1830 (4.4) 1.1 (1.0 to 1.2)
Perinatal death:
All causes† 481 (10.0) 24.4 (18.9 to 31.5) 247 (2.0) 4.6 (3.5 to 6.1) 103 (0.6) 1.4 (1.1 to 2.0) 68 (0.4) 120 (0.3) 0.6 (0.5 to 0.9)
Fetal abnormality or rhesus 71 (1.5) 15.0 (8.6 to 26.1) 38 (0.3) 3.2 (1.8 to 5.8) 21 (0.1) 1.3 (0.7 to 2.6) 15 (0.1) 26 (0.1) 0.6 (0.3 to 1.2)
Unexplained stillbirth 188 (3.9) 30.5 (19.2 to 48.3) 87 (0.7) 5.5 (3.4 to 9.0) 37 (0.2) 1.8 (1.0 to 3.0) 20 (0.1) 36 (0.1) 0.6 (0.4 to 1.1)
All other stillbirths 109 (2.3) 20.4 (12.2 to 34.1) 55 (0.5) 4.1 (2.4 to 7.0) 21 (0.1) 1.2 (0.6 to 2.2) 17 (0.1) 24 (0.1) 0.5 (0.3 to 0.9)
All other neonatal deaths 110 (2.3) 23.4 (13.6 to 40.1) 65 (0.5) 5.5 (3.1 to 9.6) 23 (0.2) 1.5 (0.8 to 2.8) 15 (0.1) 34 (0.1) 0.8 (0.4 to 1.5)
All percentages calculated relative to appropriate denominators (see methods).
*Reference category for odds ratios was women with interpregnancy interval of 18-23 months.
†Seven perinatal deaths were not classified.
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status, height, socioeconomic deprivation category,
smoking, previous birth weight vigesimal, or previous
caesarean section in predicting adverse obstetric
outcome in the second pregnancy. The strengths of the
associations were virtually identical when confined to
married non-smokers aged 25 or above: in this group
an interpregnancy interval of less than six months was
associated with an odds ratios of 2.8 (1.3 to 5.9) for
extremely preterm birth and 1.7 (1.2 to 2.4) for moder-
ately preterm birth.
We considered the possibility that misclassification
of gestational age may have affected the results by
examining the association between interpregnancy
interval and absolute values of birth weight in the
second pregnancy. An interpregnancy interval of less
than six months was associated with an increased risk
of delivering a low birth weight neonate (adjusted odds
ratio 1.5, 1.2 to 1.8) or a very low birth weight neonate
(1.9, 1.0 to 3.4). We considered the possibility that
excluding the 14 255 cases with missing values for
potential confounders from the second study group
may have affected our results. However, univariate
analysis of second pregnancy outcomes including
these cases showed positive associations between a one
to five month interval (18-23 months as reference
group) and extreme preterm birth (odds ratio 2.8, 1.9
to 4.2), moderate preterm birth (2.0, 1.6 to 2.4), and
neonatal death unrelated to congenital abnormality
(3.2, 1.3 to 7.9).
Discussion
The main finding of this study is that in women having
a second birth a short preceding interpregnancy inter-
Table 2 Demographic factors at time of second pregnancy in relation to interpregnancy interval in women with previous term live
birth (n=69 055). Values are numbers (percentages)
Interpregnancy interval (months)
Total (n=69 055) P value1-5 (n=3282) 6-11 (n=8999) 12-17 (n=12 220) 18-23 (n=11 793) 24-59 (n=32 761)
Height (cm):
<155 349 (10.6) 843 (9.3) 1 068 (8.7) 1 125 (9.5) 3 614 (11.0) 6 990 (10.1)
<0.001155-170 2654 (80.9) 7160 (79.6) 9 868 (80.8) 9 398 (79.7) 26 299 (80.3) 55 379 (80.2)
>170 279 (8.5) 1005 (11.2) 1 284 (10.5) 1 270 (10.8) 2 848 (8.7) 6 686 (9.7)
Age (years):
<20 547 (16.7) 669 (7.4) 501 (4.1) 278 (2.4) 234 (0.7) 2 229 (3.2)
<0.00120-35 2624 (80.0) 7899 (87.8) 11 120 (91.0) 10 961 (92.9) 30 655 (93.6) 63 259 (91.6)
>35 111 (3.4) 431 (4.8) 599 (4.9) 554 (4.7) 1 872 (5.7) 3 567 (5.2)
Marital status:
Married 1949 (59.4) 6714 (74.6) 9 681 (79.2) 9 615 (81.5) 25 315 (77.3) 53 274 (77.2)
<0.001
Other 1333 (40.6) 2285 (25.4) 2 539 (20.8) 2 178 (18.5) 7 446 (22.7) 15 781 (22.8)
Deprivation category:
1 (least deprived) 484 (14.8) 1919 (21.3) 2 933 (24.0) 2 720 (23.1) 6 045 (18.4) 14 101 (20.4)
<0.0012-4 1915 (58.4) 5397 (60.0) 7 242 (59.3) 7 104 (60.2) 19 809 (60.5) 41 467 (60.0)
5 (most deprived) 883 (26.9) 1683 (18.7) 2 045 (16.7) 1 969 (16.7) 6 907 (21.1) 13 487 (19.5)
Smoking status:
Non-smoker 1839 (56.0) 6078 (67.5) 8 560 (70.0) 8 309 (70.5) 21 279 (65.0) 46 065 (66.7)
<0.001Ex-smoker 193 (5.9) 536 (6.0) 797 (6.5) 759 (6.4) 2 533 (7.7) 4 818 (7.0)
Smoker 1250 (38.1) 2385 (26.5) 2 863 (23.4) 2 725 (23.1) 8 949 (27.3) 18 172 (26.3)
Table 3 Crude and adjusted odds ratios for interpregnancy interval and the outcome of the second pregnancy (n=69 055)
Outcome of
second
pregnancy
Interpregnancy interval*
1-5 months (n=3282) 6-11 months (n=8999) 12-17 months (n=12 220)
18-23
months*
(n=11 793) 24-59 months (n=32 761)
No (%)
Odds ratio (95% CI)
No (%)
Odds ratio (95% CI)
No (%)
Odds ratio (95% CI)
No (%) No (%)
Odds ratio (95% CI)
Crude Adjusted† Crude Adjusted† Crude Adjusted† Crude Adjusted†
Birth weight
<5th centile
99
(3.0)
1.1
(0.9 to 1.4)
0.8
(0.7 to 1.1)
234
(2.6)
1.0
(0.8 to 1.1)
0.9
(0.8 to 1.1)
325
(2.7)
1.0
(0.8 to 1.1)
1.0
(0.8 to 1.2)
321
(2.7)
987
(3.0)
1.1
(1.0 to 1.3)
1.0
(0.9 to 1.1)
Preterm delivery:
24-32
weeks
32
(1.0)
3.1
(1.9 to 4.9)
2.2
(1.4 to 3.6)
46
(0.5)
1.6
(1.0 to 2.4)
1.4
(0.9 to 2.2)
48
(0.4)
1.2
(0.8 to 1.9)
1.2
(0.8 to 1.8)
38
(0.3)
122
(0.4)
1.2
(0.8 to 1.7)
1.1
(0.8 to 1.6)
33-36
weeks
130
(4.0)
2.0
(1.6 to 2.4)
1.6
(1.3 to 2.0)
218
(2.4)
1.2
(1.0 to 1.4)
1.1
(0.9 to 1.3)
280
(2.3)
1.1
(0.9 to 1.3)
1.1
(0.9 to 1.3)
244
(2.1)
800
(2.5)
1.2
(1.0 to 1.4)
1.2
(1.0 to 1.3)
Perinatal death:
Fetal
abnormality
or rhesus
6
(0.2)
1.4
(0.6 to 3.7)
1.2
(0.5 to 3.3)
12
(0.1)
1.0
(0.5 to 2.2)
1.0
(0.5 to 2.1)
17
(0.1)
1.1
(0.5 to 2.2)
1.2
(0.5 to 2.2)
15
(0.1)
45
(0.1)
1.1
(0.6 to 1.9)
1.1
(0.6 to 2.0)
Unexplained
stillbirth
7
(0.2)
1.6
(0.6 to 3.8)
1.2
(0.5 to 3.0)
10
(0.1)
0.8
(0.4 to 1.8)
0.7
(0.3 to 1.7)
20
(0.2)
1.2
(0.6 to 2.3)
1.2
(0.6 to 2.3)
16
(0.1)
55
(0.2)
1.2
(0.7 to 2.2)
1.2
(0.7 to 2.1)
All other
stillbirths
5
(0.2)
2.6
(0.8 to 8.1)
2.3
(0.7 to 7.2)
9
(0.1)
1.7
(0.6 to 4.5)
1.7
(0.6 to 4.5)
12
(0.1)
1.7
(0.7 to 4.2)
1.7
(0.7 to 4.3)
7
(0.1)
27
(0.1)
1.4
(0.6 to 3.2)
1.2
(0.5 to 2.8)
All other
neonatal
deaths
9
(0.3)
5.4
(1.9 to 15.2)
3.6
(1.2 to 10.7)
10
(0.1)
2.2
(0.8 to 6.0)
1.9
(0.7 to 5.2)
2
(0.0)
0.3
(0.1 to 1.6)
0.3
(0.1 to 1.5)
6
(0.1)
20
(0.1)
1.2
(0.5 to 3.0)
1.2
(0.5 to 3.0)
All percentages calculated relative to appropriate denominators (see methods).
*Reference category for odds ratios was women with interpregnancy interval of 18-23 months.
†Adjusted for maternal age, marital status, height, socioeconomic deprivation category, smoking, previous birth weight vigesimal, and previous caesarean section.
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val was an independent risk factor for extremely
preterm birth, moderately preterm birth, and neonatal
death not due to congenital abnormality. The
association occurred even among women whose first
pregnancy was a term live birth and persisted after
adjustment for maternal age, marital status, height,
socioeconomic deprivation category, smoking, previ-
ous birth weight vigesimal, and previous caesarean sec-
tion. The association was specific to preterm birth and
neonatal death, as no association existed between a
short interpregnancy interval and the risk of delivering
a growth restricted infant and the confidence intervals
were sufficiently narrow to exclude even a weak associ-
ation. When we examined the outcome of all first
births in relation to the subsequent interpregnancy
interval, women with a short interpregnancy interval
had a significant excess of intrauterine growth
restriction, preterm birth, and perinatal deaths in their
first births. Indeed, approximately 10% of women with
an interval of less than six months had a first birth that
had ended in perinatal death, compared with less than
1% of women with an interval of 18-23 months. These
observations are consistent with previous studies and
underline the importance of excluding women with
complications in their first birth when examining asso-
ciations between interpregnancy interval and the
outcome of the second birth.11
An association has previously been shown between
maternal age less than 20 years at the time of the sec-
ond birth and adverse obstetric outcome.23 In the
present study we could show that this association was
independent of interpregnancy interval and complica-
tions of the first pregnancy. However, the association
between maternal age less than 20 years and adverse
outcome was attenuated by adjustment for marital
status, socioeconomic deprivation category, smoking
status, height, previous birth weight vigesimal, and pre-
vious caesarean section, although a statistically
significant association persisted in multivariate analysis
(table 4). We cannot exclude the possibility that mater-
nal age less than 20 years is a marker for some other
environmental factor. However, it is unlikely that the
associations with a short interpregnancy interval were
due to unmeasured or residual confounding. Firstly,
after adjustment for maternal age, adjustment for
other maternal factors had very little effect (table 4).
Secondly, the strength of the association was virtually
unchanged when we confined the analysis to married,
non-smoking women aged 25 and above. Thirdly, no
statistically significant first order interactions occurred
between a short interpregnancy interval and other
maternal factors. Finally, the association was specific
for preterm birth and neonatal death. No association
existed between a short interpregnancy interval and
delivering a small for gestational age baby. In contrast,
a high socioeconomic deprivation category (that is,
more deprived) was significantly associated with deliv-
ering a small for gestational age baby in multivariate
analysis (data not shown).
The lack of association between interpregnancy
interval and growth restriction also suggests that the
relation between a short interpregnancy interval and
other adverse outcomes is unlikely to be due to deple-
tion of maternal nutritional reserves. A specific associ-
ation between a short interpregnancy interval and
preterm birth is biologically plausible. The control of
parturition is thought to be mediated by a two step
process of activation and stimulation.24 Activation is
defined as the up regulation of expression of a range of
contraction associated proteins, such as G protein cou-
pled receptors, in the weeks leading up to term. Stimu-
lation is defined as the process by which synthesis and
release of natural agonists for these receptors, such as
prostaglandins, initiates uterine contraction. We
hypothesise that failure to allow expression of contrac-
tion associated proteins to return to prepregnancy
levels may be the mechanism by which a short
interpregnancy interval predisposes to preterm birth.
We propose that women should be informed of a
small but significantly elevated risk of preterm birth
What is already known on this topic
Women with a short interval between pregnancies
are at increased risk of obstetric complications
These women also differ in their previous obstetric
complications and demographic characteristics
Whether the increased risk of adverse outcome
after a short interpregnancy interval is merely due
to confounding by obstetric and demographic
associations is unclear
What this study adds
Women with short intervals between pregnancies
are much more likely to have had complicated
first births and to have demographic risk factors
for obstetric complications
Even among women with an uncomplicated first
birth and after adjustment for maternal
demographics, a short interpregnancy interval was
associated an increased risk of preterm birth and
neonatal death
Table 4 Interpregnancy interval, maternal age, other demographic factors, and risk of adverse obstetric outcome
Outcome
Odds ratios (95% CI) for interpregnancy interval <6 months Odds ratios (95% CI) for age <20 years
Crude Adjusted 1 Adjusted 2 Adjusted 3 Crude Adjusted 1 Adjusted 2 Adjusted 3
Delivery 24-32 weeks 3.1 (1.9 to 4.9) 2.3 (1.4 to 3.8) 2.5 (1.5 to 4.0) 2.2 (1.4 to 3.6) 4.0 (2.6 to 6.2) 3.2 (2.0 to 5.1) 2.6 (1.6 to 4.2) 2.0 (1.2 to 3.4)
Delivery 33-36 weeks 2.0 (1.6 to 2.4) 1.7 (1.3 to 2.1) 1.7 (1.4 to 2.1) 1.6 (1.3 to 2.0) 2.3 (1.9 to 2.9) 2.2 (1.7 to 2.7) 1.6 (1.3 to 2.1) 1.5 (1.2 to 2.0)
Neonatal death
unrelated to
congenital
abnormality or
rhesus
5.4 (1.9 to 15.2) 3.8 (1.3 to 11.0) 4.3 (1.5 to 12.3) 3.6 (1.2 to 10.7) 8.4 (3.2 to 22.2) 5.6 (2.0 to 15.9) 5.0 (1.6 to 15.7) 3.5 (1.0 to 11.6)
Adjusted 1=adjusted only for maternal age or interpregnancy interval; adjusted 2=adjusted only for maternal smoking, socioeconomic deprivation, height, previous birth weight vigesimal, and
previous caesarean section; adjusted 3=adjusted for maternal smoking, socioeconomic deprivation, height, previous caesarean section, birth weight vigesimal, and maternal age or interpregnancy
interval.
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and perinatal death when they conceive shortly after a
birth. Contraceptive advice should be targeted towards
women who are most likely to have a subsequent short
interpregnancy interval—namely, teenagers and
women who have just experienced a perinatal loss.
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BACKGROUND: Current estimates of the average duration of human pregnancy are flawed by inaccurate 
estimation of the time of conception and by failure to account adequately for the effect of routine elective delivery 
post-term. METHODS: In this study, 1514 healthy pregnant women were studied in whom the discrepancy between 
the menstrual history and first trimester crown-rump length estimated gestational age was within -1 to +1 day 
difference. The duration of gestation was estimated using time to event analysis: non-elective delivery was taken to 
be the event, and elective delivery was taken to be censoring. RESULTS: The median time to non-elective delivery 
using the Kaplan-Meier product limit estimate was 283 days after last menstrual period (LMP) and there was no 
difference comparing male and female fetuses. The median was significantly greater for nulliparous women 
compared with multiparous women (284 versus 282 days, P < 0.0001). Multivariate analysis using Cox's proportional 
hazards model confirmed the independent effect of nulliparity on duration of pregnancy [hazard ratio, 0.75; 95% 
confidence interval (CI) 0.67-0.85] and demonstrated no effect of maternal age, previous abortions, fetal sex, high 
parity, or bleeding before 24 completed weeks of gestation. Bleeding in the third trimester of pregnancy was, 
however, associated with an earlier onset of spontaneous labour (hazard ratio, 1.38; 95% CI 1.03-1.84). 
CONCLUSION: This study provides a basis for predicting the probability of labour at a given gestational age at term. 
Key words: duration/human/pregnancy/proportional hazards models/survival analysis 
Introduction 
Attempts to characterize the normal duration of pregnancy 
extend back through history, because of the importance of 
establishing paternity. Prior to modern obstetric methods, 
reference points for conception were taken as the first day of 
the last menstrual period (LMP) or the date of an isolated act 
of sexual intercourse (Reid, 1850). The LMP is a poor surrogate 
of the time of ovulation since, even among women with a 
regular 28 day cycle, the timing of ovulation is skewed to 
the second half of the cycle (Lenton and Landgren, 1985). 
Establishing the date of intercourse is clearly subject to multiple 
sources of error. 
Modern obstetric techniques can be used to provide an 
unbiased estimate of gestational age. However, modern obstet 
ric practice also involves routine elective delivery post-term 
(Grant, 1994). When attempting to estimate the duration of 
pregnancy, the effect of routine elective delivery cannot be 
avoided using current methods. If these pregnancies are 
excluded, then there is a systematic exclusion of pregnancies 
which are prolonged. If they are included, then the average 
duration of pregnancy includes cases where the end was never 
fully established. 
A range of statistical techniques has been developed to 
estimate the average time period to the onset of a non-recurrent 
event, typically death (Hosmer and Lemeshow, 1999). These 
© European Society of Human Reproduction and Embryology 
methods (typically referred to as 'time to event analysis' or 
'survival analysis') take into account censored observations, 
i.e. observation of an individual to a given point until they no 
longer became at risk of the event. In the present study, it was 
sought to determine the average duration of human pregnancy 
among a previously described cohort of normal women (Smith 
et ai, 1998) where gestational age had been confirmed by first 
trimester ultrasound and where the estimate was adjusted for 
the effect of elective delivery using time to event analysis. A 
preliminary account of some of this work has been presented 
in abstract form (Smith, 2000). 
Materials and methods 
The results of all ultrasound scans performed between 1985 and 1995 
at the Queen Mother's Hospital, Glasgow, UK were entered into a 
computer database along with details of the woman's medical, 
gynaecological and obstetric history, antenatal complications and 
pregnancy outcome. The database included all pregnant women 
referred for antenatal care because all were scanned at their first 
antenatal visit. Those women referred early for antenatal care were 
usually seen after having amenorrhoea for 12 weeks. 
Over the 10 year period, 31 269 embryos or fetuses had at least 
one scan and a known date of delivery. Gestational age at delivery 
was recorded in 31 259 and birth weight was recorded in 30 789. Of 
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the 480 infants for whom birth weight was missing, 460 were 
delivered at <24 weeks. 
Any pregnancies with the following (number of cases) were 
excluded: history of rhesus iso-immunization (279), essential hyper 
tension (324), cardiac disease (128), type 1 diabetes mellitus (115), 
other medical problems (992), non-viable embryo or fetus at first 
scan (115), amniocentesis (1259), chorionic villous sampling (929), 
multiple pregnancy (364), antenatal detection of fetal abnormality 
(515), therapeutic termination of pregnancy (224), post-natal detection 
of fetal abnormality (560), intra-uterine contraceptive device seen on 
ultrasound (42), and second sac seen on ultrasound (85). There were 
a total of 4568 exclusions (some cases had multiple exclusions). 
The crown-rump length was measured by the sonographer using 
electronic callipers on a frozen image on a monitor. The technique 
is described elsewhere (Evans et al., 1990). The crown-rump length 
was recorded as the equivalent number of days gestational age on 
the basis of an equation [gestational age (weeks) = 8.052 >/ crown-
rump length + 23.73] previously derived at The Queen Mother's 
Hospital (Robinson and Fleming, 1975). The scans analysed in the 
present study were performed by real-time ultrasonography using 
several machines, the majority were trans-abdominal scans through 
a full bladder. 
The inclusion criteria based on the ultrasonography record were a 
single viable embryo or fetus present at the first ultrasound scan and 
a crown-rump length at the time of this scan less than the expected 
size after having amenorrhoea for 13 weeks. A total of 11 314 of the 
26 701 non-excluded cases fulfilled these criteria. 
The inclusion criteria from the menstrual history were: (i) there 
was a date recorded for the first day of the last menstrual period and 
that it was recorded as certain; (ii) there had been no oral contraceptive 
use in the preceding 3 months, and (iii) the menstrual cycle was 28 
days and regular. Of the 11 314 cases with no exclusion criteria who 
had an early ultrasound scan, 4229 fulfilled the menstrual inclusion 
criteria and had a birth weight recorded. The study group consisted 
of 1514 cases where the discrepancy between the estimated gestational 
age by the menstrual history was within ± 1 day of the ultrasound 
estimate. 
Statistical analysis 
Delivery by emergency Caesarean section or vaginal birth following 
non-induced labour were taken to be the event. Elective Caesarean 
section or any mode of delivery following an induced labour were 
taken as censoring. The cumulative probability of non-elective deliv 
ery at each day of gestation was estimated using the Kaplan-Meier 
product limit estimate. Univariate comparisons were made using the 
log rank test. Multivariate modelling was performed using Cox's 
proportional hazard's method. These techniques are described in 
detail elsewhere (Hosmer and Lemeshow, 1999). Statistical analysis 
was performed using Stata version 6.0 (Stata Corporation, College 
Station, TX, USA). 
Results 
The basic characteristics of the study group are summarized 
in Table I. The simple arithmetic median interval from the 
first day of the LMP to the date of delivery was 281 days. 
When the effect of censored observations was taken into 
account using the Kaplan-Meier product limit estimate, the 
median time from LMP to non-elective delivery was 283 days 
(95% confidence interval (CI), 282-284 days). There was no 
significant difference in the median comparing male and female 
fetuses and the number of elective deliveries was similar 
IQ = interquartile; SVD = simple vaginal delivery. 
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Figure 1. Cumulative probability of non-elective delivery at each 
day of gestational age (dGA) for multiparous (filled symbols, n = 
837) and nulliparous (hollow symbols, n = 677) women. Points are 
cumulative probability. Comparison of curves: P < 0.0001 (log 
rank test). 
comparing the two sexes (female 23.1%, male = 24.3%). The 
median time from LMP to non-elective delivery was 2 days 
longer among nulliparous women compared with multiparous 
women (Table II and Figure 1) and the difference was highly 
statistically significant (P < 0.0001). The proportion electively 
delivered was virtually identical comparing the two groups 
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(nulliparous 23.3%, multiparous 24.0%). Excluding women 
with antepartum haemorrhage and treating emergency 
Caesarean sections as censored observations had no effect on 
the estimate of the median duration of pregnancy (Table II). 
Multivariate analysis confirmed the independent effect of 
nulliparity on duration of pregnancy and demonstrated no 
effect of maternal age, previous abortions, fetal sex, high 
parity, or bleeding before 24 completed weeks of gestation 
(Table HI). Bleeding in the third trimester of pregnancy was, 
however, associated with an earlier onset of spontaneous 
labour. Exclusion of deliveries by emergency Caesarean section 
had very little effect on the hazard ratios for primparity [0.80 
(95% CI, 0.70-0.91)], third trimester bleeding [1.41 (1.03-
1.92)] or any of the other covariates (data not shown). 
Discussion 
One of the most basic descriptive variables of a mammalian 
species is the average duration of pregnancy. All previous 
estimates of the average duration of human pregnancy are 
flawed either by sub-optimal gestational dating or by the 
failure to correct adequately for the effect of routine elective 
delivery post-term. The study group in this paper had optimum 
dating by menstrual history and this was confirmed by close 
agreement with first trimester ultrasound. This provides the 
most accurate estimate of gestational age currently possible in 
spontaneous conceptions (Evans et ah, 1990). The effect of 
elective delivery was addressed in this study by the use of 
survival time analysis whereby elective deliveries were treated 
as censored observations. Using survival analysis in this cohort, 
the overall average duration of pregnancy was 283 days, two 
days longer than the simple arithmetic median interval from 
LMP to date of delivery. 
Unlike previous studies (Bergsjo et al, 1990), there was no 
apparent difference in the duration of pregnancy comparing 
male and female fetuses (Tables II and III). Previous findings 
of a difference in gestational duration according to fetal sex 
may reflect a relationship between the timing of fertilization 
relative to the LMP and fetal sex (James, 1994). The duration 
of pregnancy was approximately two days longer in nulliparous 
women. This was not due to a confounding effect of associated 
variables (maternal age, previous abortions etc) since nulli 
parity was still associated with later delivery after adjusting 
for these variables (Table III). The event used in the current 
analysis was birth, rather than the onset of labour. Labour in 
nulliparous women is, on average, three hours longer than in 
multiparous women (Nesheim, 1988). This is clearly not 
sufficient to explain the observed 2 day difference in duration 
of pregnancy comparing nulliparous and multiparous women. 
The physiological regulation of the onset of parturition in 
the human is still only partially understood. Current models 
postulate key roles for the fetal hypothalamo-pituitary-adrenal 
axis (Nathanielsz et a/., 1998) and for the placenta (Majzoub 
and Karalis, 1999). The observed effect of parity does not 
exclude a key role for the fetus and placenta since important 
fetal variables, such as weight, differ between nulliparous and 
multiparous women (Kramer, 1987). 
The clinical significance of this study is that it provides a 
basis for predicting the probability of labour at a given 
gestational age at term. This may be useful when planning 
trials of, for instance, routine induction of labour, or for the 
timing of procedures such as elective Caesarean section. The 
present data allow the probability that a woman might go into 
labour prior to a scheduled date for elective delivery to be 
estimated. Furthermore, the cumulative probability of delivery 
tended towards 1.0 at 300 days. However, the increased risk 
of stillbirth with very advanced gestational age (Yudkin et al., 
1987) means that virtually no pregnancy would be allowed to 
continue into the 43rd week and very high rates of censoring 
undermine the estimates of the probability of delivery at these 
advanced gestational ages. 
The observation that bleeding in the third trimester was 
associated with an earlier onset of spontaneous delivery is 
plausible. However, given the relatively small number of 
women affected by third trimester bleeding, there was virtually 
no effect on the median duration of pregnancy when these 
cases were excluded (Table II). It is likely that a proportion 
of these cases were due to abruption which can initiate uterine 
activity. It is likely that labour in these women was initiated 
before the physiologically determined onset by a pathological 
process. However, the 'event' was non-elective delivery, i.e. 
including delivery by emergency Caesarean section. This was 
done since over 75% of emergency Caesarean sections are 
performed after the onset of labour (Macara and Murphy, 
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1994). It might be argued that third trimester bleeding due 
both to abruption and placenta praevia could lead to emergency 
Caesarean section before the onset of labour and that the 
apparent association between third trimester bleeding and early 
onset of labour may simply reflect an association between 
bleeding and emergency Caesarean section. However, the 
hazard ratios associated with both third trimester bleeding and 
nulliparity were very similar when emergency Caesarean 
sections were excluded. Treating emergency Caesarean sections 
as spontaneous births might also be criticized since a small 
proportion of these will have been performed prior to the onset 
of labour. Furthermore, when Caesarean section is performed 
during labour, birth necessarily occurs earlier than if vaginal 
birth had been awaited. However, the influence of these factors 
would be expected to be relatively minor and, indeed, treating 
emergency Caesarean section as censoring had no significant 
effect on the estimated median duration of pregnancy (Table II). 
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Sex, Birth Weight, and the Risk of Stillbirth in Scotland, 1980-1996
Gordon C. S. Smith
The aim of this study was to determine whether the risk of stillbirth associated with male fetal sex was
modified by fetal growth. The study group consisted of all singleton first births weighing greater than 500 g
delivered between 28 and 43 weeks gestation in Scotland in 1980-1996 (n = 469,152). Overall, male fetuses
were at an increased risk of stillbirth (relative risk = 1.19, 95 percent confidence interval: 1.10, 1.29). There was
a significant negative interaction between male sex and increasing birth weight quintile in term, but not preterm,
births. The interaction was virtually identical when calculated independently for births in the periods 1980-1987
and 1988-1996. There were linear decreases in the proportion of stillbirths and the proportion of birth weights
in the lowest quintile over the period 1980-1996. Adjustment for year of birth did not affect the relation between
male sex and stillbirth. However, adjustment for birth weight resulted in a loss of the association between year
of birth and risk of stillbirth. The authors concluded that 1) the association between male sex and stillbirth
diminishes with increasing birth weight quintile, and 2) there was a fall in the proportion of stillbirths in Scotland
between 1980 and 1996, which may have been due to a fall in the proportion of small babies over the same
period. Am J Epidemiol 2000;151:614—19.
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The risk of mortality differs between males and
females in a number of areas of adult human medicine
(1-3). Analysis of the mechanisms of such differences
is hampered by social and cultural variation in lifestyle
between men and women, which may interact with and
obscure fundamental sexual differences in human biol-
ogy (4, 5). Fetal sex has a major effect on a number of
aspects of human pregnancy, such as intrauterine
growth (6), late fetal death (4, 7-9), preterm birth (10),
and necessity for emergency Cesarean delivery (11).
These associations allow for the analysis of sex differ-
ences in morbidity and mortality in isolation from
behavioral and cultural modification and confounding.
It has been suggested previously that the excess of
male stillbirths may be related to trauma secondary to
the greater average size of males (4). However, animal
studies have demonstrated sex differences in the fetal
stress response (12-15). Human fetuses that are small
for gestational age are at increased risk of late fetal
death (16). The aim of this study was to test the
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hypothesis that the increased risk of stillbirth in males
varies with fetal growth.
MATERIALS AND METHODS
Source of data
Data were collected from the Scottish morbidity
record (maternity), a national database of pregnancy
information that has been greater than 99 percent com-
plete since the late 1970s (17). To eliminate interac-
tions between number of previous pregnancies, birth
weight, and risk of stillbirth, we restricted analysis to
women having their first baby. There were a total of
478,655 records of singleton and twin first pregnan-
cies. The following exclusions were made (number of
records): twins {n = 4,946); missing gestational age (n
= 2,416); missing sex (n = 30); missing weight {n =
467); gestational age at delivery of less than 28 or
greater than 43 weeks (n = 1,936); and weight less
than 500 g {n = 164). The study group was 469,152 (a
small number of records had multiple exclusions
and/or missing values), which was greater than 99 per-
cent of all singleton births over the period. Gestational
age was recorded as completed weeks of gestation and
was calculated on the basis of the estimated date of
delivery (280 days from the first day of the last men-
strual period, corrected to a 28-day menstrual cycle) in
the patient's clinical record. Term was defined as 37
weeks' gestation. Fetal death was assumed when a
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baby was born that exhibited no signs of life. When a
baby exhibited any signs of life, however briefly, it
was classified as a livebirth.
Birth weight qulntlles and deciles
Analysis of birth weight across a range of gesta-
tional ages was performed using birth weight quin-
tiles or deciles. Quintiles were used in the compari-
son between males and females to increase the
number of stillbirths in each group. For births at each
week of gestation, the birth weights of males and
females were independently classed as quintiles. For
example, if 1,000 males and 1,000 females were born
in a given week, the pooled quintile would be the
smallest 200 boys and the smallest 200 girls. The sex-
specific quintiles for all weeks of gestation were then
pooled., i.e., the lowest quintile is the smallest 20
percent of boys and smallest 20 percent of girls born
at each week of gestation from 28 to 43 weeks.
Adjustment of the odds ratio for year of birth for birth
weight was performed using birth weight deciles,
which were also calculated independently for each
week of gestation for males and females and pooled.
Year-specific quintiles were also calculated to correct
for variation in birth weight over the study period.
Quintiles were calculated as above for four periods:
1980-1984, 1985-1988, 1989-1992, and 1993-1996
(inclusive), and then the quintiles from the four time
periods were pooled.
Statistical analysis
Dichotomous outcomes were compared by using rel-
ative risks. The null hypothesis that the relative risk of
being male was the same across strata was tested using
the Mantel-Haenszel test of heterogeneity (18). Adjusted
odds ratios for factors and interactions were calculated
using logistic regression analysis, and the goodness-of-
fit was assessed using the Pearson chi-squared test (18).
Continuous variables were summarized by the median
and interquartile ranges. Statistical analysis was per-
formed using the Stata software package, version 6.0
(Stata Corporation, College Station, Texas). Statistical
significance was assumed at the 5 percent level.
RESULTS
There were 1,469 male stillbirths and 239,808 male
livebirths, and 1,162 female stillbirths and 226,713
female livebirths (stillbirth male relative risk = 1.19,
95 percent confidence interval (CI): 1.10, 1.29; popu-
lation attributable fraction, 9.1 percent). The relative
risk of stillbirth varied according to birth weight quin-
tile (figure 1). When term and preterm births were
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FIGURE 1. Relative risk (logt0 scale) of stillbirth associated with
male sex related to birth weight quintiles in Scotland, 1980-1996.
Mantel-Haenszel test for heterogeneity x2 = 11.5, p = 0.02. Bars are
95% confidence intervals.
analyzed separately, the trend was evident only among
term births (figure 2).
The relation was examined using logistic regression
analysis. Preliminary analysis demonstrated that the
goodness-of-fit was improved if birth weight quintile
was modeled as a series of categorical variables rather
than as a continuous variable, indicating that the rela-
tion between birth weight quintile and risk of stillbirth
is nonlinear. An interaction term between male sex and
birth weight quintile demonstrated a significant nega-
tive interaction with increasing birth weight quintile.
The log-likelihood was virtually unchanged if the
interaction between male sex and birth weight quintile
was modeled as interactions with each quintile as a
categorical variable (log likelihood, -15,645.2) or with
quintile as a continuous variable (log likelihood,
-15,646.0), and therefore the model with the fewer
parameters (the latter) was used (table 1).
Preliminary analyses demonstrated significant inter-
actions between term birth and 1) male sex, 2) birth
weight quintile, and 3) the interaction between sex and
birth weight quintile. Therefore, further comparison of
term and preterm births was made using separate logis-
tic regression models. When confined to term deliver-
ies, the adjusted odds ratio of the interaction between
male sex and birth weight quintile was still statistically
significant, whereas it was no longer significant when
the analysis was confined to preterm deliveries (table
1). The adjusted odds ratio of the interaction for term
births between 1980 and 1987 was 0.86 (95 percent
CI: 0.76, 0.97) and for births between 1988 and 1996,
it was 0.87 (95 percent CI: 0.78, 0.98). The adjusted
odds ratio of the interaction for term births using year-
specific quintiles (see Materials and Methods) was
0.88 (95 percent CI: 0.81, 0.95).
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The number and birth weight of livebirths and still-
births at each week of gestation are tabulated for males
and females (table 2). More males (n = 16,011 at
28-36 weeks vs. 225,266 at term) than females (n =
13,070 at 28-36 weeks vs. 214,805 at term) were
delivered preterm (relative risk of preterm delivery for
males = 1.16, 95 percent CI: 1.13, 1.18; population
attributable fraction, 7.5 percent).
There were linear decreases in the proportion of
stillborn babies per year over the period 1980-1996
(yearly fall, 0.007 percent of total annual births; 95
percent CI: 0.003, 0.010) and the proportion of infants
in the lowest birth weight quintile over the same
period (yearly fall, 0.27 of percent total annual births;
95 percent CI: 0.22, 0.31). The odds ratio for stillbirth
associated with male sex was unchanged by adjust-
ment for year of birth, but advancing year of birth was
no longer significantly associated with a decreased
Term
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FIGURE 2. Relative risk (log10 scale) of term and preterm stillbirths
associated with male sex related to birth weight quintile in Scotland,
1980-1996. a, term births (Mantel-Haenszel test for heterogeneity
X2 = 11.4, p = 0.02); and b, preterm births (x1 = 1.07, p = 0.9). Bars
are 95% confidence intervals.
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risk of stillbirth after adjustment for birth weight
(table 3).
DISCUSSION
The main finding of this study is that the increased
risk of stillbirth associated with male sex progressively
diminished with increasing birth weight (figure 1).
These data suggest that the increased risk of stillbirth
among males may be related, at least in part, to a
greater risk of stillbirth in the face of a given degree of
growth impairment. This sexual difference may be
mediated by physiologic variation at the level of the
maternal response to the conceptus, at the placenta, or
may be related to sexual differences in fetal physiol-
ogy (12-15). The biologic basis of the association war-
rants investigation.
Further epidemiologic studies might determine
whether the effect is observed in other populations. If
the association does represent an impaired response of
males to growth restriction, it might be expected that
the excess of male stillbirths would be more marked in
racial groups with higher incidences of growth restric-
tion and stillbirth, such as African Americans (19).
Interestingly, falling proportions of stillbirths in
Britain in the 20th century have been associated with a
fall in the ratio of male to female stillbirths (20).
Males are generally larger than females, but the use
of quintiles specific for sex and gestational age cor-
rected for this effect. It is possible that the association
merely represents the delayed expulsion of male
fetuses, i.e., that males are more likely to be macerated
than are females. The database did not have informa-
tion on whether stillbirths were macerated. This seems
an unlikely explanation, however, since the relation
was strong at term, when prenatal visits occur at
weekly intervals and the chance of intrauterine death
being undetected for a prolonged period is lowest.
TABLE 3. Logistic regression analysis of sex, year of birth,
and birth weight decile In determining the risk of stillbirth,
Scotland, 1980-1996
Logistic
regression
model»
Untvartate
Year and male sex
Year, male sex, and
birth weight decile
Ysarcrf birth
ORt
0.987
0.987
0.994
95%Clf
0.980, 0.995
0.979, 0.995
0.986,1.001
OR
1.20
1.20
1.20
Male sex
95% Cl
1.11,
1.11,
1.11,
1.29
1.29
1.30
• The reference group for male sex was female. Year was
entered as a continuous variable, and the odds ratio is for a change
in year of birth of +1 year. Birth weight decile was modeled as a
series of categorical variables. Goodness of fit: model of year and
sex, p = 0.86; model of year, sex, and birth weight decile, p = 0.17.
t OR, odds ratio; Cl, confidence interval.
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The database does not record the individual esti-
mates of gestational age on the basis of ultrasound
(where performed) and menstrual history. The gesta-
tional age at delivery is recorded in the database on the
basis of the estimated date of delivery as recorded in
the patient's clinical record. Where ultrasound was
performed, clinical judgment of gestational age
depends on the gestational age at the time of ultra-
sound, the reliability of the menstrual history, and the
degree of discrepancy between the menstrual and
ultrasound estimates. Published criteria exist in Britain
that attempt to standardize the corrections (21). It
seems unlikely that any error arising from these issues
may result in a systematic male-female bias, as male
fetuses are no more likely to deviate from their
expected size at dating ultrasound examination than
are female fetuses (22).
The data cover a period of 17 years. The proportion
of cases in which the estimated date of delivery is
adjusted on the basis of ultrasound measurements is
likely to have increased over this period, and other
changes in obstetric practice have occurred that might
affect the number of stillbirths and the ability to detect
poor fetal growth. Such changes are unlikely to
explain the association between male sex and risk of
stillbirth, since the odds ratio for male sex was not
changed by adjustment for year of birth (table 3) and
the interaction between male sex and birth weight
quintile was virtually identical when 1980-1987 and
1988-1996 were compared.
Over the study period, there was a fall in the pro-
portion of babies with a birth weight in the lowest
quintile. The latter finding is consistent with previous
studies in Scotland that have demonstrated an increase
in average birth weights between 1980 and 1992, and
the factors that might have mediated this change have
been discussed in detail elsewhere (23). The interac-
tion between male sex and lowest birth weight quin-
tile in determining the risk of stillbirth is unlikely to
be an artifact of this variation over the study period,
since the interaction was of a similar magnitude and
statistical significance when the birth weight quintiles
were calculated for 4- to 5-year periods and then
pooled.
There was also a fall in the proportion of stillbirths
over the study period (figure 1 and table 2).
Interestingly, adjustment for birth weight decile
resulted in a loss of the association between year of
birth and risk of stillbirth. This suggests that the fall in
the number of stillbirths over the study period may be
due to the reduction in the number of smaller babies,
which is consistent with the observation that being
small for gestational age is associated with an
increased risk of stillbirth (16).
The relation between birth weight quintile and sex
was less marked when confined to babies born
preterm. However, when preterm deliveries are ana-
lyzed, the birth weight quintiles necessarily refer to
babies born preterm. Since some premature births are
associated with preceding growth restriction (22) it
follows that the size of liveborn, preterm babies may
not be representative of the size of ongoing pregnan-
cies in utero. Since the population that is at risk of fetal
death is all ongoing pregnancies, rather than just that
fraction of pregnancies that deliver (24), the loss of the
association in preterm babies may reflect the difficulty
in categorizing birth weight in preterm babies rather
than a real biologic difference. Furthermore, as has
been previously demonstrated (10), more males than
females were delivered preterm, which further compli-
cates the reference group.
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Summary
Background Caesarean section is associated with an
increased risk of disorders of placentation in subsequent
pregnancies, but effects on the rate of antepartum stillbirth are
unknown. We aimed to establish whether previous caesarean
delivery is associated with an increased risk of antepartum
stillbirth.
Methods We linked pregnancy discharge data from the
Scottish Morbidity Record (1980–98) and the Scottish Stillbirth
and Infant Death Enquiry (1985–98). We estimated the relative
risk of antepartum stillbirth in second pregnancies using time-
to-event analyses.
Findings For 120 633 singleton second births, there were 68
antepartum stillbirths in 17 754 women previously delivered by
caesarean section (2·39 per 10 000 women per week) and
244 in 102 879 women previously delivered vaginally (1·44;
p<0·001). Risk of unexplained stillbirth associated with
previous caesarean delivery differed significantly with
gestational age (p=0·04); the excess risk was apparent from
34 weeks (hazard ratio 2·23 [95% CI 1·48–3·36]). Risk was
not attenuated by adjustment for maternal characteristics or
outcome of the first pregnancy (2·74 [1·74–4·30]). The
absolute risk of unexplained stillbirth at or after 39 weeks’
gestation was 1·1 per 1000 women who had had a previous
caesarean section and 0·5 per 1000 in those who had not. The
difference was due mostly to an excess of unexplained
stillbirths among women previously delivered by caesarean
section.
Interpretation Delivery by caesarean section in the first
pregnancy could increase the risk of unexplained stillbirth in
the second. In women with one previous caesarean delivery,
the risk of unexplained antepartum stillbirth at or after 
39 weeks’ gestation is about double the risk of stillbirth or
neonatal death from intrapartum uterine rupture.
Lancet 2003: 362: 1779–84
See Commentary page 1774
Introduction
Rates of caesarean section have risen substantially in recent
years.1 The causal factors are complex and incompletely
understood.2,3 Concerns have been expressed about
potential adverse effects, especially in relation to short-term
morbidity in the mother and child.4,5 Studies on the effects
of previous caesarean section on future pregnancies have
focused mainly on the maternal and fetal risks of scar
rupture associated with vaginal birth.6,7 However, it has also
been noted that placental complications, such as abruption
and placenta praevia, are more common in women who
have previously undergone caesarean section,8,9 and the
association with abruption has been observed in women
with no previous history of abruption and is independent of
obvious confounders.10 The effect of previous caesarean
delivery on the risk of antepartum perinatal death in
subsequent pregnancies is not known. We did a large-scale,
retrospective, cohort study to establish whether caesarean
delivery in a first pregnancy was associated with an
increased risk of antepartum stillbirth in the second. 
Methods
Data sources
The Scottish Morbidity Record (SMR2) collects
information on clinical and demographic characteristics and
outcomes for all patients discharged from Scottish
maternity hospitals. The register is subjected to regular
quality assurance checks and has been more than 99%
complete since the late 1970s.11 A quality assurance exercise
was done in 1996–97 in which 5% of case records (n=1414)
were compared with the SMR2 database during a 6-month
period. All fields used in the present study had fewer than
2% errors, with the exception of maternal height (4·4%),
estimated gestation (5·6%), induction of labour (6·4%),
and duration of labour (13·5%) (Chalmers J, Consultant in
Public Health, Information and Statistics Division of the
National Health Service [NHS], personal communication). 
We identified records from the SMR2 between 1980–98
and linked them to records from the Scottish Stillbirth and
Infant Death Enquiry (1985–98)—a national register in
which all perinatal deaths in Scotland are classified. Coding
of the cause of death is done by one individual (the Scottish
coordinator) in the Information and Statistics Division of
the NHS on the basis of clinical information obtained from
local coordinators and pathologists. Cases are identified
through registration of stillbirths and neonatal deaths with
the General Registrar’s Office, which is a legal requirement
for a perinatal death. The register is almost 100% complete
and has been described in detail.12,13
Study population
We identified all second births in Scotland between
1992–98. We selected this range because smoking status
was not included in the SMR2 database before 1992. Study
exclusion criteria were multiple pregnancy, delivery outside
24–43 weeks’ gestation, birthweight less than 500 g, and
perinatal deaths due to congenital anomaly or rhesus
isoimmunisation. We also excluded records with missing
values. We linked records from the second pregnancy to
Caesarean section and risk of unexplained stillbirth in subsequent
pregnancy
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records from the first pregnancy in the same woman using a
probability-based matching approach.14 We excluded first
pregnancy records using the same criteria as second
pregnancy records, and excluded pairs of records if the
interpregnancy interval was negative or implausibly short or
if there was a discrepancy between the documented method
of delivery in the first record and the previous caesarean
delivery field in the second record.
Definitions of maternal and obstetric characteristics
We adjusted the risk of unexplained antepartum stillbirth
for socioeconomic deprivation, smoking, maternal age, and
maternal height. Postcode of residence was used to 
derive Carstairs socioeconomic deprivation scores.15 Scores
were based on 1991 Census data on car ownership,
unemployment, overcrowding, and social class within
postcode sectors of residence that contain, on average,
around 1600 residents. The deprivation scores were used to
categorise women by quintile of socioeconomic deprivation.
Higher quintiles indicate a greater degree of deprivation.
Smoking was defined as the smoking status of the woman at
the time of first attendance for antenatal care. Maternal age
was defined as the age of the mother at the time of birth.
Maternal height was measured in cm and the value used
was that recorded in every woman’s clinical record.
Gestational age at birth was defined as completed weeks of
gestation on the basis of the estimated date of delivery in
every woman’s clinical record. Gestational age has been
confirmed by ultrasound in the first half of pregnancy in
more than 95% of women in the UK since the early 1990s.16
Extremely and moderately preterm birth were defined as
occurring between 24–32 and 33–36 weeks’ gestation,
respectively. Birthweight was categorised into 20 sex-
specific and gestational-age-specific percentiles derived from
livebirths in the whole population. A small-for-gestational-
age baby was defined as a liveborn baby with a birthweight
in the smallest percentile (ie, the 0–5th percentile).
Interpregnancy interval was defined as the number of days
from the first birth until the estimated date of the last
menstrual period of the second. The estimated date of the
last menstrual period was calculated by subtracting the
estimated gestational age from the date of delivery.
Definition of stillbirths
We classified stillbirths as antepartum and intrapartum.
Deaths caused by congenital anomaly were defined as any
structural or genetic defect incompatible with life, or
potentially treatable but causing death. The cause of
antepartum stillbirth was classified according to a modified
version of the Wigglesworth hierarchical system.13,17 Still-
births were classified according to a hierarchy of direct
obstetric causes (in order): toxaemia, haemorrhage (ante-
partum), mechanical, maternal, miscellaneous, and
unexplained. Mechanical included death caused by uterine
rupture. The hierarchy dictates that a perinatal death in
which there was severe pre-eclampsia complicated by
abruption would be classified as being due to toxaemia,
since toxaemia is above haemorrhage in the hierarchy. The
cause of perinatal death in the first pregnancy was
categorised into unexplained antepartum stillbirth and all
other perinatal deaths. If the first birth had occurred
between 1980–84, all perinatal deaths were classified as “all
other perinatal deaths”.
Statistical analyses
We summarised continuous variables as medians and IQRs,
and compared groups using the Mann-Whitney U test. 
2 tests were used for univariate comparisons of
dichotomous data (more than five observations expected in
all cells) or Fisher’s exact test (five or fewer expected
observations in one or more cells). The p values for all
hypothesis tests were two-sided and significance was set at
p<0·05. The risk of stillbirth was compared between groups
using time-to-event analyses in which week of gestation was
used as the timescale, antepartum stillbirth due to the
specified cause was defined as the event, and all other
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No previous Previous p*
caesarean caesarean 
(n=102879) (n=17754)
Maternal characteristics
Age, years (median [IQR]) 28 (25–32) 30 (26–33) <0·001
Height, cm (median [IQR]) 162 (158–167) 160 (156–165) <0·001
Deprivation quintile, n (%)
1 (least deprived) 20 175 (19·6%) 3610 (20·3%)
2 19 826 (19·3%) 3568 (20·1%)
3 20 711 (20·1%) 3501 (19·7%)
4 20 184 (19·6%) 3481 (19·6%)
5 (most deprived) 21 983 (21·4%) 3594 (20·2%) 0·001
Smoking status
Non-smoker, n (%) 64 391 (62·6%) 11 807 (66·5%)
Ex-smoker, n (%) 7472 (7·3%) 1329 (7·5%)
Smoker, n (%) 31 016 (30·2%) 4618 (26·0%) <0·001
Outcome second pregnancy
Interpregnancy interval, 829 841 0·24
days (median [IQR]) (499–1365) (515–1338)
Gestational age at delivery, 40 (39–41) 39 (38–40) <0·001
weeks (median [IQR])
Gestational age at delivery
24–32 weeks, n (%) 749 (0·7%) 183 (1·0%)
33–36 weeks, n (%) 3472 (3·4%) 789 (4·4%)
37–43 weeks, n (%) 98 658 (95·9%) 16 782 (94·5%) <0·001
Birthweight, g (median [IQR]) 3480 3420 <0·001
(3150–3810) (3060–3760)
Birthweight
<5th percentile, n (%) 3304 (3·2%) 722 (4·1%) <0·001
>95th percentile, n (%) 6669 (6·5%) 1493 (8·4%) <0·001
Antepartum stillbirth, n (%) 244 (0·2%) 68 (0·4%) <0·001
Outcome first pregnancy†
Gestational age at delivery, 40 (39–41) 40 (38–41) <0·001
weeks (median [IQR])
Gestational age at delivery
24–32 weeks, n (%) 968 (1·1%) 535 (3·5%)
33–36 weeks, n (%) 3632 (4·1%) 1184 (7·7%)
37–43 weeks, n (%) 83 823 (94·8%) 13 648 (88·8%) <0·001
Birthweight, g (median [IQR]) 3340 3370 <0·001
(3020–3650) (2920–3770)
Birthweight
<5th percentile, n (%) 4922 (5·6%) 1163 (7·6%) <0·001
>95th percentile, n (%) 2438 (2·8%) 998 (6·5%) <0·001
Perinatal death
Unexplained stillbirth, n (%) 371 (0·4%) 3 (0·02%) <0·001
Other, n (%) 568 (0·6%) 175 (1·1%)
*By Mann-Whitney U, 2, or Fisher’s exact test as appropriate. †n for no
previous caesarean=88 423; n for previous caesarean=15 367.
Table 1: Maternal characteristics and obstetric outcome in
relation to previous caesarean section in 120 633 second births
No previous caesarean Previous caesarean p*
(n=102 879) (n=17 754)
Number Incidence† Number Incidence†
Cause of stillbirth
All causes 244‡ 0·144 68 0·239 0·0001
Toxaemia 14 0·008 3 0·011 0·71
Haemorrhage 46 0·027 10 0·035 0·46
Mechanical 3 0·002 2 0·007 0·08
Miscellaneous 9 0·005 3 0·011 0·28
Maternal 8 0·005 7 0·025 0·0004
Maternal 6 0·004 3 0·011 0·11
(excluding
diabetes)
Unexplained 163 0·096 43 0·151 0·004
*Log rank test. †Per 1000 women per week. ‡One death in this group was
unclassified.
Table 2: Risk of antepartum stillbirth after 24 weeks’ gestation in
relation to previous caesarean section in 120 633 second births
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births were treated as censored. In this method, ongoing
pregnancies are the denominator,18 but censoring due to
birth is accounted for and multivariate analysis can be
done.19 This approach allows assessment of the relative
risk accounting for variation in the duration of
pregnancy,  and is appropriate for situations in which
not all individuals would ultimately experience the
event.20 Survival data were plotted as cumulative
percentage with event as recommended for rare
outcomes,21 and univariate statistical comparisons were
by log-rank test. Crude and adjusted hazard ratios were
estimated with a proportional hazards model.22 The
proportional hazards assumption was tested using the
global test of Grambsch and Therneau.23 The absolute
risk of stillbirth was assessed using the prospective risk of
stillbirth—ie, the number of stillbirths at or after a given
week of gestation divided by the total number of births
at or after a given week.24 The risks of preterm birth and
of extremes of birthweight percentile were assessed with
multivariate logistic regression analysis. All continuous
covariates in regression models were categorised. The
significance of interaction terms was assessed with the
likelihood ratio test and significance set at p<0·01. All
analyses were done with Stata software, version 7.0.
Results
There were 411 685 singleton births in Scotland between
1992 and 1998, excluding deaths due to fetal abnormality
or rhesus isoimmunisation; 144 202 (35%) were second
births. Of these, 408 (0·3%) did not have information for
gestational age or birthweight, or these values were outside
24–43 weeks or less than 500 g, respectively. Of the
remaining 143 794 records, data were missing for previous
caesarean delivery in 14 (<0·1%), height in 12 866 (9·0%),
deprivation category in 448 (0·3%), smoking status in
13 395 (9·3%), and maternal age in one (<0·1%). In total,
23 161 (16·1%) records had one or more missing values,
leaving a study group of 120 633 women.
There was a record for the first pregnancy in 105930
(87·8%) of the study group. 31 (<0·1%) were excluded
because the interpregnancy interval was less than 28 days.
Of the remaining 105899, mode of delivery in the first
pregnancy was not noted in 40 (<0·1%) women, and there
was a discrepancy between the mode of delivery field in the
first record and the previous caesarean section field 
in the second record in 1617 (1·5%). Of the remaining 
104242 first pregnancy records, 448 (0·4%) had no note of
gestational age or birthweight, or these values were outside
24–43 weeks or less than 500 g, respectively. Four (<0·1%)
records were excluded because of a missing value for fetal
sex, leaving a subgroup of 103 790 births with complete
data on both pregnancies—86·0% of the study group. Of
these births, 2812 (2·7%) of first births had occurred
between 1980 and 1984, predating the Scottish Stillbirth
and Infant Death Enquiry, and the causes of 16 perinatal
deaths that occurred in this group during the first pregnancy
had not been classified.
Women who had previously been delivered by caesarean
section were older, shorter, less likely to smoke, and less
likely to live in an area of high socioeconomic deprivation
(table 1). Women whose first delivery was by caesarean
section were more likely to have had complications in the
first pregnancy. They had an excess of moderate and
extreme prematurity, an excess of very small and very large
for gestational age babies, and fewer unexplained stillbirths
but an excess of other perinatal deaths. On univariate
analysis of second pregnancy outcomes, women who had
had a previous caesarean section delivered earlier, delivered
smaller neonates, and were more likely to have an
antepartum stillbirth than women who had previously
delivered vaginally (table 1). 
The main determinant of the excess of stillbirths in
women who had had a previous caesarean section was
unexplained stillbirth (table 2). For all gestational ages, the
hazard ratio for unexplained stillbirth in women with
previous caesarean delivery was 1·64 (95% CI 1·17–2·30),
p=0·004. However, the hazards associated with previous
vaginal birth and previous caesarean section were
significantly non-proportional during gestational age
24–42 weeks (p=0·04). The excess risk associated with
previous caesarean delivery became apparent from
ARTICLES
THE LANCET • Vol 362 • November 29, 2003 • www.thelancet.com 1781
Gestational age (weeks)
Log-rank p=0·004
24 26 28 30 40 42
0
0·1
0·2
0·3
0·4
0·5
0·6
0·7
C
um
ul
at
iv
e 
pr
op
or
tio
n 
(%
)
32 34 36 38
No previous caesarean delivery
Previous caesarean delivery
No previous
caesarean
Previous
caesarean
10
28
79
10
28
11
10
25
40
10
27
10
10
23
13
10
18
58
10
04
27
94
36
5
61
60
6
41
61
17
75
4
17
74
0
17
71
8
17
68
6
17
60
7
17
49
2
17
18
7
15
66
6
75
95 63
1
Figure 1: Cumulative proportion of unexplained stillbirths per
week of gestation
Hazard ratio for women with previous caesarean delivery relative to women
with a previous vaginal birth=1·64 (95% CI 1·17–2·30).
No previous caesarean section Caesarean section in first pregnancy
Ongoing Stillbirths Other Weekly rate* Cumulative rate* Ongoing Still- Other Weekly rate* Cumulative rate*
pregnancies (n) births (n) pregnancies births births
(n) (n) (n) (n)
Week of gestation
34 101 858 7 540 0·07 (0·02–0·12) 0·07 (0·02–0·12) 17 492 4 122 0·23 (0·00–0·45) 0·23 (0·00–0·45)
35 101 311 3 881 0·03 (0·00–0·06) 0·10 (0·05–0·18) 17 366 2 177 0·12 (0·00–0·28) 0·35 (0·16–0·77)
36 100 427 12 1757 0·12 (0·05–0·19) 0·22 (0·14–0·33) 17 187 4 401 0·24 (0·00–0·47) 0·58 (0·31–1·08)
37 98 658 14 4279 0·15 (0·07–0·22) 0·36 (0·26–0·50) 16 782 2 1114 0·12 (0·00–0·29) 0·70 (0·40–1·24)
38 94 365 16 11 726 0·18 (0·09–0·27) 0·54 (0·42–0·72) 15 666 7 4390 0·52 (0·13–0·90) 1·22 (0·78–1·92)
39 82 623 13 21 004 0·18 (0·08–0·28) 0·73 (0·57–0·93) 11 269 4 3670 0·42 (0·01–0·84) 1·65 (1·08–2·51)
40 61 606 17 35 311 0·39 (0·20–0·57) 1·11 (0·88–1·40) 7595 4 4180 0·73 (0·01–1·44) 2·37 (1·56–3·60)
41 26 278 7 22 110 0·46 (0·12–0·80) 1·57 (1·20–2·06) 3411 2 2778 0·99 (0·00–2·36) 3·36 (2·03–5·55)
42 4161 2 4091 0·95 (0·0–2·26) 2·51 (1·46–4·34) 631 2 615 6·20 (0·00–14·80) 9·52 (3·82–23·62)
*Per 1000 ongoing pregnancies.
Table 3: Number of events and life table analysis of unexplained stillbirths at or after 34 weeks’ gestation in second pregnancies in
relation to previous caesarean delivery (n=119 350)
Page 167
For personal use. Only reproduce with permission from The Lancet publishing Group.
34 weeks’ gestation (figure 1). There was no evidence of
non-proportionality of the hazards before 34 weeks’
(p=0·79) and at or after 34 weeks’ gestation (p=0·96). The
hazard ratio associated with previous caesarean delivery was
0·97 (0·52–1·78), p=0·91, before 34 weeks’ and 2·23
(1·48–3·36), p<0·001 at or after 34 weeks’ gestation.
Therefore, we included births only at or after 34 weeks’
gestation in subsequent analyses.
Table 3 shows the actual number of events at each week
of gestation. The excess rate of stillbirths in the previous
caesarean group is not merely a result of excess risk at or
after 41 weeks’ gestation, since if births were censored at 
39 weeks’ gestation a significant excess of deaths remained
in this group (log-rank p=0·02). Adjustment for maternal
demographic or obstetric characteristics did not attenuate
the association between previous caesarean birth and
unexplained stillbirth (table 4). Exclusion of women whose
first birth had occurred before 1985 had no effect on the
association between previous caesarean delivery and
unexplained stillbirth (adjusted hazard ratio 2·56
[1·61–4·08], p<0·001). Previous caesarean delivery, other
maternal characteristics, and the outcome of the first
pregnancy did not interact significantly in determining the
risk of unexplained stillbirth in the second pregnancy.
The association between previous caesarean and stillbirth
was similar if the analysis was confined to women who had
delivered at term in their first birth (adjusted hazard ratio
2·74 [1·92–5·48], p<0·001) or at or after 40 weeks’
gestation in their first birth (3·45 [2·01–5·94], p<0·001).
We analysed the 96 737 women whose first pregnancy was
delivered at term to establish whether the association
between previous caesarean delivery and the risk of
unexplained stillbirth might be accounted for by the original
indication for caesarean section. The risk of unexplained
stillbirth in the second pregnancy did not significantly differ
(p=0·67) between women who had caesarean section before
labour started (n=5364, hazard ratio 1·99 [0·94–4·20]),
women whose first labour had lasted 1–9 h before caesarean
(n=3258, hazard ratio 2·92 [1·33–6·45]), and women
whose labour had lasted 10 h or more before first caesarean
delivery (n=4906, hazard ratio 2·90 [1·47–5·73]).
If we included only women delivered at term by
intrapartum caesarean section in their first birth (n=8164),
there was no association between the duration of labour in
the first birth (expressed as a continuous variable in hours)
and the risk of unexplained stillbirth in their second
pregnancy (adjusted hazard ratio 1·02 [0·94–1·10],
p=0·66). There was no association between operative
vaginal delivery in the first birth (forceps or vacuum
extraction, n=21740) and unexplained stillbirth in the
second pregnancy (adjusted hazard ratio 1·05 [0·62–1·79],
p=0·84).
For unexplained stillbirths at or after 34 weeks’ gestation,
the median birthweight in women with a previous caesarean
delivery was smaller than in women whose first birth was
vaginal (2820 g [IQR 2240–3062] vs 3110 [2540–3480],
respectively, p=0·04), and more were at or below the fifth
percentile for gestational age (12 [39%] of 31 vs 15 [16%]
of 91, respectively, p=0·01). Also, there was a non-
significant trend towards fewer babies in the upper quintile
of birthweight for gestational age (three [10%] of 31 vs 19
[21%] of 91, respectively, p=0·19) which was significant if
restricted to stillbirths at term and post term (one [5%] of
21, vs 18 [26%] of 69, respectively, p=0·04). The overall
autopsy rate in the 206 unexplained stillbirths in the whole
study group was 77·2%. There was no difference in the rate
of autopsies between women who had not had a previous
caesarean section (129 of 163) and those previously
delivered by caesarean section (30 of 43, p=0·19).
We estimated the absolute risk of stillbirth associated with
previous caesarean delivery using the prospective risk of
stillbirth.24 The prospective risk of stillbirth, from 34 weeks’
gestation, was 1·77 per 1000 for women who had had a
previous caesarean delivery, and 0·89 for other women; the
risk difference was 0·88 (0·23–1·53). For antepartum
stillbirths between 34 and 38 weeks (to estimate the
additional risk among women who have a planned repeat
caesarean section at the start of the 39th week) the risk was
1·09 per 1000 for women who had had a previous caesarean
delivery, and 0·51 per 1000 for other women; the risk
difference was 0·58 per 1000 (0·07–1·08). The prospective
risk of stillbirth from 39 weeks’ gestation was 1·06 per 1000
for women with a previous caesarean delivery and 0·47 per
1000 for other women.
Significant associations between previous caesarean
delivery and intrauterine growth restriction and preterm
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Risk relative to women with no previous caesarean
Crude OR (95% CI) p Adjusted OR 1 (95% CI)† p Adjusted OR 2 (95% CI)‡ p
Outcome of first pregnancy
Unexplained stillbirth 34 weeks* 2·48 (1·61–3·85) <0·001 2·65 (1·70–4·13) <0·001 2·74 (1·74–4·30) <0·001
Birthweight <5th percentile 1·28 (1·17–1·40) <0·001 1·17 (1·07–1·29) 0·001 1·15 (1·04–1·26) 0·005
Birthweight >95th percentile 1·33 (1·25–1·42) <0·001 1·47 (1·38–1·57) <0·001 1·07 (0·99–1·14) 0·07
Delivery 24–32 weeks 1·45 (1·21–1·73) <0·001 1·45 (1·21–1·74) <0·001 1·08 (0·89–1·30) 0·46
Delivery 33–36 weeks 1·39 (1·28–1·51) <0·001 1·38 (1·26–1·50) <0·001 1·15 (1·05–1·26) 0·002
OR=odds ratio. *These values are crude and adjusted hazard ratios rather than odds ratios. †Adjusted for maternal age, height, social deprivation quintile, and smoking
status. Birthweight outcomes were also adjusted for an interaction term between smoking and age. ‡Adjusted for all covariates as in 1, but also for interpregnancy
interval and features of the first pregnancy: moderate and extreme preterm birth, birthweight percentile, unexplained stillbirth, and other perinatal death. 
Table 4: Risk of adverse pregnancy outcome in second pregnancies in relation to previous caesarean delivery adjusted for outcome
of first pregnancy (n=103790)
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Figure 2: Cumulative proportion of stillbirths due to maternal
disease per week of gestation
Hazard ratio for women with previous caesarean delivery relative to
women with a previous vaginal birth=5·12 (95% CI 1·85–14·12).
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birth persisted in multivariate analysis (table 4). Women
who had been delivered by caesarean section in their first
pregnancy also had significantly more stillbirths attributed
to maternal disease (figure 2). If deaths due to diabetes were
excluded from the analyses, the association between
previous caesarean section and stillbirth due to maternal
disease was no longer significant (table 2). The univariate
hazard ratio for unexplained stillbirth associated with
previous caesarean section was very similar if women with
missing values were included (hazard ratio 1·98
[1·36–2·89], p<0·001).
Discussion
Our results show that women whose first birth was by
caesarean section were at significantly increased risk of
having an antepartum stillbirth in their second pregnancy,
mainly because of increased risk of unexplained stillbirth.
The association with unexplained stillbirth was not
attenuated by adjustment for maternal age, height, smoking
status, social deprivation, and interpregnancy interval, or for
key outcomes of the first pregnancy: birthweight percentile,
preterm delivery, and perinatal death.
Our results are of relevance for women considering
caesarean delivery who are planning further pregnancies.
The absolute risk of perinatal death associated with vaginal
breech delivery at term is around 8·3 per 1000 births.25
Caesarean section reduces the risk of perinatal morbidity
and mortality associated with vaginal breech birth.26 The
overall excess risk of stillbirth in a second pregnancy that
was associated with a previous caesarean delivery was below
one per 1000, which is unlikely to influence the decision to
have a caesarean section for breech presentation in a first
pregnancy. However, if women are being counselled about
caesarean birth with no clear obstetric advantage, such as
caesarean section for maternal request, the possible effect
on the risk of unexplained stillbirth in future pregnancies
should be discussed.
Our results are also of relevance for women who have
previously been delivered by caesarean section who are
considering mode of delivery in a subsequent pregnancy.
Previous studies have focused on the risk of perinatal death
caused by intrapartum uterine rupture; we have estimated
the absolute risk of this event as 0·45 per 1000.7 However,
from 39 weeks’ gestation onwards, the absolute risk of
unexplained stillbirth in women who had had a previous
caesarean delivery was greater than double this risk at 1·06
per 1000. The current data suggest that an additional
benefit of planned repeat caesarean delivery at 39 weeks’
gestation may be to reduce the risk of unexplained stillbirth.
This issue should be discussed with women who have had a
previous caesarean delivery when considering mode of
delivery in the second pregnancy. Although induction of
labour at 39 weeks’ gestation would also address this risk, it
is associated with an increased risk of scar rupture.6
However, it is not known whether induction of labour is
associated with an increased risk of perinatal death due to
uterine rupture.
The increased risk of antepartum stillbirth in women
previously delivered by caesarean section is unlikely to be
due to a confounding effect of some unmeasured risk factor.
Unlike deaths from maternal disease, the association with
previous caesarean delivery became evident from 34 weeks’
gestation onwards, and persisted at term and post term. If
our results were biased by other complications of pregnancy,
this difference would have been expected to be greater
before term, since women who have had a previous
caesarean and complications of an earlier pregnancy are
more likely to be delivered by planned repeat caesarean
section at term.6 Time-to-event analysis corrects for
censoring for elective delivery, which clearly will differ
between women who have and have not had a previous
caesarean birth. 
The association between previous caesarean delivery and
unexplained stillbirth in the second pregnancy was not
attenuated by restricting the analysis to women who gave
birth at or after 40 weeks’ gestation in their first pregnancy.
If the association were the result of some unmeasured
confounding association with major complications in the
first pregnancy, we would have anticipated a weaker
association in this group. Moreover, the association was
unaltered by adjustment for maternal factors or obstetric
history. 50% of emergency caesarean sections in first
pregnancies are for dystocia—ie, failure to progress.27 The
strength of the association was similar whether the first
caesarean section was antepartum or intrapartum, and did
not vary with the duration of labour before the first
caesarean section, indicating that the association was
independent of the indication for caesarean delivery.
Furthermore, the association between first caesarean birth
and stillbirth in the second pregnancy is unlikely to be due to
a confounding factor associated with difficult labour, since
there was no an association between operative vaginal birth
(forceps or vacuum extraction) in the first pregnancy and the
risk of unexplained stillbirth in the second.
The database did not include information on maternal
weight, and it was not possible to adjust for maternal body-
mass index. Obesity is associated with a doubling in risk of
late fetal death in parous women.28 Also, some study results
have suggested that obese women are at increased risk of
caesarean section,29 although results are inconsistent.30 Our
results might be accounted for by a confounding effect of
obesity, but this is unlikely for several reasons. First,
stillbirths in the previous caesarean group were less likely to
be large and more likely to be small for gestational age,
which is the opposite of the pattern expected with obesity.
Second, after adjustment for first pregnancy outcome,
previous caesarean section and delivering a large for
gestational age baby were not associated (table 4), but the
association with unexplained stillbirth persisted. Third, the
association between previous caesarean birth and stillbirth
was stronger than that described for a body-mass index
greater than 30.28 Moreover, if the excess of antepartum
stillbirths in the previous caesarean delivery group was
caused by a confounding effect of a known risk factor, it was
not being addressed; these deaths occurred at term, when
elective caesarean delivery has little risk of neonatal death.7
Although the association between previous caesarean
delivery and the risk of unexplained stillbirth is unlikely to be
due to an unmeasured confounder, we cannot exclude this
possibility. However, interventional trials are unlikely to be
able to resolve this issue. The largest randomised controlled
trial of caesarean delivery, to our knowledge, was the term
breech trial, which had around 1000 participants in each
group.26 Even if all these women were followed up and all
women had a subsequent pregnancy, an analysis of these
data would have less than 3% power to detect the increased
risk of unexplained stillbirth that we have observed.
Furthermore, this power calculation does not account for
the fact that 43% of women randomised to vaginal birth
were actually delivered by caesarean section.26
The strengths of the dataset that we used are that it
combined obstetric and demographic variables with almost
complete perinatal death data, including the timing and
cause of death; and that women had free access to obstetric
care. Case-control studies could allow for adjustment for
more maternal factors, but would introduce recall bias.
Women previously delivered by caesarean section were
also at increased risk of stillbirth due to maternal disease as a
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result of an excess of deaths attributed to diabetes 
(table 2). Diabetes increases the risk of caesarean section
and antepartum stillbirths;31 the association with stillbirths
attributed to maternal disease probably indicates a
confounding effect of diabetes. Unlike the risk of
unexplained stillbirth, the association between previous
caesarean delivery and stillbirth caused by maternal disease
was only apparent preterm (figure 2). With respect to
gestational age, this pattern supports our interpretation that
confounding by a known risk factor for antepartum stillbirth
would be expected to cause an increased risk preterm that
would not be apparent at term and post term. The patterns
of association indicate that our results are unlikely to be due
to misclassification of stillbirths as unexplained that were in
fact due to maternal disease. Moreover, we saw no effect of
adjustment for age or any interaction between maternal age
and previous caesarean section that might suggest
confounding by maternal disease.
It was not a prior hypothesis that the association between
previous caesarean delivery and unexplained stillbirth would
vary with gestational age. The separation into before and
after 34 weeks’ gestation was done as a result of our analysis.
Further studies will be required to confirm this finding.
However, non-proportionality of the hazards was confirmed
by a formal statistical test. Moreover, the association
between previous caesarean section and unexplained
stillbirth was still highly significant across the whole range of
gestation.
The association between unexplained stillbirth and
previous caesarean section is biologically plausible. It is
possible that intentional or inadvertent ligation of major
uterine vessels at the time of first caesarean section could
affect uterine blood flow in future pregnancies. Further-
more, previous caesarean delivery is also known to be
associated with an increased risk of abnormal placentation
leading to abruption, placenta praevia, and morbid
adherence of the placenta.8–10 Stillbirth is associated with a
high resistance pattern of uterine artery and umbilical artery
blood flow, which may indicate maldevelopment of the
villous tree.32–34 The association between previous caesarean
and stillbirth might be, therefore, another manifestation of
abnormal placentation caused by a uterine scar. Consistent
with this interpretation, stillbirths in women with a previous
caesarean section were more likely to be small for gestational
age than stillbirths in other women. Previous caesarean
section was also associated with an increased risk of preterm
birth and delivering a liveborn small for gestational age
infant. This association might also be due to uteroplacental
dysfunction or to the association between previous caesarean
birth and abruption—since abruption is associated both with
fetal growth restriction and with preterm birth.35 We are not
aware of any studies in which the effects have been assessed
of caesarean delivery on uterine blood flow and mechanisms
of placentation in future pregnancies. Such work could
identify the biological basis for our results.
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Women with a previous stillbirth are known to be at increased risk of stillbirth in subsequent pregnancies.
However, few studies have addressed the association between other complications of pregnancy and the future
risk of stillbirth. Using linkage of national pregnancy and perinatal death registries, the authors performed a retro-
spective cohort study of 133,163 women having a second birth in Scotland between 1992 and 2001 whose ﬁrst
infant was liveborn. The risk of unexplained stillbirth was increased among women with a previous preterm birth
(adjusted hazard ratio (HR) ¼ 2.04, 95% conﬁdence interval (CI): 1.34, 3.11), previous delivery of a small for
gestational age (SGA) infant (HR ¼ 2.14, 95% CI: 1.59, 2.87), and previous preeclampsia (HR ¼ 1.68, 95% CI:
1.07, 2.62). The associations were similar after adjustment for maternal age, height, marital and smoking status,
and interpregnancy interval. There was a statistically signiﬁcant positive interaction between previous delivery of
a SGA infant and previous preeclampsia (p ¼ 0.01): Women with this combination in their ﬁrst pregnancy had an
approximately ﬁvefold risk of unexplained stillbirth in the second pregnancy (HR ¼ 4.95, 95% CI: 2.63, 9.32).
Associations were stronger with SGA unexplained stillbirths. The authors conclude that complicated ﬁrst births of
liveborn infants are associated with an increased risk of unexplained stillbirth in the next pregnancy.
pregnancy complications; risk; stillbirth
Abbreviations: CI, conﬁdence interval; HR, hazard ratio; ICD, International Classiﬁcation of Diseases; OR, odds ratio;
SGA, small for gestational age.
Antepartum stillbirth is death of the fetus before the on-
set of labor. It accounts for two thirds of all perinatal deaths
and affects approximately one in 200 pregnancies (1). Approx-
imately two thirds of antepartum stillbirths have no direct
cause and are referred to as ‘‘unexplained.’’ The risk of both
unexplained stillbirth and other pregnancy complications is
associated with indicators of placental function, such as low
levels of pregnancy-associated plasma protein A (2, 3), high
levels of maternal serum alpha-fetoprotein (4), and a high
resistance pattern of uterine artery Doppler flow velocimetry
(5). Consequently, it is plausible that unexplained stillbirth
and other complications of pregnancy are different clinical
manifestations of a common problem in placentation.
It is well recognized that specific pregnancy complica-
tions, such as spontaneous preterm delivery and abruption,
are likely to recur (6, 7). It is likely that this reflects, at least
in part, a persistent predisposition to impaired placenta-
tion. Given that unexplained stillbirth and other pregnancy
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complications appear to have common placental determi-
nants, we hypothesized that women who had pregnancies
complicated by preeclampsia, preterm birth, or intrauterine
growth restriction may be at increased risk of unexplained
stillbirth in their subsequent pregnancies. Here we report the
relation between complications in a first livebirth and the
risk of unexplained stillbirth in 133,163 second pregnancies.
MATERIALS AND METHODS
Data sources
The Scottish Morbidity Record 2 collects information on
clinical and demographic characteristics and outcomes for
all patients discharged from Scottish maternity hospitals.
The register is subjected to regular quality assurance checks
and has been greater than 99 percent complete since the late
1970s (8). A quality assurance exercise was performed in
1996–1997, where 5 percent of case records were compared
with the Scottish Morbidity Record 2 database over a 6-
month period (n ¼ 1,414). This exercise demonstrated that
all fields used in the present study had less than 2 percent
errors with the exception of the following (percent errors in
parentheses): maternal height (4.4 percent) and estimated
gestation (5.6 percent). International Classification of Dis-
eases (ICD) diagnostic codes were found to be 80–90 per-
cent accurate for the first four diagnoses and 70–80 percent
accurate for the remainder (9).
Records of singleton births from the Scottish Morbidity
Record 2 between 1985 and 2001 were identified and linked
to records from the Scottish Stillbirth and Infant Death En-
quiry (a national register that routinely classifies all perina-
tal deaths in Scotland) by use of a probability-based matching
approach, which has been shown to match correctly approx-
imately 98 percent of records (10). Coding of the cause of
death is performed by a single medically qualified individ-
ual (the Scottish coordinator) in the Information and Sta-
tistics Division of the National Health Service on the basis
of clinical information obtained from local coordinators
and pathologists. Cases are identified through registration
of stillbirths and neonatal deaths with the General Regis-
trar’s Office, which is a legal requirement following a peri-
natal death. The register is 100 percent complete when
compared with the death certificate database and has been
described in detail elsewhere (11, 12). Approval for the re-
cord linkage was provided by the Privacy Advisory Com-
mittee of the Information and Statistics Division of the
National Health Service Scotland.
Study cohort
The population studied consisted of all second births in
Scotland between 1992 and 2001, where there was a record
for the first birth in the linked database. The analysis fo-
cused on second births after 1991, since smoking status was
included only in the Scottish Morbidity Record 2 database
from 1992 onward. Women were excluded whose first re-
cord had missing data for gestation or for infant’s sex or
birth weight; where the gestational age at delivery was out-
side the range of 24–43 weeks; and where the infant was
stillborn. Women were excluded whose second record had
missing data for gestation, infant’s sex, birth weight, or any
of the other maternal characteristics. Records were also ex-
cluded where the second infant died during the perinatal
period as the result of congenital abnormality or rhesus iso-
immunization or where delivery was outside the range of
24–43 weeks. Women were also excluded where the pair of
records yielded an interpregnancy interval that was negative
or implausibly short and where there was a discrepancy be-
tween the documented mode of delivery in the first record and
the previous cesarean delivery field in the second record.
Deﬁnitions of maternal and obstetric characteristics
In the comparison of risk of unexplained antepartum still-
birth, the following demographic factors were considered as
possible confounders: socioeconomic deprivation, smoking,
maternal age, maternal height, and marital status. The post-
code of residence was used to derive Carstairs socioeco-
nomic deprivation scores (13). These are based on 1991
census data on car ownership, unemployment, overcrowding,
and social class within postcode sectors of residence that
contain, on average, around 1,600 residents. The deprivation
scores were then used to assign women to categories of
socioeconomic deprivation within the study cohort. Higher
numbers indicate a greater degree of deprivation. ‘‘Smok-
ing’’ was defined as the smoking status of the woman at the
time of first attendance for antenatal care. ‘‘Maternal age’’
was defined as the age of the mother at the time of birth.
Maternal height was measured in centimeters, and the value
used was that documented in each woman’s clinical record.
‘‘Gestational age at birth’’ was defined as the completed
weeks of gestation on the basis of the estimated date of de-
livery in each woman’s clinical record. Gestational age has
been confirmed by ultrasound in the first half of pregnancy in
more than 95 percent of women in the United Kingdom since
the early 1990s (14). ‘‘Preterm birth’’ was defined as birth
before 37 weeks of gestation. Birth weight was classified into
sex- and gestational age-specific percentiles on the basis of
1,002,834 singleton livebirths between 1985 and 2001 en-
tered into the Scottish Morbidity Record 2. ‘‘Small for ges-
tational age (SGA) birth weight’’ was defined as a birth
weight in the smallest 10 percent for sex and gestation.
‘‘Interpregnancy interval’’ was defined as the number of days
from the first birth until the estimated date of the last men-
strual period of the second. The estimated date of the last
menstrual period was calculated by subtracting the estimated
gestational age from the date of delivery. ‘‘Preeclampsia’’
was defined as the presence of an appropriate diagnostic code
(ICD, Ninth Revision, code 642.4 or 642.5 or ICD, Tenth
Revision, code O140, O141, or O149) in the delivery record.
Deﬁnition of stillbirths
Stillbirths were classified as antepartum (deaths before
the onset of labor) and intrapartum (deaths during labor).
‘‘Deaths caused by congenital anomaly’’ were defined as any
structural or genetic defect incompatible with life or poten-
tially treatable but causing death. The cause of antepartum
stillbirth was classified in the Scottish Stillbirth and Infant
Previous Pregnancy Complications and Risk of Stillbirth 195
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Death Enquiry according to a modified version of the
Wigglesworth hierarchical system (15), which is described
in detail elsewhere (12). Stillbirths were classified according
to direct obstetric causes (in order): toxemia (i.e., pre-
eclampsia or eclampsia), hemorrhage (antepartum), mechan-
ical, maternal, miscellaneous, and unexplained. Unexplained
stillbirths included those that were SGA. The hierarchy dic-
tates that a perinatal death where there was severe pre-
eclampsia complicated by abruption would be classified as
being due to toxemia, since toxemia is above hemorrhage in
the hierarchy.
Statistical analyses
Continuous variables were summarized by the median
and interquartile range, and comparisons between groups
were made by the Mann-Whitney U test. Univariate com-
parisons of dichotomous data were made by use of the chi-
square test and the test for trend, as appropriate. The
p values for all hypothesis tests were two sided, and statis-
tical significance was set at p < 0.05. The risk of stillbirth
was compared between groups by time-to-event analyses
(Kaplan-Meier and Cox proportional hazard model) in
which the week of gestation was used as the time scale,
antepartum stillbirth due to the specified cause was defined
as the event, and all other births were treated as censored.
This method uses ongoing pregnancies as the denominator,
as previously suggested (16), but accounts for censoring due
to birth, allows multivariate analysis (17), and can be used in
situations where not all individuals would ultimately expe-
rience the event (18). This analytical approach allows as-
sessment of the relative risk accounting for variation in the
duration of pregnancy. Survival data were plotted as the
cumulative percentage with event as recommended for rare
outcomes (19), and univariate statistical comparisons were
made with the log-rank test. Crude and adjusted hazard
ratios were estimated by use of the proportional hazards
model (20). The statistical significance of interactions be-
tween first pregnancy outcomes was assessed with the likeli-
hood ratio test. The proportional hazards assumption was
tested with the test of Grambsch and Therneau (21) as pre-
viously described for the analysis of stillbirth risk (9, 22).
Logistic regression analysis was used to estimate adjusted
odds ratios within given gestational windows. In these anal-
yses, the number of antepartum stillbirths within the given
range was the numerator, and the number of all births at the
given or later gestations was the denominator. All statistical
analyses were performed with STATA, version 8.2, software
(StataCorp LP, College Station, Texas).
RESULTS
The Scottish Morbidity Record 2 contained 196,842 re-
cords of second singleton births between 1992 and 2001. Of
these, 166,552 (84.6 percent) could be linked to a record for
the first birth; 33,389 of these records (20.0 percent) were
excluded (figure 1), leaving a study group of 133,163. There
were 357 (0.3 percent) antepartum stillbirths not due to fetal
abnormality or rhesus isoimmunization: 105 (29.4 percent)
were explained (toxemia, hemorrhage, mechanical, maternal,
and miscellaneous), and 252 (70.6 percent) were unex-
plained. Women whose second pregnancy ended in antepar-
tum stillbirth were more likely in their first pregnancy to
have delivered a SGA infant, delivered preterm, had a di-
agnosis of preeclampsia, and delivered by cesarean section
(table 1). The interpregnancy interval varied in relation to
whether the second pregnancy was an antepartum stillbirth,
with a greater proportion of these women experiencing very
prolonged intervals. Women experiencing a stillbirth were
shorter and, at the time of the second pregnancy, were more
likely to live in an area of high socioeconomic deprivation,
to smoke, and to be unmarried.
Preterm birth, delivery of a SGA infant, and preeclampsia
in the first pregnancy were each associated with an approx-
imately two- to threefold risk of stillbirth in the second
pregnancy (table 2). The risk of explained stillbirth was
approximately sixfold among women with a previous pre-
term delivery and approximately threefold among women
with previous delivery of a SGA infant or with preeclamp-
sia. When analyzed by cause of stillbirth, previous preterm
birth was associated with a sixfold risk of stillbirth due to
preeclampsia, a fourfold risk of stillbirth due to abruption,
and a 16-fold risk of stillbirth due to maternal disease. Pre-
vious delivery of a SGA infant was associated with sixfold
risk of stillbirth due to preeclampsia and a fourfold risk of
stillbirth due to abruption. Previous preeclampsia was as-
sociated with an 11-fold risk of stillbirth due to preeclamp-
sia and a sixfold risk of stillbirth due to maternal disease.
166,552
164,428
133,163
Perinatal death exclusions:
1,060 first pregnancies ended in stillbirth
268 second pregnancies ended in perinatal death due to 
congenital abnormality or rhesus isoimmunization
Comparison of first and second pregnancy record:
79 negative or implausibly short interpregnancy interval
2,861 discrepancy between mode of delivery in first pregnancy
and previous cesarean section field in second
Missing data in first pregnancy record:
sex = 6, birth weight  = 65
Missing data in second pregnancy record:
height = 18,857; deprivation category = 343; smoking  = 15,067
Total 31,265 excluded
Gestational age missing or outside range 24-43 weeks:
528 first pregnancies
289 second pregnancies
Total 2,124 excluded
FIGURE 1. Selection of study cohort from all second singleton births
in Scotland recorded in the Scottish Morbidity Record 2, 1992–2001.
196 Smith et al.
Am J Epidemiol 2007;165:194–202
Page 173
Preterm birth, delivery of a SGA infant, and preeclampsia in
the first pregnancy were each associated with an approxi-
mately twofold risk of unexplained stillbirth. The strength
of association was very similar when the analysis was con-
fined to previous spontaneous preterm birth (hazard ratio
(HR)¼ 1.92, 95 percent confidence interval (CI): 1.14, 3.23).
In relation to the risk of unexplained stillbirth, there were
no statistically significant interactions between previous
TABLE 1. Maternal characteristics and outcome by occurrence of antepartum stillbirth
in the second pregnancy, Scotland, 1992–2001
Not antepartum stillbirth
(n ¼ 132,806)
Antepartum stillbirth
(n ¼ 357) p value*
No. % No. %
First pregnancy outcome
Small for gestational
age infant
No 116,673 87.9 272 76.2 <0.001
Yes 16,133 12.2 85 23.8
Gestation at birth
Term 125,165 94.3 307 86.0 <0.001
Preterm 7,641 5.8 50 14.0
Preeclampsia
No 125,747 94.7 320 89.6 <0.001
Yes 7,059 5.3 37 10.4
Cesarean section
No 112,582 84.8 264 74.0 <0.001
Yes 20,224 15.2 93 26.1
Second pregnancy characteristics
Interpregnancy interval
<6 months 5,242 4.0 15 4.2 0.02
6–11 months 13,828 10.4 29 8.1
12–23 months 37,997 28.6 94 26.3
24 months–5 years 58,140 43.8 152 42.6
6–10 years 16,301 12.3 60 16.8
>10 years 1,298 1.0 7 2.0
Age, years (median
(interquartile range)) 29 25, 32 28 23, 32 0.1
Height, cm (median
(interquartile range)) 162 158, 167 161 157, 165 <0.001
Deprivation category
1 (least deprived) 8,253 6.2 9 2.5 <0.001
2 18,606 14.0 43 12.0
3 28,650 21.6 67 18.8
4 32,293 24.3 87 24.4
5 20,373 15.3 75 21.0
6 15,920 12.0 46 12.9
7 (most deprived) 8,711 6.6 30 8.0
Smoking status
Never 85,288 64.2 193 54.1 <0.001
Current 37,595 28.3 149 41.7
Former 9,923 7.5 15 4.2
Marital status
Married 92,521 69.7 214 59.9 <0.001
Other 40,285 30.3 143 40.1
* Mann-Whitney U, chi-square test for trend, or chi-square test as appropriate.
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preterm delivery and previous delivery of a SGA infant
(HRinteraction ¼ 1.10, 95 percent CI: 0.41, 2.95; p ¼ 0.85)
or between previous preterm birth and previous preeclamp-
sia (HRinteraction¼ 0.48, 95 percent CI: 0.15, 1.59; p¼ 0.21).
However, there was a statistically significant interaction be-
tween previous preeclampsia and previous delivery of
a SGA infant (HRinteraction ¼ 3.37, 95 percent CI: 1.34,
8.45; p ¼ 0.01). All subsequent analysis of the risk of un-
explained stillbirth examined combinations of previous
delivery of a SGA infant and previous preeclampsia. The
risk of unexplained stillbirth was approximately 60 per-
cent higher among women with a previous preterm birth
(figure 2A; table 3). The risk of unexplained stillbirth wasTA
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FIGURE 2. Kaplan-Meier plot of cumulative probability of unex-
plained stillbirth (expressed per 1,000 pregnancies) in the second
birth in relation to the outcome of the ﬁrst birth, Scotland, 1992–2001.
A, comparison of women whose ﬁrst birth was at term (dashed line)
with those who had previously delivered preterm (solid line); B, com-
parison of women who delivered an appropriate for gestational age
infant and had no diagnosis of preeclampsia in their ﬁrst pregnancy
(dashed line) with women who delivered a small for gestational age
(SGA) infant and had a documented diagnosis of preeclampsia in
their ﬁrst pregnancy (solid line).
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TABLE 3. Unadjusted and adjusted hazard ratios for unexplained stillbirth in the second pregnancy,
Scotland, 1992–2001
Maternal and obstetric
characteristics
Univariate analysis Multivariate analysis
Hazard
ratio
95%
conﬁdence
interval
p value*
Hazard
ratio
95%
conﬁdence
interval
p value*
First pregnancy predictors
Gestation at birth
Term Referent Referent
Preterm 2.04 1.34, 3.11 <0.001 1.62 1.04, 2.51 0.04y
Small for gestational age or
preeclampsia
Not small for gestational age or
preeclampsia Referent <0.001 Referent <0.001
Small for gestational age alone 1.83 1.32, 2.53 1.67 1.20, 2.33
Preeclampsia alone 1.02 0.54, 1.93 0.88 0.46, 1.68
Small for gestational age and
preeclampsia 6.83 3.72, 12.55 4.95 2.63, 9.32
Previous cesarean section
No Referent Referent
Yes 1.95 1.46, 2.60 <0.001 1.75 1.30, 2.37 <0.001y
Second pregnancy predictors
Interpregnancy interval
<6 months 0.98 0.52, 1.88 0.07z 0.88 0.45, 1.70 0.3
6–11 months 0.72 0.45, 1.16 0.72 0.44, 1.16
12–23 months 0.82 0.62, 1.12 0.85 0.62, 1.16
24 months–5 years Referent Referent
6–10 years 1.15 0.80, 1.67 1.08 0.74, 1.58
>10 years 2.42 1.06, 5.49 2.06 0.89, 4.77
Age, years
<20 1.35 0.65, 2.79 0.04 1.33 0.61, 2.88 0.2
20–24 1.41 1.00, 1.99 1.32 0.92, 1.90
25–29 Referent Referent
30–34 1.09 0.79, 1.50 1.1 0.81, 1.56
35–39 1.47 0.96, 2.25 1.48 0.96, 2.28
>39 2.99 1.30, 6.86 2.93 1.27, 6.79
Deprivation category
1 (least deprived) 0.37 0.16, 0.85 0.2z 0.40 0.17, 0.92 0.3
2 0.84 0.54, 1.28 0.89 0.57, 1.37
3 0.95 0.66, 1.36 0.99 0.69, 1.43
4 Referent Referent
5 1.12 0.76, 1.64 1.08 0.73, 1.58
6 1.02 0.67, 1.57 0.96 0.63, 1.47
7 (most deprived) 1.20 0.73, 1.98 1.06 0.63, 1.76
Height, cm
<155 1.29 0.83, 2.00 0.049z 1.06 0.68, 1.65 0.3
155–159 1.59 1.14, 2.21 1.47 1.05, 2.05
160–164 Referent Referent
165–169 1.06 0.74, 1.51 1.12 0.78, 1.60
170–174 0.89 0.55, 1.44 0.97 0.60, 1.58
>174 0.99 0.48, 2.06 1.15 0.55, 2.39
Smoking
Never Referent 0.03 Referent 0.2
Current 1.34 1.03, 1.74 1.07 0.80, 1.44
Former 0.74 0.42, 1.30 0.67 0.38, 1.18
Marital status
Married Referent Referent
Other 1.37 1.06, 1.77 0.02 1.20 0.89, 1.62 0.2
* p value is test for heterogeneity except where otherwise noted.
y p < 0.01 for test of proportional hazards assumption (Biometrika 1994;81:515–26 (21)).
z p < 0.05 for linear trend.
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approximately 70 percent higher among women with a pre-
vious delivery of a SGA infant in the absence of a diagnosis
of preeclampsia. A previous diagnosis of preeclampsia was
not associated with the subsequent risk of unexplained still-
birth if the infant was appropriate for gestational age. How-
ever, the risk of unexplained stillbirth was fivefold among
women with the combination of previous preeclampsia and
delivery of a SGA infant (figure 2B; table 3). The associa-
tion between previous preterm birth and previous cesarean
section significantly varied across the range of 24–43 weeks
(table 3). The association with previous preterm birth was
strong at 24–32 weeks (odds ratio (OR) ¼ 2.71, 95 percent
CI: 1.56, 4.71) and not statistically significant at 33–36
weeks (OR ¼ 1.34, 95 percent CI: 0.52, 3.47) or 37–43
weeks (OR ¼ 0.39, 95 percent CI: 0.12, 1.24).
We found an association between cesarean delivery in the
first pregnancy and the risk of unexplained stillbirth in the
second (table 4), which is consistent with our previous
study (9). However, there would have been considerable
overlap between the patients in our previous study (eligible
second births in Scotland in 1992–1998) and those in the
present study. We repeated the analysis of previous cesar-
ean delivery confined to the 32,628 births from 1999 to
2001, that is, in women who were not included in our pre-
vious analysis. The hazard ratio for unexplained stillbirth
associated with previous cesarean delivery in births from
1999 to 2001 was 2.27 (95 percent CI: 1.38, 3.73; p ¼
0.001).
We analyzed the relation between the outcome of the first
pregnancy and the risk of unexplained stillbirth, dividing
the outcome into those that were SGA and those that were
appropriate for gestational age. Associations tended to be
stronger for unexplained stillbirth where the birth weight
was SGA (table 4).
The main analysis was then performed in the approxi-
mately 31,000 women excluded because of missing data
in relation to the second pregnancy. This addressed whether
the cohort studied may have been unrepresentative of the
whole population; for example, it may have systematically
excluded women who delivered without booking for pre-
natal care, leading to biases. Among these women, the un-
adjusted hazard ratio for unexplained stillbirth was 2.57 (95
percent CI: 1.27, 5.18) for women with a prior history of
preterm birth, 2.08 (95 percent CI: 1.18, 3.67) for women
with previous delivery of a SGA infant, and 1.91 (95 percent
CI: 0.91, 4.00) for women with previous preeclampsia. The
strength of the associations did not significantly differ from
those observed among women with complete data (p ¼ 0.7,
0.9, and 0.8, respectively).
DISCUSSION
It is well recognized that women who have a stillbirth in
one pregnancy are at increased risk of stillbirth in future
pregnancies (23). These women are typically offered addi-
tional fetal surveillance and early elective delivery at term.
The key finding of the present study is that women who
experienced preterm birth, delivery of a SGA infant, or pre-
eclampsia in a first birth of a liveborn infant were also at
increased risk of unexplained stillbirth in the second. More-
over, there was a synergistic association between previous
delivery of a SGA infant and previous preeclampsia: This
combination carried a fivefold risk of unexplained stillbirth
in the second pregnancy.
Previous preterm birth, previous delivery of a SGA infant,
and previous preeclampsia were also associated with an in-
creased risk of explained stillbirth. These observations are
likely to reflect, at least in part, the recurrence of specific
complications, such as abruption and preeclampsia. The as-
sociation between prior complications and the risk of ex-
plained stillbirth in the second pregnancy may also reflect
common associations among preexisting maternal disease,
obstetric complications, and stillbirth. For example, women
with insulin-dependent diabetes mellitus are at increased
TABLE 4. Relation between ﬁrst pregnancy outcome and small for gestational age and appropriate for
gestational age unexplained stillbirth, Scotland, 1992–2001*
Outcome of ﬁrst pregnancy
Small for gestational age Appropriate for gestational age
Hazard
ratio
95%
conﬁdence
interval
p value
Hazard
ratio
95%
conﬁdence
interval
p value
Gestation at ﬁrst birth
Preterm 3.38 1.87, 6.11 <0.001 1.39 0.75, 2.57 0.3
Small for gestational age or
preeclampsia
Small for gestational age alone 2.73 1.65, 4.49 <0.001 1.42 0.92, 2.20 0.1
Preeclampsia alone 1.30 0.47, 3.59 0.6 0.89 0.39, 2.02 0.8
Small for gestational age and
preeclampsia 5.91 1.85, 18.85 0.003 7.25 3.54, 14.82 <0.001
Mode of delivery
Cesarean 3.34 2.15, 5.19 <0.001 1.38 0.93, 2.04 0.1
* The referent category for preterm was previous term birth, for small for gestational age and/or preeclampsia was
women who had neither outcome, and for mode of delivery was any form of vaginal delivery.
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risk of preterm birth and preeclampsia (24). The increased
risk of explained stillbirth among women with previous com-
plicated births is, therefore, plausible but probably merely
reflects the known recurrence risk of obstetric complications
and common associations among maternal disease, obstetric
complications, and stillbirth.
There has been only one large-scale study, to our knowl-
edge, that has previously addressed the association between
previous obstetric complications and the future risk of still-
birth (25). The major weakness of that study was that they
lacked data on the cause of stillbirth. Therefore, antepartum
and intrapartum stillbirths were pooled, as were explained
and unexplained stillbirths. That study demonstrated an ap-
proximately twofold risk of stillbirth associated with both
previous preterm birth and previous delivery of a SGA in-
fant. No data were reported on previous preeclampsia. It was
unclear from that study whether these associations were ex-
plained by simply recurrence of complications (abruption
and preeclampsia) or by common associations with maternal
disease, as discussed above. In the present study, we show
that prior pregnancy complications are associated with the
risk of both explained and unexplained antepartum stillbirth.
The current findings are biologically plausible. Previous
studies have shown that the same biochemical or biophysi-
cal measurements of placental function in early pregnancy
are associated with both unexplained stillbirth and other
adverse obstetric outcomes (2–5). Although the determi-
nants of poor placentation remain obscure, it is known that
placentally related complications tend to recur (6). Further-
more, women with elevated levels of maternal serum alpha-
fetoprotein (an indicator of placental permeability) in one
pregnancy are more likely to have elevated levels of this
protein in the next pregnancy (26). The current findings sug-
gest that women who have a tendency to impaired pla-
centation may manifest this with different complications
in different pregnancies. The factors that determine which
complications arise in a given pregnancy remain unclear.
Consistent with this interpretation, the association that we
found between previous pregnancy complications and the
risk of unexplained stillbirth tended to be stronger for un-
explained stillbirths where the infant was SGA. Previous
studies have shown associations between placental function
and SGA unexplained stillbirths but not those with birth
weight appropriate for gestational age (3).
We had previously demonstrated an association between
cesarean delivery in the first pregnancy and the risk of un-
explained stillbirth in the second (9). We observed a very
similar association in the current analysis. However, the cur-
rent data expand on our previous analysis in two ways.
First, we now show that the association is similar after ad-
justment for a diagnosis of preeclampsia in the first preg-
nancy. Second, we repeated the analysis confined to births
between 1999 and 2001 (our previous study had examined
second births in Scotland between 1992 and 1998, and many
of these would also have been included in the present study).
We found a very similar strength of association between
previous cesarean delivery in the first pregnancy and the
risk of unexplained stillbirth in the second in births between
1999 and 2001. Thus, it is unlikely that this association is a
chance finding.
In conclusion, women with previous placentally related
complications in a livebirth are at increased risk of unex-
plained stillbirth. The association is particularly strong among
those with the combination of previous preeclampsia and
previous delivery of a SGA infant, which suggests that the
underlying defect in placentation leading to that combina-
tion may be similar to the defect predisposing to stillbirth.
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Risk of Perinatal Death Associated With
Labor After Previous Cesarean Delivery
in Uncomplicated Term Pregnancies
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INCREASING RATES OF CESAREANdelivery are a major cause forconcern in almost all developedcountries.1 A number of strategies
have been proposed that aim to re-
duce the overall proportion of cesar-
ean deliveries, including trial of labor
after previous cesarean deliveries.2 Ob-
servational studies3,4 suggest that trial
of labor is associated with a signifi-
cantly increased risk of uterine rup-
ture. A meta-analysis reported an
increased risk of perinatal death asso-
ciated with trial of labor5 but included
premature births between 28 and 36
weeks’ gestation and breech deliver-
ies.6 There is no large-scale study of the
relative and absolute risks of perinatal
death among women previously deliv-
ered by cesarean method but with an
uncomplicated pregnancy at term. In
the present study, we sought to ad-
dress this by linking national registers
of pregnancy discharge data and peri-
natal deaths.
METHODS
The analysis was designed to deter-
mine the risk of intrapartum stillbirth
or neonatal death unrelated to congen-
ital abnormality among women with an
uncomplicated term pregnancy who
had a trial of labor following at least 1
previous cesarean delivery. Trial of la-
bor was defined as any vaginal or emer-
gency (unplanned) cesarean delivery
Author Affiliations are listed at the end of this
article.
Corresponding Author and Reprints: Gordon C. S.
Smith, MD, PhD, Department of Obstetrics and Gyn-
aecology, Cambridge University, Rosie Maternity Hos-
pital, Cambridge, CB2 2QQ, England (e-mail: gcss2
@cam.ac.uk).
Context Trial of labor after previous cesarean delivery is associated with increased
risk of uterine rupture. However, no reliable data exist on the effect of a trial of labor
on the risk of perinatal death in otherwise uncomplicated term pregnancies.
Objective To determine the risk of intrapartum stillbirth or neonatal death not re-
lated to congenital abnormality among women with uncomplicated term pregnancies
who had a trial of labor after previous cesarean delivery, compared with women hav-
ing a planned repeat cesarean delivery, and multiparous and nulliparous women at
term not delivered by planned cesarean method.
Design and Setting Population-based, retrospective cohort study of data from the
linked Scottish Morbidity Record and Stillbirth and Neonatal Death Enquiry encom-
passing births in Scotland between January 1, 1992, and December 31, 1997.
Population A total of 313238 singleton births between 37 and 43 weeks’ gesta-
tional age in which the fetus was in a cephalic presentation.
Main Outcome Measure Delivery-related perinatal death, defined as intrapar-
tum stillbirth or neonatal death unrelated to congenital anomaly, compared among
the 4 groups.
Results Among women who had a trial of labor following previous cesarean deliv-
ery (n=15515), the overall rate of delivery-related perinatal death was 12.9 (95% con-
fidence interval [CI], 7.9-19.9) per 10000 women. This was approximately 11 times
greater (odds ratio [OR], 11.6; 95% CI, 1.6-86.7) than the risk associated with planned
repeat cesarean delivery (n=9014), more than twice (OR, 2.2; 95% CI, 1.3-3.5) the
risk associated with other multiparous women in labor (n=151549), and similar to the
risk among nulliparous women in labor (n=137160; OR, 1.3; 95% CI, 0.8-2.1). The
associations were not explained by differences in maternal height, smoking status, so-
cioeconomic status, age, fetal growth, or week of gestation at delivery. Among women
having a trial of labor, the rate of death due to mechanical causes, including uterine
rupture, was 4.5 (95% CI, 1.8-9.3) per 10000 women. This was more than 8 times
greater than other multiparous women (OR, 8.5; 95% CI, 3.2-22.3) and nulliparous
women (OR, 8.8; 95% CI, 3.2-24.2).
Conclusions The absolute risk of perinatal death associated with trial of labor follow-
ing previous cesarean delivery is low. However, in our study, the risk was significantly
higher than that associated with planned repeat cesarean delivery, and there was a marked
excess of deaths due to uterine rupture compared with other women in labor.
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occurring at or beyond 37 weeks’ ges-
tation in a woman who had previously
been delivered by cesarean method.
These women were compared with 3
groups: (1) women having planned re-
peat cesarean delivery, (2) other mul-
tiparous women at term not delivered
by planned cesarean method, and (3)
nulliparous women at term not deliv-
ered by planned cesarean method. Nul-
liparous women were women with no
previous pregnancies or whose previ-
ous pregnancies all ended in abortion.
Population
The Scottish Morbidity Record (SMR2)
collects information on clinical and de-
mographic characteristics and out-
comes for all patients discharged from
Scottish maternity hospitals. The regis-
ter is subjected to regular quality assur-
ance checks and has been more than
99% complete since the late 1970s.7 An
analysis of 1414 records from 1996
through 1997 demonstrated that the reg-
ister was free of significant errors in more
than 98% of records in all the fields used
in the present analysis, with the excep-
tion of postcode (94.0%), height
(96.2%), estimated gestation (94.4%),
and method of induction of labor
(93.6%) (Jim Chalmers, MBChB, Infor-
mation and Statistics Division, Na-
tional Health Service, Edinburgh, Scot-
land, written communication, April
2001). The SMR2 records were linked
to records from the Scottish Stillbirth and
Neonatal Death Enquiry. This national
register has routinely classified all peri-
natal deaths in Scotland since 1983. It
is almost 100% complete and has been
described in detail elsewhere.8
Study Group
The study group consisted of all births
in Scotland between January 1, 1992,
and December 31, 1997. The exclu-
sion criteria for the study group were
multiple pregnancy, noncephalic pre-
sentation, delivery outside the range of
37 to 43 weeks’ gestation, perinatal
deaths due to congenital anomaly, an-
tepartum stillbirth not due to congen-
ital anomaly, and deliveries by planned
cesarean method, except among women
who had been delivered by cesarean
method in a previous pregnancy.
The main outcome of this study was
delivery-related perinatal death, de-
fined as intrapartum stillbirth or neo-
natal death not caused by congenital
anomaly. Stillbirths were defined as
newborns that showed no signs of life
following delivery. Stillbirths were sub-
divided into antepartum (deaths be-
fore the onset of labor) and intrapar-
tum (deaths during labor). Neonatal
death was defined as death during the
first 4 weeks of life in a live newborn.
Deaths caused by congenital anomaly
were defined as any structural or ge-
netic defect incompatible with life or
potentially treatable but causing death.
In the comparison of risk of perinatal
death among groups of women, the fol-
lowing factors were considered as pos-
sible confounders: socioeconomic dep-
rivation, smoking,maternal age,maternal
height, gestational age, and birth weight.
Postcode of residence was used to de-
rive Carstairs socioeconomic depriva-
tion scores.9 These are based on 1991
census data on car ownership, unem-
ployment, overcrowding, and social class
within postcode sectors of residence that
contain, on average, approximately 1600
residents. The deprivation scores were
thenused tocategorizewomen intoquin-
tiles of socioeconomic deprivation within
the study cohort. Higher quintiles indi-
cate a greater degree of deprivation.
Smoking was defined as the smoking sta-
tus of the woman at the time of first at-
tendance for antenatal care. Maternal age
was defined as the age of the mother at
the time of birth. Maternal height was
measured in centimeters, and the value
used was that documented in each wom-
an’s clinical record. Height is generally
measured using a free-standing or wall-
mountedheightmeasure.Gestational age
at birth was defined as completed weeks
of gestation on the basis of the esti-
mated date of delivery in each woman’s
clinical record. Gestational age has been
confirmed by ultrasound in the first half
of pregnancy in more than 95% of
women in the United Kingdom since the
early 1990s.10 Birth weight was catego-
rized into sex- and gestational age-
specific deciles, using a method previ-
ously described in detail.11 Low birth
weight was defined as birth weight of less
than 2500 g.
The cause of perinatal death was clas-
sified according to a hierarchical sys-
tem that is described in detail else-
where.12 Deaths were initially classified
according to the following direct obstet-
ric causes (in order): toxemia, hemor-
rhage, mechanical, maternal, and none
of these obstetric causes. Mechanical was
defined as death from uterine rupture,
cord compression (including pro-
lapse), birth trauma, or asphyxia asso-
ciated with disproportion. In the ab-
sence of any of the listed direct obstetric
causes, the deaths were classified by the
pediatric diagnoses and these were
grouped into intrapartum anoxia, other
(pulmonary causes, intracranial hemor-
rhage, infection, other hemorrhage, and
miscellaneous), andunexplained.Thehi-
erarchy dictates that a perinatal death
where there was severe preeclampsia
complicated by abruption would be clas-
sified as being due to toxemia because
toxemia is above both hemorrhage and
intrapartum anoxia in the hierarchy.
Statistical Analyses
Continuous variables were summa-
rized by the median and interquartile
range, and comparisons between groups
were performed using the Mann-
Whitney U test. Univariate compari-
sons of dichotomous data were per-
formedusingthe2 test(5observations
inall cells)orFisherexact test (5obser-
vations in1 cells). Ordinal data were
comparedusing the2 test for trend.The
P values for all hypothesis tests were
2-sidedand.05was thesignificance level.
Adjustedrateswereobtainedusingdirect
standardization.Crudeandadjustedodds
ratios (ORs) were obtained using logis-
tic regression analysis. Cases with miss-
ing values were excluded from the
multivariate analysis. The statistical sig-
nificance of interaction terms was
assessed using the likelihood ratio test.
Model goodness-of-fit was assessed
using the Hosmer-Lemeshow test based
on deciles of probability.13 All statistical
analyses were performed using version
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7.0 of the Stata software package (Stata
Corp, College Station, Tex).
RESULTS
Of the SMR2 records with a perinatal
death documented, 97.8% could be
linked to a corresponding record in the
Stillbirth and Neonatal Death En-
quiry. From 1992 through 1997, there
were 356958 records of singleton births
in Scotland in the SMR2 database.
Among these records, there were 697
(0.2%) with missing values for gesta-
tional age, 4873 (1.4%) with missing
values for presentation at delivery, and
8 (0.1%) with missing values for
number of previous cesarean deliver-
ies. A total of 5564 records had 1 or
more missing values, leaving 351394
records. Among this group, there were
16427 fetuses (4.7%) with a nonce-
phalic presentation, 621 perinatal
deaths (0.2%) related to congenital
anomaly, 1479 antepartum stillbirths
(0.4%) unrelated to congenital anomaly,
20628 births (5.9%) outside the range
of 37 to 43 weeks’ gestational age, and
9827 births (2.8%) by planned cesar-
ean method where the women had not
had a previous cesarean delivery. A total
of 38156 records had 1 or more exclu-
sion criteria, resulting in a study group
of 313238 (87.8% of all singleton births
during the study period).
The study group was subdivided into
15515 women previously delivered by
cesarean method who had a trial of la-
bor, 9014 women who had previously
been delivered by cesarean method who
delivered by planned cesarean method
in the current pregnancy, 137160 nul-
liparous women who were not deliv-
ered by planned cesarean method, and
151549 multiparous women who had
not had a previous cesarean delivery
and did not deliver by planned cesar-
ean method in the current pregnancy.
Within the study group, there were
missing values for maternal height in
26825 women (8.6%), for smoking sta-
tus in 29730 (9.5%), for deprivation
quintile in 4 975 (1.6%), for birth
weight in 61 (0.1%), and for 5-minute
Apgar score in 36 (0.1%).
The study group characteristics and
basic outcome data are given in TABLE 1.
The highest rate of perinatal death (12.9
per 10000 women) was seen among
women having a trial of labor (TABLE 2).
The risk of a delivery-related perinatal
death among women having a trial of la-
bor was more than 11 times (OR, 11.6;
95% confidence interval [CI], 1.6-
86.7) that of women having a planned
repeat cesarean delivery (TABLE 3). The
risk of death associated with a trial of la-
bor was similar when compared with
nulliparous women in labor (OR, 1.3;
95% CI, 0.8-2.1) but was more than
twice that of other multiparous women
in labor (OR, 2.2; 95% CI, 1.3-3.5).
When delivery-related perinatal deaths
among all women who had previously
been delivered by cesarean method were
analyzed, it was estimated that 91% (95%
CI, 36%-99%) could be attributed to the
increased risk of death associated with
a trial of labor.
Statistical comparison with the
planned repeat cesarean delivery group
was problematic because there was only
Table 1. Study Group Characteristics and Crude Outcome Data by Method of Delivery and Obstetric History*
Characteristics
Previous Cesarean Delivery No Previous Cesarean Delivery
Trial of Labor
(n = 15 515)
Planned Repeat
Cesarean Delivery
(n = 9014)
P
Value†
Nulliparous
(n = 137 160)
P
Value†
Multiparous
(n = 151 549)
P
Value†
Age, median (IQR), y 30 (26-33) 31 (27-34) .001 26 (21-29) .001 29 (26-32) .001
Height, median (IQR), cm 161 (157-165) 159 (154-163) .001 163 (158-167) .001 162 (158-167) .001
Deprivation quintile
1 (Least deprived) 2776 (18.2) 1860 (21.0) 25 031 (18.6) 27 734 (18.6)
2 3069 (20.1) 1680 (18.9) 25 718 (19.1) 28 814 (19.3)
3 2970 (19.4) 1617 (18.2) .02 26 816 (19.9) .59 29 543 (19.8) .64
4 3154 (20.7) 1788 (20.1) 28 099 (20.8) 30 085 (20.2)
5 (Most deprived) 3298 (21.6) 1935 (21.8) 29 245 (21.7) 33 031 (22.1)
Missing data 248 134 2251 2342
Smoking status, No. (%)
Nonsmoker 8423 (60.1) 5524 (67.4) 74 589 (59.8) 82 338 (60.3)
Ex-smoker 980 (7.0) 588 (7.2) .001 13 098 (10.5) .001 9247 (6.8) .85
Current 4620 (33.0) 2079 (25.4) 36 960 (29.7) 45 062 (33.0)
Missing data 1492 823 12 513 14 902
Gestation, median (IQR), wk 40 (39-41) 38 (38-39) .001 40 (39-41) .001 40 (39-41) .03
Birth weight, median (IQR), g 3460 (3120-3800) 3380 (3062-3720) .001 3390 (3080-3700) .001 3500 (3190-3830) .001
Low birth weight, No. (%) 455 (2.9) 249 (2.8) .45 3649 (2.7) .05 2570 (1.7) .001
5-Minute Apgar score 4, No. (%) 105 (0.68) 40 (0.44) .02 816 (0.60) .21 918 (0.61) .28
Intrapartum death, No. (%) 7 (0.05) 0 (0) .05 39 (0.03) .23 31 (0.02) .08
Neonatal death, No. (%) 13 (0.08) 1 (0.01) .02 96 (0.07) .52 59 (0.04) .02
*IQR indicates interquartile range.
†Statistical comparison with trial of labor. Continuous data compared using Mann-Whitney U test, categorical data compared using Fisher exact test or 2 test as appropriate (see
“Methods” section), and ordinal data compared using 2 test for trend.
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a single death among the 9014 women.
All the records with missing values were
among the 9013 survivors and, there-
fore, excluding missing records re-
sulted in a weaker association between
trial of labor and perinatal death com-
pared with planned repeat cesarean de-
livery simply by reducing the denomi-
nator in the latter group (Table 3).
However, among the cases with non-
missing values, adjusting for maternal
age, smoking status, height, depriva-
tion quintile, gestational age at birth, and
birth weight decile strengthened the as-
sociation between trial of labor and peri-
natal death when compared with elec-
tive repeat cesarean delivery (OR, 11.7;
95% CI, 1.4-101.6). When women hav-
ing a trial of labor were compared with
nulliparous and other multiparous
women, adjusting for maternal age,
smoking status, height, deprivation
quintile, gestational age at birth, and
birth weight decile had no effect on the
ORs (Table 3).
When the analyses were confined to
births at or after 40 weeks’ gestation,
the results were similar (Table 2). Al-
though there were no deaths among the
1064 planned repeat cesarean deliver-
ies at or after 40 weeks’ gestation, the
numbers were too small to be statisti-
cally significantly lower than the trial
of labor group. Among births at or af-
ter 40 weeks’ gestation, the risk of death
associated with a trial of labor was simi-
lar when compared with nulliparous
women in labor (OR, 1.2; 95% CI, 0.6-
2.2) but higher when compared with
other multiparous women in labor (OR,
2.7; 95% CI, 1.4-5.2).
Among women previously deliv-
ered by cesarean method, 369 (2.4%)
of those having a trial of labor had more
than 1 previous cesarean delivery,
whereas 2962 (32.9%) of those deliv-
ered by planned cesarean method had
more than 1 previous cesarean deliv-
ery. Of the 20 perinatal deaths among
women having a trial of labor, 19
women (95%) had only 1 previous ce-
sarean delivery. Among women previ-
ously delivered by cesarean method,
5206 (33.6%) of those having a trial of
labor had previously had a vaginal birth,
whereas 988 (11.0%) of those deliv-
ered by planned cesarean method had
previously had a vaginal birth. Of the
20 perinatal deaths among women hav-
ing a trial of labor, 5 women (25%) had
previously had a vaginal birth. Among
the trial of labor group, there were 12
perinatal deaths among 3945 neo-
nates born by emergency cesarean de-
livery and 8 deaths among 11570 neo-
nates delivered vaginally (P=.001).
The rates of perinatal death due to dif-
ferent causesdifferedamong the4groups
(TABLE 4). Compared with other mul-
tiparous women, women having a trial
of labor had more than 8 times the risk
of a perinatal death due to a mechanical
cause (OR, 8.5; 95% CI, 3.2-22.3) and
almost 3 times the risk of a perinatal
death due to intrapartum anoxia (OR,
Table 2. Rates of Perinatal Death in Relation to Previous Cesarean Delivery and Mode of Delivery*
Outcomes
Previous Cesarean Delivery No Previous Cesarean Delivery
Trial of
Labor
Planned Repeat
Cesarean Delivery
P
Value†
Nulliparous
Labor
P
Value†
Multiparous
Labor
P
Value†
All births
No. of deaths/births 20/15 515 1/9014 .001 135/137 160 .29 90/151 549 .004
Rate per 10 000 (95% CI) 12.9 (7.9-19.9) 1.1 (0.0-6.1) 9.8 (8.3-11.6) 5.9 (4.8-7.3)
Births at or after 40 weeks’ gestation
No. of deaths/births 11/9574 0/1064 .62 89/90 496 .61 41/95 596 .006
Rate per 10 000 (95% CI) 11.5 (5.7-20.5) 0 (0.0-34.6)‡ 9.8 (7.9-12.1) 4.3 (3.1-5.8)
Records with no missing values
(all term births)
No. of deaths/births 13/12 904 1/7648 .02 113/113 359 .88 69/124 987 .06
Rate per 10 000 (95% CI) 10.1 (5.4-17.2) 1.3 (0.0-7.3) 10.0 (8.2-12.0) 5.5 (4.3-7.0)
Standardized rate (95% CI)§ 9.9 (4.3-15.6) 0.4 (0.0-1.1) 10.0 (8.0-12.0) 5.5 (4.1-6.8)
*CI indicates confidence interval.
†Fisher exact test comparison with trial of labor group.
‡One-sided 97.5% CI.
§Standardized for maternal age, smoking, height, and social deprivation against whole study group.
The standardized rate should be interpreted with caution since there was only a single event.
Table 3. Crude and Adjusted Odds Ratio for Delivery-Related Perinatal Death Associated With Trial of Labor*
Comparison
1 or More Missing Values No Missing Values
Crude OR
(95% CI)
P
Value
Crude OR
(95% CI)
P
Value
Adjusted OR
(95% CI)†
P
Value
Trial of labor vs planned repeat cesarean delivery‡ 11.6 (1.6-86.7) .02 7.7 (1.0-59.0) .05 11.7 (1.4-101.6) .03
Trial of labor vs other multiparous women 2.2 (1.3-3.5) .002 1.8 (1.0-3.3) .05 1.7 (1.0-3.2) .07
Trial of labor vs nulliparous women 1.3 (0.8-2.1) .26 1.0 (0.6-1.8) .97 0.9 (0.5-1.7) .79
*Goodness-of-fit models were as follows (Hosmer-Lemeshow test): P = .98, P = .98, and P = .23, respectively. No statistically significant interactions in any model between pre-
vious cesarean delivery and the following: maternal age, smoking status, height, socioeconomic deprivation, use of prostaglandin E2 to induce labor, gestational age at birth, and
birth weight decile for gestational age. OR indicates odds ratio; CI, confidence interval.
†The ORs were adjusted for maternal age, smoking status, height, deprivation quintile, gestational age at birth, and birth weight decile for gestational age.
‡Number of deaths in reference category too small to yield stable estimates.
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2.8; 95% CI, 1.3-6.5). When compared
with nulliparous women, women hav-
ing a trial of labor had an increased risk
of perinatal death due to mechanical
causes alone (OR, 8.8; 95% CI, 3.2-24.2).
Women undergoing a trial of labor
were less likely to have a prostaglan-
din E2 (PGE2) induction, had shorter
labors, had lower rates of operative vagi-
nal delivery, and had higher rates of
emergency cesarean delivery than nul-
liparous women (TABLE 5). Women un-
dergoing a trial of labor were more
likely to have a PGE2 induction, had
longer labors, and had higher rates of
both operative vaginal and cesarean de-
livery than other multiparous women.
Among women having a trial of labor,
there were 3 perinatal deaths among
2395 women induced with PGE2 and
17 deaths among 13120 women not
treated with PGE2 (P.99).
In addition to the 15515 women
who fulfilled the criteria for trial of
labor at term, there were 35 women
who fulfilled the same criteria except
that the newborn was an antepartum
stillbirth not caused by congenital
abnormality at term. Fifteen of these
women delivered before 39 weeks, 10
delivered in the 39th week of gesta-
tion, and 10 delivered at or after 40
weeks’ gestation.
Table 4. Rates of Different Causes of Perinatal Death in Relation to Previous Cesarean Delivery and Mode of Delivery*
Cause of Death
Previous Cesarean Delivery No Previous Cesarean Delivery
Trial of
Labor
(n = 15 515)
Planned Additional
Cesarean Delivery
(n = 9014)
P
Value†
Nulliparous
Labor
(n = 137 160)
P
Value†
Multiparous
Labor
(n = 151 549)
P
Value†
Toxemia
No. of deaths 1 0 .99 6 .53 2 .25
Rate per 10 000 (95% CI) 0.6 (0.0-3.6) 0.0 (0.0-4.1)‡ 0.4 (0.0-1.0) 0.1 (0.0-0.5)
Hemorrhage
No. of deaths 1 0 .99 9 .99 14 .99
Rate per 10 000 (95% CI) 0.6 (0.0-3.6) 0.0 (0.0-4.1)‡ 0.7 (0.3-1.2) 0.9 (0.5-1.6)
Mechanical
No. of deaths 7 0 .05 7 .001 8 .001
Rate per 10 000 (95% CI) 4.5 (1.8-9.3) 0.0 (0.0-4.1)‡ 0.5 (0.2-1.1) 0.5 (0.2-1.0)
Maternal
No. of deaths 1 1 .99 14 .99 7 .54
Rate per 10 000 (95% CI) 0.6 (0.0-3.6) 0.6 (0.0-6.2) 1.0 (0.6-1.7) 0.5 (0.2-1.0)
Intrapartum anoxia
No. of deaths 7 0 .05 71 .85 24 .02
Rate per 10 000 (95% CI) 4.5 (1.8-9.3) 0.0 (0.0-4.1)‡ 5.2 (4.0-6.5) 1.6 (1.0-2.4)
Other pediatric
No. of deaths 2 0 .53 18 .99 14 .66
Rate per 10 000 (95% CI) 1.3 (0.2-4.6) 0.0 (0.0-4.1)‡ 1.3 (0.8-2.1) 0.9 (0.5-1.6)
Unexplained
No. of deaths 1 0 .99 10 .99 21 .72
Rate per 10 000 (95% CI) 0.6 (0.0-3.6) 0.0 (0.0-4.1)‡ 0.7 (0.4-1.3) 1.4 (0.9-2.1)
*CI indicates confidence interval.
†Fisher exact test comparison with trial of labor group.
‡One-sided 97.5% CI.
Table 5. Management of Labor by Parity and Obstetric History*
Previous
Cesarean Delivery
Trial of Labor
(n = 15 515)
No Previous Cesarean Delivery
Nulliparous
(n = 137 160)
P
Value†
Multiparous
(n = 151 549)
P
Value†
Prostaglandin E2 induction, No. (%) 2395 (15.4) 24 878 (18.1) .001 21 130 (13.9) .001
Duration of labor, median (IQR), h 7 (4-10) 9 (6-12) .001 5 (3-7) .001
Mode of delivery, No. (%)
Spontaneous 9076 (58.5) 88 864 (64.8) 143 079 (94.4)
Assisted vaginal delivery 2494 (16.1) 31 128 (22.7) .001 4821 (3.2) .001
Emergency cesarean delivery 3945 (25.4) 17 168 (12.5) 3649 (2.4)
Timing of perinatal death, wk
39 3 21
.62
32
.06
39 17 114 58
*IQR indicates interquartile range.
†Statistical comparison with trial of labor group. Continuous data compared using Mann-Whitney U test, and categorical data compared using Fisher exact test or 2 test as ap-
propriate (see “Methods” section).
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COMMENT
The ideal means to determine the risks
and benefits of trial of labor vs planned
repeat cesarean delivery would be a ran-
domized controlled trial. In practice,
this would be difficult to perform be-
cause many women would be un-
happy to have such a decision made in
a random manner and large numbers
of women would be required for a study
powered to detect differences in such
rare outcomes as uterine rupture and
perinatal death. In the absence of ran-
domized controlled trial evidence,
analysis of observational data must be
used to estimate the risks of these rare
outcomes. A recent observational study4
has reported on the relative and abso-
lute risks of uterine rupture associ-
ated with trial of labor. Herein, we
report the risk of perinatal death asso-
ciated with trial of labor among women
at term with a singleton pregnancy in
a cephalic presentation.
In the present study, the risk of de-
livery-related perinatal death among
women having a trial of labor was more
than 11 times that of women having a
planned repeat cesarean delivery.
Women having a planned repeat cesar-
ean delivery experienced the lowest
death rate among any of the groups. The
low rate of death was explained by the
absence of any risk of intrapartum still-
birth and a significantly lower risk of
neonatal death. The risk associated with
planned repeat cesarean delivery at term
was so low that only a single death oc-
curred in Scotland during the 6 years
of the study period. Multivariate sta-
tistical comparison among groups is
problematic when the number of events
is so small, and larger studies will be
required to analyze adequate numbers
of deaths following planned cesarean
delivery. However, selection bias is un-
likely to explain the lower risk of death
among women having a planned re-
peat cesarean delivery, because they are
more likely to have medical and ob-
stetric complications than women of-
fered a trial of labor.4 Consistent with
this, adjusting for maternal age, smok-
ing status, height, deprivation quin-
tile, gestational age at birth, and birth
weight decile for gestational age
strengthened the association between
trial of labor and perinatal death when
compared with women having a
planned repeat cesarean delivery,
though the CIs were wide because of
the small number of cases.
Our observed rate of perinatal death
associated with planned repeat cesar-
ean delivery, 1.1 per 10000 women, is
much lower than previously cited.5
However, previously published peri-
natal mortality figures for both trial of
labor and planned cesarean delivery did
not exclude breech presentations and
preterm newborns delivered between 28
and 36 weeks’ gestation.6 Since prema-
turity and breech presentation are as-
sociated with an excess of perinatal
mortality,14,15 these data are unhelpful
in informing women who reach term
with a fetus presenting cephalically.
This group accounted for 84% of
women with a previous cesarean de-
livery in our study.
When compared with other multipa-
rous women in labor, women having a
trial of labor had approximately twice
the rate of delivery-related perinatal
death. This finding was due to an in-
creased risk of death due to mechani-
cal causes, including uterine rupture,
and death due to intrapartum anoxia
not related to uterine rupture. The over-
all rate of delivery-related perinatal
death among women having a trial of
labor was not significantly greater than
nulliparous women in labor. The in-
creased number of deaths due to me-
chanical causes among women having
a trial of labor compared with nullipa-
rous women was offset by a lower rate
of death due to other causes. The ob-
servation that the level of risk of non-
mechanical perinatal death among
women having a trial of labor was in-
termediate between other multipa-
rous and nulliparous women prob-
ably reflects the fact that approximately
one third of women having a trial of la-
bor had previously had a vaginal birth.
There are other possible factors that
could contribute to differences in out-
come among the groups that were not
recorded in the database, such as epi-
dural anesthesia, use of electronic fe-
tal monitoring, and details of mater-
nal medical and obstetric complications.
Further studies will be required to de-
termine whether systematic variation in
any of these variables may contribute
to differences in the risk of delivery-
related perinatal death among these
groups.
The data presented in this article are
collected nationally and form an ex-
tract of a larger data set, which is re-
ported in detail elsewhere.12 Overall, the
statistics were comparable with previ-
ous analyses of perinatal deaths. The
overall rate of intrapartum stillbirth un-
related to congenital abnormality of 2.5
per 10000 births was comparable with
previous studies from Scandinavia,16
and the total proportion of all still-
births that were classified as intrapar-
tum was 11%, which is similar to na-
tional data from England.17 The number
of neonatal deaths observed in our study
was lower than a report from Wales,18
which described 7.4 neonatal deaths at-
tributable to an intrapartum event per
10000 births. However, that study in-
cluded neonates of all gestational ages,
using a birth-weight cutoff of more than
1499 g, which would have included a
significant proportion of preterm births.
Current recommendations are that
planned cesarean delivery should be
performed in the 39th week of gesta-
tion to reduce the risk of neonatal res-
piratory morbidity.19 It could be ar-
gued that uterine rupture may occur in
earlier weeks of gestation and that the
apparent protective effect of planned ce-
sarean delivery is exaggerated. How-
ever, 85% of delivery-related perinatal
deaths at term among women having
a trial of labor occurred at or after 39
weeks’ gestation. This is consistent with
the observation that approximately 15%
of multiparous women will undergo la-
bor between the start of the 37th week
and the start of the 39th week of ges-
tation.20 Therefore, it seems likely that
most deaths could have been avoided
by planned cesarean delivery at the start
of the 39th week of gestation. More-
over, planned cesarean delivery at this
time would also avoid exposure to the
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risk of antepartum stillbirth while
awaiting the onset of labor. There were
20 antepartum stillbirths among women
having a trial of labor at or after 39
weeks’ gestation and a proportion of
these may also have been prevented by
planned cesarean delivery at the start
of the 39th week of gestation. There-
fore, the potential protective effect on
perinatal death of planned cesarean de-
livery over trial of labor may be greater
than estimated in the present study of
intrapartum stillbirths and neonatal
deaths.
The definition of a trial of labor used
in this study was that a woman who had
previously been delivered by cesarean
method was delivered at term by a
method other than planned cesarean.
However, it is likely that a small pro-
portion of these women were due to
have a planned cesarean delivery but
presented in labor before their sched-
uled date and an emergency cesarean
delivery was performed in early labor.
Moreover, the database did not in-
clude information on the nature of the
incision used in the previous cesarean
delivery. For this reason, we repeated
the analysis confined to births at or af-
ter 40 weeks’ gestation. By this time, all
women scheduled for planned cesar-
ean delivery should have had the pro-
cedure, including any women who had
previously had a classic cesarean de-
livery. The risks of perinatal death were
virtually unchanged, suggesting that our
results are robust. The outcome of trial
of labor was comparable with previ-
ous studies: 75% had a vaginal deliv-
ery, which was almost identical to an
analysis of more than 17000 trials of
labor from Switzerland.6
Our data provide essential informa-
tion for women to make an informed
choice about a trial of labor. Overall,
the point estimate of the risk of a peri-
natal death associated with a trial of la-
bor is 1 in 775, and the 95% CIs indi-
cate that the risk is unlikely to be higher
than 1 in 500. The point estimate of the
risk of a perinatal death due to uterine
rupture associated with a trial of labor
is 1 in 2200, and the 95% CIs indicate
that the risk is unlikely to be higher than
approximately 1 in 1000.
Considerable caution should be ap-
plied when extrapolating these data to
considering possible benefits of planned
cesarean delivery among women who
have not previously had a cesarean
birth. More than one third of delivery-
related perinatal deaths among mul-
tiparous women who had not previ-
ously been delivered by cesarean
method were observed before 39 weeks
of gestation. Scheduling planned ce-
sarean delivery for the start of the 39th
week of gestation may have failed to
prevent many of these deaths. More-
over, we present no data on the risk of
perinatal death following planned ce-
sarean delivery among nulliparous
women.
Obstetricians have faced pressure
from government and health care in-
surers to advocate vaginal birth after ce-
sarean delivery as one strategy to re-
duce the overall rate of cesarean
delivery. However, this pressure has
been exerted in the absence of any re-
liable information on the risks to the
newborn for most women. This study
is the first to our knowledge that is
adequately powered and analyzed to
provide information on the risks of
perinatal death associated with the man-
agement of women with a history of
cesarean delivery but an otherwise
uncomplicated pregnancy at term.
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Factors predisposing to perinatal death related to uterine rupture
during attempted vaginal birth after caesarean section: retrospective
cohort study
Gordon C S Smith, Jill P Pell, Dharmintra Pasupathy, Richard Dobbie
Abstract
Objective To determine the factors associated with an
increased risk of perinatal death related to uterine rupture
during attempted vaginal birth after caesarean section.
Design Population based retrospective cohort study.
Setting Data from the linked Scottish Morbidity Record and
Stillbirth and Infant Death Survey of births in Scotland,
1985-98.
Participants All women with one previous caesarean delivery
who gave birth to a singleton infant at term by a means other
than planned repeat caesarean section (n = 35 854).
Main outcome measures All intrapartum uterine rupture and
uterine rupture resulting in perinatal death (that is, death of the
fetus or neonate).
Results The overall proportion of vaginal births was 74.2% and
of uterine rupture was 0.35%. The risk of intrapartum uterine
rupture was higher among women who had not previously
given birth vaginally (adjusted odds ratio 2.5, 95% confidence
interval 1.6 to 3.9, P < 0.001) and those whose labour was
induced with prostaglandin (2.9, 2.0 to 4.3, P < 0.001). Both
factors were also associated with an increased risk of perinatal
death due to uterine rupture. Delivery in a hospital with < 3000
births a year did not increase the overall risk of uterine rupture
(1.1, 0.8 to 1.5, P = 0.67). However, the risk of perinatal death
due to uterine rupture was significantly higher in hospitals with
< 3000 births a year (one per 1300 births) than in hospitals
with ≥ 3000 births a year (one per 4700; 3.4, 1.0 to 14.3,
P = 0.04).
Conclusion Women who have not previously given birth
vaginally and those whose labour is induced with prostaglandin
are at increased risk of uterine rupture when attempting vaginal
birth after caesarean section. The risk of consequent death of
the infant is higher in units with lower annual numbers of
births.
Introduction
Uterine rupture during attempted vaginal birth after a previous
caesarean section is a rare event that affects about one in 200
women,1 and consequent death of the infant is even rarer, affect-
ing about one per 2000.2 Analysis of the factors determining
perinatal death due to uterine rupture therefore requires data
from large numbers of women. Most large scale databases of
births lack detailed information on the cause of perinatal death
and the obstetric characteristics of the population. Consequently,
we know of no reports of the risk factors for perinatal death due
to uterine rupture during attempted vaginal birth after previous
caesarean section. We linked national registries of pregnancy
discharge data and perinatal death to determine the factors
associated with this event.
Methods
The inclusion criteria for the study were that a woman had previ-
ously had one caesarean section and was delivered in her current
pregnancy by a means other than planned caesarean section.We
excluded women with more than one previous caesarean, those
with multiple gestations, those delivering before 37 weeks’ gesta-
tion, and those delivering beyond 43 weeks’ gestation. We also
excluded cases in which the infant died from causes other than
intrapartum uterine rupture.
Data sources—The Scottish Morbidity Record (SMR2) collects
information on clinical and demographic characteristics and
outcomes for all patients discharged from Scottish maternity
hospitals. The register is subjected to regular quality assurance
checks and has been > 99% complete since the late 1970s.3 The
register collects both specific obstetric data and up to six ICD-9
(international classification of diseases, ninth revision) or ICD-10
(10th revision) diagnostic codes relating to the admission. In
1996-7 a quality assurance analysis comparing 1414 records
with the clinical notes showed that the register was free from sig-
nificant errors in > 98% of records in all the specific fields used
in the present analysis. Exceptions were postcode (94.0%), height
(96.2%), estimated gestation (94.4%), and method of induction of
labour (93.6%). The previous caesarean section field was 99.7%
accurate. ICD diagnostic codes were found to be 80-90%
accurate for the first four diagnoses and 70-80% accurate for the
remainder (Jim Chalmers, personal communication). SMR2
records were linked to records from the Scottish Stillbirth and
Infant Death Survey. This national register routinely classifies all
perinatal deaths in Scotland. Coding of the cause of death is per-
formed by a single medically qualified individual, and the survey
is described in detail elsewhere.4
Definitions—We defined trial of labour as a singleton delivery
at term by a means other than planned caesarean section in
women with only one previous caesarean delivery. The definition
of perinatal death due to uterine rupture was that the obstetric
cause of death was coded as “mechanical” under the modified
Wigglesworth classification5 and that the ICD-9 diagnostic code
for intrapartum uterine rupture (665.1) was listed under the spe-
cific diagnoses. Intrapartum uterine ruptures that did not result
in perinatal death were identified with ICD-9 and ICD-10
diagnostic codes 665.1 and O711, respectively, from the
Cite this article as: BMJ, doi:10.1136/bmj.38160.634352.55 (published 19 July 2004)
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diagnostic fields in the SMR2 record related to hospital
discharge after delivery. Hospital throughput was defined as the
total number of births recorded in the SMR2 database for the
given hospital over the given year. Hospital throughput was cat-
egorised into above or below the median (3000 births). Other
maternal characteristics were defined as previously described.2
Statistical analyses—We summarised continuous variables with
medians and interquartile ranges and used the Mann-Whitney U
test for comparisons between groups and Fisher’s exact test for
univariate comparisons of dichotomous data. P values for all
hypothesis tests were two sided. Multivariate analysis was
performed using logistic regression analysis. The significance of
interaction terms was assessed with the likelihood ratio test. The
goodness of fit of models was assessed with the Hosmer and
Lemeshow test based on tenths of probability.6 Because of the
rarity of the event we used exact logistic regression to model the
risk of perinatal death due to uterine rupture.7 When we treated
annual number of births as a continuous variable in the exact
model, we rounded it to the nearest 50 to make the model com-
putationally feasible. All statistical analyses were performed with
the Stata software package version 8.2 (StataCorp, College
Station, TX), except for exact logistic regression, which was per-
formed with LogXact version 5.0 (Cytel Software Corporation,
Cambridge, MA).
Results
There were 871 283 SMR2 birth records for Scotland for 1985-
98. In total 39 729 (4.6%) women had had one previous caesar-
ean delivery and were delivered by a means other than planned
caesarean section. There were 452 (1.1%) multiple births, 3462
(8.7%) births outside the range of 37-43 weeks’ gestation, and
543 (1.4%) perinatal deaths due to causes other than
intrapartum uterine rupture. We excluded a further 32 ( < 0.1%)
records because the women were documented as being
primigravid, despite having had a previous caesarean delivery.
We therefore excluded 3875 (9.8%) records (some cases were
excluded in more than one category), leaving a study group of
35 854. We compared the demographic and obstetric character-
istics of the study group according to whether there was a peri-
natal death due to uterine rupture (table 1).
There was no association between the annual number of
deliveries and the risk of emergency caesarean delivery (odds
ratio 1.00, 95% confidence interval 0.98 to 1.01, P = 0.58) or
uterine rupture overall (0.98, 0.86 to 1.11, P = 0.70), but there was
a significant negative association with the risk of perinatal death
due to uterine rupture (0.68, 0.46 to 0.99, P = 0.04) (figure).
On univariate analysis, with the 35 854 women who
attempted vaginal birth as the denominator, the risk of uterine
rupture was higher in women who had not previously given
birth vaginally and in women who had been induced with pros-
taglandin but not with other methods of induction (table 2).
Though delivery in a hospital with < 3000 births a year was not
associated with the risk of uterine rupture overall, the other asso-
ciations remained highly significant in multivariate analysis and
the point estimates were similar (table 3). There were enough
uterine ruptures for us to test the goodness of fit of the model
and to examine interactions between the variables. The goodness
of fit was adequate (P > 0.05), and there were no significant first
order interactions between any of the variables with each other
or with the year of birth.
The risk of perinatal death due to uterine rupture was also
higher in women who had not previously given birth vaginally
and in women who had been induced with prostaglandins but
not with other methods of induction (table 2). However, in addi-
tion, delivery in a hospital with < 3000 births a year was associ-
ated with a significantly increased risk of perinatal death due to
uterine rupture. The risk of perinatal death was about one in
1300 in hospitals with < 3000 births a year and one in 4700 in
hospitals with ≥ 3000 births a year. Because of the small number
of deaths caused by uterine rupture, significance was generally
attenuated in multivariate analysis (table 3). However, the point
estimates were similar to those from the univariate analysis, indi-
cating that the associations seen in univariate analysis were not
due to confounding by the factors included in the model. There
were too few events for us to assess goodness of fit or first order
interactions.
Among the 124 cases of uterine rupture, there were 17
(13.7%) intrapartum stillbirths or neonatal deaths. There were 63
uterine ruptures in hospitals delivering < 3000 women per year
and 13 (20.6%) resulted in perinatal death. In hospitals
delivering ≥ 3000 women a year there were 61 uterine ruptures
and four (6.6%) resulted in perinatal death (P=0.03). Among
women with uterine rupture, the relative risk of perinatal death
in a hospital with < 3000 births a year was about threefold (table
4).
Table 1 Maternal demographic and obstetric characteristics in relation to
perinatal death due to uterine rupture. Figures are numbers (percentages)
unless stated otherwise
No perinatal death*
(n=35 837) Perinatal death (n=17) P value†
Median (IQR) age
(years)
29 (26-32) 27 (25-31) 0.61
Median (IQR) height
(cm)
161 (157-165) 158 (153-163) 0.13
Height data missing 2927 (8.2) 2 (11.8) 0.64
Marital status:
Married 28 548 (79.7) 15 (88.2) >0.9
Other 7 289 (20.3) 2 (17.8)
Fifth of deprivation distribution:
1 (least deprived) 6 418 (17.9) 2 (11.8) 0.82
2 6 731 (18.8) 3 (17.6)
3 6 854 (19.1) 2 (11.8)
4 7 219 (20.1) 5 (29.4)
5 (most deprived) 8 182 (22.8) 5 (29.4)
Missing 433 (1.2) 0 (0.0)
No of previous vaginal births
None 23 176 (64.7) 15 (88.2) 0.04
One or more 12 661 (35.3) 2 (11.8)
No of spontaneous abortions:
None 27 574 (76.9) 12 (70.6) 0.57
≥1 8 263 (23.1) 5 (29.4)
No of therapeutic abortions:
None 32 202 (89.9) 16 (94.1) >0.9
≥1 3 635 (10.1) 1 (5.9)
Year of delivery:
<1992 17 539 (48.9) 9 (52.9) 0.74
≥1992 18 298 (51.1) 8 (47.1)
Median (IQR) No of
deliveries in hospital
in given year
3120 (1794-4 129) 2154 (1681-2718) 0.05
Sex of infant:
Female 17 594 (49.1) 11 (64.7) 0.23
Male 18 243 (50.9) 6 (35.3)
Median (IQR) weight (g)
of infant
3445 (3118-3780) 3242 (3150-3840) 0.76
IQR=interquartile range.
*Includes 35 730 women who did not have uterine rupture documented and 107 women who
had uterine rupture documented but it did not result in stillbirth or neonatal death of infant.
†Mann-Whitney U test or Fisher’s exact test, as appropriate.
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When we confined the analysis to births ≥ 40 weeks’
gestation, the risk of uterine rupture was significantly associated
with no previous vaginal birth (odds ratio 2.0, 95% confidence
interval 1.2 to 3.4, P = 0.009) and induction of labour with pros-
taglandin (2.2, 1.4 to 3.5, P = 0.001). Formal tests of interaction
between each of these variables and gestation ≥ 40 weeks
showed that the strength of the associations did not significantly
differ before and after 40 weeks (P = 0.2 and 0.3, respectively).
Among the 22 170 births ≥ 40 weeks’ gestation, there were seven
deaths out of 10 602 births in hospitals with < 3000 births a year
and one death out of 11 568 births in hospitals with ≥ 3000
births a year (P=0.02).
Of the 12 633 women who had previously given birth
vaginally, 1499 (11.8%) were induced with prostaglandin
compared with 2976 of the 20 215 (12.8%) women who had not
done so (P = 0.006). We used a logistic regression model to esti-
mate the absolute risk of uterine rupture (including cases in
which the infant survived and cases in which the infant died) in
relation to different combinations of parity and induction of
labour with prostaglandin in relation to 1998 rates. Among
women who had not previously given birth vaginally, the risk of
uterine rupture without induction of labour with prostaglandin
was one in 210 and with induction of labour with prostaglandin
was one in 71. Among women with a previous vaginal birth, the
risk of uterine rupture without induction of labour with prostag-
landin was one in 514 and with induction of labour with
prostaglandin was one in 175.
Discussion
We found that after a previous caesarean section women who
had not previously given birth vaginally and those who had
labour induced with prostaglandin were at increased risk of uter-
ine rupture. The same two factors were associated with the risk of
perinatal death due to uterine rupture. In contrast, delivering in
a hospital with low throughput was not associated with uterine
rupture overall but was associated with an increased risk of peri-
natal death due to uterine rupture. We found that uterine
rupture was three times more likely to result in death of the
infant if the delivery took place in a hospital with < 3000 births
a year. Confining trials of labour to larger obstetric units may
therefore reduce the risk of perinatal death associated with uter-
ine rupture during a trial of labour.
The finding that units with high throughput had lower rates
of perinatal death due to uterine rupture is plausible. Hospitals
with greater throughput are more likely to have resident obstet-
ric, anaesthetic, and neonatal services as well as a dedicated
obstetric operating theatre. These factors would allow a faster
response to fetal distress due to uterine rupture, which in turn
would allow more rapid delivery and resuscitation of the
neonate. We did not have information on the structure of
services at each unit over the period of study. However, the
factors are likely to be highly correlated and interdependent. A
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Table 2 Univariate obstetric associations with uterine rupture and perinatal death due to uterine rupture. Figures are numbers (percentages) unless stated
otherwise
Characteristics
Uterine rupture Perinatal death due to uterine rupture
Yes (n=124) No (n=35 730)
Relative risk (95%
CI) P value* Yes (n=17) No† (n=35 837)
Relative risk (95%
CI) P value*
<3000 births a year 63 (50.8) 16 930 (47.4) 1.1 (0.8 to 1.6) 0.47 13 (76.5) 16 980 (47.4) 3.6 (1.2 to 11.1) 0.03
No previous vaginal birth 102 (82.3) 23 089 (64.6) 2.5 (1.6 to 4.0) <0.0001 15 (88.2) 23 176 (64.7) 4.1 (0.9 to 17.9) 0.04
Induction of labour
without prostaglandin‡
13 (10.5) 4416 (12.4) 1.1 (0.6 to 2.0) 0.75 2 (11.8) 4427 (12.4) 1.2 (0.3 to 5.6) 0.68
Induction of labour with
prostaglandin‡
39 (31.4) 4436 (12.4) 3.3 (2.2 to 4.8) <0.0001 5 (29.4) 4470 (12.5) 3.0 (1.0 to 8.8) 0.05
Gestation >41 weeks 8 (6.4) 1867 (5.2) 1.2 (0.6 to 2.6) 0.54 0 (0.0) 1875 (5.2) — >0.9
*Fisher’s exact test (two sided).
†Includes 35 730 women who did not have uterine rupture documented and 107 women who had uterine rupture documented but it did not result in stillbirth or neonatal death.
‡Same reference category for both: all women in whom labour was not induced.
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unit with no resident obstetric or anaesthetic cover is unlikely to
have a dedicated obstetric operating theatre or a resident experi-
enced neonatologist. Therefore, even if these data were available,
it would be extremely difficult to determine the independent
contributions of each of these factors in reducing the risk of
death. Therefore, the total number of births is a useful compos-
ite measure of the level of support and has the pragmatic advan-
tage of being easy to define.
Study strengths and weaknesses
Previous large scale analyses of the factors determining uterine
rupture could not reliably distinguish between asymptomatic
dehiscence of the previous caesarean section scar and clinically
significant, symptomatic uterine rupture.1 8 9 The failure to define
the event may lead to ascertainment bias. As asymptomatic
dehiscence of the scar will generally be identified during a subse-
quent caesarean section, there will be increased ascertainment of
uterine rupture for any exposure that is associated with an
increased risk of caesarean delivery. As we were able to study
perinatal death due to uterine rupture, this allowed us to identify
catastrophic rupture that would be ascertained irrespective of
the mode of delivery. We conclude that the associations between
uterine rupture and no previous vaginal birth and induction of
labour with prostaglandin are unlikely to be explained by ascer-
tainment bias. Previous studies have suggested that the protective
effect of a previous vaginal birth is observed whether it preceded
or followed the first caesarean delivery.10
Findings are comparable with previous studies
The estimates of absolute risk in the present analysis are compa-
rable with those from previous studies. The overall rate of
successful vaginal delivery of 74.2% is similar to the generally
quoted overall figure of 75%.11 The overall rate of uterine rupture
of 0.35% is consistent with that reported in a previous large scale
Swiss study.9 The overall risk of perinatal death due to uterine
rupture (one in 2100) is similar to the one in 2600 reported in a
study from Washington State, USA.1 The risk among large
obstetric units (one per 4700) is similar to a case series from a
large obstetric centre in California (one per 4200).12 Although
the total number of perinatal deaths in our study was relatively
small (17), this is almost three times more than reported in a
recent meta-analysis of all previous studies.13 Guise et al
commented that the risk of death in Scotland, as cited from our
previous report,2 was 10 times higher than reported in other
studies.13 However, the figure they quoted was for perinatal death
due to all causes related to delivery. The absolute risk of death
due to uterine rupture in our previous study (4.5 per 10 000) was
similar to the overall risk in our current analysis. Both fall within
the 95% confidence intervals of the meta-analysis. We believe
that the current data give the best estimate of the absolute risk of
perinatal death among women attempting vaginal birth after
caesarean.
A previous population based study had shown an association
between induction of labour with prostaglandin and uterine
rupture.1 This finding led the American College of Obstetricians
and Gynecologists to recommend avoidance of prostaglandin in
women with a previous caesarean section. However, the number
of women was small (366) and this was less than 2% of the study
population. In the present study, we had data on 4475 women
who had labour induced with prostaglandin, which was 12.5% of
our cohort. Our analyses confirmed that induction of labour
with prostaglandin, but not other methods, was independently
associated with an increased risk of uterine rupture, including
catastrophic rupture leading to perinatal death. It remains to be
determined whether this is due to a specific pharmacological
effect or whether the use of prostaglandin is merely a marker for
a woman with an unfavourable cervix.
We defined trial of labour as any woman who had a single
previous caesarean birth who was delivered at term by a means
other than planned caesarean section. The cohort studied prob-
ably includes some women who were due for planned repeat
caesarean section but attended in early labour, had an
emergency caesarean delivery, and did not truly attempt vaginal
birth. However, women delivering at or after 40 weeks are
unlikely to have requested planned repeat caesarean section. We
found that the nature and strength of associations in the present
study were similar when we confined analyses to births at or after
40 weeks’ gestation, and misclassification of attempted vaginal
birth is unlikely to have significantly affected our results.
Conclusion
In summary, we have shown that the risk of uterine rupture is
increased among women who have not previously given birth
vaginally and those undergoing induction of labour with
prostaglandin. Our data show that the risk of consequent death
of the infant is lower in obstetric units with higher throughput.
Although other interpretations could be made, we believe the
most plausible explanation for these findings is that the facilities
generally available at larger obstetric units reduce the risk of
Table 3 Multivariate analysis (with odds ratios and 95% confidence intervals) of risk of uterine rupture and perinatal death due to uterine rupture
Characteristics
All uterine rupture Perinatal death due to uterine rupture
Adjusted OR (95% CI)*† P value Adjusted OR (95% CI)* P value
<3000 births a year 1.1 (0.8 to 1.5) 0.67 3.4 (1.0 to 14.3) 0.04
No previous vaginal birth 2.5 (1.6 to 3.9) <0.001 4.1 (0.9 to 36.6) 0.06
Induction of labour with prostaglandin 2.9 (2.0 to 4.3) <0.001 2.5 (0.7 to 7.7) 0.17
*Adjusted for each of other factors.
†Also adjusted for year of delivery.
Table 4 Factors associated with perinatal death among women with documented uterine rupture. Figures are numbers (percentages) unless stated otherwise
Characteristics
Uterine rupture led to
perinatal death (n=17)
Uterine rupture did not lead to
perinatal death (n=107) Relative risk (95% CI) P value*
†Adjusted odds ratio (95%
CI) P value†
<3000 births a year 13 (76.5) 50 (46.7) 3.1 (1.1 to 9.1) 0.03 3.9‡ (1.2 to 12.8) 0.03
No previous vaginal birth 15 (88.2) 87 (81.3) 1.6 (0.4 to 6.6) 0.73 1.7 (0.4 to 8.3) 0.79
Induction of labour with
prostaglandin†
5 (29.4) 34 (31.8) 0.9 (0.3 to 2.4) >0.9 0.8 (0.2 to 2.6) 0.85
*Fisher’s exact test.
†From exact logistic regression.
‡Univariate odds ratio=3.7. Higher value of adjusted odds ratios compared with relative risk is due to relatively high incidence of event in group.
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perinatal death in the event of uterine rupture. The same is
probably true of other obstetric emergencies. Perinatal deaths
could, therefore, potentially be reduced by confining high risk
births to large obstetric units or by providing additional facilities
at smaller units.
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A B S T R A C T
Background
There is currently no validated method for antepartum prediction of the risk of failed vaginal
birth after cesarean section and no information on the relationship between the risk of
emergency cesarean delivery and the risk of uterine rupture.
Methods and Findings
We linked a national maternity hospital discharge database and a national registry of
perinatal deaths. We studied 23,286 women with one prior cesarean delivery who attempted
vaginal birth at or after 40-wk gestation. The population was randomly split into model
development and validation groups. The factors associated with emergency cesarean section
were maternal age (adjusted odds ratio [OR] ¼ 1.22 per 5-y increase, 95% confidence interval
[CI]: 1.16 to 1.28), maternal height (adjusted OR¼ 0.75 per 5-cm increase, 95% CI: 0.73 to 0.78),
male fetus (adjusted OR¼ 1.18, 95% CI: 1.08 to 1.29), no previous vaginal birth (adjusted OR¼
5.08, 95% CI: 4.52 to 5.72), prostaglandin induction of labor (adjusted OR¼1.42, 95% CI: 1.26 to
1.60), and birth at 41-wk (adjusted OR¼1.30, 95% CI: 1.18 to 1.42) or 42-wk (adjusted OR¼1.38,
95% CI: 1.17 to 1.62) gestation compared with 40-wk. In the validation group, 36% of the
women had a low predicted risk of caesarean section (,20%) and 16.5% of women had a high
predicted risk (.40%); 10.9% and 47.7% of these women, respectively, actually had deliveries
by caesarean section. The predicted risk of caesarean section was also associated with the risk
of all uterine rupture (OR for a 5% increase in predicted risk¼ 1.22, 95% CI: 1.14 to 1.31) and
uterine rupture associated with perinatal death (OR for a 5% increase in predicted risk¼ 1.32,
95% CI: 1.02 to 1.73). The observed incidence of uterine rupture was 2.0 per 1,000 among
women at low risk of cesarean section and 9.1 per 1,000 among those at high risk (relative risk
¼ 4.5, 95% CI: 2.6 to 8.1). We present the model in a simple-to-use format.
Conclusions
We present, to our knowledge, the first validated model for antepartum prediction of the risk
of failed vaginal birth after prior cesarean section. Women at increased risk of emergency
caesarean section are also at increased risk of uterine rupture, including catastrophic rupture
leading to perinatal death.
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Introduction
Encouraging women with a prior cesarean delivery to
attempt vaginal birth in subsequent pregnancies is a strategy
that has been employed to address rising rates of cesarean
delivery. However, a series of retrospective studies published
in the last ﬁve to ten years have indicated an increased risk of
serious adverse outcomes among women who attempted
vaginal birth compared with those who had a planned repeat
cesarean delivery [1–3]. A recent large-scale prospective study
has shown that among women with a prior cesarean delivery,
the rates of maternal complications are highest among
women who attempt vaginal birth and fail (14.1%), inter-
mediate among women who have a planned cesarean delivery
(3.6%), and lowest among women who attempt vaginal birth
and succeed (2.4%) [4]. Therefore, the balance of risks and
beneﬁts of trial of labor versus planned repeat cesarean
section itself depends on the risk of emergency cesarean
section should labor be attempted.
Many studies have addressed methods for identifying
women at low and high risk of failure of an attempted
vaginal birth after a prior cesarean. A recent systematic
review reported that only two of the six available tools had
been validated [5]. Both of these incorporated data that
would only be available when a women presented in labor,
such as the results of electronic fetal monitoring and cervical
dilatation on admission [6,7]. Currently, therefore, there is no
validated antepartum tool to predict the risk of a failed
attempt at vaginal birth among women with a prior cesarean
delivery. Moreover, there are no data on whether women at
increased risk of cesarean section are also at increased risk of
uterine rupture. We sought to develop a simple, validated
model to predict the risk of emergency cesarean section
among women attempting vaginal birth and to determine
whether women at increased risk of cesarean section were
also at increased risk of uterine rupture, including cata-
strophic rupture leading to death of the infant.
Methods
Population
The Scottish Morbidity Record (SMR2) collects informa-
tion on clinical and demographic characteristics and out-
comes for all patients discharged from Scottish maternity
hospitals. The register is subjected to regular quality
assurance checks and has been more than 99% complete
since the late 1970s [8]. A quality assurance analysis compared
1,414 records in 1996–1997 with the clinical notes. This
analysis demonstrated that the register was free from
signiﬁcant errors in more than 98% of records in all the
speciﬁc ﬁelds used in the present analysis, with the exception
of postcode (94.0%), height (96.2%), estimated gestation
(94.4%), and method of induction of labor (93.6%). The
previous cesarean section ﬁeld was 99.7% accurate. Interna-
tional classiﬁcation of disease (ICD) diagnostic codes were
found to be 80%–90% accurate for the ﬁrst four diagnoses
and 70%–80% accurate for the remainder [9]. SMR2 records
were linked to records from the Scottish Stillbirth and
Neonatal Death Enquiry. This national register has routinely
classiﬁed all perinatal deaths in Scotland since 1983. It is
virtually 100% complete and has been described in detail
elsewhere [10]. The predictors of cesarean section employed
in the current study were those that were recorded in the
SMR2 and which had been identiﬁed in previous studies as
possible risk factors for emergency cesarean delivery.
Study Group
The population was drawn from all term singleton births to
women with one prior cesarean section in Scotland between
1985 and 2001, inclusive. The exclusion criteria for the study
group were preterm birth, perinatal deaths due to congenital
anomaly, antepartum stillbirth due to any cause, deliveries by
planned cesarean section, and women documented as being
primigravid despite also being documented as having had a
prior cesarean delivery. The primary analysis was conﬁned to
women who delivered at or after 40-wk gestation.
Definitions
Emergency cesarean section was deﬁned as any non-
planned cesarean delivery. Maternal age was deﬁned as the
age of the mother at the time of birth. Maternal height was
measured in centimeters, and the value used was that
documented in each woman’s clinical record. Gestational
age at birth was deﬁned as completed wk of gestation on the
basis of the estimated date of delivery in each woman’s
clinical record. Gestational age has been conﬁrmed by
ultrasound in the ﬁrst half of pregnancy in more than 95%
of women in the United Kingdom since the early 1990s [11].
Hospital throughput was deﬁned as the total number of
births recorded in the SMR2 database for the given hospital
over the given year and was categorized into above or below
the national median (3,000 births).9
Perinatal deaths were classiﬁed on the basis of data from
the Scottish Stillbirth and Neonatal Death Enquiry [10].
Death caused by congenital anomaly was deﬁned as any
structural or genetic defect incompatible with life or
potentially treatable but causing death. The registry sub-
classiﬁes stillbirths into antepartum (deaths before the onset
of labor) and intrapartum (deaths during labor). A death was
taken to be due to intrapartum uterine rupture if it was an
intrapartum stillbirth or neonatal death, when the cause of
death was documented as intrapartum anoxia, when the
obstetric cause of death was coded as ‘‘mechanical’’ under the
modiﬁed Wigglesworth classiﬁcation [12], and when the ICD9
code for intrapartum uterine rupture (665.1) was listed as a
speciﬁc diagnosis. Intrapartum uterine ruptures not resulting
in perinatal death were identiﬁed using ICD9 and ICD10
diagnostic codes 665.1 and O711, respectively, from the
diagnostic ﬁelds in the SMR2 record related to hospital
discharge following delivery.
Statistical Analyses
Continuous variables were summarized by the median and
interquartile range (IQR), and comparisons between groups
were performed using the Mann-Whitney U test. Univariate
comparisons of categorical data were performed using
Fisher’s exact test. The p values for all hypothesis tests were
two-sided. The risk of adverse outcomes was modeled using
multivariate logistic regression [11]. First order interactions
were assessed using the likelihood ratio test and signiﬁcance
assumed at p , 0.05 after correction for the number of
comparisons using the Bonferroni method. The goodness of
ﬁt of logistic regression models was assessed using the
Hosmer and Lemeshow test. Assessment of linearity of age
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and height in logistic models was performed using fractional
polynomials. Cases with extreme values of age or height (0.1
percentile and 99.9 percentile) were excluded. Out-of-
sample validation of the model was performed by dividing the
cohort into model development and model validation groups.
Models were constructed for the development group and the
predicted numbers of cesarean sections were related to the
observed number of events in the validation group when
categorized into deciles of predicted probability. Selection of
model development and validation groups was initially
random and the process was then repeated selecting the
groups on speciﬁc characteristics (hospital throughput,
deprivation category and year of delivery). Random alloca-
tion into two groups was performed using a pseudo-random
number. The predictive ability of models was assessed by the
area under the receiver operating characteristic (ROC) curve,
and curves were compared using the algorithm described by
De Long et al [12]. The ﬁnal logistic regression model ﬁtted to
the entire cohort was expressed as adjusted log likelihood
ratios (ALLRs) using a modiﬁcation of our recently described
method [13] (see Supporting Information for details). Logistic
regression analysis of the risk of perinatal death was
performed using exact logistic regression due to the rarity
of the event. All statistical analyses were performed using the
Stata software package version 8.2 (Stata Corporation,
College Station, Texas, United States), except exact logistic
regression which was performed using LogExact version 5.0.1
(Cytel Software Corporation, Cambridge, Massachusetts,
United States).
Results
Between 1985 and 2001, 68,380 women delivered who had
one prior cesarean delivery. We excluded 150 (0.2%) births
outside the range 24 to 43 wk, 4,700 (6.9%) preterm births,
366 (0.5%) antepartum stillbirths, 21,677 (31.7%) women
delivered by planned cesarean section, 124 (0.2%) women
whose infant was a perinatal death attributed to a congenital
abnormality, and 76 (0.1%) women documented as being
primigravid. A total of 25,836 (37.8%) women had one or
more of these exclusions, leaving 42,544 (62.2%) women.
Among the 25,964 (61.0%) women who delivered at or after
40-wk gestation, 2,585 (10.0%) had a missing value for height,
one (,0.1%) had a missing value for age, 51 (0.2%) had an
extreme value of height, and 41 (0.2%) had an extreme value
of maternal age, leaving 23,286 women eligible for study.
These women were randomly allocated to a model develop-
ment or model validation group, and the demographics and
basic outcome data for the cohort were tabulated (Table 1).
Women who had previously had a vaginal birth were older
than those with no previous vaginal birth (median IQR: 30
[27–34] versus 29 [25–32], respectively, p , 0.001).
In univariate and multivariate analysis in the model
development group, all factors were signiﬁcantly associated
with the risk of emergency cesarean section except induction
of labor using a means other than prostaglandin (Table 2).
The area under the ROC curve in the development group was
0.706, which was signiﬁcantly greater than for any of the
individual predictors (all p , 0.001). There were no statisti-
cally signiﬁcant ﬁrst order interactions between the predic-
tors. When the model was applied to the validation group, the
area under the ROC curve was 0.708 (Table 3). The observed
proportion of emergency cesarean deliveries and the pro-
portion predicted by the multivariate model derived from the
model development group were similar (Figure 1A). In the
validation group, 36% of the women had a low predicted risk
of caesarean section (,20%) and 16.5% of women had a high
predicted risk (.40%); 10.9% and 47.7% of these women,
respectively, actually had deliveries by caesarean section.
The process of model development and validation was then
repeated with nonrandom selection of the development and
validation samples. Three nonrandom procedures for selec-
tion were evaluated, namely, hospital throughput (,3,000
births per year and 3,000 births per year), deprivation
category (Carstairs category ,5 and Carstairs category 5),
and year of birth (1985–1992 and 1993–2001). The area under
the ROC curve was similar when the development and
validation samples were compared, (Table 3) and when the
data were plotted according to the predicted risk, the
expected and observed number of cesarean deliveries were
similar in the validation samples (Figure 1B–1D).
A logistic regression model was then ﬁtted for the whole
cohort. The area under the ROC curve was 0.707 and the
global goodness-of-ﬁt test showed no evidence of poor ﬁt (p¼
0.95). The output was converted to ALLRs (Table 4) using a
modiﬁcation of our previously described method [13]. The
calculation of a summary ALLR for a series of maternal
characteristics is illustrated in the box. The summary ALLR
could also be used in combination with a published nomo-
gram to generate a predicted probability [14]. Assuming a
prior probability of emergency cesarean delivery of 26%, a
summary ALLR of 0.71 or less was associated with a less than
20% chance of emergency cesarean section, and a summary
ALLR of 1.91 or more was associated with a greater than 40%
chance of emergency cesarean section.
The probability of cesarean section was calculated for each
woman in the cohort using the multivariate model. We then
analyzed the risk of uterine rupture in relation to the
Table 1. Characteristics of Population by Allocation to Devel-
opment or Validation Group
Characteristic Development
(n ¼ 11,643)
Validation
(n ¼ 11,643)
Age, y (median IQR) 29 (26–32) 29 (26–32)
Height, cm (median IQR) 161 (157–165) 161 (157–165)
Previous vaginal birth 3,923 (33.7) 3,847 (33.0)
Year of delivery 1992 5,765 (49.5) 5,850 (50.2)
Gestation at delivery, wk
40 6,619 (56.8) 6,543 (56.2)
41 4,076 (35.0) 4,094 (35.2)
42 948 (8.1) 1,006 (8.6)
Method of induction
None 8,262 (71.0) 8,260 (71.0)
Non-prostaglandin 1,577 (13.5) 1,576 (13.5)
Prostaglandin 1,804 (15.5) 1,807 (15.5)
Male sex of infant 5,810 (49.9) 5,882 (50.5)
Birth weight, kg (median IQR) 3.58 (3.27–3.88) 3.58 (3.26–3.90)
Emergency cesarean 3,067 (26.4) 2,986 (25.6)
Uterine rupture 58 (0.5) 43 (0.4)
Uterine rupture leading
to perinatal death
5 (0.04) 3 (0.03)
All data n (%) unless stated otherwise.
DOI: 10.1371/journal.pmed.0020252.t001
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predicted risk of emergency cesarean section. The predicted
probability of cesarean section was also associated with the
risk of all uterine rupture (Figure 2; odds ratio for a 5%
increase in predicted risk¼1.22, 95% conﬁdence interval [CI]:
1.14 to 1.31) and uterine rupture associated with perinatal
death (odds ratio for a 5% increase in predicted risk ¼ 1.32,
95% CI: 1.02 to 1.73). Among women with a predicted
cesarean section risk of less than 20%, the incidence of
uterine rupture was 2.0 (95% CI: 1.1 to 3.2) per 1,000, and
among women with a cesarean section risk of greater than
40%, the incidence of uterine rupture was 9.1 (95% CI: 6.4 to
12.6) per 1,000, relative risk 4.5, (95% CI: 2.6 to 8.1).
The population studied had excluded women who deliv-
ered at 37- to 39-wk gestation. A model (excluding week of
gestation) was ﬁtted for women delivering between 40- and
42-wk and was evaluated among women delivered at 37- to
39-wk gestation in whom the documented duration of labor
was greater than or equal to 4 h but otherwise applying the
same inclusion and exclusion criteria as the main study
cohort. The area under the ROC curve was 0.692. Among the
10,147 eligible women who delivered at 37 to 39 wk, there
were 1,826 cesarean deliveries (18.0% compared with 26.0%
in the rest of the population), giving a pretest odds of 0.22.
When the probability of cesarean section was estimated using
a prior odds of 0.22 and the ALLRs listed in Table 4
(excluding week of gestation), the observed and expected
number of cesarean deliveries were similar (Figure 3).
Discussion
Women who have had a prior cesarean delivery need to
choose whether to have a planned repeat cesarean section or
to attempt vaginal birth in subsequent pregnancies. The risk
of maternal morbidity depends on whether the attempt at
vaginal birth is successful [1,4]. An informed discussion of this
decision requires an assessment of the risk of emergency
cesarean section. However, there is, at present, no validated
method that allows antepartum assessment of the risks of
emergency cesarean section [5], and counseling of women is,
at best, semiquantitative. In the present study we provide a
Table 2. Univariate and Multivariate Analysis of Predictors of Emergency Cesarean Section in the Model Development Group (n ¼
11,643)
Maternal
Characteristic
Category Univariate Analysis Multivariate Analysis
OR (95% CI) p-Value Area under
ROC Curve
OR (95% CI) p-Value
Maternal age Per 5-y increase 1.05 (1.01–1.10) 0.03 0.52 1.22 (1.16–1.28) ,0.001
Maternal height Per 5-cm increase 0.79 (0.77–0.82) ,0.001 0.58 0.75 (0.73–0.78) ,0.001
Sex of infant Femalea (1.0) — (1.0) —
Male 1.18 (1.08–1.28) ,0.001 0.52 1.18 (1.08–1.29) ,0.001
Previous vaginal birth Yesa (1.0) — (1.0) —
No 4.58 (4.08–5.13) ,0.001 0.64 5.08 (4.52–5.72) ,0.001
Method of induction of labor Nonea (1.0) — (1.0) —
Non-prostaglandin 1.01 (0.89–1.14) 0.87 1.00 (0.88–1.15) 0.95
Prostaglandin 1.49 (1.34–1.67) ,0.001 0.54 1.42 (1.26–1.60) ,0.001
Gestational age (wk) 40a (1.0) — (1.0) —
41 1.33 (1.21–1.45) ,0.001 1.30 (1.18–1.42) ,0.001
42 1.46 (1.26–1.69) ,0.001 0.54 1.38 (1.17–1.62) ,0.001
Age and height were linear in both univariate and multivariate analysis (assessed by fractional polynomials).
Global goodness-of-fit test for multivariate model: p ¼ 0.79.
aReferent category.
DOI: 10.1371/journal.pmed.0020252.t002
Table 3. Assessment of the Modeling Approach in Development and Validation Samples
Characteristic Development Sample Validation Sample
Group n Area under ROC
Curve (95% CI)
Group n Area under ROC
Curve (95% CI)
Random allocationa 1 (arbitrary) 11,643 0.706 (0.695–0.716) 2 (arbitrary) 11,643 0.708 (0.698–0.718)
Hospital throughputa ,3,000 births/year 11,807 0.705 (0.694–0.715 3,000 births/year 11,479 0.709 (0.699–0.719)
Socio-economic deprivationa Carstairs score ,5 14,868 0.702 (0.693–0.711) Carstairs score 5 8,418 0.715 (0.703–0.727)
Year of deliverya 1985–1992 11,615 0.710 (0.700–0.720) 1993–2001 11,671 0.701 (0.691–0.711)
Week of gestationb 40 wk 23,286 0.704 (0.697–0.711) ,40 wk 10,149 0.692 (0.679–0.705)
All models used the same covariates listed in Table 2 except the model used where comparison was on the basis of week of gestation: gestational age was not included as a covariate in that model.
aIn the first four models, comparisons are within the group who delivered at 40 wk.
bThe whole population who delivered at 40 wk was used to develop the model which was validated among women delivering between 37–39 wk who had a documented duration of labor 4 h.
The number of events in each of the development samples was 3,067, 2,999, 3,870, 2,768, and 6,053 (from the top to the bottom row, respectively). The number of events in each of the validation samples was 2,986, 3,054, 2,183, 3,285, and
1,826 (from the top to the bottom row, respectively).
DOI: 10.1371/journal.pmed.0020252.t003
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validated model that classiﬁes over half this population as
being at low or high risk of emergency cesarean section, on
the basis of thresholds suggested by a previous systematic
review [5]. When the model was validated, 36% of women had
a predicted risk of cesarean section of less than 20%, and
their overall cesarean section rate was 10.9%. Conversely,
16.5% of women had a predicted risk of cesarean section of
greater than 40%, and their overall cesarean section rate was
47.7%.
One of the other principal concerns among women who
have had a prior cesarean section is the risk of intrapartum
uterine rupture. Uterine rupture is associated with an
increased risk of severe maternal complications, such as
hysterectomy and hemorrhage [1,4] and with an increased
risk of severe effects on the infant, including hypoxic
ischemic encephalopathy[4] and perinatal death [9]. Even if
a woman had a low risk of emergency cesarean section, she
may choose to have a planned repeat cesarean section due to
concerns about the possibility of uterine rupture. However,
we found that women who were at low risk of emergency
cesarean section were also at low risk of uterine rupture,
including catastrophic rupture leading to perinatal death.
Among women with a predicted cesarean section risk of less
than 20%, the incidence of uterine rupture was 2.0 per 1,000,
whereas among women with a cesarean section risk of greater
than 40%, the incidence of uterine rupture was 9.1 per 1,000.
This is the ﬁrst study, to our knowledge, to demonstrate a
direct association between the risk of a failed attempt at
vaginal birth and the risk of uterine rupture. This cannot be
explained by ascertainment bias because the association was
still apparent when the analysis was conﬁned to catastrophic
uterine rupture leading to death of the infant, which would
be ascertained irrespective of the mode of delivery.
In order for this model to be clinically useful, it needs to be
presented in a way that practicing clinicians can understand
and apply. To this end, we have employed a method for
converting the logistic regression model into ALLRs. These
can be used like conventional likelihood ratios and an
example is given in the box. The prior odds are multiplied
by the appropriate ALLRs to give the posterior odds from
which the probability of cesarean section can be derived.
Because this method is very similar to that used for Down
syndrome screening, we feel that it is likely to be generally
understood by practicing clinicians. A previous method has
been described in detail to convert logistic regression models
into a Bayesian format [15]. This method provides identical
results to our method for simple models. However, for models
with categorical variables containing three or more groups or
in which the scaling of a continuous variable changes between
the univariate and multivariate analysis, the previously
described method does not generate identical estimates of
probability. Our method always generates estimates of
probability that are identical to the logistic regression model.
It can be thought of, therefore, as a simple format for the
presentation of logistic regression models.
The present study has a number of strengths over previous
studies. First, we had a population of over 23,000 women. The
largest previous study included approximately 5,000 women
[6]. Second, we were able to ascertain uterine rupture in our
population, including uterine rupture leading to perinatal
death. Studies using registry-based data have the profound
weakness that uterine rupture may be inconsistently deﬁned
Figure 1. Observed and Expected Proportion of Cesarean Deliveries in the Model Validation Group by Decile of Predicted Probability
The white bars indicate the observed proportion and the black bars indicate the expected proportion of cesarean deliveries, based on estimates derived
from logistic regression model fitted to the development group. Different graphs represent different procedures for selecting development and
validation groups: (A) random selection, (B) selected on hospital throughput, (C) selected on deprivation category (Carstairs score), and (D) selected on
year of delivery. Area under the ROC curve for each model is listed in Table 3.
DOI: 10.1371/journal.pmed.0020252.g001
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and include cases of avascular wound dehiscence detected at
the time of cesarean delivery [2]. This study design could lead
to ascertainment bias because women having cesarean
delivery would be more likely to have avascular wound
dehiscence identiﬁed. However, our data sources allowed us
to identify uterine ruptures that led to death of the infant.
Third, because of the large numbers, we could conﬁne the
analysis to women delivered at or after 40-wk gestation.
Large-scale registries lack details such as whether an attempt
at vaginal birth was planned. Planned cesarean sections are
typically performed at 38–39 wk in the United Kingdom [16].
By conﬁning the analysis to births at or after 40 wk, we could
exclude women who were not truly attempting vaginal birth.
Fourth, the risk of cesarean section could be estimated using
information available in the antepartum period. Counseling
of women regarding vaginal birth frequently involves the
distinction between attempting vaginal birth if the onset of
labor is spontaneous but not attempting it if labor needs to
be induced, particularly if prostaglandins are used to ripen
the cervix [17]. For this reason, we included week of delivery
and method of induction of labor in the model, and,
therefore, the current model can inform such decisions.
Excluding gestation and mode of induction had very little
practical effect on the predictive ability of the model (data
not shown). Fifth, we analyzed continuous variables contin-
uously rather than categorizing them, which increases
statistical power. This analysis may explain why we observed
a positive association between maternal age and risk of
cesarean section, whereas some other studies have not [7].
Interestingly, the association with age became much stronger
in multivariate analysis. This result may reﬂect negative
confounding by previous vaginal birth. This factor was
strongly protective against cesarean delivery, and these
women were signiﬁcantly older than other women.
The present study has some weaknesses. First, the data were
obtained from Scotland and there may be concerns in
applying this model to other populations. However, we
assessed the robustness of the predictors employed by
selecting records for the development and validation groups
on the basis of factors that might reﬂect variation in other
populations. We found the model was similarly predictive in
and out of sample when these categorizations were per-
formed by hospital throughput, socio-economic deprivation
category, and year of birth. This ﬁnding suggests that the
Table 4. ALLRs for Maternal Characteristics and Fetal Sex Derived
from Logistic Regression Model Fitted for the Whole Population
Category Value ALLR Category Value ALLR
Height (cm) 143 2.68 Age (y) 18 0.62
144 2.54 19 0.65
145 2.40 20 0.68
146 2.27 21 0.71
147 2.15 22 0.74
148 2.04 23 0.77
149 1.93 24 0.81
150 1.82 25 0.84
151 1.72 26 0.88
152 1.63 27 0.92
153 1.54 28 0.96
154 1.46 29 1.00
155 1.38 30 1.04
156 1.31 31 1.09
157 1.24 32 1.13
158 1.17 33 1.18
159 1.11 34 1.23
160 1.05 35 1.29
161 0.99 36 1.34
162 0.94 37 1.40
163 0.89 38 1.46
164 0.84 39 1.53
165 0.80 40 1.59
166 0.75 41 1.66
167 0.71 42 1.74
168 0.67 43 1.81
169 0.64 Previous vaginal birth Yes 0.30
170 0.60 No 1.51
171 0.57 Gestation (wk) 40 0.88
172 0.54 41 1.13
173 0.51 42 1.26
174 0.48 Method of induction None 0.93
175 0.46 Non-prostaglandin 0.99
176 0.43 Prostaglandin 1.37
177 0.41 Sex of infant Female 0.91
178 0.39 Male 1.10
179 0.37
180 0.35
181 0.33
182 0.31
Derived from the following logistic regression model: log odds (cesarean)¼5.091þ (0.0433 age)þ (0.0553height)
þ (0.193 3 male) þ (1.633 3 no previous vaginal birth) þ (0.067 3 non-prostaglandin induction) þ (0.393 3
prostaglandin induction) þ (0.248 3 delivered at 41 wk) þ (0.355 3 delivered at 42 wk), where age is expressed in
years and height is expressed in centimeters and all other variables are yes ¼ 1 and no ¼ 0.
DOI: 10.1371/journal.pmed.0020252.t004
Figure 2. Proportion of Uterine Ruptures in Relation to the Quintile of
Predicted Probability of Emergency Cesarean Delivery for the Whole
Population
n¼ 23,286; p , 0.001 (Chi square test for trend).
DOI: 10.1371/journal.pmed.0020252.g002
Box 1.
Sample Calculation. Background risk of cesarean section ¼ 26%.
Convert into odds if prior odds of cesarean section¼ 26/74¼ 0.35.
Example. A 37-y-old woman, 160 cm tall, with no previous vaginal birth,
and with a male infant wishes to know probability of cesarean section if
she requires induction of labor at 41 wk gestation using prostaglandin.
Summary. ALLR ¼ 1.40 3 1.05 3 1.51 3 1.10 3 1.13 3 1.37 ¼ 3.78.
Posterior odds¼0.3533.78¼1.32. Chance of cesarean delivery¼1.32/(1
þ 1.32) ¼ 0.57 or 57%. (This is identical to the estimated risk using the
logistic regression equation in the footnote of Table 4).
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maternal and obstetric characteristics used in the model are
likely to be robust even when applied to populations with
different obstetric practices. Second, we lacked data on other
factors that might be predictive of the risk of emergency
cesarean delivery, such as body mass index, the indication for
the previous cesarean section, and whether a previous vaginal
birth preceded or followed the previous cesarean section.
Nevertheless, we report the ﬁrst validated model to give
useful discrimination of risk to greater than 50% of the
population [5].
A further potential weakness with the model is that it was
derived from women delivering at or after 40-wk gestation. As
discussed above, we conﬁned the primary analysis to this
group in order to identify women who were truly attempting
vaginal birth. Some women who were scheduled for planned
cesarean section will have attended prior to this date in labor.
Such women would be documented as an intrapartum
emergency cesarean section but did not truly attempt vaginal
delivery. However, we needed to assess the validity of the
model for women who deliver at earlier week of gestation at
term. Another means to identify women who were truly
attempting vaginal birth is to conﬁne analysis to those with a
documented duration of labor of at least 4 h. We evaluated
the model in women who were delivered between 37 and 39
wk who had labor for 4 h or longer. The discriminative power
of the model was comparable, with an area under the ROC
curve of 0.692. These women had a lower prior risk of
cesarean section (18%) than women at or after 40-wk
gestation (26%). When ALLRs were employed and the lower
overall rate of cesarean delivery was accounted for by using
the prior odds of 0.22, the observed and expected numbers of
cesarean deliveries were similar (Figure 3). We conclude that
the ALLR-based model is appropriate for births between 37–
39 wk if lower prior odds of cesarean delivery are employed.
Moreover, this analysis highlights one advantage of an ALLR-
based approach, namely, that it is simple to adjust the
estimate of probability for a lower or higher prior odds of the
outcome.
In conclusion, we present a simple, validated model for
clinical estimation of the risk of emergency cesarean section
among women with a prior cesarean delivery attempting
vaginal birth. Women at high risk of cesarean delivery are also
at increased risk of uterine rupture, including catastrophic
rupture leading to perinatal death.
Supporting Information
The full logistic regression model for calculating ALLRs is
logðoddsjx1; x2; . . . xnÞ ¼ aþ b1x1 þ b2x2 þ . . .þ bnxn ð1Þ
where x1, x2,. . ., xn are the predictor variables, b1, b2,. . ., bn are their
regression coefﬁcients, and a is the constant. Let the ﬁtted values of a,
b1, b2,. . ., bn be a^; b^1; b^2; . . . b^n:
The log likelihood ratio for x1, for example, may be deﬁned as the
log odds of the outcome conditional on x1, x2,. . ., xn minus the log
odds of the outcome conditional on x2,. . ., xn. The latter odds cannot
in general be derived from equation 1 because the effects of the
omitted x1 are partly picked up by x2,. . ., xn: the true likelihood ratio
for x1 therefore depends on the values of x2,. . ., xn. We have created
ALLRs that do not depend on the values of x2,. . ., xn.
To create the ALLRs, we force the coefﬁcients in the second model to
be the same as those estimated in the ﬁrst model, but allowing a
different intercept:
logðoddsjx2; . . . xnÞ ¼ a1 þ b^2x2 þ . . .þ b^nxn ð2Þ
In this model, only the parameter a1 is to be estimated; the other
parameters take their ﬁtted values from equation 1. We can then
calculate the ALLR for x1as
ALLR1 ¼ a^þ b^1x1  a^1: ð3Þ
This procedure is repeated for each variable x2; . . . ; xnto calculate
ALLR2; . . . ;ALLRn
A small correction factor must be added to the ALLRs in order to
ensure that the sum of the overall log odds and all the ALLRs is
exactly equal to the log odds computed from equation 1. The
appropriate correction factor is cid, where d ¼ a^ a^0 þ
P
i ða^i  a^Þ,
a^0 is the overall log odds, and
P
i ci ¼ 1: In this paper, d¼0.021 and
all correction factors were smaller than 0.01 in magnitude. To ensure
that values of each ALLRi straddle 1, ci is calculated as mi/(m1þ. . .þmn)
where mi is the sample minimum or maximum (depending on
whether d is positive or negative) of ALLRi.
At the end of this procedure, the sum of the overall log odds and all
the ALLRs exactly equals the log odds computed from equation 1.
Our procedure is therefore nothing more than a restatement of the
results of the logistic regression in an easily interpretable format.
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Birth order, gestational age, and risk of delivery related
perinatal death in twins: retrospective cohort study
Gordon C S Smith, Jill P Pell, Richard Dobbie
Abstract
Objective To determine whether twins born second
are at increased risk of perinatal death because of
complications during labour and delivery.
Design Retrospective cohort study.
Setting Scotland, 1992 and 1997.
Participants All twin births at or after 24 weeks’
gestation, excluding twin pairs in which either twin
died before labour or delivery or died during or after
labour and delivery because of congenital
abnormality, non›immune hydrops, or twin to twin
transfusion syndrome.
Main outcome measure Delivery related perinatal
deaths (deaths during labour or the neonatal period).
Results Overall, delivery related perinatal deaths were
recorded for 23 first twins only and 23 second twins
only of 1438 twin pairs born before 36 weeks
(preterm) by means other than planned caesarean
section (P > 0.99). No deaths of first twins and nine
deaths of second twins (P=0.004) were recorded
among the 2436 twin pairs born at or after 36 weeks
(term). Discordance between first and second twins
differed significantly in preterm and term births
(P=0.007). Seven of nine deaths of second twins at
term were due to anoxia during the birth (2.9 (95%
confidence interval 1.2 to 5.9) per 1000); five of these
deaths were associated with mechanical problems
with the second delivery following vaginal delivery of
the first twin. No deaths were recorded among 454
second twins delivered at term by planned caesarean
section.
Conclusions Second twins born at term are at higher
risk than first twins of death due to complications of
delivery. Previous studies may not have shown an
increased risk because of inadequate categorisation of
deaths, lack of statistical power, inappropriate
analyses, and pooling of data about preterm births
and term births.
Introduction
Obstetricians recognise that second twins are vulner›
able to complications during labour and delivery.1 It is
not clear, however, whether this is reflected in
increased rates of perinatal mortality. Analysis of
observational studies in the 1960s seemed to show that
second twins were at higher risk of perinatal death
than first twins.2 These findings were subsequently
refuted by a number of large scale studies that failed to
show a higher risk3–6 or that showed only a very slightly
higher risk.7 Previous large scale studies have generally
lacked detailed information on the cause and timing of
perinatal death. Consequently, differences in outcomes
related to complications during delivery of the second
twin may have been masked by other causes of death,
such as prematurity, congenital abnormality, and
antepartum events. We conducted a large scale,
retrospective cohort study of delivery related perinatal
deaths in twin pregnancies by linking a national regis›
ter of data on discharges after childbirth to a national
register of perinatal deaths.
Methods
Population
The Scottish morbidity record collects information on
clinical and demographic characteristics and outcomes
for all patients admitted to Scottish maternity hospitals.
The register is subject to regular quality assurance
checks, and data are available for more than 99% of
registered births.8 We used the register to identify all
births between 1992 and 1997 and linked these
records to records from the Scottish Stillbirth and
Infant Death Enquiry, which has routinely classified all
perinatal deaths in Scotland since 1983. It is virtually
100% complete and has been described in detail
elsewhere.9 10 The study used publicly collected data
collected by NHS Scotland without identifiers and its
use, therefore, did not require ethical approval.
Classification of perinatal deaths
Stillbirths were defined as babies born at or after 24
weeks’ gestation who showed no signs of life after
delivery. Stillbirths were subdivided into antepartum
deaths (before the onset of labour) and intrapartum
deaths (during labour). Neonatal death was defined as
death during the first four weeks of life in a liveborn
baby. The Scottish Stillbirth and Infant Death Enquiry’s
register documents the cause of death in two fields.
Firstly, all deaths are classified according to a modified
version of the Wigglesworth hierarchical system, which
lists obstetric and paediatric causes11; the specific
categories are described in detail elsewhere.10 Secondly,
each record has up to three obstetric and three paedi›
atric ICD›9 (International Classification of Diseases,
ninth revision) codes.
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We excluded all deaths that were due to congenital
abnormality (Scottish Stillbirth and Infant Death
Enquiry classifications 1›7), non›immune hydrops
(ICD›9 code 778.0), and twin to twin transfusion
syndrome (ICD›9 code 762.3). We defined delivery
related perinatal death as intrapartum stillbirth or
neonatal death not caused by congenital anomaly,
hydrops, or twin to twin transfusion syndrome. The
cause of death was subdivided into three paediatric
categories: intrapartum anoxia, pulmonary causes, and
all other paediatric causes. Within the category of
intrapartum anoxia, we used the obstetric classification
to identify deaths for which there was a direct obstetric
mechanical cause, such as uterine rupture, malpresen›
tation, cord compression (including prolapse), birth
trauma, or anoxia associated with disproportion.
Definitions
Socioeconomic deprivation, smoking, parity, maternal
age, and gestational age were defined as described pre›
viously.12 Term was defined as >36 weeks’ gestation for
twin pregnancies.6
Statistical analyses
Continuous variables were summarised by the median
and the interquartile range. Paired continuous data
were compared by using the Wilcoxon signed rank test,
and unpaired continuous data were compared by
using the Mann›Whitney U test. Discordance in birth
weight was described by the absolute difference,
expressed as a percentage of the weight of the larger
twin. Univariate comparisons of unpaired dichoto›
mous data were performed using Fisher’s exact test, ÷2
test, and ÷2 test for trend, as appropriate, and multivari›
ate comparison was made using logistic regression.
Univariate comparison of dichotomous outcomes in
first and second twins was performed using the McNe›
mar test, and multivariate comparison was performed
by using conditional logistic regression. Socioeco›
nomic deprivation, smoking, parity, height, and mater›
nal age were categorised as in table 1 and were entered
into the logistic regression model as a series of dummy
variables. In each case the referent category is
identified in the table. The P values for all hypothesis
tests were two sided. The 95% confidence intervals for
risk of death were calculated using the binomial distri›
bution. All statistical analyses were performed using
version 7.0 of the Stata software package.
Results
Between 1992 and 1997, 4707 women delivered twins
in Scotland. Gestational age was missing in the records
for two of these women ( < 0.1%). Of the remaining
women, 4690 (99.7%) gave birth at or after 24 weeks’
gestation. Records were excluded when one or both
twins died from antepartum stillbirth (n=117), con›
genital abnormality (n=26), twin to twin transfusion
syndrome (n=19), or non›immune hydrops (n=6). As
some overlap existed between these groups, a total of
145 (3.1%) pregnancies were excluded. Among the
Table 1 Maternal characteristics in relation to preterm birth among 3874 women with twin pregnancies delivered by a means other
than planned caesarean section. Values are numbers (percentages) unless otherwise specified
Characteristics
Gestational age at delivery Odds ratio (95% CI) for delivery at <36 weeks
<36 weeks
(n=1438)
>36 weeks
(n=2436) Unadjusted P value* Adjusted P value†
Age:
<20 63 (4.4) 70 (2.9) 1.0
0.0008
1.0
0.74
20›24 234 (16.3) 328 (13.5) 0.8 (0.5 to 1.2) 1.2 (0.8 to 1.9)
25›29 487 (33.9) 814 (33.4) 0.7 (0.5 to 1.0) 1.1 (0.7 to 1.8)
30›34 449 (31.2) 858 (35.2) 0.6 (0.4 to 0.8) 1.2 (0.7 to 1.8)
>34 205 (14.3) 366 (15.0) 0.6 (0.4 to 0.9) 1.3 (0.8 to 2.1)
Parity:
0 754 (52.4) 904 (37.1) 1.0
<0.0001
1.0
<0.00011 387 (26.9) 904 (37.1) 0.5 (0.4 to 0.6) 0.5 (0.4 to 0.6)
>1 297 (20.6) 628 (25.8) 0.6 (0.5 to 0.7) 0.5 (0.4 to 0.7)
Smoking status:
Non›smoker 686 (57.1) 1304 (60.3) 1.0
0.07
1.0
0.09Ex›smoker 114 (9.5) 198 (9.1) 1.1 (0.9 to 1.4) 1.0 (0.8 to 1.3)
Smoker 402 (33.4) 662 (30.6) 1.2 (1.0 to 1.3) 1.2 (1.0 to 1.4)
Missing 236 272
Deprivation category:
1 (least deprived) 272 (19.3) 527 (22.0) 1.0
0.0005
1.0
0.26
2 250 (17.7) 495 (20.7) 1.0 (0.8 to 1.2) 1.0 (0.8 to 1.3)
3 272 (19.3) 452 (18.9) 1.2 (1.0 to 1.4) 1.1 (0.9 to 1.4)
4 309 (21.9) 478 (20.0) 1.3 (1.0 to 1.5) 1.2 (0.9 to 1.5)
5 (most deprived) 305 (21.6) 443 (18.5) 1.3 (1.1 to 1.6) 1.3 (1.0 to 1.6)
Missing 28 41
Height (cm):
<155 121 (10.1) 195 (8.8) 1.0
0.0005
1.0
0.002
155›159 264 (22.0) 399 (18.0) 1.1 (0.8 to 1.4) 1.1 (0.8 to 1.5)
160›164 374 (31.2) 686 (31.0) 0.9 (0.7 to 1.1) 0.9 (0.7 to 1.2)
165›169 277 (23.1) 564 (25.5) 0.8 (0.6 to 1.0) 0.8 (0.6 to 1.0)
>170 164 (13.7) 367 (16.6) 0.7 (0.5 to 1.0) 0.7 (0.5 to 1.0)
Missing 238 225
*÷2 test for trend.
†Likelihood ratio test.
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remaining 4545 pregnancies, 671 (14.8%) were
delivered by planned caesarean section and 3874
(85.2%) by other means. On univariate analysis, age,
socioeconomic status, height, and parity varied accord›
ing to gestational age at the time of delivery in the
group that excluded planned caesarean deliveries, but
only parity and maternal height were independent
predictors of preterm birth (table 1).
The numbers of deaths of first and second twins
born before 36 weeks’ gestation did not differ
significantly (table 2). Among births at or after 36
weeks’ gestation, no deaths were recorded among first
twins and nine deaths among second twins (3.7 (95%
confidence interval 1.7 to 7.0) per 1000 deliveries;
P=0.004 for excess of deaths of second twins). Discord›
ance between first and second twins was significantly
different in preterm and term births (P=0.007; table 2).
Of the nine deaths of second twins at term, five
were intrapartum stillbirths and four were neonatal
deaths. Seven of the nine deaths were attributed to
intrapartum anoxia (2.9 (1.2 to 5.9) per 1000
deliveries). Analysis of deaths due to intrapartum
anoxia showed no difference between first and second
twins born preterm (P > 0.99), a significant difference
between first and second twins born at term (P=0.02),
and a significant difference in the discordance between
first and second twins for preterm and term births
(P=0.04). The cause of death was classified as mechani›
cal in five of the seven anoxic deaths at term; this
equated to 2.1 (0.7 to 4.8) per 1000 deliveries. Both
twins were delivered vaginally in six out of the seven
deliveries at term in which the second twin died from
anoxia and in all five of the deliveries at term in which
anoxia had an obstetric mechanical cause. Both twins
were delivered by emergency caesarean section in one
case in which the second twin died from intrapartum
anoxia. Among the 2427 term pregnancies for which
both twins were delivered by a means other than
planned caesarean section and for which neither twin
died, 581 (23.9%) emergency caesarean sections were
done for one or both twins.
No differences in any maternal characteristics for
twins delivered at term by a means other than planned
caesarean section were seen according to whether the
second twin died (table 3). When twins’ characteristics
were compared, no difference was seen in the
proportion that were discordant for sex, but the
percentage discrepancy in birth weight was signifi›
cantly higher for pairs of twins in which the second
twin died than for pairs in which both twins survived
(15.1% v 9.5%; P=0.02). When the actual weights for the
nine pregnancies in which the second twin died during
delivery at term were analysed, four of the second twins
were larger than the first twins and five were smaller;
the median birth weight did not differ between the first
and second twins (2590 (interquartile range 2410›
3060) g v (2400 (2268›2840) g; P=0.55).
When the risk of death for deliveries from 24 weeks
onwards by a means other than planned caesarean
section was analysed with conditional logistic
regression, a significant interaction between birth
order and gestational age was confirmed: the odds
ratio for the interaction term between gestational age,
expressed as a continuous variable in weeks, and the
second twin was 1.16 (1.01 to 1.35; P=0.04). No signifi›
cant interactions were seen between second twin and
maternal age, parity, height, smoking, or deprivation
category (all P > 0.05). In a model that included all of
these interaction terms, the interaction between
second twin and gestational age was significant (odds
ratio 1.36, 1.01 to 1.85; P=0.04).
When outcomes for the 454 twin pairs delivered at
term by planned caesarean section were analysed, no
delivery related perinatal deaths of either first or
Table 2 Delivery related perinatal deaths of first and second twins delivered by a means other than planned caesarean section in relation to gestational age
and cause of death
Cause of death
Preterm births (n=1438)* Term births (n=2436) P value for
preterm v
term§First twin Second twin Both twins
P
value†
Odds ratio (95% CI)
for second twin First twin
Second
twin‡ Both twins P value†
All 23 23 42 >0.99 1.0 (0.6 to 1.8) 0 9 0 0.004 0.007
Intrapartum anoxia 5 5 2 >0.99 1.0 (0.3 to 3.5) 0 7 0 0.02 0.04
Pulmonary causes 18 19 25 >0.99 1.1 (0.6 to 2.0) 0 0 0
All other paediatric
causes
11 10 4 >0.99 0.9 (0.4 to 2.1) 0 2 0 0.5 0.48
*In 11 of the preterm births, both twins died but because of different causes.
†McNemar’s exact test for discordance between first twins and second twins.
‡Odds ratio for death of the second twin could not be calculated because the odds of death among first twins at term were zero in all categories.
§Fisher’s exact test of discordant twin pairs, preterm versus term.
Table 3 Maternal and obstetric characteristics of pregnancies at term according to death of second twin among women not delivered
by planned caesarean section. Values are numbers (%) unless otherwise specified
Characteristics Both twins survived (n=2427) Second twin died (n=9) P value*
Mother
Median (interquartile range) maternal age (years) 30 (26›33) 29 (26›32) 0.99
Median (interquartile range) height (cm) 163 (159›167) 162 (158›165) 0.72
Nulliparous 900 (37.1)† 4 (44.4) 0.73
Smoker 660 (30.6)† 2 (22.2) >0.99
In upper two fifths of deprivation category 1000 (41.9)† 5 (55.6) 0.50
Twin
Discordant for sex 808 (34.0) 2 (22.2) 0.73
Median (interquartile range) % discrepancy in birth weight 9.5 (4.5›15.9) 15.1 (12.1›21.0) 0.02
*Percentage estimated after records with missing values were excluded.
†Fisher’s exact test or Mann Whitney U test, as appropriate.
Papers
page 3 of 5BMJ VOLUME 325 2 NOVEMBER 2002 bmj.com
Page 209
second twins were seen. Among women who gave birth
at term, deaths of second twins delivered by planned
caesarean section and those delivered by other means
did not differ significantly (P=0.22, Fisher’s exact test).
Discussion
We observed an excess of delivery related perinatal
deaths of second twins born at term compared with
their cotwins. No difference in outcome was seen
between first and second twins born preterm. The
absolute risk of perinatal death for second twins born
at term was approximately 1 in 270 for all causes, 1 in
350 for death due to intrapartum anoxia, and 1 in 500
for anoxic death due to a mechanical cause. These
absolute risks are high in comparison with singleton
births in Scotland over the same period: for singleton
pregnancies at term delivered by a means other than
planned caesarean section, delivery related perinatal
death occurred in about 1 in 1000 births among
nulliparous women and 1 in 2000 births among
multiparous women; death due to a mechanical obstet›
ric cause occurred in only 1 in 20 000 births.13
Methodological issues
Many studies have examined the issue of delivery
related mortality in second twins. These studies have
compared the outcome of second twins born vaginally
either with vaginally delivered cotwins2 3 5–7 or with sec›
ond twins delivered by caesarean section.4 14–16 They
failed to show a significant association between birth
order and the risk of delivery related perinatal death.
We were able to make both comparisons in our study
and also addressed several limitations in methods that
were apparent in previous studies.
Firstly, this study examined the outcomes of over
4500 twin pairs. Many previous studies that examined
perinatal mortality in relation to birth order had fewer
than 1000 twin pairs and many had fewer than 500
twin pairs (see Boggess 17 for review). Given the relative
rarity of delivery related perinatal death caused by
intrapartum anoxia,13 such studies are clearly under›
powered and would inevitably yield negative findings.
Secondly, to our knowledge, this study is the only
large scale analysis to include data on both
intrapartum stillbirths and neonatal deaths but to
exclude antepartum deaths. Given that most delivery
related perinatal deaths in second twins at term were
intrapartum stillbirths, previous large scale studies that
excluded stillbirths probably underestimated the risk
to the second twin.3–5 7 The only large scale study that
included stillbirths was unable to distinguish between
antepartum and intrapartum stillbirths.6
Thirdly, most studies have compared first and
second twins across the whole range of gestational ages
rather than stratified by gestational age.3 5 7 The former
method is legitimate only if the relative risk is homoge›
neous across the range of gestational ages. A statistical
interaction between birth order and gestational age,
however, is predictable. Eighty per cent of twins
delivered at 24 weeks die compared with less than 1%
at term.6 The principal determinant of the risk of death
is prematurity, which clearly is the same for both twins.
The potential for birth order to increase the baseline
risk due to complications during labour and delivery,
therefore, would be expected to increase with
advancing gestational age. Our study confirmed a posi›
tive interaction between being a second twin and
gestational age and thus confirms that the assumption
of homogeneity implicit in previous analyses was
invalid. Other maternal factors were also associated
with preterm birth (table 1). Multivariate conditional
logistic regression showed that the interaction between
gestational age and birth order was not explained by
an interaction between birth order and any of the other
factors.
Finally, our statistical analysis took into account the
paired nature of the data. Many previous studies,
including previous large scale analyses,3–7 compared
data on first and second twins by using statistical tech›
niques that assume independence of observations. The
use of unpaired tests for paired data is inappropriate
and results in loss of statistical power. We overcame this
using McNemar’s test and conditional logistic
regression. If we had used the same analytical
approach as some previous studies (failed to stratify by
gestational age and used a statistical test for unpaired
data), we would have observed, overall, 67 deaths
among all first twins and 75 among second twins; this
would have failed to reach significance (÷2 test, P=0.49).
The excess of deaths due to intrapartum anoxia
was significant only for twins born at term (table 2).
Although no significant difference was seen between
the risks of death for first and second twins born
preterm, the confidence intervals for the odds ratio of
death of the preterm second twin (relative to the first
twin) due to intrapartum anoxia were 0.3 to 3.5. Our
data cannot exclude an excess risk of anoxic death for
preterm second twins; further larger analyses are
required.
Discordance
No maternal characteristics were associated with an
increased risk of delivery related perinatal death for
second twins delivered at term (table 3). The absolute
discrepancy in weight between twins was greater, how›
ever, in pregnancies complicated by death of the
second twin at term. Interestingly, the discrepancies
were equally distributed between pregnancies in which
the second twin was larger than the first and those in
which the first twin was larger. The actual number of
events was too small to establish the relation between
the direction of the weight difference and the cause of
death. The registers we used lacked information on the
presentation of the second twin before delivery of the
first. However, the presentation of the second twin
changes after delivery of the first twin in 20% of cases,1
so it may not be possible to predict, before the first twin
is delivered, which cases will be complicated by
malpresentation of the second twin.
Caesarean deliveries
Since the excess of deaths of second twins at term
seems to be attributable to labour, current data suggest
that planned caesarean delivery may be protective
against perinatal death among twins. Though no
deaths occurred among 454 second twins delivered by
planned caesarean section at term, the numbers were
too small to confirm a protective effect of planned cae›
sarean section. Previous studies on the association
between caesarean section and the risk of perinatal
death among second twins included fewer cases than
reported in this study14–16 or lacked information on
Papers
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whether the procedure was planned or an emergency
procedure.4 Sample size calculations show that it will
be difficult to obtain randomised controlled trial data
to test the hypothesis that planned caesarean section
would be protective against perinatal death in twin
pregnancies. With a rate of three deaths of second
twins due to intrapartum anoxia per 1000 deliveries,
allowing 80% power for a one sided test, and assuming
that the rate of perinatal death in the planned
caesarean group is zero, a randomised controlled trial
would need to recruit about 6500 women with twin
pregnancies. We propose that women with twins
should be counselled about the risk to the second twin
and the theoretical possibility of a protective effect of
planned caesarean section when considering mode of
delivery at term.
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What is already known on this topic
It is difficult to assess the wellbeing of second twins
during labour
Deliveries of second twins are at increased risk of
mechanical problems, such as cord prolapse and
malpresentation, after vaginal delivery of first
twins
Increased risks of perinatal death in second twins
have not been shown, but the methods of these
studies were flawed
What this study adds
Second twins delivered at term are at increased
risk of delivery related perinatal deaths
Intrapartum anoxia caused 75% of these deaths in
second twins, and most of these resulted from
mechanical problems after vaginal delivery of first
twins
Planned caesarean section of twins at term may
prevent perinatal deaths
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Mode of delivery and the risk of delivery-related perinatal death
among twins at term: a retrospective cohort study of 8073 births
Gordon C.S. Smith,a Imran Shah,a Ian R. White,b Jill P. Pell,c Richard Dobbied
Objective To determine the risk of perinatal death among twins born at term in relation to mode of delivery.
Design Retrospective cohort study.
Setting Scotland 1985–2001.
Population All twin births at or after 36 weeks of gestation, excluding antepartum stillbirths and perinatal
deaths due to congenital abnormality (n ¼ 8073).
Methods The outcome of first and second twins was compared using McNemar’s test and the outcome of twin
pairs in relation to mode of delivery was compared using exact logistic regression.
Main outcome measures Intrapartum stillbirth or neonatal death of either twin.
Results Overall, there were six deaths of first twins and 30 deaths of second twins (OR for second twin 5.00,
95% CI 2.00–14.70). The odds ratio for death of the second twin due to intrapartum anoxia was 21 (95% CI
3.4–868.5). The associations were similar for twins delivered following induction of labour and for sex
discordant twins. However, there was no association between birth order and the risk of death among 1472
deliveries by planned caesarean section. There was death of either twin among 2 of 1472 (0.14%) deliveries
by planned caesarean section and 34 of 6601 (0.52%) deliveries by other means (P ¼ 0.05, odds ratio for
planned caesarean section 0.26 [95% CI 0.03–1.03]). The association was similar when adjusted for
potential confounders. Assuming causality, we estimate that 264 caesarean deliveries (95% CI 158–808)
would be required to prevent each death.
Conclusion Planned caesarean section may reduce the risk of perinatal death of twins at term by approx-
imately 75% compared with attempting vaginal birth. This is principally due to reducing the risk of death of
the second twin due to intrapartum anoxia.
INTRODUCTION
The effect of birth order on the risk of perinatal death
among twins has been the subject of study for some years.
Clinically, it is well recognised that the second twin is at
increased risk of complications during labour due to diffi-
culties in fetal monitoring and the possibility of traumatic
delivery following vaginal birth of the first twin.1 However,
large scale epidemiological studies have generally failed to
confirm increased perinatal mortality in relation to birth
order.2 – 4 We recently re-examined this and found a marked
excess of delivery-related perinatal deaths among second
twins compared with first twins.5 The failure of previous
studies to show this was due to lack of details regarding the
timing and cause of perinatal death, failure to stratify by
gestational age and the use of unpaired statistical tests to
compare the outcome of first and second twins. Our
findings suggested that delivery of all twins by planned
caesarean section might reduce the risk of perinatal death.
However, our own and other analyses lacked sufficient
numbers to make this comparison. In the present study,
we analysed data from over 8000 twin pairs born at or after
36 weeks of gestation and sought to determine the associa-
tion between mode of delivery and the risk of perinatal death.
METHODS
The Scottish Morbidity Record (SMR2) collects infor-
mation on clinical and demographic characteristics and
outcomes for all patients admitted to Scottish maternity
hospitals. The register is subjected to regular quality
assurance checks and has been greater than 99% complete
since the late 1970s.6 A quality assurance exercise in 1996/
97 demonstrated that mode of delivery was free of major or
minor errors for 99.2% of cases in singletons or first twins
and 95.2% of second twins [Dr Jim Chalmers MB ChB,
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Information and Statistics Division, National Health Ser-
vice (NHS), Scotland, personal e-mail communication]. The
SMR2 register was used to identify all births between 1985
and 2001. These were linked to records from the Scottish
Stillbirth and Infant Death Enquiry (SSBIDE), which has
routinely classified all perinatal deaths in Scotland since
1983. It is virtually 100% complete and has been described
in detail elsewhere.7,8 Record linkage employs a probabil-
ity based matching approach which has approximately a
1% error rate overall and the method is described in detail
elsewhere.9 The SMR2 does not have an indicator of birth
order whereas the SSBIDE does have such an indicator.
It was possible, therefore, to establish the mode of delivery
and presentation of the first twin in cases where one twin
died.
Perinatal deaths were classified by the information in
the SSBIDE where coding of the cause of death is per-
formed by a single medically qualified individual7 using a
modification of the Wigglesworth classification.10 Still-
births were subdivided into antepartum (deaths before the
onset of labour) and intrapartum (deaths during labour).
There can be ambiguity in this regard, but the definition
by its nature lacks a gold standard and depends on the
judgement of the coordinator on the basis of clinical and
autopsy data. Neonatal death was defined as death during
the first four weeks of life in a liveborn baby. Death due to
congenital abnormality is classified under the hierarchical
system and was defined as any structural or genetic defect
incompatible with life or potentially treatable but causing
death and these were excluded. Having excluded deaths
due to congenital abnormality and rhesus isoimmunisa-
tion, deaths are then classed according to direct obstetric
causes (in order): toxaemia, haemorrhage (including
abruption), mechanical, maternal and then cases with none
of these obstetric causes. Mechanical is defined as death
from a direct physical obstetric cause such as cord com-
pression (including prolapse), birth trauma or asphyxia
associated with disproportion. In the absence of any of the
listed direct obstetric causes, the deaths were classified by
the paediatric diagnoses and these were grouped into
intrapartum anoxia and all others. The cause of deaths
was subdivided into deaths due to intrapartum anoxia and
all other causes. Within the category of intrapartum anoxia
we used the obstetric classification to identify those where
there was a direct obstetric mechanical causes.
We defined delivery-related perinatal death as intrapar-
tum stillbirth or neonatal death not caused by congenital
anomaly. Term was defined as 36 weeks of gestation for
twin pregnancies.11 Small for gestational age (SGA) was
defined as 5th centile for sex and gestational age, using
centiles generated within the study cohort. Hospital
throughput was defined as the total number of births
recorded in the SMR2 database for the given hospital over
the given year. Other maternal characteristics were defined
as previously described.12 Information on maternal weight
and body mass index were not available.
Continuous variables were summarised by the median
and inter-quartile range (IQR). Paired continuous data were
compared using the Wilcoxon signed rank test and unpaired
continuous data were compared using the Mann–Whitney
U test. Discordance in birthweight was described by the
absolute difference expressed as a percentage of the weight
Table 1. Maternal, obstetric and demographic factors in relation to death
of either twin.
Characteristics Both twins
survived
(n ¼ 8037)
Death of
either twin
(n ¼ 36)
P*
Age ( years)
<25 1497 (18.6) 2 (5.6) 0.3
25–29 2708 (33.7) 15 (41.7)
30–34 2650 (33.0) 14 (38.9)
>34 1182 (14.7) 5 (13.9)
Parity
0 3081 (38.3) 16 (44.4) 0.6
1 2975 (37.0) 12 (33.3)
>1 1981 (24.7) 8 (22.2)
Deprivation categoryy
1 (least deprived) 1712 (21.6) 6 (17.1) 0.9
2 1513 (19.1) 8 (22.9)
3 1530 (19.3) 8 (22.9)
4 1537 (19.4) 5 (14.3)
5 (most deprived) 1632 (20.6) 8 (22.9)
Height (cm)y
<155 693 (9.8) 4 (11.8) 0.5
155–159 1343 (19.0) 6 (17.7)
160–164 2205 (31.1) 13 (38.2)
165–169 1675 (23.6) 7 (20.6)
>170 1172 (16.5) 4 (11.8)
Mode of delivery
Planned caesarean 1470 (18.3) 2 (5.6) 0.05
SGAy
None 7241 (90.5) 28 (80.0) 0.04
Either twin 764 (9.5) 7 (20.0)
Birthweight discrepancyy
Median percent
birthweight (IQR)
9.6 (4.5– 16.3) 14.7 (6.3–24.0) 0.001
Sex discordance of twin pairsy
Concordant 5406 (67.4) 28 (77.8) 0.2
Discordant 2615 (32.6) 8 (22.2)
Year of birth
Median year of
birth (IQR)
1993 (1989–1997) 1991 (1987– 1995) 0.01
Values are presented as n (%) unless otherwise stated; SGA denotes small
for gestational age.
* Fisher’s Exact Test, m2 test, Mann– Whitney U test or trend test as
appropriate.
y Cases with missing data excluded (n ¼ 951 for height and n ¼ 114 for
deprivation category and 33 cases had missing data for sex or birthweight).
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of the larger twin. Univariate comparisons of unpaired
dichotomous data were performed using Fisher’s Exact Test.
Due to the small number of events among women delivered
by planned caesarean section, multivariate comparison was
made using exact logistic regression. Univariate comparison
of dichotomous outcomes in first and second twins was per-
formed using McNemar’s test. The P values for all hypothe-
sis tests were two sided. The 95% confidence intervals for
risk of death were calculated using the binomial distri-
bution. All statistical analyses were performed using the
Stata software package (Stata, TX, USA), version 8.2 or
LogExact version 5.0 (Cytel Software, MA, USA).
RESULTS
There were 8213 records of twin pairs born at or after
36 weeks of gestation in the linked database. We excluded
95 (1.2%) cases where one or both twins were antepartum
stillbirths, 34 (0.4%) where one or both twins were an in-
trapartum stillbirth or neonatal death due to congenital ab-
normality, 17 records where one twin was documented as
being delivered by planned caesarean section but the other
was not and six pregnancies where induction of labour was
recorded but the mode of delivery was documented as
planned caesarean section for both twins. Some of the
records had multiple exclusions and the remaining 8073
records formed the study group which was 98.3% of all doc-
umented twin births at term. There were 36 delivery-related
perinatal deaths among this group, which equated to 22.9%
of all perinatal deaths documented in the 8213 twin pairs
delivered at term. There was no cases among the 8073 re-
cords where both twins of a pair died.
The demographic, maternal and obstetric characteristics
of the study group are tabulated by whether there was a
delivery-related perinatal death. Death of either twin was
associated with delivery by a means other than planned
caesarean section, with increased discordance in birth-
weight and with delivery at earlier years within the study
period, but was not significantly associated with other
maternal, demographic or obstetric factors (Table 1). The
risk of death of either twin did not increase with advanc-
ing week of gestation from 36 weeks (P ¼ 0.12) or hos-
pital throughput, expressed as number of births per annum
(P ¼ 0.93). Of the 8073 deliveries, 1472 (18.2%) were
planned caesarean sections and 1759 (21.8%) were emer-
gency caesarean sections, giving an overall caesarean
section rate of 40.0%. The proportion of women delivered
by planned caesarean section increased over the period of
study (odds ratio of planned section per one year, 1.05,
95% CI 1.04–1.07, P <0.001). Among the hospitals that
delivered more than 100 twins over the study period, the
median proportion of planned caesarean deliveries was
18.6%, the IQR 16.9–20.8% and the range was 10.6–30.0%.
Overall, there was a fivefold excess of death among
second twins compared with first twins (Table 2). This was
due to a 21-fold excess risk of death of the second twin due
to intrapartum anoxia. The associations between birth order
Table 2. Univariate associations between delivery related perinatal death and birth order.
Cause of death First twin n (%) Second twin, n (%) OR (95% CI) for second twin P*
All twin births (n ¼ 8073)
All cause 6 (0.07) 30 (0.37) 5.0 (2.0–14.7) 0.0001
Intrapartum anoxia 1 (0.01) 21 (0.26) 21.0 (3.4–868.5) <0.0001
Other causes 5 (0.06) 9 (0.11) 1.8 (0.5–6.8) 0.4
Deliveries by planned caesarean section (n ¼ 1472)
All causey 0 2 (0.14) l (0.2–l) 0.5
Intrapartum anoxiay 0 0 l (0.2–l) –
Other causesy 0 2 (0.14) l (0.2–l) 0.5
Deliveries by means other than planned caesarean section (n ¼ 6601)
All cause 6 (0.09) 28 (0.42) 4.7 (1.9–13.8) 0.0002
Intrapartum anoxia 1 (0.02) 21 (0.32) 21.0 (3.4–868.5) <0.0001
Other causes 5 (0.08) 7 (0.11) 1.4 (0.4–5.6) 0.8
Induced deliveries (n ¼ 3087)
All cause 2 (0.06) 11 (0.36) 5.5 (1.2–51.1) 0.02
Intrapartum anoxiay 0 7 (0.23) l (1.4–l) 0.02
Other causes 2 (0.06) 4 (0.13) 2.0 (0.3–22.1) 0.7
Sex discordant twins only (n ¼ 2623)
All cause 1 7 7.0 (0.9–315.5) 0.07
Intrapartum anoxiay 0 7 l (1.4–l) 0.02
Other causes 1 0 0.0 (0.0–39.0) >0.99
* McNemar’s exact test for discordance between first and second twins.
y Odds ratio (OR) for death of the second twin could not be calculated because the odds of death among first twins were zero.
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and perinatal death were similar when confined to twins
delivered by a means other than planned caesarean section,
those where labour was induced and those where both twins
were sex discordant. When the analysis was confined to
twin pairs delivered by planned caesarean section, there
was no overall excess risk of death of the second twin,
although the number of events was too small to exclude
a significant effect of birth order.
When women delivered by planned caesarean section
(n ¼ 1472) were compared with women delivered by other
means (n ¼ 6601) they were older (median [IQR] in years:
30 [27–34] vs 29 [25–32], P < 0.0001) and smaller stature
(median [IQR] in cm: 162 [157–167] vs 163 [159–167],
P ¼ 0.0005) than other women. Twin pairs delivered by
planned caesarean section had greater birthweight discor-
dance (median [IQR] percentage discrepancy: 10.3 [5.1–
17.0] vs 9.4 [4.5–16.2], P ¼ 0.0008) and were more likely
to be sex discordant (35.3% vs 32.0%, P ¼ 0.01) and one
or both twins were more likely to be SGA (11.2% vs
9.2%, P ¼ 0.02).
The risk of perinatal death was approximately 75%
lower among women delivered by planned caesarean sec-
tion (Table 3). The odds ratio for planned caesarean section
was essentially unaffected by adjusting for birthweight
discrepancy, SGA or year of birth. Among those twins
delivered by a means other than planned caesarean section,
the all-cause risk of death of the first twin was 0.9 per
1000 deliveries (95% CI 0.3–2.0), the all-cause risk of
death in the second twin was 4.2 per 1000 deliveries (95%
CI 2.8–6.1), the risk of death of the second twin due to
intrapartum anoxia was 3.2 per 1000 deliveries (95% CI
2.0–4.9) and the risk of death of the second twin due to
intrapartum anoxia secondary to an obstetric mechanical
cause was 1.5 per 1000 (95% CI 0.7–2.8). The risk dif-
ference (95% CI) associated with planned caesarean section
compared with other modes of delivery was 3.79 (1.24–
6.34) per 1000 for death of either twin indicating that the
number of caesarean sections required to prevent each
death, assuming causality, was 264 (95% CI 158–808).
There were 34 deaths of either twin among the 6601 women
delivered by a means other than planned caesarean section.
In none of these cases was the first twin a vaginal breech
birth. Of the 34 deaths, there were 24 cephalic vaginal
births of the first twin. In the remaining 10 cases, both
twins were delivered by emergency caesarean section.
Among these the presentation of the first twin was cephalic
in 6 out of 10, undocumented in 2 and breech in 2. There-
fore, the first twin presented cephalically in 30 (88%) of
the 34 cases, which resulted in death of either twin.
DISCUSSION
We have recently demonstrated that among twin pairs
born at term, there is a marked excess of delivery-related
perinatal deaths among second twins.5 Three quarters of
these deaths were due to intrapartum anoxia and over half
were related to a direct obstetric mechanical cause. This
was consistent with a Swedish study of over a million term
births, which demonstrated a fourfold risk of a depressed
5-minute Apgar score among second but not first twins.13
We hypothesised that planned caesarean delivery of twins
would reduce the risk of perinatal death, primarily by
reducing the risk of anoxic death of the second twin. In
the present study, we show that delivery by planned
caesarean section was associated with a 75% lower risk
of perinatal death of either twin when compared with those
delivered by other means. This reduction in risk was not
significantly changed by adjusting for potential confound-
ers. Residual confounding and bias are unlikely to explain
our results since planned caesarean section would typically
be employed in the presence of risk factors for adverse
outcome. Consistent with this, women delivered by planned
caesarean section were older and shorter than other mothers
and their offspring had greater birthweight discrepancies
and increased rates of SGA.
These findings suggest that delivering all twins by
planned caesarean section may reduce the number of
perinatal deaths. Currently, planned caesarean delivery is
usually offered to women with twins where the first twin is
presenting by the breech.1 However, in the present study,
approximately 90% of the deaths occurred among twin
pairs where the first was in a cephalic presentation. As-
suming causality, we estimate that 264 caesarean deliveries
would need to be performed to prevent each death. Many
women may chose to accept the small risk of perinatal
death in order to achieve vaginal birth and facilities should
be provided to allow this choice. However, we suggest that
all women with twins should be informed of the likely
reduction in risk of perinatal death associated with planned
caesarean delivery and that this option should be made
available to those who chose not to accept the risk. Women
and clinicians who remain uncertain should consider par-
ticipating in the randomised controlled trial of planned
caesarean section for twins that is currently under way.14
Table 3. Crude and adjusted odds ratios for the risk of death of either twin
associated with planned caesarean section.*
Odds ratio (95% CI) Py
Unadjusted (all cases) 0.26 (0.03– 1.03) 0.06y
Unadjusted (excluding missing data)z 0.27 (0.03– 1.06) 0.07
Adjusted for year of birth 0.30 (0.03– 1.16) 0.10
Adjusted for SGAz 0.26 (0.03– 1.03) 0.06
Adjusted for birthweight discrepancyz 0.26 (0.03– 1.02) 0.05
* Factors included in the model were those with statistically significant
univariate associations.
y P value from exact logistic regression (two sided). The two-sided P
value from Fisher’s exact test was 0.05. One-sided P value ¼ 0.028 both
tests.
z 33 cases were excluded from all these analyses because they have a
missing record for sex and /or a missing birthweight measurement for
either twin.
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This information must be placed in the context of
short and long term maternal morbidity associated with
caesarean delivery.15 However, attempting vaginal birth
of twins carries its own maternal risks. For example, ap-
proximately 4% of twin deliveries result in caesarean de-
livery of the second twin following vaginal birth of the
first.16,17 This scenario carries a 20-fold risk of general
anaesthesia.17 Given the high rates of caesarean delivery
among twins,16 the greater risks of emergency compared
with planned caesarean section18 and the specific intra-
partum complications associated with twins,17 it is not clear
that the risk of severe maternal morbidity would be in-
creased by a decision for planned caesarean section. For
example, maternal mortality is 70% higher when caesarean
delivery is performed intrapartum rather than as a planned
procedure.18 In our study, 27% of women not delivered by
planned caesarean section were delivered by emergency
section. The increased use of general anaesthesia for twin
sections may result in an even higher relative risk of mor-
tality comparing emergency caesarean delivery in twins
with planned procedures. Thus, it may be that maternal
morbidity may be neutral or could even favour planned
caesarean section. The question may be answered by a ran-
domised controlled trial. Such trials will inevitably be
under-powered for severe maternal morbidity and for ma-
ternal mortality.
Many previous studies have addressed the issue of mode
of delivery and the risk of perinatal death among twins.
However, meta-analysis of these studies did not clearly
indicate whether planned caesarean section was likely to
reduce the risk of death.19 Analysis of this question requires
detailed information about the cause of death. Many types
of death could not be prevented by planned caesarean
section at term, such as antepartum stillbirths and deaths
due to lethal congenital abnormality. Collectively, these
accounted for more than three quarters of all perinatal
deaths among twins at term in the present study. Failure
to exclude these outcomes from analyses of perinatal
mortality would obscure the potential protective effect of
planned caesarean section on truly delivery-related perina-
tal deaths. Moreover, since delivery-related perinatal death
among twins is relatively rare, the question can only be
addressed by a database that combines large number of
women with detailed information on the cause of perina-
tal death. Finally, obstetric details are also required in or-
der to differentiate between key factors, such as planned
versus emergency caesarean section. This is the first ade-
quately powered analysis, to our knowledge, that combines
detailed information on obstetric characteristics and the
cause of perinatal death in a sufficient number of term twin
births.
The observation of reduced risk of perinatal death follow-
ing planned caesarean section is biologically plausible. Of
the 34 deaths among infants delivered by other means, ap-
proximately two-thirds were due to intrapartum anoxia.
Planned caesarean section eliminates the risk of death due
to intrapartum anoxia. It is clearly plausible, therefore, that
planned caesarean section would reduce the risk of death
among twin births. The absolute risk of death of the second
twin due to this event was approximately 3.2 per 1000. This
is approximately 10 times higher than among singleton
births at term.12 Caesarean section is associated with an in-
creased risk of future antepartum stillbirth. However, the ab-
solute risk is in the region of 0.9 per 100020 and would not
mitigate against the benefit of planned caesarean section on
the basis of the current analysis. The two-sided P value for
planned caesarean delivery was at the borderline level of
statistical significance (P ¼ 0.05 using Fisher’s Exact Test
and P ¼ 0.06 using univariate exact logistic regression). We
reported the two-sided value to be conservative. Given the
prior hypothesis that caesarean section might be protective,
a one-sided test may have been appropriate, which yielded
P values of 0.028 using both exact methods.
We lacked data to estimate reliably whether the second
twin was in a cephalic or non-cephalic presentation. How-
ever, presentation of the second twin changes in up to 20% of
cases following delivery of the first.1 Further studies, possi-
bly using a case–control design, will be required to address
this issue. We also lacked data on chorionicity. However, the
effect of birth order was virtually identical in sex discordant
as sex concordant twins. Sex discordant twins pairs are,
necessarily, both dizygous and dichorionic and the effect of
birth order cannot therefore be explained by complications
arising from monochorionic twinning. The excess risk of
death among second twins was also observed among
women having labour induced indicating that the lower
risk of death among twins delivered by planned caesarean
section did not indicate a general lower risk of adverse
events among twin pairs delivered electively.
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RESEARCH
Birth order of twins and risk of perinatal death related to
delivery in England, Northern Ireland, and Wales, 1994-
2003: retrospective cohort study
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ABSTRACT
Objective To determine the effect of birth order on the risk
of perinatal death in twin pregnancies.
Design Retrospective cohort study.
Setting England, Northern Ireland, and Wales, 1994-
2003.
Participants 1377 twin pregnancies with one intrapartum
stillbirth or neonatal death from causes other than
congenital abnormality and one surviving infant.
Main outcomemeasures The risk of perinatal death in the
first and second twin estimated with conditional logistic
regression.
Results Therewas no association between birth order and
the risk of death overall (odds ratio 1.0, 95% confidence
interval 0.9 to 1.1). However, there was a highly
significant interaction with gestational age (P<0.001).
There was no association between birth order and the risk
of death among infants born before 36 weeks’ gestation
but there was an increased risk of death among second
twins born at term (2.3, 1.7 to 3.2, P<0.001), which was
stronger for deaths caused by intrapartum anoxia or
trauma (3.4, 2.2 to 5.3). Among term births, there was a
trend (P=0.1) towards a greater risk of the second twin
dying from anoxia among those delivered vaginally (4.1,
1.8 to 9.5) compared with those delivered by caesarean
section (1.8, 0.9 to 3.6).
Conclusions In this cohort, compared with first twins,
second twins born at term were at increased risk of
perinatal death related to delivery. Vaginally delivered
second twins had a fourfold risk of death caused by
intrapartum anoxia.
INTRODUCTION
Though vaginal delivery of a second twin is recognised
as a time of obstetric risk, we do not know whether
second twins are at increased risk of perinatal death.
Many studies on the association between birth order
and the risk of death havemethodological flaws, speci-
fically, the failure to identify deaths truly related to
delivery, the failure to use paired statistical tests to
compare the outcome of first and second twins, and
the failure to stratify analyses by gestational age.1 An
analysis of nationally collected data on pregnancy and
perinatal death from Scotland in 1992 and 1997
showed a significantly increased risk of intrapartum
stillbirth or neonatal death among second twins born
at term, but included only nine such deaths.2 A follow-
up study of the same data source over a more pro-
longed period (1985 to 2001) showed a similar associa-
tion but includedonly 36 deaths at term.3A subsequent
analysis of US data found no variation in the risk of
neonatal death related to birth order among twins
and concluded that the increased perinatal mortality
among second twins was “merely an artefact of mortal-
ity comparisons.”4 Data from multiple sources, how-
ever, indicate an increased risk of morbidity for the
second twin at term: a large scale study from Sweden
found that second twins had a fourfold risk of anApgar
score <7 at five minutes,5 and a recent analysis of data
from Nova Scotia found a threefold risk of morbidity
for the second twin delivered vaginally but no excess
risk for those delivered by planned caesarean section.6
It remains unclear, therefore, whether attempted vagi-
nal delivery of the second twin at term is associated
with an increased risk of perinatal death. We studied
the association between birth order and the risk of peri-
natal death among twin pregnancies in England,
Northern Ireland, and Wales, 1994-2003.
METHODS
Data on perinatal death in England, Northern Ireland,
and Wales have been collected nationally since 1994.
This is currently coordinated by the Confidential
Enquiry into Maternal and Child Health (CEMACH)
and had previously been done by the Confidential
Enquiry into Stillbirths and Deaths in Infancy
(CESDI). A network of local clinicians and health pro-
fessionals at hospital level notify regional offices of
perinatal deaths. Coroners’ officers, child health sys-
tems, and congenital anomaly registers also report
deaths.Regionalmanagers then code thedeath accord-
ing to the information provided, which includes
autopsy results (if performed). From 1995, data from
England and Wales were linked to the Office for
National Statistics’ registry of death certifications,
ensuring 100% ascertainment of all registered still-
births and neonatal deaths. In 1994, the dataset was
about 95% complete when compared with national
1Department of Obstetrics and
Gynaecology, Cambridge
University, Box 223, The Rosie
Hospital, Cambridge CB2 2QQ
2Confidential Enquiry into
Maternal and Child Health,
London NW1 5SD
3Medical Research Council
Biostatistics Unit, Institute of
Public Health, Cambridge CB2
2SR
Correspondence to: G C S Smith
gcss2@cam.ac.uk
doi: 10.1136/bmj.39118.483819.55
BMJ | ONLINE FIRST | bmj.com page 1 of 5
Page 218
death registrations. The death registry was compiled
nationally at the inquiry’s central office in London,
and the CEMACH database includes all records
obtained by CESDI. We used the registry of deaths
for 1994-2003 for our analyses.
The data source included only information on
deaths. We obtained the total number of twin births
over the period of time from the Office of National
Statistics and the Northern Ireland Statistics and
Research Agency. However, these lack any detailed
obstetric data. Hence, we had no information from
cases where both twins survived and, in cases where
only one twin died, we had no information on the char-
acteristics of the survivor.We could still study the asso-
ciation between birth order and the risk of death,
however, as statistical methods for comparison of a
dichotomous outcome (such as death) in pairs uses
only those instances that are discordant for the out-
come of interest (see below and elsewhere for review1
). Our analyses with this study design, however, were
limited to the relative risk of death for the second twin
referent to the first and determination of whether the
relative risk of death for the second twin varies in rela-
tion to any characteristic common to both, such as
gestational age and maternal characteristics.
We classified events using a series of fields in the
available database. Firstly, we classified deaths as still-
birth, early neonatal death, and late neonatal death. A
further field documented whether death of the infant
took place before or after the onset of labour or
whether the time of death was unknown. Intrapartum
stillbirth was defined as a birth when the infant was
born showing no signs of life and the death was docu-
mented as occurring during labour. Neonatal death
was defined as death of a liveborn infant within the
first four weeks of life. We classified cause of death
according to a modified version of the Wigglesworth
system into one of nine categories: congenital defect/
malformation; unexplained antepartum fetal death;
death from intrapartum “asphyxia,” “anoxia,” or
“trauma”; immaturity; infection; other specific causes;
injury or non-intrapartum trauma; sudden infant
death; and unclassifiable.7 We excluded those deaths
where the cause was stated to be a lethal or severe con-
genital abnormality and classified all other intrapartum
stillbirths and neonatal deaths as perinatal deaths
related to delivery. We also analysed anoxic deaths as
a subgroup of these events, which we defined as those
where the cause was classified as “death from intra-
partum asphyxia, anoxia, or trauma.” As the study
used wholly anonymised data and data collection was
part of a national clinical audit, we did not require indi-
vidual consent.
Statistics
We used conditional logistic regression to estimate the
odds ratio of death for the second twin referent to the
first. The method ignores concordant pairs (that is,
where both twins survived or both twins died) and is
therefore appropriate in a dataset containing data on
deaths only. We tested for interactions between birth
order and both maternal and obstetric characteristics
with interaction terms and assumed significance at
P<0.05. The characteristics tested for interaction
were gestational age, maternal age (expressed as a con-
tinuous variable), maternal ethnicity (white versus all
others), and method of delivery. Interactions were
expressed as odds ratios with 95% confidence inter-
vals. The latter illustrates the power of the study to
exclude a given degree of effect modification and is
preferable to post hoc power calculations.8 All statisti-
cal analysis was performed with Stata version 8.2 (Sta-
taCorp, College Station, TX).
RESULTS
The database had records for 5758 twin pregnancies in
1994-2003 where death of one or both infants was
recorded. In 4221 of these, one infant died and the
other survived. From these, we excluded eight records
(0.2%) that did not document birth order, 55 (1.3%)
where the gestational age at birth was missing, 450
(10.7%) where delivery was before 24 weeks, 178
(4.7%) where a therapeutic abortion was performed,
1975 (46.8%) where death was classed as stillbirth
and the timing of fetal death was before labour or
unknown, and 752 (17.8%) where the infant had a
lethal or severe congenital abnormality. A total of
2844 records (67.4%) had one or more of these exclu-
sions, leaving a study group of 1377 in which there was
one intrapartum stillbirth or neonatal death but the
other twin survived. The table shows the characteris-
tics of this group (table). Over the same period of time,
the Office for National Statistics documented a total of
96 116 certified twin pregnancies in England and
Wales and the Northern Ireland Statistics and
Research Agency recorded 3482, giving a total of
99 598 twin pregnancies as our denominator. Further
details of the denominator, such as gestational age at
birth and method of delivery, were not available.
Birth orderwas not associatedwith the overall risk of
perinatal death related to delivery: the odds ratio for
the second twinwas 1.0 (95% confidence interval 0.9 to
1.1). There were no significant interactions between
birth order andmaternal age (odds ratio for interaction
0.9, 0.7 to 1.1, P=0.2) or white ethnicity (1.2, 0.9 to 1.5,
P=0.2). There was, however, a highly significant inter-
action with gestational age (P<0.001). There was no
association between birth order and the risk of death
among infants born before 36 weeks’ gestation (fig 1),
but there was an increased risk of death among second
twins born at term (2.3, 1.7 to 3.2, P<0.001). When we
confined the analysis to deaths caused by anoxia, there
was a weak association with being a second twin for all
births (1.4, 1.1 to 1.8, P=0.02). Again, there was a
highly significant interaction with gestational age
(P<0.001). When we stratified by gestational age, we
found no association between birth order and the risk
of death caused by anoxia before 36 weeks (fig 1) but a
strong association for births at and beyond 36 weeks
(3.4, 2.2 to 5.3).
We then assessed the risk of perinatal death related
to delivery among second twins born at term in
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relation to method of delivery in the 121 twin pairs for
whomwe had this information.When we looked at all
causes of perinatal death related to delivery we found
no significant difference in those delivered by caesar-
ean section (odds ratio for interaction term 0.9, 0.4 to
1.8, P=0.7). When we confined the analysis to deaths
caused by intrapartum anoxia we found an interaction
of borderline significance between birth order and cae-
sarean section (0.4, 0.1 to 1.3, P=0.1). Theodds ratio for
the second twin was 1.8 (0.9 to 3.6) among those deliv-
ered by caesarean section and 4.1 (1.8 to 9.5) among
those delivered vaginally (fig 2). There were only 19
twin pairs delivered by planned caesarean section at
term where one died and the other survived. Among
this group, the odds ratio for any perinatal death of the
second twin related to delivery was 1.4 (0.6 to 3.4) and
1.0 (0.1 to 7.1) for death caused by anoxia.
Sensitivity analyses
We performed two sensitivity analyses. Firstly, we
repeated the analysis excluding eligible births from
1994 (n=178), when the dataset was less complete.
The results were similar to the main analysis, with a
significant interaction between birth order and gesta-
tional age (P<0.001) and no significant association
between birth order and the risk of death at preterm
gestations but a significantly increased risk of all
cause death for the second twin at term (2.4, 1.7 to
3.5) and for death caused by anoxia (3.3, 2.0 to 5.4).
Secondly, we repeated the analysis including cases
Characteristics of the study cohort. Figures are numbers
(percentage) unless stated otherwise
Data
Maternal age (years):
Median (IQR) 29 (25-33)
Missing 55 (4.0)
Ethnicity:
White 1118 (81.2)
Black 88 (6.4)
Other 124 (9.0)
Missing 47 (3.4)
Gestational age (weeks):
24-27 703 (51.0)
28-31 367 (26.7)
32-35 130 (9.4)
≥36 177 (12.9)
Presentation†:
Cephalic 471 (34.2)
Breech 327 (23.8)
Other 77 (5.6)
Missing* 502 (36.5)
Mode of delivery†:
Spontaneous vaginal 343 (24.9)
Assisted vaginal 114 (8.3)
Elective caesarean 74 (5.4)
Emergency caesarean 442 (32.1)
Other/missing* 404 (29.3)
Sex of infant†:
Male 786 (57.1)
Female 587 (42.6)
Missing 4 (0.3)
Birth weight (g)†:
Median (IQR) 970 (730-1440)
Missing 14 (1.0)
Cause of death:
Asphyxia, anoxia, or trauma 242 (17.6)
Immaturity 735 (53.5)
Infection 164 (11.9)
Other specific 187 (13.6)
Injury 4 (0.3)
Unexplained‡ 39 (2.8)
Missing or unclassifiable 6 (0.4)
IQR=interquartile range.
*Recorded only from 1996 onwards; 93.8% of missing records for mode
of delivery and 74.7% of missing records for presentation were for births
before 1996.
†For infant who died; data were not available for the survivor.
‡Includes in utero and neonatal deaths.
All deaths
24-27
28-31
32-35
≥36
All
Anoxia
24-27
28-31
32-35
≥36
All
359/344
192/175
74/56
53/124
678/699
24/17
24/17
29/21
25/85
102/140
0.25 0.5 1 2 4 8
Weeks' gestation No of deaths
first twin/second twin
Odds ratio of death of second twin
Fig 1 | Odds ratio for perinatal death related to delivery of
second twin for all causes and deaths caused by anoxia,
stratified by gestational age. Numbers of deaths are actual
numbers of losses of first and second twins, confined to births
where other twin survived
All deaths
Caesarean
Vaginal
All
Anoxia
Caesarean
Vaginal
All
23/42
18/38
41/80
12/21
7/29
19/50
No of deaths
first twin/second twin
0.25 0.5 1 2 4 8
Odds ratio of death of second twin
Method of delivery
Fig 2 | Odds ratio for perinatal death related to delivery of
second twin at term gestation for all deaths and deaths
causedbyanoxia, stratifiedbymethodofdelivery.Numbers of
deaths are actual numbers of losses of first and second twins,
confined to births where the other twin survived (excludes
cases with missing record of method of delivery)
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where the baby was stillborn but the timing of death in
relation to the onset of labour was documented as
“unknown” (n=179). The results were similar to the
main dataset, with a significant interaction between
birth order and gestational age (P<0.001) and no sig-
nificant association between birth order and the risk of
death at preterm gestations but a significantly
increased risk of all cause death for the second twin at
term (2.3, 1.8 to 3.0) and for death caused by anoxia
(3.3, 2.1 to 5.0).
DISCUSSION
In this retrospective cohort study we found an
increased risk of death of second twins compared
with first twins born at term in England, Northern Ire-
land, and Wales, 1994-2003. There was an interaction
between the effect of birth order and gestational age.
There was no association between birth order and the
risk of death among infants born at preterm gestations,
but we found a strong association between birth order
and the risk of death at term. The interaction between
birth order and gestational age is unlikely to be a
chance finding. Firstly, it was highly significant
(P<0.001). Secondly, we had previously observed
such an interaction in another population,2 and the pre-
sence of an interaction was a prior hypothesis. Thirdly,
it is biologically plausible. The risk of death at term is
low and a small absolute risk of complications for the
second twinwill result in amuch greater relative risk of
death (when compared with the first twin) than at pre-
term gestations, where the background risk of death is
high for both.2 The association between birth order
and the risk of perinatal death at term was stronger
for deaths attributed to intrapartum anoxia. These
findings clearly show an increased risk for death of
the second twin delivered at term, principally because
of complications of labour and delivery.
Comparison with other research
A previous observational study found a lower risk of
death of either twin with planned caesarean delivery.3
Consistent with this, the risk of anoxic death of the sec-
ond twin was lower among those delivered by caesar-
ean section than those delivered vaginally, although
not significantly so. The data source we used was con-
fined to infants who died so we did not know how the
surviving twin had been delivered. In some cases
where the second twin died after a caesarean delivery,
the first twin may have been delivered vaginally. This
delivery combination is known to increase the risk of
death for the second twin.9 10 It is likely, therefore, that
the protective effect of caesarean delivery would be
greater than our results suggest. The number of
planned caesarean sections in the present analysis
was too small to confirm or exclude a significant asso-
ciation between birth order and the risk of perinatal
death with this method of delivery.
A large scale study of US birth and death certifica-
tions (1995-7) published in 2004 found no significant
difference in the risk of neonatal death among second
twins.4 The analysis, however, had several weaknesses
—namely, the failure to use paired statistical compar-
ison of first and second twins, the known shortcomings
of the US birth and death certification databases,11 12
and stratification by birth weight rather than gesta-
tional age. Moreover, other analyses of the same data
source suggested an increased risk of death of the sec-
ond twin related to delivery: the risk of neonatal death
of the second twin was lower when both babies were
delivered by caesarean section compared with those
delivered vaginally.9 10 The US data also lack informa-
tion on whether death of the infant occurred before or
during labour and cannot, therefore, address the effect
of birth order on the risk of intrapartum stillbirth. The
strengths of our study are the use of more appropriate
statistical methods and that data were available for a
large number of losses, including detailed information
on both the timing and cause of perinatal death.
Our results are consistent with those of several pre-
vious studies of birth order and perinatal morbidity.
These have shown an increased risk of a depressed
five minute Apgar score in the second twin.5 13 We
found no association between birth order and the risk
of perinatal death at preterm gestations, whereas other
studies have shown an increased risk of fetal distress or
morbidity for second twins born preterm.13 Our inter-
pretation of these findings is that labour and delivery
are associated with risks to the second twin at all gesta-
tions. Themajor determinant of perinatal death at pre-
term gestations, however, is the degree of prematurity.
Hence, a small additional risk to the second twin dur-
ing vaginal birth has no significant effect on the relative
risk of death, except at term.Other studieswith data on
both twins have identified risk factors for death of the
second twin, includingdiscordant birthweights,2 deliv-
ery by a means other than planned caesarean section,3
operative vaginal delivery of the first twin (when com-
pared with spontaneous vaginal delivery of the first
twin),14 and a prolonged interval between delivery of
the first twin and delivery of the second.13
The findings of this and other studies suggest that
planned caesarean section may be beneficial for all
twins. Direct evidence for a protective effect of caesar-
ean section would require a randomised controlled
trial, although statistical power might be a problem.2
This and previous studies have important lessons for
any randomised controlled trial of planned caesarean
WHAT IS ALREADY KNOWN ON THIS TOPIC
Vaginal delivery of the second twin is recognisedasa timeof
high risk
Recent studies of the effect of birth order on the risk of
perinatal death have produced inconsistent results
WHAT THIS STUDY ADDS
There was no association between birth order and the
relative risk of perinatal death related to delivery among
preterm twins
At term, the second twin had a greater than twofold risk of
perinatal death related to delivery and a greater than
threefold risk of death caused by intrapartum anoxia
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section for all twin pregnancies. Inclusion of preterm
birthsmaymask a protective effect of caesarean section
on perinatal mortality if the principal effect of caesar-
ean section is to reduce the risk of complications for the
second twin. Moreover, this and previous studies
showed that it is a minority of all perinatal deaths of
twins that are related to complications during labour
and delivery. Failure to exclude losses that are largely
independent of method of delivery, including antepar-
tum stillbirth anddeaths causedby congenital abnorm-
ality or prematurity, may mask a protective effect of
caesarean delivery.
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SHORT COMMUNICATION
Estimating human fetal blood volume on the basis of gestational
age and fetal abdominal circumference
Gordon C.S. Smith*, Alan D. Cameron
Introduction
Intravascular transfusion of the human fetus is now a
standard procedure for the management of fetal anaemia
both due to allo-immunisation and parvovirus infection.
The volume of blood required to correct a given degree of
anaemia depends on the fetal blood volume as well as the
severity of the anaemia. While the latter can be measured
directly at the time of cordocentesis, the fetal blood volume
is estimated on the basis of an empirically derived equation
using the relationship between the volume of blood per
kilogram of weight at each week of gestation and assuming
that the fetus is on the 50th percentile of weight for the
given gestational age1. In the present study, we sought to
test the hypothesis that combining gestational age with an
ultrasonic estimate of fetal weight might improve the
ability to predict fetal blood volume and thus the post-
transfusion haematocrit (Hct).
Methods
Inclusion criteria
Over the period 1992–2000, we obtained case records of
pregnancies where fetal intrauterine transfusion had been
performed in our unit in the management of fetal anaemia
secondary to allo-immunisation. From these records, trans-
fusion details were obtained where an ultrasound scan
performed within seven days of the transfusion had
recorded an abdominal circumference (measured using
standard techniques2) and the baby was not affected by
hydrops. We identified a total of 280 transfusions in 91
pregnancies where these criteria were met and where the
donor, pre- and post-transfusion Hct, and volume of donor
blood transfused had been recorded. The criteria were met
and complete data were available for approximately 80% of
the procedures.
Clinical procedure
Fetal blood transfusions were only included where the
blood was administered through an intravascular route
(usually the umbilical vein). The Hct prior and following
transfusion was estimated from a 2-mL sample using a
Coulter counter.
Analysis
The estimated blood volume (EBV) in millilitres (mL)
was calculated from the following equation1:
EBV ¼ ðDonVol  ðDonHct  PostHctÞ þ 2
 ðPostHct  PreHctÞÞ=ðPostHct  PreHctÞ
ð1Þ
where: DonVol ¼ volume of donor blood transfused;
DonHct ¼ Hct of donor blood; PreHct ¼ Hct preceding
transfusion; PostHct ¼ Hct following transfusion.
Regression equations were then constructed to estimate
the blood volume from the gestational age and/or the
abdominal circumference in a randomly selected subset
of 154 transfusions. The ability of these equations to
predict post-transfusion Hct was then compared with the
Nicolaides et al.’s equation1 in the remaining 126 cases.
Statistical analysis was performed using Stata version 6.0
for the PC.
Results
In a sample of 154 cases, regression analysis was
performed to derive equations which would predict the
fetal blood volume on the basis of (1) gestational age, (2)
abdominal circumference, and (3) gestational age and the
BJOG: an International Journal of Obstetrics and Gynaecology
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abdominal circumference. Preliminary analysis demonstra-
ted that the relationship between both gestational age and
abdominal circumference was linear. On the basis of these
equations, the post-transfusion Hct on a further 126 cases
was predicted. The difference (unsigned) between the
actual post-transfusion Hct in the 126 cases and the value
predicted from regression equations derived from the other
154 cases was compared. The magnitude of the difference
was virtually identical when the equation was based on
gestational age alone (median difference ¼ 1.60 [interquar-
tile range 0.78–3.07]), abdominal circumference alone
(1.76 [0.90–3.31]), both gestational age and abdominal
circumference (1.62 [0.75–3.24]), or when the post-trans-
fusion Hct was estimated using the Nicolaides et al.
equation1 (1.74 [0.72–3.26]). The differences were vir-
tually identical when gestational age and abdominal cir-
cumference were modelled as second-order polynomials
(data not shown).
Equations were then derived from the whole population
to predict fetal blood volume from the gestational age
(Fig. 1A) or from the fetal abdominal circumference
(Fig. 1B).
Discussion
The principle aim of the present study was to determine
whether incorporation of an ultrasonic index of fetal size
improved the empirical prediction of fetal blood volume.
We found that a model combining abdominal circumference
and gestational age did not result in a better prediction of the
post-transfusion Hct than using either parameter on its own.
In practice, most cases with Rhesus allo-immunisation in
the UK will have an accurate estimate of gestational age
based on early ultrasound. However, in the event that a
women books late for antenatal care and requires fetal blood
transfusion, we suggest that the equation described in
Fig. 1B should provide a similar level of accuracy to current
methods for estimating post-transfusion Hct. Finally,
current methods for estimating the amount of blood to
transfuse require the use of standard curves. We propose
the following simple spreadsheet equations to estimate the
volume of blood required using gestational age alone:
ððE  AÞ=ðB  EÞÞ  ðF  DÞ ð2Þ
In cases where the gestational age is not known with
certainty, the following equation allows the volume of
blood required for transfusion on the basis of the abdominal
circumference alone:
ððE  AÞ=ðB  EÞÞ  ðH  DÞ ð3Þ
where: A ¼ pre-transfusion Hct (%); B ¼ Hct of donor
blood (%); C ¼ gestational age (weeks); D ¼ sample
volume (mL); E ¼ target Hct (typically 40%—allows for
overtransfusion); F ¼ estimated fetal blood volume (mL)
on the basis of gestational age ¼ (11.2C)  209.4; G ¼
abdominal circumference (mm); H = estimated fetal blood
volume (mL) on the basis of abdominal circumference ¼
(0.95G)  123.4.
These equations should only be used when the gesta-
tional age is between 21 and 35 weeks (Equation 2) or
where the abdominal circumference is between 160 and
340 mm (Equation 3) and there is no hydrops.
References
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fetoplacental blood volume in erythroblastosis fetalis. Am J Obstet
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Fig. 1. Linear regression analysis of relationship between estimated fetal
blood volume (EFBV) at the time of intrauterine transfusion and (A)
gestational age in weeks and (B) fetal abdominal circumference. Equations:
(a) EFBV ¼ (11.2GA)  209.4; (b) EFBV ¼ (0.95AC)  123.4, where
EFBV is measured in millilitres, gestational age is measured in completed
weeks, and abdominal circumference is measured in millimetres.
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BSTRACT
 
Background
 
Previous studies have demonstrated
a correlation between first-trimester size and birth
weight. It is not known, however, whether low birth
weight is related to first-trimester growth. We sought
to determine whether the risk of low birth weight
and birth weight that was low for gestational age is
related to the size of the embryo or the fetus in the
first trimester.
 
Methods
 
From a data base of ultrasound records
of more than 30,000 pregnancies, we identified wom-
en who had no important medical problems, a normal
menstrual history, and a first-trimester ultrasound
scan in which the crown—rump length of the embryo
or fetus had been measured. We examined the rela-
tion between the outcome of 4229 pregnancies and
the difference between the measured and the ex-
pected crown—rump length in the first trimester, ex-
pressed as equivalent days of growth.
 
Results
 
A first-trimester crown—rump length that
was two to six days smaller than expected was asso-
ciated with an increased risk (as compared with a
normal or slightly larger than expected crown—rump
length) of a birth weight below 2500 g (relative risk,
1.8; 95 percent confidence interval, 1.3 to 2.4), a birth
weight below 2500 g at term (relative risk, 2.3; 95
percent confidence interval, 1.4 to 3.8), a birth weight
below the fifth percentile for gestational age (relative
risk, 3.0; 95 percent confidence interval, 2.0 to 4.4),
and delivery between 24 and 32 weeks of gestation
(relative risk, 2.1; 95 percent confidence interval, 1.1
to 4.0), but not with delivery between 33 and 36
weeks (relative risk, 1.0; 95 percent confidence inter-
val, 0.7 to 1.5).
 
Conclusions
 
Suboptimal first-trimester growth may
be associated with low birth weight, low birth-
weight percentile, and premature delivery. (N Engl J
Med 1998;339:1817-22.)
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OW birth weight (less than 2500 g) and
birth weight that is low for gestational age
are associated with increased perinatal mor-
bidity and mortality,
 
1
 
 short- and long-term
childhood morbidity and mortality,
 
2,3
 
 and a range of
cardiovascular and metabolic diseases in later life.
 
4
 
Consequently, the factors determining birth weight
(other than gestational age) have been the focus of
intense study for many years, and the risk factors for
low birth weight at term have been reviewed in
detail.
 
5
 
It has previously been suggested that variations in
fetal size are largely determined in the second half of
L
 
pregnancy.
 
6
 
 However, a 1993 study demonstrated
a correlation between first-trimester crown—rump
length and birth weight.
 
7
 
 We tested the hypothesis
that a smaller-than-expected crown—rump length in
the first trimester is associated with low birth weight
and birth weight that is low for gestational age.
 
METHODS
 
Source of Data
 
The results of all ultrasound scans obtained between 1985 and
1995 at the Queen MotherÕs Hospital, Glasgow, United King-
dom, were entered into a computer data base along with details
of the womenÕs medical, gynecologic, and obstetrical history,
antenatal complications, and pregnancy outcome. The data base
included all pregnant women referred for antenatal care, because
all underwent ultrasonography at their first antenatal visit. 
Over the 10-year period, 31,269 embryos or fetuses with a
known date of delivery were scanned at least once. The gestation-
al age at delivery was recorded for 31,259, and birth weight was
recorded for 30,789. Of the 480 infants for whom birth weight
was missing, 460 were delivered at less than 24 weeks.
We excluded pregnancies in which any of the following was
present or had occurred: a history of rhesus isoimmunization
(279 cases), essential hypertension (324 cases), cardiac disease
(128 cases), type 1 diabetes mellitus (115 cases), other medical
problems (992 cases), nonviable embryo or fetus at first scanning
(115 cases), amniocentesis (1259 cases), chorionic-villus sam-
pling (929 cases), multiple pregnancy (364 cases), antenatal de-
tection of fetal abnormality (515 cases), therapeutic termination
of pregnancy (224 cases), postnatal detection of fetal abnormality
(560 cases), intrauterine contraceptive device seen on ultrasonog-
raphy (42 cases), and second sac seen on ultrasonography (85
cases). There were a total of 4568 exclusions (some cases had
multiple reasons for exclusion).
The crown—rump length was measured by the sonographer us-
ing electronic calipers on a frozen image on a monitor.
 
8
 
 The
crown—rump length was converted to the equivalent number of
days of gestational age on the basis of the following equation:
The equation had been previously derived at the Queen MotherÕs
Hospital with static ultrasonography
 
9
 
 and subsequently validated
with real-time scanners (both transabdominal
 
10
 
 and transvagi-
nal
 
11,12
 
). It is currently recommended by the British Medical Ul-
trasound Society for first-trimester estimation of gestational age.
 
8
 
The scans analyzed in the present study were obtained by real-
time ultrasonography with several machines; the majority were
transabdominal scans through a full urinary bladder.
gestational 
age in days= 8.052
 
Ö
 
crown—rump length in millimeters +23.73.
Page 231
 1818
 
Æ
 
December 17, 1998
 
The New England Journal  of  Medicine
 
The inclusion criteria based on the ultrasonographic record
were a single viable embryo or fetus present when the first ultra-
sound scan was obtained and a crown—rump length at the time
of this scan that was less than the expected size in women who
had had amenorrhea for 13 weeks. These criteria were fulfilled by
11,314 of the 26,701 nonexcluded cases.
The inclusion criteria from the menstrual history were that
there was a date recorded for the first day of the last menstrual
period and that it was recorded as certain, that the woman had
not taken an oral contraceptive in the preceding 3 months, and
that she had a regular 28-day menstrual cycle. Of the 11,314
women with no exclusion criteria who had an early ultrasound
scan, 4229 fulfilled the menstrual inclusion criteria and had had
their infantsÕ birth weights recorded.
 
Analysis of the Data
 
The aim of the analysis was to relate first-trimester growth to
the outcome of the pregnancy. The difference between the actual
and predicted crown—rump length was expressed in days of ges-
tation Ñ that is, the estimated age in postmenstrual days accord-
ing to crown—rump length minus the number of days of amen-
orrhea (i.e., the number of days since the beginning of the last
menstrual period). A negative difference indicated an embryo (up
to eight weeks of postconception age) or a fetus (after eight weeks
of postconception age) that was smaller than expected. In preg-
nancies with a known date of conception through in vitro fertil-
ization, the crown—rump length expressed in this way has 95 per-
cent confidence intervals of approximately five to six days of
postconception age in the first trimester.
 
13
 
 Therefore, our analysis
focused on the 3397 embryos and fetuses in which the difference
was between `6 and +6 days, because larger differences were un-
likely to be due to variations in growth. Similarly, in the manage-
ment of these pregnancies, the estimated gestational age was only
altered on the basis of the crown—rump length when the differ-
ence was outside this range. Variation outside this range is pre-
sumably due to deviation of the time of ovulation from the as-
sumed day 14 or to incorrect recollection of the menstrual
history. A normal crown—rump length was defined as a value one
day or less above or below the expected value (`1 to +1), be-
cause this is approximately equivalent to the standard deviation of
repeated measurements in the first trimester.
 
9
 
Low birth weight was defined as birth weight below 2500 g,
and low birth weight at term was defined as birth weight below
2500 g at 37 or more weeks of gestation. Birth weight was also
classified as above or below the fifth percentile for gestational age.
Term was defined as at least 37 weeks of gestation, and preterm
deliveries were subdivided into two groups Ñ those at 24 to 32
weeks of gestation and those at 33 to 36 weeks of gestation.
 
Measurement of Maternal Serum Alpha-Fetoprotein
 
Maternal serum alpha-fetoprotein was measured between 15
and 20 weeks of gestation and quantified as multiples of the me-
dian for a given gestational age.
 
14
 
 These values were not corrected
for maternal stature, since the data base contained only the ana-
lyte values.
 
Birth-Weight Percentiles
 
The birth-weight percentiles we used were derived from
120,250 live births in Scotland before 1985. A description of the
collection and analysis of data on 55,387 live births between
1975 and 1979 has been published.
 
15
 
Statistical Analysis
 
Numerical data were summarized as medians and interquartile
ranges, and groups were compared with the Mann—Whitney
U test. Proportions were compared with use of FisherÕs exact test
(two-tailed) and relative risks and 95 percent confidence intervals.
The effect of multiple variables on dichotomous outcomes was
analyzed by logistic-regression analysis. Statistical analysis was
performed with the Stata software package (release 5.0 for Win-
dows NT, Stata, College Station, Tex.).
 
RESULTS
 
The distribution of the differences between the
values for observed and expected crown—rump
length was skewed toward negative values: the mode
was 0 days, the median was `1 day, and the inter-
quartile range was `4 to 0 days. When the compar-
ison was made between embryos or fetuses that were
smaller than expected, approximately as large as ex-
pected, and larger than expected, there were signifi-
cant differences in the proportions of infants with
low birth weight (<2500 g), low birth weight at
term (<2500 g at 37 or more weeks), birth weight
below the fifth percentile for gestational age, deliv-
ery between 24 and 32 weeks, and birth weight
greater than 4000 g (Table 1). The association be-
tween smaller-than-expected crown—rump length
and low birth weight was significant in pregnancies
with values of `7 to `2 for the number of days of
difference between observed and expected length
(Fig. 1).
The proportions with these outcomes in the
groups with larger-than-expected (+2 to +6 days)
and normal (`1 to +1 day) crown—rump lengths
were similar (Table 1). These two groups were there-
fore pooled to form the reference group. As com-
pared with this group, embryos or fetuses with a
smaller-than-expected crown—rump length (`6 to
`2 days) had an increased risk of low birth weight,
low birth weight at term, birth weight below the
fifth percentile for gestational age, and delivery be-
tween 24 and 32 weeks, but not delivery between
33 and 36 weeks (Table 2). The associations were
still significant when gestational age at delivery was
calculated from the crown—rump length rather than
from the last menstrual period (Table 2). The rela-
tive risks were of similar magnitude and statistical
significance when the normal group (`1 to +1 day)
was used as the reference group.
A smaller-than-expected crown—rump length was
associated with an increase of borderline significance
in the risk of an elevated maternal serum alpha-
fetoprotein concentration in the second trimester
(P=0.09) (Table 2). An elevated maternal serum
alpha-fetoprotein concentration was significantly
associated with low birth weight, low birth weight
at term, and premature delivery among embryos
or fetuses with smaller-than-expected crown—rump
lengths (Table 3).
A smaller-than-expected crown—rump length was
associated with several other potential risk factors
for low birth weight (Table 4). Furthermore, the
proportion of embryos or fetuses with smaller-than-
expected crown—rump lengths was slightly higher
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*Crown—rump length was expressed as equivalent days of growth. Smaller than expected was `6
to `2 days, normal `1 to +1 day, and larger than expected +2 to +6 days.
 P values are for the comparison of proportions in the three groups by FisherÕs exact test. Gesta-
tional age at delivery was calculated from the last menstrual period. 
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% (no. with outcome/no. without outcome)
 
Birth weight <2500 g 6.4 (83/1206) 3.5 (53/1461) 4.0 (24/570) 0.001
Birth weight <2500 g 
at ¨37 wk
2.9 (38/1251) 1.3 (20/1494) 1.2 (7/587) 0.004
Birth weight <5th percentile 5.0 (65/1224) 1.6 (24/1490) 2.0 (12/582) <0.001
Birth weight >4000 g 9.2 (119/1170) 11.5 (174/1340) 12.8 (76/518) 0.04
Delivery at 24—32 wk 1.7 (22/1267) 0.7 (11/1503) 1.0 (6/587) 0.05
Delivery at 33—36 wk 3.9 (50/1239) 3.6 (55/1459) 3.9 (23/570) 0.93
 
Figure 1.
 
 Proportion of Infants with Birth Weights of Less Than 2500 g According to the Difference between
Observed and Expected First-Trimester Crown—Rump Lengths.
P values are for the comparison with the group with normal crown—rump length (`1 to +1 day) by FisherÕs
exact test (two-tailed). The proportion of infants with low birth weight in the pooled group for whom the
difference was `9 to +6 days was not significantly different from the proportion of infants for whom the
difference was less than `9 days (32 of 492; P=0.12) or greater than +6 days (2 of 63; P=0.77). The crown—
rump length was expressed as equivalent days of growth.
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for scans performed before the 10th week of amen-
orrhea than for scans performed later: 42 percent
(261 of 622) as compared with 37 percent (1028 of
2775) (P=0.02). However, the relations between
first-trimester growth and these outcomes were still
significant in multivariate logistic-regression analyses
that included a number of other risk factors and ear-
ly ultrasound studies as covariates (Table 5).
 
DISCUSSION
 
The central findings of our study are that there is
a significant relation between smaller-than-expected
size in the first trimester and low birth weight
(<2500 g), birth weight that is low for gestational
age, and extremely premature delivery (24 to 32
weeks) among otherwise normal babies. Restricted
growth of the embryo or fetus in very early preg-
 
*Crown—rump length was expressed as equivalent days of growth. Smaller than expected was `6 to `2 days, and
normal or larger than expected `1 to +6 days. 
 CI denotes confidence interval. 
àP values are for the comparison between groups by a two-tailed FisherÕs exact test.
⁄Testing of alpha-fetoprotein was optional; 82 percent of the patients elected to have the test performed. 
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no. with outcome/
no. without outcome
 
Birth weight <2500 g 83/1206 77/2031 1.8 (1.3—2.4) <0.001
Birth weight <2500 g at ¨37 wk according to last menstrual 
period
38/1251 27/2081 2.3 (1.4—3.8) <0.001
Birth weight <2500 g at ¨37 wk according to crown—rump 
length
33/1256 26/2081 2.1 (1.2—3.5) 0.006
Birth weight <5th percentile according to last menstrual period 65/1224 36/2072 3.0 (2.0—4.4) <0.001
Birth weight <5th percentile according to crown—rump length 45/1244 42/2066 1.8 (1.2—2.7) 0.01
Alpha-fetoprotein >2´ median⁄ 41/1050 44/1657 1.5 (1.0—2.2) 0.09
Emergency cesarean section 120/1169 204/1904 1.0 (0.8—1.2) 0.76
Perinatal death 3/1286 6/2102 0.8 (0.2—3.3) 1.0
Delivery at 24—32 wk according to last menstrual period 22/1267 17/2090 2.1 (1.1—4.0) 0.02
Delivery at 24—32 wk according to crown—rump length 23/1266 17/2091 2.2 (1.2—4.1) 0.01
Delivery at 33—36 wk according to last menstrual period 50/1239 78/2029 1.0 (0.7—1.5) 0.78
*AFP denotes maternal serum alpha-fetoprotein, RR relative risk, and CI confidence interval. Crown—rump length was
expressed as equivalent days of growth. Smaller than expected was `6 to `2 days, and normal or larger than expected
`1 to +6 days. An elevated alpha-fetoprotein level was defined as a level more than two times the median.
 P values are for the comparison between groups by a two-tailed FisherÕs exact test. 
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Birth weight <2500 g 8/33 58/992 3.5 (1.8—6.9) 0.002 2/42 64/1593 1.2 (0.3—4.7) 0.69
Birth weight <2500 g 
at ¨37 wk
4/37 24/1026 4.3 (1.6—11.7) 0.02 1/43 25/1632 1.5 (0.2—10.9) 0.50
Delivery at 24—32 wk 3/38 15/1035 5.1 (1.5—17.0) 0.03 1/43 13/1644 2.9 (0.4—21.7) 0.31
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nancy may be causally related to these outcomes.
However, given the highly selected nature of the
pregnancies in which these measurements can be
made, the proportion of these outcomes that might
be attributed to first-trimester growth in the general
population is not known.
In our study, unlike studies of conceptions by
means of in vitro fertilization, the exact postconcep-
tion age at the time of ultrasonography was un-
known. The size of the embryo or fetus in the first
trimester may also differ from the expected size be-
cause of variation in the timing of ovulation. If ovu-
lation occurred on day 17 and was followed by nor-
mal conception, implantation, and growth, the fetus
would be the equivalent of 3 days smaller than would
be expected if ovulation had taken place on day 14.
If this fetus was then born 41 weeks after the last
menstrual period, gestational age would be the post-
conception equivalent of 40 weeks and 4 days, but
the infantÕs birth weight would be judged by the 41-
week percentile. However, the relations of a smaller-
than-expected crown—rump length with low birth
weight at term and birth weight below the fifth per-
centile were still significant when gestational age at
delivery was calculated from the crown—rump length.
We found that the risk of low birth weight was
lowest among embryos or fetuses with a normal or
larger-than-expected crown—rump length (difference
from expected of `1 to +6 days). The risk of low
birth weight was increased when the difference be-
tween the observed and expected crown—rump length
was `7 to `2 days. Outside this range, the risk of
low birth weight was similar to the average for the
whole group. We interpret this pattern to mean that
when the differences between observed and expect-
ed crown—rump length are large, the measurement
gives little information about the growth of the em-
bryo or fetus, because large differences are most
likely due to an incorrectly estimated postconcep-
tion age that largely obscures the variation related to
growth.7,13 Therefore, the risk of low birth weight
is similar to the average. In groups with moderately
negative values (`7 to `2 days), there is a greater
proportion of cases in which the embryo or fetus is
smaller than expected because of below-average
growth, and therefore the risk of low birth weight is
higher. However, as the difference between the ob-
served and expected sizes nears zero and then be-
comes positive, the proportion of cases in which the
growth of the embryo or fetus is suboptimal is small-
er, and therefore the risk of low birth weight is lower.
The distribution of the difference between ob-
served and expected crown—rump length was skewed
toward negative values. This is unlikely to be due to
an error in the equation used, since the mode of the
difference was zero, and 36 percent of measure-
ments were within –1 day of the estimated value.
The skewing is more likely to be due to a skewing
*Crown—rump length was expressed as equivalent days of growth.
Smaller than expected was `6 to `2 days, and normal or larger than ex-
pected `1 to +6 days.
 Medians were compared by the Mann—Whitney U test, and proportions
by FisherÕs exact test (two-tailed).
TABLE 4. FREQUENCY OF POSSIBLE RISK FACTORS FOR LOW BIRTH 
WEIGHT AND LOW WEIGHT FOR GESTATIONAL AGE ACCORDING 
TO THE DIFFERENCE BETWEEN OBSERVED AND EXPECTED 
FIRST-TRIMESTER CROWN—RUMP LENGTHS.
RISK FACTOR CROWN—RUMP LENGTH*
P
VALUE 
SMALLER 
THAN
EXPECTED
(N=1289)
NORMAL OR
LARGER THAN
EXPECTED
(N=2108)
median (interquartile range)
MotherÕs age (yr) 28 (25—31) 27 (24—30) <0.001
Gestational age at time of 
ultrasound scan (days)
According to last 
menstrual period
According to crown—
rump length
83 (72—89)
79 (74—87)
81 (73—86)
82 (74—87)
<0.001
<0.001
Parity 1 (0—1) 1 (0—1) 0.17
No. of previous spon-
taneous abortions
0 (0—0) 0 (0—0) 0.77
No. of previous thera-
peutic abortions
0 (0—0) 0 (0—0) 0.74
% (no.)
MotherÕs age, <20 yr 5.2 (67) 3.3 (69) 0.007
MotherÕs age, >40 yr 0.0 (0) 0.2 (5) 0.16
Mother nulliparous 48.3 (622) 45.2 (952) 0.08
Parity >3 1.8 (23) 1.7 (36) 0.89
Bleeding
1st trimester
2nd trimester
3rd trimester
10.9 (141)
3.2 (41)
5.2 (67)
9.0 (189)
2.6 (55)
4.6 (98)
0.06
0.34
0.51
Pregnancy-induced
hypertension
10.9 (141) 11.1 (235) 0.87
Elective delivery 28.7 (370) 23.3 (491) <0.001
Male infant 49.4 (637) 52.2 (1101) 0.11
*The logistic-regression models included age; parity; previous sponta-
neous abortions; previous therapeutic abortions; bleeding in the first, sec-
ond, and third trimesters; pregnancy-induced hypertension; elective deliv-
ery; fetal sex; and ultrasound scanning before 10 weeks. The adjusted
odds ratio associated with a smaller-than-expected crown—rump length
(difference from expected, `6 to `2 days) is with reference to the pooled
group with either normal crown—rump length (`1 to +1 day) or a larger-
than-expected crown—rump length (+2 to +6 days). CI denotes confi-
dence interval.
TABLE 5. ADJUSTED ODDS RATIOS FOR ADVERSE OUTCOMES 
ASSOCIATED WITH A SMALLER-THAN-EXPECTED
CROWN—RUMP LENGTH.*
OUTCOME
ADJUSTED ODDS RATIO
(95% CI)
P
VALUE
Birth weight <2500 g 1.7 (1.2—2.3) 0.002
Birth weight <2500 g at ¨37 wk 2.1 (1.3—3.5) 0.004
Birth weight <5th percentile 2.8 (1.9—4.3) <0.001
Delivery at 24—32 wk 2.0 (1.1—4.0) 0.03
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in the timing of ovulation toward the second half of
the cycle.16 It may also be related to skewing in the
distribution of embryonic or fetal size toward small
stature.
The prediction of adverse outcome by a smaller-
than-expected crown—rump length was additive with
the predictive power of a high maternal serum alpha-
fetoprotein concentration in the second trimester
(Table 3). The apparent lack of a significant relation
between maternal serum alpha-fetoprotein concen-
trations and adverse outcomes in cases involving
normal or larger-than-expected crown—rump lengths
may be due to the small number of adverse out-
comes in this group.
If there is a causal relation between poor first-tri-
mester growth and low birth weight, it may be that
a suboptimal environment in the first trimester lim-
its fetal growth for the remainder of pregnancy. Al-
ternatively, poor growth in the first trimester may be
secondary to a disorder of placentation that is man-
ifested throughout pregnancy by suboptimal trans-
fer of nutrients to the fetus. It also seems likely that
some fetuses may be physiologically small through-
out pregnancy.
The association between a smaller-than-expected
crown—rump length and delivery between 24 and
32 weeks, but not between 33 and 36 weeks, is con-
sistent with the hypothesis that the pathophysiology
of extremely premature delivery may be different
from that of moderately premature delivery.17 Fur-
thermore, it suggests that in at least a proportion of
cases, extremely premature delivery may be the re-
sult of a chronically suboptimal intrauterine envi-
ronment, a possibility that is consistent with the re-
sults of other studies of the causes of premature
delivery.18
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Background
Physiological and biochemical studies suggest that normal parturition at term is 
dependent on programmed development of the uterus in early pregnancy. It is rec-
ognized that a short cervix in mid-pregnancy is associated with an increased risk 
of spontaneous preterm birth. We hypothesized that a long cervix in mid-preg-
nancy would be associated with an increased risk of cesarean delivery during labor 
at term.
Methods
We studied 27,472 primiparous women who had a cervical length of 16 mm or more 
at a median of 23 weeks of gestation and who ultimately delivered a live infant in 
labor at term.
Results
The rate of cesarean delivery at term was lowest (16.0%) among women with a mid-
pregnancy cervical length in the lowest quartile (16 to 30 mm) and was signifi-
cantly greater in the second quartile (18.4%, 31 to 35 mm), third quartile (21.7%, 
36 to 39 mm), and fourth quartile (25.7%, 40 to 67 mm) (P<0.001 for trend). The 
odds ratio for cesarean delivery among women in the fourth quartile, as compared 
with the first quartile, was 1.81 (95% confidence interval [CI], 1.66 to 1.97), and the 
odds ratio adjusted for maternal age, body-mass index, smoking status, race or 
ethnic group, gestational age at birth, spontaneous or induced labor, birth-weight 
percentile, and hospital of delivery was 1.68 (95% CI, 1.53 to 1.84; P<0.001). The 
increased risk of cesarean delivery was attributable to procedures performed for 
poor progress in labor.
Conclusions
The cervical length at mid-pregnancy is an independent predictor of the risk of 
cesarean delivery at term in primiparous women.
Copyright © 2008 Massachusetts Medical Society. All rights reserved. 
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Rates of cesarean delivery have in-creased dramatically throughout the de-veloped world in recent years.1 This trend 
has recently increased because of declining rates 
of vaginal birth after cesarean delivery.1 With the 
decrease in vaginal birth after cesarean delivery, 
the rate of primary cesarean delivery will become 
an even more important determinant of overall 
cesarean rates. The major cause of primary ce-
sarean delivery is poor progress during labor 
(dystocia).2 A number of risk factors for such 
poor progress have been identified, such as ad-
vanced maternal age,3 obesity,4 and delivery after 
40 weeks of gestation.5 However, the biologic 
mechanisms that lead to poor progress during 
labor are poorly understood.
Studies of parturition in animals suggest that 
preparation for labor is evident at relatively early 
stages of gestation.6,7 In women, it is well rec-
ognized that the cervix undergoes preparative 
changes in the weeks before the onset of labor8 
and also that a short cervix in mid-pregnancy is 
associated with an increased risk of spontaneous 
preterm birth.9 We conducted a study to determine 
whether the length of the cervix in mid-preg-
nancy was associated with the risk of intrapar-
tum cesarean delivery at term among primipa-
rous women.
Me thods
The data analyzed in our study were obtained as 
part of multicenter studies of screening and in-
tervention during pregnancy, conducted between 
1998 and 2006, at eight hospitals in and around 
London: Basildon Hospital, Basildon; Queen Eliz-
abeth Hospital, Woolwich; Harold Wood Hospi-
tal, Romford; King George Hospital, Ilford; King’s 
College Hospital, London; Queen Mary’s Hospi-
tal, Sidcup; University Hospital, Lewisham, Lon-
don; and Southend University Hospital, Essex. 
Women recruited to the studies underwent trans-
vaginal ultrasonography, including assessment of 
cervical length and uterine-artery Doppler flow 
velocimetry, between 22 and 24 weeks of gesta-
tion. Women with a short cervix (15 mm or less 
in length) recruited between January 1998 and 
May 2002 were offered participation in a trial of 
cervical cerclage, and those recruited between 
September 2003 and May 2006 were offered par-
ticipation in a trial of vaginal administration of 
progesterone. Between January 2001 and July 
2002, women with a mean pulsatility index of 1.6 
or more (representing approximately the top 5% 
of values in the general population, with increas-
ing values indicating decreasing diastolic veloci-
ty, a measure of placental impedance to blood 
flow) were offered participation in a trial of low-
dose aspirin as prophylaxis for preeclampsia. 
The details of these trials are reported else-
where.10-12
Measurements of cervical length were per-
formed with the use of transvaginal ultrasono-
graphic images13 by ultrasonographers trained 
in these methods. Quality control of the screen-
ing, handling of data, and verification of adher-
ence to protocols at the various centers was 
performed on a regular basis by the trial coordi-
nators. Clinical details and medical and obstet-
rical histories were obtained during face-to-face 
interviews with the mothers that were conducted 
by a research obstetrician using a structured 
questionnaire.
The inclusion criteria for the current analysis 
were that the women were primiparous, had a 
cervical-length measurement performed, and ul-
timately delivered at term. We excluded women 
who had a stillbirth or therapeutic abortion, 
women whose cervical length was 15 mm or less, 
and women whose infants were delivered by pre-
labor cesarean section. Hence, all women ran-
domly assigned to either the control group or 
the interventional group of the cervical-cerclage 
trial or the progesterone trial were excluded 
from the present study.
The outcome of each pregnancy was obtained 
from the computerized delivery records in each 
participating hospital. This information included 
data on the mode of delivery, the gestational age 
at birth, whether the patient was in labor, wheth-
er the onset of labor was spontaneous or induced, 
and the indications for operative delivery. Out-
come data for the infant were also recorded, in-
cluding whether the birth was a live birth or 
stillbirth, the birth weight, and the sex. The data 
were entered into the computer soon after deliv-
ery by the attending midwife or obstetrician. The 
primary outcome was cesarean delivery performed 
during labor at term. We performed subgroup 
analyses on the basis of whether the indication 
or indications for cesarean delivery recorded in 
the computerized medical records included a 
failure to progress in labor.
These studies were approved by the South 
Copyright © 2008 Massachusetts Medical Society. All rights reserved. 
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Thames Multicenter Research Ethics Commit-
tee, as well as the local ethics committees of the 
individual hospitals. Written informed consent 
was obtained from the women who agreed to 
participate.
Statistical Analysis
Continuous variables were summarized by calcu-
lating the median and interquartile range, and 
subgroups of patients were compared with the 
use of the Kruskal–Wallis test. Univariate com-
parisons of categorical data were performed with 
the chi-square test for trend. All reported P val-
ues are two-sided, and a P value of less than 0.05 
was considered to indicate statistical signifi-
cance. Birth weight was analyzed as the percen-
tile for sex and week of gestation. For the analy-
sis of main effects, all variables were categorized. 
Adjusted odds ratios were obtained by means of 
multivariable logistic-regression analysis.14 The 
independent variables included were cervical 
length, maternal age, body-mass index, smoking 
status, race or ethnic group, gestational age at 
birth, spontaneous or induced labor, birth-weight 
percentile, and hospital of delivery.
We planned to assess the interaction between 
cervical length and all other variables. We tested 
interaction terms between cervical length and 
other maternal variables using cervical length as 
a continuous variable and the other variables as 
categorical variables. The statistical significance 
of the interactions was assessed with the use of 
backward stepwise regression, in which statisti-
cal significance was estimated by means of the 
likelihood-ratio test to assess the effect of remov-
ing interaction terms for all strata of the given 
variable.14 Given that eight tests of interaction 
were performed, the threshold for statistical sig-
nificance for interaction terms was reduced to 
P values of less than 0.00625 (according to the 
Bonferroni method). Since cesarean delivery is a 
common outcome, adjusted odds ratios from 
multivariable logistic regression were converted 
into adjusted relative risks, according to the 
method of Zhang and Yu.15 Adjusted relative risks 
were compared with adjusted incidence-rate ratios 
obtained from Poisson regression.16 We estimat-
ed attributable fractions by using the method of 
Greenland and Drescher.17 All statistical analyses 
were performed with the Stata software package, 
version 10.
R esult s
Data were available from a total of 59,314 wom-
en. We excluded 682 records (1.1%) because the 
patient had a cervical length of 15 mm or less 
and 252 records (0.4%) because of a stillbirth or 
therapeutic abortion. A total of 58,405 wom- 
en (98.5%) had neither outcome, and 30,452 of 
these women (52.1%) were primiparous. Of these 
30,452 women, 1635 (5.4%) delivered preterm; 
of the remaining 28,817 women, 1345 (4.7%) de-
livered by prelabor cesarean section. This left a 
study group of 27,472 women, representing 90.2% 
of all eligible primiparous women screened. The 
median gestational age at the time of measure-
ment of cervical length was 23 weeks (interquar-
tile range, 22 weeks 5 days to 23 weeks 2 days).
Table 1 summarizes the characteristics of the 
cohort in relation to the quartile of cervical 
length. The cervical length at 23 weeks of gesta-
tion was positively associated with increasing 
maternal age, nonsmoking (vs. smoking), increas-
ing body-mass index, white race, increasing ges-
tational age at birth, induced (vs. spontaneous) 
labor, and increasing birth-weight percentile. 
A total of 5542 women underwent cesarean sec-
tion. In 4615 of these procedures (83.3%), failure 
of labor to progress was included in the list of 
indications.
The rate of cesarean delivery was lowest 
among women with a cervical length at 23 weeks 
in the lowest quartile (16.0%) and was significant-
ly greater in the second quartile (18.4%), third 
quartile (21.7%), and fourth quartile (25.7%) 
(P<0.001 for trend). The risk of cesarean delivery 
increased with increasing absolute values of mid-
pregnancy cervical length. Rates of cesarean de-
livery started to rise at a cervical length of 25 mm 
and plateaued at a cervical length of 50 mm, ap-
proximately doubling across the range of ob-
served values (Fig. 1). The association between 
cervical length and the rate of cesarean delivery 
was attributable to the procedure being per-
formed in women for whom the indication in-
cluded poor progress during labor.
Adjustment for a range of characteristics (ma-
ternal age, body-mass index, smoking status, race 
or ethnic group, gestational age at birth, sponta-
neous or induced labor, birth-weight percentile, 
and hospital of delivery) slightly attenuated but 
did not eliminate the significant association bet-
Copyright © 2008 Massachusetts Medical Society. All rights reserved. 
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tween cervical length and the risk of cesarean 
delivery at term (Table 2). When the outcome was 
limited to cesarean delivery because of a failure 
of labor to progress, the association with cervi-
cal length was slightly stronger (see the Supple-
mentary Appendix, available with the full text 
of this article at www.nejm.org). There were no 
significant interactions between cervical length 
and any of the maternal characteristics in pre-
dicting the risk of intrapartum cesarean delivery 
(Fig. 2). The interaction between cervical length 
and birth-weight percentile had a P value of 0.01, 
but this value was greater than 0.00625, the 
threshold of significance used for the analysis of 
interaction, and the stratified analysis showed 
no clear pattern of interaction across the strata 
of birth-weight percentile (Fig. 2).
The attributable fraction for cesarean delivery 
associated with the upper three quartiles of cer-
vical length was 20.5% (95% confidence interval 
[CI], 16.6 to 24.1). After adjustment for maternal 
characteristics, this fraction was 17.2% (95% CI, 
13.4 to 20.9).
Since cesarean delivery was common, the out-
put of logistic-regression models was also ex-
pressed as the adjusted relative risk.15 The ad-
Table 1. Baseline Characteristics of the Cohort, According to the Quartile of Cervical Length at 23 Weeks of Gestation.*
Maternal Characteristic  
or Outcome Quartile of Cervical Length P Value
1 (N = 7061) 2 (N = 8075) 3 (N = 6065) 4 (N = 6271)
Cervical length — mm 16–30 31–35 36–39 40–67 <0.001
Age — yr
Median 27.0 28.0 28.8 29.4 <0.001
IQR 22.0–31.5 23.0–31.7 24.2–32.0 25.3–32.9
Body-mass index†
Median 23.5 23.8 23.9 24.2 <0.001
IQR 21.3–26.5 21.5–26.7 21.6–27.0 22.0–27.3
Current smoker — no. (%) 949 (13.4) 1027 (12.7) 685 (11.3) 586 (9.3) <0.001
Race or ethnic group — no. (%)‡
White 4384 (62.1) 5653 (70.0) 4483 (73.9) 4726 (75.4) <0.001
Black 1963 (27.8) 1592 (19.7) 1054 (17.4) 1046 (16.7) <0.001
Other 714 (10.1) 830 (10.3) 528 (8.7) 499 (8.0) <0.001
Gestational age at birth — wk
Median 40.0 40.0 40.0 40.3 <0.001
IQR 39.0–41.0 39.0–41.0 39.1–41.0 39.4–41.1
Induced labor — no. (%) 1101 (15.6) 1444 (17.9) 1068 (17.6) 1402 (22.4) <0.001
Birth-weight percentile
Median 46 49 52 54 <0.001
IQR 21–72 25–74 28–76 28–78
Cesarean delivery — no. (%)
All 1133 (16.0) 1482 (18.4) 1315 (21.7) 1612 (25.7) <0.001
Poor progress during labor§ 884 (12.5) 1195 (14.8) 1101 (18.2) 1435 (22.9) <0.001
Other 249 (3.5) 287 (3.6) 214 (3.5) 177 (2.8) 0.03
* Numbers among the quartiles are unequal owing to ties. P values were calculated with the use of the chi-square test for 
trend or the Kruskal–Wallis test, as appropriate. IQR denotes interquartile range.
† The body-mass index is the weight in kilograms divided by the square of the height in meters.
‡ Race or ethnic group was self-reported.
§ Poor progress during labor was reported in computerized medical records listing this condition as an indication for ce-
sarean delivery.
Copyright © 2008 Massachusetts Medical Society. All rights reserved. 
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justed relative risk of cesarean delivery for the 
highest quartile of cervical length was 1.49 (95% 
CI, 1.39 to 1.59). This value was very similar to 
the adjusted incidence-rate ratio (1.45; 95% CI, 
1.34 to 1.57) estimated with the use of Poisson 
regression, an analysis that is also recommend-
ed for common outcomes.16
Discussion
We found that the risk of intrapartum cesarean 
delivery at term among primiparous women was 
associated with the length of the cervix in mid-
pregnancy. The risk of cesarean delivery began to 
increase when the cervical length at 23 weeks 
was greater than 25 mm and approximately dou-
bled across the range of lengths. The relationship 
persisted after adjustment for several maternal 
characteristics. There was no strong evidence of 
an interaction between cervical length and other 
factors associated with the risk of cesarean deliv-
ery. These findings suggest that cervical length 
at mid-pregnancy is an important indicator of 
the risk of primary cesarean delivery at term.
We hypothesize that poor progress during 
labor at term is determined by the development 
of the uterus at much earlier stages of preg-
nancy. In the present study, we tested a predic-
tion arising from that hypothesis — namely, 
that a long cervix in mid-pregnancy would be 
associated with an increased risk of emergency 
cesarean delivery during labor at term. The most 
common cause of intrapartum primary cesarean 
section is poor progress during labor. This is 
cited as the sole indication, or as a joint indica-
tion with fetal distress, in approximately 80% of 
intrapartum procedures at term among primipa-
rous women,18 and the proportion was very 
similar in the present study. Our analysis of ce-
sarean delivery according to the indication for it 
was consistent with this finding, showing that 
the increased risk of this event among women 
who had a long cervix in mid-pregnancy was 
explained by the increased risk of poor progress 
during labor. It has previously been shown that 
cervical length at 37 weeks of gestation is strong-
ly associated with the risk of cesarean section 
for poor progress during labor.19 Our study did 
not involve serial measurement of cervical length 
throughout pregnancy. Hence, we could not de-
termine whether the association between cervical 
length at mid-pregnancy and the risk of cesarean 
delivery at term was related to the cervical 
length at earlier or later gestational ages.
Our findings are consistent with those from 
studies of a range of animal species, which have 
shown that changes in preparation for labor and 
delivery occur through the second half of preg-
nancy,8 and from longitudinal studies of preg-
nant rodents, which have showed a clear pattern 
of biochemical changes occurring in mid-preg-
nancy that are preparative for the ultimate pro-
cess of labor.7,20 The relation between such 
physiological and biochemical changes in mid-
pregnancy in animals and variation in the cervi-
cal length at mid-pregnancy in women is cur-
rently unclear. Further study is needed to assess 
the possibility that a long cervix in mid-preg-
nancy may reflect dysfunctional development of 
the uterus, which is ultimately manifested in the 
need for cesarean delivery at term.
This study was a secondary analysis of data 
that were obtained for other purposes. Because 
the primary outcome of the original interven-
tional trials was spontaneous preterm birth, the 
indication for cesarean delivery was ascertained 
only from the computerized delivery record, and 
we do not have data to validate the listed indica-
tions. Moreover, it is possible that the associa-
tion between cervical length at mid-pregnancy 
and the risk of cesarean delivery was a chance 
finding. However, the association was signifi-
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Figure 1. Proportion of Cesarean Deliveries in Relation to Absolute Values 
of Cervical Length Measured at 23 Weeks of Gestation.
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Table 2. Unadjusted and Adjusted Odds Ratios for Cesarean Delivery, According to Overall Outcome Characteristics.
Variable Unadjusted Analysis Adjusted Analysis
Odds Ratio (95% CI) P Value Odds Ratio (95% CI)* P Value
Quartile of cervical length
1 (referent) 1.0 1.0
2 1.18 (1.08–1.28) <0.001 1.16 (1.06–1.27) 0.001
3 1.45 (1.33–1.58) <0.001 1.43 (1.31–1.57) <0.001
4 1.81 (1.66–1.97) <0.001 1.68 (1.53–1.84) <0.001
Age
<20 yr 0.44 (0.39–0.51) <0.001 0.49 (0.42–0.56) <0.001
20–24 yr 0.67 (0.61–0.73) <0.001 0.69 (0.62–0.76) <0.001
25–29 yr (referent) 1.0 1.0
30–34 yr 1.19 (1.11–1.29) <0.001 1.23 (1.14–1.33) <0.001
35–39 yr 1.57 (1.42–1.73) <0.001 1.57 (1.41–1.74) <0.001
≥40 yr 1.71 (1.37–2.15) <0.001 1.59 (1.25–2.03) <0.001
Body-mass index (before pregnancy)
<20.0 0.72 (0.63–0.81) <0.001 0.82 (0.73–0.93) <0.001
20.0–24.9 (referent) 1.0 1.0
25.0–29.9 1.57 (1.47–1.68) <0.001 1.40 (1.30–1.50) <0.001
30.0–34.9 2.02 (1.83–2.24) <0.001 1.68 (1.51–1.87) <0.001
≥35.0 2.60 (2.27–2.97) <0.001 2.05 (1.77–2.37) <0.001
Current smoker
No (referent) 1.0 1.0
Yes 0.73 (0.66–0.81) <0.001 1.04 (0.94–1.16) 0.45
Race or ethnic group
White (referent) 1.0 1.0
Black 1.40 (1.30–1.50) <0.001 1.81 (1.66–1.97) <0.001
Other 0.96 (0.86–1.06) 0.40 1.41 (1.26–1.59) <0.001
Gestational age at birth
37 wk 1.20 (1.05–1.38) 0.009 1.01 (0.87–1.17) 0.87
38 wk 0.88 (0.79–0.98) 0.02 0.78 (0.70–0.88) <0.001
39 wk 0.78 (0.71–0.85) <0.001 0.75 (0.68–0.82) <0.001
40 wk (referent) 1.0 1.0
41 wk 1.47 (1.36–1.59) <0.001 1.25 (1.15–1.36) <0.001
≥42 wk 2.38 (2.13–2.67) <0.001 1.44 (1.27–1.64) <0.001
Onset of labor
Spontaneous (referent) 1.0 1.0
Induced 2.80 (2.61–2.99) <0.001 2.37 (2.19–2.56) <0.001
Birth-weight percentile
1–3 1.51 (1.29–1.77) <0.001 1.49 (1.26–1.77) <0.001
4–10 0.92 (0.81–1.04) 0.16 0.91 (0.80–1.03) 0.15
11–20 0.83 (0.75–0.93) 0.001 0.85 (0.76–0.96) 0.007
21–80 (referent) 1.0 1.0
81–90 1.40 (1.27–1.54) <0.001 1.35 (1.22–1.49) <0.001
91–97 1.85 (1.67–2.06) <0.001 1.81 (1.62–2.03) <0.001
98–100 3.15 (2.73–3.65) <0.001 2.87 (2.46–3.36) <0.001
* These odds ratios and 95% CIs were adjusted for maternal age, body-mass index, smoking status, race or ethnic group, 
gestational age at birth, spontaneous or induced labor, birth-weight percentile, and hospital of delivery.
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cant at a P value of less than 0.001. Hence, the 
probability of this being a chance finding is very 
low. Although the association persisted in the 
multivariable analysis, it is also possible that it 
reflects residual confounding either due to a 
failure to measure important maternal variables 
directly or due to unmeasured confounders. For 
example, body-mass index is a proxy measure of 
adiposity, and residual confounding by this vari-
able cannot be ruled out. If residual confound-
ing by obesity explained the association found in 
the multivariable analysis, it is likely that an in-
teraction between body-mass index and cervical 
length would have been observed. However, the 
association between cervical length and emer-
gency cesarean delivery was similar among lean 
women, those of normal weight, and those who 
were overweight or obese (Fig. 2). Similarly, the 
relation between cervical length and cesarean 
delivery was consistent across strata of other 
maternal and outcome factors and across the 
eight hospitals studied.
Our study excluded women who delivered 
preterm. Women who deliver preterm are a het-
erogeneous group, consisting both of those with 
spontaneous preterm births and those with in-
dicated preterm births. Moreover, intrapartum 
cesarean delivery for breech presentation is 
common before term, and the inclusion of pre-
term births would have complicated the inter-
pretation of associations between cervical length 
and cesarean delivery for failure of labor to 
progress. Since the study group consisted of ap-
proximately 90% of all primiparous women 
screened, our findings are relevant to the gen-
eral population of primiparous women.
Poor progress during labor at term is the 
most common indication for primary cesarean 
section and, hence, an important determinant of 
overall rates of cesarean section. Our finding 
that a long cervix in mid-pregnancy is predictive 
of cesarean section during labor at term sug-
gests that poor progress during labor in women 
who deliver at term may be related to dysfunc-
tional development of the uterus at much earlier 
stages of pregnancy.
Supported by a grant from the Fetal Medicine Foundation 
(1037116).
No potential conflict of interest relevant to this article was 
reported.
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Figure 2. Odds Ratios for Cesarean Delivery per 10-mm Increase in Cervical 
Length, According to Overall Outcome Characteristics.
Odds ratios were stratified for each characteristic and adjusted for all other 
characteristics listed. P values were estimated with the u  of the likeli-
hood-ratio test. Given that eight comparisons were made, the threshold for 
statistical significance was P<0.00625.
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Appendix
The members of the Fetal Medicine Foundation Second Trimester Screening Group were as follows: University Hospital Lewisham, London: 
A. Delfino, M. Fokialaki, S. Flint; Queen Elizabeth Hospital, Woolrich: F. Molina, S. Turan, K. Gajewska, V. Palanappian; King’s College Hospital, 
London: E. Karanastasi, A.M. Cacho, C. Skentou; King George Hospital, Ilford: L. Thompson, J. Webber, E. Osei; Basildon Hospital, Basildon: 
M.S. To, G. Fletcher, J. Parminter; Harold Wood Hospital, Romford: A. Moakes, C. Otigbah, R. Utidjian; Queen Mary’s Hospital, Sidcup: S. 
Preston, A. Morgan, A. Abbas; Southend University Hospital, Essex: P. Hagan, M. Singh — all in the United Kingdom.
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Maternal Uterine Artery Doppler Flow
Velocimetry and the Risk of Stillbirth
Gordon C. S. Smith, MD, PhD, Christina K. H. Yu, MB, ChB, Aris T. Papageorghiou, MB, ChB,
Anna Maria Cacho, MB, ChB, and Kypros H. Nicolaides, MD, for the Fetal Medicine Foundation
Second Trimester Screening Group
OBJECTIVE: We sought to relate the risk of antepartum
stillbirth to uterine artery Doppler flow velocimetry at
22–24 weeks.
METHODS: Data were available from 30,519 unselected
women from seven units in the UK who had uterine
artery Doppler performed between 22 and 24 weeks of
gestation. The risk of stillbirth (n109) was assessed using
time to event and logistic regression analysis. Stillbirths
were subdivided into placental (due to abruption, pre-
eclampsia, or growth restriction) or unexplained.
RESULTS: The risk of placental stillbirth was increased
among women with a mean pulsatility index in the top
decile (adjusted hazard ratio [HR] 5.5, 95% confidence
interval [CI] 2.8–10.6) and those with a bilateral notch
(adjusted HR 3.9, 95% CI 2.0–7.8). The relationship be-
tween a mean pulsatility index in the top decile and the
risk of unexplained stillbirth was weaker (adjusted HR
2.5, 95% CI 1.1–5.6) and there was no association with a
bilateral notch. Placental stillbirths occurred at earlier
gestations than unexplained stillbirths (median [inter-
quartile range] 30 [26–36] compared with 38 [36–40],
P<.001). Consequently, being in the top 5% of predicted
risk of stillbirth on the basis of the combination of mean
pulsatility index and notching was a good predictor
(sensitivity, specificity, and positive likelihood ratio) of all
cause stillbirth up to 32 weeks (58%, 95%, and 12.1,
respectively) but a poor predictor of stillbirth at later
gestations (7%, 95%, and 1.3, respectively).
CONCLUSION: Abnormal uterine artery Doppler was a
better predictor of the risk of stillbirth due to placental
causes than unexplained stillbirth. Consequently, abnor-
mal uterine artery Doppler was a good predictor of
stillbirth at extreme preterm gestations but a poor pre-
dictor of stillbirth at term.
(Obstet Gynecol 2007;109:144–51)
LEVEL OF EVIDENCE: II
Death of the fetus before the onset of labor (antepar-tum stillbirth) is the single most important cause of
perinatal death.1 Some of these deaths are clearly di-
rectly related to function of the placenta, such as those
due to abruption. Approximately two thirds have no
direct cause and are referred to as unexplained.2 How-
ever, many of these are associated with growth restric-
tion3 and are also thought to be related to placental
function.4 Invasion of maternal vessels by the tropho-
blast is a key process in early placentation.5 Conse-
quently, vascular resistance in the uterine circulation
normally decreases in the first half of pregnancy. This
process can be quantified by Doppler flow velocimetry
of the uterine arteries, and previous studies have shown
associations between high resistance patterns of flow
and a range of complications in pregnancy.6,7 However,
the nature of the association with stillbirth is unclear
both in terms of different causes of stillbirth and the
timing of losses. The aims of the present study were 1) to
relate the risk of stillbirth to indices of Doppler flow
velocimetry of the uterine arteries performed at 22–24
weeks of gestation in relation to presumed placental and
nonplacental causes of stillbirth and the timing of still-
birth, and 2) to characterize the properties of uterine
artery Doppler as a screening test for stillbirth in an
unselected population.
MATERIALS AND METHODS
The data analyzed in the present study were obtained
as part of a multicenter study of screening and
intervention in pregnancy involving seven hospitals
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in and around London (Basildon Hospital; Green-
wich Hospital; Harold Wood Hospital, Romford;
King George Hospital, Ilford; King’s College Hospi-
tal, London; Queen Mary’s Hospital, Sidcup; Univer-
sity Hospital Lewisham, London). Women recruited
to the study had a scan at 22–24 weeks of gestation,
which included assessment of cervical length and
uterine artery Doppler flow velocimetry. Those with a
short cervix were offered participation in a trial of
cervical cerclage, and those with a mean pulsatility
index of 1.6 or above were offered participation in a
trial of low-dose aspirin as prophylaxis for preeclamp-
sia. These studies were approved by the South
Thames Multicenter Research Ethics Committee, as
well as the local ethics committees of individual
hospitals. Written informed consent was obtained
from the women agreeing to participate in the study.
The details of these trials are reported elsewhere.8,9
The current analysis used this cohort but excluded
women recruited to the trial of cervical cerclage.Maternal
details and past medical and obstetric history were ob-
tained using a questionnaire. Uterine artery Doppler
studies were performed by using transvaginal ultrasonog-
raphy10 by ultrasonographers trained in this method.
Each uterine artery was identified using color flow map-
ping, and three similar consecutive waveforms were
obtained using pulsed wave Doppler. The pulsatility
index was measured, and the mean pulsatility index of
the two uterine arteries was calculated.6 Quality control of
screening, handling of data, and verification of adherence
to protocols at the different centers was performed on a
regular basis by the trial coordinators. The study period
was October 1999 to August 2002. Women with a mean
pulsatility index greater than 1.6, which in an earlier study
represented the 95th centile,10 were followed up with
growth scans, blood pressure measurements, and urinal-
ysis for protein at 28, 32, and 36 weeks. Women with
normal uterine artery Doppler received routine antenatal
care. Maternal history and Doppler findings were re-
corded in a computer database at the time of the Doppler
studies in each participating center.
For the purposes of dichotomizing uterine mean
pulsatility index, those women with values in the top
10% were considered to have elevated mean pulsatility
index; this was 1.43 and above in the present analysis.
Outcome was ascertained by computerized databases in
each of the centers. In all cases of adverse outcome
(abruption, preterm birth, preeclampsia, and stillbirth),
the clinical case record (and stillbirth autopsy, where
performed) was reviewed by a medically qualified indi-
vidual, the diagnosis confirmed, and further details were
obtained, as necessary. Stillbirths were defined as deliv-
ery of an infant which showed no signs of life. Losses
due to congenital abnormality were excluded. Stillbirth
was defined as all intrauterine fetal deaths subsequent to
themeasurement of uterine artery Doppler. Themedian
gestational age of assessment of uterine artery Doppler
was 23 weeks. Stillbirths were divided into those where
the fetus was thought to have died before the onset of
labor (antepartum) and those where the fetus was
thought to have been alive at the start of labor. All
analyses for the present study focused on antepartum
stillbirths. The presumed cause of stillbirth was obtained
from the case notes. Where the women suffered severe
preeclampsia or had an abruption, these were assumed
to have caused the stillbirth. Abruption was diagnosed
on the basis of clinical presentation and the presence of
a retroplacental clot. Preeclampsia was defined accord-
ing to the guidelines of the International Society for the
Study of Hypertension in Pregnancy. This requires two
recordings of diastolic blood pressure of more than 90
mm Hg at least 4 hours apart in previously normoten-
sive women, and proteinuria of 300 mg or more in 24
hours, or two readings of at least two pluses on dipstick
analysis of midstream or catheter urine specimens if no
24-hour collection is available.
In the absence of a direct cause, stillbirths were
regarded as unexplained. These were subdivided into
those where the birth weight was less than the 10th
percentile for sex and gestation (small for gestational age)
and those where the birth weight percentile was above
this threshold (appropriate for gestational age). Unex-
plained stillbirths where the fetus was small for gestational
age were assumed to be due to intrauterine growth
restriction. Stillbirths due to preeclampsia, abruption, or
small for gestational age unexplained stillbirths were
collectively considered to be placentally related stillbirths.
Body mass index was defined as the woman’s
prepregnancy weight in kilograms divided by her
height in meters squared. Primigravid women were
defined as those who had no previous births and any
previous pregnancies had been spontaneous losses
before 16 weeks or therapeutic abortions. Previous
preterm birth was defined as a woman who had any
previous live birth before 37 weeks of gestation.
Previous loss was defined as any woman who had
given birth to an infant showing no signs of life at or
after 16 weeks of gestation and thus included prior
intrauterine fetal deaths and stillbirths. Parous women
with no previous complications were defined as those
whose previous births had all been live births at term.
Continuous variables were summarized by the me-
dian and interquartile range (IQR) and comparisons
between groups were made using the Mann-Whitney U
test. Univariable comparisons of dichotomous data were
made using the 2 test. The P values for all hypothesis
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tests were two-tailed, and statistical significance was set
at P.05. The risk of stillbirth was compared between
groups using time-to-event analyses (Kaplan-Meier and
Cox proportional hazards model) in which gestational
age was used as the time scale, antepartum stillbirth due
to the specified cause was defined as the event, and all
other births were treated as censored. This method uses
ongoing pregnancies as the denominator, as previously
suggested,11 but accounts for censoring due to birth,
allows multivariable analysis,12 and can be used in
situations where not all individuals would ultimately
experience the event.13 This analytic approach allows
assessment of the relative risk accounting for variation in
the duration of pregnancy. Survival data were plotted as
cumulative percentage, with event as recommended for
rare outcomes,14 and univariable statistical comparisons
were made using the log rank test. Crude and adjusted
hazard ratios were estimated using the proportional
hazards model.15 The proportional hazards assumption
was tested using the test of Grambsch and Therneau16 as
previously described for the analysis of stillbirth risk.17,18
Logistic regression analysis was used to estimate ad-
justed odds ratios within given gestational windows. In
these analyses, the number of antepartum stillbirths
within the given range was the numerator and the
number of all births at the given or later gestations was
the denominator. Mean pulsatility index was treated as
a continuous variable in the logistic regression analysis.
Linearity in the log odds scale was assessed using
fractional polynomials.19 For predictive models, vari-
ables were selected using backward stepwise logistic
regression,20 with the threshold for removal being
P.05. Logistic regression models were converted to
tables of likelihood ratios using a previously described
method.21 All statistical analyses were performed using
the Stata 8 software package (Stata Corporation, College
Station, TX).
RESULTS
Data were available from 30,755 women who had
uterine artery Doppler performed between 22 and 24
weeks of gestation. Two hundred fifty-six women with
a short cervix or who had cervical cerclage or both
were excluded, leaving a study group of 30,519.
There were 5 (2.0%) stillbirths among 255 women
randomly assigned to aspirin and 4 (1.6%) stillbirths
among 256 women assigned to placebo (P.8). There
were 109 antepartum stillbirths in the cohort. Women
who had an antepartum stillbirth had higher body
mass index, were more likely to be African American
and were more likely to have had a complicated
previous pregnancy (Table 1). Two of the stillbirths
Table 1. Maternal and Doppler Characteristics in Relation to Ultimate Outcome of Pregnancy
No Stillbirth
(n30,410)
Stillbirth
(n109) P*
Characteristics
Maternal age (yr) 30 (26-34) 31 (26-34) .4
Height 1.63 (1.58–1.68) 1.63 (1.58–1.68) .4
Body mass index 25 (22-28) 26 (23–30) .002
Smoker
Nonsmoker or ex-smoker 25,897 (85.2) 88 (80.7)
Current smoker 4,513 (14.8) 21 (19.3) .2
Ethnic group
Asian or other 2,885 (9.5) 6 (5.5)
African American 5,502 (18.1) 43 (39.4) .001
White 22,023 (72.4) 60 (55.0)
Past obstetric history
Primigravid 15,462 (50.8) 52 (47.7) .001
Parous (uncomplicated) 12,019 (39.5) 36 (33.0)
Previous preterm birth 2,291 (7.5) 12 (11.0)
Previous IUFD or stillbirth 638 (2.1) 9 (8.3)
Doppler findings
Uterine notch
None 24,173 (79.5) 67 (61.5)
Unilateral 3,207 (10.6) 6 (5.5) .001
Bilateral 3,030 (10.0) 36 (33.0)
Mean PI 1.02 (0.87–1.21) 1.26 (0.95–1.64) .001
Mean PI in top decile 2,950 (9.7) 39 (35.8) .001
IUFD, intrauterine fetal death; PI, pulsatility index.
Data are n (%) or median (interquartile range), as appropriate.
*P value by Fisher exact test or Mann-Whitney U test, as appropriate.
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were related to road traffic accidents, four to maternal
diabetes, and one to second trimester rupture of the
membranes. All further analyses focused on the re-
maining 102, of which 54 were attributed to a placen-
tal cause (abruption, preeclampsia, or intrauterine
growth restriction, or any combination of these) and
48 that were unexplained, with a birth weight appro-
priate for gestational age. Stillbirths due to a placental
cause occurred at earlier gestations than unexplained
stillbirths (Fig. 1).
A uterine artery mean pulsatility index in the top
decile and a bilateral notch were both associated with
an increased risk of all-cause stillbirth and stillbirth
due to a placental cause (Table 2). A uterine artery
mean pulsatility index in the top decile was also
associated with the risk of unexplained stillbirth.
There were no associations between a unilateral notch
and the risk of any type of stillbirth. The relationship
between a composite index of abnormal Doppler
(uterine mean pulsatility index in the top decile or
bilateral notch or both) and the Kaplan-Meier cumu-
lative risk of stillbirth is plotted in Figure 2. This
illustrates that abnormal uterine artery Doppler was
more strongly associated with all-cause stillbirth and
stillbirth due to placental causes at extreme preterm
gestations (Fig. 2). The relative risk of unexplained
stillbirth among women with abnormal uterine artery
Doppler was similar across the whole range of gesta-
tion. Overall, 4,769 (15.6%) of women had abnormal
Doppler (either mean pulsatility index in the top
decile or bilateral notches). Among these women, the
absolute risks per 1,000 (95% confidence interval of
stillbirth were 5.9 (3.9–8.5) up to 32 weeks and 3.1
(1.8–5.2) at or after 33 weeks of gestation. The risks of
these events for the whole population were 1.3 (1.0–
1.8) and 2.0 (1.5–2.6), respectively. The relative risk of
stillbirth associated with abnormal Doppler did not
significantly differ across the seven centers in relation
Fig. 1. Timing of stillbirths in relation to whether the cause
was placental (A) or unexplained (B). The median (inter-
quartile range) of delivery in weeks was 30 (26–36) for
placental stillbirths and 38 (36–40) for unexplained still-
births (Mann Whitney U test, P.001).
Smith. Uterine Artery Doppler and Stillbirth Risk. Obstet
Gynecol 2007.
Table 2. Time-to-Event Analysis of Stillbirth Risk in Relation to Second Trimester Uterine Artery Doppler
Doppler
Findings
All
Stillbirth
Placental
Stillbirth
Unexplained
Stillbirth
HR 1* P HR 2† P HR 1* P HR 2† P HR 1* P HR 2† P
Top decile
PI 4.6 (2.9–7.5) .001 4.0 (2.4–6.5) .001 6.5 (3.4–12.6)‡ .001 5.5 (2.8–10.6) .001 2.8 (1.2–6.3) .01 2.5 (1.1–5.6) .03
Unilateral
notch 0.5 (0.2–1.2) .1 0.5 (0.2–1.3) .2 0.4 (0.1–1.6) .2 0.4 (0.1–1.8) .2 0.6 (0.3–1.9) .4 0.7 (0.2–2.0) .5
Bilateral
notch 2.4§(1.4–3.9) .001 2.5‡ (1.5–4.1) .001 3.9 (2.0–7.6) .001 3.9 (2.0–7.8) .001 0.9‡ (0.4–2.5) .9 1.0‡ (0.4–2.7) .9
HR, hazard ratio; PI, pulsatility index.
Data in parentheses are 95% confidence intervals.
* Adjusted for other Doppler parameters only.
† Adjusted for other Doppler parameters and maternal age, height, body mass index, smoking, ethnicity, and past obstetric history.
‡ P.05, test of proportional hazards assumption.
§ P.01, test of proportional hazards assumption.
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either to all-cause stillbirth (P.2) or stillbirth due to a
placental cause (P.3).
The ability of combinations of Doppler and ma-
ternal indices to predict stillbirth risk were then
explored in relation to all-cause stillbirth, separately
examining events before 33 weeks of gestation and
those at 33 weeks and beyond (Table 3). Uterine
artery Doppler was a better predictor of stillbirth
before 33 weeks of gestation than maternal character-
istics. Conversely, maternal characteristics performed
better at later gestations. When the population in the
top 5% of predicted risk were regarded as having
screened positive, combined models of maternal and
Doppler characteristics had a sensitivity of approxi-
mately 50% for early stillbirths but only 20% for late
stillbirths. Logistic regression models for each event
were generated using selection of significant variables
and then converted to likelihood ratios (Tables 4 and
5). These provide a means to estimate stillbirth risk on
the basis of uterine Doppler and maternal
characteristics.
DISCUSSION
We show that an abnormal pattern of uterine artery
Doppler flow velocimetry at 22–24 weeks is strongly
associated with the subsequent risk of stillbirth. The
strength of the association was much greater for
stillbirths due to placental causes than for unex-
plained stillbirths where the fetus had a birth weight
appropriate for gestational age. The former group of
stillbirths tended to occur at much earlier weeks of
gestation. Consequently, abnormal uterine artery
Doppler performed much better as a screening test for
stillbirth at extreme preterm gestations than those
occurring at late gestation.
The approach of characterizing an arbitrary
threshold of mean pulsatility index as being elevated
results in loss of information. Moreover, some mater-
nal characteristics were also significantly predictive of
the risk of stillbirth. Prediction of the risk of stillbirth
for an individual women would ideally take into
account the precise level of the mean pulsatility index
and combine this with her other characteristics to
produce an estimate of her personal risk. We ad-
dressed these issues by developing multivariable lo-
gistic regression models that incorporated mean pul-
satility index as a continuous variable along with the
maternal characteristics. Although this addresses the
two issues above, estimating a summary probability
from such a model requires very sophisticated statis-
tical knowledge. We addressed this by using a re-
cently described method to convert logistic regression
models into tables of likelihood ratios.21 A summary
Fig. 2. Kaplan-Meier plots of cumulative probability of
stillbirth expressed as cumulative risk of failure in relation
to abnormal Doppler (solid line, uterine artery mean pul-
satility index in top decile or bilateral notch or both)
compared with normal Doppler (broken line, all other
women). Hazard ratio (HR) for abnormal Doppler: A. All
stillbirths: HR 4.4 (95% confidence interval [CI] 2.9–6.5),
log rank test, P.001, proportional hazard test P.001; B.
Stillbirths due to a placental cause: HR 7.8 (95% CI
4.5–13.4), log rank test, P.001, proportional hazard test
P.002. C. Unexplained stillbirth: HR2.1 (95% CI 1.1–
4.0), log rank test, P.03, proportional hazard test P.7.
Smith. Uterine Artery Doppler and Stillbirth Risk. Obstet
Gynecol 2007.
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likelihood ratio can be calculated by multiplying the
combination of likelihood ratios which are associated
with a given woman’s characteristics. The back-
ground risk of stillbirth is then multiplied by the
summary likelihood ratio and the woman’s individual
risk can be calculated. Before widespread application
of these models, their accuracy should be evaluated in
other populations. The fact that the association be-
tween abnormal uterine artery Doppler and the risk
of stillbirth did not significantly vary across the seven
centers suggests that these models are likely to be
generalizable. Moreover, an advantage of the likeli-
hood ratio approach is that it is relatively simple to
account for variation in the background risk of still-
birth when applied to other populations.
The data from the present study are essential for
the design of any interventional studies that aim to
reduce the risk of stillbirth in an unselected popula-
tion screened using uterine artery Doppler. A series of
randomized controlled trials of uterine and umbilical
artery Doppler have been conducted. Meta-analysis
of these trials demonstrates no reduction in perinatal
mortality.22 However, these trials were conducted in
the absence of detailed information about the screen-
ing properties of the test. The key properties which
need to be known when designing a trial are the range
of gestational age where the risk is increased and the
absolute risk of stillbirth over that period. The timing
of the risk is essential for planning the timing of any
intervention. The absolute risk of a loss associated
with an abnormal test result is essential for a power
calculation. Previous trials were conducted in the
absence of these data.22 The current model could be
used in a trial to identify women at increased risk of
stillbirth. There are a number of possible interven-
tions in the high-risk group. One example would be
intensive fetal surveillance (computerized cardioto-
cography, biometry, uteroplacental and venous
Doppler, and biophysical profile) with delivery of
those deemed to be at imminent risk of intrauterine
fetal death.
A relative weakness of the present analysis was
that the Doppler results were revealed and clinical
management was modified on the basis of the result.
The effect of this on the present analysis is difficult to
assess. The nature of the intervention was that women
with an elevated uterine mean pulsatility index were
scanned every 4 weeks. This is comparable to the
protocol used in a randomized controlled trial of
uterine artery Doppler that did not demonstrate a
protective effect on perinatal mortality.23 However, it
is possible that some fetal deaths may have been
prevented by this intervention or by the attending
obstetrician being aware of the abnormal uterine
artery Doppler. Further studies with a noninterven-
tional design would be required to eliminate this
potential source of error.
A further weakness in the present study relates to
classification of stillbirths on the basis of birth weight.
If the interval between death of the fetus and birth is
Table 3. Screening Characteristics of Combinations of Maternal and Doppler Indices in Predicting Early
and Late Stillbirths
Top 5% Screen Positive*
Outcome and
Predictors
Area Under
ROC Curve* Sensitivity Specificity
Positive
LR
Negative
LR
All-cause stillbirth at 32 wk or less
Doppler† alone 0.84 (0.77–0.91) 58.5 (42.1–73.7) 95.2 (94.9–95.4) 12.1 0.44
Doppler† and maternal‡ 0.89 (0.84–0.95) 53.7 (37.4–69.3) 95.1 (94.8–95.3) 10.9 0.49
Maternal‡ alone 0.75 (0.66–0.83) 31.7 (18.1–48.1) 95.1 (94.8–95.3) 6.4 0.72
Selected Doppler and maternal§ 0.87 (0.80–0.93) 61.0 (44.5–75.8) 95.1 (94.8–95.3) 12.4 0.41
All cause stillbirth at 33 wk or more
Doppler† alone 0.62 (0.54–0.70) 6.6 (1.8–15.9) 95.1 (94.8–95.3) 1.3 0.98
Doppler† and maternal‡ 0.70 (0.64–0.77) 21.3 (11.9–33.7) 95.0 (94.8–95.3) 4.3 0.83
Maternal‡ alone 0.68 (0.61–0.75) 18.0 (9.4–30.0) 95.1 (94.8–95.3) 3.7 0.86
Selected Doppler and maternal§ 0.67 (0.60–0.75) 13.1 (5.8–24.2) 95.1 (94.8–95.3) 2.7 0.91
ROC, receiver operating characteristic; LR, likelihood ratio.
Data in parentheses are 95% confidence intervals.
*The area under the ROC curve was calculated using the estimated probability of stillbirth from the given logistic model. The sensitivity,
specificity, and likelihood ratios were estimated when women in the top 5% of predicted risk were deemed to have screened positive.
† Doppler scores are mean pulsatility index (expressed as a continuous variable), unilateral notch and bilateral notch. In all models, mean
pulsatility index was linear in the log odds scale on the basis of fractional polynomial analysis.
‡ Maternal characteristics in the model were age, height, body mass index, smoking, ethnicity, and past obstetric history.
§ Details of the selected models are provided in Tables 4 and 5.
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prolonged, maceration of the fetus may occur. Con-
sequently, the birth weight of the stillborn infant may
not accurately reflect growth in fetal life. Moreover,
dichotomizing infants as small or appropriate for
gestational age on the basis of birth weight does not
identify those infants that were constitutionally small.
Moreover, infants with an apparently appropriate
birth weight for gestational age may not have
achieved their true growth potential. Therefore, clas-
sification of unexplained stillbirths by birth weight
does not perfectly discriminate between those that
were growth restricted and those that were not.
Indeed, failure of correct classification may account
for the association between unexplained stillbirth and
abnormal uterine artery Doppler. Further studies may
be able to address this using more sophisticated
indicators of intrauterine growth restriction, such as
serial antenatal scanning or neonatal anthropometry.
In conclusion, we show that a high resistance pattern
of flow in the uterine artery is associatedwith an increased
risk of stillbirth. The association is strongest for stillbirths
due to placental dysfunction and, since these tend to
occur at earlier gestations, is strongest for stillbirths occur-
ring at extreme preterm gestations. Uterine artery Dopp-
ler is a relatively poor predictor of unexplained stillbirth
unrelated to fetal growth restriction.
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Early Pregnancy Levels of Pregnancy-Associated Plasma
Protein A and the Risk of Intrauterine Growth
Restriction, Premature Birth, Preeclampsia,
and Stillbirth
GORDON C. S. SMITH, EMILY J. STENHOUSE, JENNIFER A. CROSSLEY, DAVID A. AITKEN,
ALAN D. CAMERON, AND J. MICHAEL CONNOR
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Genetics (J.A.C., D.A.A., J.M.C.), Yorkhill National Health Service Trust, Glasgow, G3 8SJ, United Kingdom
The risk of adverse perinatal outcome among 8839 women
recruited to a multicenter, prospective cohort study was re-
lated to maternal circulating concentrations of trophoblast-
derived proteins at 8–14 wk gestation. Women with a preg-
nancy-associated plasma protein A (PAPP-A) in the lowest
fifth percentile at 8–14 wk gestation had an increased risk of
intrauterine growth restriction [adjusted odds ratio, 2.9; 95%
confidence interval (CI), 2.0–4.1], extremely premature deliv-
ery (adjusted odds ratio, 2.9; 95% CI, 1.6–5.5), moderately pre-
mature delivery (adjusted odds ratio, 2.4; 95% CI, 1.7–3.5), pre-
eclampsia (adjusted odds ratio, 2.3; 95% CI, 1.6–3.3), and
stillbirth (adjusted odds ratio, 3.6; 95% CI, 1.2–11.0). The
strengths of the associations were similar when the test was
performed before 13 wk gestation or between 13 and 14 wk
gestation. In contrast, levels of free -human CG, another cir-
culating protein synthesized by the syncytiotrophoblast, were
not predictive of later outcome in multivariate analysis.
PAPP-A has been identified as a protease specific for IGF
binding proteins. We conclude that control of the IGF system
in the first and early second trimester trophoblast may have
a key role in determining subsequent pregnancy outcome.
(J Clin Endocrinol Metab 87: 1762–1767, 2002)
INTRAUTERINE GROWTH RESTRICTION and pretermbirth are major determinants of perinatal morbidity and
mortality. Much of routine prenatal care involves detecting
women at increased risk of these adverse events and target-
ing intensive monitoring and interventions. Standard re-
views of fetal physiology suggested that variation in human
fetal growth was largely a phenomenon of the second half of
pregnancy (1), and it is during this phase of pregnancy when
women receive the bulk of prenatal care. However, a pre-
vious study showed that embryos and fetuses that were
smaller than expected in the first trimester of pregnancy were
more likely to have pregnancy complications, including in-
trauterine growth restriction and preterm birth (2). In the
present study, we investigated whether circulating concen-
trations of two trophoblast-derived proteins in early preg-
nancy [pregnancy-associated plasma protein A (PAPP-A)
and free -subunit human CG (FhCG)] might identify
women at increased risk of subsequent adverse perinatal
outcomes.
Materials and Methods
Blood samples were obtained from women between 8 and 14 wk
gestation, attending 15 maternity hospitals in southern Scotland, as part
of a prospective, nonintervention multicenter study on combined ul-
trasound and biochemical screening for Down’s syndrome, which is
being reported elsewhere (Crossley et al., submitted for publication).
Women were sent an information leaflet along with their booking no-
tification and were invited to participate in the study when first attend-
ing for prenatal care. Gestational age at the time of recruitment was
assessed by crown-rump length (CRL) and/or biparietal diameter, as
recommended, using previously described protocols (3). Signed consent
was obtained from all patients, and ethical approval was obtained from
the institutional committees of all participating centers and from the
regional multicenter ethics committee. No results were reported to either
the obstetrician or patient, and prenatal care was not modified in any
way by participation in the study.
Seven data collection
Relevant patient and pregnancy information were entered on the
study data form, which was sent along with a clotted blood sample to
the study coordinating center, where the data were entered into the
study database. Samples were assayed for PAPP-A and FhCG using the
Kryptor immunoassay analyzer (Brahms, Berlin, Germany; formerly sup-
plied by CIS-Bio International, Burgess Hill, UK). Kryptor assays are
based on time- resolved amplified cryptate emission technology.
PAPP-A exists complexed 2:2 with the precursor of eosinophil major
basic protein, and the PAPP-A assay measures this PAPP-A/precursor
of eosinophil major basic protein complex. The detection limit of the
assay is 0.004 IU/liter (International reference preparation 78/610), and
the coefficient of variation was found to be 3.5% at 4.58 IU/liter and 5.7%
at 12.90 IU/liter. The FhCG assay is specific for the unbound -subunit
of hCG and measures both nicked and unnicked forms. The detection
limit of the assay is 0.1 IU/liter (International reference preparation
75/551), and the coefficient of variation was found to be 4.3% at 17.6
IU/liter and 3.5% at 48.4 IU/liter. FhCG and PAPP-A levels were
converted to multiples of the median (MOMs) using the CRL or bipa-
rietal diameter measurement when the sample was obtained as an es-
timate of gestation. Because PAPP-A levels are reduced in smokers by
around 15%, when compared with nonsmokers (4), separate medians
were used for each group. PAPP-A and FhCG MOM values were
corrected for maternal weight using reciprocal-linear regression (5).
Outcome data were gathered from each woman’s clinical record, after
Abbreviations: BMI, Body mass index; BW, birth weight; CI, confi-
dence interval; CRL, crown-rump length; FhCG, free -human CG;
IGFBP, IGF binding protein; MOM, multiple of the median.
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delivery, using predefined criteria and coded by a team of two research
midwives, two obstetricians, and two clinical scientists.
Selection of study cohort
The database included 9002 records of singleton pregnancies where
values for PAPP-A, FhCG, and gestational age at the time of sampling
were documented and outcome data were available. We excluded 121
(1.3%) records with missing values for birth weight (BW), 68 (0.8%) with
missing values for perinatal outcome (i.e. stillbirth or livebirth), 99 (1.1%)
records where the gestational age at delivery was outside the range of
24–43 wk, and 26 (0.3%) records where the karyotype was abnormal or
missing. This left a study group of 8839 (some records had multiple
exclusions or missing values).
Definitions and denominators
Nulliparous women were defined as women either having their first
pregnancy or women whose births were preceded only by pregnancies
that resulted in abortion before 24 wk gestation. Gestational age was
defined as the number of completed weeks of gestation. A small-for-
gestational-age baby was defined as a liveborn baby that was less than
the fifth percentile of BW for the given week of gestation, using per-
centiles derived from 409,541 live births in Scotland between 1992–1998
(G. C. S. Smith, unpublished data). The denominator was all live births.
Very preterm delivery was defined as birth of a live-born baby between
24 and 32 wk gestation inclusive and the denominator was all live births
at or after 24 wk gestation. Moderately preterm delivery was defined as
live births between 33 and 36 wk gestation inclusive and the denomi-
nator was all live-births at or after 33 wk gestation. Spontaneous preterm
birth was defined as vaginal delivery of a liveborn baby between 24–36
wk where labor had not been induced. The denominator was sponta-
neous preterm births plus term births. Stillbirth was defined as delivery
of a dead baby at or after 24 wk gestational age and the denominator was
all births at or after 24 wk gestational age. Preeclampsia was defined as
pregnancy-induced hypertension with proteinuria. Maternal age was
defined as the age of the mother, in completed years, at term. Maternal
height was measured in centimeters, maternal weight was measured in
kilograms at the time of blood sampling, and body mass index (BMI) was
calculated using weight divided by height squared. Nonsmoking was
defined as never having smoked, at the time of first attendance for
prenatal care; exsmokers were defined as women who stopped smoking
either before or during pregnancy; and smokers were defined as women
who smoked throughout pregnancy.
Statistical analyses
Separate analyses were undertaken for five dichotomous outcomes:
delivery of a small-for-gestational-age baby, moderately preterm deliv-
ery, extremely preterm delivery, preeclampsia, and stillbirth. Univariate
comparisons of dichotomous data were performed using the chi-square
test (more than five observations in all cells) or Fisher’s exact test (five
or fewer observations in one or more cells). Ordinal data were compared
using the chi-square test for trend. The P values for all hypotheses tests
were two-sided. Crude and adjusted odds ratios were obtained using
logistic regression analysis (6). Height and BMI were categorized into
strata, age was dichotomized into 35 and 35, and gestational age at
the time of sampling was dichotomized into 13 wk and 13 wk. The
statistical significance of interaction terms was assessed using the like-
lihood ratio test. The goodness quality of fit of models was assessed
using the Hosmer and Lemeshow test based on deciles of probability.
All statistical analyses were performed using the Stata software package
(Stata Corporation, College Station, TX), version 7.0.
Results
Among the study group, there were missing values for
parity in 512 records (5.8%), for height in 739 (8.4%), for BMI
in 814 (9.2%), for smoking status in 342 (3.9%), for ethnicity
in 557 (6.3%), and for maternal age in 49 (0.6%). The basic
demographic and outcome data are given in Table 1. Values
of PAPP-A measured in the study ranged from 0.09–27.70
IU/liter, and values of FhCG ranged from 3.2–265 IU/liter.
When the proportion of adverse events was compared
among deciles of PAPP-A, the lowest decile of PAPP-A con-
sistently had the highest proportion of adverse outcomes
(Fig. 1). Moreover, there was an association between intra-
uterine growth restriction and moderately premature deliv-
ery across the whole range of PAPP-A (Fig. 1). When out-
comes were compared in relation to FhCG, there was a
trend for increased proportions of growth-restricted babies
with decreasing FhCG, but not with any of the other outcomes
(Fig. 2). The number of stillbirths was too small to test for trend,
but the highest proportion of stillbirths was seen in the lowest
deciles of both PAPP-A and FhCG (Figs. 1 and 2).
We then determined the ability of the lowest 5% of MOMs
TABLE 1. Characteristics and outcomes of study group (n  8839)
Study group characteristics
Age (yr) Median (IQR) 30.7 (26.9–34.0)
Age  35 yr 1693 (19.2%)
Parity Median (IQR) 1 (0–1)
Nulliparous 3924 (44.4%)
Ethnicity Non-Caucasian 221 (2.5%)
Smoking status Nonsmokers 5976 (67.6%)
Exsmokers 703 (8.0%)
Current smokers 1818 (20.6%)
Height (cm) Median (IQR) 163 (159–168)
Weight (kg) Median (IQR) 63.9 (57.5–72.1)
BMI Median (IQR) 23.8 (21.7–26.6)
Gestational age at sampling Median (IQR) (in days) 87 (81–93)
13 wk 5388 (60.4%)
Outcome data
BW (g)* Median (IQR) 3450 (3110–3780)
Less than 5th percentilea 370 (4.2%)
Gestational age at deliverya 24–32 wk 86 (1.0%)
33–36 wk 326 (3.7%)
37–43 wk 8405 (95.3%)
Stillbirths 22 (0.3%)
Data are number (%) unless stated otherwise. IQR, Interquartile range.
a Excludes stillbirths.
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for each serum marker to identify women at increased risk
of adverse outcomes in later pregnancy (Table 2). Women
with the lowest 5% of PAPP-A MOMs were at increased risk
of intrauterine growth restriction, moderately and extremely
premature birth, preeclampsia, and stillbirth. Women with
the lowest 5% of FhCG MOMs were at increased risk of
intrauterine growth restriction but none of the other
outcomes.
In multivariate analysis (Table 3), PAPP-A remained
highly significantly predictive of all adverse outcomes when
adjusted for FhCG, BMI, height, ethnicity, parity, smoking
status, maternal age, and gestational age at the time of sam-
pling. There were no statistically significant interactions be-
tween PAPP-A and the other covariates. FhCG was no
longer significantly positively predictive of any adverse out-
come when adjusted for PAPP-A, BMI, height, ethnicity,
parity, smoking status, maternal age, and gestational age at
the time of sampling. There were no statistically significant
interactions between FhCG and any of these other covari-
ates. When the analysis was confined to spontaneous pre-
term births, there was a positive association with the lowest
5% of PAPP-A MOMs [adjusted odds ratio, 2.0; 95% confi-
dence interval (CI), 1.2–3.3; P 0.005] but no association with
the lowest 5% of FhCG MOMs (adjusted odds ratio, 0.7; 95%
CI, 0.4–1.4; P  0.32).
Discussion
In this study, we demonstrate that maternal circulating
concentrations of PAPP-A at 8–14 wk gestation are signifi-
cantly predictive of adverse perinatal outcome in later preg-
nancy. The strength of the association between PAPP-A and
outcome before 13 wk gestation was similar to that at13 wk
gestation. These data indicate that, in a proportion of women,
adverse pregnancy outcome is determined in the first tri-
mester of pregnancy.
We had previously studied ultrasonic measurement of the
CRL of the fetus and found that embryos and fetuses that
were smaller than expected in the first trimester were more
likely to be low BW, low BW at term, in the smallest fifth
percentile of weight for gestational age, and born extremely
prematurely (2). That study had certain weaknesses. First,
the fetus might be smaller than expected because of variation
in the assumed day of ovulation. Second, we were able to
obtain an ideal menstrual history and early ultrasound in
only approximately 10% of women, which meant that the
FIG. 1. Proportion of adverse perinatal out-
comes related to PAPP-A decile. The P value
is the chi-square test for trend. When data
from the smallest decile were excluded, the
test for trend remained statistically signifi-
cant for BW less than fifth percentile (P 
0.0001) and delivery between 33–36 wk (P
0.006) but was no longer statistically signif-
icant for preeclampsia (P  0.22). The chi-
square test was not performed on stillbirth
data, because of the small number of adverse
events.
1764 J Clin Endocrinol Metab, April 2002, 87(4):1762–1767 Smith et al. • First Trimester PAPP-A and Outcome
Page 256
technique could not be used as a screening test. Our current
findings of an association between low PAPP-A and adverse
outcome provide additional weight to our hypothesis that
adverse perinatal outcome may be determined in early preg-
nancy. These observations suggest that measurement of spe-
cific circulating trophoblast-derived proteins in the first tri-
mester of pregnancy may provide a potential screening tool
to identify women at increased risk of subsequent adverse
pregnancy outcome.
There is an extensive literature on the use of trophoblast-
derived steroids and proteins, including PAPP-A, as bio-
chemical tests of fetal well-being in the third trimester of
pregnancy (7), although these are not currently widely used
in antepartum monitoring. Previous studies of first-trimester
measurement of PAPP-A and perinatal outcome have re-
ported inconsistent results. One study compared first-
trimester PAPP-A levels in 73 babies ultimately born less
than the fifth percentile for gestational age and 87 babies
ultimately born preterm with matched controls. There was
no statistically significant difference between the groups (8).
However, another study found a positive correlation be-
tween PAPP-A at 8–14 wk and eventual BW (9), and an
FIG. 2. Proportion of adverse perinatal
outcomes related to FhCG decile. The P
value is the chi-square test for trend. When
data from the smallest decile were ex-
cluded, the test for trend remained statis-
tically significant for BW less than fifth
percentile (P  0.03). The chi-square test
was not performed on stillbirth data, be-
cause of the small number of adverse
events.
TABLE 2. Univariate analysis of first-trimester biochemistry and perinatal outcomes
PAPP-A FhCG
Smallest 5th
percentile
(n  461)
5th
Percentile
(n  8378)
Odds
ratio
(95% CI)
P Smallest 5th
percentile
(n  456)
5th
Percentile
(n  8383)
Odds
ratio
(95% CI)
P
BW  5th percentile
for gestational age
46 (10.0%) 324 (3.9%) 2.8 (2.0–3.8) 0.0001 30 (6.6%) 340 (4.1%) 1.7 (1.1–2.5) 0.008
Delivery, 24–32 wk 12 (2.6%) 74 (0.9%) 3.0 (1.6–5.5) 0.0002 6 (1.3%) 80 (1.0%) 1.4 (0.6–3.1) 0.44
Delivery, 33–36 wk 35 (7.9%) 291 (3.5%) 2.2 (1.6–3.4) 0.0001 10 (2.2%) 316 (3.8%) 0.6 (0.3–1.1) 0.09
Preeclampsia 35 (7.6%) 296 (3.5%) 2.1 (1.6–3.2) 0.0001 19 (4.1%) 312 (3.7%) 1.1 (0.7–1.8) 0.63
Stillbirth 4 (0.9%) 18 (0.2%) 4.0 (1.4–11.5) 0.03 3 (0.7%) 19 (0.2%) 2.9 (0.9–9.8) 0.10
Statistical comparison by 2 test or Fisher’s exact test, as appropriate.
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analysis of 60 in vitro fertilization pregnancies described
lower concentrations of PAPP-A in the first trimester among
8 women who eventually delivered preterm (10). Another
study of 5297 women demonstrated lower PAPP-A levels at
10–14 wk gestation among women who miscarried, deliv-
ered babies small for gestational age, and developed pre-
eclampsia (11). However, PAPP-A was used in these women
to estimate the risk of the fetus having Down’s syndrome,
and the study failed to take into account the effect of invasive
procedures, which may well have explained the association
with loss before 24 wk. Moreover, none of these studies took
into account smoking status. Because smoking is associated
with many of these outcomes (12) and is also associated with
low PAPP-A (4), these studies are difficult to interpret. The
advantages of the present study are: that it was a prospective
cohort study, that the levels of serum markers did not in-
fluence clinical management, that key maternal factors such
as weight and smoking were taken into account, and that it
included much larger numbers of women who ultimately
experienced adverse events.
The pattern of the association varied for different out-
comes (Fig. 1). In the case of preeclampsia, stillbirth, and
extremely premature birth, the association was only with the
smallest decile of PAPP-A. In the case of growth restriction
and moderately premature delivery, the association was ob-
served across the whole range of PAPP-A. Moreover, low
FhCG was also associated with growth restriction, although
this was lost after adjusting for PAPP-A, whereas low FhCG
was not significantly associated with the other outcomes,
even in univariate analysis (Tables 2 and 3). Both PAPP-A
and FhCG are produced by the syncytiotrophoblast (13, 14).
It seems likely that these different patterns of association may
reflect different pathophysiological mechanisms relating
first-trimester trophoblast function and later adverse peri-
natal outcome. The fact that the strength and pattern of the
association differed for the two trophoblast-derived proteins
suggests that PAPP-A is not acting as a simple marker of the
volume or health of the trophoblast but that the association
reflects a specific property of PAPP-A in the physiological
regulation of trophoblast function.
The precise mechanisms linking first-trimester levels of
trophoblast-derived proteins and adverse outcomes will re-
quire further study. PAPP-A has been identified as a protease
for IGF binding protein (IGFBP)-4 (15). IGFBPs bind IGF-I
and IGF-II, inhibiting their interaction with cell surface re-
ceptors and have, therefore, a key role in modulating IGF
activity (16). Because PAPP-A breaks down IGFBP (15), low
levels of PAPP-A would be expected to be associated with
high levels of IGFBP and, therefore, low levels of free IGF.
The IGFs have a key role in regulating fetal growth (17). The
IGFs have also been shown to control uptake of glucose and
amino acids in cultured trophoblast (18) and are thought to
have an important role in the autocrine and paracrine control
of trophoblast invasion of the decidua (19). The current ob-
servation that PAPP-A was predictive of a range of adverse
obstetric outcomes implies a fundamental role of this system
in development of the placenta in early pregnancy, and the
observed association between low PAPP-A and poor peri-
natal outcome is clearly biologically plausible.
In summary, first-trimester serum concentrations of
PAPP-A, a trophoblast-specific protein regulating IGF func-
tion, is highly predictive of a range of subsequent adverse
pregnancy outcomes. These observations imply that adverse
outcome in late pregnancy may be determined in the first
trimester of pregnancy, that control of the IGF system in early
pregnancy may be critical in normal placental development,
and that women at high risk of adverse pregnancy outcome
may be identified in very early pregnancy.
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weight baby (adjusted odds ratio, 0.2; 95%
CI, 0.1–0.6; P40.002). In contrast, there was
no significant independent relationship in
the case of free b-CG (adjusted odds ratio,
0.6; 95% CI, 0.2–1.3; P40.17).
The factors that determine variation in
birth weight are fetal growth and the dura-
tion of pregnancy. We examined the rela-
tionship between PAPP-A concentration and
fetal growth using multiple linear-regression
analysis, and identified a strong, positive
correlation between first-trimester levels of
PAPP-A and eventual birth weight at 38–41
weeks of gestation (Fig. 1a). There was no
strong association between free b-CG levels
and birth weight at the same gestational age.
The relationship between first-trimester
concentrations of  PAPP-A or free b-CG and
the timing of labour at full term was deter-
mined using time-to-event analysis9. Vaginal
delivery after non-induced labour was taken
as the event and all other modes of delivery
were treated as censored. Lower concentra-
tions of PAPP-A during the first trimester
were associated with an earlier onset of
spontaneous labour at full term (Fig. 1b). 
In a multivariate proportional hazards
model, there was a strongly additive and
inverse relationship between levels of
PAPP-A and free b-CG, and the likelihood
of spontaneous labour on any given day of
gestation at full term (adjusted hazard ratio
for a one log10 unit change in MOM (95%
CI): PAPP-A, 0.81 (0.69–0.96), P40.003;
free b-CG, 0.79 (0.69–0.91), P*0.001).
The association between PAPP-A levels,
fetal growth and the timing of labour is
biologically plausible, as PAPP-A is highly
expressed in first-trimester trophoblasts5
and may be responsible for activation of
IGFs. Our results indicate that the risk of
delivering a low-birth-weight baby at full
term may be determined by the placental
activity of IGFs in very early pregnancy.
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Development
Early-pregnancy origins
of low birth weight
Low birth weight is a significant cause ofmorbidity and mortality among new-borns, and may result from impaired
placental function during the first trimester
of pregnancy1. Here we show that the risk
of delivering a low-birth-weight baby at
term after an uncomplicated pregnancy
varies with maternal circulating concentra-
tions of a placental protein, pregnancy-
associated plasma protein-A (PAPP-A) in
the first 10 weeks after conception. Poor
fetal growth may therefore already have
been determined by the time obstetric
monitoring begins after completion of the
first trimester.
PAPP-A acts as a protease on the binding
proteins of insulin-like growth factor
(IGF)2,3 and may therefore increase the
known stimulatory effects of placental 
IGFs4. Circulating concentrations of PAPP-A
increase during the first three months of
pregnancy, and this protein is highly
expressed in trophoblasts5. We therefore
investigated a possible link between the 
birth weight of a baby at term and maternal
levels of PAPP-A during the first trimester.
We determined the specificity of associations
with PAPP-A by comparing it with the 
free b-subunit of human chorionic
gonadotrophin (b-CG), another tropho-
blast-derived protein whose circulating 
levels change in the first trimester6 but which
is functionally unrelated to the IGF system.
As part of a prospective, multicentre,
non-interventional cohort study, we obtain-
ed serum from 4,288 women at 8–12 
weeks of gestation (dated by ultrasound,
equivalent to 6–10 weeks after conception),
who ultimately had uncomplicated singleton
pregnancies and delivered normal, live
babies at full term. We had complete data for
these women on maternal age, parity, height,
body-mass index, race and smoking status.
Serum levels of PAPP-A and free b-CG
were measured using a Kryptor immuno-
assay analyser (Brahms Diagnostica) and
converted to multiples of the appropriate
gestational median (MOM), corrected for
smoking status7 and maternal weight8. 
There was a greater proportion of low-
birth-weight infants (under 2,500 g) deliv-
ered to women with a first-trimester PAPP-A
concentration in the lowest 5% (9 out of 201,
4.5%) compared with other women (65 out
of 4,087, 1.6%; P40.002). Using multivari-
ate logistic regression (adjusting for maternal
height, race, body-mass index, smoking 
status and elective delivery), a one log10 unit
increase in first trimester PAPP-A MOM
(roughly equivalent to the range from the 1st
to the 99th percentile) was associated with an
80% reduction in the risk of a low-birth-
Figure 1 Association between pregnancy-associated plasma 
protein-A (PAPP-A), birth weight at 38–41 weeks of gestation and
timing of labour at full term. a, Eventual birth weight plotted against
PAPP-A multiples of the median (MOM; on a log10 scale) from a 
linear regression analysis. Curves (from bottom to top) represent
gestational ages of 38, 39, 40 and 41 weeks. Coefficients (95%
CI) for change in birth weight associated with a one log10 unit
change in PAPP-A MOM: 38 weeks, 380 (209–552); 39 weeks,
231 (113–349); 40 weeks, 196 (104–289); 41 weeks, 221
(112–331); P*0.0001 in each case. Coefficients were virtually
unchanged after adjusting for age, parity, body-mass index, height,
smoking status and race. b, Cumulative hazard (Nelson–Aelen
cumulative hazard function10) of spontaneous labour on each day
of gestation at full term, comparing the lowest (top curve) and
highest (bottom curve) quintiles of first-trimester PAPP-A MOMs.
Univariate comparison, P40.0003 (log rank test).
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PRELIMINARY
COMMUNICATION
First-Trimester Placentation and the Risk
of Antepartum Stillbirth
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STILLBIRTH AFFECTS APPROXI-mately 1 in 200 pregnancies andis therefore approximately 10times more common than sud-
den infant death syndrome.1 In approxi-
mately 85% of stillbirths, death of the
fetus occurs prior to labor.2 The main
epidemiological factors associatedwith
an increased risk of stillbirth are ad-
vanced gestational age, advanced ma-
ternal age, nulliparity, high parity,
smoking, obesity, and poor obstetric
history.3 However, most of these asso-
ciations are relativelyweak. Effective in-
terventions have been described to re-
duce perinatal mortality, such as
Doppler ultrasonography of umbilical
artery blood flow4 and induction of la-
bor, which is used in prolonged preg-
nancy.5 However, application of these
interventions requires identification of
women at high risk of stillbirth.
We have shown that the risk of a
number of pregnancy complications,
such as preterm birth and low birth
weight, is determined, at least in part,
during the first trimester of preg-
nancy.6,7 However, it is not known
whether the risk of stillbirth is also de-
termined during the first trimester. In
the present large-scale, multicenter,
prospective cohort study, we deter-
mined the risk of antepartum still-
birth in relation tomaternal serum lev-
els of 2 proteins derived from the
placenta—pregnancy-associatedplasma
protein A (PAPP-A) and the free sub-
unit of human chorionic gonadotro-
pin (HCG)—measured during the first
10 weeks after conception.
METHODS
We used data from the Combined Ul-
trasound and Biochemical Screening
(CUBS)8 study, a prospective, multi-
center study of screening forDown syn-
drome. The CUBS study evaluated the
use of ultrasound measurement of fe-
tal nuchal translucency in combina-
tion with analysis of maternal serum
levels of PAPP-A and free  subunit of
HCG as a first-trimester screening test
for Down syndrome in a routine pre-
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Context Preterm birth and low birth weight are determined, at least in part, during
the first trimester of pregnancy. However, it is unknown whether the risk of stillbirth
is also determined during the first trimester.
Objective To determine whether the risk of antepartum stillbirth varies in relation
to circulating markers of placental function measured during the first trimester of preg-
nancy.
Design, Setting, and Participants Multicenter, prospective cohort study (con-
ducted in Scotland from 1998 through 2000) of 7934womenwho had singleton births
at or after 24 weeks’ gestation, who had blood taken during the first 10 weeks after
conception, andwhowere entered into national registries of births and perinatal deaths.
MainOutcomeMeasures Antepartum stillbirths and stillbirths due to specific causes.
Results There were 8 stillbirths among the 400 women with levels of pregnancy-
associated plasma protein A (PAPP-A) in the lowest fifth percentile compared with 17
among the remaining 7534 women (incidence rate per 10000 women per week of
gestation: 13.4 vs 1.4, respectively; hazard ratio [HR], 9.2 [95% confidence interval
{CI}, 4.0-21.4]; P.001). When analyzed by cause of stillbirth, low level of PAPP-A
was strongly associated with stillbirth due to placental dysfunction, defined as abrup-
tion or unexplained stillbirth associated with growth restriction (incidence rate: 11.7
vs 0.3, respectively; HR, 46.0 [95%CI, 11.9-178.0]; P.001), but was not associated
with other causes of stillbirth (incidence rate: 1.7 vs 1.1, respectively; HR, 1.4 [95%
CI, 0.2-10.6]; P=.75). There was no relationship between having a low level of PAPP-A
and maternal age, ethnicity, parity, height, body mass index, race, or marital status.
Adjustment for maternal factors did not attenuate the strength of associations ob-
served. There was no association betweenmaternal circulating levels of the free  sub-
unit of human chorionic gonadotropin and stillbirth risk.
Conclusion The risk of stillbirth in late pregnancy may be determined by placental
function in the first 10 weeks after conception.
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natal clinic setting. Information leaf-
lets about the studywere sent towomen
with the notification of their first ap-
pointment for prenatal care. Those
women whose first visit was within 14
weeks’ gestation were invited to par-
ticipate and those who agreed signed
a consent form. Participation in the
study involved obtaining a measure-
ment of nuchal translucency at the time
of the first ultrasound and an addi-
tional blood sample at the time of phle-
botomy for routine prenatal investiga-
tions.No resultswere reported to either
the obstetrician or patient and prena-
tal care was not modified in any way
due to participation in the study. Ethi-
cal approval was obtained from the eth-
ics committee for Scottish Multi-
center Research. Fifteen Scottish
maternity units participated during a
2-year period between 1997 and 1999
and 98.6% of records came from births
in 11 of the hospitals. Ninety-eight per-
cent of the births occurred betweenMay
1998 and July 2000. Births to women
recruited to the study constituted 28.6%
of all births in the 11 hospitals during
that period.
Pregnancy outcome was ascer-
tained by record linkage to the Scot-
tish Morbidity Record9 and the Scot-
tish Stillbirth and Infant Death
Enquiry.1 The Scottish Morbidity Rec-
ord is a national registry of pregnancy
outcome data and the Scottish Still-
birth and Infant Death Enquiry is a na-
tional registry that routinely classifies
all perinatal deaths in Scotland. Both
registries are close to 100% complete
and are described in detail else-
where.1,9 The study cohort for the cur-
rent analysis was defined by women
who participated in the CUBS study,
had a PAPP-A level recorded prior to
91 days’ gestation (equivalent to 77
days after conception) assessed by
crown-rump length, andwere linked to
the ScottishMorbidity Record inwhich
singleton birth occurred at or after 24
weeks’ gestation. This cutoff was cho-
sen because ascertainment of still-
births at less than 24 weeks’ gestation
is incomplete and the causes are not de-
fined in the Scottish Stillbirth and In-
fantDeathEnquiry.1 Therewere nodata
on spontaneous and therapeutic abor-
tions.
Definitions and Denominators
Maternal height, smoking status, mari-
tal status, ethnicity, and bodymass in-
dex (weight in kilograms divided by the
height in meters squared) were ascer-
tained at the time of the first prenatal
visit. Maternal age was defined as the
age at delivery. Socioeconomic status
was estimated based on the postcode of
residence, using Carstairs socioeco-
nomic deprivation categories10 (based
on 1991 Census data on car owner-
ship, unemployment, overcrowding,
and social class within postcode sec-
tors of residence, which contain ap-
proximately 1600 residents). Women
were categorized into quintiles of
socioeconomic deprivation. The ges-
tational age at birthwas defined as com-
pletedweeks of gestation. Racewas self-
reported byquestionnaire (optionswere
white and other). Many studies have
shown disparity in stillbirth risk com-
paring racial groups, but our popula-
tion had a small proportion of non-
white women.
The cause of perinatal deathwas clas-
sified by a modified version of the
Wigglesworth system.8 Explained still-
births were defined as those in which
therewas an apparent direct cause, such
as fetal abnormality, placental abrup-
tion, ormaternal diabetes. All other still-
births were classified as unexplained.
Unexplained stillbirths were subdi-
vided into those thatwere small for ges-
tational age (SGA; in the smallest fifth
percentile for sex and week of gesta-
tion) and those appropriate for gesta-
tional age. Unexplained SGA still-
births were assumed to reflect chronic
placental insufficiency. Therefore, still-
births due to abruption or SGA unex-
plained stillbirths were considered col-
lectively as stillbirths due to placental
causes.
Statistical Analyses
Levels of PAPP-A and free  subunit of
HCGwere expressed asmultiples of the
median for gestational age, which is the
convention for biochemical indices in
pregnancy that vary with week of ges-
tation. Because PAPP-A levels vary in-
versely with maternal weight, mul-
tiples of the median were corrected for
maternal weight using reciprocal-
linear regression. Thismethod iswidely
used in prenatal screening and is de-
scribed in detail elsewhere.11 Separate
multiples of themedian forPAPP-A level
were estimated for smokers because
PAPP-A level is reduced by 15% among
smokers.8Univariate comparisonof con-
tinuous variables was performed using
theMann-Whitney test and of categori-
cal data using the Fisher exact test. All
P valueswere 2-sided. Statistical signifi-
cance was assumed at P.05.
The association between PAPP-A
level and stillbirthwas assessed by com-
paring women with levels in the low-
est fifth percentile withwomen in other
percentiles.We previously showed that
a low PAPP-A level was associatedwith
a range of adverse outcomes. How-
ever, we also studied PAPP-A level as
a continuous variable and categorized
it by quintiles. The risk of stillbirth was
compared between groups using time
to event analyses in whichweek of ges-
tation from 24weeks onward was used
as the time scale. The gestational age
at delivery was taken as the time of the
event in the case of antepartum still-
birth or the time of censoring in the case
of all other births. Thismethoduses on-
going pregnancies as the denomina-
tor, as previously suggested,12 but ac-
counts for censoring due to birth and
allowsmultivariate analysis2 and can be
used in situations in which not all in-
dividuals would ultimately experi-
ence the event.13 This analytic ap-
proach allows assessment of the relative
risk accounting for variation in the du-
ration of pregnancy. Survival data were
plotted as a cumulative percentage of
the event, which is recommended for
rare outcomes,14 and univariate statis-
tical comparisons weremade using the
log-rank test. Crude and adjusted haz-
ard ratios were estimated using a Cox
proportional hazardsmodel.15 The pro-
portional hazards assumption was
tested using the global test ofGrambsch
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and Therneau.16 Goodness of fit was as-
sessed by the global test described by
May andHosmer.17Missing valueswere
imputed using multiple imputation.18
All statistical analyses were per-
formed using STATA statistical soft-
ware (version 8.2, STATA Corp, Col-
lege Station, Tex).
RESULTS
The linked database contained 11729
records of women who had a PAPP-A
level recorded and had an entry in the
Scottish Morbidity Record. In 3 re-
cords (0.1%), the gestational age at
delivery was less than 24 weeks, leav-
ing a cohort of 11726 singleton births
at or after 24 weeks’ gestation. Among
these, 7934 (67.7%)were assayed prior
to 13 weeks’ gestation (equivalent to
77 days after conception). The me-
dian gestational age at sampling was
11.9 weeks (69 days after conception;
interquartile range [IQR], 65-73 days).
There was no relationship between low
PAPP-A level and maternal character-
istics (TABLE 1). Circulating serum lev-
els of PAPP-A (expressed in multiples
of themedian for gestational age) were
lower inmale fetuses comparedwith fe-
male (median [IQR], 0.97 [0.67-1.41]
vs 1.03 [0.71-1.46], respectively;
P.001).
There were 25 (0.3%) antepartum
stillbirths in the study group. An au-
topsywas performedon19 (76%) of the
stillborns. Ten stillbirths were attrib-
uted to placental causes—4 due to
Table 1. Maternal Characteristics in Relation to Levels of PAPP-A in the First 10 Weeks After
Conception*
Percentile of PAPP-A Level
P Value
Fifth
(n = 400)†
Fifth
(n = 7534)
Age, median (IQR), y 29 (25-33) 30 (26-33) .26
Marital status
Married 244 (61.0) 4597 (61.0)
Other 135 (33.8) 2416 (32.1) .39
Missing data 21 (5.2) 521 (6.9)
Deprivation quintile
1 (Least deprived) 82 (20.5) 1653 (21.9)
2 61 (15.2) 1177 (15.6)
3 78 (19.5) 1613 (21.4)
.60
4 102 (25.5) 1645 (21.8)
5 (Most deprived) 77 (19.2) 1440 (19.1)
Missing data 0 6 (0.1)
Ethnicity
White 373 (93.2) 6912 (91.7)
Other 6 (1.5) 182 (2.4) .44
Missing data 21 (5.2) 440 (5.8)
Smoking status
Nonsmoker 277 (69.2) 5161 (68.5)
Former smoker 31 (7.8) 615 (8.2)
.91
Current smoker 89 (22.3) 1719 (22.8)
Missing data 3 (0.8) 39 (0.5)
No. of previous births
None 226 (56.5) 4158 (55.2)
.61
1 174 (43.5) 3376 (44.8)
No. of previous abortions
None 276 (69.0) 5363 (71.2)
.35
1 124 (31.0) 2171 (28.8)
Height, median (IQR), cm 163 (159-168) 163 (159-168) .53
Missing data 10 (2.5) 151 (2.0) .49
Body mass index, median (IQR)‡ 23.7 (21.6-27.1) 23.9 (21.6-26.9) .91
Missing data 43 (10.8) 644 (8.6) .13
Abbreviations: IQR, interquartile range; PAPP-A, pregnancy-associated plasma protein A.
*Values are presented as number (percentage) unless otherwise indicated.
†The lowest fifth percentile of PAPP-A was equivalent to 0.4 multiples of the median.
‡Calculated as weight in kilograms square of height in meters.
Table 2. Low PAPP-A in the First 10 Weeks After Conception and the Risk of Stillbirth*
Stillbirth
Category
No. (%) in
Fifth Percentile
of PAPP-A Level
(n = 400)
Incidence
Rate†
No. (%) in Fifth
Percentile of
PAPP-A Level
(n = 7534)
Incidence
Rate†
Unadjusted
HR (95% CI)
P
Value
Adjusted
HR (95% CI)‡
P
Value
All cause 8 (2.0)§ 13.4 17 (0.2) 1.4 9.2 (4.0-21.4) .001 9.4 (4.1-21.9) .001
Due to abruption 3 (0.8) 5.0 1 (0.1) 0.1 58.0 (6.0-557.3) .001 60.5 (6.1-597.0) .001
All unexplained 4 (1.0) 6.7 12 (0.2) 0.9 6.6 (2.1-20.4) .001 7.2 (2.3-22.4) .001
Unexplained SGA 4 (1.0) 6.7 2 (0.1) 0.2 40.0 (7.3-218.3) .001 46.6 (8.3-262.1) .001
All placenta-related 7 (1.8) 11.7 3 (0.1) 0.3 46.0 (11.9-178.0) .001 52.6 (13.3-207.8) .001
Not related to placental
dysfunction
1 (0.2) 1.7 14 (0.2) 1.1 1.4 (0.2-10.6) .75 1.4 (0.2-10.9) .73
Abbreviations: CI, confidence interval; HR, hazard ratio; PAPP-A, pregnancy-associated plasma protein A; SGA, small for gestational age.
*The earliest stillbirth occurred at 24 weeks and the latest occurred at 41 weeks.
†Incidence expressed per 10000 women per week of gestation from 24 weeks.
‡Adjusted for maternal age, height, body mass index, marital status, ethnicity, socioeconomic deprivation category, smoking, and fetal sex.
§Attributable fraction=28.4%.
Attributable fraction=68.4%.
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abruption and 6 were SGA unex-
plained stillbirths. An autopsywas per-
formed on all of the SGA unexplained
stillbirths. Among the 400womenwith
PAPP-A levels in the lowest fifth per-
centile (0.4 multiples of the me-
dian), 8 (2%) had a stillbirth due to any
cause, 3 (0.8%) had a stillbirth due to
abruption, 4 (1.0%) had a stillbirth due
to SGA unexplained stillbirth, and 7
(1.8%) had a stillbirth due to placen-
tal causes. When compared with the
rest of the population, a low PAPP-A
level was associatedwith a 9.2-fold risk
of all-cause stillbirth (TABLE 2 ,
FIGURE 1A), a 58.0-fold risk of still-
birth due to abruption, a 40.0-fold risk
of SGA unexplained stillbirth, and a
46.0-fold risk of stillbirth due to pla-
cental dysfunction (Figure 1B). There
were 2 stillbirths due to chromosomal
abnormality in the study group and one
of these was to a mother with a low
PAPP-A level. This was the sole still-
birth among this group not due to a pla-
cental cause.
The proportion of stillbirths due to
placental dysfunctionwas 7 of 8 among
women with a low PAPP-A level com-
pared with 3 of 17 in the other women
(P=.002). FIGURE 2 illustrates the re-
lationship between quintiles of PAPP-A
level and the risk of stillbirth due to pla-
cental dysfunction. There were no still-
births due to placental dysfunction
among women with PAPP-A levels in
the upper 3 quintiles. There was no re-
lationship between free  subunit of
HCG quintile and the risk of all-cause
stillbirth (P=.59) or stillbirth due to pla-
cental dysfunction (Figure 2).
The numbers of all-cause stillbirths
were sufficient to test the goodness of
fit of themultivariatemodel, to test the
proportional hazards assumption, and
to determine whether there were any
interactions between PAPP-A and the
other factors. There was no evidence of
poor fit (P= .93), there was no evi-
dence of nonproportionality (P=.25),
and there were no statistically signifi-
cant interactions between PAPP-A level
and the other maternal characteristics
(all P.01). When treated as a con-
tinuous variable, the hazard ratio as-
sociated with an increase in multiples
of themedian for PAPP-A levelwas 0.13
(95% confidence interval [CI], 0.04-
0.40) and for free subunit ofHCGwas
1.06 (95% CI, 0.67-1.69). The mul-
tiples of the median of PAPP-A level
among stillbirths caused by placental
dysfunction was 0.34 (IQR, 0.27-
0.45) and for other births was 1.00
(IQR, 0.69-1.43) (P.001).
COMMENT
The main finding of this study is that
women in the first 10 weeks after con-
ceptionwithcirculating levels ofPAPP-A
in the lowest fifthpercentilehadagreater
than 40-fold risk of having an intrauter-
ine fetal death due to placental dysfunc-
tion, which was independent of mater-
nal characteristics. There was no
relationship betweenmaternal circulat-
ing levels of free  subunit of HCG and
stillbirth due to any cause. The strengths
of thepresent study are that all datawere
collected prospectively and all out-
comesweredefined independentlyof the
study. Because level of PAPP-Awas not
used in the clinical estimation of Down
syndrome risk, there is no potential for
confounding due to bias in the use of in-
vasive procedures. The study design ex-
cluded women who had a therapeutic
Figure 1. Cumulative Risk of Stillbirth Among Women With Normal or Low Levels of
Pregnancy-Associated Plasma Protein A (PAPP-A)
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Figure 2. Placental Stillbirths in Relation to Level of Pregnancy-Associated Plasma Protein A
and Level of Free  Subunit of Human Chorionic Gonadotropin
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P value is from the Fisher exact test (virtually identical P values obtained when estimated using log-rank test of
survival comparing the 5 quintiles). The upper limits of the quintiles of pregnancy-associated plasma protein A
level are 0.63, 0.87, 1.15, 1.55, 9.1. The upper limits of the quintiles of free  subunit of human chorionic
gonadotropin are 0.61, 0.87, 1.18, 1.72, 9.53.
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abortion due to a chromosomal abnor-
mality. It is likely that some of these
women would have had low PAPP-A
levels. However, because chromo-
somal abnormalities are relatively rare,
excluding thesewomenwould have vir-
tually no effect on the strength of the as-
sociation between stillbirth and placen-
tal dysfunction.Ourdata suggest that the
placental dysfunction causing stillbirth
may be an end point of impaired pla-
cental function in the first 10 weeks af-
ter conception.
We had previously described a 3.6-
fold risk of all-cause stillbirth among
womenwith low levels ofPAPP-A.19This
was based on partial follow-up of the
CUBS cohort.8 However, 40% of the
8839 women in that analysis were
sampled in the second trimester and the
partial follow-up included insufficient
numbers of women sampled in the first
trimester for subanalysis. Moreover, it
was not a prior hypothesis that levels of
PAPP-A would be associated with still-
birth and detailed information on the
cause of stillbirth was not retrieved in
our previous study.We addressed these
weaknesses in the present study by link-
ing the entire CUBS cohort to a na-
tional database of perinatal deaths. Con-
sequently, in the present study, we had
data for almost 8000 women sampled
before 13 weeks’ gestation and still-
births could be classified according to
the cause. This is the first study, to our
knowledge, which demonstrates an as-
sociation between a biochemical mea-
surement in the first trimester and the
risk of stillbirth.Moreover, the strength
of the association betweenPAPP-A level
and stillbirth caused by placental dys-
function is oneof strongest described for
this outcome.
Themainweakness of this study is the
relatively small number of events,which
leads to wide 95% CIs. However, the
lower limit of the 95% CI of the hazard
ratio for placental causes of stillbirthwas
12 and this study is, therefore, pow-
ered to demonstrate a strong associa-
tion. Many studies of stillbirth are lim-
ited by incomplete ascertainment of
cases. However, in the present study as-
certainment of events is likely to be close
to 100% because it is a legal require-
ment to register a stillbirth in Scotland
and the perinatal death database used is
virtually 100% complete when com-
pared against death registries.1 Thepres-
ent study could be criticized because the
women received prenatal care rela-
tively early so theCUBS cohortmay not
be representative of the general popu-
lation.However, the studywas prospec-
tive and ascertainment of stillbirth and
definition of its cause for the present
analysis was completely independent of
the CUBS study. It is unlikely, there-
fore, that there are biases amongwomen
with low levels of PAPP-A that might
lead to a spurious associationwith still-
birth.Moreover, adjustment for a range
ofmaternal characteristics, including all
the previously describedmaternal char-
acteristics associatedwith stillbirth,3 did
not affect the strength of the associa-
tionwithPAPP-A level.Given the above,
it is unlikely that the association be-
tween PAPP-A level and stillbirth is due
to confounding. The primary purpose
of the CUBS study was to assess meth-
ods for Down syndrome screening and
the association described with still-
birth is the result of a secondary analy-
sis. However, the strength and statisti-
cal significance of the associations
observedmake it unlikely that these are
chance findings.
The current study focused on still-
births at or after 24weeks’ gestation be-
cause the data available on these events
are close to 100% complete. The data
sourcesused in thepresent study are less
robust for fetal losses between 20 and
23weeks’ gestation.1 Further studieswill
be required to determine the associa-
tion between PAPP-A level and losses at
earlier gestational ages. However, the
present study is clinically relevant be-
cause the stillbirths occurred at gesta-
tional ages in which the fetus is viable.
Interventions have been described that
have been shown to reduce perinatal
mortality among high-riskwomen, spe-
cifically, Doppler ultrasonography of
umbilical artery blood flow4 and induc-
tion of labor in prolonged pregnancy.5
This raises the possibility that PAPP-A
level might be clinically useful when
combined with an intervention. The
positive predictive value for placental
causes of stillbirth was 1.8% among
womenwith a PAPP-A level in the low-
est fifth percentile. Although low, given
the rarity of this event, this may justify
closer prenatal surveillance and elec-
tive delivery prior to 40 weeks’ gesta-
tion. However, further studies are re-
quired to confirm this association before
clinical practice is changed. Further-
more, it may be that other proteins de-
rived from the placenta in the first tri-
mester have a higher positive predictive
value. This is an area that we are cur-
rently studying.
A specific association between
PAPP-A level and stillbirth is biologi-
cally plausible. PAPP-A has been iden-
tified as a protease for insulinlike growth
factor binding proteins 4 and 5.20 Mes-
senger RNA for PAPP-A has been iden-
tified in placental X cells and syncytio-
trophoblast and the protein has been
localized to placental septae, anchor-
ing villi, and chorionic villi.21 Low lev-
els of PAPP-Awould be expected to lead
to lower levels of free insulinlike growth
factor. The insulinlike growth factor 2
is thought to have a key role in tropho-
blast function22 and, therefore, it is plau-
sible that low levels of PAPP-A reflect
poor placental function in early preg-
nancy. Consistent with this, it has re-
cently been shown that mice homozy-
gous for targeted disruption of the
PAPP-A gene exhibit severe early onset
intrauterine growth restriction.23 Level
of PAPP-A is unlikely to be acting sim-
ply as a marker of placental volume.
There was no association between still-
birth risk and levels of free subunit of
HCG, which is a protein derived from
the placenta that is not involved in the
control of the insulinlike growth factor
system. The current findings indicate
that catastrophic complications of late
pregnancy may be determined by im-
paired placental function in the first 10
weeks after conception, which pre-
cedes prenatal care.
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Circulating Angiogenic Factors in Early
Pregnancy and the Risk of Preeclampsia,
Intrauterine Growth Restriction, Spontaneous
Preterm Birth, and Stillbirth
Gordon C. S. Smith, MD, PhD, Jennifer A. Crossley, PhD, David A. Aitken, PhD, Nicola Jenkins,
Fiona Lyall, PhD, Alan D. Cameron, MD, J. Michael Connor, MD, DSc, and Richard Dobbie, BSc
OBJECTIVE: To estimate the relationship between ma-
ternal serum levels of placental growth factor (PlGF) and
soluble fms-like tyrosine kinase-1 (sFlt-1) in early preg-
nancy with the risk of subsequent adverse outcome.
METHODS: A nested, case–control study was performed
within a prospective cohort study of Down syndrome
screening. Maternal serum levels of sFlt-1 and PlGF at
10–14 weeks of gestation were compared between 939
women with complicated pregnancies and 937 controls.
Associations were quantified as the odds ratio for a one
decile increase in the corrected level of the analyte.
RESULTS: Higher levels of sFlt-1 were not associated
with the risk of preeclampsia but were associated with a
reduced risk of delivery of a small for gestational age
infant (odds ratio [OR] 0.92, 95% confidence interval [CI]
0.88–0.96), extreme (24–32 weeks) spontaneous preterm
birth (OR 0.90, 95% CI 0.83–0.99), moderate (33–36
weeks) spontaneous preterm birth (OR 0.93, 95% CI
0.88–0.98), and stillbirth associated with abruption or
growth restriction (OR 0.77, 95% CI 0.61–0.95). Higher
levels of PlGF were associated with a reduced risk of
preeclampsia (OR 0.95, 95% CI 0.90–0.99) and delivery of
a small for gestational age infant (OR 0.95, 95% CI
0.91–0.99). Associations were minimally affected by ad-
justment for maternal characteristics.
CONCLUSION: Higher early pregnancy levels of sFlt-1
and PlGF were associated with a decreased risk of
adverse perinatal outcome.
(Obstet Gynecol 2007;109:1316–24)
LEVEL OF EVIDENCE: II
Preeclampsia, intrauterine growth restriction, andpreterm birth account for a large proportion of
perinatal mortality. There are currently very few
interventions in routine clinical practice that have
been clearly shown to reduce perinatal deaths due to
these complications. The lack of available interven-
tions reflects continuing uncertainty regarding the
underlying biologic processes that lead to these out-
comes. Recently, a novel approach to preeclampsia
has been proposed. Human and animal studies have
suggested that a protein released from the placenta,
soluble fms-like tyrosine kinase-1 (sFlt-1), may cause
the maternal endothelial dysfunction which is charac-
teristic of preeclampsia.1–3 Recent animal studies have
suggested that administration of vascular endothelial
growth factor A121 (VEGF-A121) to bind and inactivate
sFlt-1 may attenuate the preeclamptic phenotype in
the animal model.4 This approach may have promise
as a means of treating preeclampsia or preventing its
onset in high-risk women. However, there are mini-
mal data on the association between circulating an-
giogenic factors and other complications of preg-
nancy. Here we report the association between
maternal serum levels of sFlt-1 and placental growth
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factor (PlGF) at 10–14 weeks of gestation and the risk
of preeclampsia, delivery of a small for gestational age
(SGA) infant, spontaneous preterm birth, or stillbirth
MATERIALS AND METHODS
We performed a nested case–control study using
serum samples that were stored as part of the Com-
bined Ultrasound and Biochemical Screening study, a
prospective, noninterventional, multicenter study of
screening for Down syndrome.5 The Combined Ul-
trasound and Biochemical Screening study evaluated
the use of ultrasound measurement of fetal nuchal
translucency in combination with analysis of maternal
serum pregnancy-associated plasma protein A and
the free subunit of hCG as a first trimester screening
test for Down syndrome in a routine prenatal clinic
setting. Information leaflets about the study were sent
to women with the notification of their first appoint-
ment for prenatal care. Those women with a singleton
pregnancy whose first visit was at 14 weeks of gesta-
tion or less were invited to participate, and those who
agreed signed a consent form. Participation in the
study involved measurement of nuchal translucency
at the time of the first ultrasonography and obtaining
additional blood at the time of phlebotomy for rou-
tine prenatal investigations. Serum was analyzed for
pregnancy-associated plasma protein A and free
-hCG, and the remainder of the sample was frozen
and stored. No results were reported to either the
obstetrician or patient, and prenatal care was not
modified in any way by participation in the study.
Ethical approval for the cohort study and the
subsequent nested case–control study was obtained
from the Scottish Multicenter Research Ethics Com-
mittee. Fifteen Scottish maternity units participated,5
recruiting women over a 2-year period between 1997
and 1999. A total of 96.6% of records came from
births in 11 hospitals (see Appendix). Ninety-eight
percent of the births occurred between May 1998 and
July 2000. Births to women recruited to the study
constituted 28.6% of all births in these 11 hospitals
over that period of time.
The outcome of the pregnancy was ascertained in
two ways. First, case notes were manually retrieved
from approximately 75% of the cohort, and they were
used to identify women diagnosed with preeclamp-
sia.6 Preeclampsia was defined as women for whom
the diagnosis was documented in the clinical record,
and this was performed by trained midwives. To
obtain outcome data on birth weight percentile, spon-
taneous preterm birth, and stillbirth for the entire
cohort, records were linked to the Scottish Morbidity
Record, a national register of pregnancy outcome
data,7 and the Scottish Stillbirth and Infant Death
Enquiry, a national register that routinely classifies all
perinatal deaths in Scotland.8 Both registries are close
to 100% complete and are described in detail
elsewhere.7,8
Maternal height, smoking status, marital status,
ethnicity, and body mass index (weight in kg divided
by the height in meters squared) were ascertained at
the time of the first prenatal visit. Maternal age was
defined as the age at delivery. Socioeconomic status
was estimated based on the post code of residence,
using Carstairs socioeconomic deprivation categories9
(based on 1991 Census data on car ownership, unem-
ployment, overcrowding, and social class within post
code sectors of residence, which contain, on average,
around 1,600 residents), and women were categorized
into quintiles of socioeconomic deprivation. The ges-
tational age at birth was defined as completed weeks
of gestation and was based on ultrasound dating
performed between 10 weeks and 14 weeks of gesta-
tion. Cases were defined as women who had one or
more of the following: a diagnosis of preeclampsia; an
SGA infant (a liveborn infant with a birth weight less
than the 3rd percentile for sex and gestational age);
and spontaneous preterm delivery, which was divided
into extreme (between 24 weeks and 32 weeks of
gestational age) and moderate (between 33 weeks and
36 weeks of gestational age), or stillbirth. Spontaneous
preterm deliveries were defined as those where 1) the
birth was vaginal or there was a documented duration
of labor and 2) labor was not documented as having
been induced. All other preterm births were regarded
as indicated. Indicated preterm birth was not ana-
lyzed as a separate outcome, but was used in the
subclassification of preeclampsia: complicated pre-
eclampsia was defined as cases where the mother was
had a medically indicated preterm birth or where the
fetus was SGA.
Stillbirths excluded those due to congenital ab-
normality or rhesus disease. The cause of perinatal
death was classified by a modified version of the
Wigglesworth system.8 Explained stillbirths were de-
fined as those where there was an apparent direct
cause, such as placental abruption. All other stillbirths
were classified as unexplained. Unexplained still-
births were subdivided into those that were SGA and
those appropriate for gestational age. Unexplained
SGA stillbirths were assumed to reflect chronic pla-
cental insufficiency. Therefore, stillbirths due to pla-
cental abruption and SGA unexplained stillbirths
were also considered collectively as stillbirths due to
placental causes, as previously described.10 Controls
were selected at random from among cohort mem-
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bers who delivered a liveborn infant of birth weight
between the 10th and 90th percentile at or after 37
weeks of gestation.
Assays were performed by enzyme-linked immu-
nosorbent assay for human sFlt-1 and free PlGF using
commercial kits (product numbers DVR100 and
DPG 00, respectively; R&D Systems, Abingdon,
United Kingdom). All analyses were performed
within the West of Scotland Regional Genetics Ser-
vice of the Institute of Medical Genetics, Glasgow,
which performs all prenatal biochemical screening
assays for the West of Scotland.11 The minimal detect-
able concentrations in the assays for sFlt-1 and PlGF
were 5 and 7 pg/mL. The interassay and intra-assay
coefficients of variation were 14.9% and 10.4%, re-
spectively, for sFlt-1 and 13.7% and 11.3%, respec-
tively, for PlGF.
Maternal serum levels of sFlt-1 and PlGF were
expressed as multiples of the median (MoM) for
gestational age, as is conventional for biochemical
indices in pregnancy which vary with week of
gestation. The gestational age–specific medians
were calculated from the control group. Multiples
of the median values were corrected for maternal
weight using reciprocal-linear regression. This is
widely employed in standardizing biochemical tests
for Down syndrome screening and is described in
detail elsewhere.12 Where levels of an analyte var-
ied in relation to maternal smoking, MoMs were
adjusted for smoking status using the data from
controls. Cut points for deciles were estimated from
the controls and used to classify the levels of the
analytes for both cases and controls into deciles.
Univariable comparison of continuous variables
was performed using the Mann-Whitney U test and
categorical data using the 2 and the 2 for trend.13
All P values were two-tailed. Statistical significance
was assumed at P.05. Comparison of cases and
controls was by odds ratios and 95% confidence
intervals (CIs). Multivariable analysis was by logis-
tic regression. Interactions were assessed using the
likelihood ratio test14 and statistical significance of
interactions was assumed at P.05, after correcting
for the number of comparisons using the Bonfer-
roni method. Due to the rarity of the event, exact
logistic regression was used for the analysis of
stillbirth data.15 All statistical analyses were per-
formed using the Stata 8.2 software package (Stata-
Corp LP, College Station, TX), LogExact 5 (Cytel
Corporation, Cambridge, MA) or SPSS 12.0 (SPSS
Inc., Chicago, IL).
RESULTS
The study group consisted of 939 cases and 937
controls. Among the cases, 309 had a diagnosis of
preeclampsia, 65 were spontaneous preterm births
between 24 and 32 weeks of gestation, 227 were
spontaneous preterm births between 33 and 36 weeks
of gestation, 333 had a birth weight less than the 3rd
percentile, and 26 were stillbirths, 14 of which had a
placental cause. Twenty-one women had two of the
preceding diagnoses. Among the 309 women with
preeclampsia, 3 (1.0%) had a spontaneous preterm
birth, 58 (18.8%) had an indicated preterm birth, and
of the 248 births at term, 16 (6.4%) had a birth weight
less than the 3rd percentile.
Blood was obtained between 70 and 104 days of
gestation in 1,876 (99.5%) of the study group. The
median gestational age at sampling was 87 days of
gestation (interquartile range 82–92 days). Median
sFlt-1 concentration declined from 996 pg/mL at 10
weeks to 834 pg/mL at 14 weeks gestational age.
Median PlGF concentrations rose from 38.5 pg/mL at
10 weeks to 76.4 pg/mL at 14 weeks gestational age.
There were weak inverse relationships between ma-
ternal weight and levels of both sFlt-1 and PlGF. The
median MoM for PlGF was 36% higher among smok-
ers whereas there was no significant difference in
sFlt-1 between smokers and nonsmokers. Calculation
of MoMs and the cutoff points for deciles and quin-
tiles are described in the Appendix.
The characteristics of the cohort are tabulated by
status as case or control (Table 1). Cases were
younger, were less likely to be married, were more
likely to live in an area of high socioeconomic depri-
vation, were less likely to be white, were more likely
to smoke, were more likely to be primigravid, had
more previous early pregnancy losses, and were
shorter than controls. There were negative linear
associations between decile of sFlt-1 and the risk of all
adverse outcomes, delivery of an SGA infant, both
extreme and moderate spontaneous preterm birth,
and stillbirths due to a placental cause (Fig. 1 and
Table 2). There was no association between sFlt-1
levels and the risk of preeclampsia. There were
negative linear associations between decile of PlGF
and the risk of preeclampsia and delivery of an SGA
infant (Fig. 2 and Table 2). There was no relationship
between levels of either analyte and nonplacental
causes of stillbirth (data not shown). We repeated the
analyses removing the top and bottom deciles of the
given analyte to determine whether the odds ratios
were strongly influenced by extreme values. In all but
one case, the point estimate of the odds ratio fell
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within the 95% confidence intervals in Table 2,
indicating that the results were consistent with those
including the whole cohort. The exception was the
association between sFlt-1 and extreme preterm birth.
When the top and bottom deciles were excluded, the
odds ratio for a 1-decile increase in sFlt-1 was 1.08
(95% confidence interval 0.94–1.24, P.3).
Adjusting for the level of the other analyte and for
maternal characteristics had a minimal effect on the
nature and strength of associations (Table 2). There
were no statistically significant interactions between
decile of either analyte and maternal characteristics
(all P.05, adjusted for number of comparisons).
There was a statistically significant interaction be-
tween decile of sFlt-1 and decile of PlGF in relation to
all adverse outcome (odds ratio for the interaction
1.015, 95% CI 1.004–1.026, P.007). The interaction
was weaker for preeclampsia but stronger for all other
outcomes. The interaction between sFlt-1 and PlGF
was then assessed for a composite adverse outcome,
namely all cases where there was no diagnosis of
preeclampsia. This analysis demonstrated a highly
statistically significant interaction between the two
analytes (odds ratio for the interaction 1.018, 95% CI
1.006–1.031, P.003). When the analysis of the rela-
tionship between sFlt-1 and this composite outcome
was stratified by the level of PlGF, it was apparent that
the association was stronger when PlGF was lower
(Fig. 3).
The association between PlGF and preeclampsia
was more marked among women with complicated
preeclampsia (defined as being associated with pre-
term delivery or with an SGA infant; odds ratio 0.88,
95% CI 0.81 to 0.96) than among women with
preeclampsia who delivered an infant with birth
weight appropriate for gestational age at term (odds
Table 1. Maternal Characteristics in Relation to Case or Control Status
Controls
(n937)
Cases
(n939) P*
Age (y) 30 (26-33) 29 (25-33) .003
Missing 0 (0.0) 5 (0.5) .02
Marital status
Married 565 (60.3) 517 (55.1)
Other 302 (32.2) 352 (37.5) .05
Missing 70 (7.5) 70 (7.5)
Deprivation quintile
1 (least deprived) 204 (21.8) 165 (17.6)
2 161 (17.2) 135 (14.4)
3 189 (20.2) 204 (21.7) .04
4 207 (22.1) 217 (23.1)
5 (most deprived) 173 (18.5) 213 (22.7)
Missing 3 (0.3) 5 (0.5)
Ethnicity
White 859 (91.7) 834 (88.8)
Other 20 (2.1) 38 (4.1) .04
Missing 58 (6.2) 67 (7.1)
Smoking status
Nonsmoker 671 (71.6) 544 (57.9)
Ex-smoker 76 (8.1) 70 (7.5) .001
Current smoker 182 (19.4) 314 (33.4)
Missing 8 (0.8) 11 (1.2)
Number of previous births
None 428 (45.7) 532 (56.7)
One or more 509 (54.3) 402 (42.8) .001
Missing 0 (0.0) 5 (0.5)
Number of previous early losses
None 692 (73.8) 666 (70.9)
One or more 245 (26.2) 268 (28.5) .04
Missing 0 (0.0) 5 (0.5)
Height (m) 1.63 (1.59–1.68) 1.62 (1.57–1.66) .001
Missing 14 (1.5) 30 (3.2) .02
Body mass index 23.6 (21.6–26.5) 23.7 (21.3–27.2) .9
Missing 68 (7.3) 72 (7.7) .7
Data are n (%) or median (interquartile range).
* P values calculated by Mann-Whitney U test, 2 test, or 2 test for trend, as appropriate.
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ratio 0.99, 95% CI 0.95 to 1.04). There was no
significant association between sFlt-1 and either com-
plicated (odds ratio 0.96, 95% CI 0.89–1.04) or un-
complicated preeclampsia (odds ratio 1.01, 95% CI
0.96–1.06). When the analyses were confined to
women whose blood was obtained before 13 weeks of
gestation, the pattern of associations was very similar
to the findings for the whole population (Fig. 4).
DISCUSSION
We found no association between circulating levels of
sFlt-1 at 10–14 weeks of gestation and the risk of
preeclampsia, but a decreased risk of the disease
among women with higher levels of PlGF. These
findings are in complete agreement with a previous
large-scale nested case–control study that found no
association between maternal serum levels of sFlt-1
and the risk of preeclampsia in early pregnancy but a
reduced risk of the disease among women with high
levels of PlGF from 13 weeks onward.3 However, we
demonstrate that women with higher circulating lev-
els of sFlt-1 at 10–14 weeks of gestation were at lower
risk of other complications of pregnancy, specifically
delivery of an SGA infant, spontaneous preterm birth,
Fig. 1. Proportions of cases and controls in relation to decile of soluble fms-like tyrosine kinase-1 for all adverse outcome
(A), preeclampsia (B), delivery of a small for gestational age infant (C), extreme preterm delivery (D), moderate preterm
delivery (E), and stillbirth (F). P values of test for homogeneity were .001, .9, .001, .001, .002, and .1, respectively. P
values of test for trend were .001, .5, .001, .02, .004, and .01, respectively. Outcomes are defined in the Materials and
Methods section. Stillbirths are confined to those with a presumed placental cause. sFlt-1, soluble fms-like tyrosine kinase-1.
Smith. sFlt-1, PlGF, and Adverse Pregnancy Outcome. Obstet Gynecol 2007.
1320 Smith et al sFlt-1, PlGF, and Adverse Pregnancy Outcome OBSTETRICS & GYNECOLOGY
Page 271
and stillbirth. Higher levels of PlGF at 10–14 weeks of
gestation were associated with a decreased risk of
delivery of an SGA infant but were not associated
with the other outcomes.
The finding of improved outcome in association
with higher levels of sFlt-1 is of particular interest. It
could be that high circulating levels of sFlt-1 have
some physiologic role in early pregnancy. Alterna-
tively, it could be that high levels of sFlt-1 reflect some
other aspect of placental function that is in turn
associated with better outcome. It is unlikely that
sFlt-1 is acting simply as a marker of placental mass,
because we have previously related maternal serum
levels of the free -hCG at the same gestational age to
the risk of later adverse outcome and failed to dem-
onstrate any association.6
Previous studies have related maternal serum
levels of sFlt-1 in pregnancy to the risk of adverse
outcome for the offspring. Two demonstrated no
association between maternal levels of sFlt-1 and the
risk of delivering an SGA infant.16,17 A further study
demonstrated elevated levels of sFlt-1 at 23–25 weeks
gestational age among women with high-resistance
patterns of uterine artery flow velocimetry and estab-
lished early onset growth restriction.18 None of these
studies corrected sFlt-1 levels for the gestational age at
the time of sampling or for maternal weight, and none
included more than 30 cases. Previous studies had
demonstrated inconsistent relationships between lev-
els of PlGF and the risk of delivering an SGA infant,
with both higher19 and lower20,21 levels of PlGF
reported.
We observed a statistically significant interaction
between sFlt-1 and PlGF. There was no prior hypoth-
esis that these factors would interact. We found that
among women with low PlGF, elevated levels of
sFlt-1 were significantly protective against adverse
perinatal outcome, whereas there was no association
between levels of sFlt-1 among women with PlGF
levels in the upper two quintiles (Fig. 3). The assay
employed in this study measured free PlGF. Soluble
Flt-1 binds PlGF, and high levels of sFlt-1 would be
anticipated to lead to low levels of free PlGF. The
interaction could indicate that low circulating PlGF
due to high levels of sFlt-1 is associated with better
outcome than low circulating PlGF due to other
causes, such as reduced placental production. Alter-
natively, it could indicate that a protective effect of
sFlt-1 is antagonized by high circulating levels of
PlGF.
Higher levels of sFlt-1 in late pregnancy are
associated with an increased risk of preeclampsia. In
contrast, we show that higher levels of sFlt-1 in very
early pregnancy are associated with a decreased risk
of other pregnancy complications. This finding is
potentially clinically relevant. It has been hypothe-
Table 2. Associations Between Decile of Maternal Serum sFlt-1 and PlGF and the Risk of Adverse
Outcome
sFlt-1 PlGF
Outcome OR* 95% CI P OR* 95% CI P
Univariable
All 0.95 0.92–0.98 .001 0.97 0.94–1.00 .06
Preeclampsia 1.02 0.97–1.06 .5 0.95 0.90–0.99 .02
SGA 0.92 0.88–0.96 .001 0.95 0.91–0.99 .02
Preterm delivery (wk)
24–32 0.90 0.83–0.99 .02 1.02 0.93–1.11 .7
33–36 0.93 0.88–0.98 .004 0.99 0.95–1.04 .8
Stillbirth (placental)† 0.77 0.61–0.95 .01 0.91 0.74–1.10 .3
Adjusted for other analyte and maternal characteristics‡
All 0.94 0.91–0.97 .001 0.98 0.94–1.01 .3
Preeclampsia 0.99 0.94–1.04 .7 0.93 0.88–0.98 .02
SGA 0.92 0.87–0.96 .001 0.93 0.89–0.98 .007
Preterm delivery (wk)
24–32 0.90 0.82–1.00 .05 1.05 0.95–1.16 .3
33–36 0.93 0.88–0.98 .008 1.01 0.96–1.07 .6
Stillbirth (placental)† 0.71 0.53–0.91 .005 0.94 0.74–1.17 .6
sFlt-1, soluble fms-like tyrosine kinase-1; PlGF, placental growth factor; OR, odds ratio; CI, confidence interval; SGA, small for gestational
age.
* Odds ratios are for a one decile increase in the level of the analyte.
† Associations with stillbirth estimated using exact logistic regression.
‡ Maternal characteristics were age, ethnicity, parity, body mass index, height, smoking status, and hospital of delivery. Due to
computational constraints, multivariable analysis for stillbirth risk did not include hospital of delivery.
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sized that there is a causal association between ele-
vated maternal levels of sFlt-1 and preeclampsia.3 It is
proposed that sFlt-1 is released by the placenta into
the maternal circulation and binds maternal PlGF and
VEGF-A, leading to maternal endothelial dysfunc-
tion,3 and animal studies are consistent with this
model.1,4 These data suggest that administration of
VEGF-A121, or alternative approaches to reducing
maternal circulating levels of sFlt-1, may be therapeu-
tically useful among women with established pre-
eclampsia or among women who are at increased risk
of the disease. The current data indicate that this has
the potential to be harmful in early pregnancy. It may
be prudent to conduct further observational studies of
the associations in late pregnancy before evaluation of
such treatments.
Haig22 has advanced the hypothesis that “pre-
eclampsia can be interpreted as an attempt by a
poorly nourished fetus to increase its supply of nutri-
ents by increasing the resistance of its mother’s pe-
ripheral circulation.” Given that high levels of sFlt-1
are associated with an increased risk of preeclampsia
Fig. 2. Proportions of cases and controls in relation to decile of placental growth factor for all adverse outcome (A),
preeclampsia (B), delivery of a small for gestational age infant (C), extreme preterm delivery (D), moderate preterm delivery
(E), and stillbirth (F). P values of test for homogeneity were .6, .3, .4, .5, .2, and .9, respectively. P values of test for trend
were .06, .02, .02, .7, .8, and .3, respectively. Outcomes are defined in the Materials and Methods section. Stillbirths are
confined to those with a presumed placental cause. PlGF, placental growth factor.
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but a decreased risk of growth restriction, preterm
birth, and stillbirth, it is possible that high levels of
sFlt-1 in the maternal circulation represent a physio-
logic signal from the placenta to optimize uterine
perfusion. Longitudinal assessment of sFlt-1 in preg-
nancy in combination with maternal blood pressure
and assessment of uteroplacental blood flow would
help determine whether sFlt-1 may have such a role.
The biologic basis for the association between
sFlt-1 and preterm birth warrants further study. There
are some data that indicate an association is biologi-
cally plausible. Studies of pregnant human uterus
have demonstrated expression of VEGF-A in the
myometrium.23 Studies in the pregnant rat demon-
strated expression of VEGF-A and its main functional
receptor in the cervix. Moreover, VEGF-A expres-
sion peaks in association with ripening of the cervix.24
If VEGF-A also had a role in human cervical ripen-
ing, low levels of sFlt-1 could result in increased free
VEGF-A and hence promote preterm birth. There are
no data on the possible effects of PlGF on the
myometrium and cervix, and this should also be
addressed.
In conclusion, higher levels of sFlt-1 in early
pregnancy were associated with a decreased risk of
intrauterine growth restriction, spontaneous preterm
labor, and stillbirth. Strategies aimed at reducing the
risk of preeclampsia by inactivating sFlt-1 in the
maternal circulation may adversely affect perinatal
outcome.
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APPENDIX
Regressed median of soluble fms-like tyrosine kinase-1
(sFlt-1) in relation to gestational age:
sFlt-1 (in pg/mL)e(6.38933.366/x), where x is the gesta-
tional age in days.
Regressed multiple of the median of sFlt-1 in relation
to maternal weight:
Multiple of the median of sFlt-10.694418.2822/x,
where x is the maternal weight in kilograms.
Regressed median of placental growth factor (PlGF) in
relation to gestational age:
PlGF (in pg/mL)e(2.0710.02288/x), where x is the gesta-
tional age in days.
Regressed multiple of the median of PlGF in relation to
maternal weight:
Multiple of the median of PlGF0.86099.8629/x,
where x is the maternal weight in kilograms.
Correction of multiple of the median of PlGF for
maternal smoking:
Smokers: Multiples of the median (MoM) value di-
vided by 1.29. Nonsmokers: MoM value divided by 0.95
Cut points for deciles of sFlt-1 (expressed as MoM):
0.572, 0.702, 0.814, 0.909, 1.016, 1.117, 1.219, 1.366,
and 1.611.
Cut points for deciles of PlGF (expressed as MoM):
0.610, 0.720, 0.824, 0.907, 1.003, 1.092, 1.197, 1.332,
and 1.575
Cut point for quintiles of PlGF (expressed as MoM):
0.720, 0.907, 1.092, and 1.332.
Eleven hospitals recruiting 98.6% of patients:
The Queen Mother’s Hospital, Glasgow; Simpson Ma-
ternity, Edinburgh; Southern General Hospital, Glasgow;
Royal Maternity Hospital, Glasgow; Royal Alexandria Hos-
pital, Paisley; Ninewells, Dundee; Ayrshire Central Hospi-
tal, Irvine; Forth Park, Kikcaldy; Stirling Royal Infirmary,
Stirling; Falkirk and District Royal Infirmary, Falkirk, and
Inverclyde Royal Hospital, Greenock.
1324 Smith et al sFlt-1, PlGF, and Adverse Pregnancy Outcome OBSTETRICS & GYNECOLOGY
Page 275
Maternal and biochemical predictors of
antepartum stillbirth among nulliparous women
in relation to gestational age of fetal death
GCS Smith,a I Shah,a IR White,b JP Pell,c JA Crossley,d R Dobbiee
a Department of Obstetrics and Gynaecology, Cambridge University, Rosie Maternity Hospital, Cambridge, UK b MRC Biostatistics Unit,
Institute of Public Health, Cambridge, UK c Department of Public Health, Greater Glasgow NHS Board, Glasgow, UK d Institute of Medical
Genetics, Yorkhill NHS Trust, Glasgow, UK e Information and Statistics Division, Common Services Agency, Edinburgh, UK
Correspondence: Prof GCS Smith, Department of Obstetrics and Gynaecology, Cambridge University, Rosie Maternity Hospital, Cambridge
CB2 2SW, UK. Email gcss2@cam.ac.uk
Accepted 24 February 2007.
Objective To determine whether maternal serum levels of
alphafetoprotein (a-FP) and human chorionic gonadotrophin
(hCG) at 15–21 weeks provided clinically useful prediction of
stillbirth in first pregnancies.
Design Retrospective study of record linkage of a regional serum
screening laboratory to national registries of pregnancy outcome
and perinatal death.
Setting West of Scotland, 1992–2001.
Population A total of 84 769 eligible primigravid women
delivering an infant at or beyond 24 weeks of gestation.
Methods The risk of stillbirth between 24 and 43 weeks was
assessed using the Cox proportional hazards model. Logistic
regression models within gestational windows were then used to
estimate predicted probability. Screening performance was assessed
as area under the receiver operating characteristic (ROC) curve.
Main outcome measure Antepartum stillbirth unrelated to
congenital abnormality.
Results The odds ratio (95% CI) for stillbirth at 24–28 weeks for
women in the top 1% were 11.97 (5.34–26.83) for a-FP and 5.80
(2.19–15.40) for hCG. The corresponding odds ratios for stillbirth
at or after 37 weeks were 2.44 (0.74–8.10) and 0.79 (0.11–5.86),
respectively. Adding biochemical to maternal data increased the
area under the ROC curve from 0.66 to 0.75 for stillbirth between
24 and 28 weeks but only increased it from 0.64 to 0.65 for
stillbirth at term and post-term. Women in the top 5% of
predicted risk had a positive likelihood ratio of 7.8 at 24–28 weeks,
3.7 at 29–32 weeks, 5.1 at 33–36 weeks and 3.4 at 37–43 weeks,
and the corresponding positive predictive values were 0.97, 0.33,
0.47 and 0.63%, respectively.
Conclusions Maternal serum levels of a-FP and hCG were
statistically associated with stillbirth risk. However, the predictive
ability was generally poor except for losses at extreme preterm
gestations, where prevention may be difficult and interventions
have the potential to cause significant harm.
Keywords a-fetopcoteins, chorionic gonadotrophins, risk, stillbirth.
Please cite this paper as: Smith G, Shah I, White I, Pell J, Crossley J, Dobbie R. Maternal and biochemical predictors of antepartum stillbirth among nulliparous
women in relation to gestational age of fetal death. BJOG 2007;114:705–714.
Introduction
Intrauterine fetal death before the onset of labour (ante-
partum stillbirth) is one of the most common severe com-
plications of pregnancy. It affects approximately 1 in 200
pregnancies and accounts for almost two-thirds of all peri-
natal deaths.1 Antepartum stillbirth is potentially preventable
by elective delivery.2 The effect of this intervention depends
on the gestational age. At extreme preterm gestations, delivery
may result in either neonatal death or survival with long-term
impairment.3 However, elective delivery at term carries a low
risk of infant or maternal morbidity and mortality.4,5 Hence,
assessment of stillbirth risk and knowledge of the gestational
age where the risk is increased is clinically important.
Nulliparous women are at increased risk of antepartum
stillbirth.6 Moreover, the outcome of previous pregnancies
is one of the most informative predictors of the risk of
complications in future pregnancies,7–9 and clearly, this in-
formation is not available among nulliparous women. Hence,
developing novel predictors of stillbirth risk is particularly
important for the care of nulliparous women. Elevated
maternal serum levels of alphafetoprotein (a-FP) and human
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chorionic gonadotrophin (hCG) are associated with an
increased risk of antepartum stillbirth.10,11 However, the
gestational age dependence of these associations is currently
unclear, as are the properties of these measurements as a
screening test for stillbirth risk. Moreover, many maternal
characteristics are also associated with stillbirth risk.7 The ges-
tational age dependence and screening performance of these,
both in isolation and in combination with a-FP and hCG, are
also currently unclear.
We obtained complete demographic and second-trimester
biochemical screening data on approximately 85 000 nulli-
parous women and addressed the following aims: (1) to assess
the relationship between maternal characteristics and serum
screening data and the risk of stillbirth, (2) to determine
whether the associations between maternal and biochemical
factors varied according to gestational age and (3) to charac-
terise the screening properties of a combined model at differ-
ent gestational ages.
Methods
Data sources and woman selection
The Scottish Morbidity Record collects information on clin-
ical and demographic characteristics and outcomes for all
women discharged from Scottish maternity hospitals. The
register is subjected to regular quality assurance checks and
has been greater than 99% complete since the late 1970s.12
The Scottish Stillbirth and Infant Death Enquiry is a national
register that routinely classifies all perinatal deaths in Scot-
land.1 All women attending for antenatal care in the West of
Scotland are offered biochemical screening, using maternal
serum levels of a-FP and hCG to assess their risk of having
a fetus affected by Down syndrome and structural fetal abnor-
mality, and approximately 81% of them accept screening.13
The laboratory information management system for the West
of Scotland antenatal screening programme in the Institute
of Medical Genetics in Glasgow contains a database of the
maternal information and biochemical screening results, and
electronic storage of these data in their current form was com-
menced in September 1991. A probability-based matching
approach14 was employed using maternal identifiers to link
the Scottish Morbidity Record, the Scottish Stillbirth and
Infant Death Enquiry and the antenatal screening database
in the Institute of Medical Genetics. We excluded multiple
births and births outside the range 24–43 weeks of gesta-
tion. Ethical approval for the linkage was obtained from the
Privacy Advisory Committee of the Information and Statistics
Division of the NHS, Scotland.
Definitions
Maternal age, parity, postcode of residence and all outcome
data were obtained solely from the Scottish Morbidity
Record. Maternal weight was obtained solely from the
biochemical database. Maternal height and smoking were
obtained from the Scottish Morbidity Record, except in cases
where they were missing from the Scottish Morbidity Record,
the biochemical database was employed. The smoking status
(current, past, never) was determined from information at the
time of the first antenatal visit. Maternal age was defined as
the age of the mother at the time of delivery. Body mass index
(BMI) was calculated from the weight in kilogram recorded at
the time of sampling for a-FP assay divided by the height in
metres squared. Socio-economic status was estimated based
on the postcode of residence, using Carstairs socio-economic
deprivation categories15 (based on 1991 Census data on car
ownership, unemployment, overcrowding and social class
within postcode sectors of residence which contain, on aver-
age, around 1600 residents).
The gestational age at birth was defined as the completed
weeks of gestation on the basis of the estimated date of deliv-
ery in each woman’s clinical record; standard national criteria
exist for the estimation of date of delivery using menstrual and
ultrasound data.16 The gestational age has been confirmed by
ultrasound scan in the first half of pregnancy in more than
95% of pregnancies in the UK from the early 1990s.17 The
birthweight was categorised into sex- and gestational-age-
specific percentiles, as previously described in detail.18 Small
for gestational age (SGA) was defined as birthweight in the
smallest 5% for sex and week of gestation of delivery, and
those above this threshold were considered appropriate for
gestational age (AGA). Maternal serum levels of a-FP and
hCG were quantified as multiples of the median (MoM) for
week of gestation, corrected for maternal weight.19
The cause of antepartum stillbirth was classified according
to a modified version of the Wigglesworth hierarchical sys-
tem which is described in detail elsewhere.1 Stillbirths were
defined as antepartum or intrapartum, and the cause of still-
birth was classified according to direct obstetric causes (in
order): congenital abnormality, pre-eclampsia, haemorrhage
(antepartum), mechanical, maternal, miscellaneous and un-
explained. The hierarchy dictates that a perinatal death where
there was severe pre-eclampsia complicated by abruption
would be classified as being caused by pre-eclampsia, as pre-
eclampsia is above haemorrhage in the hierarchy. Similarly,
a stillbirth where the infant was SGA and the mother had pre-
eclampsia would be defined as being caused by pre-eclampsia.
Deaths caused by congenital anomaly were defined as ‘any
structural or genetic defect incompatible with life or poten-
tially treatable but causing death’ and were excluded. Hence,
women who had a loss or therapeutic abortion where the
fetus was affected by structural or chromosomal abnormali-
ties associated with maternal serum screening were excluded
from the analysis. Stillbirths caused by mechanical, maternal
and miscellaneous causes were combined into the category of
‘other’. There was no information on whether women had an
amniocentesis. However, serum screening was performed no
Smith et al.
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later than 21 weeks, and all procedure-related losses would be
expected to have occurred prior to 24 weeks. Classification is
performed by a single, medically qualified individual (the
Scottish Coordinator) with the results of postmortem inves-
tigations, where obtained.
Statistical analysis
Continuous variables were summarised by the median and
interquartile range (IQR). Univariate comparisons were per-
formed using the Mann–Whitney U test, the chi-square test
and the chi-square test for trend, as appropriate. The P values
for all the hypothesis tests were two sided, and statistical
significance was assumed at P < 0.05. All the variables were
treated as categorical. Biochemical data were categorised into
quintiles, with the last quintile split into the top 5, 6–10 and
11–20%. For detailed analysis, the top 5% was further sub-
divided into the top 1, 2–3 and 4–5%. We preformed univar-
iate and multivariate Cox regression using gestational age as
the time scale, antepartum stillbirth as the event, and all other
births as censored. The proportional hazards assumption was
tested using the method of Grambsch and Therneau.20 The
rationale for and advantages of this approach are discussed in
detail elsewhere.21 Risk factors for stillbirth within four ges-
tational windows were then explored using logistic regression
analysis. Each woman contributed one record for each gesta-
tional window covered by her pregnancy. Stillbirth within the
gestational window was taken to be the event, and all births at
that or a later gestation were taken as the denominator. Fac-
tors whose associations with stillbirth had been shown in the
proportional hazards model to vary significantly with gesta-
tion were included with an interaction term with gestational
window, whereas the rest of the predictors were included
without interactions. The predicted probability of stillbirth
in each gestational window was obtained from the logistic
model. The performance of the model in each gestational
window was assessed via the area under the receiver operat-
ing characteristic (ROC) curve. Further, the positive predic-
tive value, sensitivity, specificity and positive and negative
likelihood ratios were estimated using different thresholds
of predicted risk as screen positive, specifically, the top 5,
Table 1. Comparison of maternal and outcome characteristics by occurrence of antepartum stillbirths
No antepartum
stillbirth (n 5 84 363)
Antepartum
stillbirth (n 5 406)
P*
Maternal characteristics
Age, median (IQR) 26 (22–30) 27 (22–31) 0.1
Height, median (IQR) 163 (158–167) 162 (157–167) 0.007
BMI, median (IQR) 23.5 (21.4–26.3) 24.0 (21.8–27.9) ,0.001
Deprivation category
1 (least deprived) 3121 (3.7) 6 (1.5) 0.02
2 8729 (10.4) 33 (8.1)
3 15 481 (18.4) 66 (16.3)
4 20 979 (24.9) 108 (26.6)
5 14 219 (16.9) 64 (15.8)
6 13 143 (15.6) 79 (19.5)
7 (most deprived) 8691 (10.3) 50 (12.3)
Smoking status
Never 52 202 (61.9) 185 (45.6) ,0.001
Current 24 258 (28.8) 185 (45.6)
Former 7903 (9.4) 36 (8.9)
Marital status
Married 43 375 (51.4) 195 (48.0) 0.2
Other 40 988 (48.6) 211 (52.0)
Maternal serum a-FP (multiple of the median), median (IQR) 1.03 (0.83–1.29) 1.16 (0.89 to 1.46) ,0.001
Maternal serum hCG (multiple of the median), median (IQR) 1.03 (0.74–1.45) 1.09 (0.74 to 1.59) 0.03
Gestational age at birth (weeks)
24–28 328 (0.4) 106 (26.1) ,0.001
29–32 782 (0.9) 75 (18.5)
33–36 4135 (4.9) 76 (18.7)
37–43 79 118 (93.8) 149 (36.7)
*Mann–Whitney U test, chi-square test or chi-square test for trend, as appropriate.
a-FP and stillbirth prediction in first pregnancies
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10 and 20%. All statistical analyses were performed using
the Stata software package (Stata Corporation, College
Station, TX, USA), version 8.2.
Results
There were 216 563 records of singleton births with a recorded
value of maternal serum a-FP and hCG levels which could be
linked to Scottish morbidity record 2, and 97 264 (44.9%) of
these were first births. Among this group, we excluded
69 (0.1%) deliveries that were outside the range of 24–43
gestational weeks and 133 (0.1%) deaths caused by fetal
abnormality or rhesus isoimmunisation. Of the remaining
97 062 records, 12 293 (12.7%) had missing data on one or
more variable (2 [<0.1%] maternal age, 1297 [1.3%] height,
6927 [7.1%] BMI, 171 [0.2%] deprivation category, 5724
[5.9%] smoking status and 5 [0.01%] previous spontaneous
early pregnancy losses), leaving a study group of 84 769 births
(87.3% of eligible births).
The upper limits of percentiles (all expressed as MoM) for
the 20th, 40th, 60th, 80th, 90th, 95th, 97th and 99th per-
centiles were 0.77, 0.93, 1.10, 1.35, 1.59, 1.83, 2.03 and 2.52,
respectively, for a-FP and 0.66, 0.88, 1.13, 1.53, 1.92, 2.33,
2.65 and 3.44, respectively, for hCG. Women who experi-
enced antepartum stillbirth in their first pregnancy were
shorter, had higher median BMI, were more likely to live in
an area of high socio-economic deprivation and were more
likely to smoke (Table 1). There was no difference in median
maternal age or marital status in relation to stillbirth. Women
who experienced stillbirths had higher second-trimester
levels of a-FP and hCG. An elevated value of a-FP was
associated with an increased risk of stillbirth caused by
pre-eclampsia, haemorrhage and of unexplained stillbirth
(Table 2). The association with unexplained stillbirth was
stronger where the birthweight was SGA. An elevated level
of hCG was strongly associated with the risk of stillbirth
caused by pre-eclampsia and weakly associated with unex-
plained stillbirth. The latter relationship was similar for
AGA and SGA losses (Table 3).
When the risk of all-cause stillbirth was assessed using
a Cox proportional hazards model, it was positively associa-
ted with maternal age, deprivation category and BMI and
Table 2. Association between second-trimester maternal serum levels of a-FP and different causes of stillbirth
Causes
of stillbirth
a-FP • 95th percentile (n 5 80 408) a-FP > 95th percentile (n 5 4361) Odds ratio 95% CI P*
Experienced outcome Percent Experienced outcome Percent
All causes 353 0.43 53 1.21 2.79 2.09–3.73 ,0.001
Pre-eclampsia 26 0.03 11 0.25 7.82 3.91–15.62 ,0.001
Haemorrhage 43 0.05 7 0.16 3.00 1.38–6.55 0.005
Unexplained (All) 250 0.31 31 0.71 2.30 1.58–3.33 ,0.001
Unexplained (SGA) 62 0.07 12 0.28 3.58 1.94–6.58 ,0.001
Unexplained (AGA) 188 0.23 19 0.44 1.87 1.17–2.98 0.009
Other 34 0.04 4 0.09 2.17 0.80–5.87 0.1
CI, confidence interval.
*Chi-square test or Fisher’s exact test as appropriate.
Table 3. Association between second-trimester maternal serum levels of hCG and different causes of stillbirth
Causes of
stillbirth
hCG • 95th percentile (n 5 80 408) hCG > 95th percentile (n 5 4361) Odds ratio 95% CI P*
Experienced outcome Percent Experienced outcome Percent
All causes 365 0.45 41 0.94 1.93 1.39–2.66 ,0.001
Pre-eclampsia 26 0.03 11 0.25 7.24 3.62–14.45 ,0.001
Haemorrhage 45 0.06 5 0.11 1.90 0.78–4.64 0.2
Unexplained (All) 258 0.32 23 0.53 1.52 1.00–2.33 0.05
Unexplained (SGA) 68 0.08 6 0.14 1.51 0.67–3.40 0.3
Unexplained (AGA) 190 0.24 17 0.39 1.53 0.93–2.50 0.09
Other 36 0.04 2 0.05 0.95 0.00–3.57 .0.9
CI, confidence interval.
*Chi-square test or Fisher’s exact test as appropriate.
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Table 4. Risk of antepartum stillbirth in relation to maternal second-trimester serum biochemistry and demographic characteristics
Variables Univariate Multivariate
Hazard ratio 95% CI P Hazard ratio 95% CI P
a-FP percentile
1–20 0.84 0.59–1.20 0.87 0.61–1.25
21–40 0.96 0.68–1.36 0.99 0.70–1.39
41–60 Reference Reference
61–80 1.34 0.98–1.84 1.30 0.95–1.78
81–90 1.44 1.00–2.08 1.36 0.95–1.96
91–95 1.49 0.94–2.35 1.33 0.84–2.10
96–97 1.76 0.95–3.26 1.60 0.86–2.95
98–99 2.86 1.70–4.81 2.48 1.47–4.17
100 8.13* 5.07–13.06 6.34 3.92–10.25
Trend test ,0.001 ,0.001
Heterogeneity test ,0.001 ,0.001
hCG percentile
1–20 1.21 0.88–1.66 1.08 0.79–1.48
21–40 0.83 0.59–1.17 0.80 0.57–1.13
41–60 Reference Reference
61–80 1.04 0.76–1.43 1.10 0.80–1.51
81–90 1.16 0.80–1.67 1.27 0.87–1.84
91–95 1.29** 0.82–2.01 1.44** 0.91–2.25
96–97 1.53 0.83–2.81 1.70 0.92–3.15
98–99 2.11* 1.25–3.58 2.28* 1.34–3.89
100 3.03* 1.65–5.58 3.10* 1.67–5.77
Trend test 0.002 ,0.001
Heterogeneity test ,0.001 ,0.001
Age (years)
,20 1.12 0.82–1.53 0.89 0.63–1.25
20–24 1.03 0.78–1.35 0.86 0.65–1.15
25–29 Reference Reference
30–34 1.20 0.92–1.57 1.28 0.98–1.67
35–39 1.74 1.19–2.53 1.79 1.23–2.61
.39 2.49 1.02–6.09 2.29 0.94–5.62
Trend test 0.04 ,0.001
Heterogeneity test 0.02 0.004
Deprivation category
1 (least deprived) 0.38 0.17–0.86 0.42 0.19–0.97
2 0.73 0.50–1.08 0.77 0.52–1.14
3 0.83 0.61–1.13 0.86 0.63–1.16
4 Reference Reference
5 0.88 0.64–1.20 0.85 0.63–1.16
6 1.18 0.88–1.58 1.14 0.85–1.53
7 (most deprived) 1.15 0.82–1.60 1.05 0.75–1.48
Trend test 0.001 0.02
Heterogeneity test 0.02 0.09
Height (cm)
,150 1.07 0.44–2.62 0.88 0.36–2.16
150–154 1.59 1.12–2.26 1.47 1.03–2.10
155–159 1.48 1.12–1.95 1.44 1.10–1.90
160–164 Reference Reference
165–169 1.18 0.90–1.55 1.20 0.92–1.58
170–174 0.85 0.59–1.24 0.89 0.61–1.29
.174 1.08 0.64–1.83 1.12 0.66–1.90
Trend test 0.006 0.045
Heterogeneity test 0.01 0.05
(continued)
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negatively associated with height (Table 4). The strength of
association with these maternal characteristics did not signifi-
cantly vary over the range of gestation from 24 to 43 weeks.
The risk of stillbirth was also positively associated with
second-trimester maternal serum levels of a-FP and hCG.
The cumulative probability of stillbirth associated with ele-
vated levels of these analytes is plotted, and the strength of
association varied with gestational age (Figure 1). High levels
of a-FP and hCG were strongly associated with stillbirth
between 24 and 28 weeks of gestation. In both cases, the
strength of association became weaker with advancing gesta-
tional age, and there was no statistically significant association
between levels of these analytes and the risk of stillbirth at or
after 37 weeks of gestation (Table 5).
There were no statistically significant interactions between
a-FP and hCG and maternal characteristics and no significant
interactions between the two analytes. Because of the large
number of comparisons, the threshold for statistical signifi-
cance was set at P < 0.01. There was a trend towards an
interaction between a-FP levels in the top 5% and hCG levels
in the top 5%: the hazard ratio for the interaction term was
2.20 (95% CI 1.06–4.56, P = 0.03). Four hundred and seventy-
nine women had levels of both analytes in the top 5%, and 14
(2.9%) of these pregnancies ended in stillbirth. The hazard
ratio for stillbirth among this group was 7.3 (95% CI 4.3–12.5,
P < 0.001). Again, the association declined significantly with
advancing gestational age (P < 0.05), and there was no statis-
tically significant association at term (OR 3.0, 95% CI 0.7–
12.1, P = 0.1), although the numbers were too small to
exclude a significant association.
The screening characteristics of the model were assessed at
the different gestational ages using the predicted probability
of stillbirth from the logistic regression models (Table 6). The
top 5% of the population for predicted risk had a likelihood
ratio for stillbirth of more than seven for 24–28 weeks. The
likelihood ratio associated with the top 5% of predicted risk
steadily declined with advancing category of gestational age
and was lowest for stillbirth at or beyond 37 weeks, being
approximately three. The screening characteristics of the
predicted probabilities were then assessed using the area
under the ROC curve, and models containing only maternal
variables were compared with those which also included
second-trimester serum screening results (Table 7). Adding
biochemical data significantly increased the area under the
ROC curve for stillbirth between 24–28 weeks and 29–32 weeks
but had a minimal effect for stillbirth prediction at term.
Discussion
The main finding of this paper is that women with elevated
serum levels of a-FP and hCG in the second trimester of
pregnancy were at increased risk of stillbirth and that these
associations were strongest for stillbirth at extreme preterm
gestations. In contrast, the association between stillbirth and
maternal characteristics was similar over the period of 24–
43 weeks. Consequently, a model combining maternal
Table 4. (Continued)
Variables Univariate Multivariate
Hazard ratio 95% CI P Hazard ratio 95% CI P
Smoking
Nonsmoker Reference Reference
Current smoker 2.19 1.78–2.68 2.48 1.98–3.11
Ex-smoker 1.28 0.90–1.83 1.40 0.98–2.01
Heterogeneity test ,0.001 ,0.001
BMI (kg/m2)
,20 1.43 1.05–1.97 1.36 0.99–1.87
20–24 Reference Reference
25–29 1.47 1.16–1.86 1.44 1.13–1.82
.30 2.12 1.60–2.81 1.96 1.47–2.60
Trend test ,0.001 ,0.001
Heterogeneity test ,0.001 ,0.001
Marital status
Married Reference Reference
Other 1.15 0.95–1.40 1.03 0.82–1.29
Heterogeneity test 0.2 0.82
CI, confidence interval.
Test of proportional hazards assumption: *P , 0.05, **P , 0.01, all others P  0.05.
Global test of proportional hazards assumption for multivariate model: P 5 0.05.
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characteristics and biochemical data performed reasonably
well in predicting stillbirth risk at extreme preterm gestations
(24–28 weeks): women in the top 5% of predicted risk had
a positive likelihood ratio of seven and included 36% of all
losses between 24 and 28 weeks of gestation. In contrast,
a model combining maternal characteristics and biochemical
data performed poorly at predicting stillbirth at term: women
in the top 5% of predicted risk had a positive likelihood ratio
of three and only included 15% of losses at or after 37 weeks
of gestation.
These findings are of clinical relevance. Measurement of
a-FP and hCG is in widespread use as a well validated method
of screening for Down syndrome.13 It is generally recognised
that elevated levels of these proteins are associated with an
increased risk of other adverse outcomes, including stillbirth.
Some authors suggest that women with elevated levels of a-FP
or hCG should have close surveillance of their pregnancies,
such as growth scans at intervals of 2–4 weeks.22 However,
the current data suggest that if surveillance is thought to be
beneficial, it should commence at 24 weeks. Moreover, if
serial scans are reassuring up to 36 weeks, it may well be safe
to discontinue further assessment.
The current analysis also addresses whether selecting
women for further fetal assessment on the basis of second-
trimester serum screening data is justifiable. There are no
studies that directly indicate that the use of a-FP and hCG
measurements to screen for stillbirth improves outcome. A
successful screening programme has two major components,
namely (1) effective assessment of risk and (2) application of
an effective intervention among women who screen positive.
The primary intervention to prevent stillbirth is delivery of
the infant prior to intrauterine demise. In assessing the effect
of delivery of high-risk infants on overall perinatal mortality,
the gestational age where the fetus is presumed to be at risk is
crucial. The risk of neonatal death is around 30–40% at 24–25
weeks23 and less than 0.1% at term.5 Therefore, at term, elec-
tive delivery of an infant at high risk of stillbirth carries a small
risk of increasing overall perinatal mortality. Hence, if a risk
factor is strongly predictive of stillbirth at term, elective deliv-
ery at term is likely to be beneficial and is unlikely to cause
serious harm. This practice is widespread in clinical obstetrics.
Women with risk factors such as insulin-dependent diabetes
mellitus or a history of stillbirth are commonly offered elec-
tive delivery at around 38 weeks of gestation. However, the
current data do not suggest that routine elective delivery at
term is indicated on the basis of elevated levels of a-FP or
hCG in the second trimester.
The stronger association with stillbirth at preterm gesta-
tions raises the possibility that a-FP and hCG measurements
may be used to screen for fetuses at risk of stillbirth at preterm
gestations. However, the management of a pregnancy where
the fetus is thought to be at increased risk of stillbirth at pre-
term gestations is more complex. Elective delivery at extreme
preterm gestations would clearly not simply be on the basis
of a raised a-FP or hCG level. Rather, women with a raised
a-FP or hCG would have an increased level of fetal surveil-
lance (such as ultrasound scanning and computerised cardio-
tocography), and those with severely abnormal findings would
be considered for delivery. However, no assessment of fetal
wellbeing is completely accurate. Therefore, identifying and
delivering fetuses at risk of stillbirth between 24 and 28 weeks
could lead to neonatal deaths as a consequence of iatrogenic
prematurity among infants who would not have died had they
been left in utero. Moreover, even if the infants survived, ele-
ctive delivery could lead to long-term severe disability as
approximately 40% of long-term survivors of extreme preterm
birth may be severely disabled.3 It is possible that some parents
would prefer a stillbirth to occur than have delivery of an infant
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Figure 1. Kaplan–Meier plot of cumulative probability of stillbirth from 24
to 43 weeks of gestation comparing women with elevated (top 5%)
maternal serum levels (solid line) with all other women (dashed line):
(A) a-FP and (B) hCG. Hazard ratio for top 5% (95% CI) is 3.33 (2.32–4.77)
for a-FP and 2.06 (1.41–3.02) for hCG. Test of proportional hazards
assumption: P < 0.05 for both and remained statistically significant
when included in multivariate Cox model with all other maternal
characteristics.
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Table 5. Adjusted odds ratios for the risk of antepartum stillbirth in relation to maternal serum levels of a-FP and hCG for four different gestational age categories
Variables Gestational age of
24–28 weeks, n 5 84 769
Gestational age of
29–32 weeks, n 5 84 335
Gestational age of
33–36 weeks, n 5 83 478
Gestational age of
37–43 weeks, n 5 79 267
OR 95% CI P value OR 95% CI P value OR 95% CI P value OR 95% CI P value
Maternal serum a-FP percentile
1–20 0.78 0.33–1.82 0.6 0.87 0.40–1.91 0.7 1.29 0.61–2.71 0.5 0.75 0.42, 1.35 0.3
21–40 1.18 0.55–2.51 0.7 0.61 0.25–1.45 0.3 0.58 0.23–1.44 0.2 1.29 0.78, 2.13 0.3
41–60 Reference — Reference — Reference — Reference —
61–80 1.41 0.70–2.83 0.3 1.07 0.52–2.20 0.8 1.53 0.77–3.07 0.2 1.24 0.75–2.03 0.4
81–90 2.12 1.02–4.42 0.04 1.03 0.43–2.47 0.9 1.54 0.69–3.45 0.3 1.00 0.54–1.88 .0.9
91–95 2.42 1.06–5.54 0.04 1.52 0.58–3.96 0.4 0.55 0.12–2.44 0.4 0.94 0.41–2.16 0.9
96–97 3.04 1.08–8.55 0.04 2.45 0.80–7.48 0.1 — — — 1.01 0.30–3.32 .0.9
98–99 4.06 1.61–10.23 0.003 2.57 0.84–7.86 0.10 2.12 0.60–7.47 0.2 1.45 0.51–4.15 0.5
100 11.97 5.34–26.83 ,0.001 4.79 1.54–14.86 0.007 5.76 1.85–17.96 0.003 2.44 0.74–8.10 0.1
Maternal serum hCG percentile
1–20 0.80 0.37–1.71 0.6 1.68 0.80–3.53 0.2 0.89 0.46–1.73 0.7 1.07 0.65–1.75 0.8
21–40 0.96 0.47–2.00 0.9 1.11 0.49–2.53 0.8 0.50 0.22–1.11 0.09 0.76 0.44–1.31 0.3
41–60 Reference — Reference — Reference — Referent —
61–80 1.20 0.60–2.39 0.6 1.20 0.54–2.68 0.7 0.80 0.40–1.61 0.5 1.20 0.74–1.96 0.5
81–90 1.99 0.97–4.09 0.06 1.12 0.41–3.04 0.8 1.16 0.53–2.52 0.7 1.01 0.53–1.90 .0.9
91–95 2.86 1.31–6.26 0.009 2.58 0.99–6.67 0.05 0.70 0.21–2.38 0.6 0.71 0.28–1.84 0.5
96–97 3.87 1.49–10.05 0.005 1.86 0.41–8.45 0.4 0.59 0.08–4.40 0.6 1.13 0.34–3.70 0.8
98–99 5.20 2.25–12.01 ,0.001 1.71 0.38–7.78 0.5 1.13 0.26–4.90 0.87 1.48 0.52–4.22 0.5
100 5.80 2.19–15.40 ,0.001 4.90 1.34–17.94 0.02 2.16 0.49–9.47 0.3 0.79 0.11–5.86 0.8
CI, confidence interval, HR, hazard ratio; OR, odds ratio.
The OR for the other variables were virtually identical to the adjusted hazard ratios listed in Table 4. The only OR which differed from the HR at the first decimal place was for maternal age
greater than 39 years: the HR was 2.29 and the adjusted OR was 2.14.
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which would be severely disabled in the long term. Further-
more, delivery at extreme preterm gestations also carries issues
of maternal morbidity. Delivery would usually be by caesarean
section, often using the classical method. This carries immedi-
ate risks of maternal morbidity and is associated with signifi-
cant risks in future pregnancies.24 Thus, the beneficial effects of
preventing stillbirth in those who would have died may be
offset by the harmful effects among those who were false pos-
itives. Finally, the use of a-FP and hCG measurements to
screen for stillbirth has not been subjected to an economic
analysis. From the above, even if it did result in decreased
perinatal mortality, the costs of preventing each stillbirth
may be substantial, including costs of fetal monitoring, elective
preterm delivery, neonatal intensive care and long-term costs,
including management of future pregnancy (e.g. after classical
caesarean section) and care of disabled infants. We conclude
that although statistical associations can be shown between
stillbirth risk and both biochemical and maternal data, popu-
lation-based screening for stillbirth risk on the basis of these
associations should not be undertaken without direct evidence
that screening and intervention improve outcome and are eco-
nomically justifiable, particularly when performed at extreme
preterm gestations.
The current data are also of biological interest. This is the
first large-scale study of a-FP and hCG which had detailed
information on the cause of antepartum stillbirth and it
considerably extends the understanding of the association
between maternal serum markers in the second trimester of
pregnancy and the risk of stillbirth. An elevated level of
a-FP was most strongly associated with stillbirth caused by
Table 6. Screening performance of the predicted probability from multivariate logistic regression models containing maternal and biochemical data
Gestational age and
predicted risk
Positive predicted
value (%)
Sensitivity (%) Specificity (%) Positive LR Negative LR
24–28 weeks
Top 5% 0.97 36.68 95.04 7.80 0.65
Top 10% 0.52 41.51 90.04 4.17 0.65
Top 20% 0.34 54.72 80.04 2.74 0.57
29–32 weeks
Top 5% 0.33 18.67 95.01 3.74 0.86
Top 10% 0.28 32.00 90.02 3.21 0.76
Top 20% 0.20 44.00 80.02 2.20 0.70
33–36 weeks
Top 5% 0.47 25.00 95.13 5.13 0.79
Top 10% 0.32 34.21 90.23 3.50 0.73
Top 20% 0.21 46.05 80.45 2.36 0.67
37–43 weeks
Top 5% 0.63 16.78 95.02 3.38 0.88
Top 10% 0.42 22.15 90.03 2.22 0.86
Top 20% 0.33 35.57 80.03 1.78 0.81
LR, likelihood ratio.
The risk (per 1000 subsequent births) of antepartum stillbirth is as follows: 1.25 (95% CI 1.01–1.49) for gestational age group 24–28 weeks,
0.89 (95% CI 0.69–1.09) for gestational age group 29–32 weeks, 0.91 (95% CI 0.71–1.11) for gestational age group 33–36 weeks and
1.88 (95% CI 1.58–2.18) for gestational age 37–43 weeks.
Table 7. Area under the ROC curve from the two multivariate logistic regression models for the four different gestational age groups
Model
predictors
Gestational age,
24–28 weeks
Gestational age,
29–32 weeks
Gestational age,
33–36 weeks
Gestational age,
37–43 weeks
Area* 95% CI Area* 95% CI Area* 95% CI Area* 95% CI
Maternal only 0.66 0.61–0.71 0.69 0.64–0.75 0.64 0.58–0.70 0.64 0.60–0.68
Maternal and biochemical 0.75 0.70–0.80 0.74 0.69–0.79 0.71 0.65–0.77 0.65 0.61–0.69
CI, confidence interval.
*Area under the ROC curve.
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pre-eclampsia (seven- to eight-fold risk), was moderately
associated with stillbirth associated with haemorrhage (pri-
marily abruption) and SGA unexplained stillbirth (three- to
four-fold risk) and weakly associated with unexplained still-
births which had AGA birthweight (two-fold risk). Elevated
levels of hCG were also strongly associated with stillbirth
caused by pre-eclampsia (seven- to eight-fold risk) and
weakly associated with unexplained stillbirth (1.5-fold risk)
The latter seemed to be unrelated to fetal growth. Finally,
there was a trend towards a synergistic association between
elevated a-FP and hCG and the risk of antepartum still-
birth. These data indicate the complexity of placental
determinants of stillbirth caused by different causes. The
biochemical data employed in the present study did not
perform well as uterine artery Doppler flow velocimetry as
a predictor of stillbirth. A recent study of more than 30 000
women has shown that the area under the ROC curve for this
modality was 0.84 for losses before 32 weeks, and the women
in the top 5% of predicted risk on the basis of Doppler alone
had a positive likelihood ratio of 12.1.25 However, similar
to a-FP and hCG, adding uterine artery Doppler data to
a model including maternal characteristics had a minimal
effect (increase of 0.02) on the area under the ROC curve
for stillbirths at later gestations.
In conclusion, we show that elevated levels of a-FP and
hCG were strongly associated with stillbirth at extreme
preterm gestations, and the strength of association with still-
birth declined with advancing gestational age. These findings
have implications for the clinical use of second-trimester
maternal serum levels of a-FP and hCG in obstetric risk
assessment.
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Maternal and biochemical predictors of
spontaneous preterm birth among
nulliparous women: a systematic analysis
in relation to the degree of prematurity
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Background Nulliparous women are at increased risk of spontaneous preterm birth. Other
maternal and biochemical risk factors have also been described. However, it is
unclear whether these associations are strong enough to offer clinically useful
prediction. It is also unclear whether the predictive power of these factors varies
in relation to the degree of prematurity.
Methods The risk of spontaneous preterm birth associated with maternal characteristics
and second trimester serum screening data was analysed in a dataset of 84 391
first births in Scotland between 1992 and 2001 using Cox and logistic regression.
Variation in the relative risk of preterm birth over the period 24–36 weeks was
assessed using a test of the proportional hazards assumption.
Results The risk of spontaneous preterm birth was positively associated with maternal
serum levels of alpha-fetoprotein, socioeconomic deprivation, number of
previous therapeutic abortions, smoking, and being unmarried and was
negatively associated with height and body mass index. The risk of preterm
birth at 24–28 weeks, but not later gestations, was increased in association with
maternal levels of human chorionic gonadotrophin .95th percentile, maternal
age ,20, and two or more previous miscarriages. The area under the receiver
operating characterise curve (95% CI) for models based on these factors was
0.67 (0.63–0.71) for 24–28 weeks, 0.65 (0.62–0.68) for 29–32 weeks, and 0.62
(0.61–0.63) for 33–36 weeks.
Conclusions Time to event analytic methods can identify factors that are differentially
associated with spontaneous preterm birth according to the degree of
prematurity. However, models based on maternal and biochemical data perform
poorly as a screening test for any degree of spontaneous preterm birth.
Keywords alpha-Fetoproteins, chorionic gonadotrophin, labour, premature, proportional
hazards models, risk
Preterm birth is a major source of morbidity and mortality in
the neonatal period and in infancy and later childhood.
1–4
One of the major clinical risk factors for spontaneous preterm
birth is a previous pregnancy that ended in this event. Self
evidently, this information is not available for woman having
a first birth, making risk assessment in this substantial
proportion of the population problematic. A number of
other factors have, however, been shown to be associated
with the risk of spontaneous preterm birth, and these have
been reviewed elsewhere.
5,6
However, it remains unclear
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whether the combined information available from such
characteristics provides useful predictive information.
A further complication in assessing risk factors for spontan-
eous preterm birth is the degree of prematurity. Whereas
birth between 33 and 36 weeks gestation carries a relatively
favourable short-term and long-term prognosis, extreme
preterm birth is associated with high absolute risks of death
and severe disability.
1,4
The profoundly different consequences
of extreme, moderate, and mild prematurity mean that
interventions to reduce the risk of these events should be
targeted at the clinically important extreme cases. However,
many analyses of factors associated with the risk of preterm
birth fail to distinguish between different degrees of prema-
turity. Moreover, we are unaware of any widely utilized
approach to determine objectively whether the relative risk
associated with a given factor significantly varies across the
range of gestational age.
We have previously proposed that time to event analytic
methods, specifically Cox proportional hazards regression,
might be employed in assessing the factors associated with
the spontaneous onset of labour.
7
Tests have been developed
using residuals estimated from the Cox model, which allow a
formal test of the assumption that the relative risk of an event
associated with a given factor is the same across a period of
time.
8
This analytic approach could also be used to determine
whether the strength of association between the risk of
spontaneous preterm birth and maternal or obstetric factors
varies in relation to the degree of prematurity. We are unaware
of any study that has previously performed such an analysis.
In the present study, we analysed data from over 80 000
women having first pregnancies in the West of Scotland and
sought to determine (i) which maternal and biochemical factors
are associated with the relative risk of spontaneous preterm
birth over the period 24–36 weeks gestation, (ii) whether the
relative risks associated with these factors significantly varied
over the period 24–36 weeks, and (iii) whether these factors
could yield clinically useful prediction of risk.
Methods
Data sources and patient selection
The Scottish Morbidity Record collects information on clinical
and demographic characteristics and outcomes for all women
discharged from Scottish maternity hospitals. The register is
subjected to regular quality assurance checks and has been
.99% complete since the late 1970s.9 The Scottish Stillbirth
and Infant Death Enquiry is a national register, which routinely
classifies all perinatal deaths in Scotland.
10
All women
attending for prenatal care in the West of Scotland are offered
biochemical screening, using maternal serum levels of alpha-
fetoprotein (AFP) and human chorionic gonadotrophin (hCG),
to assess their risk of having a fetus affected by Down syndrome
and/or structural fetal abnormality.11 The laboratory informa-
tion management system for the West of Scotland prenatal
screening programme in the Institute of Medical Genetics in
Glasgow contains a database of the maternal information and
biochemical screening results, and electronic storage of these
data in their current form was commenced in September 1991.
A probability-based matching approach
12
was employed using
maternal identifiers to link the Scottish Morbidity Record, the
Scottish Stillbirth and Infant Death Enquiry, and the prenatal
screening database in the Institute of Medical Genetics. We
excluded multiparous patients, multiple births, stillbirths, and
births outside the range 24–43 weeks gestation. Ethical
approval for the linkage was obtained from the Privacy
Advisory Committee of the Information and Statistics Division
of the National Health Service, Scotland.
The maternal age, parity, previous miscarriages and thera-
peutic abortions, postcode of residence, and all outcome data
were obtained solely from the Scottish Morbidity Record.
Maternal weight was obtained solely from the biochemical
database. Maternal height and smoking were obtained from the
Scottish Morbidity Record except in cases where they were
missing from the Scottish Morbidity Record and the biochem-
ical database was employed. The smoking status (current, past,
never) was determined from information at the time of the first
prenatal visit. The maternal age was defined as the age of the
mother at the time of delivery. The body mass index was
calculated from the weight in kilograms recorded at the time of
sampling for serum screening assay divided by the height in
metres squared. Socioeconomic status was estimated based on
the postcode of residence, using Carstairs socioeconomic
deprivation categories
13
(based on 1991 Census data on car
ownership, unemployment, overcrowding, and social class
within postcode sectors of residence containing, on average,
~1600 residents).
Definitions
Previous miscarriage was defined as previous delivery of a
conceptus showing no signs of life before 24 weeks gestation,
excluding therapeutic abortions. Previous therapeutic abortion
was defined as previous therapeutic termination of pregnancy
by any means prior to 24 weeks gestation. Spontaneous birth
was defined as all births that were vaginal or had a documented
duration of labour but were not recorded as having had labour
induced. Elective births were taken to be all other births. The
gestational age at birth was defined as the completed weeks of
gestation on the basis of the estimated date of delivery in each
woman’s clinical record; standard national criteria exist for the
estimation of date of delivery using menstrual and ultrasound
data.14 The gestational age has been confirmed by ultrasound
scan in the first half of pregnancy in .95% of pregnancies in
the UK from the early 1990s.
15
Maternal serum levels of AFP
and hCG were quantified as multiples of the median for week
of gestation, corrected for maternal weight.16
Statistical analysis
Continuous variables were summarized by the median and
inter-quartile range. Univariate comparisons were performed
using the Kruskal–Wallis test, the chi-squared test, and the
chi-squared test for trend, as appropriate. The P-values for all
hypothesis tests were two-sided, and we set statistical signi-
ficance at P , 0.05. All the variables were treated as categorical.
Biochemical data were categorized into quintiles with the
highest quintile split into a decile and vigesimals. We
preformed univariate and multivariate Cox regression using
gestational age as the time scale, spontaneous labour as the
event, elective preterm deliveries as censored at the gestation of
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birth, and all term deliveries censored at the start of the 37th
week. The proportional hazards assumption was tested using
the method of Grambsch and Therneau.
8
This was used to
determine whether the relative risk of spontaneous preterm
birth associated with a given factor varied across the range
24–36 weeks gestation. Preterm delivery was then divided into
extreme (24–28 weeks), moderate (29–32 weeks), and mild
(33–36 weeks), thus, dividing the span of gestation into
approximate thirds. Logistic regression analysis was used to
estimate adjusted odds ratios associated with the different
degrees of prematurity using spontaneous preterm birth within
the given range as the event, excluding elective preterm births
within the gestational age range, and using spontaneous
preterm birth within the age range and all births at later
gestations as the denominator. Factors which had been shown
in the proportional hazards model to vary significantly with
gestation, were allowed to vary in the three preterm gestational
age groups, whereas the rest of the predictors remained fixed.
The predicted probability of each outcome was obtained from
the logistic model. The screening performance of the model was
assessed using the predicted probability to estimate the area
under the receiver operating characteristic (ROC) curve.
Further, the positive predictive value, sensitivity, specificity,
and positive and negative likelihood ratios were estimated
using different thresholds of predicted risk as screen positive
(predicted probability in the top 1, 5, 10, or 20%). All statistical
analyses were performed using the Stata software package
(Stata Corporation, TX, USA), version 8.2.
Results
There were 216 563 records of singleton births with a recorded
value of maternal serum AFP and hCG, which could be linked
to the Scottish Morbidity Record, and 97 264 (44.9%) of these
were first births. Among this group we excluded 69 (0.1%)
deliveries that were outside the range of 24–43 gestational
weeks and 518 (0.5%) antepartum stillbirths. Of the remaining
96 677 records, 12 286 (12.7%) had missing data on one or
more variable [47 (0.1%) maternal age, 1290 (1.3%) height,
6907 (7.1%) body mass index, 171 (0.2%) deprivation
category, 5691 (5.9%) smoking status, and 5 (0.01%) previous
miscarriages] leaving a study group of 84 391 births.
When categorized by gestational age at birth, there were
significant differences in the proportion of spontaneous births,
maternal height, deprivation category, smoking status, previous
miscarriages, previous therapeutic abortions, marital status, and
second trimester levels of AFP and hCG (Table 1). The risk of
spontaneous preterm birth over the range 24–36 weeks was
then assessed using a multivariate Cox model (Table 2). There
were linear trends between the risk of spontaneous preterm
birth and second trimester maternal serum levels of AFP and
hCG. The risk of spontaneous preterm birth also varied
according to maternal age, marital status, and smoking status;
decreased linearly with height and body mass index; and,
increased linearly with maternal deprivation category, number
of previous miscarriages, and number of previous therapeutic
abortions. The relative risk of preterm birth varied across the
range 24–36 weeks in association with high levels of hCG
(P 5 0.008), maternal age ,20 (P 5 0.0001), and the number
of previous miscarriages (P 5 0.006).
The nature of variation across the range of gestational ages
was then assessed using logistic regression for each of the
categories of spontaneous preterm birth (Table 3). Separate
odds ratios were estimated within each of the windows of
gestational age for each of the variables where the relative risk
had been shown to vary over the range 24–36 weeks. For the
other variables where Cox modelling had shown the relative
risk was constant, a single odds ratio was estimated across the
range 24–36 weeks. Using this approach, high levels of hCG
and age ,20 were associated with extreme preterm birth but
not moderate or mild preterm birth. The number of previous
miscarriages was associated with all categories of preterm birth,
but the association was strongest for extreme prematurity and
weakest for mild prematurity.
The screening performance of the multivariate logistic
regression models were then assessed for the different degrees
of prematurity assuming classification of the top 1, 5, 10, or
20% of predicted risk as having screened positive (Table 4). The
positive likelihood ratios were highest for extreme prematurity
(5.5 for women in the top 1% of predicted risk). However,
owing to the fact that mild prematurity was much more
common, the positive predictive value was greatest for the
model of mild prematurity. In no case did any positive
predictive value exceed 10%. Finally, the predictive ability
of the models was assessed using the area under the ROC
curve. Values were highest for extreme preterm birth and
lowest for mild preterm birth. Adding AFP and hCG to the
maternal characteristics resulted in an increase in the area
under the ROC of 0.04 at all gestations (Table 5).
Discussion
In the present study, we demonstrated in a large population of
primigravid women that the risk of spontaneous preterm birth
was significantly associated with marital status, smoking status,
height, body mass index, socioeconomic deprivation category,
previous miscarriages and therapeutic abortions, and with
maternal serum levels of AFP in the second trimester. We also
demonstrated significant variation in the relative risk of
spontaneous birth across the range 24–36 weeks gestation
associated with maternal age ,20, elevated levels of hCG, and
with number of previous miscarriages. Each of these factors
was strongly associated with extreme preterm birth but not
associated, or only weakly associated, with moderate or mild
spontaneous preterm birth.
The results of the current study expand considerably on
previous studies. In relation to elevated hCG, a number of
studies had shown increased rates of preterm delivery,17–21 but
others had shown no association
22
or only a very weak
association.
23
However, these analyses did not distinguish
between spontaneous and elective preterm birth. A study,
which did make this distinction, demonstrated that elevated
hCG was associated with elective preterm birth, but there was
no significant association with spontaneous preterm birth.
24
However, no attempt was made to analyse this outcome in
relation to the degree of severity of preterm delivery. In
relation to maternal age ,20, we had previously analysed
routinely data from Scotland and shown no association
between this characteristic and the risk of preterm birth at
either 24–32 weeks or 33–36 weeks.25 However, we also
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pooled spontaneous and elective preterm birth. With regard to
prior miscarriages, a previous Swedish study had indicated a
history of prior losses was more strongly associated with
extreme preterm delivery.
26
However, there was no direct
statistical test of whether the apparent variation in relation to
the degree of prematurity was more than would be expected by
chance. Finally, a previous analysis of spontaneous preterm
birth in relation to the number of previous therapeutic
abortions suggested that the association was stronger for
extreme preterm delivery.
27
However, there was considerable
overlap in the confidence intervals for odds ratios for the
different degrees of prematurity and, again, that study lacked a
specific test that the apparent variation between the groups was
statistically significant. We confirm that the number of prior
therapeutic abortions is associated with the risk of spontaneous
preterm birth but show that the association is similar for
different degrees of prematurity.
Many previous studies have analysed risk factors according to
different degrees of prematurity. Variation in the strength of
associations is critical since the consequences of preterm
delivery vary profoundly in relation to the degree of prema-
turity. However, this is the first study, to our knowledge, to use
Cox modelling and a test of the proportional hazards
assumption to address whether the relative risk of spontaneous
preterm birth associated with a given factor varies in relation to
the degree of prematurity. Other approaches to this question
are possible. First, categories of prematurity can be created and
separate logistic regression models can be estimated, as we
described in Table 3. Moreover, by stacking the datasets for
the different outcomes and use of interaction terms, it can be
determined whether odds ratios significantly vary among the
categories. However, this requires deliberate selection of
categories. In contrast, using the Cox method, gestational
age is treated continuously. This will increase the power to
Table 1 Maternal, demographic, and obstetrical characteristics in relation to gestation age among 84 391 first births in Scotland, 1992–2001
Gestational age at delivery (weeks)
Characteristics 24–28 (n 5 335) 29–32 (n 5 790) 33–36 (n 5 4,150) 37–43 (n 5 79,116) *P 5
Delivery
Spontaneous birth 202 (60.3) 356 (45.1) 2,528 (60.9) 50 311 (63.6) ,0.001
Other 133 (39.7) 434 (54.9) 1622 (39.1) 28 805 (36.4)
Age (years) 26 (21–30) 27 (22–31) 26 (22–30) 26 (22–30) 0.2
Height (cm) 162 (157–166) 162 (157–166) 162 (157–166) 163 (158–167) ,0.001
Body mass index 23.7 (21.2–27.1) 23.5 (21.2–26.5) 23.4 (21.1–26.4) 23.5 (21.4–26.3) 0.07
Deprivation category
1 (least deprived) 12 (3.6) 18 (2.3) 147 (3.5) 2947 (3.7)
2 35 (10.5) 75 (9.5) 388 (9.4) 8240 (10.4)
3 48 (14.3) 132 (16.7) 737 (17.8) 14 565 (18.4)
4 75 (22.4) 183 (23.2) 1010 (24.3) 19 715 (24.9) ,0.001
5 66 (19.7) 144 (18.2) 694 (16.7) 13 324 (16.8)
6 48 (14.3) 146 (18.5) 680 (16.4) 12 268 (15.5)
7 (most deprived) 51 (15.2) 92 (11.7) 494 (11.9) 8057 (10.2)
Smoking status
Non-smoker 206 (61.5) 481 (60.9) 2418 (58.3) 49 115 (62.1)
Smoker 110 (32.8) 259 (32.8) 1388 (33.5) 22 512 (28.5) ,0.001
Ex-smoker 19 (5.7) 50 (6.3) 344 (8.3) 7489 (9.5)
Previous miscarriages
0 270 (80.6) 656 (83.0) 3497 (84.3) 68 961 (87.2)
1 47 (14.0) 96 (12.2) 531 (12.8) 8541 (10.8) ,0.001
>2 18 (5.4) 38 (4.8) 122 (2.9) 1614 (2.0)
Previous therapeutic abortions
0 295 (88.1) 696 (88.1) 3709 (89.4) 71 567 (90.5)
1 34 (10.2) 88 (11.1) 381 (9.2) 6837 (8.6) ,0.001
>2 6 (1.8) 6 (0.8) 60 (1.5) 712 (0.9)
Marital status
Married 153 (45.7) 381 (48.2) 2017 (48.6) 40 859 (51.6) ,0.001
Other 182 (54.3) 409 (51.8) 2133 (51.4) 38 257 (48.4)
AFP (MoM) 1.18 (0.91–1.58) 1.17 (0.90–1.55) 1.13 (0.89–1.44) 1.02 (0.82–1.28) ,0.001
hCG (MoM) 1.15 (0.76–1.76) 1.14 (0.80–1.66) 1.04 (0.74–1.48) 1.03 (0.74–1.44) ,0.001
AFP denotes alpha-fetoprotein, hCG denotes human chorionic gonadotrophin and MoM denotes multiple of the median. Continuous data expressed as
median (inter-quartile range) and continuous data expressed as n (%).
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Table 2 Cox regression analysis of the risk of spontaneous preterm birth across the range 24–36 weeks gestation among 84 391 first births in
Scotland, 1992–2001
Univariate Multivariate*
Variables HR 95% CI P 5 PH test HR 95% CI P 5 PH test
AFP percentile
0–20 0.86 0.76–0.97 0.7 0.85 0.75–0.96 0.8
21–40 0.95 0.84–1.07 0.7 0.95 0.84–1.07 0.7
41–60 (1.0)* (1.0)* (1.0)*
61–80 1.29 1.15–1.45 0.2 1.29 1.16–1.45 0.1
81–90 1.41 1.23–1.61 0.3 1.40 1.23–1.61 0.3
91–95 1.83 1.57–2.13 0.1 1.83 1.57–2.13 0.1
96–100 2.44 2.12–2.81 0.07 2.45 2.12–2.82 0.1
Trend test ,0.001 ,0.001
Heterogeneity test ,0.001 ,0.001
hCG percentile
0–20 1.05 0.94–1.17 0.9 1.04 0.93–1.16 0.9
21–40 0.97 0.87–1.08 0.4 0.97 0.87–1.09 0.4
41–60 (1.0)* (1.0)* (1.0)*
61–80 0.94 0.84–1.06 0.8 0.95 0.85–1.06 0.8
81–90 0.88 0.76–1.01 0.7 0.88 0.77–1.02 0.7
91–95 0.82 0.68–0.99 0.7 0.81 0.67–0.98 0.8
96–100 1.07 0.90–1.27 0.047 1.02 0.86–1.21 0.008
Trend test 0.047 0.04
Heterogeneity test 0.047 0.1
Age (years)
,20 1.32 1.18–1.46 0.0001 1.11 0.98–1.25 0.0001
20–24 1.03 0.93–1.13 0.3 0.92 0.83–1.02 0.3
25–29 (1.0)* (1.0)* (1.0)*
30–34 1.03 0.94–1.14 0.07 1.05 0.95–1.16 0.1
35–39 1.08 0.92–1.27 0.06 1.07 0.91–1.26 0.1
.39 1.38 0.91–2.09 0.5 1.28 0.85–1.93 0.8
Trend test 0.004 0.5
Heterogeneity test ,0.001 0.02
Marital
Married (1.0)* (1.0)* (1.0)*
Other 1.22 1.14–1.31 0.09 1.10 1.01–1.19 0.5
Heterogeneity test ,0.001 0.03
Smoking
Non (1.0)* (1.0)* (1.0)*
Current 1.36 1.26–1.46 0.4 1.19 1.09–1.29 0.1
Ex 0.93 0.81–1.06 0.3 0.92 0.80–1.05 0.2
Heterogeneity test ,0.001 ,0.001
Height (cm)
,150 1.45 1.12–1.87 0.9 1.39 1.07–1.79 0.9
150–154 1.25 1.10–1.42 0.2 1.23 1.08–1.40 0.2
155–159 1.13 1.02–1.25 0.4 1.12 1.01–1.24 0.4
160–164 (1.0)* (1.0)* (1.0)*
165–169 0.90 0.82–1.00 0.7 0.91 0.82–1.00 0.7
170–174 0.84 0.74–0.96 0.7 0.85 0.75–0.96 0.6
.174 0.62 0.50–0.78 0.8 0.62 0.49–0.78 0.9
Trend test ,0.001 ,0.001
Heterogeneity test ,0.001 ,0.001
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detect variation in the relative risk and removes the possibility
of data-derived or investigator-derived categorization. We
propose that this method may be useful in systematically
determining whether an association varies in relation to the
degree of prematurity. Such an approach is usefully combined
with categorization, which then allows a simpler assessment of
the pattern of variation in relation to the degree of prematurity.
A further strength of the present study is its size. Deliveries
prior to 28 weeks account for ~60% of all neonatal deaths of
preterm infants.
10
However, extreme preterm birth is rare. In
our study, the risk of spontaneous preterm birth between 24
and 28 weeks was 1 in 500. It follows, therefore, that very
large-scale studies are required to address the factors associated
with this outcome. In practice, many studies of preterm birth
are insufficiently powerful to assess the risk of extreme preterm
birth and, in effect, use moderate and mild preterm birth as
proxies of this outcome. This approach is only valid if the
relative risk of spontaneous preterm birth does not vary in
relation to known risk factors over the range 24–36 weeks. In
the present study we show that this is not the case.
Clinical prediction of the risk of spontaneous preterm birth
among women with no previous births is an area of profound
clinical interest. Recent studies have indicated that use of
progesterone analogues may reduce the risk of spontaneous
preterm birth among women deemed to be at high risk of this
event.
28
The majority of women recruited to these trials are
selected as high risk on the basis of previous preterm deliveries,
as this is the maternal characteristic most strongly associated
with the risk of spontaneous preterm birth.
5
This method of
selection is clearly effective, as the rate of preterm birth in the
control group in one major trial exceeded 50%.
29
Given the
devastating consequences to the infant of extreme preterm
Table 2 (continued)
Univariate Multivariate*
Variables HR 95% CI P 5 PH test HR 95% CI P 5 PH test
Body mass index
,20 1.48 1.34–1.64 0.4 1.43 1.30–1.59 0.8
20–24 (1.0)* (1.0)* (1.0)*
25–29 0.91 0.83–0.99 0.6 0.89 0.81–0.97 0.5
.30 0.86 0.76–0.98 0.2 0.80 0.70–0.92 0.2
Trend test ,0.001 ,0.001
Heterogeneity test ,0.001 ,0.001
Deprivation category
1 (least deprived) 1.02 0.84–1.25 0.9 1.10 0.90–1.35 0.8
2 0.92 0.80–1.06 0.3 0.96 0.84–1.10 0.2
3 0.99 0.89–1.11 0.5 1.02 0.92–1.15 0.6
4 (1.0)* (1.0)* (1.0)*
5 1.09 0.97–1.22 0.3 1.06 0.95–1.18 0.4
6 1.12 1.00–1.26 0.4 1.08 0.96–1.21 0.4
7 (most deprived) 1.30 1.15–1.47 0.4 1.16 1.03–1.32 0.6
Trend test ,0.001 0.03
Heterogeneity test ,0.001 0.2
Previous miscarriages
0 (1.0)* (1.0)* (1.0)*
1 1.31 1.18–1.46 0.1 1.31 1.18–1.45 0.09
>2 1.53 1.25–1.88 0.006 1.50 1.22–1.84 0.005
Trend test ,0.001 ,0.001
Heterogeneity test ,0.001 ,0.001
Therapeutic abortions
0 (1.0)* (1.0)* (1.0)*
1 1.18 1.05–1.33 0.6 1.19 1.06–1.34 0.3
>2 1.91 1.46–2.51 0.3 1.90 1.44–2.49 0.2
Trend test ,0.001 ,0.001
Heterogeneity test ,0.001 ,0.001
HR, hazard ratio; CI, confidence interval; AFP, alpha fetoprotein; hCG, human chorionic gonadotrophin; PH test, proportional hazards test (Grambsch and
Therneau
8
). Global test of the proportional hazards assumption for multivariate model: P 5 0.007. The six cut points (multiples of the median) for AFP were
0.78, 0.95, 1.12, 1.37, 1.60, and 1.84 i.e. AFP 96–100 was equivalent to MoM of >1.84. The six cut points (multiples of the median) for hCG were 0.68, 0.91,
1.17, 1.57, 1.97, and 2.39.
* Referent category, i.e. hazard within each other category expressed as a ratio to hazard in referent category.
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Table 3 Multivariate logistic regression analysis of factors associated with extreme, moderate, and mild spontaneous preterm birth among
84 391 first births in Scotland, 1992–2001
Gestational age 24–28
n 5 202/84 258
Gestational age 29–32
n 5 790/83 622
Gestational age 33–36
n 5 4150/81 644
Variables *Adjusted OR 95% CI P 5 *Adjusted OR 95% CI P 5 *Adjusted OR 95% CI P 5
hCG percentile
0–20 1.20 0.74–1.94 0.5 1.06 0.78–1.44 0.7 1.03 0.91–1.17 0.6
21–40 1.56 0.99–2.47 0.06 0.64 0.45–0.91 0.01 0.99 0.87–1.12 0.9
41–60 (1.0)
a
(1.0)
a
(1.0)
a
61–80 1.29 0.80–2.08 0.3 0.84 0.61–1.16 0.3 0.95 0.84–1.08 0.4
81–90 1.27 0.72–2.26 0.4 0.79 0.52–1.19 0.3 0.88 0.75–1.03 0.1
91–95 1.07 0.49–2.35 0.9 0.73 0.42–1.27 0.3 0.81 0.66–1.01 0.06
96–100 2.74 1.57–4.81 ,0.001 1.09 0.68–1.73 0.7 0.92 0.75–1.13 0.4
Age (years)
,20 2.35 1.58–3.47 ,0.001 1.19 0.86–1.64 0.3 1.02 0.90–1.17 0.7
20–24 1.20 0.80–1.80 0.4 0.92 0.68–1.24 0.6 0.90 0.80–1.00 0.06
25–29 (1.0)
a
(1.0)
a
(1.0)
a
30–34 1.21 0.80–1.85 0.4 1.24 0.93–1.66 0.1 1.02 0.91–1.14 0.8
35–39 1.36 0.72–2.56 0.4 1.34 0.86–2.10 0.2 1.02 0.85–1.23 0.8
.39 0.91 0.12–6.65 0.9 2.46 0.99–6.09 0.05 1.16 0.71–1.90 0.6
Previous miscarriages
0 (1.0)
a
(1.0)
a
(1.0)
a
1 1.77 1.21–2.59 0.003 1.23 0.90–1.68 0.2 1.29 1.15–1.46 ,0.001
>2 2.81 1.47–5.38 0.002 2.24 1.36–3.68 0.002 1.32 1.03–1.69 0.03
OR, odds ratio, CI, confidence interval, hCG, human chorionic gonadotrophin; n, number of spontaneous preterm births within the interval (numerator) and
the number of spontaneous preterm births within the interval plus the number of all births at later gestations (denominator).
* Adjusted for AFP, hCG, maternal age, socioeconomic deprivation category, height, smoking status, body mass index, prior spontaneous miscarriages, prior
therapeutic abortions, and marital status.
a
Referent category, i.e. odds for each other category expressed as a ratio to odds in referent category.
Table 4 Screening performance of predictive models for extreme, moderate, and mild spontaneous preterm birth among 84 391 first births in
Scotland, 1992–2001
Percentile of predicted risk PPV (%) Sensitivity (%) Specificity (%) Positive LR Negative LR
24–28 weeks
.99th percentile 1.31 5.45 99.01 5.51 0.96
.95th percentile 0.81 16.83 95.03 3.39 0.88
.90th percentile 0.65 27.23 90.04 2.73 0.81
.80th percentile 0.53 44.55 80.07 2.24 0.69
29–32 weeks
.99th percentile 1.44 3.37 99.01 3.41 0.98
.95th percentile 1.29 15.17 95.04 3.06 0.89
.90th percentile 1.05 24.72 90.06 2.49 0.84
.80th percentile 0.84 39.61 80.08 1.99 0.75
33–36 weeks
.99th percentile 9.80 3.16 99.07 3.40 0.93
.95th percentile 7.08 11.43 95.21 2.38 0.93
.90th percentile 6.22 20.09 90.32 2.08 0.88
.80th percentile 5.37 34.65 80.47 1.78 0.81
PPV denotes positive predictive value and LR denotes likelihood ratio. Analysis based on the predicted probability from multivariate logistic regression model
where the associations with age, hCG, and number of previous miscarriages were allowed to vary over the gestational age groups, whereas all the other
variables were fixed across the gestational age groups.
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birth and the possibility of an effective intervention, predictive
tools to identify women at high risk of extreme preterm
delivery in their first pregnancy are urgently required.
However, characterization of the parameters used in the
present study indicate that, in our population, the model
employed performed poorly as a screening tool with positive
predictive values of ,10%. This suggests that maternal
characteristics and second trimester maternal serum screening,
although statistically associated with the risk of preterm birth,
are insufficiently informative to be used to identify women at
clinically significant risk of preterm birth. This may reflect the
fact that spontaneous preterm birth has multiple aetiologies. If
population-based screening and intervention to prevent pre-
term birth in nulliparous women is to be attempted, other
specific methods will be required, such as cervical ultrasound or
fetal fibronectin assay from vaginal swabs.
30
In summary, we show that the risk of spontaneous preterm
delivery among nulliparous women with no previous births is
associated with a number of maternal characteristics and with
second trimester maternal serum levels of placentally derived
proteins. High levels of hCG, maternal age ,20 and two or
more previous miscarriages were more strongly associated with
extreme preterm delivery than moderate or mild preterm
delivery. However, models using maternal characteristics and
second trimester serum screening results did not have the
predictive ability for any degree of spontaneous preterm birth,
which would allow useful population-based screening.
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KEY MESSAGES
 The risk of spontaneous preterm birth among nulliparous women was positively associated with maternal serum
levels of AFP, socioeconomic deprivation, number of previous therapeutic abortions, smoking, and being
unmarried and negatively associated with height and body mass index.
 High levels of hCG, maternal age ,20, and two or more previous miscarriages were more strongly associated
with extreme preterm delivery than moderate or mild preterm delivery.
 Models using maternal characteristics and second trimester serum screening results did not have the predictive
ability for any degree of spontaneous preterm birth, which would allow useful population-based screening.
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Pregnancy-Associated Plasma Protein A and
Alpha-fetoprotein and Prediction of Adverse
Perinatal Outcome
Gordon C. S. Smith, MD, PhD, Imran Shah, MSc, Jennifer A. Crossley, PhD, David A. Aitken, PhD,
Jill P. Pell, MD, Scott M. Nelson, MB, PhD, Alan D. Cameron, MD, Michael J. Connor, MD, DSc,
and Richard Dobbie, BSc
OBJECTIVE: To describe the association between preg-
nancy associated plasma protein A (PAPP-A), alpha-
fetoprotein (AFP) and adverse perinatal outcome.
METHODS: We conducted a multicenter prospective
cohort study of 8,483 women attending for prenatal care
in southern Scotland between 1998 and 2000. The risk of
delivering a small for gestational age infant, delivering
preterm, and stillbirth were related to maternal serum
levels of PAPP-A and AFP.
RESULTS: Women with a low PAPP-A were not more
likely to have elevated levels of AFP. Compared with
women with a normal PAPP-A and a normal AFP, the
odds ratio for delivering a small for gestational age infant
for women with a high AFP was 0.9 (95% confidence
interval [CI] 0.5–1.6), for women with a low PAPP-A was
2.8 (95% CI 2.0–4.0), and for women with both a high
AFP and a low PAPP-A was 8.5 (95% CI 3.6–20.0). The
odds ratio for delivering preterm for women with a high
AFP was 1.8 (95% CI 1.3–2.7), for women with a low
PAPP-A was 1.9 (95% CI 1.3–2.7), and for women with
both a low PAPP-A and a high AFP was 9.9 (95% CI
4.4–22.0). These interactions were statistically significant
for both outcomes (P  .03 and .04, respectively). There
was a nonsignificant trend toward a similar interaction in
relation to stillbirth risk. Of the women with the combi-
nation of a low PAPP-A and high AFP, 32.1% (95% CI
15.9–52.4) delivered a low birth weight infant.
CONCLUSION: Low maternal serum levels of PAPP-A
between 10 and 14 weeks and high levels of AFP between
15 and 21 weeks gestation are synergistically associated
with adverse perinatal outcome.
(Obstet Gynecol 2006;107:161–6)
LEVEL OF EVIDENCE: II-2
Insulin-like growth factor II (IGF-II) is expressed inhigh levels in trophoblast and is thought to have a
key role in the control of trophoblast invasion.1
Recent evidence indicates that the activity of the IGF
system may be important in very early human preg-
nancy. A number of studies have related maternal
circulating concentrations of pregnancy-associated
plasma protein A (PAPP-A), a trophoblast derived
protease for IGF binding proteins 4 and 5, to eventual
perinatal outcome. These studies have shown that low
levels of PAPP-A are associated with increased risks
of intrauterine growth restriction, preterm birth, and
stillbirth.2–4 These associations are evident even when
confined to samples obtained in the first 10 weeks
postconception.5,6 Consistent with this, mice that are
null mutant for the gene encoding PAPP-A have
severe early onset intrauterine growth restriction.7
It has been appreciated for many years that, in
the absence of congenital abnormality, high maternal
serum levels of alpha-fetoprotein (AFP) in the second
trimester of pregnancy are associated with an in-
creased risk of adverse perinatal outcome.8 AFP is the
major fetal oncotic protein and, when the fetus is
structurally normal, high maternal circulating levels
are thought to reflect a defect in placentation. It is not
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yet known, however, whether the placental defect
associated with increased placental permeability to
AFP is related to the activity of the IGF system. The
aim of this study was to describe the relationship
between low PAPP-A, high AFP, and intrauterine
growth restriction, preterm birth, and stillbirth.
MATERIALS AND METHODS
We used data from the Combined Ultrasound and
Biochemical Screening9 study, a prospective, nonin-
terventional, multicenter study of screening for Down
syndrome. The study evaluated the use of ultrasound
measurement of fetal nuchal translucency in combi-
nation with analysis of maternal serum PAPP-A and
the free  subunit of human chorionic gonadotrophin
as a first trimester screening test for Down syndrome
in a routine prenatal clinic setting. Information leaf-
lets about the study were sent to women with the
notification of their first appointment for prenatal
care. Those women whose first visit was at 14 weeks
of gestation or less were invited to participate, and
those who agreed signed a consent form. Participation
in the study involved measuring nuchal translucency
at the time of the first ultrasound and obtaining
additional blood at the time of phlebotomy for rou-
tine prenatal investigations. No results were reported
to either the obstetrician or patient, and prenatal care
was not modified in any way by participation in the
study. Ethical approval was obtained from the Scot-
tish Multicenter Research Ethics Committee. Fifteen
Scottish maternity units participated in the Combined
Ultrasound and Biochemical Screening study during
a 2-year period between 1997 and 1999, and 98.6% of
records came from births in 11 of the hospitals.
Ninety-eight percent of the births occurred between
May 1998 and July 2000. Births to women recruited
to the study constituted 28.6% of all births in the 11
hospitals during that period.
Maternal levels of PAPP-A were measured from
blood obtained at the time of the first prenatal visit
(10–14 weeks) as part of the Combined Ultrasound
and Biochemical Screening study. Maternal levels of
AFP were determined by two methods. First, we
performed record linkage of the Combined Ultra-
sound and Biochemical Screening database to the
database of the laboratory information management
system for the prenatal screening program of theWest
of Scotland Regional Genetics Service of the Institute
of Medical Genetics in Glasgow. Second, part of the
cohort was followed up by manual retrieval of the
case notes, and the AFP level was obtained directly
from the case record. PAPP-A was assayed between
10 and 14 weeks gestation and AFP between 15 and
21 weeks. The outcome of the pregnancy was ascer-
tained by linkage of the Combined Ultrasound and
Biochemical Screening database to the Scottish Mor-
bidity Record10 and the Scottish Stillbirth and Infant
Death Enquiry.11 The Scottish Morbidity Record is a
national register of perinatal outcome data,10 and the
Scottish Stillbirth and Infant Death Enquiry is a
national register that routinely classifies all perinatal
deaths in Scotland.11 The Scottish Stillbirth and Infant
Death Enquiry has data on 100% of registered still-
births,11 and the Scottish Morbidity Record contains
data on 99.6% of certified births.10 The record linkage
and the details of the other data sources and defini-
tions are described in detail elsewhere.6,12 The study
cohort (N  8,483) for the current analysis was
defined by women who participated in the Combined
Ultrasound and Biochemical Screening study, who
had both PAPP-A and AFP results documented, and
who could be linked to the Scottish Morbidity Record
where singleton birth occurred at or after 24 weeks
gestation.
Small for gestational age (SGA) was defined on
the basis of centiles derived from the cohort, and
preterm birth was defined as delivery before 37
completed weeks of gestation. Socioeconomic status
was estimated on the basis of the postal code of the
mother’s residence, according to Carstairs socioeco-
nomic-deprivation categories (based on 1991 Census
data on car ownership, employment status, number of
occupants per household room, and social class
within postal-code sectors of residence that contain,
on average, about 1,600 residents).13 Higher scores
indicate residence within areas of greater deprivation.
Maternal serum levels of PAPP-A and AFP were
expressed as multiples of the median (MoM) for
gestational age, as is conventional for biochemical
indices in pregnancy that vary with week of gestation.
Because PAPP-A and AFP levels vary inversely with
maternal weight, MoM were corrected for maternal
weight using reciprocal-linear regression. This is
widely employed in prenatal screening and is de-
scribed in detail elsewhere.14 Separate PAPP-A MoM
were estimated for smokers, because PAPP-A is re-
duced by 15% among smokers.9 Low PAPP-A was
defined as the lowest 5% of values for gestational age
( 0.4 MoM), and high AFP was defined as the top
5% of values for gestational age ( 1.7 MoM). Uni-
variate comparison of continuous variables was per-
formed using the Mann-Whitney U test and categor-
ical data using the Fisher exact test. All P values were
2-tailed. Statistical significance was assumed at P 
.05. Multivariate analysis was performed using logistic
regression.15 Cases with missing data on covariates
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were dropped from the multivariate analysis. Interac-
tion terms were assessed using the likelihood ratio
test. All statistical analyses were performed using the
Stata 8 software package (Stata Corporation, College
Station, TX).
RESULTS
The linked database contained 11,729 records of
women who had a PAPP-A documented and had a
Scottish Morbidity Record. Three (0.03%) records were
excluded because the gestational age at delivery was less
than 24 weeks, 2 (0.02%) because of missing data on sex
of the baby, and 3 (0.03%) because of missing data on
weight. Of the remaining 11,721 births, 8,483 (72.4%)
had an AFP level recorded, and these women consti-
tuted the study cohort. The characteristics of the study
cohort are described in Table 1.
Low PAPP-A was associated with an increased
risk of delivering an SGA infant, preterm birth, and
stillbirth (Table 2). An elevated AFP was associated
with an increased risk of preterm birth and stillbirth
(Table 2). Women with a low level of PAPP-A were
not at increased risk of having a high AFP (odds ratio
1.3, 95% confidence interval [CI] 0.9–1.9). Adjusting
each factor for the other was without material effect
on the strength of associations (Table 3). Similarly
adjusting for maternal characteristics had a minimal
effect on the strength of the associations (Table 3).
We then studied outcome for high AFP and low
PAPP-A, either singly or in combination, with refer-
ence to women with normal values of both AFP and
PAPP-A (this is a different referent category from
Table 3 and thus odds ratios differ slightly from Table
3). The odds ratio for delivering a small for gestational
age infant for women with a high AFP was 0.9 (95%
CI 0.5–1.6), for women with a low PAPP-A was 2.8
(95% CI 2.0–4.0), and for women with both a high
AFP and a low PAPP-A was 8.5 (95% CI 3.6–20.0).
The odds ratio for delivering preterm for women with
a high AFP was 1.8 (95% CI 1.3–2.7), for women with
a low PAPP-A was 1.9 (95% CI 1.3–2.7), and for
women with both a low PAPP-A and a high AFP was
9.9 (95% CI 4.4–22.0). The odds ratio for antepartum
stillbirth for women with a high AFP was 2.5 (95% CI
0.6–10.9), for women with a low PAPP-A was 2.2
(95% CI 0.5–9.7), and for women with both a low
PAPP-A and a high AFP was 36.7 (95% CI 8.0–
167.6). Receiver operating characteristic curve analy-
sis of PAPP-A, AFP, and maternal characteristics in
predicting adverse outcome is shown in Table 4.
There were statistically significant positive interac-
tions (Fig. 1) between PAPP-A and AFP in the risk of
delivering a SGA infant (P  .03), preterm birth (P 
.04) and a trend toward a positive interaction in the
risk of stillbirth (P  .14). Of the women with the
combination of a low PAPP-A and high AFP, 32.1%
(95% CI 15.9–52.4) delivered a low birth weight
infant.
Table 1. Characteristics of Study Population (N  8,483)
Characteristics
Normal Outcome
(n  7,715)
Adverse Outcome
(n  768) P*
Median (IQR) age (y) 30 (27–33) 29 (25–33)  .001
Parity† (nulliparous) 3,665 (47.5) 428 (55.7)  .001
Ethnicity† (non-Caucasian) 180 (2.5) 28 (3.9) .02
Smoking status†
Nonsmokers 5,503 (71.8) 419 (55.0)
Ex-smokers 643 (8.4) 57 (7.5)  .001
Current smokers 1,522 (19.9) 286 (37.5)
Median (IQR) height (cm)† 163 (159–168) 162 (156–166)  .001
Median (IQR) BMI† 23.9 (21.8–26.8) 23.1 (21.0–25.9)  .001
Deprivation category†
1 (least deprived) 1,885 (24.5) 125 (16.3)
2 1,299 (16.9) 104 (13.5)
3 1,474 (19.1) 159 (20.7)  .001
4 1,734 (22.5) 197 (25.7)
5 (most deprived) 1,315 (17.1) 183 (23.8)
Marital status† (married) 4,872 (67.5) 405 (57.1)  .001
IQR, interquartile range; BMI, body mass index.
Normal outcome is defined as not small for gestational age, not preterm, not low birth weight, and not stillborn. Adverse outcome is defined
as 1 or more of these outcomes. Values are n (%) unless otherwise specified.
* P from Mann-Whitney U test, 2 test or 2 test for trend as appropriate.
† Missing values n (%) of demographic variables as follows: ethnicity 510 (6.0), smoking status 53 (0.6) , parity 1 (0.01), height 191 (2.3), BMI
715 (8.4), deprivation category 8 (0.09), and marital status 559 (6.6).
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DISCUSSION
A number of lines of evidence support an important
role for the activity of the IGF system in the first
trimester of pregnancy in determining perinatal out-
come. Insulin-like growth factor II is highly expressed
in trophoblast and is likely to control both maternal
Table 2. Univariate Associations Between Pregnancy-Associated Plasma Protein A and Alpha-fetoprotein
and Outcome
PAPP-A AFP
< 5th
Percentile
(n  457)
> 5th
Percentile
(n  8,026) OR (95% CI) P
<95th
Percentile
(n  8,071)
>95th
Percentile
(n  412) OR (95% CI) P
SGA 50 (10.9) 303 (3.8) 3.1 (2.3–4.3)  .001 333 (4.1) 20 (4.9) 1.2 (0.7–1.9) .47
Preterm birth 45 (9.9) 380 (4.7) 2.2 (1.6–3.0)  .001 385 (4.8) 40 (9.7) 2.1 (1.5–3.0)  .001
Stillbirth 4 (0.9) 18 (0.2) 3.9 (1.3–11.7) .01 18 (0.2) 4 (1.0) 4.4 (1.5–13.0) .008
PAPP-A, pregnancy-associated plasma protein A; AFP, alpha-fetoprotein; OR, odds ratio; CI, confidence interval; SGA, small for
gestational age.
Data are expressed as n (%) and OR (95% CI). The difference in the number of births in the top fifth percentile of AFP (n  412) and the
lowest fifth percentile of PAPPA (n  457) is due to their being ties in the data set. In an event of a tie, where percentiles are the same,
they are grouped into the lower percentile category. As a result, the lowest fifth percentile of PAPPA has 5.4% births (greater than 5%)
and the highest fifth percentile of AFP has 4.9% births (less than 5%).
Table 3. Multivariate Analysis of Association Between Pregnancy-Associated Plasma Protein A, Alpha-
fetoprotein, and Maternal Characteristics in Predicting Adverse Perinatal Outcome
Outcome/Adjustment
PAPP-A AFP
OR (95% CI) P OR (95% CI) P
SGA
Unadjusted 3.1 (2.3–4.3)  .001 1.2 (0.7–1.9) .47
Adjusted for each other 3.1 (2.3–4.3)  .001 1.2 (0.7–1.8) .54
Adjusted for each other and maternal characteristics* 2.8 (1.9–4.1)  .001 0.9 (0.5–1.5) .67
Preterm delivery
Unadjusted 2.2 (1.6–3.0)  .001 2.1 (1.5–3.0)  .001
Adjusted for each other 2.2 (1.6–3.0)  .001 2.1 (1.5–3.0)  .001
Adjusted for each other and maternal characteristics* 2.4 (1.7–3.4)  .001 1.8 (1.2–2.7) .002
Stillbirth
Unadjusted 3.9 (1.3–11.7) .01 4.4 (1.5–13.0) .008
Adjusted for each other 3.8 (1.3–11.3) .02 4.2 (1.4–12.6) .009
Adjusted for each other and maternal characteristics*† — — — —
PAPP-A, pregnancy associated plasma protein A; AFP, alpha-fetoprotein; OR, odds ratio; CI, confidence interval; SGA, small for
gestational age.
Values are OR (95% CI). Odds ratios are for a low PAPP-A referent to a normal PAPP-A (irrespective of AFP) and for a high AFP referent
to a normal AFP (irrespective of PAPP-A).
* Maternal characteristics included in the model were age, height, body mass index, deprivation category, marital status, smoking status,
ethnicity, parity, and hospital where the birth took place.
† Number of events too small for estimation using full multivariate model.
Table 4. Receiver Operating Characteristic Curve Analysis of Pregnancy-Associated Plasma Protein A,
Alpha-fetoprotein, and Maternal Characteristics in Predicting Adverse Outcome
Model
Small for Gestational Age Infant Preterm Delivery
Area Under ROC Curve 95% CI Area Under ROC Curve 95% CI
PAPP-A alone 0.55 0.49–0.60 0.53 0.49–0.57
AFP alone 0.50 0.46–0.55 0.52 0.48–0.57
PAPP-A and AFP 0.55 0.50–0.59 0.54 0.51–0.58
PAPP-A, AFP, and maternal characteristics* 0.77 0.74–0.80 0.64 0.61–0.67
ROC, receiver operating characteristic; CI, confidence interval; PAPP-A, pregnancy-associated plasma protein A; AFP, alpha-fetoprotein.
* Maternal characteristics included in the model were age, height, body mass index, deprivation category, marital status, smoking status,
ethnicity, parity, and hospital where the birth took place.
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and placental tissues at the site of implantation.1 Low
maternal levels of PAPP-A, a trophoblast-derived
protease for IGF binding proteins-4 and IGF binding
proteins-5,16 are associated with increased risks of
intrauterine growth restriction, preterm birth, and
stillbirth.2–4 Mice which are null mutant for the
PAPP-A gene are also at increased risk of early-onset
intrauterine growth restriction,7 which supports a
causal role for PAPP-A in determining outcome.
Many previous studies had shown that high ma-
ternal levels of the fetal oncotic protein, AFP, were
associated with an increased risk of complications in
later pregnancy.8 It was not apparent, however,
whether PAPP-A was a marker for the same placental
defect that leads to high rates of placental transfer of
AFP. The present study had 3 major findings. First,
we show that women who had low levels of PAPP-A
were not more likely to have elevated levels of AFP in
the second trimester of pregnancy. This suggests that
the pathophysiologic process leading to high placen-
tal transfer rates of AFP is not related to the IGF
system, insofar as it can be assessed by circulating
levels of PAPP-A. Second, we show that adjustment
for the levels of PAPP-A had a minimal effect on the
strength of association between AFP and adverse
outcome, and vice versa. If low levels of PAPP-A and
high levels of AFP were markers of the same under-
lying defect in placental function, it would have been
anticipated that adjustment of 1 factor for the level of
the other would have resulted in a weaker association.
The lack of an effect of such adjustment suggests that
low PAPP-A and high AFP are consequences of
distinct processes and that extreme levels indicate
different aspects of placental dysfunction. Finally, we
show the combination of a low PAPP-A and a high
AFP was synergistically associated with adverse out-
come. This indicates that the consequences of the 2
underlying processes must interact. These clinical
observations indicate complexity in the placental
determinants of adverse perinatal outcome and un-
derline the importance of understanding the biology
of trophoblast function in early pregnancy as a deter-
minant of complications in late pregnancy.
The combination of low PAPP-A and high AFP is
not likely to be clinically useful as a means of popu-
lation-based screening to identify women at high risk
of pregnancy complications. Relatively few women
will have the combination of a low PAPP-A and a
high AFP. Consequently, the sensitivity of this test
will be low and would not, in itself, justify population-
based screening for these outcomes. However, mater-
nal serum levels of PAPP-A and AFP are used in
Down syndrome screening, and inevitably, this pro-
cess will identify women who have the combination
of both a low PAPP-A and a high AFP. Women with
this combination had a 32.1% risk of delivering a low
Fig. 1. Odds ratios for combinations of low pregnancy-
associated plasma protein A and high alpha-fetoprotein in
predicting delivery of a small for gestational age infant (A),
preterm delivery (B), and stillbirth (C). The odds ratios for
interaction terms between a low pregnancy-associated
plasma protein A and a high alpha-fetoprotein were 3.4
(95% CI 1.2–9.8, P  .03) for small for gestational age, 2.8
(95% CI 1.1–7.2, P .04) for preterm birth and 6.6 (95% CI
0.5–78.9, P  .14) for stillbirth. All odds ratios are referent
to women with both a normal pregnancy-associated plasma
protein A and a normal alpha-fetoprotein. SGA, small for
gestational age; AFP, alpha-fetoprotein; PAPPA, pregnancy-
associated plasma protein A.
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birth weight neonate ( 2,500 g), a composite out-
come of poor growth and preterm birth. The current
data justify very close surveillance of these women,
because they have a high absolute risk of adverse
outcome. Serial umbilical artery Doppler flow veloci-
metry may be the preferred method of surveillance,
because its use has been shown to reduce perinatal
mortality in high-risk pregnancies.17
The data sources employed in the present study
also included measurement of the free  subunit of
human chorionic gonadotrophin in the first trimester
of pregnancy and human chorionic gonadotrophin in
the second. We did not analyze whether these factors
were associated with adverse outcome, because pre-
vious studies have shown the former is not indepen-
dently associated with adverse outcome,2 and the
latter is only weakly associated.18 Moreover, the num-
ber of cases in the present study were insufficient to
study third- or fourth-order interactions or interac-
tions associated with more extreme values of PAPP-A
or AFP.
In conclusion, we show that low PAPP-A and
high AFP synergistically predict preterm birth and
intrauterine growth restriction. We speculate that the
synergistic predictive ability of these tests reflects the
combined effect of 2 independent pathophysiologic
processes in early placental development.
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Risk of Sudden Infant Death Syndrome and Week of Gestation of
Term Birth
Gordon C. S. Smith, MD, PhD*; Jill P. Pell, MD‡; and Richard Dobbie, BSc§
ABSTRACT. Objective. We sought to determine if the
risk of sudden infant death syndrome (SIDS) varied ac-
cording to week of delivery at term among elective and
nonelective births.
Design. Retrospective cohort study.
Participants. All single infants live born between 37
and 42 weeks gestation in Scotland between 1992 and
1995 documented in the Scottish Morbidity Record.
Outcome. Death in the first year of life where SIDS
was in the principal position on the death certificate.
Results. There were 202 622 eligible births and 119
deaths attributed to SIDS. Among infants delivered elec-
tively, there was no significant association between risk
of SIDS and week of delivery. Among those delivered
nonelectively, the risk of SIDS declined significantly
with each week of gestation (odds ratio .72, 95% confi-
dence interval .60–.86). This trend was only minimally
attenuated by adjustment for maternal age, parity, smok-
ing and socioeconomic deprivation category, infant sex,
Apgar score, mode of delivery, and birth weight decile
(adjusted odds ratio .78, 95% confidence interval .65–.93).
Conclusions. We hypothesize that early spontaneous
labor at term and SIDS may be linked because of a
common association with suboptimal intrauterine
environment. Pediatrics 2003;111:1367–1371; pregnancy,
gestational age, labor, sudden infant death syndrome,
smoking.
ABBREVIATIONS. CI, confidence interval; HPAA, hypothalamo-
pituitary adrenal axis; SIDS, sudden infant death syndrome.
Previous epidemiologic studies on the etiologyof sudden infant death syndrome (SIDS) haveidentified a number of obstetric risk factors,
such as maternal cigarette smoking in pregnancy,
low birth weight, low maternal age and high parity,
and a number of postnatal environmental factors,
such as socioeconomic deprivation, parental ciga-
rette smoking, sleeping position, and bedding mate-
rial.1–5 Identifying infants at increased risk of SIDS
allows education and monitoring to be targeted to-
ward high-risk families. Identification of modifiable
environmental risk factors led to public information
campaigns which have been followed by a dramatic
decrease in the incidence of SIDS.4,6 Despite these
improvements, the pathophysiology of SIDS is still
unclear and it remains the most common cause of
postneonatal death in the first year of life.7
Moderate and severe preterm birth are associated
with an increased risk of SIDS and account for a
significant etiologic fraction of all SIDS deaths.8 We
have recently shown that early pregnancy levels of
circulating placental proteins are associated both
with spontaneous preterm birth9 and with the earlier
onset of labor at term.10 We hypothesize that in some
pregnancies the early onset of labor at term reflects a
suboptimal intrauterine environment. The aim of the
present study was to determine if the risk of SIDS
varied with the timing of spontaneous labor among
infants born at term.
METHODS
Patient Selection
The Scottish Morbidity Record collects information on clinical
and demographic characteristics and outcomes for all women
discharged from Scottish maternity hospitals. The register is sub-
jected to regular quality assurance checks and has been 99%
complete since the late 1970s.11 Data were extracted on all single
live born infants delivered between 37 and 42 weeks gestation in
Scotland between 1992 and 1995. Scottish Morbidity Record
records were linked to the death database held by the Registrar
General for Scotland’s Office to determine the date and principal
cause of death of those infants who died. We excluded from both
the univariate and multivariate analyses those infants with miss-
ing values for any of the covariates of interest and those infants
who died in their first year of life from a cause other than SIDS.
Definitions
SIDS was defined as the death of an infant for whom the
principal cause of death on the death certificate was coded as 798.0
using the International Classification of Diseases, Ninth Revision. Over
the period studied, a diagnosis of SIDS could only be written on a
death certificate in Scotland following thorough investigation of
the circumstances of the death including a postmortem examina-
tion performed by an approved pediatric pathologist.
Gestational age has been confirmed by ultrasound scan in the
first half of pregnancy in 95% of pregnancies in the United
Kingdom from the early 1990s.12 Gestational age at birth was
defined as completed weeks of gestation on the basis of the
estimated date of delivery in each woman’s clinical record and
standard national criteria exist for the estimation of date of deliv-
ery using menstrual and ultrasound data.13 Smoking status was
defined as the smoking status of the woman at the time of first
attendance for antenatal care. Maternal age was defined as the age
of the mother at the time of delivery. Birth weight was categorized
into sex and gestational age-specific deciles, as previously de-
scribed in detail.14 Elective delivery was defined as delivery by
planned cesarean section or delivery by any mode following in-
duction of labor. Postal code of residence was used to derive
Carstairs socioeconomic deprivation categories.15 These are based
on 1991 Census data on car ownership, unemployment, over-
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crowding, and social class within postal code sectors of residence
which contain, on average, 1600 residents.
Statistical Analyses
Continuous variables were summarized by the median and
interquartile range, and comparisons between groups were per-
formed using the Mann-Whitney U test. Correlation was tested
using Spearman’s . Univariate comparisons of dichotomous data
were performed using the 2 test. Ordinal data were compared
using the 2 test for trend. The P values for all hypothesis tests
were 2-sided. Crude and adjusted odds ratios were obtained using
logistic regression analyses. Maternal age, height, socioeconomic
deprivation score and mode of delivery, and the offspring’s birth
weight decile, Apgar score, and sex were categorized and treated
as dummy variables. Week of gestation at term was treated as a
continuous variable and linearity or nonlinearity (in the log odds
scale) was assessed using fractional polynomials.16 The possible
effect of deaths attributed to other causes was taken into account
using a proportional hazards model, where age was the time scale,
death attributed to SIDS was the event, deaths in the first year of
life attributed to causes other than SIDS were treated as censored,
as were all survivors at 1 year of life. Regression techniques
employed robust standard errors to allow for dependence within
individuals using a maternal identifier. The statistical significance
of interaction terms was assessed using the likelihood ratio test
and significance assumed at P .01. The goodness of fit of models
was assessed using the Hosmer and Lemeshow17 test based on
deciles of probability. All statistical analyses were performed us-
ing the Stata software package (Stata Corporation, College Station,
TX), version 7.0.
RESULTS
Between 1992–1995, there were 241 846 single live
births in Scotland. Gestational age at birth was miss-
ing in 666 (.3%), and recorded but outside the range
of 37 to 42 weeks in 13 714 (5.7%). Among the re-
maining 227 466 births, there were missing values for
parity in 155 (.1%), deprivation category in 741 (.3%),
birth weight in 62 (.1%), and maternal smoking in
23 626 (10.4%). Overall, 24 413 had 1 or more missing
values, leaving 203 053 live births between 37 and 42
weeks gestation with complete data. Within this
group, there were 431 (.2%) deaths before the first
year of life attributed to causes other than SIDS,
leaving a study group of 202 622. There were 119
deaths attributed to SIDS in the group which equated
to a rate of 5.9 per 10 000 (95% confidence interval
[CI] 4.9–7.0) for the study cohort. The proportion of
infants dying from SIDS did not change significantly
between 1992 and 1995 (P  .98, 2 test for trend).
Table 1 compares the maternal demographic and
obstetric characteristics of those infants who died
from SIDS with those who did not (Table 1). On
univariate analysis, the mothers of infants who died
from SIDS were younger at delivery, of higher parity,
TABLE 1. Comparison of Maternal, Demographic, and Obstetric Characteristics by Occurrence of
SIDS
SIDS
(N  119)
Non-SIDS
(N  202 503)
*P Value
Maternal characteristics median (IQR) median (IQR)
Age 24 (20–29) 28 (24–31) .001
Height (cm) 161 (156–166) 162 (157–167) .19
Parity number (%) number (%)
Nulliparous 43 (36.1) 89 588 (44.2)
Para 1–2 63 (52.9) 100 176 (49.5)
Para 3–4 11 (9.2) 11 388 (5.6)
Parity 5 2 (1.7) 1351 (.7) .001
Deprivation category
1 (least deprived) 2 (1.7) 10 584 (5.2)
2 5 (4.2) 25 963 (12.8)
3 18 (15.1) 42 357 (20.9)
4 32 (26.9) 50 243 (24.8)
5 18 (15.1) 32 606 (16.1)
6 17 (14.3) 24 527 (12.1)
7 (most deprived) 27 (22.7) 16 223 (8.0) .001
Smoker 80 (67.2) 63 578 (31.4) .001
Obstetric characteristics
Week of gestation of delivery
37 13 (10.9) 10 216 (5.0)
38 23 (19.3) 26 721 (13.2)
39 24 (20.2) 41 466 (20.5)
40 36 (30.2) 69 050 (34.1)
41 19 (16.0) 44 537 (22.0)
42 4 (3.4) 10 513 (5.2) .02
Male 77 (64.7) 102 873 (50.8) .002
Elective delivery 33 (27.7) 59 950 (29.6) .65
Mode of delivery
Spontaneous vaginal 96 (80.7) 149 172 (73.4)
Operative vaginal 7 (5.9) 24 221 (12.0)
Prelabor cesarean section 9 (7.6) 16 691 (8.2)
Postlabor cesarean section 7 (5.9) 12 372 (6.1) .21
Missing 0 47
Birth weight decile for sex and gestational age
Lowest decile 24 (20.2) 20 190 (10.0) .001
Highest decile 7 (5.9) 19 875 (9.8) .15
median (IQR) median (IQR)
Birth weight (g) 3180 (2880–3540) 3400 (3120–3760) .001
IQR indicates interquartile range.
* P value is from the Mann-Whitney U test, the 2 test or the 2 test for trend as appropriate.
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were more likely to live in an area of high socioeco-
nomic deprivation and were more likely to smoke.
Infants who died from SIDS were of lower absolute
birth weight, lower birth weight decile for sex and
gestational age, were more likely to deliver at earlier
weeks of gestation, and were more likely to be male.
The median age of death attributed to SIDS was 78
days (interquartile range: 42–138 days). There was no
association between gestation at delivery and age of
death attributed to SIDS among infants born elec-
tively (Spearman’s   .06, P  .75) or following
spontaneous labor (Spearman’s   .19, P  .08).
The relationship between the risk of SIDS and the
week of gestation at delivery was then examined
separately for elective and nonelective births. There
was no significant trend between week of delivery at
term and the risk of SIDS among infants delivered
electively, whereas among infants delivered nonelec-
tively the risk of SIDS decreased with increasing
gestational age at delivery (Fig 1). The relationship
between week of gestation and risk of SIDS was
explored further using logistic regression. The odds
ratio for each week of gestation at term for SIDS
among nonelective births was .72 (95% CI .60–.86,
P  .001) and for elective births was .90 (95% CI
.70–1.15, P .41). Addition of a polynomial term did
not significantly improve either model (P  .38 and
P  .36). Adjusting for potential confounders (ma-
ternal age, parity, deprivation category, mode of de-
livery, smoking status, birth weight decile, Apgar
score, and sex) only slightly attenuated the associa-
tion among nonelective births (adjusted odds ratio
.78, 95% CI .65–.93) and minimally altered the odds
ratio for week of gestation among elective births
(adjusted odds ratio .88, 95% CI .68–1.13). The odds
ratio of SIDS at each week of gestation among non-
elective births is tabulated (Table 2).
The association between week of gestation and the
risk of SIDS among nonelective births was very sim-
ilar when confined to women who booked before 20
weeks gestation (odds ratio .74, 95% CI .60–.91) or
before 13 weeks gestation (odds ratio .69, 95% CI
.50–.96). The association was also very similar when
the risk of SIDS was calculated having taken into
account infant deaths attributed to other causes us-
ing a proportional hazards model for both nonelec-
tive (hazard ratio .72, 95% CI .60–.86) and elective
births (hazard ratio .90, 95% CI .70–1.15). There were
no statistically significant interactions between week
of delivery at term among either elective or nonelec-
tive births and the other factors in predicting the risk
of SIDS (all P  .01). Goodness of fit tests were
performed for logistic models and these were not
statistically significant for either nonelective (P .96)
or elective births (P  .72).
There was limited information available on the
indication for elective delivery. However, we could
identify women who were delivered by planned ce-
sarean section who had an infant presenting by the
breech and women having planned repeat cesarean
births. The incidence of SIDS in this group (4 of 9766,
4.1 per 10 000) was very similar to the other women
delivered electively (29 of 50 217, 5.8 per 10 000; P 
.52).
DISCUSSION
The factors predisposing to SIDS have been the
subject of intense study for many years. The inci-
dence of SIDS declined in many countries in the early
1990s as the importance of postnatal environmental
factors, such as sleeping position and cigarette
smoke, was recognized. The sharp decline in inci-
dence took place between 1989–1991 in Scotland,6
and over the period of the present study the rate of
SIDS was relatively stable. A number of obstetric
factors are known to affect the risk of SIDS, including
preterm birth. The main finding of the present study
is that even within gestational ages regarded as term
(from 37 weeks onwards), the risk of SIDS decreased
progressively with advancing gestational age at de-
livery (Fig 1 and Table 2). This association was not
explained by known risk factors for SIDS, such as
maternal cigarette smoking, fetal sex, fetal growth,
maternal age, parity, and socioeconomic deprivation.
There was no comparable trend among infants de-
livered electively, and the differing patterns of asso-
ciation persisted after adjusting for mode of delivery.
This suggests that the increased risk was not attrib-
uted to early delivery, but to the early onset of labor.
We hypothesize that the factors which predispose to
earlier onset of spontaneous labor at term may also
predispose to SIDS.
Fig 1. Death rates for SIDS in relation to week of
delivery among women delivered electively (N 
59 983) and nonelectively (N 142 639). P value is the
2 test for trend.
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It is possible that the lack of association between
gestational age and risk of SIDS could be explained
by bias. If infants born electively before 40 weeks had
an increased risk of SIDS, then it is possible that
those allowed to proceed to 40 weeks and beyond
were selected and had a lower risk of SIDS. There-
fore, a false relationship between gestational age and
SIDS might be observed. However, the infants born
electively before 40 weeks had a very similar risk of
SIDS to infants born nonelectively at or after 40
weeks gestation. The excess of deaths occurred
among infants nonelectively delivered at the earlier
weeks of term. The rate of death in this group was
higher than elective births at all gestational ages and
spontaneous births at later weeks of gestation. It is
possible that the association with early term birth
reflected misclassification of gestational age and in-
creased numbers of truly preterm infants at the ear-
lier weeks of gestation at term. However, this is
unlikely since confining the analysis to women who
booked in the first trimester of pregnancy, when
ultrasound estimation of gestational age is most ac-
curate,13 tended to strengthen rather than weaken
the association.
This study focused on the relationship between
obstetric factors and the risk of SIDS. Although this
analysis is retrospective, these data were collected
during pregnancy and immediately following deliv-
ery and were thus prospective in relation to SIDS;
this is one of the main strengths of our study design.
However, we lacked information on some other fac-
tors which are thought to influence the risk of SIDS.
For example, the method of infant feeding was un-
known. It is possible that differences in successful
breastfeeding in relation to week of delivery may
account for some of the observed association. How-
ever, this would not explain the observed difference
between elective and nonelective births. There were
missing values for 10% of the population, princi-
pally smoking status. This is unlikely to bias the
analysis and the proportion with missing values is
comparable to other national databases.18
A number of studies have demonstrated an in-
creased risk of SIDS following preterm birth.4,19 Be-
cause SIDS is independently associated with admis-
sion to neonatal intensive care,19 it is difficult to
determine if the association with preterm birth was a
consequence of preterm delivery or was associated
with the factors which led to the preterm delivery.
Our study is the first to demonstrate an association
between earlier onset of labor at term and the risk of
SIDS in the infant. Although the biological determi-
nants of the onset of labor at term are not yet fully
understood, activation of the fetal hypothalamopitu-
itary adrenal axis (HPAA) is thought to be a key
physiologic event precipitating the process.20 The
factors controlling the fetal HPAA are complex, and
possibly include corticotrophin-releasing hormone
from the placenta21 and suppression of the fetal
HPAA by maternal steroids.22 However, a number of
physiologic stresses activate the fetal HPAA.23 Pre-
vious studies have also shown an association be-
tween spontaneous preterm birth and intrauterine
growth restriction.24–26 We hypothesize that early
activation of the fetal HPAA and the resultant early
onset of labor at term may reflect an adverse intra-
uterine environment. Consistent with this, we have
recently demonstrated that low levels of placentally
derived proteins in early pregnancy are associated
with earlier onset of labor at term.10 We hypothesize
that the association demonstrated between early on-
set of spontaneous labor and risk of SIDS may result
from a suboptimal intrauterine environment predis-
posing to both events.
It has been hypothesized, on the basis of postmor-
tem findings, that SIDS forms a continuum with
unexplained death of the fetus in utero.27 Consistent
with this, the conditions share a number of risk fac-
tors, such as maternal cigarette smoking during
pregnancy,28 poor fetal growth,29 and male sex.14
However, the risk of unexplained fetal death in-
creases with advancing gestational age,30,31 whereas
the risk of SIDS declined (Table 2). Moreover, the risk
of SIDS is lower among first pregnancies,4,19 whereas
the risk of unexplained fetal death is higher among
first pregnancies.31 We hypothesize that the differ-
ences in risk factors for SIDS and unexplained fetal
death may be explained by the initiation of labor. We
propose that if the suboptimal intrauterine environ-
ment prematurely initiates the endocrine cascade
leading to parturition, the infant is live born but is at
increased risk of subsequent SIDS. If the fetus is
exposed to a suboptimal intrauterine environment
but labor is not initiated, there is an increased risk of
intrauterine death. We hypothesize that the lower
risk of SIDS and higher risk of unexplained fetal
death among nulliparous women may reflect a
higher threshold for activation of the fetal HPAA to
TABLE 2. Crude and Adjusted Odds Ratios for SIDS Associated With Week of Delivery at Term Among Infants Born Following the
Onset of Spontaneous Labor
Week of
Gestation
Births (N) SIDS Deaths
N (%)
Crude
Odds Ratio*
(95% CI)
P Value§ Adjusted
Odds Ratio†
(95% CI)
P Value§
37 654 10 (.15) 3.1 (1.5–6.4) .002 2.5 (1.2–5.2) .015
38 15 722 16 (.10) 2.1 (1.1–3.8) .02 1.8 (.9–3.3) .075
39 32 285 19 (.06) 1.2 (.7–2.2) .54 1.1 (.6–2.1) .66
40* 54 981 27 (.05) (1.0) (1.0)
41 28 492 14 (.05) 1.0 (.5–1.9) .99 1.1 (.6–2.1) .80
42 4611 0 (0) – .27 –
* Referent category.
† Adjusted for maternal age, parity, deprivation category, birth weight decile, male sex, maternal smoking, and mode of delivery.
§ P value from Wald test except comparison between 40 weeks and 42 weeks, which was by Fisher’s exact test.
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initiate labor. Consistent with this, the onset of spon-
taneous labor at term is later among nulliparous
women.32
CONCLUSIONS
The earlier onset of spontaneous labor at term is
associated with an increased risk of subsequent SIDS.
We hypothesize that this may reflect a common as-
sociation with suboptimal intrauterine environment.
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background
 
Unexplained stillbirth and the sudden infant death syndrome (SIDS) share some fea-
tures. A raised maternal serum level of alpha-fetoprotein during the second trimester
of pregnancy is a marker of placental dysfunction and a strong predictor of the risk of
unexplained stillbirth. It is unknown whether alpha-fetoprotein levels also predict the
risk of SIDS.
 
methods
 
We linked a prenatal-screening database for women in western Scotland with databases
of maternity, perinatal death, and birth and death certifications to assess the associa-
tion between second-trimester levels of maternal serum alpha-fetoprotein and the sub-
sequent risk of SIDS.
 
results
 
Among 214,532 women with singleton births, there were 114 cases of SIDS (inci-
dence, 2.7 per 10,000 births among women with alpha-fetoprotein levels in the lowest
quintile and 7.5 per 10,000 births among those with levels in the highest quintile).
When the lowest quintile was used as a referent, the unadjusted odds ratios for SIDS for
the second through fifth quintiles were 1.7 (95 percent confidence interval, 0.8 to 3.5),
1.8 (95 percent confidence interval, 0.9 to 3.7), 2.5 (95 percent confidence interval, 1.3
to 4.8), and 2.8 (95 percent confidence interval, 1.4 to 5.4), respectively (P for
trend=0.001). The risk of SIDS varied inversely with the birth-weight percentile and
the gestational age at delivery; after adjustment for these factors, the odds ratios for
SIDS were 1.7 (95 percent confidence interval, 0.8 to 3.5), 1.7 (95 percent confidence
interval, 0.8 to 3.5), 2.2 (95 percent confidence interval, 1.1 to 4.4), and 2.2 (95 percent
confidence interval, 1.1 to 4.3), respectively (P for trend=0.01).
 
conclusions
 
There is a direct association between second-trimester maternal serum alpha-fetopro-
tein levels and the risk of SIDS, which may be mediated in part through impaired fetal
growth and preterm birth.
abstract
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he sudden infant death syndrome
 
(SIDS) is defined as the death of an infant
during the first year of life in cases in
which all identifiable causes of death can be ruled
out by appropriate assessment. Observational stud-
ies have highlighted the prone sleeping position
and environmental tobacco smoke in the infant’s
bedroom as factors that are associated with SIDS.
 
1
 
Widespread public health campaigns directed at
modifying these behaviors have been followed by a
sharp reduction in the incidence of SIDS. However,
SIDS remains the most important single cause of
infant death in the industrialized world.
 
1,2
 
 A num-
ber of studies have identified obstetrical factors
that are associated with an increased risk of SIDS,
such as poor intrauterine growth and premature
birth.
 
1
 
 Moreover, as programs designed to address
environmental risk factors have become wide-
spread, the relative importance of obstetrical deter-
minants has increased.
 
3
 
 
The mechanisms linking complications of preg-
nancy and the risk of SIDS remain obscure. Previ-
ous studies have suggested similarities between
unexplained stillbirth and SIDS with respect to
clinical and pathological findings, suggesting that
the two conditions may be related.
 
4,5
 
 A raised ma-
ternal serum level of alpha-fetoprotein during the
second trimester of pregnancy is one of the best
biochemical predictors of the risk of unexplained
stillbirth.
 
6
 
 If SIDS and unexplained stillbirth have
common pathophysiological determinants, there
might be a direct association between maternal se-
rum alpha-fetoprotein levels and the risk of SIDS.
We designed this study to test the hypothesis that
the risk of SIDS would increase with increasing
maternal serum levels of alpha-fetoprotein in a
large Scottish database linking biochemical, preg-
nancy, birth, and death records for 214,532 live-
born singleton infants.
 
sources of data
 
The Scottish Morbidity Record is a registry in
which information on clinical and demographic
characteristics and outcomes is collected for all
women discharged from Scottish maternity hospi-
tals. The registry is subjected to regular quality-
assurance checks and has been more than 99 per-
cent complete since the late 1970s.
 
7
 
 The Scottish
Stillbirth and Infant Death Enquiry is a national
registry that routinely classifies all perinatal deaths
in Scotland.
 
2
 
 All women attending prenatal care in
western Scotland are offered biochemical screen-
ing, with their serum levels of alpha-fetoprotein
and human chorionic gonadotropin used to assess
their risk of having a fetus affected by Down’s syn-
drome or a structural abnormality.
 
8
 
 The laboratory
information management system for the prenatal
screening program of the West of Scotland Regional
Genetics Service of the Institute of Medical Genet-
ics, in Glasgow, contains a database of maternal in-
formation and biochemical-screening results. Elec-
tronic storage of these data in their current form
was started in September 1991. Although serum
alpha-fetoprotein was measured during screening
before this date, the data were not archived in a for-
mat that allowed weight-adjusted multiples of the
median to be calculated. The General Register
Office, Scotland, maintains electronic birth and
death records.
We used a probability-based, matching ap-
proach
 
9
 
 with maternal identifiers to link the Scot-
tish Morbidity Record, the Scottish Stillbirth and
Infant Death Enquiry database, the Institute of Med-
ical Genetics prenatal screening database, and the
General Register Office database of birth certifi-
cates. The birth certificates contained offspring
identifiers that were then used to link biochemical
data, pregnancy data, and data on perinatal deaths
to the death-certificate registry to identify deaths
among the offspring. We excluded multiple births,
stillbirths, and births before or after 24 to 43 weeks
of gestation. Approval of the study was obtained
t
methods
 
Figure 1. Incidence of SIDS According to the Year of Birth 
among 1,321,646 Live Singleton Births in Scotland, 
1980 to 2001.
 
The range in the annual number of births was 48,740 
to 65,688, and the range in the annual number of deaths 
attributed to SIDS was 29 to 131.
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from the Privacy Advisory Committee of the Infor-
mation and Statistics Division, National Health
Service, Scotland.
 
definitions
 
For purposes of this study, SIDS was defined as the
death of an infant during the first year of life with
this diagnosis listed as the principal cause of death
on the death certificate (code 798.0 in the 
 
Interna-
tional Classification of Diseases, 9th Revision 
 
[ICD-9] or
code R95 in the 
 
International Classification of Diseases,
10th Revision
 
 [ICD-10]). During the period studied,
a diagnosis of SIDS could be written on a death cer-
tificate in Scotland only after thorough investiga-
tion of the circumstances of the death. The mini-
mal requirements are described by the Crown
Office
 
10
 
 (the government body that oversees the
Procurator Fiscal, whose duties include the investi-
gation of sudden deaths), and an autopsy is manda-
tory. In practice, the investigation of these deaths
was frequently much more involved.
 
11
 
 A previous,
detailed study in which Scottish death certificates
between 1992 and 1995 showed 201 deaths attri-
buted to SIDS found that standard diagnostic crite-
ria were fulfilled in all cases.
 
12
 
 SIDS is a diagnosis
of exclusion and is not made in the presence of a
major congenital abnormality. The death certifi-
cate could contain up to three ICD-9 or ICD-10 di-
 
Table 1. Demographic and Obstetrical Characteristics of the Cohort.*
Characteristic SIDS (N=114) No SIDS (N=214,418) P Value†
Mother‡
 
Age — yr <0.001
Median 25 28
Interquartile range 20–31 24–32
Height — cm 0.002
Median 160 162
Interquartile range 157–165 158–167
Body-mass index§ 0.008
Median 23.2 23.9
Interquartile range 20.9–25.5 21.7–27.0
Parity — no. (%) 0.005
Nulliparous 42 (36.8) 96,234 (44.9)
1 or 2 57 (50.0) 106,175 (49.5)
3 or 4 14 (12.3) 10,862 (5.1)
≥5 1 (0.9) 1,123 (0.5)
Carstairs deprivation category — no. (%) <0.001
1 (least deprived) 2 (1.8) 8,909 (4.2)
2 6 (5.3) 22,571 (10.5)
3 14 (12.3) 41,147 (19.2)
4 18 (15.8) 52,748 (24.6)
5 20 (17.5) 34,412 (16.1)
6 19 (16.7) 31,383 (14.7)
7 (most deprived) 35 (30.7) 22,893 (10.7)
Smoking status — no. (%) <0.001
Never smoked 29 (27.1) 124,261 (61.9)
Former smoker 4 (3.7) 15,302 (7.6)
Current smoker 74 (69.1) 61,264 (30.5)
Serum alpha-fetoprotein multiple of the median 0.002
Median 1.11 1.01
Interquartile range 0.91–1.39 0.81–1.27
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agnostic codes. We ruled out coexisting congenital
abnormalities by searching the second and third
diagnostic codes (for ICD-9 codes 740.0 to 759.9
or ICD-10 codes beginning with “Q”); none of the
cases in which death had been attributed to SIDS
on the certificate also had these codes.
The mother’s age and parity, the postal code of
her residence, and all outcome data were obtained
solely from the Scottish Morbidity Record. The
mother’s weight was obtained solely from the bio-
chemical database. Her height and smoking status
were obtained from the Scottish Morbidity Record
or, in cases in which they were missing from the
Scottish Morbidity Record, from the biochemical
database. The smoking status (current, former, or
never) was determined on the basis of information
gathered at the time of the first prenatal visit or at
the time of prenatal screening if this information
was obtained from the biochemical database. The
mother’s age was defined as the age of the mother
at the time of delivery. Her body-mass index was
calculated as the weight in kilograms recorded at
the time of sampling for the alpha-fetoprotein as-
say divided by the square of the height in meters.
Socioeconomic status was estimated on the basis
of the postal code of the mother’s residence, ac-
cording to Carstairs socioeconomic-deprivation
categories
 
13
 
 (based on 1991 Census data on car
ownership, employment status, number of occu-
pants per household room, and social class within
postal-code sectors of residence that contain, on
average, about 1600 residents). 
 
* Of the 114 cases of death attributed to SIDS, data were missing on the mother’s height in 2 (1.8 percent), body-mass in-
dex in 9 (7.9 percent), and smoking status in 7 (6.1 percent). Of the remaining 214,418 records, data were missing on the 
mother’s height in 2510 (1.2 percent), body-mass index in 15,877 (7.4 percent), parity in 24 (<0.1 percent), deprivation 
category in 355 (0.2 percent), and smoking status in 13,591 (6.3 percent) and were missing on the infant’s sex in 9 (<0.1 
percent), birth-weight percentile in 61 (<0.1 percent), and birth weight in 53 (<0.1 percent).
† P values were calculated by the Mann–Whitney U test, the chi-square test, or the chi-square test for trend, as appropriate.
‡ The mother’s age is the age at the time of delivery, and the body-mass index and smoking status are those documented 
at her first visit for prenatal care. The Carstairs deprivation category is estimated on the basis of socioeconomic indicators 
in the area of residence; the method of calculation has been described in detail elsewhere.
 
13 
 
The multiple of the median 
is the ratio of an individual value to the median value for the given week of gestation, corrected for maternal weight.
 
17
 
§ The body-mass index is the weight in kilograms divided by the square of the height in meters.
 
Table 1. (Continued.)
Characteristic SIDS (N=114) No SIDS (N=214,418) P Value†
 
Serum alpha-fetoprotein quintiles — no. (%) 0.001
1 12 (10.5) 43,912 (20.5)
2 20 (17.5) 42,185 (19.7)
3 21 (18.4) 42,660 (19.9)
4 29 (25.4) 43,193 (20.1)
5 32 (28.1) 42,468 (19.8)
Serum human chorionic gonadotropin multiple of the median 0.20
Median 0.95 1.00
Interquartile range 0.60–1.44 0.71–1.40
 
Infant
 
Male sex — no. (%) 72 (63.2) 109,883 (51.2) 0.01
Birth-weight percentile <0.001
Median 28 50
Interquartile range 12–56 25–75
Birth weight — g <0.001
Median 3000 3410
Interquartile range 2530–3310 3060–3750
Gestational age — wk <0.001
Median 39 40
Interquartile range 37–40 39–41
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The gestational age at birth was defined as the
number of weeks of gestation completed, on the
basis of the estimated date of delivery in each wom-
an’s clinical record; standard national criteria exist
for estimation of the date of delivery with the use of
menstrual and ultrasonographic data.
 
14
 
 Since the
early 1990s, the estimated gestational age has been
confirmed by ultrasonography during the first half
of pregnancy in more than 95 percent of pregnan-
cies in the United Kingdom.
 
15
 
 The birth weight
was categorized into sex-specific and gestational-
age–specific percentiles, as previously described in
detail.
 
16
 
 Maternal serum levels of alpha-fetopro-
tein and human chorionic gonadotropin were quan-
tified as multiples of the median (the ratio of the in-
dividual value to the median value) for the given
week of gestation, after correction for the mother’s
weight.
 
17
 
statistical analysis
 
Univariate comparisons were performed with the
Mann–Whitney U test, the chi-square test, and the
chi-square test for trend, as appropriate. The P val-
ues for all hypothesis tests were two-sided. Crude
and adjusted odds ratios for SIDS were obtained by
means of logistic-regression analysis.
 
18
 
 Biochemi-
cal data were categorized into deciles or quintiles.
The mother’s age, height, body-mass index, and
parity were treated continuously in logistic-regres-
sion models, as were the birth-weight percentile
and the gestational age (in weeks) at delivery. Non-
linearity of continuous variables in the logistic re-
gression was tested and modeled with the use of
fractional polynomials. The regression techniques
involved the use of robust standard errors, as well
as unique maternal identifiers, to account for de-
pendence between births to the same mother.
The statistical significance of interaction terms
was assessed by means of the Wald test, and results
were considered significant when the P value was
less than 0.01. Observations for which values were
missing for variables that were more than 99.8 per-
cent complete in the linked database were dropped
from the multivariate analysis. For variables that
were 99.8 percent or less complete in the linked da-
tabase, missing values were estimated by multiple
multivariate imputation.
 
19
 
 The goodness of fit of
the models was assessed with a Hosmer–Leme-
show test based on deciles of probability. All statis-
tical analyses were performed with use of Stata
software, version 8.2.
A total of 1,321,646 live singleton births at 24 to 43
weeks of gestation were recorded in the Scottish
Morbidity Record between 1980 and 2001, and
1673 of the infants died from SIDS (12.7 per
10,000). Figure 1 shows the incidence of SIDS ac-
cording to year of birth and indicates a sharp de-
cline around 1990 and 1991, coincident with the
public appreciation of the effects of a prone sleep-
ing position and environmental tobacco smoke on
the risk of SIDS. There were 216,563 linked rec-
ords for singleton births for which the maternal se-
rum alpha-fetoprotein level had been recorded. Of
these, we excluded 867 (0.40 percent) with extreme
levels of alpha-fetoprotein (defined as values at or
below the 0.2nd percentile or at or above the 99.8th
percentile), 1060 stillbirths (0.49 percent), and 131
births at a gestational age of less than 24 weeks or
more than 43 weeks (0.06 percent); 2031 records
listed one or more of these reasons for exclusion.
Thus, the study cohort comprised 214,532 live
births between November 15, 1991, and December
31, 2001.
There were 114 deaths attributed to SIDS in the
cohort, yielding an incidence of 5.3 (95 percent
confidence interval, 4.4 to 6.4) per 10,000 live
births. The incidence in the whole of Scotland over
the same period was 6.5 (95 percent confidence in-
terval, 5.8 to 7.2) per 10,000 live births. There were
880 deaths during the first year of life in the cohort.
In 311 of these deaths (35.3 percent), one or more
of the three diagnostic codes included on the death
certificate was the code for a congenital abnormal-
ity. There were no congenital abnormalities listed
among the three diagnostic codes on the death cer-
tificate in the 114 cases of SIDS.
The assays for alpha-fetoprotein were per-
formed between 15 and 21 weeks of gestation. The
range of the maternal serum level of alpha-fetopro-
tein, expressed as multiples of the median, was
0.35 to 3.75; the 5th percentile was 0.59 and the
95th percentile 1.82. The quintiles of the maternal
serum level of alpha-fetoprotein, expressed as mul-
tiples of the median for gestational age, were less
than or equal to 0.77; greater than 0.77 but less than
or equal to 0.93; greater than 0.93 but less than or
equal to 1.10; greater than 1.10 but less than or
equal to 1.35; and greater than 1.35. The demo-
graphic and obstetrical characteristics of the study
cohort are shown in Table 1. Women whose infants
results
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ultimately died of SIDS were younger, shorter, had
a lower body-mass index, were of higher parity,
were more likely to live in a very socioeconomically
deprived area, were more likely to smoke, had
higher second-trimester levels of alpha-fetopro-
tein, were more likely to have delivered a male in-
fant, had offspring with lower birth-weight per-
centiles, and had delivered earlier than women
whose infants did not die of SIDS (Table 1).
The risk of SIDS increased with increasing sec-
ond-trimester maternal serum levels of alpha-feto-
protein (Fig. 2). The incidence of SIDS was 2.7 per
10,000 births among women with alpha-fetopro-
tein levels in the lowest quintile and 7.5 per 10,000
births among those with levels in the highest quin-
tile, and there was a linear trend across the quin-
tiles (Table 2). The risk of SIDS was inversely relat-
ed to the birth-weight decile and the gestational
age at birth (Fig. 3). Adjusting for these factors at-
tenuated the strength of the association between
alpha-fetoprotein levels and the risk of SIDS, but a
significant relationship persisted: adjusted odds
ratios for the second through fifth quintiles were
1.7 (95 percent confidence interval, 0.8 to 3.5), 1.7
(95 percent confidence interval, 0.8 to 3.5), 2.2 (95
percent confidence interval, 1.1 to 4.4), and 2.2 (95
percent confidence interval, 1.1 to 4.3), respective-
ly (P for trend=0.01). In multivariate analysis, the
risk of SIDS also varied according to the sex of the
infant and the mother’s age, parity, and smoking
status (Table 2). Further adjustment for these fac-
tors did not materially affect the association be-
tween the alpha-fetoprotein level and the risk of
SIDS (Table 2).
There were no significant interactions between
the maternal serum alpha-fetoprotein level and any
of the maternal or obstetrical characteristics in any
of the models. The goodness of fit of all the models
appeared to be adequate, as assessed by global
tests of goodness of fit, which showed no signifi-
cant difference between the observed and expected
numbers of deaths attributed to SIDS when women
were categorized according to the decile of proba-
bility predicted by the multivariate model. When
maternal serum alpha-fetoprotein was treated as a
continuous variable in logistic-regression models,
the unadjusted odds ratio for SIDS associated with
an increase of 1 in the multiple of the median was
2.0 (95 percent confidence interval, 1.4 to 3.0;
P<0.001). The odds ratio adjusted for birth-weight
percentile and gestational age was 1.6 (95 percent
confidence interval, 1.1 to 2.3; P=0.02); the odds
ratio adjusted for birth-weight percentile, gesta-
tional age, and all maternal characteristics was 1.5
(95 percent confidence interval, 1.0 to 2.2; P=0.03);
and the odds ratio adjusted for birth weight as a
continuous variable was 1.6 (95 percent confi-
dence interval, 1.1 to 2.3; P=0.02). When all other
continuous variables were categorized and miss-
ing values treated with the use of indicator varia-
bles, the adjusted odds ratio for an increase of 1 in
the multiple of the median of maternal serum al-
pha-fetoprotein was 1.6 (95 percent confidence in-
terval, 1.1 to 2.3; P=0.02). 
There was no significant association between
the risk of SIDS and maternal serum levels of hu-
man chorionic gonadotropin, either expressed as
a continuous variable (odds ratio for an increase of
1 in the multiple of the median for gestational age,
0.92; 95 percent confidence interval, 0.67 to 1.24;
P=0.57) or categorized into quintiles (P for trend=
0.19).
The present study shows that the risk of an infant’s
death from SIDS increased with increasing serum
levels of alpha-fetoprotein in the mother during
the second trimester of pregnancy. The risk of SIDS
among the infants of women with alpha-fetopro-
tein levels in the highest quintile was 2.8 times that
among infants whose mothers’ levels was in the
lowest quintile, although the absolute risk of SIDS
remained low, even in the highest quintile (7.5 per
10,000 live births). We observed no significant as-
sociation between serum levels of human chorion-
ic gonadotropin and the risk of SIDS.
Both preterm birth and intrauterine growth re-
discussion
 
Figure 2. Incidence of SIDS, According to the Decile 
of Maternal Serum Alpha-Fetoprotein Level.
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* All data were treated as continuous except the quintile of serum alpha-fetoprotein, the Carstairs deprivation category, 
smoking status, and the infant’s sex. CI denotes confidence interval.
† P=0.37 by the global test of goodness of fit (evaluated separately for each imputed data set and the lowest P value 
reported).
‡ The relationship between the mother’s age (in years) and the risk of SIDS was nonlinear and was fitted with use of the 
following polynominals: the square of the age and the square of the age multiplied by the log of the age. Point estimates 
of the odds ratios and 95 percent confidence intervals (with reference to an age of 20 years) are given to illustrate the pat-
 
tern of association. All other continuous variables were linear in the log odds scale.
 
Table 2. Unadjusted and Adjusted Odds Ratios for SIDS in Relation to Characteristics of the Mother and Infant.*
Variable Unadjusted Analysis
Analysis Adjusted for Characteristics 
of Mother and Infant†
 
Odds Ratio
(95% CI) P Value
Odds Ratio
(95% CI) P Value
 
Mother
 
Serum alpha-fetoprotein quintile
1 (referent) 1.0 1.0 
2 1.7 (0.8–3.5) 0.13 1.7 (0.8–3.6) 0.13
3 1.8 (0.9–3.7) 0.10 1.8 (0.9–3.6) 0.12
4 2.5 (1.3–4.8) 0.009 2.2 (1.1–4.4) 0.02
5 2.8 (1.4–5.4) 0.003 2.2 (1.1–4.2) 0.02
0.001 for trend 0.01 for trend
Age (yr)‡
20 (referent) 1.0 1.0 
25 0.5 (0.4–0.6) <0.001 0.5 (0.4–0.6) <0.001
30 0.3 (0.2–0.5) <0.001 0.3 (0.2–0.5) <0.001
35 0.4 (0.2–0.6) <0.001 0.3 (0.2–0.55) <0.001
40 0.7 (0.4–1.3) 0.26 0.5 (0.2–1.1) 0.10
Height (per 10-cm increase) 0.6 (0.5–0.8) 0.001 0.8 (0.6–1.1) 0.24
Body-mass index (per 5-unit increase) 0.8 (0.6–1.0) 0.07 0.9 (0.7–1.2) 0.62
Parity (per one-birth increase) 1.4 (1.2–1.6) <0.001 1.5 (1.3–1.7) <0.001
Carstairs deprivation category 
1 (least deprived; referent) 1.0 1.0 
2 1.2 (0.2–5.9) 0.84 1.0 (0.2–4.8) 0.97
3 1.5 (0.3–6.7) 0.58 1.0 (0.2–4.4) 0.98
4 1.5 (0.4–6.6) 0.57 0.8 (0.2–3.7) 0.79
5 2.6 (0.6–11.1) 0.20 1.2 (0.3–5.1) 0.83
6 2.7 (0.6–11.6) 0.18 1.2 (0.3–5.2) 0.83
7 (most deprived) 6.8 (1.6–28.3) 0.008 2.2 (0.5–9.6) 0.28
Smoking status
Never smoked (referent) 1.0 1.0 
Former smoker 1.3 (0.4–3.5) 0.67 1.1 (0.4–3.1) 0.90
Current smoker 4.9 (3.1–7.6) <0.001 2.5 (1.5–4.1) <0.001
 
Infant
 
Male sex 1.6 (1.1–2.4) 0.01 1.6 (1.1–2.3) 0.02
Birth-weight percentile (per 10-percentile
increase)
0.8 (0.8–0.9) <0.001 0.9 (0.8–1.0) 0.003
Gestational age (per 1-wk increase) 0.8 (0.8–0.9) <0.001 0.8 (0.8–0.9) <0.001
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striction are associated with an elevated maternal
serum level of alpha-fetoprotein.
 
6
 
 The association
between the maternal serum alpha-fetoprotein lev-
el and the risk of SIDS appeared to be mediated in
part by these factors. However, even after adjusting
for gestational age at birth and birth-weight per-
centile, we found that the infants of mothers with
alpha-fetoprotein levels in the upper two quintiles
had a risk of SIDS that was more than twice the risk
among infants of mothers with values in the lowest
quintile.
Alpha-fetoprotein is the main protein contrib-
uting to oncotic pressure in the fetal circulation
and is comparable to albumin in adults.
 
20
 
 Elevated
maternal serum levels of alpha-fetoprotein in the
absence of fetal abnormality are thought to indi-
cate increased placental permeability and therefore
a defect in placental function.
 
6
 
 Associations be-
tween elevated maternal serum levels of alpha-
fetoprotein and both poor fetal growth and pre-
term birth
 
21
 
 are believed to reflect the role of defec-
tive early placental function in these outcomes. Ad-
justing for gestational age and birth weight may
thus result in an underestimation of the associa-
tion between maternal serum alpha-fetoprotein
levels and the risk of SIDS, since an adverse early
intrauterine environment may mediate the subse-
quent risk of SIDS in part by its consequences on
fetal growth and the timing of birth. In this study, a
significant association remained after adjustment
for these factors, however, suggesting that the in-
trauterine environment may influence the proba-
bility that a given postnatal environment will lead
to SIDS. Experimental studies have shown that fe-
tal hypoxemia induces a chemoreceptor-mediated
redistribution of cardiac output, increasing flow to
the cardiac and cerebral circulations.
 
22
 
 Chronic,
mild fetal hypoxemia leads to premature matura-
tion of fetal cardiovascular control, manifested as a
lower heart rate and a higher blood pressure early
during gestation.
 
23
 
 We speculate that a suboptimal
intrauterine environment may lead to altered car-
diorespiratory control, which could in turn predis-
pose an infant toward SIDS, although this hypoth-
esis requires further study.
The strengths of the present study include its
large size, the availability of detailed information
on the characteristics of the mothers, and the fact
that all exposure data were collected independently
of the ascertainment of events. Whereas previous
studies have shown that the risk of SIDS varies ac-
cording to both preterm birth and intrauterine
growth restriction,
 
1
 
 many studies have dichoto-
mized gestational age at birth as term or preterm
and have dichotomized birth weight as above or
below a given percentile for gestational age. We
found continuous relationships between gesta-
tional age at birth and the risk of SIDS as well as be-
tween birth-weight percentile and the risk of SIDS;
this approach reduces the likelihood of residual
confounding due to categorization of continuous
variables. Nevertheless, some misclassification is
possible. We relied on women’s postal codes to
classify their socioeconomic status, and for wom-
en who reported smoking, we did not have data on
the number of cigarettes they smoked. However,
after adjustment for gestational age and birth-
weight percentile, further adjustment for charac-
teristics of the mothers based on the available data
had no material effect.
 
Figure 3. Incidence of SIDS According to Birth-Weight 
Decile (Top Panel) and Gestational Age at Birth (Bottom 
Panel).
 
In the graph shown in the bottom panel, all births at or 
before 30 weeks of gestation were pooled and plotted at 
30 weeks because of the small number of these births.
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The sharp decline in the incidence of SIDS after
the inception of public health programs aimed at
improving infants’ sleeping conditions has led to a
search for factors that might explain the remaining
cases. The observed association between elevated
maternal serum alpha-fetoprotein levels during
the second trimester and the incidence of SIDS
suggests that an adverse intrauterine environment
during the first half of pregnancy may be another
important determinant of the risk of SIDS.
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ABSTRACT
OBJECTIVE. We sought to develop a simple robust method for assessing the risk for
sudden infant death syndrome (SIDS) on the basis of obstetric characteristics.
METHODS. A population-based retrospective cohort study was conducted of data from
the linked Scottish Morbidity Record, Stillbirth and Infant Death Enquiry and
General Registrar’s Office database of births and deaths, encompassing births in
Scotland between 1992 and 2001. All women who had a singleton live birth
between 24 and 43 weeks’ gestation and for whom data were available (n 
505 011), divided into model development and validation samples, were studied.
The main outcome measure was death of the infant in the first year of life as a
result of SIDS.
RESULTS. The risk for SIDS was modeled in the development sample using logistic
regression with the following predictors: maternal age, parity, marital status,
smoking, and the birth weight and the gender of the infant. When the model was
evaluated in the validation sample, the area under the receiver operating charac-
teristic curve was 0.84 and the incidence of SIDS was 0.7 per 10 000 (95%
confidence interval: 0.3–1.4) among 126 253 women in the lower 50% of pre-
dicted risk and 29.7 per 10 000 (95% confidence interval: 23.4–37.2) among the
25 250 women in the top 10% of predicted risk. A logistic-regression model then
was developed for the whole population, and the output was converted into
adjusted likelihood ratios. These are tabulated and provide a simple method for
assessing the risk for SIDS associated with any combination of obstetric charac-
teristics.
CONCLUSIONS. A model that uses maternal characteristics and outcome at birth is
predictive of the risk for SIDS. This model is presented in a simple form that allows
calculation of the individual risk for SIDS.
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THE FACTORS THAT determine the risk for sudden in-fant death syndrome (SIDS) have been the focus of
studies for many years.1 Identification of modifiable en-
vironmental exposures led to the “Back to Sleep” cam-
paign and a dramatic fall in the incidence of SIDS. De-
spite this, SIDS remains the most common cause of
death in infancy.2,3 After an apparent SIDS death, there
should be an analysis of all of the factors that may have
contributed to the event. The procedures for this have
been reviewed recently4,5 and include detailed investiga-
tion of the scene of death and a thorough autopsy.
Previous risks for SIDS are also taken into account in this
process, including an assessment of whether there were
any obstetric risk factors for SIDS. Many studies have
addressed both prenatal and postnatal predictors of the
risk for SIDS.1 However, these analyses are presented in
a manner that does not allow easy and accurate assess-
ment of the absolute risk associated with a given com-
bination of characteristics. Our aim was to (1) develop a
valid model that relates the risk for SIDS accurately to
obstetric characteristics and (2) present it in a format
that is simple to understand and use.
METHODS
The study design was a retrospective cohort study of all
singleton live births in Scotland who were between 24
and 43 weeks’ gestation (inclusive) and documented in
the Scottish Morbidity Record (SMR2) between 1992
and 2001. The outcome was death as a result of SIDS in
the first year of life, ascertained through death certificate
data from the General Registrar’s Office (GRO).
Data Sources and Patient Selection
The SMR2 collects information on clinical and demo-
graphic characteristics and outcomes for all women who
are discharged from Scottish maternity hospitals. The
register is subjected to regular quality assurance checks
and has been 99% complete since the late 1970s.6 The
Scottish Stillbirth and Infant Death Enquiry is a national
register that routinely classifies all perinatal deaths in
Scotland.3 The GRO maintains computerized birth and
death registration records. A probability-based matching
approach7 that used maternal identifiers to link the
SMR2, the Scottish Stillbirth and Infant Death Enquiry,
and the GRO database of birth certificates was used. The
birth certificate contained offspring identifiers that then
were used to link the pregnancy and perinatal death data
to the death certificate register to identify deaths in
infancy.
Deﬁnitions
SIDS was defined as death of an infant in whom the
principal cause on the GRO death certificate was coded
as 798.0 using the International Classification of Diseases,
Ninth Revision or R95 using International Classification of
Diseases, 10th Revision. During the period studied, a diag-
nosis of SIDS could be written on a death certificate in
Scotland only after thorough investigation of the cir-
cumstances of the death. The minimum requirements
are described by the Crown Office,8 and an autopsy was
mandatory. In practice, the investigation of these deaths
was frequently much more involved.9 A previous de-
tailed study of deaths attributed to SIDS on Scottish
death certificates between 1992 and 1995 found that
standard diagnostic criteria were fulfilled in all cases.10
Maternal age was defined as the age of the mother at the
time of delivery. Smoking and marital status were de-
fined as the status of the woman at the time of first
attendance for prenatal care. Parity was defined as the
total number of previous births, excluding abortions.
Gestational age at birth was defined as completed weeks
of gestation at the time of delivery. Gestational age has
been confirmed by ultrasound scan in the first half of
pregnancy in 95% of pregnancies in the United King-
dom from the early 1990s.11
Statistical Analysis
Univariate comparisons were performed using the
Mann-Whitney U test, the 2 test, and the 2 test for
trend, as appropriate. The P values for all hypothesis
tests were 2-sided. Crude and adjusted odds ratios (ORs)
were obtained by using logistic-regression analyses.12
Parity, maternal age, and the infant’s birth weight all
were treated continuously in logistic-regression models.
Treating these variables in this manner avoids loss of
information as a result of categorization. We excluded
cases with extremes of birth weight (500 or 5000 g)
to avoid overly influential effects of outliers. This im-
proves the reliability of modeling of birth weight for the
vast majority of the population. Because very small
numbers of cases had values outside this range, esti-
mates of probability for these extreme cases would be
potentially unstable. Nonlinearity in the log odds scale
was tested and modeled using fractional polynomials.
Regression techniques used robust standard errors to
allow for dependence of different births to the same
mother using a maternal identifier. The statistical signif-
icance of interaction terms was assessed using the Wald
test, and significance was assumed at P  .01. Observa-
tions with missing values were excluded. The population
was randomly assigned to a model development and a
model validation sample. Goodness of fit was assessed
using the Hosmer-Lemeshow test based on deciles of
probability. The discrimination of the model was as-
sessed by the area under the receiver operating charac-
teristic (ROC) curve. The final logistic-regression model
fitted to the entire cohort was converted into adjusted
likelihood ratios using a modification of our recently
described method13 (see Appendix for details). All statis-
tical analyses were performed using the Stata 8.2 soft-
ware package (Stata Corp, College Station, TX).
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RESULTS
There were a total of 563 719 linked records of singleton
births. Among these, there were 2955 (0.5%) stillbirths,
1043 (0.2%) births outside the range of 24 to 43 weeks’
gestation, 270 (0.05%) births for which the weight was
500 g, and 1103 (0.2%) for which the weight was
5000 g. A total of 5099 (0.9%) had 1 or both of these
characteristics, leaving 558 620 live-born infants who
weighed between 500 and 5000 g and were delivered
between 24 and 43 weeks’ gestation. Among this group,
there were 53 372 (9.6%) cases with missing data on
smoking status, 263 (0.05%) with missing data on par-
ity, 19 (0.01%) with missing data on gender, and 15
(0.01%) with missing data on maternal age. A total of
53 609 (9.6%) records had 1 or missing variables, leav-
ing a study group of 505 011. The characteristics of the
study group are tabulated in relation to whether the
infant ultimately died from SIDS (Table 1). There were
317 SIDS deaths, giving an incidence of 6.3 (95% con-
fidence interval [CI]: 5.6–7.0) per 10 000.
Univariate and multivariate logistic-regression analy-
ses are tabulated for the model development group (n 
252 506; Table 2). There were significant associations
between all of the factors studied and the risk for SIDS
with the exception of being an ex-smoker. The relation-
ships between the risk for SIDS and parity, maternal age,
and birth weight were linear (in the log odds scale) in
both univariate analysis and multivariate analysis. There
were no statistically significant interactions between any
of the variables.
The model then was used to assess the risk for SIDS in
relation to the same characteristics in the validation
group (n  252 505, ie, out of sample). The area under
the ROC curve was 0.84 when tested out of sample. The
observed and predicted number of SIDS cases is plotted
versus deciles of predicted probability (Fig 1). There
were 9 SIDS deaths among the 126 253 women in the
lower half of predicted risk, an incidence of 0.7 cases per
10 000 (95% CI: 0.3–1.4). There were 75 SIDS events
among the 25 245 women in the top decile of predicted
risk, an incidence of 29.7 cases per 10 000 (95% CI:
23.4–37.2). The model then was fitted for the whole
population of 505 011. The area under the ROC curve
for the model was 0.81 and the goodness of fit was
adequate (P .49). The fitted model then was converted
into adjusted likelihood ratios (Table 3). The calculation
of the risk for SIDS associated with any combination of
characteristics is illustrated in Fig 2. Overall, 12 387
(2.4%) cases had a summary likelihood ratio 5. There
were 55 SIDS cases among this group, giving an inci-
dence of 44.4 per 10 000 (95% CI: 33.5–57.8).
Because 99% of missing data were on smoking
TABLE 1 Comparison of Maternal, Demographic, and Obstetric Characteristics by Occurrence of SIDS (n
 505 011)
SIDS
(n 317)
Non-SIDS
(n 504 694)
Pa
Maternal characteristics
Maternal age, y 24 (20–28) 28 (24–32) .001
Parity
Nulliparous 115 (36.3) 226 261 (44.8)
1 100 (31.6) 176 603 (35.0)
2 68 (21.5) 69 398 (13.8) .001
3 20 (6.3) 21 874 (4.3)
4 10 (3.2) 6817 (1.4)
4 4 (1.3) 3741 (0.7)
Smoking status
Nonsmoker 73 (23.0) 305 663 (60.6)
Smoker 230 (72.6) 155 535 (30.8) .001
Ex-smoker 14 (4.4) 43 496 (8.6)
Marital status
Other 221 (69.7) 195 444 (38.7)
Married 96 (30.2) 309 250 (61.3) .001
Outcome
Gender
Female 125 (39.4) 246 419 (48.8)
Male 192 (60.6) 258 275 (51.2) .001
Gestational age 39 (38–40) 40 (39–41) .001
Preterm birth
24–32 12 (3.8) 5098 (1.0)
33–36 34 (10.7) 22 576 (4.5) .001
Term 271 (85.5) 477 020 (94.5)
Birth weight, g 3030 (2625–3380) 3410 (3060–3745) .001
Data are expressed as n (%) or median (interquartile range), as appropriate.
a P value is from the Mann Whitney U test, the 2 test, or the 2 test for trend, as appropriate.
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status, we fitted a model for the 53 372 women with
missing data on this characteristic. The constant and
coefficients were very similar to the other women (data
not shown).
DISCUSSION
The investigation of a sudden infant death requires a
detailed analysis of all of the factors that may have
contributed to the event, and the procedures for this
have been reviewed recently.4,5 This includes detailed
investigation of the scene of death and thorough post-
mortem investigations. It is recognized, however, that a
number of characteristics of the pregnancy contribute to
the risk for SIDS.1 It is self-evident that a thorough
examination of the likely cause of death involves an
assessment of the previous risk relating to the outcome
of the pregnancy. Many previous studies have developed
statistical models to characterize obstetric predictors of
SIDS. However, none of these is presented in a way that
allows the simple and intuitive assessment of the abso-
lute risk for this event associated with a given combina-
tion of birth characteristics. The aim of the present study
was to develop a method that was valid, had discrimi-
native power, and was simple to use.
We developed a logistic-regression model and related
the risk for SIDS to marital and smoking status, maternal
age and parity, and the birth weight and the gender of
the infant. Birth weight is a reflection of both fetal
growth and gestational age at birth. We previously dem-
onstrated log linear relationships between the risk for
SIDS and both week of gestation of birth and birth
weight percentile.14 In the present study, we used birth
weight. Performance of the model was virtually identical
to a model using week of gestation at birth and birth
weight percentile (data not shown). Birth weight has the
advantage of being less dependent on definition than
gestational age and is more likely to be known than the
exact birth weight percentile. We assessed the calibra-
tion and discrimination of the model in the validation
sample. This demonstrated that the model fit the out-of-
sample data well and had good discriminative power. A
previous study had performed out-of-sample validation
of 4 risk scoring systems for SIDS and found sensitivities
of 41%, 53%, 62%, and 71% when the top 20% of
predicted risk were classified as high risk; the best per-
forming model included 17 predictors.15 In our own
study using a model that had just 6 predictors, 72% of
cases in the validation sample were in the top 20% of
predicted risk.
A number of studies have shown that women with a
previous SIDS event have an approximately fivefold risk
for recurrence compared with the general popula-
tion.16–19 In the United Kingdom, these women are of-
fered a structured scheme for the care of the next infant,
which involves symptom diaries, apnea monitors, scales,
and weekly home visits by the family health visitor.20
Logically, the 2.4% of women with a summary likeli-
hood ratio of 5 on the basis of the model might be
offered a similar intervention, although this would re-
quire additional evaluation of efficacy and economic
justification. However, application of this model assumes
TABLE 2 Unadjusted and AdjustedOR for Risk for SIDS in Relation toObstetric Characteristics Among
Model Development Group (n 252 506)
Variables Unadjusted OR
(95% CI)
P Adjusted OR
(95% CI)a
P
Maternal characteristics
Age (per 5-y increase) 0.59 (0.50–0.69) .001 0.65 (0.53–0.79) .001
Parity (per birth) 1.18 (1.06–1.33) .004 1.39 (1.23–1.58) .001
Married 0.28 (0.20–0.38) .001 0.54 (0.38–0.78) .001
Ex-smoker 1.52 (0.77–3.02) .23 1.19 (0.60–2.39) .62
Smoker 4.90 (3.48–6.90) .001 2.49 (1.73–3.60) .001
Pregnancy outcome
Male 1.44 (1.06–1.96) .02 1.53 (1.13–2.07) .007
Birth weight (per 500-g increase) 0.65 (0.59–0.72) .001 0.72 (0.64–0.81) .001
All datawere treated as continuous variables except for smoking,marital status, andgender. The referent categories for the 3 categorical variables
were nonsmokers, unmarried women, and female infants, respectively.
a Global test of goodness of ﬁt (within sample): P .48.
FIGURE 1
Observed and expected number of cases of SIDS in validation sample (n 252 505) in
relation to deciles of predicted probability from the model generated from the develop-
ment sample (n  252 506). Distribution of cases comparing observed and expected
(Hosmer-Lemeshow test of goodness of ﬁt): P .05.
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TABLE 3 Adjusted Likelihood Ratios for Maternal and Obstetric
Characteristics and the Risk for SIDS
Characteristic Adjusted Likelihood
Ratios
Age, y
15 2.84
16 2.60
17 2.38
18 2.18
19 1.99
20 1.83
21 1.67
22 1.53
23 1.40
24 1.28
25 1.18
26 1.08
27 0.99
28 0.90
29 0.83
30 0.76
31 0.69
32 0.63
33 0.58
34 0.53
35 0.49
36 0.45
37 0.41
38 0.37
39 0.34
40 0.31
41 0.29
42 0.26
43 0.24
44 0.22
45 0.20
Birth weight, g
500 7.73
550 7.44
600 7.17
650 6.90
700 6.64
750 6.40
800 6.16
850 5.93
900 5.71
950 5.50
1000 5.29
1050 5.10
1100 4.91
1150 4.73
1200 4.55
1250 4.38
1300 4.22
1350 4.06
1400 3.91
1450 3.77
1500 3.63
1550 3.49
1600 3.36
1650 3.24
1700 3.12
1750 3.00
1800 2.89
1850 2.78
TABLE 3 Continued
Characteristic Adjusted Likelihood
Ratios
1900 2.68
1950 2.58
2000 2.48
2050 2.39
2100 2.30
2150 2.22
2200 2.13
2250 2.05
2300 1.98
2350 1.90
2400 1.83
2450 1.77
2500 1.70
2550 1.64
2600 1.58
2650 1.52
2700 1.46
2750 1.41
2800 1.35
2850 1.30
2900 1.26
2950 1.21
3000 1.16
3050 1.12
3100 1.08
3150 1.04
3200 1.00
3250 0.96
3300 0.93
3350 0.89
3400 0.86
3450 0.83
3500 0.80
3550 0.77
3600 0.74
3650 0.71
3700 0.69
3750 0.66
3800 0.64
3850 0.61
3900 0.59
3950 0.57
4000 0.55
4050 0.53
4100 0.51
4150 0.49
4200 0.47
4250 0.45
4300 0.44
4350 0.42
4400 0.40
4450 0.39
4500 0.37
Smoking status
Nonsmoker 0.52
Smoker 1.59
Marital status
Unmarried 1.23
Married 0.71
Parity
0 0.73
1 1.06
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that the relationships between the variables studied and
the risk for SIDS are similar in other populations.
The absolute risk for an outcome associated with a
given combination of characteristics can be estimated
from a logistic-regression equation using the constant
and the coefficients. The constant reflects the baseline
risk, and the sum of the coefficients reflects the modifi-
cation of the baseline risk associated with the given
combination of characteristics. However, typically, med-
ical publications do not report the constant; therefore,
this calculation cannot be performed. Moreover, even if
provided with the constant and the coefficients, only a
tiny minority of doctors would have the knowledge to
perform this calculation. We sought to simplify estima-
tion of the absolute risk from a logistic-regression model
by expressing the output as adjusted likelihood ratios
rather than as ORs. In fact, a likelihood ratio is merely a
special type of OR. Taking the example of expressing the
risk for a given outcome among male individuals, the OR
associated with being male is the odds of the disease in
male individuals divided by the odds of the disease
among female individuals. The likelihood ratio associ-
ated with being male is the odds of the disease in male
individuals divided by the odds of the disease in the
whole population. Therefore, the OR expresses the risk
relative to another category of the given characteristic
(eg, male relative to female), whereas the likelihood
ratio expresses the risk relative to the whole population.
Using the example of gender, 2 likelihood ratios are
generated: 1 expresses the risk for male individuals, and
1 expresses the risk for female individuals.
Estimating the absolute risk of a given event associ-
ated with any combination of characteristics is relatively
simple using adjusted likelihood ratios (see Fig 2). The
prior risk of disease is the odds in the population. The
risk associated with any combination of variables is cal-
culated by multiplying the prior risk by the appropriate
likelihood ratios (Table 3). Therefore, estimating the ab-
solute risk requires relatively little statistical expertise.
Because the output of the model is in the form of an
individual estimated probability, our approach avoids
the loss of information involved in dichotomizing infants
as “high” or “low” risk on the basis of an arbitrary
threshold on an abstract numerical scale. Informing par-
ents that their infant is at high risk of SIDS may cause
unjustified anxiety, because the risk may be small in
absolute terms. The likelihood ratio based approach has
the key advantage that the output of the model is ex-
pressed in terms of the absolute risk associated with the
given individual’s combination of characteristics.
Expressing logistic-regression models in the form of
adjusted likelihood ratios has several other advantages.
First, if a predictor variable is unknown, then it may
simply be ignored: omitting a variable in a likelihood
ratio–based model makes the plausible assumption that
the individual has the background risk for the popula-
tion in relation to the given characteristic. Second, the
use of adjusted likelihood ratios removes the need to
select a reference category. In contrast, in logistic-regres-
sion analysis, a category of risk has to be regarded as
referent. By choosing an extreme category as referent,
ORs for all of the other categories will tend to be farther
from unity. Therefore, the OR for a given characteristic
may reflect the deviation in risk from the rest of the
population in the referent category as well as the cate-
gory in question. In contrast, by expressing the output of
logistic-regression models as likelihood ratios, the odds
of disease associated with any given feature are ex-
pressed relative to the odds in the whole population.
Finally, because the model uses the previous odds as the
starting point, there is the potential for using the ad-
justed likelihood ratios in other populations in which the
incidence of the disease is higher or lower and account-
ing for this by using the local incidence to estimate the
previous odds. This should be done carefully, however,
as it assumes that variation in the incidence between
populations does not depend on variation in the preva-
lence of the risk factors included in the model.
Other multivariate methods can be used to generate
adjusted likelihood ratios, such as distribution modeling,
which is used widely in Down syndrome screening.21
However, these methods do not directly incorporate bi-
nary variables, such as gender. Moreover, logistic-re-
TABLE 3 Continued
Characteristic Adjusted Likelihood
Ratios
2 1.54
3 2.23
4 3.23
5 4.69
Gender
Female 0.78
Male 1.23
The logistic-regression equation was as follows: log odds3.583 age(0.440) pari-
ty(0.372) birthweight (0.379)male(0.454)married(0.551) smoker(1.116), where
male, married, and smoker are indicator variables 1 if true or 0 if other and all continuous
variables are expressed as the same units listed in Table 2.
FIGURE 2
Sample calculation using adjusted likelihood ratios.
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gression modeling is much more widely used in the
analysis of risk, and many model-building tools have
been developed for this method. A previous attempt was
made to express logistic regression in the form of likeli-
hood ratios.22 However, the previous method of calcula-
tion does not agree with the multivariate logistic-regres-
sion output if the model contains categorical variables
with 2 levels or if the transformation of a continuous
variable changed between the univariate and the multi-
variate model.
CONCLUSIONS
We present a novel method for estimating the risk for
SIDS in relation to a given combination of maternal and
obstetric characteristics. This is simple to use and gives
arithmetically identical results to much more complex
statistical models.
APPENDIX: ESTIMATING LIKELIHOOD RATIOS
The logistic-regression model is log(odds)  a  b1x1 
b2x2 … bnxn. The adjusted likelihood ratios are calcu-
lated as multiples of exp(b1x1), exp(b2x2), etc, in 2 stages.
In the first stage, we fit the above model with the
term b1x1 replaced with an unknown constant d1 and
with all other terms (including the constant) fixed at
their previous estimated values. The estimated value of
d1 captures the risk before x1 is known, so the likelihood
ratio is exp(b1x1  d1). This is repeated for each term
b2x2, …, bnxn, and the constant is replaced by a  (a 
d1  d2 … dn).
Because of the nonlinearity of the log odds function,
a may not exactly equal the overall log odds of the
outcome, a0, if the x variables are correlated. In the
second stage, we therefore compute a correction factor
cj(a0  a), where c1 … cn  1, and we report likeli-
hood ratios exp[bjxj  dj  cj(a0  a)]. In this article, cj
is calculated as mj/(m1 … mn), where mj is the sample
minimum or maximum (depending on whether a0  a
is positive or negative) of bjxj dj: this procedure ensures
that the range of adjusted likelihood ratios spans 1.
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Objective: To determine whether neonatal respiratory morbidity at term is associated with an increased
risk of later asthma and whether this may explain previously described associations between caesarean
delivery and asthma.
Design: Retrospective cohort study using Scottish Morbidity Record (SMR) data of maternity (SMR02),
neonatal (SMR11), and acute hospital (SMR01) discharges.
Setting: Scotland.
Participants: All singleton births at term between 1992–1995 in 23 Scottish maternity hospitals.
Main outcome measures: Hospital admission with a diagnosis of asthma in the principal position between
1992 and 2000.
Results: Children who had a diagnosis of transient tachypnoea of the newborn or respiratory distress
syndrome were at increased risk of being admitted to hospital with a diagnosis of asthma (hazard ratio
(HR) 1.7, 95% confidence interval (95% CI) 1.4 to 2.2, p,0.001). This association was observed both
among children delivered vaginally (HR 1.5, 95% CI 1.1 to 2.0, p = 0.007) and among those delivered by
caesarean section (HR 2.2, 95% CI 1.6 to 3.0, p,0.001). In the absence of neonatal respiratory
morbidity, delivery by caesarean section was weakly associated with the risk of asthma in childhood (HR
1.1, 95% CI 1.0 to 1.2, p = 0.004). The strengths of the associations were similar whether the caesarean
delivery was planned or emergency and were not significantly altered by adjustment for maternal,
obstetric, and other neonatal characteristics.
Conclusions: Neonatal respiratory morbidity at term is associated with an increased risk of asthma in
childhood which may explain previously described associations between caesarean delivery and later
asthma.
R
ecent studies have demonstrated that children delivered
by caesarean section have an increased risk of hospital
admission for asthma in childhood.1 2 It has been
hypothesised that this may be explained by effects of mode
of delivery on the gut and susceptibility to atopy. However,
caesarean delivery is a well recognised cause of neonatal
respiratory morbidity at term, specifically, transient tachyp-
noea of the newborn and respiratory distress syndrome.3 4 A
number of previous studies have demonstrated that neonatal
respiratory morbidity secondary to preterm delivery is
associated with an increased risk of later asthma.5–8
However, there are no studies, to our knowledge, which
have examined the risk of later asthma in relation to neonatal
respiratory morbidity confined to term births. The aims of the
present study were to determine whether neonatal respira-
tory morbidity at term was associated with an increased risk
of later asthma and to determine whether any observed
association varied in relation to mode of delivery.
METHODS
Patient selection
The Scottish Morbidity Record 2 (SMR02) collects informa-
tion on clinical and demographic characteristics and out-
comes for all women discharged from Scottish maternity
hospitals. The register is subjected to regular quality
assurance checks and has been greater than 99% complete
since the late 1970s.9 Data were extracted on all singleton
liveborn infants delivered between 37 and 43 weeks gestation
inclusive in Scotland between 1992 and 1995 (inclusive).
SMR02 records were linked to the SMR11 (1992–1995)
database, which collects discharge data on all neonates
delivered in Scottish hospitals, and to the SMR01, which
collects discharge data on all acute hospital admissions in
Scotland. SMR01 admissions were analysed from 1st January
1992 to 31st December 2000, providing between 5 and 9 years
of follow up on the cohort. All linkages were performed using
a probability based matching approach which has been
described in detail elsewhere.10 Therefore, the final linked file
contained demographic, obstetric, and neonatal character-
istics and dates of hospital admission of the child. Ethical
approval for the linkage was obtained from the Privacy
Advisory Committee of the Information and Statistics
Division of the National Health Service in Scotland. The data
sources employed are given in table 1.
Exclusion criteria
Multiple pregnancies, stillbirths, births outside the range 37–
43 weeks gestation, births in hospitals that performed less
than 100 planned caesarean deliveries over the study period,
and vaginal breech births were all excluded. Records were
also excluded where there were missing values for any of the
covariates.
Obstetric definitions
Gestational age at birth was defined as completed weeks of
gestation on the basis of the estimated date of delivery in
each woman’s clinical record. Gestational age has been
confirmed by ultrasound scan in the first half of pregnancy in
more than 95% of pregnancies in the UK since the early
Abbreviations: HR, hazard ratio; ICD, International Classification of
Disease; IQR, inter-quartile range; RDS, respiratory distress syndrome;
SMR, Scottish Morbidity Record; TTN, transient tachypnoea of the
newborn
956
www.archdischild.com
Page 328
1990s11 and standard national criteria exist for the estimation
of date of delivery using menstrual and ultrasound data.12
Smoking was defined as the smoking status of the woman at
the time of first attendance for antenatal care. Maternal age
was defined as the age of the mother at the time of delivery.
Postcode of residence was used to derive Carstairs socio-
economic deprivation categories.13 These are based on 1991
Census data on car ownership, unemployment, overcrowd-
ing, and social class within postcode sectors of residence
which contain, on average, around 1600 residents.
Emergency caesarean section was defined as any non-
planned caesarean delivery. Mothers with asthma were
diagnosed by ICD9 diagnostic code 493 in any position.
Paediatric definit ions
Neonatal respiratory morbidity was documented in the
SMR11 record using ICD9 diagnostic codes. Neonatal
respiratory morbidity was defined as respiratory distress
syndrome (769.9) or transient tachypnoea of the newborn
(770.6) in any position. Infants who had neither of these
diagnoses formed the reference category. Infants with other
perinatal respiratory diagnoses were excluded (770.2–770.5
and 770.7–770.9) since these diagnoses were either rare or
non-specific and therefore difficult to analyse and interpret.
Infants with aspiration documented were also excluded
(770.1). Hospital admissions in childhood for asthma were
classified by ICD9 or ICD10 codes from the SMR01 registry
and admission for asthma was defined as 493 (ICD9) or J45–
J46 (ICD10) in the principal position. We also obtained data
on hospital discharge for a condition which should be
independent of mode of delivery in order to detect bias
towards hospital admission in relation to mode of delivery
due to selective migration. The outcome studied was fracture
of an upper limb long bone, defined as 812–813 (ICD9) or
S422–S424, S52 (ICD10) in the principal position.
Statistical analyses
Continuous variables were summarised by the median and
inter-quartile range (IQR) and comparisons between groups
were performed using the Mann-Whitney U test. Univariate
comparisons of categorical data were performed using the x2
test. The p values for all hypothesis tests were two sided and
statistical significance was assumed at p,0.05. The risk of
asthma and fractured long bone was assessed using a
proportional hazards model of the time to first hospital
admission. All categorical covariates were modelled by
dummy variables. Birth weight was converted to a z score
relative to the mean birth weight for the week of gestation of
delivery and sex. The proportional hazards assumption was
tested using the test of Grambsch and Therneau.14 If the
proportional hazards assumption was violated by a covariate,
multivariate analysis was stratified by categories of the given
factor. Otherwise, all numerical variables (gestational age,
maternal age, height, and normalised birth weight) were
treated as continuous in the statistical models. Assessment of
linearity in the log hazard scale and selection of polynomials
was performed using fractional polynomials.15 All models
employed robust standard errors and the analysis clustered
on a maternal identifier to allow for dependence within
siblings. The statistical significance of interaction terms was
assessed using the Wald test (accounting for clustering) and
statistical significance of interactions was assumed at
p,0.01. The goodness of fit of models was assessed using
the May and Hosmer test.16 All statistical analyses were
performed using the Stata software package (Stata, TX,
USA), version 8.2.
RESULTS
There were records for 241 846 singleton live births in
Scotland over the period 1992–1995. We excluded 27 604
(11.4%) records where the hospital of delivery performed less
than 100 planned caesarean deliveries or the gestational age
was outside the range 37–43 weeks. Among the remaining
214 242 births, there were missing values for maternal height
in 16 572 (7.7%), for smoking in 21 880 (10.2%), for sex in
four (,0.1%), for deprivation category in 727 (0.3%), for
birth weight in 38 (,0.1%), for mode of delivery in 66
(,0.1%), for parity in 151 (0.1%), induced labour in 13
(,0.1%), and neonatal respiratory diagnosis in 2929 (1.4%).
In total 37 454 records (17.5%) had one or more of these
missing values. Of the remaining 176 788 records, there was
a perinatal respiratory diagnosis other than transient
tachypnoea or respiratory distress syndrome in 3050 (1.7%)
and 615 (0.3%) were vaginal breech births. There was overlap
between these categories and the final study group was
173 319.
The demographic, obstetric, and neonatal characteristics of
the study group are tabulated by neonatal respiratory
morbidity (table 2). With the exceptions of deprivation
category and whether labour was induced, all the character-
istics of the group varied according to neonatal respiratory
morbidity. Infants who experienced neonatal respiratory
morbidity were at increased risk of hospital admission with
a diagnosis of asthma in later childhood (fig 1). A test for
interaction between caesarean delivery and neonatal respira-
tory morbidity demonstrated a trend for a stronger associa-
tion between neonatal respiratory morbidity among babies
delivered by caesarean section: the hazard ratio (HR) for the
interaction was 1.4 (95% confidence interval (CI) 0.9 to 2.2,
p=0.1). Further analysis was performed following separa-
tion into those delivered vaginally and those delivered by
caesarean section.
The crude number of events, years of follow up, and
expected number of admissions are given in table 3. Among
those delivered by caesarean section, the association between
neonatal respiratory morbidity and later asthma did not
significantly differ according to whether the procedure was
planned or emergency (p=0.9). The associations were
minimally affected by adjusting for maternal, other obstetric,
and neonatal characteristics (table 3). There were no
significant interactions between mode of delivery or neonatal
respiratory morbidity and any of these other factors in the
multivariate model.
Table 1 Data sources
Database Data type Years* Data extracted
SMR02 Maternal hospital discharge 1992–1995 Obstetric, maternal (including ICD9 diagnoses), and neonatal characteristics
SMR11 Neonatal discharge 1992–1995 Neonatal diagnoses (ICD9)
GRO Death certificate 1992–2000 Deaths
SMR01 General and paediatric hospital discharge 1992–2000 Hospital discharges with diagnosis of asthma (ICD9 and ICD10)
GRO, General Registrar’s Office; ICD, International Classification of Disease; SMR, Scottish Morbidity Record.
*All dates are inclusive.
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Including the 3050 cases with a non-infective perinatal
respiratory diagnosis other than transient tachypnoea or
respiratory distress syndrome had virtually no effect on the
HRs in table 3. We examined the risk of hospital admission
for fractured long bone after 3 months of age to test for bias
in hospital admission in relation to mode of delivery or
neonatal morbidity, for example due to selective migration.
There were 2218 hospital admissions with a fractured upper
limb long bone. There was no statistically significant
association between admission for long bone fracture and
neonatal respiratory morbidity (adjusted HR 0.8, 95% CI 0.5
to 1.2, p=0.2).
DISCUSSION
This is the first study to our knowledge to examine the risk of
later asthma among children who experience neonatal
respiratory morbidity confined to births at term. The main
finding of this paper is that neonates who experience
respiratory distress syndrome or transient tachypnoea of
the newborn at term are at increased risk of asthma in
childhood. The relationship was unaltered by adjusting for
hospital of birth, maternal age, height, deprivation category,
parity and smoking, induction of labour, week of gestation of
delivery, and the child’s birth weight, sex, and Apgar score.
The association is plausible since previous studies have
shown increased risks of later asthma associated with
neonatal respiratory morbidity secondary to preterm deliv-
ery.5–8
It is possible that the association between neonatal
respiratory morbidity is explained by some unmeasured
confounder. For instance, it has been shown that the
offspring of asthmatic women are more likely to experience
neonatal respiratory morbidity in neonatal life.17 However, we
found no effect of adjusting for a maternal diagnosis of
asthma. Moreover, caesarean section is a well recognised
cause of neonatal respiratory morbidity3 4 and in our own
study we estimated that two thirds of neonatal respiratory
morbidity in the caesarean delivery group could be attributed
to the mode of delivery. If the relationship between neonatal
respiratory morbidity and later asthma was due to the effect
of an unmeasured confounder, we would have anticipated a
weaker association between neonatal respiratory morbidity
and asthma in the caesarean delivery group, since most
neonatal respiratory morbidity was determined by the mode
of delivery. However, the interaction term between neonatal
respiratory morbidity and caesarean delivery was 1.4 and had
confidence intervals of 0.9 to 2.2. This indicates that the
relationship between neonatal respiratory morbidity and later
asthma is at least as strong in the caesarean delivery group
Figure 1 Cumulative incidence of hospital admission for asthma over
the first 8–9 years of life for children born at term with neonatal
respiratory morbidity (broken line, defined as respiratory distress
syndrome or transient tachypnoea of the newborn) and those with no
neonatal respiratory morbidity (solid line). Comparison of curves (log
rank test): p,0.001. HR for neonatal respiratory morbidity = 1.7, 95%
CI 1.4 to 2.2.
Table 2 Demographic, obstetric, and neonatal characteristics of cohort by neonatal respiratory morbidity
No RDS/TTN,
n = 170 909
RDS/TTN,
n = 2230 p*
Maternal Age (years) Median (IQR) 28 (24–31) 28 (24–31) 0.007
characteristics Parity Nulliparous 75 960 (44.4) 1066 (47.8) 0.002
Multiparous 94 949 (55.6) 1164 (52.2)
Deprivation category, n (%) 1 (least deprived) 9113 (5.3) 112 (5.0) 0.47
2 22 797 (13.3) 280 (12.6)
3 34 091 (10.0) 456 (20.5)
4 41 606 (24.3) 547 (24.5)
5 27 895 (16.3) 382 (17.1)
6 21 685 (12.7) 258 (11.6)
7 (most deprived) 13 722 (8.0) 195 (8.7)
Height (cm) Median (IQR) 162 (157–166) 162 (157–166) ,0.001
Smoking Non-smoker 103 259 (60.4) 1421 (63.7) 0.001
Status, n (%) Ex-smoker 14 140 (8.3) 192 (8.6)
Smoker 53 510 (31.3) 617 (27.7)
Maternal asthma 385 (0.2) 9 (0.4) 0.08
Obstetric Mode of delivery, n (%) Vaginal birth 146 404 (85.7) 1366 (61.3) ,0.001
characteristics Emergency caesarean 14 718 (8.6) 411 (18.4) ,0.001
Elective caesarean 9787 (5.7) 453 (20.3) ,0.001
Gestational age at delivery
(weeks)
Median (IQR) 40 (39–41) 40 (38–41) ,0.001
Onset of labour, n (%) Spontaneous 129 064 (75.5) 1686 (75.6) 0.92
Induced 41 845 (24.5) 544 (24.4)
Neonatal Sex, n (%) Female 84 536 (49.5) 757 (34.0) ,0.001
characteristics Male 86 373 (50.5) 1473 (66.1)
Birth weight (g) Median (IQR) 3440 (3120–3760) 3489 (3100–3860) ,0.001
5 min ,7 2340 (1.4) 114 (5.1) ,0.001
Apgar, n (%) 7–10 168 569 (98.6) 2116 (94.9)
*x2 test or Mann-Whitney U test, as appropriate.
Although the medians and IQR do not differ, the groups were different due to less than 1 unit differences in these variables between the two groups.
IQR, inter-quartile range; RDS, respiratory distress syndrome; TTN, transient tachypnoea of the newborn.
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and, indeed, there was a trend towards a stronger association
among women delivered by caesarean section than those
delivered vaginally.
Previous studies had demonstrated increased risks of
asthma among children delivered by caesarean section.1 2
However, these studies lacked data on neonatal complica-
tions and hypothesised that the relationship may be
explained by effects of caesarean section on intestinal
microbial flora leading to susceptibility to atopic conditions.
Both studies described relatively weak associations with odds
ratios for asthma among children delivered by caesarean
section of 1.2 to 1.4. Our data suggest that the association
between caesarean delivery and later asthma may be
mediated by neonatal respiratory morbidity. This would
explain why the overall association between caesarean birth
and asthma is weak since the majority of infants delivered by
caesarean section do not experience neonatal respiratory
morbidity. Serial population prevalence studies have sug-
gested that rates of wheezing disorders in children are
increasing.18 Given that this has occurred over a period where
caesarean delivery rates have increased, further research is
required to determine the possible contribution of increasing
rates of caesarean delivery to the increased prevalence of
childhood wheezing.
The strengths of the present study are the scale and the fact
that exposure data were collected prospectively and indepen-
dently of outcome data. As with other large scale registry
based studies, however, the amount of information on each
individual case was relatively limited. We lacked data on
breast feeding. However, recent large scale longitudinal
studies have cast doubt on the protective effect of breastfeed-
ing on asthma risk19 and studies which have shown an
increased risk of asthma among bottle fed infants describe a
relative risk of asthma in the region of 1.420 which could
clearly not cause a relative risk of 2.2 by confounding. It is
likely that the indication for caesarean section may lead to
systematic differences in treatment in neonatal life compared
with infants delivered vaginally. It is theoretically possible,
for example, that the association with later asthma might be
explained by a confounding effect of early antibiotic
treatment. However, the incidence of suspected or proven
sepsis among infants delivered by emergency caesarean
section is 14% compared with 2% among infants delivered
by planned caesarean section.21 Since we saw virtually
identical relationships between planned and emergency
caesarean section and later asthma, the association is
unlikely to be explained by confounding effects of either
the indication for caesarean delivery or post-natal treatment
of the child.
The outcome measured was hospital admission for asthma
which will necessarily involve the severe end of the disease
spectrum. Further studies should address the relationship
between neonatal respiratory morbidity and asthma mana-
ged in the community. The follow up period in our study was
limited to childhood. Recent studies have reported a greater
than threefold risk of asthma in adulthood and caesarean
delivery.22 The possible role of neonatal respiratory morbidity
in the aetiology of adult asthma remains to be determined.
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Fifteen of the original cohort had died at follow up,
one from asthma. Of the remaining 464, 403
participated in the current review, giving a continuing
participation rate of 87%. In all, 267 participants
attended the laboratory for measurement of lung func›
tion. We calculated mean values of lung function using
standard two sample t tests and confidence intervals of
the mean by standard methods.
The table shows the clinical expression of asthma at
age 42 according to severity of disease at recruitment.
The distribution of severity at age 42 has not changed
from that at age 35.5 The proportion of cases with no
recent asthma has increased steadily from 20% at age
14 years to 40% (126/317) at age 42.
Lung function was similar to that of controls in
participants who had had wheezy bronchitis in
childhood (table). Participants who had had asthma
aged 7 had reduced lung function at age 42.
Comment
Our study shows that the pattern of asthma during
childhood predicts outcome. Most children with persist›
ent asthma had continuing symptoms into adult life and
reduced lung function. However, children who had
intermittent symptoms associated with respiratory tract
infections generally had complete resolution of symp›
toms in adult life. The small number of participants who
still had mild, intermittent symptoms at age 42 had nor›
mal lung function. This good outcome was achieved
despite the fact that anti›inflammatory treatments were
not available for most of their childhood.
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Spontaneous loss of early pregnancy and risk of ischaemic
heart disease in later life: retrospective cohort study
Gordon C S Smith, Jill P Pell, David Walsh
We recently showed that complications in late
pregnancy are associated with an increased risk of
maternal ischaemic heart disease (IHD) in later life.1
We hypothesised that this may reflect common
determinants, such as thrombophilic genetic defects
and anticardiolipin antibodies. Spontaneous losses of
pregnancy are also associated with inherited and
acquired thrombophilias in the mother.2 We examined
whether spontaneous losses of early pregnancy are
associated with maternal risk of IHD.
Participants, methods, and results
We used routine national maternity data (SMR2) to
identify all 129 290 eligible women who delivered their
first liveborn infant in Scotland during 1981›5. The
exclusion and inclusion criteria, definitions, and demo›
graphic characteristics were as previously described.1
We used national death (GRO) and discharge (SMR1)
data to determine the risk of death or hospital admis›
sion due to IHD during 1981›99. The cumulative
probabilities of survival free from IHD events were
assessed with Cox’s proportional hazards models with
age as the time scale (Stata version 7.0, StataCorp, Col›
lege Station, TX,USA).
A history of any spontaneous loss of early
pregnancy before the first live birth was associated with
an increased risk of IHD (table). The association was
independent of maternal age at the time of first birth,
height, socioeconomic deprivation, essential hyper›
tension, and complications during the first pregnancy.
The magnitude of the risk increased with the number
of previous losses. By contrast, there was no association
between therapeutic abortion and subsequent risk of
IHD (adjusted hazard ratio 0.93, 95% confidence inter›
val 0.59 to 1.46). Only 0.1% (162) of women had had a
hernia repair, and there was no significant association
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Distribution of asthma and lung function in participants aged 42 according to severity of asthma at age 7 or 10
Symptoms age 7
No (%) at age 42 Lung function at age 42
No recent
asthma (n=199)
Infrequent
asthma (n=58)
Frequent asthma
(n=76)
Persistent
asthma (n=70)
Total
(n=403)
No measured
(n=267)
FEV1/FVC
(95% CI)
Mean % of
predicted FEV1
(95% CI)
Mild wheezy bronchitis 40 (66) 12 (20) 9 (15) 0 61 40 80 (79 to 82) 109 (103 to 114)
Wheezy bronchitis 50 (57) 13 (15) 16 (18) 9 (10) 88 62 79 (76 to 81) 102 (98 to 106)
Asthma 28 (29) 19 (19) 27 (28) 24 (24) 98 70 75* (73 to 77) 95* (92 to 99)
Severe asthma 8 (11) 9 (13) 20 (29) 33 (47) 70 42 70* (67 to 74) 85* (78 to 91)
Control 73 (85) 5 (6) 4 (5) 4 (5) 86 53 80 (78 to 82) 104 (101 to 108)
FEV1=forced expiratory volume in 1 second; FVC=forced vital capacity.
*P<0.001 compared with controls.
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with spontaneous early pregnancy loss (0.93, 0.55 to
1.59), suggesting that there was no bias due to selective
migration. We did not have data on the smoking status
of women in the 1981›5 cohort. However, we had data
on 181 636 women who had a first livebirth from 1992
to 1998, inclusive. The proportion of women who were
current smokers at the first attendance for prenatal
care was only marginally higher among women with a
history of spontaneous loss of early pregnancy (28.4%)
than among those with no such history (26.8%).
Comment
To our knowledge, this is the first study to show a spe›
cific association between spontaneous abortion and
maternal risk of IHD. Our findings may explain the
results of previous studies that have found an
association between the total number of pregnancies
and maternal risk of IHD as women who suffer recur›
rent losses of early pregnancy must have more
pregnancies to achieve their target family size.3
However, it is unlikely that the association between
spontaneous abortion and maternal IHD is simply an
effect of parity as there was no association with
therapeutic abortion.
The strengths of our study are that prospective data
collection precluded bias and, in contrast with a
case›control study, we were able to include women who
subsequently died. However, further studies are required
to corroborate our findings and to confirm that the
association is independent of smoking and other
confounding factors, such as maternal disease (for
example, diabetes and polycystic ovarian syndrome).
Several studies have shown associations between
acquired and inherited thrombophilias and both spon›
taneous loss of early pregnancy 2 and IHD.4 5 Implanta›
tion of the embryo and development of the placenta
involve complex adaptations of the mother’s cardiovas›
cular and microvascular systems. We hypothesise that
occult cardiovascular, microvascular, or haemostatic
dysfunction result in pregnancy complications during
reproductive years and in overt cardiovascular disease
in later life. A woman’s reproductive history may, there›
fore, inform future cardiovascular risk.
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Incidence of erectile dysfunction and characteristics of
patients before and after the introduction of sildenafil in
the United Kingdom: cross sectional study with
comparison patients
James A Kaye, Hershel Jick
Erectile dysfunction, the consistent inability to achieve
or maintain an erection sufficient for satisfactory
sexual performance, is reported to occur in association
with cardiovascular disease, diabetes, hypertension,
hypercholesterolaemia, smoking, spinal cord injury,
prostate cancer, genitourinary surgery, psychiatric
disorders, and the use of many drugs, including
alcohol.1 Sildenafil (Viagra), an oral treatment for erec›
Maternal ischaemic heart disease events and number of previous spontaneous losses of early pregnancy losses. Figures are hazard
ratios (95% confidence interval)*
No of losses of early pregnancy
0†(n=117 538) 1›2(n=11 371) >3(n=381) >1(n=11 752)
No (%) of events 261 (0.2) 48 (0.4) 4 (1.0) 52 (0.4)
Crude 1.0 1.44 (1.06 to 1.97), P=0.02 2.34 (0.87 to 6.32), P=0.09 1.49 (1.10 to 2.01), P=0.009
Adjusted for case mix‡ 1.0 1.47 (1.08 to 2.00), P=0.02 2.32 (0.86 to 6.27), P=0.10 1.51 (1.12 to 2.04), P=0.007
Adjusted for case mix‡ and obstetric
complications§
1.0 1.48 (1.09 to 2.02), P=0.01 2.35 (0.87 to 6.36), P=0.09 1.52 (1.13 to 2.06), P=0.006
*All covariates in multivariate models were significantly associated with ischaemic heart disease. Proportional hazard assumption tested with Stata “stphtest”
command with Schoenfeld residuals. There was no evidence for violation of assumption in any model (all P>0.5).
†Reference category.
‡Age, height, deprivation, and essential hypertension in first pregnancy.
§Lowest fifth of birthweight distribution, preterm delivery, pre›eclampsia.
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Birth Weight and the Risk of Cardiovascular Disease in the Maternal Grandparents
Gordon C. S. Smith*, Angela M. Wood, Ian R. White, Jill P. Pell, and Joanne Hattie
* Correspondence to Dr. Gordon C. S. Smith, Department of Obstetrics and Gynaecology, University of Cambridge, The Rosie
Hospital, Cambridge CB2 0SW, United Kingdom (e-mail: gcss2@cam.ac.uk).
Initially submitted June 28, 2009; accepted for publication December 14, 2009.
Pregnancy complications and cardiovascular disease share some common determinants. It has previously been
hypothesized that family history of cardiovascular disease would be associated with low birth weight. Records from
120,317 Scottish births, 1992–2006, were linked to hospital admission and death certiﬁcate data for 71,681 pairs of
maternal grandparents. There was a negative relation between the birth weight of the baby and the risk of either
grandparent’s experiencing ischemic heart disease (for a 1-kg increase in birth weight, hazard ratio ¼ 0.86, 95%
conﬁdence interval: 0.83, 0.89) or cerebrovascular disease (hazard ratio ¼ 0.82, 95% conﬁdence interval: 0.77,
0.87). Further analysis demonstrated that the associations were explained by increased risks of both delivering
a small-for-gestational-age infant and delivering preterm among women whose parents had experienced cardio-
vascular disease. Adjustment for the mother’s characteristics at the time of the birth attenuated the relation, but
signiﬁcant associations persisted: With a 1-kg increase in birth weight, the adjusted hazard ratio for ischemic heart
disease ¼ 0.93 (95% conﬁdence interval: 0.89, 0.96) and for cerebrovascular disease ¼ 0.93 (95% conﬁdence
interval: 0.89, 0.96). Familial aggregation of common determinants of pregnancy complications and cardiovascular
disease is the likely explanation for the relation between an infant’s birth weight and the risk of cardiovascular
disease in other family members.
birth weight; family health; fetal growth retardation; myocardial ischemia; pregnancy; premature birth; stroke;
venous thromboembolism
Abbreviations: ICD, International Classiﬁcation of Diseases; SMR01, a registry of all general hospital admissions; SMR02, Scottish
Morbidity Record.
It has previously been shown that there is a strong relation
between the birth weight of an infant and the mother’s sub-
sequent risk of ischemic heart disease (1–3). Others, as well
as ourselves, have speculated that this may reflect common
determinants of pregnancy complications and ischemic
heart disease, which could be genetic, physiologic, environ-
mental, or socioeconomic. Both genetic and nongenetic de-
terminants of heart disease tend to persist within a family,
a phenomenon known as familial aggregation (4). Hence, if
low birth weight and ischemic heart disease share common
determinants, it would be predicted that the risk of cardio-
vascular disease would be increased in the grandparents of
the low-birth-weight infant. We have previously analyzed
self-reported family history of ischemic heart disease
among 3,320 women with known outcome of a singleton
pregnancy and found a trend toward increased risk of a fam-
ily history among women with a history of a low-birth-
weight infant (5). In the present study, we report the risk
of death or hospital admission for ischemic heart disease,
cerebrovascular disease, and venous thromboembolism in
71,681 pairs of maternal grandparents in relation to the birth
weight of 120,317 singleton, liveborn grandchildren.
MATERIALS AND METHODS
The Information Services Division of the National Health
Service in Scotland and the General Registrar’s Office main-
tain a series of registries that provided the data sources
for the present study. The Information Services Division
maintains a registry of maternal, obstetric, and offspring
1
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characteristics relating to all births in Scotland, the Scottish
Morbidity Record (SMR02), and a registry of all general
hospital admissions (SMR01). The General Registrar’s Of-
fice maintains a computerized registry of all births and
deaths. Since 1967, the registry of births contained comput-
erized records of the names and dates of birth of the infant
and both parents. We linked the pregnancy record of the
mother to the death and hospital admissions records of her
parents (i.e., the grandparents of the infant) using the preg-
nant woman’s own birth certificate as the common source of
identifiers. Approval of the study was provided by the Pri-
vacy Advisory Committee of the Information Services Di-
vision. Analysis was performed in 2 ways, reflecting the fact
that, in familial studies, the same event may be regarded as
an event in one analysis and an exposure in another (4). The
primary analysis was the risk of cardiovascular disease in the
maternal grandparents in relation to the birth weight of
the infant. The secondary analysis was designed to explore
the basis for any such association, as low birth weight can be
a reflection of a reduced rate of fetal growth, earlier delivery,
or a combination of both. Hence, in the secondary analysis,
the outcomes were taken to be delivery of a small-for-
gestational-age infant or preterm birth, with the experience
of disease in the grandparents as an exposure. In both anal-
yses, we excluded maternity records where the pregnancy
was a multiple birth, where the birth weight was less than
400 g, or where the gestational age at delivery was less than
24 weeks.
Record linkage
All records were linked by using the combination of full
name and date of birth. Previous experience has indicated
approximately 98% accuracy of linkage of records in
Scotland with a probabilistic approach (6). The Scottish
Morbidity Record (SMR02) database yielded the maternal
characteristics and the outcome of the pregnancy. Pregnancy
records were obtained between 1992 and 2006. We confined
analysis to records collected from 1992 onward, as smoking
data began to be collected at this date. The SMR02 record
included the mother’s maiden name (i.e., her family name
when she was born) and her own date of birth. This was used
to link her pregnancy record to her own birth certificate.
This linkage was, therefore, only possible for women who
had been born in Scotland and where the mother’s maiden
name was documented in the SMR02 (this is not a compul-
sory field in the registry). The birth certificate was then used
to obtain the names and dates of birth of the woman’s
mother and father. These details were then used to identify
hospital admissions (SMR01) or deaths (General Registrar’s
Office death certificate database) for the woman’s parents
between 1981 and 2006 (inclusive). In order to maintain
confidentiality, this part of the process was conducted by
using a process of pseudorandomization (Web Figure 1).
(This information is described in the first of 2 supplemen-
tary figures; each is referred to as ‘‘Web figure’’ in the text
and is posted on the Journal’s website (http://aje
.oxfordjournals.org/).) The final data set consisted, there-
fore, of the characteristics of the mother at the time of
pregnancy, the outcome of the pregnancy, and the experi-
ence of hospital admission or death of the mother’s parents.
Throughout the paper, the mother’s parents are referred to as
the ‘‘maternal grandparents.’’
Deﬁnitions
The postal code of residence at the time of the pregnancy
was used to derive Carstairs socioeconomic deprivation
scores (7). Parity was defined as the number of previous
livebirths or stillbirths. Smoking was defined as the smoking
status of the woman at the time of first attendance for ante-
natal care. Maternal height was measured in centimeters,
and the value used was that documented in each woman’s
clinical record. Maternal age was defined as the age of the
mother at the time of birth. Marital status was defined as
married or unmarried. Gestational age at birth was defined
as completed weeks of gestation on the basis of the esti-
mated date of delivery in each woman’s clinical record.
Gestational age has been confirmed by ultrasound in the first
half of pregnancy in more than 95% of women in the United
Kingdom since the early 1990s (8). Preterm birth was de-
fined as birth before 37 weeks’ gestation. Birth weight was
classified into sex- and gestational age-specific percentiles
derived from the study cohort. Small-for-gestational-age
birth weight was defined as a birth weight in the smallest
5% for sex and week of gestational age at delivery. Pre-
eclampsia was defined as the presence of an appropriate
International Classification of Diseases (ICD), Ninth Revi-
sion, code 642.4 or 642.5 or ICD, Tenth Revision, diagnostic
codes O140, O141, and O149 in the delivery record. Events
in the maternal grandparents were defined on the basis of
ICD codes listed in the principal position of the hospital
record or death certificate. Ischemic heart disease was de-
fined as either ICD, Ninth Revision, codes 410–414 or ICD,
Tenth Revision, codes I20–25; cerebrovascular disease was
defined as either ICD, Ninth Revision, codes 430–438 or
ICD, Tenth Revision, codes I60–I69 or G45; and venous
thromboembolism was defined as either ICD, Ninth Revi-
sion, code 453.8, 453.9, or 415.1 or ICD, Tenth Revision,
code I82.8, I82.9, or I26.
Statistical analysis
Continuous variables were summarized by the median
and interquartile range, and comparisons between groups
were performed by using the Kruskal-Wallis test. Unad-
justed comparisons of categorical data were performed by
using the chi-square test and the test for trend, as appropri-
ate. The P values for all hypothesis tests were 2 sided, and
statistical significance was assumed at P < 0.05. Covari-
ables with >5% missing values (height and smoking status)
were imputed by using multiple imputation by chain equa-
tions (9). Five imputations were created with a set of appro-
priate imputation models constructed from all covariables
and all outcome variables (time-to-event outcome variables
were log transformed). Almost identical results were ob-
tained from analyses of the complete cases and using miss-
ing indicator variables for height and smoking status.
The risk of cardiovascular disease in each maternal
grandparent was estimated by using a Cox proportional haz-
ards model, with grandparental age as the time scale. The
2 Smith et al.
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unit of analysis was the grandparent, and the birth weight of
the grandchild was the exposure. Because the same grand-
parent entered the model multiple times, corresponding to
the number of grandchildren in the data set, the analyses
were clustered on the grandparental identifier to allow de-
pendence between grandchildren for each grandparent (a
pair of grandparents were assumed independent). This ap-
proach allowed for any pattern of dependence within the
grandparent cluster. The risk of pregnancy ending in deliv-
ery of a small-for-gestational-age infant, preterm birth, or
Table 1. Summary of Maternal Characteristics at the Time of First Eligible Pregnancy (n ¼ 78,294), Scotland, 1992–2006a
No History of Disease
(n 5 67,727)
At Least 1 Grandparent With a History of Diseaseb
Ischemic Heart Disease
(n 5 7,983)
Cerebrovascular Disease
(n 5 2,828)
Venous Thromboembolism
(n 5 715)
No. % No. % P Value No. % P Value No. % P Value
Maternal characteristics
Age, years
(median (IQR))
20 (18–23)c 20 (18–23)c <0.001 20 (18–23)c 0.33 20 (18–23)c 0.09
Marital status
Unmarried 61,297 90.5 7,180 89.9 0.10 2,561 90.6 0.93 644 90.1 0.69
Married 6,430 9.5 803 10.1 267 9.4 71 9.9
Deprivation
1 (least deprived) 1,424 2.1 137 1.7 <0.001 40 1.4 <0.001 5 0.7 <0.001
2 5,533 8.2 479 6.0 177 6.3 34 4.8
3 11,701 17.3 1,213 15.2 399 14.1 122 17.1
4 18,277 27.0 2,057 25.8 706 25.0 187 26.2
5 13,779 20.3 1,735 21.7 590 20.9 140 19.6
6 9,741 14.4 1,291 16.2 501 17.7 126 17.6
7 (most deprived) 7,282 10.8 1,071 13.4 415 14.7 101 14.1
Height, cm
Median (IQR) 163 (159–167) 163 (158–167) <0.001 162 (158–167) <0.001 163 (158–167) 0.76
Missing 13,898 20.5 1,574 19.7 564 19.9 145 20.3
Smoking status
Nonsmoker 29,834 44.1 3,251 40.7 <0.001 1,135 40.1 <0.001 287 40.1 0.18
Smoker 24,566 36.3 3,324 41.6 1,165 41.2 281 39.3
Former smoker 8,286 12.2 829 10.4 296 10.5 95 13.3
Missing 5,041 7.4 579 7.3 232 8.2 52 7.3
Parity
0 64,631 95.4 7,627 95.5 0.8 2,690 95.1 0.83 679 95.0 0.16
1 3,052 4.5 350 4.4 136 4.8 35 4.9
2 20 0.04 5 0.06 1 0.04 0 0.0
3 14 0.02 1 0.01 1 0.04 1 0.14
Infant characteristics
Sex
Male 35,072 51.8 4,153 52.0 0.7 1,462 51.7 0.93 386 54 0.24
Female 32,653 48.2 3,830 48.0 1,366 48.3 329 46.0
Gestational age,
weeks
Median (IQR) 40 (39–41) 40 (39–41) <0.001 40 (39–41) 0.04 40 (39–41) 0.15
Preterm 4,577 6.7 597 7.5 0.02 217 7.7 0.06 57 8.0 0.20
Birth weight, g
(median (IQR))
3,340 (2,990–3,660) 3,290 (2,940–3,620) <0.001 3,290 (2,950–3,620) <0.001 3,320 (2,980–3,640) 0.23
Abbreviations: IQR, interquartile range; SD, standard deviation.
a P value for comparison with no history of disease using the Mann-Whitney U test, the chi-square test, or the chi-square test for trend, as
appropriate.
b Diagnoses are not mutually exclusive.
c The mean ages of women in columns from left to right: 20.73 (SD, 3.42), 20.94 (SD, 3.51), 20.81 (SD, 3.47), and 20.64 (SD, 3.30) years.
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preeclampsia was assessed by using multivariable logistic
regression analysis. The unit of analysis was the grandchild,
and the exposure was history of disease in either grandpar-
ent up to the end of 2006. Analyses were clustered on the
pairs of grandparents to allow dependence between grand-
children with the same set of grandparents. All analyses of
pregnancy outcome were adjusted for both grandparents’
age at censoring, as the design of the study is such that
the length of available follow-up on the grandparent varies,
and this is clearly a major determinant of the risk of an
event. The statistical significance of interaction terms was
assessed by using the Wald test. In the multiple imputation
and logistic regression models, all categorical covariables
were modeled by dummy variables. Maternal age, height,
and birth weight percentile were all treated continuously in
the regression models. All available maternal characteristics
were included in multivariable analyses. Assessment of lin-
earity was performed by using fractional polynomials in the
observed data (i.e., not the imputed data for height). All
statistical analyses were performed by using STATA, ver-
sion 10.1, software (StataCorp LP, College Station, Texas).
RESULTS
We were able to link 130,904 SMR02 records to the
mother’s birth certificate. A total of 8,413 records had miss-
ing name and/or date of birth of 1 or both parents in the birth
certificate, leaving 122,491 pregnancy records with com-
plete data on grandparental identifiers. A total of 2,174 re-
cords were excluded as they included 1 or more of the
following: multiple births (n ¼ 1,043, 0.85%); antepartum
or intrapartum stillbirth (n ¼ 573, 0.5%); birth weight less
than 400 g (n ¼ 47, <0.01%); gestational age outside the
range 24–43 weeks (n ¼ 75, <0.01%); or missing maternal
age, deprivation category, birth weight, gestational age, or
sex (n ¼ 519, 0.5%). The final linked data set consisted of
120,317 pregnancy records from a total of 78,294 women,
with hospital admission and death data on 71,681 pairs of
maternal grandparents.
When tabulated by the maternal characteristics at the time
of the first eligible recorded pregnancy, grandparental his-
tory of both ischemic heart disease and cerebrovascular dis-
ease was positively associated with the mother’s age at the
time of delivery, her being married, her Carstairs category of
socioeconomic deprivation, smoking and parity, and pre-
term birth (Table 1). Grandparental history of both ischemic
heart disease and cerebrovascular disease was negatively
associated with the mother’s height, the gestational age at
delivery, and the birth weight of the infant. The unadjusted
grandparental rates of ischemic heart disease and cerebro-
vascular disease are plotted against birth weight category
(Figure 1). The median age of grandparents at censoring
who had no history of disease was 53 years, the interquartile
range was 49–57, and the 90th percentile was 61. As they
were followed up for 26 years, 90% of the group were aged
35 years or less at the time when their cardiovascular events
started to be identified. Hence, only a small number of
events would have been missed because of left truncation.
A 1-kg increase in the birth weight of the infant was
associated with a 14% decrease in the grandparental risk
of ischemic heart disease (Table 2) and an 18% decrease
in the grandparental risk of cerebrovascular disease
(Table 3). Adjustment for the maternal characteristics at
the time of birth reduced the associations to 7% and 11%,
respectively. Other maternal characteristics at the time of
birth were also associated with grandparental risk of disease
in multivariable analysis. Grandparental risk of both ische-
mic heart disease and cerebrovascular disease was positively
associated with the mother’s Carstairs socioeconomic dep-
rivation category, smoking, and parity, and it was negatively
associated with the mother’s age and height at the time of
the delivery. There was no association between the birth
weight of the infant and the grandparental risk of venous
thromboembolism (Table 4), although this outcome was
positively associated with the mother’s Carstairs socioeco-
nomic deprivation category and parity at the time of the
birth. There was no evidence that the association between
birth weight and either ischemic heart disease or cerebro-
vascular disease significantly varied according to maternal
age, marital status, deprivation category, height, smoking
status, or parity (Web Figure 2).
The risk of delivery of a small-for-gestational-age infant,
preterm delivery, and preeclampsia was then analyzed
in relation to the maternal grandparents’ experience of car-
diovascular disease. The odds of delivering a small-for-
gestational-age infant were increased by 19% where either
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Figure 1. Rates of ischemic heart disease (IHD) (A) and cerebro-
vascular disease (CVD) (B) in either maternal grandparent (ex-
pressed per 1,000 person-years) in relation to the birth weight of the
infant, Scotland, 1992–2006. Bars are conﬁdence intervals and are
adjusted for clustering (refer to Materials and Methods).
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maternal grandparent had experienced ischemic heart dis-
ease and by 33% where either had experienced cerebrovas-
cular disease (Table 5). These associations were attenuated
by about one-half and one-third, respectively, following ad-
justment for the maternal characteristics at the time of birth.
The odds of delivering preterm were increased by 12%
where either maternal grandparent had experienced ische-
mic heart disease and by 23% where either had experienced
cerebrovascular disease (Table 5). These associations were
attenuated by about one-third and one-fifth, respectively,
following adjustment for the maternal characteristics at
the time of birth. The odds of preeclampsia were increased
only in multivariable analysis in association with grandpa-
rental ischemic heart disease (Table 5). This association
may have been masked in unadjusted analysis by negative
confounding by smoking, given the protective effect of
smoking on the risk of preeclampsia (10) and its positive
association with the risk of ischemic heart disease (11).
There was no association between grandparental experience
of venous thromboembolism and any of the obstetric
outcomes.
DISCUSSION
The main finding of the current analysis is that increased
birth weight of the infant was associated with a decreased
risk of death or hospital admission from cardiovascular dis-
ease in the maternal grandparents. For each 1-kg increase in
birth weight, the grandparental risk of ischemic heart dis-
ease declined by 14%, and the risk of cerebrovascular
disease declined by 18%. Adjustment for the maternal char-
acteristics at the time of birth reduced the associations to 7%
and 11%, respectively. Previous studies have also demon-
strated associations between an individual’s birth weight
and his/her personal risk of ischemic heart disease in later
life, estimated as a 16% reduction in the odds of ischemic
heart disease for each 1-kg increase in birth weight (12). In
a previous analysis using record linkage of routinely col-
lected data from Scotland, we also demonstrated a strong
association between the birth weight of the infant and the
mother’s risk of ischemic heart disease in the next 15–20
years (2), and this has also been observed in other popula-
tions (1, 13). Hence, low birth weight is associated with an
increased risk of cardiovascular disease for the individual,
Table 2. Birth Weight, Other Maternal Characteristics, and the Grandparental Risk of Hospital
Admission for Ischemic Heart Disease, Scotland, 1992–2006
Death or Hospital Admission of Either Maternal Grandparent With
Ischemic Heart Disease
Unadjusted Analysis Adjusted Analysis
Hazard
Ratio
95%
Conﬁdence
Interval
P Value
Hazard
Ratio
95%
Conﬁdence
Interval
P Value
Birth weight (per kg) 0.86 0.83, 0.89 <0.001 0.93 0.89, 0.96 <0.001
Age, years (per 5 years) 0.87 0.85, 0.89 <0.001 0.89 0.86, 0.92 <0.001
Marital status
Unmarried 1.0 1.0
Married 0.83 0.79, 0.88 <0.001 0.98 0.92, 1.05 0.64
Deprivation
1 (least deprived) 0.76 0.64, 0.89 <0.001 0.83 0.70, 0.98 <0.001
2 0.68 0.62, 0.75 0.72 0.65, 0.80
3 0.88 0.82, 0.94 0.90 0.84, 0.97
4 1.0 1.0
5 1.16 1.09, 1.23 1.13 1.06, 1.20
6 1.19 1.12, 1.28 1.15 1.07, 1.24
7 (most deprived) 1.44 1.33, 1.55 1.35 1.26, 1.47
Height (per 5 cm) 0.93 0.91, 0.95 <0.001 0.96 0.93, 0.98 <0.001
Smoking status
Nonsmoker 1.0 <0.001 1.0 <0.001
Former smoker 0.94 0.88, 1.01 0.94 0.92, 1.05
Smoker 1.31 1.25, 1.37 1.19 1.13, 1.25
Parity
0 1.0 <0.001 1.0 <0.001
1 1.05 1.03, 1.08 1.11 1.08, 1.15
2 1.25 1.11, 1.41 1.32 1.16, 1.50
3 1.54 0.91, 2.60 1.66 0.99, 2.76
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his/her parents, and his/her maternal grandparents. The find-
ings are analogous with the relation between family history
of type 2 diabetes mellitus and gestational diabetes. The
latter association does not reflect a direct effect of a diagno-
sis of diabetes mellitus in a relative on the risk of gestational
diabetes in a pregnant woman. Rather, it reflects a common
dependence of both outcomes on insulin resistance. Simi-
larly, we infer that factors leading to ischemic heart disease
and cerebrovascular disease also lead to pregnancy compli-
cations resulting in low birth weight. We speculate that fa-
milial aggregation of these factors leads to associations
between birth weight and the risk of cardiovascular disease
in all members of a family.
Analysis of the association by birth weight allowed direct
comparison with other related studies, but this did not re-
solve which of the 2 main determinants of birth weight (the
rate of fetal growth during pregnancy and the gestational age
at birth) accounted for the association. We observed that
grandparental experience of cardiovascular disease was as-
sociated with both an increased risk of delivery of a small-
for-gestational-age infant and an increased risk of preterm
birth. These associations were variably explained by other
maternal characteristics. The persistence of associations be-
tween pregnancy outcome and grandparental experience of
disease in multivariable analysis could simply reflect the
effect of unmeasured socioeconomic and environmental fac-
tors. It could also reflect the effect of common genetic risk
factors for pregnancy complications and ischemic heart dis-
ease. For example, previous studies have demonstrated an
inverse relation between parental blood pressure and the
birth weight of the infant (14, 15). It is possible that grand-
parental carriage of a genetic predisposition toward hyper-
tension could lead to an increased risk of cardiovascular
disease in the individual and that passing the allele on to
the daughter could lead to an increased risk of her delivering
a low-birth-weight infant. Thrombophilic mutations are an-
other candidate genetic link, as these are associated with
both cardiovascular disease (16, 17) and pregnancy compli-
cations (18). However, we observed no relation between the
birth weight of the infant and the grandparental incidence
of venous thromboembolism despite the fact that these
mutations are strongly associated with the risk of venous
thromboembolism (18).
We had previously analyzed data from over 3,000
women, relating pregnancy complications ascertained
through the SMR02 and the woman’s self-reported family
Table 3. Birth Weight, Other Maternal Characteristics, and the Grandparental Risk of Hospital
Admission for Cerebrovascular Disease, Scotland, 1992–2006
Death or Hospital Admission of Either Maternal Grandparent With
Cerebrovascular Disease
Unadjusted Analysis Adjusted Analysis
Hazard
Ratio
95%
Conﬁdence
Interval
P Value
Hazard
Ratio
95%
Conﬁdence
Interval
P Value
Birth weight (per kg) 0.82 0.77, 0.87 <0.001 0.89 0.84, 0.95 <0.001
Age, years (per 5 years) 0.84 0.80, 0.87 <0.001 0.86 0.81, 0.90 <0.001
Marital status
Unmarried 1.0 1.0 0.17
Married 0.76 0.68, 0.84 <0.001 0.92 0.82, 1.03
Deprivation
1 (least deprived) 0.56 0.41, 0.77 <0.001 0.64 0.46, 0.87 <0.001
2 0.76 0.64, 0.90 0.82 0.69, 0.96
3 0.84 0.74, 0.96 0.87 0.77, 0.99
4 1.0 1.0
5 1.11 0.99, 1.24 1.08 0.96, 1.20
6 1.35 1.19, 1.53 1.28 1.13, 1.46
7 (most deprived) 1.49 1.30, 1.71 1.38 1.20, 1.58
Height (per 5 cm) 0.91 0.88, 0.94 <0.001 0.94 0.91, 0.97 <0.001
Smoking status
Nonsmoker 1.0 <0.001 1.0 <0.001
Former smoker 0.91 0.81, 1.02 0.91 0.81, 1.03
Smoker 1.36 1.25, 1.47 1.20 1.11, 1.31
Parity
0 1.0 0.01 1.0 <0.001
1 1.06 1.02, 1.11 1.15 1.08, 1.22
2 1.29 1.05, 1.57 1.39 1.12, 1.72
3 0.88 0.36, 2.13 0.97 0.40, 2.37
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history of ischemic heart disease using data from a cohort
study (5). We described a similar association between low
birth weight and family history of ischemic heart disease,
although this was of borderline statistical significance, given
the small numbers. The present study has a number of
strengths over the previous study. First, we had similarly
detailed information on pregnancy complications but had
data available from more than 100,000 births. Second,
ascertainment of grandparental history of disease was per-
formed by record linkage to national registries. This pre-
cluded the possibility of recall bias. Moreover, we were
able also to study the relation between birth weight and
the risk of other cardiovascular conditions in the maternal
grandparents, such as cerebrovascular disease and venous
Table 4. Birth Weight, Other Maternal Characteristics, and the Grandparental Risk of Hospital
Admission for Venous Thromboembolism, Scotland, 1992–2006
Death or Hospital Admission of Either Maternal Grandparent With
Venous Thromboembolism
Unadjusted Analysis Adjusted Analysis
Hazard
Ratio
95%
Conﬁdence
Interval
P Value
Hazard
Ratio
95%
Conﬁdence
Interval
P Value
Birth weight (per kg) 0.93 0.83, 1.05 0.27 0.96 0.85, 1.09 0.56
Age, years (per 5 years) 0.82 0.75, 0.89 <0.001 0.81 0.73, 0.90 <0.001
Marital status
Unmarried 1.0 1.0
Married 0.85 0.69, 1.06 0.24 1.04 0.83, 1.30 0.73
Deprivation
1 (least deprived) 0.26 0.10, 0.67 <0.001 0.28 0.11, 0.73 0.006
2 0.73 0.52, 1.03 0.76 0.54, 1.07
3 1.00 0.79, 1.26 1.01 0.80, 1.28
4 1.0 1.0
5 1.09 0.86, 1.37 1.07 0.85, 1.35
6 1.21 0.94, 1.55 1.18 0.92, 1.52
7 (most deprived) 1.44 1.10, 1.88 1.39 1.06, 1.83
Height (per 5 cm) 1.01 0.94, 1.09 0.73 1.04 0.96, 1.12 0.36
Smoking status
Nonsmoker 1.0 0.10 1.0 0.54
Former smoker 1.09 0.87, 1.36 1.07 0.85, 1.34
Smoker 1.21 1.02, 1.42 1.10 0.92, 1.32
Parity
0 1.0 0.10 1.0 0.02
1 1.05 0.95, 1.15 1.16 1.02, 1.32
2 0.95 0.57, 1.59 1.12 0.65, 1.94
3 2.88 1.08, 7.67 3.44 1.25, 9.47
Table 5. Experience of Disease in Either Maternal Grandparent and the Risk of Pregnancy Complications, Scotland, 1992–2006
Outcome
Ischemic Heart Disease Cerebrovascular Disease
Unadjusteda Adjusteda,b Unadjusteda Adjusteda,b
Odds
Ratio
95%
Conﬁdence
interval
P Value
Odds
Ratio
95%
Conﬁdence
interval
P Value
Odds
Ratio
95%
Conﬁdence
interval
P Value
Odds
Ratio
95%
Conﬁdence
interval
P Value
Small for gestational
age
1.19 1.10, 1.30 <0.001 1.09 1.00, 1.19 0.06 1.33 1.16, 1.51 <0.001 1.21 1.06, 1.38 0.005
Preterm birth 1.12 1.04, 1.21 0.005 1.07 0.99, 1.16 0.08 1.23 1.09, 1.40 0.001 1.18 1.04, 1.33 0.01
Preeclampsia 1.08 0.95, 1.23 0.24 1.16 1.02, 1.33 0.02 0.87 0.70, 1.09 0.23 0.95 0.76, 1.18 0.64
a All odds ratios are adjusted for grandparents’ age at censoring.
b Also adjusted for maternal age, marital status, smoking status, Carstairs socioeconomic category, height, and parity.
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thromboembolism. Finally, the likelihood of a positive fam-
ily history of disease also depends on the age of the rela-
tives. Use of the Cox model to quantify the risk of events in
the grandparents allowed us to account directly for variation
in the age of the maternal grandparents.
The current study also had a number of weaknesses. First,
we relied on registry-based classification of both exposures
and events. Hence, smoking status is self-reported and not
validated by cotinine assay. Moreover, definition of both
grandparental disease and pregnancy complications may
be prone to error. For example, preeclampsia is ascertained
only by ICD codes, and we have no information on the
criteria for the diagnosis. Similarly, we do not have access
to the results of tests used to diagnose cardiovascular dis-
ease, such as troponin or electrocardiogram for ischemic
heart disease, neuroimaging for cerebrovascular disease,
and venography and angiography for venous thromboembo-
lism. Furthermore, record linkage could only be performed
for women who had been born in Scotland and where the
maiden name was recorded in the SMR02. As this was not
a mandatory field in the SMR02, the linkage systematically
favored unmarried women. Moreover, the computerized
registry of births was available only for births since 1967.
Therefore, the linkage design was constrained to a maximum
maternal age of 39 years (i.e., a woman born in 1967 who
had a birth in 2006). Hence, the linkage also favored in-
clusion of younger women. Consequently, the cohort is
not a random or, indeed, a representative sample of the
Scottish population. At the time of the first eligible preg-
nancy, the median age was 20 years, and approximately 90%
of the women were unmarried. Compared with another co-
hort of livebirths in Scotland in 1992–2001 (19), the current
cohort also had higher proportions of smoking and preterm
birth and lower median birth weights. In order to address
the possibility that the association may vary according to the
nature of the population studied, the repeated analysis was
stratifying by the mother’s characteristics at the time of birth
(Web Figure 2). This demonstrated that the association be-
tween birth weight and the risk of cardiovascular disease
in the maternal grandparents was similar across strata of
maternal age, marital status, socioeconomic deprivation,
height, smoking status, and parity. Nevertheless, the se-
lected nature of the current cohort may mean that the expe-
rience of cardiovascular disease in their family members
may differ compared with other populations. However, our
findings are also consistent with other analyses. A number
of studies have also reported associations between a family
history of cardiovascular disease and the risk of preeclamp-
sia (20–23), and the present analysis also demonstrated
an association between preeclampsia and grandparental
ischemic heart disease. Furthermore, a previous study ex-
amined a cohort of parents of women who experienced pre-
eclampsia and intrauterine growth restriction, and they were
found to exhibit abnormalities of glycemic control, anthro-
pometry, blood pressure, and low density lipoprotein (24).
The analysis also revealed associations between the
mother’s other characteristics and her parents’ experience
of disease, although interpretation of these findings should
be cautious as these were secondary analyses. There were
striking associations between the Carstairs socioeconomic
category of the woman’s area of residence at the time of
the pregnancy and the risk of cardiovascular disease in her
parents, with the difference in the risk of the 3 outcomes
studied varying up to 5-fold across the range of deprivation
category. Similarly, maternal smoking and short stature
were associated with an increased risk of ischemic heart
disease and cerebrovascular disease in her parents. Socio-
economic deprivation, smoking, and short stature are all risk
factors for ischemic heart disease in women (11, 25, 26).
These observations support the concept that familial aggre-
gation of demographic and environmental risk factors may
explain a proportion of the familial aggregation of cardio-
vascular disease. Interestingly, there was a positive associ-
ation between a woman’s parity and her parents’ risk of
cardiovascular disease. Previous studies have indicated
a positive association between number of pregnancies and
personal risk of ischemic heart disease (27), and it has been
speculated that this could be a direct effect of pregnancy.
However, the association between higher parity and parental
risk of disease could not plausibly be explained by a direct
effect of the pregnancy. Hence, the present observation is
supportive of the view that high parity may be associated
with the risk of ischemic heart disease by a noncausal
mechanism (28).
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Objective To determine whether women 
experiencing recurrent miscarriage were more 
likely to have a family history of cardiovascular 
disease. 
Design Retrospective cohort study. 
Setting Women having a first birth in Scotland 
between 1992-2006. 
Sample 74,730 first births were linked to the 
hospital admission and death certification data for 
the women’s parents through the women’s birth 
certificates.  
Methods The incidence of cardiovascular 
disease in the women’s parents was related to 
the number of miscarriages experienced prior to 
their daughters’ first births using a Cox 
proportional hazards model.  
Main outcome measures Death or hospital 
admission of the women’s parents for ischaemic 
heart disease (IHD), cerebrovascular disease 
(CVD) or venous thromboembolism (VTE). 
Main results There was an increased incidence 
of IHD in the parents of women who experienced 
two miscarriages prior to their first birth (hazard 
ratio 1.25, 95% confidence intervals 1.04-1.49) 
and parents of women who experienced three or 
more miscarriages prior to their first birth (hazard 
ratio 1.56, 95% confidence intervals 1.14-2.15). 
Adjustment for the characteristics of the women 
at the time of the first birth was without material 
effect. There was no significant association 
between miscarriage and family history of CVD or 
VTE. There was no significant association 
between the number of therapeutic abortions 
prior to the first birth and the incidence of any 
type of cardiovascular disease in the women’s 
parents. 
Conclusions The parents of women who 
experience recurrent miscarriage are more likely 
to experience IHD. Recurrent miscarriage and 
IHD may have common patho-physiological 
pathways and genetic predispositions. 
 
Key words: epidemiology, family history, 
miscarriage, ischaemic heart disease, 
cerebrovascular disease, venous 
thromboembolism. 
______________________________________________________________________ 
 
 
Introduction. 
 
Studies in the 1950s and 1960s demonstrated 
that women who experienced miscarriage were 
more likely to have IHD in later life.1 However, it 
was unclear if this was independent of the total 
number of pregnancies, which has itself been 
identified as a risk factor for IHD.2 We addressed 
this studying 129,290 women having first births in 
Scotland and related their subsequent experience 
of IHD to the number of miscarriages and 
therapeutic abortions experienced prior to their 
first birth.3 That study confirmed a specific 
association between miscarriage and the 
subsequent risk of IHD. We speculated that the 
association may indicate common risk factors for 
miscarriage and IHD, which may be inherited or 
acquired. In the present study we sought to 
determine whether there was evidence for 
common inheritable risk factors for both 
miscarriage and IHD by studying the relationship 
between women’s experience of miscarriage prior 
to the first birth and their parents’ incidence of 
cardiovascular disease. 
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Methods. 
 
Data and record linkage 
We used a linked dataset which has previously 
been described in detail.4 In brief, we used a 
national registry of pregnancy outcome data, the 
Scottish Morbidity Record 02 (SMR02), to obtain 
information about women having their first birth. 
We then used identifiers for the mother (first 
name, unmarried name and date of birth) to link 
this record to her own birth certificate using a 
probability-based matching approach. The 
parents’ names and dates of births were recorded 
on the birth certificate and this was then used to 
link the SMR02 pregnancy data to the parents’ 
records for death (the General Registrar’s Office, 
GRO) or hospital admission (SMR01). We 
identified hospital admissions for cardiovascular 
disease, specifically, ischaemic heart disease 
(IHD), cerebrovascular disease (CVD) or venous 
thromboembolism (VTE). We utilized SMR02 
records from 1992-2006. The start date was 
chosen as smoking was only recorded from this 
year onwards and the end date represented the 
latest period that data were available at the time 
of the linkage. The birth certificate database was 
maintained in a computerized form from 1967 
onwards. Hence, we were able to perform the 
linkage for women who were born in Scotland 
from 1967 onwards. Death certificate and SMR01 
records were available between 1981 and 2006. 
Hence, we were able to identify events in the 
parents during this period. Approval of the study 
was provided by the Privacy Advisory Committee 
of the Information Services Division of NHS 
Scotland. 
 
Definitions. 
The number of previous miscarriages and 
therapeutic abortions was self-reported by the 
women. Hence, this would have included losses 
occurring in the community (i.e. not requiring 
hospital admission). However, further details of 
the losses, such as gestational age, were not 
available. Hence, miscarriage was defined as 
previous spontaneous loss prior to viability. 
Demographic characteristics were available from 
the SMR02 for the women at the time of their first 
births. Postcode of residence at the time of the 
first birth was used to derive Carstairs 
socioeconomic deprivation scores.5 Smoking was 
defined as the smoking status of the woman at 
the time of first attendance for prenatal care. 
Maternal height was measured in centimetres 
and the value used was that documented in each 
woman's clinical record. Maternal age was 
defined as the age of the mother at the time of 
birth. Marital status was defined as married or 
unmarried. First singleton livebirth was defined as 
records where all previous pregnancies had all 
ended in either miscarriage or therapeutic 
abortion and the current pregnancy ended in an 
infant born weighing 400g or more between 24 
and 43 weeks gestational age, excluding 
stillbirths and multiple pregnancy. Events in the 
women’s parents were defined on the basis of 
International Classification of Disease (ICD) 
codes listed in the principal position of the 
hospital record (SMR01) or death certificate 
(GRO). Ischaemic heart disease was defined as 
either 410-414 (ICD9) or I20-25 (ICD10); CVD 
was defined as either 430-438 (ICD9) or I60–I69 
or G45 (ICD10); and VTE was defined as either 
453.8, 453.9 or 415.1 (ICD9) or I82.8, I82.9, or 
I26 (ICD10). 
 
Statistical analysis 
Continuous variables were summarized by the 
median and inter-quartile range (IQR) and 
comparisons between groups were performed 
using the Kruskal-Wallis test. Unadjusted 
comparisons of categorical data were performed 
using the Chi square test for trend. The P values 
for all hypothesis tests were two-sided and 
statistical significance was assumed at P<0.05. 
The aim of the analysis was to estimate the 
measure of association between miscarriage in 
the women and the experience of IHD in her 
parents. The approach we took was to use 
miscarriage as the exposure and to use IHD in 
the parents as the event. The rationale for this is 
addressed in the discussion. The relative hazard 
of cardiovascular disease in the women’s parents 
was estimated using a Cox proportional hazards 
model, with parental age as the time scale. The 
unit of analysis was the parents and the number 
of previous losses, miscarriage or therapeutic 
abortions, experienced by their daughters was 
the exposure. The analyses were clustered on 
the parental identifier to allow dependence 
between siblings (some parents had more than 
one daughter included in the cohort). Covariables 
with >5% missing values (height and smoking 
status) were imputed using multiple imputation by 
chain equations.6 Five imputed datasets were 
created by replacing missing values for height 
and smoking status with simulated values from a 
set of imputation models constructed from all 
covariables and all outcome variables (i.e. the 
Nelson-Aalen estimators for parental age at 
disease onset and the censoring indicators). 
Distributions of imputed values were visually 
checked for comparability with the observed data. 
Almost identical results were obtained from 
analyses of the complete-cases. All available 
maternal characteristics were included in 
multivariable analyses. Categorical covariables 
were modelled by dummy variables and maternal 
age and height were treated continuously. The 
baseline hazard for the Cox model was stratified 
by maternal age quintiles. Assessment of linearity 
was performed using fractional polynomials and 
assessment of the proportional hazards 
assumption was performed using the schoenfeld 
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residuals in the observed data (i.e. not the 
imputed data).7 Where the proportional hazards 
assumption was violated, analyses were stratified 
on the given variable. All statistical analyses were 
performed using the Stata software package 
(Stata Corporation, Texas, USA), version 10.1. 
 
Results. 
 
Our previous linkage and cohort selection 
resulted in 120,317 pregnancy records from a 
total of 78,294 women (see previous publication 
for details of selection process4). From this group, 
we now excluded 45,580 records which were not 
first births and 7 records with a missing value for 
the primary exposure (number of prior 
miscarriages). This resulted in a dataset of 
74,730 first births, with data on number of 
previous miscarriages for the women and data on 
hospital admission or death of the parents 
between 1981 and 2006 with cardiovascular 
disease. The basic characteristics of the women 
are described in relation to the number of 
miscarriages experienced prior to the first birth 
(Table 1). Women experiencing previous 
miscarriages tended to be older, more likely to be 
married and were more likely to smoke. Linkage 
identified 51,729 fathers of these women and 
51,105 mothers of these women (some mothers 
had daughters in the cohort who had different 
fathers). Among the fathers, there were records 
for death or hospital admission for 5,345 IHD 
events, 1,454 CVD events and 288 VTE events. 
Among the mothers, there were records for death 
or hospital admission for 1,908 IHD events, 1000 
CVD events and 319 VTE events.  
 
 
 
 
 
Table 1. Summary of maternal characteristics (n=74,730). 
  Number of previous miscarriages  
  0 1 2 3 or more  
  n=66,934 n=6,671 n=901 n=224 *P= 
       
Age      
 Median (IQR), years  
20 (18-23) 21 (19-24) 22 (20-25) 23 (20-25) <0.001 
Marital status       
 Un-married 60 865 (90.9) 5 915 (88.7) 765 (84.9) 188 (83.9) <0.001 
 Married  
6 069 (9.1) 757 (11.4) 136 (15.1) 36 (16.1)  
Socio-economic deprivation category     
 1 (least deprived) 1,371 (2.0) 125 (1.9) 25 (2.8) 0 (0.0) 0.03 
 2 5,342 (8.0) 546 (8.2) 68 (7.6) 13 (5.8)  
 3 11,569 (17.3) 1,088 (16.3) 135 (15.0) 36 (16.1)  
 4 18,060 (27.0) 1,795 (26.9) 230 (25.5) 69 (30.8)  
 5 13,742 (20.5) 1,420 (21.3) 208 (23.1) 47 (21.0)  
 6 9,615 (14.4) 972 (14.6) 123 (13.7) 24 (10.7)  
 7 (most deprived)  
7,235 (10.8) 725 (10.9) 112 (12.4) 35 (15.6)  
Height      
 Median  (IQR), cm 
163  
(158-167) 
163  
(159-167) 
163  
(159-167) 
162  
(158-167) 
0.75 
  Missing, n (%)  
13 375 (20.0) 1 351 (20.3) 196 (21.8) 59 (26.3)  
Smoking status      
 Non smoker 29,653 (44.3) 2,611 (39.1) 340 (37.7) 74 (33.0) <0.001 
 Smoker 24,182 (36.1) 2,796 (41.9) 368 (40.8) 107 (47.8)  
 Ex-Smoker 8,237 (12.3) 787 (11.8) 116 (12.9) 18 (8.0)  
 Missing  
4,862 (7.3) 477 (7.2) 77 (8.6) 25 (11.2)  
 
Data are n (%) unless stated otherwise. IQR denotes inter-quartile range 
*Kruskal-Wallis test or Chi square test for trend, as appropriate 
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The risk of each type of event in the parents was 
then analyzed using a Cox proportional hazard 
model, with the daughters’ experience of 
miscarriage prior to the first birth as the main 
exposure. Univariate analysis demonstrated that 
there was a significant relationship between the 
number of miscarriages experienced prior to the 
women’s first births and the incidence of IHD in 
their parents (Table 2). There was a 25% 
increase in risk among parents of women with 2 
previous losses and a 56% increase in risk 
among parents of women with 3 or more losses. 
Associations were adjusted for the other 
characteristics of the women at the time of the 
first birth. Adjustment for the maternal 
characteristics at the time of the first birth was 
without material effect. The specificity of 
relationships was examined by comparison with 
associations with the daughters’ experience of 
therapeutic abortions prior to the first birth. There 
was no independent and statistically significant 
association between the number of previous 
therapeutic abortions and the incidence of IHD in 
the women’s parents. There was no significant 
relationship between the number of miscarriages 
experienced prior to the first birth and the risk of 
CVD (Table 3) or VTE (Table 4) in the women’s 
parents. 
 
Table 2. Early pregnancy losses prior to first singleton livebirth and parental risk of ischaemic heart disease 
  Death or hospital admission of parents due to IHD 
  Unadjusted  Adjusted* 
  HR (95% CI) P=  HR (95% CI) P= 
Miscarriages      
 0 1.00   1.00  
 1 1.02 (0.94, 1.10) 0.004  1.04 (0.96, 1.12) 0.002 
 2 1.25 (1.04, 1.49)   1.29 (1.08, 1.55)  
 3 or more 1.56 (1.14, 2.15)   1.53 (1.11, 2.11)  
       
 Per miscarriage increase 1.08 (1.02, 1.14) 0.004  1.09 (1.03, 1.15) 0.001 
       
Therapeutic abortions      
 0 1.00   1.00  
 1 0.91 (0.84, 0.99) 0.10  0.96 (0.88, 1.04) 0.59 
 2 0.84 (0.65, 1.09)   0.91 (0.70, 1.18)  
 3 or more 1.15 (0.65, 2.01)   1.21 (0.68, 2.14)  
       
 Per abortion increase 0.93 (0.87, 1.00) 0.047  0.97 (0.90, 1.04) 0.40 
*Adjusted for maternal age in years, marital status, smoking status, socio-economic deprivation category 
and height and stratified by quintile of maternal age.  
IHD denotes ischaemic heart disease, HR denotes hazard ratio, CI denotes confidence intervals 
 
 
Table 3. Early pregnancy losses prior to first singleton livebirth and parental risk of cerebro-vascular disease 
  Death or hospital admission of parents due to CVD 
  Unadjusted  Adjusted* 
  HR (95% CI) P=  HR (95% CI) P= 
Miscarriages      
 0 1.00   1.00  
 1 1.05 (0.92, 1.19) 0.83  1.07 (0.94, 1.22) 0.57 
 2 1.10 (0.80, 1.53)   1.17 (0.84, 1.62)  
 3 or more 0.93 (0.52, 1.90)   0.94 (0.47, 1.87)  
       
 Per miscarriage increase 1.03 (0.94, 1.12) 0.54  1.05 (0.96, 1.15) 0.31 
       
Therapeutic abortions      
 0 1.00   1.00  
 1 0.94 (0.82, 1.09) 0.87  1.00 (0.87, 1.16) 0.97 
 2 0.99 (0.66, 1.50)   1.11 (0.73, 1.68)  
 3 or more 0.82 (0.26, 2.56)   0.94 (0.30, 2.94)  
       
 Per abortion increase 0.96 (0.85, 1.07) 0.43  1.01 (0.90, 1.13) 0.87 
*Adjusted for maternal age in years, marital status, smoking status, socio-economic deprivation category 
and height and stratified by quintile of maternal age 
CVD denotes cerebro-vascular disease, HR denotes hazard ratio, CI denotes confidence intervals 
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Table 4. Early pregnancy losses prior to first singleton livebirth and parental risk of venous thrombo-
embolism  
  Death or hospital admission of parents due to VTE 
  Unadjusted  Adjusted* 
  HR (95% CI) P=  HR (95% CI) P= 
Miscarriages      
 0 1.00   1.00  
 1 0.74 (0.55, 1.00) 0.14  0.76 (0.56, 1.03) 0.19 
 More than 1 1.03 (0.57, 1.87)   1.07 (0.59, 1.95)  
 
 Per miscarriage increase      
  1.03 (0.94, 1.12) 0.54  1.05 (0.96, 1.14) 0.28 
       
Therapeutic abortions      
 0 1.00   1.00  
 1 1.00 (0.75, 1.34) 0.99  1.05 (0.79, 1.41) 0.94 
 More than 1 0.93 (0.42, 2.08)   1.05 (0.47, 2.36)  
       
 Per abortion increase 0.99 (0.79, 1.24) 0.91  1.04 (0.83, 1.30) 0.73 
*Adjusted for maternal age in years, marital status, smoking status, socio-economic deprivation category 
and height and stratified by quintile of maternal age 
VTE denotes venous thrombo-embolism, HR denotes hazard ratio, CI denotes confidence intervals 
 
 
 
Discussion 
 
The main finding of the present study is that there 
was an increased incidence of IHD in the parents 
of women who experienced multiple miscarriages 
prior to their first birth. There was evidence of a 
“dose-dependent” relationship with a 25% 
increased risk in the parents of women 
experiencing 2 losses and a 56% increase in the 
parents of women experiencing 3 or more losses. 
The association did not appear to be explained 
by a confounding effect of the women’s age, 
marital status, smoking status, socio-economic 
deprivation or height, as adjustment for these 
factors had no material effect. Neither was there 
an association between therapeutic abortion and 
the risk of any type of cardiovascular disease in 
the women’s parents. We interpret these data as 
supporting the hypothesis that there may be 
common inheritable risk factors for both 
miscarriage and IHD. 
 
Many studies have demonstrated that women 
who experience complications during pregnancy, 
such as pre-eclampsia, preterm birth and intra-
uterine growth restriction, are at increased risk of 
developing cardiovascular disease in later life.8-11 
We have interpreted these observations as 
indicating that there are common predisposing 
factors for pregnancy complications and 
cardiovascular disease, stating “that occult 
cardiovascular, microvascular, or hemostatic 
dysfunction is manifested in pregnancy 
complications during reproductive years and in 
overt cardiovascular disease in later life”.12 We 
recently reported the relationship between late 
pregnancy complications and family history of 
cardiovascular disease. We demonstrated that 
the parents of women who experienced pre-
eclampsia, preterm birth or delivery of a small for 
gestational age infant during pregnancy had an 
increased incidence of cardiovascular disease.4 
However, a significant proportion of the 
associations was lost following statistical 
adjustment for the characteristics of the women 
at the time of the pregnancy (age, marital status, 
smoking status, socio-economic deprivation and 
height).4 We concluded that there were common 
risk factors for late complications of pregnancy 
and cardiovascular disease which demonstrated 
familial aggregation. The attenuation of the 
association in multivariate analysis led us to 
conclude that these were, in whole or in part, 
environmental in nature. In contrast, in the 
present analysis, adjustment for the same series 
of maternal characteristics had no material effect 
on the association between miscarriage and 
family history of IHD. Hence, we hypothesize that 
the most plausible explanation for the association 
between recurrent miscarriage and family history 
of IHD is the existence of common genetic or 
epigenetic risk factors for both conditions. Further 
research should address whether women with a 
history of recurrent miscarriage have higher rates 
of carriage of known genetic predisposing risk 
factors for IHD. Studies should also address 
whether they differ in relation to other risk factors, 
such as hypertension, insulin resistance, 
dyslipidaemia, elevated high sensitivity C reactive 
protein and vascular dysfunction, including 
endothelial dysfunction. It is possible that a 
history of recurrent miscarriage may be clinically 
useful in identifying women who would benefit 
from screening for cardiovascular risk factors. 
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The lack of association between women’s 
recurrent miscarriage and her parents’ 
experience of VTE is consistent with other recent 
evidence. A number of studies have suggested 
that there are associations between inherited and 
acquired thrombophilia and recurrent 
miscarriage.13 However, two recent large-scale 
studies failed to demonstrated beneficial effects 
of anti-coagulant treatment on pregnancy 
outcome among women with recurrent 
miscarriage.14;15 These observations suggest 
that, in a significant proportion of women, 
recurrent miscarriage is not related to a pro-
thrombotic tendency and the current data are 
consistent with this view. An important caveat to 
this interpretation is that there were fewer VTE 
events than IHD. Consequently, the confidence 
intervals for the associations are also consistent 
with an association between recurrent losses and 
family history of VTE of up to a 14% increase per 
previous miscarriage (Table 4). Similarly, the 
association with CVD had confidence intervals 
which were consistent with a comparable 
relationship to IHD and the negative result should 
not be interpreted as excluding a significant 
association. 
 
In the present analysis, we used a Cox 
proportional hazards model, with age as the time 
scale, to quantify variation in the incidence of 
cardiovascular disease in the women’s parents. 
This approach may be counterintuitive, as events 
in the parents could have either preceded or 
followed the experience of miscarriages in the 
daughters. Moreover, it may seem more intuitive 
to study miscarriage as the “event” with family 
history of IHD as the exposure. However, all 
measures of familial association have 
weaknesses16 and the approach we employed 
had two major strengths. First, the analysis of 
family history of heart disease was limited to the 
parents. The experience of heart disease in first 
degree relatives will depend on the number of 
siblings. If there are inheritable predispositions to 
miscarriage, it is possible that the number of 
siblings a woman has would vary according to 
her propensity to experience miscarriage. By 
confining analysis to the parents, we overcame 
this possible source of bias. Second, women who 
are older are more likely to have older parents. 
The older the parents, the more likely they are to 
have experienced disease. Women who 
experienced multiple miscarriages were older 
than those who had not (Table 1). These 
characteristics could, therefore, lead to an 
association between miscarriage and IHD 
through confounding by age. However, by 
modelling IHD in the parents using a Cox model 
with age as the time scale, we were able to 
compare the incidence of IHD independently of 
variation in the parental age. A more 
conventional indicator of family history of IHD is 
self-reported history of IHD in a first-degree 
relative. However, if we had used such a 
measure in the present analysis, the results 
would have been vulnerable to biases related to 
systematic variation in the number of siblings and 
the age of the women’s parents in relation to the 
primary exposure. Hence, although the current 
approach to assessing family history is different 
from many previous studies, the method 
employed addressed two important potential 
sources of bias. 
 
The strengths of the present analysis are that we 
were able to study a large number of women and 
were able to compare associations between 
previous miscarriage and therapeutic abortion. 
Moreover, all definitions were obtained from 
registries, hence these were not open to bias 
through selective recall, as could occur in a case 
control study. However, our study also has a 
number of weaknesses. The association was 
relatively modest with an approximate 50% 
increase in the incidence of IHD in the women’s 
parents. However, the current study was the 
result of a previously stated hypothesis3 and the 
P value for the multivariate analysis was 0.001. 
Hence, it is very unlikely to be a chance finding. 
The SMR02 lacked data on the gestational age of 
previous miscarriage. Hence, we were unable to 
determine whether the associations were related 
to first trimester losses, second trimester losses, 
or both. Furthermore, due to the constraints of 
the data, we only addressed losses prior to a first 
pregnancy. Hence, we do not have direct 
information on women who had losses but no 
births. Neither do we present information on the 
association between total number of losses in a 
woman’s life history. Registry based analysis 
relies on correct coding of both exposures and 
definitions. Hence, we do not have access to 
information that allows confirmation of either, 
such as cotinine assay for smoking status or the 
results of diagnostic tests for the parental 
experience of disease. Similarly, we lack 
information on specific causes of recurrent 
miscarriage, such as balanced chromosomal 
translocation in the parents, or diagnosis of 
antiphospholipid syndrome. Furthermore, as 
previously discussed in detail,4 the linkage 
process favoured matching records from younger 
and unmarried women. The current cohort is 
neither a random nor representative sample of 
the Scottish population. Nevertheless, we have 
addressed an important question for the first time 
using a large scale dataset and the results 
suggest a significant association. Moreover, a 
previous analyses relating birth weight, pre-
eclampsia and preterm birth to the mother’s 
subsequent risk of cardiovascular disease using 
the same data sources8 has been replicated in 
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multiple subsequent studies in many different 
countries.9-11  
 
In conclusion, we found that there was an 
increased incidence of IHD in the parents of 
women who experienced multiple miscarriages 
prior to their first birth. We hypothesize that there 
are common pathophysiological pathways linking 
IHD and recurrent miscarriage. This hypothesis 
makes the prediction that genetic risk factors for 
IHD will also be associated with an increased risk 
of recurrent miscarriage. 
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